Citrus Sinensis ID: 046106

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300---
Protein Sequence
MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP
Secondary Structure (PSIPRED)
cccccccccEEEccccccccccccHHHHHcccccccccccccccccccccccccEEEEccccccccccHHHHcccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEcccccccccEEEEccccEEEEEEEcccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccccEEEEEEEEEccccEEEEEEccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEEccccEEEcccccHHcccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccEEEEEEEccccccccccccEEEEEccccccEEEEEEcccccccccccEEEEEccEEEEEEEEEEEEEEEEcccccccccccccHHHHHcccccccccccccHHHHHHHHccccccccccccccccEEEccccccEEEEEEcccccccccccccHHHHHHHHHHHHHHHHcccHHEEEEEEEccccEEEEEccccccEHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEEHHHEEEEccccHHHHcccccEEcccEEEcccccc
Coil and Loop (DISEMBL)
meggskfpgiiglnnhvnnyddlsqgfyhklgegtnmsidsfsslqtsngggsvamsvdnssvgsneshtRILNhqglrrrandnysvahsvnrrgrvshalSDDALARALmdsnspteglenfdEWTIDLRKlnmgdafaqgafgklyrgtyngEEVAIKILerpendpeKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEyakggsvrqFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIhrdlksdnllifsdksikiADFGVARIEvqtegmtpetgtyrwmap
Flexible Loop (DISEMBL)
meggskfpGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRilnhqglrrraNDNYSVahsvnrrgrvshALSDDALARALmdsnsptegleNFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAkggsvrqfltkrqnrsvplkLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARievqtegmtpetgtyrwmap
Low Complexity Region (SEG)
MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAqvmeqqfqqevmmLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP
Disordered region (IsUnstruct)
*******PGIIGLNNHVNNYDDLSQGFYHKLG****************************************************************************************LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKIL*****************QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE**************
Disordered Region (DISOPRED)
************LNNHVNNYDDLSQ****************************************************************************************************EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPEN**EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP
Disordered Region (DISEMBL)
MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVD**********TRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP
Disordered Region (DISPRO)
*****KFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG**********LAR***DSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERP*******QVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	303	2.2.26 [Sep-21-2011]
Q2MHE4	390	Serine/threonine-protein	no	no	0.590	0.458	0.469	3e-47
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.580	0.106	0.375	2e-33
Q55GU0	916	Probable serine/threonine	yes	no	0.603	0.199	0.358	1e-30
Q66L42	940	Mitogen-activated protein	yes	no	0.554	0.178	0.417	2e-30
Q02779	954	Mitogen-activated protein	yes	no	0.554	0.176	0.417	6e-30
Q54TM7	1288	Probable serine/threonine	no	no	0.561	0.131	0.390	4e-29
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.577	0.107	0.329	9e-29
Q3U1V8	1077	Mitogen-activated protein	no	no	0.557	0.156	0.397	9e-29
Q7T2V3	1005	Mitogen-activated protein	N/A	no	0.554	0.167	0.379	1e-28
P80192	1104	Mitogen-activated protein	no	no	0.557	0.153	0.397	2e-28

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  189 bits (479), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 84/179 (46%), Positives = 123/179 (68%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEV 184
           +EWT DL +L +G+ FA GA  ++YRG Y    VA+K++  P +  E    +EQQF+ EV
Sbjct: 77  EEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEV 136

Query: 185 MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
            +L+ L HPNIV+FI AC+KP V+CI+TEY   G++R +L K++  S+ ++  ++ ALD+
Sbjct: 137 ALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDI 196

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +RGM Y+H  G+IHRDLKS+NLL+  +  +K+ADFG + +E Q        GTYRWMAP
Sbjct: 197 SRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAP 255

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  142 bits (359), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 68/181 (37%), Positives = 108/181 (59%), Gaps = 5/181 (2%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEV 184
           D+W ID  +L +G+    GAFG++++GT+ G EVA+K++     D    + +E+ F+ EV
Sbjct: 777 DDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISP---DKTITKDIERNFKDEV 833

Query: 185 MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
            ++ TL+HPN+V F+ A  KP   CIV E+   GS+   L       +P  L VK A   
Sbjct: 834 RVMTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLLKNELIPDIPFALKVKIAYQA 893

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMA 302
           ++GM ++H  G+ HRDLKS NLL+    ++K++DFG+ + +   + + PE   GT +W A
Sbjct: 894 SKGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQWTA 953

Query: 303 P 303
           P
Sbjct: 954 P 954

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  134 bits (336), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 67/187 (35%), Positives = 115/187 (61%), Gaps = 4/187 (2%)

Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVM 176
           P++  + F +  I   +L +     +G FG +Y+G + G  VAIK ++   N+    QV+
Sbjct: 645 PSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI--NEDVNNQVL 702

Query: 177 EQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
           E+ F++E+ +L+ L+HPNIV  + AC  P   C +TEY  GGS+   L  ++ + + ++L
Sbjct: 703 EE-FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQL 760

Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
             K A+ +A+GM Y+H  G+IHRD+KS NLL+    ++KI DFG+++++ ++  MT   G
Sbjct: 761 YKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIG 820

Query: 297 TYRWMAP 303
           +  WM+P
Sbjct: 821 SPIWMSP 827

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2

 Score =  133 bits (334), Expect = 2e-30,   Method: Composition-based stats.
 Identities = 78/187 (41%), Positives = 106/187 (56%), Gaps = 19/187 (10%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILE-RPENDPEKAQVMEQQFQQEVMML 187
           I   +L + +    G FGK+YR  + GEEVA+K     PE DP    V  +Q +QE  + 
Sbjct: 93  IPFHELQLEEIIGVGGFGKVYRAVWRGEEVAVKAARLDPERDP---AVTAEQVRQEARLF 149

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L+HPNI+   GAC  P   C+V EYA+GG++ + L  R+   VP  + V  A+ VARG
Sbjct: 150 GALQHPNIIALRGACLSPPNLCLVMEYARGGALSRVLAGRR---VPPHVLVNWAVQVARG 206

Query: 248 MAYVHR---LGLIHRDLKSDNLLI--------FSDKSIKIADFGVARIEVQTEGMTPETG 296
           M Y+H    + +IHRDLKS N+LI         +D  +KI DFG+AR   +T  M+   G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMSA-AG 265

Query: 297 TYRWMAP 303
           TY WMAP
Sbjct: 266 TYAWMAP 272

Activates the JUN N-terminal pathway.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q02779|M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3

 Score =  131 bits (329), Expect = 6e-30,   Method: Composition-based stats.
 Identities = 78/187 (41%), Positives = 105/187 (56%), Gaps = 19/187 (10%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILE-RPENDPEKAQVMEQQFQQEVMML 187
           I   +L + +    G FGK+YR  + GEEVA+K     PE DP    V  +Q  QE  + 
Sbjct: 93  IPFHELQLEEIIGVGGFGKVYRALWRGEEVAVKAARLDPEKDP---AVTAEQVCQEARLF 149

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L+HPNI+   GAC  P   C+V EYA+GG++ + L  R+   VP  + V  A+ VARG
Sbjct: 150 GALQHPNIIALRGACLNPPHLCLVMEYARGGALSRVLAGRR---VPPHVLVNWAVQVARG 206

Query: 248 MAYVHR---LGLIHRDLKSDNLLI--------FSDKSIKIADFGVARIEVQTEGMTPETG 296
           M Y+H    + +IHRDLKS N+LI         +D  +KI DFG+AR   +T  M+   G
Sbjct: 207 MNYLHNDAPVPIIHRDLKSINILILEAIENHNLADTVLKITDFGLAREWHKTTKMSA-AG 265

Query: 297 TYRWMAP 303
           TY WMAP
Sbjct: 266 TYAWMAP 272

Activates the JUN N-terminal pathway.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  128 bits (322), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 71/182 (39%), Positives = 109/182 (59%), Gaps = 12/182 (6%)

Query: 126  EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM 185
            EW + L ++ +G    +G +G+++RG++ G EVA+K+L    ND    +++    ++EV 
Sbjct: 843  EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLF---NDNVNLKLISD-LRKEVD 898

Query: 186  MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK--LAVKQALD 243
            +L  L+HPNIV F+GAC +P   CIVTEY   GS+   L    + S+ +   L ++   D
Sbjct: 899  LLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILL---DESIEMDWGLRLQLGFD 955

Query: 244  VARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWM 301
             ARGM Y+H     +IHRDLK+DNLL+     +K+ADFG+A ++  T   T   GT  W+
Sbjct: 956  CARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKT-MCGTTGWV 1014

Query: 302  AP 303
            AP
Sbjct: 1015 AP 1016

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  127 bits (319), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 106/182 (58%), Gaps = 7/182 (3%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEV 184
           ++W ID  +L +G+    G +G++Y+  + G EVA+K++    +    ++ ME+ F +EV
Sbjct: 777 NDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLI----SSKHVSKDMERSFFEEV 832

Query: 185 MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
            ++ +L+HPN+V F+ A  K    CIV E+   GS+   L       +P  L +K A   
Sbjct: 833 KIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNELIPEIPYALKIKMAYQA 892

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE---TGTYRWM 301
           ++GM ++H  G++HRDLKS NLL+ S  ++K++DFG+ +++ + +         GT  W+
Sbjct: 893 SKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHWI 952

Query: 302 AP 303
           AP
Sbjct: 953 AP 954

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus GN=Map3k9 PE=2 SV=2

 Score =  127 bits (319), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 74/186 (39%), Positives = 109/186 (58%), Gaps = 17/186 (9%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLA 188
           ID  +L + +    G FGK+YR  + G+EVA+K   R + D + +Q +E   +QE  + A
Sbjct: 132 IDFAELTLEEIIGIGGFGKVYRAFWAGDEVAVKA-ARHDPDEDISQTIEN-VRQEAKLFA 189

Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
            LKHPNI+   G C K    C+V E+A+GG + + L+ ++   +P  + V  A+ +ARGM
Sbjct: 190 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGM 246

Query: 249 AYVHR---LGLIHRDLKSDNLLI--------FSDKSIKIADFGVARIEVQTEGMTPETGT 297
            Y+H    + +IHRDLKS N+LI         S+K +KI DFG+AR   +T  M+   GT
Sbjct: 247 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AAGT 305

Query: 298 YRWMAP 303
           Y WMAP
Sbjct: 306 YAWMAP 311

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q7T2V3|M3K10_XENLA Mitogen-activated protein kinase kinase kinase 10 OS=Xenopus laevis GN=map3k10 PE=1 SV=1

 Score =  127 bits (319), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 71/187 (37%), Positives = 104/187 (55%), Gaps = 19/187 (10%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDP-EKAQVMEQQFQQEVMML 187
           I+  +LN+ +    G FGK+Y+G +  EEVA+K +    +DP E   V  +  +QE  + 
Sbjct: 113 IEFDELNLDEIIGVGGFGKVYKGLWRDEEVAVKAVR---HDPDEDINVTAENVRQEAKIF 169

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L HPNI+   G C KP   C+V EYA+GG + + L     + VP  + V  A+ +A+G
Sbjct: 170 CMLCHPNIIALTGVCLKPPHLCLVMEYARGGPLHRALA---GKKVPAHVLVNWAVQIAKG 226

Query: 248 MAYVHR---LGLIHRDLKSDNLLIFS--------DKSIKIADFGVARIEVQTEGMTPETG 296
           M Y+H    + +IHRDL S N+LI          +K++ I DFG+AR   +T  M+   G
Sbjct: 227 MTYLHNEAIVPIIHRDLGSSNILILEKAENDDLFNKTLNITDFGLAREWQKTTKMS-AAG 285

Query: 297 TYRWMAP 303
           TY WMAP
Sbjct: 286 TYAWMAP 292

Activates the JUN N-terminal pathway. Essential for pronephros and cement gland development.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P80192|M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3

 Score =  126 bits (317), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/186 (39%), Positives = 109/186 (58%), Gaps = 17/186 (9%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLA 188
           ID  +L + +    G FGK+YR  + G+EVA+K   R + D + +Q +E   +QE  + A
Sbjct: 139 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKLFA 196

Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
            LKHPNI+   G C K    C+V E+A+GG + + L+ ++   +P  + V  A+ +ARGM
Sbjct: 197 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGM 253

Query: 249 AYVHR---LGLIHRDLKSDNLLI--------FSDKSIKIADFGVARIEVQTEGMTPETGT 297
            Y+H    + +IHRDLKS N+LI         S+K +KI DFG+AR   +T  M+   GT
Sbjct: 254 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AAGT 312

Query: 298 YRWMAP 303
           Y WMAP
Sbjct: 313 YAWMAP 318

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade through the phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7 which in turn activate the JNKs. The MKK/JNK signaling pathway regulates stress response via activator protein-1 (JUN) and GATA4 transcription factors. Plays also a role in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	303
356523838	416	PREDICTED: serine/threonine-protein kina	1.0	0.728	0.904	1e-162
356513245	416	PREDICTED: serine/threonine-protein kina	1.0	0.728	0.894	1e-160
449470281	413	PREDICTED: serine/threonine-protein kina	0.990	0.726	0.867	1e-156
13124865	411	serine/threonine/tyrosine kinase [Arachi	0.990	0.729	0.888	1e-155
388511373	412	unknown [Lotus japonicus]	0.986	0.725	0.881	1e-153
225445686	526	PREDICTED: serine/threonine-protein kina	0.983	0.566	0.874	1e-150
118488096	419	unknown [Populus trichocarpa]	0.990	0.715	0.816	1e-141
224115648	415	predicted protein [Populus trichocarpa]	0.990	0.722	0.816	1e-140
224121260	415	predicted protein [Populus trichocarpa]	0.990	0.722	0.816	1e-140
225429872	417	PREDICTED: serine/threonine-protein kina	0.933	0.678	0.833	1e-137

>gi|356523838|ref|XP_003530541.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max]

 Score =  576 bits (1485), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 274/303 (90%), Positives = 289/303 (95%)

Query: 1   MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDN 60
           +EGG+KFPGII LN + NNY D SQGFYHKLGEGTNMSIDS  SLQTSNGGGSVAMS+DN
Sbjct: 2   LEGGAKFPGIIDLNKNNNNYYDFSQGFYHKLGEGTNMSIDSVGSLQTSNGGGSVAMSIDN 61

Query: 61  SSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEG 120
           SSVGSN+SHTR+L+HQGLRRRANDNYSVAHS NRRGRV+HALSDDALA+ALMD++SPTEG
Sbjct: 62  SSVGSNDSHTRMLDHQGLRRRANDNYSVAHSANRRGRVTHALSDDALAQALMDNSSPTEG 121

Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQF 180
           L+NFDEWTIDLRKLNMG+ FAQGAFGKLYRGTYNGE+VAIKILERPENDP KAQ+MEQQF
Sbjct: 122 LDNFDEWTIDLRKLNMGEPFAQGAFGKLYRGTYNGEDVAIKILERPENDPAKAQLMEQQF 181

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
           QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL KRQNRSVPLKLAVKQ
Sbjct: 182 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLMKRQNRSVPLKLAVKQ 241

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           ALDVARGMAYVH L LIHRDLKSDNLLIF DKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 242 ALDVARGMAYVHGLLLIHRDLKSDNLLIFGDKSIKIADFGVARIEVQTEGMTPETGTYRW 301

Query: 301 MAP 303
           MAP
Sbjct: 302 MAP 304

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513245|ref|XP_003525324.1| PREDICTED: serine/threonine-protein kinase HT1-like isoform 1 [Glycine max] gi|356513247|ref|XP_003525325.1| PREDICTED: serine/threonine-protein kinase HT1-like isoform 2 [Glycine max]

 Score =  570 bits (1468), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 271/303 (89%), Positives = 286/303 (94%)

Query: 1   MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDN 60
           +E G+KFPGII LN + NNY D SQGFYHKLGEGTNMSIDS  SLQTSNGGGSVAMS+DN
Sbjct: 2   LESGAKFPGIIDLNKNNNNYYDFSQGFYHKLGEGTNMSIDSVGSLQTSNGGGSVAMSIDN 61

Query: 61  SSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEG 120
           SSVGSN+SHTR+L+HQGLRRRANDNYSVAHS NRRGRV+HALSDDALA+ALMD++SPTEG
Sbjct: 62  SSVGSNDSHTRMLDHQGLRRRANDNYSVAHSANRRGRVTHALSDDALAQALMDNSSPTEG 121

Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQF 180
           L+NFDEWTIDLRKLNMG+ FAQGAFGKLYRGTYNGE+VAIKILERPENDP KAQ+MEQQF
Sbjct: 122 LDNFDEWTIDLRKLNMGEPFAQGAFGKLYRGTYNGEDVAIKILERPENDPAKAQLMEQQF 181

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
           QQEV MLATLKH NIVRFIGACRKPMVWCIVTEYAKGGSVRQFL KRQNRSVPLKLAVKQ
Sbjct: 182 QQEVTMLATLKHSNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLMKRQNRSVPLKLAVKQ 241

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           ALDVARGMAYVH LG IHRDLKSDNLLIF DKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 242 ALDVARGMAYVHGLGFIHRDLKSDNLLIFGDKSIKIADFGVARIEVQTEGMTPETGTYRW 301

Query: 301 MAP 303
           MAP
Sbjct: 302 MAP 304

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449470281|ref|XP_004152846.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449527925|ref|XP_004170958.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus]

 Score =  555 bits (1430), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 263/303 (86%), Positives = 285/303 (94%), Gaps = 3/303 (0%)

Query: 1   MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDN 60
           +EGG KFPG+I LN H     DLSQGFYHKLGEGTNMSIDSF+SLQTSN GGSVAMS+DN
Sbjct: 2   LEGGQKFPGMIDLNEHAY---DLSQGFYHKLGEGTNMSIDSFASLQTSNDGGSVAMSLDN 58

Query: 61  SSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEG 120
           SSVGSNESHTRILNHQGLRRRANDN++  HSVNRRGRV+H LSDDALARAL DSN+PT+G
Sbjct: 59  SSVGSNESHTRILNHQGLRRRANDNHTFQHSVNRRGRVTHHLSDDALARALFDSNTPTQG 118

Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQF 180
           LENF++WT+DLRKLNMG+AFAQGAFGKLYRGTY+GE+VAIKILERPEND EKAQ+MEQQ+
Sbjct: 119 LENFEKWTLDLRKLNMGEAFAQGAFGKLYRGTYDGEDVAIKILERPENDLEKAQLMEQQY 178

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
           QQEVMMLATLKHPNIVRFIG+C KPMVWCIVTEYAKGGSVRQFL +RQ+RSVPLKLAVKQ
Sbjct: 179 QQEVMMLATLKHPNIVRFIGSCHKPMVWCIVTEYAKGGSVRQFLMRRQSRSVPLKLAVKQ 238

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           ALDVARGM YVH LGLIHRDLKSDNLLIF+DKSIK+ADFGVARIEVQTEGMTPETGTYRW
Sbjct: 239 ALDVARGMEYVHGLGLIHRDLKSDNLLIFADKSIKVADFGVARIEVQTEGMTPETGTYRW 298

Query: 301 MAP 303
           MAP
Sbjct: 299 MAP 301

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|13124865|gb|AAK11734.1| serine/threonine/tyrosine kinase [Arachis hypogaea]

 Score =  555 bits (1429), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 270/304 (88%), Positives = 285/304 (93%), Gaps = 4/304 (1%)

Query: 1   MEGGSKFPGIIGLNNHV-NNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVD 59
           +EGG+KFPG+I LN H  +NY D SQGFYHKLGEGTNMSIDS   +QTSNGGGSVAMS+D
Sbjct: 2   LEGGAKFPGLIDLNKHTTDNYYDFSQGFYHKLGEGTNMSIDS---MQTSNGGGSVAMSID 58

Query: 60  NSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTE 119
           NSSVGSN+SHTRILNHQGLRRRANDNYSV +SVNRRGRV+HALSDDALA+ALMDS+SPTE
Sbjct: 59  NSSVGSNDSHTRILNHQGLRRRANDNYSVQNSVNRRGRVTHALSDDALAQALMDSSSPTE 118

Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQ 179
           GLENFDEWTIDLRKLNMG+AFAQGAFGKLYRGTYNGE+VAIKILERPEN+  KAQ+MEQQ
Sbjct: 119 GLENFDEWTIDLRKLNMGEAFAQGAFGKLYRGTYNGEDVAIKILERPENELSKAQLMEQQ 178

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
           FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQ L KRQNRSVPLKLAVK
Sbjct: 179 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQSLMKRQNRSVPLKLAVK 238

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR 299
           QALDVARGMAYV  LGLIHRDLKSDNLLIF  KSIKIADFGVA IEVQTEGMTPETGTYR
Sbjct: 239 QALDVARGMAYVPWLGLIHRDLKSDNLLIFGAKSIKIADFGVAGIEVQTEGMTPETGTYR 298

Query: 300 WMAP 303
           WMAP
Sbjct: 299 WMAP 302

Source: Arachis hypogaea

Species: Arachis hypogaea

Genus: Arachis

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388511373|gb|AFK43748.1| unknown [Lotus japonicus]

 Score =  546 bits (1406), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 267/303 (88%), Positives = 280/303 (92%), Gaps = 4/303 (1%)

Query: 1   MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDN 60
           +EGG+KFPG+I LN   NN  D SQGFYHKL E TNMSIDS   LQTSNGGGSVAMSVDN
Sbjct: 2   LEGGAKFPGMIDLNKTNNNIYDFSQGFYHKL-EDTNMSIDS---LQTSNGGGSVAMSVDN 57

Query: 61  SSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEG 120
           SSVGSN+SHTRILNHQGL+R A+DNYSVAHSVN RGRV+HALS DALA+ALMDSNSPTEG
Sbjct: 58  SSVGSNDSHTRILNHQGLKRHAHDNYSVAHSVNHRGRVTHALSGDALAQALMDSNSPTEG 117

Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQF 180
           L+NF EWTIDLR L+MG+AFAQGAFGKLYRGTYN EEVAIKILERPEND  KAQ+MEQQF
Sbjct: 118 LDNFHEWTIDLRNLSMGEAFAQGAFGKLYRGTYNNEEVAIKILERPENDLAKAQLMEQQF 177

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
           QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL KRQNR+VPLKLAVKQ
Sbjct: 178 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLMKRQNRAVPLKLAVKQ 237

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           ALDVARGMAYVH LGLIHRDLKSDNLLIF DKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 238 ALDVARGMAYVHGLGLIHRDLKSDNLLIFGDKSIKIADFGVARIEVQTEGMTPETGTYRW 297

Query: 301 MAP 303
           MAP
Sbjct: 298 MAP 300

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225445686|ref|XP_002267305.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera]

 Score =  535 bits (1379), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 265/303 (87%), Positives = 279/303 (92%), Gaps = 5/303 (1%)

Query: 1   MEGGSKFPGIIGLNNHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDN 60
           M  G KF GIIG+NN  N YD LSQGFYHKLGEG+NMSI+S+ SLQTSNGGGSVAMSVDN
Sbjct: 117 MLEGPKFTGIIGMNN--NEYD-LSQGFYHKLGEGSNMSIESYGSLQTSNGGGSVAMSVDN 173

Query: 61  SSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEG 120
           SSVGSN+SHTRILNHQGLRR  N+NYSVA S N RGRVSH LSDDALA+ALMDS  PT G
Sbjct: 174 SSVGSNDSHTRILNHQGLRR-VNNNYSVAAS-NNRGRVSHGLSDDALAQALMDSRYPTLG 231

Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQF 180
           LENF+EWTIDL KLNMG+AFAQGAFGKLY+GTYNGE+VAIKILERPEND EKAQ+MEQQF
Sbjct: 232 LENFEEWTIDLGKLNMGEAFAQGAFGKLYKGTYNGEDVAIKILERPENDLEKAQLMEQQF 291

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
           QQEVMMLATLKH NIVRFIG CRKPMVWCIVTEYAKGGSVRQFLTKRQNR VPLKLA+KQ
Sbjct: 292 QQEVMMLATLKHTNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTKRQNRQVPLKLAIKQ 351

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           ALDVARGMAYVH LGLIHRDLKSDNLLIF+DKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct: 352 ALDVARGMAYVHGLGLIHRDLKSDNLLIFADKSIKIADFGVARIEVQTEGMTPETGTYRW 411

Query: 301 MAP 303
           MAP
Sbjct: 412 MAP 414

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|118488096|gb|ABK95868.1| unknown [Populus trichocarpa]

 Score =  505 bits (1301), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 250/306 (81%), Positives = 270/306 (88%), Gaps = 6/306 (1%)

Query: 1   MEGGSKFPGIIGLN-NHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVD 59
           M  G KF GIIG N N+ NNY D +QGFY KLGEGTNMSIDS   LQTSN GGSV+MSVD
Sbjct: 5   MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDS---LQTSNAGGSVSMSVD 61

Query: 60  NSSVGSNESHTRILNHQGLRRRANDNYSVA--HSVNRRGRVSHALSDDALARALMDSNSP 117
           NSSVGS++S T IL+H GL+   + NYSV+   SV R G+V+HAL+DDALA+ALMD   P
Sbjct: 62  NSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKYP 121

Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVME 177
           TEGL+N+DEWTIDLRKLNMG AFAQGAFGKLYRGTYNGE+VAIKILERPEN PEKAQ+ME
Sbjct: 122 TEGLQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLME 181

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
           QQFQQEVMMLA LKHPNIVRFIG CRKPMVWCIVTEYAKGGSVRQFLT+RQNR+VPLKLA
Sbjct: 182 QQFQQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 241

Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           VKQALDVARGMAYVH LG IHRDLKSDNLLI +DKSIKIADFGVARIEVQTEGMTPETGT
Sbjct: 242 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 301

Query: 298 YRWMAP 303
           YRWMAP
Sbjct: 302 YRWMAP 307

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115648|ref|XP_002332108.1| predicted protein [Populus trichocarpa] gi|222874928|gb|EEF12059.1| predicted protein [Populus trichocarpa]

 Score =  505 bits (1300), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 250/306 (81%), Positives = 269/306 (87%), Gaps = 6/306 (1%)

Query: 1   MEGGSKFPGIIGLN-NHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVD 59
           M  G KF GIIG N N+ NNY D +QGFY KLGEGTNMSIDS   LQTSN GGSV+MSVD
Sbjct: 1   MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDS---LQTSNAGGSVSMSVD 57

Query: 60  NSSVGSNESHTRILNHQGLRRRANDNYS--VAHSVNRRGRVSHALSDDALARALMDSNSP 117
           NSSVGS++S T IL+H GL+   + NYS     SV R G+V+HAL+DDALA+ALM+   P
Sbjct: 58  NSSVGSSDSLTHILSHPGLKPVNHHNYSGTAGQSVFRPGKVTHALNDDALAQALMNPKYP 117

Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVME 177
           TEGL+N+DEWTIDLRKLNMG AFAQGAFGKLYRGTYNGE+VAIKILERPEN PEKAQVME
Sbjct: 118 TEGLQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQVME 177

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
           QQFQQEVMMLA LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLT+RQNR+VPLKLA
Sbjct: 178 QQFQQEVMMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 237

Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           VKQALDVARGMAYVH LG IHRDLKSDNLLI +DKSIKIADFGVARIEVQTEGMTPETGT
Sbjct: 238 VKQALDVARGMAYVHALGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 297

Query: 298 YRWMAP 303
           YRWMAP
Sbjct: 298 YRWMAP 303

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121260|ref|XP_002330783.1| predicted protein [Populus trichocarpa] gi|222872585|gb|EEF09716.1| predicted protein [Populus trichocarpa]

 Score =  504 bits (1299), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 250/306 (81%), Positives = 270/306 (88%), Gaps = 6/306 (1%)

Query: 1   MEGGSKFPGIIGLN-NHVNNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVD 59
           M  G KF GIIG N N+ NNY D +QGFY KLGEGTNMSIDS   LQTSN GGSV+MSVD
Sbjct: 1   MVEGPKFTGIIGGNTNNENNYYDFTQGFYQKLGEGTNMSIDS---LQTSNAGGSVSMSVD 57

Query: 60  NSSVGSNESHTRILNHQGLRRRANDNYSVA--HSVNRRGRVSHALSDDALARALMDSNSP 117
           NSSVGS++S T IL+H GL+   + NYSV+   SV R G+V+HAL+DDALA+ALMD   P
Sbjct: 58  NSSVGSSDSLTHILSHPGLKPVNHHNYSVSVGQSVFRPGKVTHALNDDALAQALMDPKYP 117

Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVME 177
           TEGL+N+DEWTIDLRKLNMG AFAQGAFGKLYRGTYNGE+VAIKILERPEN PEKAQ+ME
Sbjct: 118 TEGLQNYDEWTIDLRKLNMGTAFAQGAFGKLYRGTYNGEDVAIKILERPENSPEKAQLME 177

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
           QQFQQEVMMLA LKHPNIVRFIG CRKPMVWCIVTEYAKGGSVRQFLT+RQNR+VPLKLA
Sbjct: 178 QQFQQEVMMLANLKHPNIVRFIGGCRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLA 237

Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           VKQALDVARGMAYVH LG IHRDLKSDNLLI +DKSIKIADFGVARIEVQTEGMTPETGT
Sbjct: 238 VKQALDVARGMAYVHGLGFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGT 297

Query: 298 YRWMAP 303
           YRWMAP
Sbjct: 298 YRWMAP 303

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225429872|ref|XP_002283465.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839316|emb|CAN72362.1| hypothetical protein VITISV_000134 [Vitis vinifera]

 Score =  494 bits (1272), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 240/288 (83%), Positives = 258/288 (89%), Gaps = 5/288 (1%)

Query: 18  NNYDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQG 77
           NNY D +QGFY KLGE +NMSIDS   LQTSN G SV+MSVDNSSVGSN+S T ILNH G
Sbjct: 21  NNYFDFTQGFYQKLGEDSNMSIDS---LQTSNAGLSVSMSVDNSSVGSNDSLTHILNHPG 77

Query: 78  LRRRANDNYSVAHSVNR--RGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLN 135
           L+  A  NYSV HSV R  +G+V+HAL++DALARALMD+  PTEGLEN+DEWTIDLRKLN
Sbjct: 78  LKPVATHNYSVGHSVLRPGKGKVTHALNEDALARALMDTRYPTEGLENYDEWTIDLRKLN 137

Query: 136 MGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           MG AFAQGAFGKLYRG YNG++VAIKILERPEN PE+AQVMEQQFQQEVMMLATLKHPNI
Sbjct: 138 MGTAFAQGAFGKLYRGEYNGDDVAIKILERPENSPERAQVMEQQFQQEVMMLATLKHPNI 197

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           VRFIGACRKP+ WCIVTEYAKGGSVRQFL +RQNRSVPLKLAVKQALDVARGMAYVH LG
Sbjct: 198 VRFIGACRKPLAWCIVTEYAKGGSVRQFLMRRQNRSVPLKLAVKQALDVARGMAYVHGLG 257

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            IHRDLKSDNLLI +DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP
Sbjct: 258 FIHRDLKSDNLLIAADKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 305

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	303
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.966	0.712	0.722	4.8e-110
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.943	0.694	0.716	1.4e-105
TAIR|locus:2077244	391	ATMRK1 [Arabidopsis thaliana (	0.313	0.242	0.489	1.5e-39
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.584	0.307	0.465	7.8e-39
TAIR|locus:2091423	356	ATN1 [Arabidopsis thaliana (ta	0.603	0.514	0.451	3.4e-38
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.660	0.380	0.381	1.9e-37
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.848	0.450	0.364	6.3e-37
TAIR|locus:2157717	346	AT5G50180 [Arabidopsis thalian	0.580	0.508	0.458	6.3e-37
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.640	0.355	0.421	1e-36
TAIR|locus:2168778	353	AT5G40540 [Arabidopsis thalian	0.580	0.498	0.441	1e-36

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 1087 (387.7 bits), Expect = 4.8e-110, P = 4.8e-110
 Identities = 219/303 (72%), Positives = 247/303 (81%)

Query:     4 GSKFPGIIGLNNHVNN---YDDLSQGFYHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDN 60
             G+KF  ++ + NH NN   Y   +Q FY KL EG+NMS++S   +QTSN GGSV+MSVDN
Sbjct:     4 GAKF-NVLAVGNHHNNDNNYYAFTQEFYQKLNEGSNMSMES---MQTSNAGGSVSMSVDN 59

Query:    61 SSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEG 120
             SSVGS+++   ++ H GL+   + + SV  SV R GRV+HAL+DDALA+ALMD+  PTEG
Sbjct:    60 SSVGSSDA---LIGHPGLKPVRHYSLSVGQSVFRPGRVTHALNDDALAQALMDTRYPTEG 116

Query:   121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXX 180
             L N+DEWTIDLRKLNMG AFAQGAFGKLY+GTYNGE+VAIKILERPEN PEKA       
Sbjct:   117 LTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQF 176

Query:   181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                   LA LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLT+RQNR+VPLKLAVKQ
Sbjct:   177 QQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQ 236

Query:   241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
             ALDVARGMAYVH    IHRDLKSDNLLI +DKSIKIADFGVARIEVQTEGMTPETGTYRW
Sbjct:   237 ALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRW 296

Query:   301 MAP 303
             MAP
Sbjct:   297 MAP 299

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
 Identities = 212/296 (71%), Positives = 243/296 (82%)

Query:    11 IGLNNHVNNYDDLSQGFYHKLGE-GTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESH 69
             +G +N+ NNY   +Q FY KLGE GTNMS+DS   +QTSN GGSV+MSVDNSSVGS+++ 
Sbjct:    12 VGNHNNDNNYYAFTQDFYQKLGEEGTNMSVDS---MQTSNAGGSVSMSVDNSSVGSSDA- 67

Query:    70 TRILNHQGLRRRANDNYSVA--HSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEW 127
               ++ H GL+   +  YS++   SV R G+V+HAL+DDALA+ALMDS  PTEGL N++EW
Sbjct:    68 --LIGHPGLKPMRHP-YSLSDGQSVFRPGKVTHALNDDALAQALMDSKYPTEGLVNYEEW 124

Query:   128 TIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
             TIDLRKL+MG AFAQGAFGKLYRGTYNGE+VAIK+LER +++PEKA             L
Sbjct:   125 TIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVSML 184

Query:   188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             A LKHPNIVRFIGAC KPMVWCIVTEYAKGGSVRQFLTKRQNR+VPLKLAV QALDVARG
Sbjct:   185 AFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARG 244

Query:   248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             MAYVH    IHRDLKSDNLLI +D+SIKIADFGVARIEVQTEGMTPETGTYRWMAP
Sbjct:   245 MAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRWMAP 300

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)]

 Score = 265 (98.3 bits), Expect = 1.5e-39, Sum P(2) = 1.5e-39
 Identities = 47/96 (48%), Positives = 73/96 (76%)

Query:   209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI 268
             C+V EY  GG++++FL K+    +P+K  ++ ALD+ARG++Y+H   ++HRD+KS+N+L+
Sbjct:   182 CVVVEYVAGGTLKKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLL 241

Query:   269 FSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
               +K++KIADFGVAR+E Q  + MT ETGT  +MAP
Sbjct:   242 QPNKTLKIADFGVARVEAQNPQDMTGETGTLGYMAP 277

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 415 (151.1 bits), Expect = 7.8e-39, P = 7.8e-39
 Identities = 88/189 (46%), Positives = 120/189 (63%)

Query:   117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKIL--ERPENDPEKAX 174
             P +G    D W I+L+ L  G   A G++G LY+GTY  +EVAIK+L  ER ++D EK  
Sbjct:   276 PNDGT---DVWEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEF 332

Query:   175 XXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                         +  ++H N+V+FIGAC KP   CIVTE+  GGSV  +L K Q     L
Sbjct:   333 AQEVFI------MRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHK-QKGVFKL 385

Query:   235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE 294
                 K A+D+ +GM+Y+H+  +IHRDLK+ NLL+  ++ +K+ADFGVAR++ QT  MT E
Sbjct:   386 PTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAE 445

Query:   295 TGTYRWMAP 303
             TGTYRWMAP
Sbjct:   446 TGTYRWMAP 454

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)]

 Score = 409 (149.0 bits), Expect = 3.4e-38, P = 3.4e-38
 Identities = 84/186 (45%), Positives = 122/186 (65%)

Query:   119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXX 178
             E  E   +W +D R L +G    +GA  K+Y G Y  + VAIKI++R E+ PE+      
Sbjct:    11 EEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGES-PEEIAKRDN 69

Query:   179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV 238
                     L+ ++H N+V+FIGAC++PM+  IVTE   GG++R++L   + + + ++LAV
Sbjct:    70 RFAREIAMLSKVQHKNLVKFIGACKEPMM-VIVTELLLGGTLRKYLVSLRPKRLDIRLAV 128

Query:   239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVARIEVQTEGMTPETGT 297
               ALD+AR M  +H  G+IHRDLK +NL++ +D K++K+ADFG+AR E  TE MT ETGT
Sbjct:   129 GFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAETGT 188

Query:   298 YRWMAP 303
             YRWMAP
Sbjct:   189 YRWMAP 194

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 402 (146.6 bits), Expect = 1.9e-37, P = 1.9e-37
 Identities = 77/202 (38%), Positives = 121/202 (59%)

Query:   104 DDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKIL 163
             D   ++   ++      +E  +E+ +D+ KL  G  FA G + +LY G Y  + VA+K++
Sbjct:   177 DTGWSKLFDNTGRRVSAVEASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLI 236

Query:   164 ERPENDPEKAXXXXXXXXXXX--XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR 221
               P++D                   L+ L HPN+++F+GA + P V+C++T+Y   GS+R
Sbjct:   237 TVPDDDDNGCLGARLEKQFTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLR 296

Query:   222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
              FL K +NRS+PLK  ++ A+D+ARGM Y+H   +IHRDLK +N+LI  +  +KIADFG+
Sbjct:   297 SFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGI 356

Query:   282 ARIEVQTEGMTPETGTYRWMAP 303
             A  E   + +  + GTYRWMAP
Sbjct:   357 ACEEEYCDMLADDPGTYRWMAP 378

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 397 (144.8 bits), Expect = 6.3e-37, P = 6.3e-37
 Identities = 100/274 (36%), Positives = 151/274 (55%)

Query:    31 LGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH 90
             LGE   ++I    +  T++G       VD  S    E     L  + +R+  +   S   
Sbjct:   199 LGE-LGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKE-IRKFKDQPCSKQK 256

Query:    91 SVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYR 150
             S+       H  S + L  A ++   PT+G    DEW ID+++L +    A G++G+L+R
Sbjct:   257 SITF---FEHDKSTNELLPACVEI--PTDGT---DEWEIDMKQLKIEKKVACGSYGELFR 308

Query:   151 GTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLAT-LKHPNIVRFIGACRKPMVWC 209
             GTY  +EVAIKIL+     PE+              +   ++H N+V+FIGAC +    C
Sbjct:   309 GTYCSQEVAIKILK-----PERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLC 363

Query:   210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
             IVTE+   GS+  FL K +     ++  +K ALDV++GM Y+H+  +IHRDLK+ NLL+ 
Sbjct:   364 IVTEFMTRGSIYDFLHKHKG-VFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMD 422

Query:   270 SDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
               + +K+ADFGVAR++ ++  MT ETGTYRWMAP
Sbjct:   423 EHEVVKVADFGVARVQTESGVMTAETGTYRWMAP 456

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)]

 Score = 397 (144.8 bits), Expect = 6.3e-37, P = 6.3e-37
 Identities = 82/179 (45%), Positives = 117/179 (65%)

Query:   126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
             +W ID + L +G    +GA  K+Y G Y  + VAIKI+ R E  PE+             
Sbjct:    12 KWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGET-PEEIAKRDSRFLREVE 70

Query:   186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
              L+ ++H N+V+FIGAC++P V  IVTE  +GG++R++L   +   +  ++A+  ALD+A
Sbjct:    71 MLSRVQHKNLVKFIGACKEP-VMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIA 129

Query:   246 RGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             RGM  +H  G+IHRDLK +NLL+ +D K++K+ADFG+AR E  TE MT ETGTYRWMAP
Sbjct:   130 RGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 188

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0007020 "microtubule nucleation" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 395 (144.1 bits), Expect = 1.0e-36, P = 1.0e-36
 Identities = 86/204 (42%), Positives = 126/204 (61%)

Query:   100 HALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVA 159
             H  S + L  A ++   PT+G    DEW ID+ +L +    A G++G L+RGTY  +EVA
Sbjct:   257 HDKSSNELIPACIEI--PTDGT---DEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVA 311

Query:   160 IKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGS 219
             IK L +P+    +              +  ++H N+V+F+GAC +    CIVTE+   GS
Sbjct:   312 IKFL-KPDRVNNEMLREFSQEVFI---MRKVRHKNVVQFLGACTRSPTLCIVTEFMARGS 367

Query:   220 VRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF 279
             +  FL K Q  +  L+  +K ALDVA+GM+Y+H+  +IHRDLK+ NLL+     +K+ADF
Sbjct:   368 IYDFLHK-QKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADF 426

Query:   280 GVARIEVQTEGMTPETGTYRWMAP 303
             GVAR+++++  MT ETGTYRWMAP
Sbjct:   427 GVARVQIESGVMTAETGTYRWMAP 450

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)]

 Score = 395 (144.1 bits), Expect = 1.0e-36, P = 1.0e-36
 Identities = 79/179 (44%), Positives = 120/179 (67%)

Query:   126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
             +W +D + L +G    +GA  K+Y G Y  + VAIKI++R E+ PE+             
Sbjct:    18 KWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGES-PEEIAKRESRFAREVS 76

Query:   186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
              L+ ++H N+V+FIGAC++P++  IVTE   GG++R++L   +  S+ +++AV  ALD+A
Sbjct:    77 MLSRVQHKNLVKFIGACKEPIM-VIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYALDIA 135

Query:   246 RGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             R M  +H  G+IHRDLK ++L++ +D K++K+ADFG+AR E  TE MT ETGTYRWMAP
Sbjct:   136 RAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRWMAP 194

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_scaffold_193000046 hypothetical protein (415 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	303
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-51
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-43
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-31
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-29
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-28
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-28
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-27
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-27
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-26
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-26
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-26
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-23
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-22
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-21
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-21
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-17
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-16
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-14
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  170 bits (432), Expect = 1e-51
 Identities = 60/178 (33%), Positives = 94/178 (52%), Gaps = 13/178 (7%)

Query: 134 LNMGDAFAQGAFGKLYRGTYNG------EEVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           L +G    +GAFG++Y+GT  G       EVA+K L + +   +      ++F +E  ++
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQ----QIEEFLREARIM 55

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L HPNIV+ +G C +     IV EY  GG +  +L K + + + L   +  AL +ARG
Sbjct: 56  RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG--TYRWMAP 303
           M Y+     IHRDL + N L+  +  +KI+DFG++R     +    + G    RWMAP
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (423), Expect = 3e-50
 Identities = 58/179 (32%), Positives = 96/179 (53%), Gaps = 16/179 (8%)

Query: 134 LNMGDAFAQGAFGKLYRGTYNG------EEVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           L +G    +GAFG++Y+G   G       EVA+K L + +   +      ++F +E  ++
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQ----QIEEFLREARIM 55

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L HPN+V+ +G C +     IV EY +GG +  +L K + + + L   +  AL +ARG
Sbjct: 56  RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARG 114

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           M Y+     IHRDL + N L+  +  +KI+DFG++R ++  +    + G     RWMAP
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAP 172

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  164 bits (419), Expect = 1e-49
 Identities = 59/171 (34%), Positives = 95/171 (55%), Gaps = 15/171 (8%)

Query: 142 QGAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           +GAFG++Y+GT  G+      +VA+K L   E   E+ +   ++F +E  ++  L HPNI
Sbjct: 9   EGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEER---EEFLEEASIMKKLSHPNI 63

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           VR +G C +     IVTEY  GG +  FL ++    + LK  ++ AL +A+GM Y+    
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLESKN 122

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 303
            +HRDL + N L+  +  +KI+DFG++R   + +      G     +WMAP
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  156 bits (396), Expect = 8e-47
 Identities = 52/166 (31%), Positives = 89/166 (53%), Gaps = 10/166 (6%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FG +Y       G++VAIKI+++ ++         ++  +E+ +L  L HPNIV+  
Sbjct: 3   EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL-----EELLREIEILKKLNHPNIVKLY 57

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
           G         +V EY +GGS++  L K     +     ++  L +  G+ Y+H  G+IHR
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 260 DLKSDNLLIFSDK-SIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           DLK +N+L+ SD   +K+ADFG+++ +      +    GT  +MAP
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  154 bits (392), Expect = 1e-45
 Identities = 59/165 (35%), Positives = 94/165 (56%), Gaps = 9/165 (5%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G+FG +Y+  +   G+ VA+KIL++     +K    +Q  ++E+ +L  L HPNIVR I
Sbjct: 9   SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK----DQTARREIRILRRLSHPNIVRLI 64

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A        +V EY +GG +  +L   +   +    A K AL + RG+ Y+H  G+IHR
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHR 122

Query: 260 DLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           DLK +N+L+  +  +KIADFG+A+ +   +  +T   GT  +MAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  151 bits (385), Expect = 1e-44
 Identities = 53/164 (32%), Positives = 85/164 (51%), Gaps = 9/164 (5%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FGK+Y       G+ VAIK++       +K +   ++  +E+ +L  LKHPNIVR  
Sbjct: 9   EGSFGKVYLARDKKTGKLVAIKVI-----KKKKIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
                     +V EY +GG +   L  ++   +    A      +   + Y+H  G++HR
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKGIVHR 121

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK +N+L+  D  +K+ADFG+AR     E +T   GT  +MAP
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  150 bits (381), Expect = 5e-44
 Identities = 58/181 (32%), Positives = 95/181 (52%), Gaps = 28/181 (15%)

Query: 142 QGAFGKLYRGTYNGE-----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
           +GAFG++Y+G   G+     EVA+K L+   ++ E+     + F +E  ++  L HPN+V
Sbjct: 5   EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-----KDFLKEARVMKKLGHPNVV 59

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN-------RSVPLKLAVKQALDVARGMA 249
           R +G C +     +V EY +GG +  +L K +         ++ LK  +  A+ +A+GM 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 302
           Y+     +HRDL + N L+  D  +KI+DFG++R          +T G  P     RWMA
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP----IRWMA 175

Query: 303 P 303
           P
Sbjct: 176 P 176

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  149 bits (379), Expect = 1e-43
 Identities = 57/169 (33%), Positives = 91/169 (53%), Gaps = 13/169 (7%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FG +Y       GE +A+K +E   +  E+ +      ++E+ +L++L+HPNIVR+ 
Sbjct: 10  RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE----ALEREIRILSSLQHPNIVRYY 65

Query: 200 GACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
           G+ R        I  EY  GGS+   L  ++   +P  +  K    +  G+AY+H  G++
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNGIV 123

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 303
           HRD+K  N+L+ SD  +K+ADFG A+        EG     GT  WMAP
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  131 bits (333), Expect = 6e-37
 Identities = 67/176 (38%), Positives = 97/176 (55%), Gaps = 13/176 (7%)

Query: 133 KLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL 190
              +GD   +GAFG +Y+G     G+ VAIK +   E   E+A    +   QE+ +L  L
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS-LEKIKEEAL---KSIMQEIDLLKNL 56

Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL-KLAVKQALDVARGMA 249
           KHPNIV++IG+        I+ EYA+ GS+RQ + K       L  + V Q L   +G+A
Sbjct: 57  KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLA 113

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           Y+H  G+IHRD+K+ N+L   D  +K+ADFGVA  ++        +  GT  WMAP
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (304), Expect = 1e-32
 Identities = 53/165 (32%), Positives = 95/165 (57%), Gaps = 11/165 (6%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FG++Y+  +   G+EVAIK++        +++  +++   E+ +L   KHPNIV++ 
Sbjct: 10  KGGFGEVYKARHKRTGKEVAIKVI------KLESKEKKEKIINEIQILKKCKHPNIVKYY 63

Query: 200 GA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           G+  +K  +W IV E+  GGS++  L    N+++          ++ +G+ Y+H  G+IH
Sbjct: 64  GSYLKKDELW-IVMEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           RD+K+ N+L+ SD  +K+ DFG++     T+      GT  WMAP
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  116 bits (293), Expect = 7e-31
 Identities = 49/151 (32%), Positives = 86/151 (56%), Gaps = 14/151 (9%)

Query: 142 QGAFGKLYRGTYN------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           +G FGK+    Y+      GE+VA+K L     +  ++      F++E+ +L TL H NI
Sbjct: 14  EGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-----FEREIEILRTLDHENI 68

Query: 196 VRFIGACRKPMVW--CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
           V++ G C KP      ++ EY   GS+R +L + +++ + LK  +  +  + +GM Y+  
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS 127

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
              IHRDL + N+L+ S+  +KI+DFG+A++
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  112 bits (281), Expect = 2e-29
 Identities = 54/171 (31%), Positives = 94/171 (54%), Gaps = 7/171 (4%)

Query: 136 MGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
            G+    G+FG +Y G    +G+  A+K +   ++  +  Q   +Q +QE+ +L+ L+HP
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG-QTGQEAVKQLEQEIALLSKLQHP 62

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL-KLAVKQALDVARGMAYVH 252
           NIV+++G  R+     I  E   GGS+ + L K  +   P+ +L  +Q L    G+ Y+H
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLH 119

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
               +HRD+K  N+L+ ++  +K+ADFG+A+  V+        G+  WMAP
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  111 bits (279), Expect = 3e-29
 Identities = 58/177 (32%), Positives = 95/177 (53%), Gaps = 11/177 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM 186
           W ++L+KL +G+   +G FG + +G Y G++VA+K +        K  V  Q F +E  +
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI--------KCDVTAQAFLEETAV 52

Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +  L H N+VR +G      ++ IV E    G++  FL  R    V +   ++ +LDVA 
Sbjct: 53  MTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAE 111

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           GM Y+    L+HRDL + N+L+  D   K++DFG+AR+   + G+       +W AP
Sbjct: 112 GMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPVKWTAP 166

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 6e-29
 Identities = 60/181 (33%), Positives = 90/181 (49%), Gaps = 12/181 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVM 185
           W I    L +      G FG+++ GT+NG  +VA+K L+     PE        F QE  
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-------AFLQEAQ 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           ++  L+H  +V+    C +     IVTEY   GS+  FL   + + + L   V  A  +A
Sbjct: 54  IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 302
            GMAY+     IHRDL + N+L+  +   KIADFG+AR+ ++ +  T   G     +W A
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTA 172

Query: 303 P 303
           P
Sbjct: 173 P 173

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 9e-29
 Identities = 58/179 (32%), Positives = 92/179 (51%), Gaps = 13/179 (7%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM 186
           W I+ ++L +G    +G FG +  G Y G++VA+K L+             Q F  E  +
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASV 53

Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           + TL+HPN+V+ +G   +     IVTEY   GS+  +L  R    + L   +  ALDV  
Sbjct: 54  MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
           GM Y+     +HRDL + N+L+  D   K++DFG+A+   Q +    ++G    +W AP
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  110 bits (277), Expect = 2e-28
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 52/215 (24%)

Query: 106 ALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--GEEVAIKIL 163
           A  + ++    P E  +N +       K+       +GA G++Y+ T    G+EVAIK +
Sbjct: 6   AALKDIVSEGDPRELYKNLE-------KI------GEGASGEVYKATDRATGKEVAIKKM 52

Query: 164 ERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP-MVWCIVTEYAKGGS--- 219
            R     ++  +       E++++   KHPNIV +  +      +W +V EY  GGS   
Sbjct: 53  -RLRKQNKELII------NEILIMKDCKHPNIVDYYDSYLVGDELW-VVMEYMDGGSLTD 104

Query: 220 -VRQF---LTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK 275
            + Q    + + Q   V          +V +G+ Y+H   +IHRD+KSDN+L+  D S+K
Sbjct: 105 IITQNFVRMNEPQIAYV--------CREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVK 156

Query: 276 IADFGVARIEVQTEGMTPET-------GTYRWMAP 303
           +ADFG A    Q   +T E        GT  WMAP
Sbjct: 157 LADFGFA---AQ---LTKEKSKRNSVVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 4e-28
 Identities = 55/174 (31%), Positives = 86/174 (49%), Gaps = 11/174 (6%)

Query: 137 GDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPE-KAQVMEQQFQQEVMMLATLKHP 193
           G    QGAFG++Y       G E+A+K +    + PE K +V     + E+ +L  L+H 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV--NALECEIQLLKNLQHE 64

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            IV++ G  R      I  EY  GGSV+  L  +   ++   +  K    +  G+ Y+H 
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 303
             ++HRD+K  N+L  S  ++K+ DFG ++    I     GM   TGT  WM+P
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  108 bits (270), Expect = 9e-28
 Identities = 57/180 (31%), Positives = 90/180 (50%), Gaps = 11/180 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG-EEVAIKILERPENDPEKAQVMEQQFQQEVM 185
           W +    L +      G FG+++ G YNG  +VAIK L++    PE        F  E  
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-------FLAEAN 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           ++  L+HP +VR      +  ++ I+TEY + GS+  FL   +   + +   +  A  +A
Sbjct: 54  LMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            GMA++ R   IHRDL++ N+L+      KIADFG+AR+    E    E   +  +W AP
Sbjct: 113 EGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (270), Expect = 1e-27
 Identities = 47/170 (27%), Positives = 87/170 (51%), Gaps = 15/170 (8%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILE-RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +G+FGK  L R   +G+   +K ++    ++ E+          EV +L  L HPNI+++
Sbjct: 10  KGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-----LNEVKILKKLNHPNIIKY 64

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD----VARGMAYVHRL 254
             +  +    CIV EYA GG + Q + K++    P     +Q LD    +   + Y+H  
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP--EEQILDWFVQLCLALKYLHSR 122

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 303
            ++HRD+K  N+ + S+  +K+ DFG++++   T  +     GT  +++P
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 3e-27
 Identities = 60/174 (34%), Positives = 102/174 (58%), Gaps = 26/174 (14%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH---PNIV 196
           +GA+G +YRG +   G  VA+KI+     D + + +     Q+EV +L+ L+    PNI 
Sbjct: 11  RGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI-----QREVALLSQLRQSQPPNIT 65

Query: 197 RFIGACRK-PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK-----LAVKQALDVARGMAY 250
           ++ G+  K P +W I+ EYA+GGSVR  +     ++ P+      + +++ L VA  + Y
Sbjct: 66  KYYGSYLKGPRLW-IIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVL-VA--LKY 116

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM-TPETGTYRWMAP 303
           +H++G+IHRD+K+ N+L+ +  ++K+ DFGVA +  Q     +   GT  WMAP
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  106 bits (267), Expect = 3e-27
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 15/178 (8%)

Query: 137 GDAFAQGAFGKLYRG--TYNGEEVAIKILERP----ENDPEKAQVMEQQFQQEVMMLATL 190
           G+   +G +G++Y       GE +A+K +E P         + + M +  + E+  L  L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL-KLAVKQALDVARGMA 249
            H NIV+++G         I  EY  GGS+   L         L +   +Q L    G+A
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---EGLA 122

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 303
           Y+H  G++HRDLK+DNLL+ +D   KI+DFG+++    I    + M+ + G+  WMAP
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 4e-27
 Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 12/181 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVM 185
           W ID   + +      G FG+++ G +N    VA+K L+    DP+        F  E  
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-------DFLAEAQ 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           ++  L+HP +++    C       IVTE  K GS+ ++L     R++ L   +  A  VA
Sbjct: 54  IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVA 113

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 302
            GMAY+     IHRDL + N+L+  +   K+ADFG+AR+  +        G     +W A
Sbjct: 114 SGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTA 172

Query: 303 P 303
           P
Sbjct: 173 P 173

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  105 bits (264), Expect = 8e-27
 Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 20/169 (11%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G++G +Y+  +   G+ VAIK++   E+         Q+  +E+ +L     P IV++ 
Sbjct: 13  EGSYGSVYKAIHKETGQVVAIKVVPVEEDL--------QEIIKEISILKQCDSPYIVKYY 64

Query: 200 GACRK-PMVWCIVTEYAKGGSVRQFLTKRQNRSVP---LKLAVKQALDVARGMAYVHRLG 255
           G+  K   +W IV EY   GSV   + K  N+++    +   + Q L   +G+ Y+H   
Sbjct: 65  GSYFKNTDLW-IVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTL---KGLEYLHSNK 119

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 303
            IHRD+K+ N+L+  +   K+ADFGV+     T        GT  WMAP
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  105 bits (265), Expect = 1e-26
 Identities = 65/212 (30%), Positives = 91/212 (42%), Gaps = 48/212 (22%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKILERPENDPEKAQVMEQ 178
           EW +   +L +G    +GAFG++ +    G +       VA+K+L        K    E+
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--------KDDATEK 57

Query: 179 QFQQEV----MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                V    MM    KH NI+  +G C +     +V EYA  G++R FL  R  R    
Sbjct: 58  DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL--RARRPPGE 115

Query: 235 KLA----------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD 278
             +                V  A  VARGM ++     IHRDL + N+L+  D  +KIAD
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIAD 175

Query: 279 FGVAR-IEVQ------TEGMTPETGTYRWMAP 303
           FG+AR I         T G  P     +WMAP
Sbjct: 176 FGLARDIHHIDYYRKTTNGRLP----VKWMAP 203

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 1e-26
 Identities = 56/171 (32%), Positives = 87/171 (50%), Gaps = 17/171 (9%)

Query: 142 QGAFGKLYRGTY---NGEE--VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
            G FG + +G Y   +G+E  VA+K L+      E     +++F +E  ++A L HP IV
Sbjct: 5   HGNFGSVVKGVYLMKSGKEVEVAVKTLK-----QEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           R IG C+      +V E A  G + ++L KR+   V   L    A  VA GMAY+     
Sbjct: 60  RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV-SDLKE-LAHQVAMGMAYLESKHF 116

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETG---TYRWMAP 303
           +HRDL + N+L+ +    KI+DFG++R +   ++     T      +W AP
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 1e-26
 Identities = 56/147 (38%), Positives = 85/147 (57%), Gaps = 11/147 (7%)

Query: 142 QGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           +G FG +Y+G   G  EVA+K        P     ++++F QE  +L    HPNIV+ IG
Sbjct: 5   KGNFGDVYKGVLKGNTEVAVKTCR--STLP---PDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 201 AC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
            C  ++P+   IV E   GGS+  FL K++NR + +K  ++ +LD A GM Y+     IH
Sbjct: 60  VCVQKQPIY--IVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIH 116

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIE 285
           RDL + N L+  +  +KI+DFG++R E
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREE 143

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 1e-26
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 21/170 (12%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKI--LERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           +G+FG++Y+       + VAIK+  LE  E++ E         QQE+  L+  + P I +
Sbjct: 11  KGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-------DIQQEIQFLSQCRSPYITK 63

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL---KLAVKQALDVARGMAYVHRL 254
           + G+  K     I+ EY  GGS    L     +   L    +A     +V  G+ Y+H  
Sbjct: 64  YYGSFLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAF-ILREVLLGLEYLHEE 117

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           G IHRD+K+ N+L+  +  +K+ADFGV+ ++           GT  WMAP
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 2e-26
 Identities = 56/181 (30%), Positives = 86/181 (47%), Gaps = 17/181 (9%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVM-EQQFQQEVMM 186
           ID  +L        G FG ++ G + G+ +VAIK++        +   M E  F +E  +
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI--------REGAMSEDDFIEEAKV 52

Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV-PLKLAVKQALDVA 245
           +  L HPN+V+  G C K     IVTEY   G +  +L  R+ +     +  +    DV 
Sbjct: 53  MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVC 110

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 302
             M Y+   G IHRDL + N L+  D  +K++DFG+AR  +  +  T   GT    +W  
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAP 169

Query: 303 P 303
           P
Sbjct: 170 P 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (259), Expect = 3e-26
 Identities = 61/180 (33%), Positives = 92/180 (51%), Gaps = 11/180 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVM 185
           W I    L +      G FG+++ GT+NG  +VA+K L+     PE        F +E  
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-------SFLEEAQ 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           ++  L+H  +V+      +  ++ IVTEY   GS+  FL   + R++ L   V  A  VA
Sbjct: 54  IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            GMAY+ R+  IHRDL+S N+L+      KIADFG+AR+    E    +   +  +W AP
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (259), Expect = 3e-26
 Identities = 60/180 (33%), Positives = 91/180 (50%), Gaps = 11/180 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVM 185
           W I    L +     QG FG+++ GT+NG   VAIK L+     PE        F QE  
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-------FLQEAQ 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           ++  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L   V  A  +A
Sbjct: 54  VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +   +  +W AP
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  105 bits (262), Expect = 5e-26
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 14/172 (8%)

Query: 142 QGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP-NIVRFIG 200
           +G+FG++Y      + VA+K+L +      K     ++F +E+ +LA+L HP NIV+   
Sbjct: 10  EGSFGEVYLARDR-KLVALKVLAKKLESKSKEV---ERFLREIQILASLNHPPNIVKLYD 65

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKR-QNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
             +      +V EY  GGS+   L K  +   +    A+     +   + Y+H  G+IHR
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHR 125

Query: 260 DLKSDNLLI-FSDKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 303
           D+K +N+L+    + +K+ DFG+A++              +   GT  +MAP
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Length = 384

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  103 bits (258), Expect = 5e-26
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 14/184 (7%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTY---NGEE--VAIKILERPENDPEKAQVMEQQFQ 181
           + I    + +G    +G FG +Y+G Y     E+  VA+K   +    P   +    +F 
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVRE----KFL 55

Query: 182 QEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
           QE  ++    HP+IV+ IG   +  VW IV E A  G +R +L   +  S+ L   +  +
Sbjct: 56  QEAYIMRQFDHPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKY-SLDLASLILYS 113

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--R 299
             ++  +AY+     +HRD+ + N+L+ S   +K+ DFG++R            G    +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173

Query: 300 WMAP 303
           WMAP
Sbjct: 174 WMAP 177

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 6e-26
 Identities = 60/170 (35%), Positives = 91/170 (53%), Gaps = 22/170 (12%)

Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           G +G +Y  R    GE VAIK+++    D +   +     QQE+ ML   +HPNIV + G
Sbjct: 14  GTYGDVYKARDIATGELVAIKVIKLEPGD-DFEII-----QQEISMLKECRHPNIVAYFG 67

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLA--VKQALDVARGMAYVHRLGLI 257
           +  +     IV EY  GGS+ Q + +     +  L++A   ++ L   +G+AY+H  G I
Sbjct: 68  SYLRRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETGKI 123

Query: 258 HRDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPET---GTYRWMAP 303
           HRD+K  N+L+  D  +K+ADFGV A++   T  +       GT  WMAP
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 2e-25
 Identities = 52/187 (27%), Positives = 92/187 (49%), Gaps = 32/187 (17%)

Query: 134 LNMGDAFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           L        GAFG +Y+G +  E       VAIK+L   E    KA    ++   E  ++
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKAN---KEILDEAYVM 63

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD---- 243
           A++ HP++VR +G C    V  ++T+    G +  ++  R ++     +  +  L+    
Sbjct: 64  ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV--RNHKD---NIGSQYLLNWCVQ 117

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI----EVQ---TEGMTPETG 296
           +A+GM+Y+    L+HRDL + N+L+ + + +KI DFG+A++    E +     G  P   
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP--- 174

Query: 297 TYRWMAP 303
             +WMA 
Sbjct: 175 -IKWMAL 180

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 2e-25
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 37/202 (18%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQQ 179
           W +   K+ +     QG+FG +Y G   G         VAIK +    +  E+      +
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-----IE 55

Query: 180 FQQEVMMLATLKHPNIVRFIGAC---RKPMVWCIVTEYAKGGSVRQFLTKR--QNRSVP- 233
           F  E  ++      ++VR +G     +  +V   V E    G ++ +L  R  +  + P 
Sbjct: 56  FLNEASVMKEFNCHHVVRLLGVVSTGQPTLV---VMELMAKGDLKSYLRSRRPEAENNPG 112

Query: 234 -----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT 288
                L+  ++ A ++A GMAY+     +HRDL + N ++  D ++KI DFG+ R   +T
Sbjct: 113 LGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172

Query: 289 E-------GMTPETGTYRWMAP 303
           +       G+ P     RWMAP
Sbjct: 173 DYYRKGGKGLLP----VRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  102 bits (255), Expect = 2e-25
 Identities = 57/190 (30%), Positives = 87/190 (45%), Gaps = 27/190 (14%)

Query: 134 LNMGDAFAQGAFGKLYRGTYNG-----EEVAIKILERPENDPEKAQVMEQQFQQEVMMLA 188
           + +  A   GAFG++Y G Y G      E+ + +   PE+  E+    E  F  E ++++
Sbjct: 8   ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD---ESDFLMEALIMS 64

Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTK---RQNRSVPLKLA--VKQALD 243
              H NIVR IG   + +   I+ E   GG ++ FL +   R  R   L +   +  A D
Sbjct: 65  KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTE-------GMTP 293
           VA+G  Y+     IHRD+ + N L+      +  KIADFG+AR   +          M P
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 294 ETGTYRWMAP 303
                +WM P
Sbjct: 185 ----IKWMPP 190

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (256), Expect = 2e-25
 Identities = 53/161 (32%), Positives = 76/161 (47%), Gaps = 25/161 (15%)

Query: 158 VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VA+K+L    +D  +     + F +EV +L+ L  PNI R +G C      C++ EY + 
Sbjct: 49  VAVKVLRPDASDNAR-----EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMEN 103

Query: 218 GSVRQFLTKRQNRSVPLKLAVKQ---------ALDVARGMAYVHRLGLIHRDLKSDNLLI 268
           G + QFL K    +  L    K          A  +A GM Y+  L  +HRDL + N L+
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163

Query: 269 FSDKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 302
             + +IKIADFG++R         VQ     P     RWMA
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP----IRWMA 200

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  101 bits (253), Expect = 2e-25
 Identities = 61/180 (33%), Positives = 95/180 (52%), Gaps = 20/180 (11%)

Query: 137 GDAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           G+   +GA+G +Y G  N G+ +A+K +E   ++   A+   ++ Q+EV +L +LKH NI
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV-----KQALDVARGMAY 250
           V+++G C       I  E+  GGS+   L    NR  PL   V     KQ LD   G+AY
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILD---GVAY 117

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 303
           +H   ++HRD+K +N+++  +  IK+ DFG AR           +  +    GT  WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  101 bits (253), Expect = 3e-25
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 13/148 (8%)

Query: 142 QGAFGKLYRGTY---NGE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
            G+FG + RG +    G+   VA+K L+      +K   +   F +E  ++ +L H N++
Sbjct: 5   DGSFGVVRRGEWSTSGGKVIPVAVKCLK-----SDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 197 RFIGACR-KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           R  G     P++  +VTE A  GS+   L K       +      A+ +A GM Y+    
Sbjct: 60  RLYGVVLTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            IHRDL + N+L+ SD  +KI DFG+ R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 99.2 bits (247), Expect = 2e-24
 Identities = 49/183 (26%), Positives = 92/183 (50%), Gaps = 15/183 (8%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVME-QQFQQE 183
           W ++   + M      G +G++Y G +      VA+K L        K   ME ++F +E
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEVEEFLKE 52

Query: 184 VMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
             ++  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  A  
Sbjct: 53  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 112

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRW 300
           ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+ +  +  T   G     +W
Sbjct: 113 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKW 171

Query: 301 MAP 303
            AP
Sbjct: 172 TAP 174

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 99.0 bits (246), Expect = 2e-24
 Identities = 60/180 (33%), Positives = 92/180 (51%), Gaps = 11/180 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVM 185
           W I    L +     QG FG+++ GT+NG  +VAIK L+     PE        F QE  
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-------FLQEAQ 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           ++  L+H  +V       +  ++ IVTE+   GS+  FL +   + + L   V  A  +A
Sbjct: 54  IMKKLRHDKLVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            GMAY+ R+  IHRDL++ N+L+  +   KIADFG+AR+    E    +   +  +W AP
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.4 bits (246), Expect = 3e-24
 Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 13/175 (7%)

Query: 134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK 191
           L       QG+ G +Y+  +   G+  A+K +    ++        +Q  +E+  L + +
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCE 57

Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARGMAY 250
            P +V+  GA  K     IV EY  GGS+   L K      P L    +Q L    G+ Y
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILK---GLDY 114

Query: 251 VHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           +H    +IHRD+K  NLLI S   +KIADFG++++   T        GT  +M+P
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.8 bits (241), Expect = 2e-23
 Identities = 63/195 (32%), Positives = 94/195 (48%), Gaps = 39/195 (20%)

Query: 138 DAFAQGAFGKLYRG---TYNGEE----VAIKILERPENDPEKAQVMEQQ-FQQEVMMLAT 189
           +   +GAFGK+Y+G     N       VAIK L+      E A+   QQ F+QE  +++ 
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLK------ENAEPKVQQEFRQEAELMSD 64

Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP----LKLAVKQALD-- 243
           L+HPNIV  +G C K    C++ EY   G + +FL +    S          VK +LD  
Sbjct: 65  LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124

Query: 244 --------VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-------IEVQT 288
                   +A GM Y+     +HRDL + N L+    ++KI+DFG++R         VQ+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 289 EGMTPETGTYRWMAP 303
           + + P     RWM P
Sbjct: 185 KSLLP----VRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.1 bits (239), Expect = 2e-23
 Identities = 63/186 (33%), Positives = 92/186 (49%), Gaps = 34/186 (18%)

Query: 143 GAFGKLYRGT-----YNGEE---VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN 194
           GAFG++Y GT       G     VA+K L +   D EK +     F +E  +++   HPN
Sbjct: 6   GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-----FLKEAHLMSNFNHPN 60

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTK-RQNRSVPLKLAVKQ----ALDVARGMA 249
           IV+ +G C       I+ E  +GG +  +L   R  R  P  L +K+     LDVA+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 250 YVHRLGLIHRDLKSDNLLI-----FSDKSIKIADFGVAR-------IEVQTEGMTPETGT 297
           Y+ ++  IHRDL + N L+      +D+ +KI DFG+AR          + EG+ P    
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP---- 176

Query: 298 YRWMAP 303
            RWMAP
Sbjct: 177 VRWMAP 182

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 95.5 bits (237), Expect = 3e-23
 Identities = 61/171 (35%), Positives = 95/171 (55%), Gaps = 17/171 (9%)

Query: 140 FAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
             +G FG++++GT   +  VA+K  +  E+ P++ ++   +F  E  +L    HPNIV+ 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCK--EDLPQELKI---KFLSEARILKQYDHPNIVKL 57

Query: 199 IGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           IG C  R+P+   IV E   GG    FL K+++  +  K  VK ALD A GMAY+     
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNC 114

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG----TYRWMAP 303
           IHRDL + N L+  +  +KI+DFG++R E   +G+   +G      +W AP
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAP 163

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 6e-23
 Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 23/182 (12%)

Query: 136 MGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KH 192
           + +   +G +GK+Y+  +   G+ VAIKI++      +     E++ ++E  +L     H
Sbjct: 10  LVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIED----EEEEIKEEYNILRKYSNH 62

Query: 193 PNIVRFIGACRKP-------MVWCIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALD 243
           PNI  F GA  K         +W +V E   GGSV   +   +++ + +  +       +
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWM 301
             RG+AY+H   +IHRD+K  N+L+  +  +K+ DFGV+  ++ +      T  GT  WM
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWM 180

Query: 302 AP 303
           AP
Sbjct: 181 AP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 94.8 bits (236), Expect = 7e-23
 Identities = 56/164 (34%), Positives = 87/164 (53%), Gaps = 8/164 (4%)

Query: 142 QGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
            G FG+++ G + N   VAIKIL+   +D  K Q     FQ+EV  L  L+H +++    
Sbjct: 16  SGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQ----DFQKEVQALKRLRHKHLISLFA 69

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
            C       I+TE  + GS+  FL   + + +P+   +  A  VA GMAY+     IHRD
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD 129

Query: 261 LKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-YRWMAP 303
           L + N+L+  D   K+ADFG+AR+  +   ++ +    Y+W AP
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.0 bits (237), Expect = 7e-23
 Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 18/151 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM----LATLK-HPN 194
           +G+F  +         +E AIKIL+       K Q+++++  + V +    L  L  HP 
Sbjct: 11  EGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTRLNGHPG 63

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARGMAYVHR 253
           I++     +       V EYA  G + Q++ K  +      +    + L     + Y+H 
Sbjct: 64  IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL---ALEYLHS 120

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            G+IHRDLK +N+L+  D  IKI DFG A++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKV 151

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.8 bits (236), Expect = 1e-22
 Identities = 58/188 (30%), Positives = 87/188 (46%), Gaps = 35/188 (18%)

Query: 142 QGAFGKLYRGT-YNGEE------VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN 194
           +GAFGK++ G  Y+ E       VA+K L+  E     A    + F++E  +L   +H N
Sbjct: 15  EGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDA---RKDFEREAELLTNFQHEN 69

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTK--------RQNRSVPLKLAVKQ----AL 242
           IV+F G C +     +V EY + G + +FL          +   S   +L + Q    A+
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-------IEVQTEGMTPET 295
            +A GM Y+     +HRDL + N L+  D  +KI DFG++R         V    M P  
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP-- 187

Query: 296 GTYRWMAP 303
              RWM P
Sbjct: 188 --IRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 94.3 bits (234), Expect = 1e-22
 Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 10/180 (5%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVM 185
           W I    + +      G FG+++ G Y N  +VA+K L+     P    V  Q F +E  
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-----PGTMSV--QAFLEEAN 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           ++ TL+H  +VR      K     I+TEY   GS+  FL   +   V L   +  +  +A
Sbjct: 54  LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            GMAY+ R   IHRDL++ N+L+      KIADFG+AR+    E    E   +  +W AP
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 94.1 bits (234), Expect = 2e-22
 Identities = 62/194 (31%), Positives = 93/194 (47%), Gaps = 39/194 (20%)

Query: 142 QGAFGKLYR----GTYNGEE---VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN 194
           QGAFG++++    G    E    VA+K+L+      E +  M+  FQ+E  ++A   HPN
Sbjct: 15  QGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-----EASADMQADFQREAALMAEFDHPN 69

Query: 195 IVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSV----------------PLKL 236
           IV+ +G C   KPM  C++ EY   G + +FL  R  R+                 PL L
Sbjct: 70  IVKLLGVCAVGKPM--CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 237 A----VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE--- 289
           +    +  A  VA GMAY+     +HRDL + N L+  +  +KIADFG++R     +   
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 290 GMTPETGTYRWMAP 303
               +    RWM P
Sbjct: 188 ASENDAIPIRWMPP 201

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 3e-22
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 24/174 (13%)

Query: 143 GAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQ---FQQEVMMLATLKHPN 194
           G FG++ RG          +VAIK L        KA   ++Q   F  E  ++    HPN
Sbjct: 15  GEFGEVCRGRLKLPGKKEIDVAIKTL--------KAGSSDKQRLDFLTEASIMGQFDHPN 66

Query: 195 IVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           I+R  G     +P++  I+TEY + GS+ +FL +   +    +L V     +A GM Y+ 
Sbjct: 67  IIRLEGVVTKSRPVM--IITEYMENGSLDKFLRENDGKFTVGQL-VGMLRGIASGMKYLS 123

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG---TYRWMAP 303
            +  +HRDL + N+L+ S+   K++DFG++R    +E      G     RW AP
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.2 bits (232), Expect = 3e-22
 Identities = 54/171 (31%), Positives = 82/171 (47%), Gaps = 15/171 (8%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA   +Y      N E+VAIK +     D EK Q    + ++EV  ++   HPN+V++ 
Sbjct: 11  VGATAVVYAAICLPNNEKVAIKRI-----DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 200 GA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV-PLKLAVKQALDVARGMAYVHRLGLI 257
            +      +W +V  Y  GGS+   +     R      +      +V +G+ Y+H  G I
Sbjct: 66  TSFVVGDELW-LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET-----GTYRWMAP 303
           HRD+K+ N+L+  D S+KIADFGV+         T +      GT  WMAP
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 92.5 bits (230), Expect = 5e-22
 Identities = 44/171 (25%), Positives = 89/171 (52%), Gaps = 19/171 (11%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILE-RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR- 197
           +G++G +Y+       +  A+K ++    +  E+   +      E+ +LA++ HPNI+  
Sbjct: 10  KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-----NEIRILASVNHPNIISY 64

Query: 198 ---FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK--LAVKQALDVARGMAYVH 252
              F+   +     CIV EYA  G + + ++KR+ +   +      +  + + RG+  +H
Sbjct: 65  KEAFLDGNK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
              ++HRDLKS N+L+ ++  +KI D G++++  +    T + GT  +MAP
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT-QIGTPHYMAP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 92.5 bits (230), Expect = 5e-22
 Identities = 49/181 (27%), Positives = 87/181 (48%), Gaps = 29/181 (16%)

Query: 143 GAFGKLYRGTYNGEE-------VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           G FG+++     G E       V +K L+  +   E  Q    +F++E+ M   L H N+
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQ---SEFRRELDMFRKLSHKNV 70

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK---LAVKQAL----DVARGM 248
           VR +G CR+     ++ EY   G ++QFL   +++   LK   L+ KQ +     +A GM
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE------GMTPETGTYRWMA 302
            ++     +HRDL + N L+ S + +K++   +++    +E       + P     RW+A
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP----LRWLA 186

Query: 303 P 303
           P
Sbjct: 187 P 187

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 91.9 bits (228), Expect = 7e-22
 Identities = 51/179 (28%), Positives = 88/179 (49%), Gaps = 13/179 (7%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           I   +L +      G FG ++ G +    +VAIK +        +  + E+ F +E  ++
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-------EGAMSEEDFIEEAQVM 53

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L HP +V+  G C +    C+V E+ + G +  +L + Q      +  +   LDV  G
Sbjct: 54  MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEG 112

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           MAY+    +IHRDL + N L+  ++ +K++DFG+ R  V  +  T  TGT    +W +P
Sbjct: 113 MAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSP 170

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 92.7 bits (230), Expect = 8e-22
 Identities = 55/169 (32%), Positives = 81/169 (47%), Gaps = 33/169 (19%)

Query: 158 VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VA+KIL      P+  +     F +EV +L+ LK PNI+R +G C      C++TEY + 
Sbjct: 49  VAVKILR-----PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103

Query: 218 GSVRQFLTKRQ--NRSVPLKLAVKQ---------------ALDVARGMAYVHRLGLIHRD 260
           G + QFL+     ++      AV                 AL +A GM Y+  L  +HRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163

Query: 261 LKSDNLLIFSDKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 302
           L + N L+  + +IKIADFG++R         +Q   + P     RWMA
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLP----IRWMA 208

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 91.6 bits (227), Expect = 9e-22
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 11/180 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVM 185
           W I    L +      G FG+++  TYN   +VA+K ++     P    V  + F  E  
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSV--EAFLAEAN 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           ++ TL+H  +V+      K  ++ I+TE+   GS+  FL   +    PL   +  +  +A
Sbjct: 54  VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            GMA++ +   IHRDL++ N+L+ +    KIADFG+AR+    E    E   +  +W AP
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 1e-21
 Identities = 56/182 (30%), Positives = 94/182 (51%), Gaps = 20/182 (10%)

Query: 137 GDAFAQGAFGKLYRG--TYNGEEVAIKILERP----ENDPEKAQVMEQQFQQEVMMLATL 190
           G     G+FG +Y G    +GE +A+K +E P     +   K  +++    +E+ +L  L
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDA-LAREIALLKEL 63

Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL-KLAVKQALDVARGMA 249
           +H NIV+++G+        I  EY  GGSV   L         L +  V+Q L   +G+ 
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLN 120

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR--------WM 301
           Y+H  G+IHRD+K  N+L+ +   IKI+DFG+++ +++   ++ +T   R        WM
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWM 179

Query: 302 AP 303
           AP
Sbjct: 180 AP 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 91.6 bits (227), Expect = 2e-21
 Identities = 51/162 (31%), Positives = 84/162 (51%), Gaps = 26/162 (16%)

Query: 158 VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VA+K+L       +  +     F +E+ +++ LK+PNI+R +G C      C++TEY + 
Sbjct: 47  VAVKMLR-----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMEN 101

Query: 218 GSVRQFLTKRQNRS----------VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL 267
           G + QFL++R+  S          V +   +  A+ +A GM Y+  L  +HRDL + N L
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161

Query: 268 IFSDKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 302
           + +  +IKIADFG++R         +Q   + P     RWMA
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMA 199

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 90.3 bits (224), Expect = 2e-21
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 13/179 (7%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           ID + L        G FG +  G + G+ +VAIK+++       +  + E +F +E  ++
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L H  +V+  G C K     IVTEY   G +  +L +   R  P +L ++   DV  G
Sbjct: 54  MKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEG 112

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           MAY+     IHRDL + N L+     +K++DFG++R  +  E  T   G+    RW  P
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 170

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 89.7 bits (223), Expect = 5e-21
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 17/176 (9%)

Query: 137 GDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN 194
           G+    G FGK+Y       GE +A+K +   +NDP+      ++   E+ +L  LKHPN
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK----TIKEIADEMKVLELLKHPN 60

Query: 195 IVRFIGA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           +V++ G    R+ +   I  EY  GG++ + L     R +   +     L +  G+AY+H
Sbjct: 61  LVKYYGVEVHREKV--YIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-----TGTYRWMAP 303
             G++HRD+K  N+ +  +  IK+ DFG A           E      GT  +MAP
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 90.9 bits (225), Expect = 5e-21
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 38/208 (18%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAQVM 176
           +W +   +L +G    +G FG++      G +         VA+K+L+    D + + ++
Sbjct: 6   KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65

Query: 177 EQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
            +      MM    KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 66  SEM----EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121

Query: 229 ------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
                    +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+A
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 283 R-------IEVQTEGMTPETGTYRWMAP 303
           R        +  T G  P     +WMAP
Sbjct: 182 RDVHNIDYYKKTTNGRLP----VKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 90.4 bits (224), Expect = 6e-21
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 38/208 (18%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAQVM 176
           +W     +L +G    +G FG++ R    G +         VA+K+L+    D + A ++
Sbjct: 6   KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI 65

Query: 177 EQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL------------ 224
            +    E+M L   KH NI+  +G C +     ++ EYA  G++R+FL            
Sbjct: 66  SEM---ELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121

Query: 225 --TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
             TK     +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+A
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 283 R-------IEVQTEGMTPETGTYRWMAP 303
           R        +  + G  P     +WMAP
Sbjct: 182 RGVHDIDYYKKTSNGRLP----VKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 9e-21
 Identities = 60/175 (34%), Positives = 89/175 (50%), Gaps = 29/175 (16%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQ----EVMMLATLKHPNI 195
           +G +G +Y+      GE VA+K + R +N+       E+        E+ +L  LKHPNI
Sbjct: 9   EGTYGVVYKARDKKTGEIVALKKI-RLDNE-------EEGIPSTALREISLLKELKHPNI 60

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYVHR 253
           V+ +          +V EY     ++++L KR     P  +K  + Q L   RG+AY H 
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL---RGLAYCHS 116

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 303
             ++HRDLK  N+LI  D  +K+ADFG+AR   I ++T   T E  T  YR  AP
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYR--AP 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 2e-20
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 10/162 (6%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G +Y+      GE VAIK ++           + +   +E+ +L  L HPNI++ +
Sbjct: 9   EGTYGVVYKARDKLTGEIVAIKKIKLRFESE----GIPKTALREIKLLKELNHPNIIKLL 64

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
              R      +V E+     + + + K + R +P  L       + +G+A+ H  G++HR
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122

Query: 260 DLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRW 300
           DLK +NLLI ++  +K+ADFG+AR         T    T RW
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RW 163

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 89.0 bits (220), Expect = 2e-20
 Identities = 56/172 (32%), Positives = 95/172 (55%), Gaps = 16/172 (9%)

Query: 140 FAQGAFGKLYRGTY--NGEEV----AIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
              GAFG +Y+G +   GE V    AIKIL   E    KA V   +F  E +++A++ HP
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANV---EFMDEALIMASMDHP 69

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
           ++VR +G C  P +  +VT+    G +  ++ + ++ ++  +L +   + +A+GM Y+  
Sbjct: 70  HLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEE 127

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTY--RWMA 302
             L+HRDL + N+L+ S   +KI DFG+AR +E   +    + G    +WMA
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.0 bits (215), Expect = 4e-20
 Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 17/181 (9%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM 186
           W +++++L +     +G FG +  G Y G +VA+K +        K     Q F  E  +
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--------KNDATAQAFLAEASV 52

Query: 187 LATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
           +  L+H N+V+ +G     K  ++ IVTEY   GS+  +L  R    +     +K +LDV
Sbjct: 53  MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMA 302
              M Y+     +HRDL + N+L+  D   K++DFG+ + E  +   T +TG    +W A
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS---TQDTGKLPVKWTA 167

Query: 303 P 303
           P
Sbjct: 168 P 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 87.2 bits (216), Expect = 5e-20
 Identities = 57/178 (32%), Positives = 89/178 (50%), Gaps = 16/178 (8%)

Query: 137 GDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN 194
           G     GAF   Y  R    G  +A+K +    N   + + + +  ++E+ ++A L HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV--KQALDVARGMAYVH 252
           I+R +GA  +   + +  E+  GGSV   L+K        K AV       + RG++Y+H
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLH 120

Query: 253 RLGLIHRDLKSDNLLIFSD-KSIKIADFGVA-RIEVQTEGMTPE-----TGTYRWMAP 303
              +IHRD+K  NLLI S  + ++IADFG A R+  +  G   E      GT  +MAP
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG-AGEFQGQLLGTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 87.3 bits (216), Expect = 6e-20
 Identities = 58/162 (35%), Positives = 85/162 (52%), Gaps = 20/162 (12%)

Query: 132 RKLNMGDAFAQGAFGK--LYR------GTYNGEEVAIKILERPENDPEKAQVMEQQFQQE 183
           R L       +G FGK  LY       GT  GE VA+K L+R     E  Q     +++E
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGT--GEMVAVKTLKR-----ECGQQNTSGWKKE 56

Query: 184 VMMLATLKHPNIVRFIGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
           + +L TL H NIV++ G C +       ++ EY   GS+R +L K +     L L  +Q 
Sbjct: 57  INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ- 115

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
             +  GMAY+H    IHRDL + N+L+ +D+ +KI DFG+A+
Sbjct: 116 --ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.0 bits (213), Expect = 2e-19
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 19/199 (9%)

Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPEND 169
           PT+ L    +W      L+ G     GAFGK+   T  G        +VA+K+L+   + 
Sbjct: 21  PTQ-LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS 79

Query: 170 PEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ 228
            E+  +M      E+ +++ L  H NIV  +GAC       ++TEY   G +  FL +++
Sbjct: 80  SEREALM-----SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR 134

Query: 229 NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT 288
              + L+  +  +  VA+GMA++     IHRDL + N+L+   K +KI DFG+AR ++  
Sbjct: 135 ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMN 193

Query: 289 EGMTPETGTYR----WMAP 303
           +      G  R    WMAP
Sbjct: 194 DSNYVVKGNARLPVKWMAP 212

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 85.5 bits (211), Expect = 3e-19
 Identities = 57/171 (33%), Positives = 88/171 (51%), Gaps = 15/171 (8%)

Query: 138 DAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           +   +G+FG++Y+G  N   E VAIKI+     D E+A+   +  QQE+ +L+    P I
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL--DVARGMAYVHR 253
            R+ G+  K     I+ EY  GGS    L     +  PL+      +  ++ +G+ Y+H 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS 119

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 303
              IHRD+K+ N+L+     +K+ADFGVA     T+       GT  WMAP
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.4 bits (212), Expect = 3e-19
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 24/179 (13%)

Query: 136 MGDAFAQGAFGKLYRGTY--NGEEVAIK-ILERPENDPEKAQVMEQQFQQEVMMLATLKH 192
           +     +GA G +++      GE VA+K +  R        Q +     +E+  L   +H
Sbjct: 4   ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQAL-----REIKALQACQH 58

Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P +V+ +        + +V EY             + L + Q +S    L         +
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL--------K 110

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 303
           G+AY+H  G++HRDLK  NLLI +D  +KIADFG+AR+  + E    + +  T  + AP
Sbjct: 111 GVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.4 bits (211), Expect = 3e-19
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 38/207 (18%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAQVME 177
           W +   +L +G    +G FG++      G          +VA+K+L+    + + + ++ 
Sbjct: 13  WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS 72

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
           +      MM    KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 73  EM----EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128

Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 189 DIHHIDYYKKTTNGRLP----VKWMAP 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.0 bits (210), Expect = 4e-19
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 47/208 (22%)

Query: 133 KLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQQFQQEVM 185
            L +G    +G FGK+ + T            VA+K+L+   +  E   ++      E  
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLL-----SEFN 55

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN---------------- 229
           +L  + HP++++  GAC +     ++ EYAK GS+R FL + +                 
Sbjct: 56  LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115

Query: 230 ------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                 R++ +   +  A  ++RGM Y+  + L+HRDL + N+L+   + +KI+DFG++R
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 284 IEV--------QTEGMTPETGTYRWMAP 303
            +V        +++G  P     +WMA 
Sbjct: 176 -DVYEEDSYVKRSKGRIP----VKWMAI 198

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 84.3 bits (208), Expect = 4e-19
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 11/167 (6%)

Query: 142 QGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA 201
           +G FG+++ G    +   + +    E  P     ++ +F QE  +L    HPNIVR IG 
Sbjct: 5   RGNFGEVFSGRLRADNTPVAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDL 261
           C +     IV E  +GG    FL     R + +K  ++   + A GM Y+     IHRDL
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 262 KSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR-----WMAP 303
            + N L+     +KI+DFG++R E   +G+   TG  +     W AP
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREE--EDGVYASTGGMKQIPVKWTAP 165

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.9 bits (211), Expect = 4e-19
 Identities = 55/175 (31%), Positives = 86/175 (49%), Gaps = 26/175 (14%)

Query: 135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK- 191
            +GD    G FG +Y       GE VAIK +++     E+   +     +EV  L  L  
Sbjct: 6   QLGD----GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-----REVKSLRKLNE 56

Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP---LKLAVKQALDVARGM 248
           HPNIV+     R+      V EY +G ++ Q +  R+ +      ++  + Q   + +G+
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQ---ILQGL 112

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY---RW 300
           A++H+ G  HRDLK +NLL+   + +KIADFG+AR   +     P T  Y   RW
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYT-DYVSTRW 163

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 7e-19
 Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 30/156 (19%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G++Y+      GE VA+K + R EN+ E          +E+ +L  L+HPNIVR  
Sbjct: 9   EGTYGQVYKARNKKTGELVALKKI-RMENEKEG---FPITAIREIKLLQKLRHPNIVRLK 64

Query: 200 GACRKPMVWCIVTEYAKGG----------SVRQFLTKRQNR-SVP-LKLAVKQALDVARG 247
                     IVT   KG            +   L   + + +   +K  +KQ L    G
Sbjct: 65  ---------EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---EG 112

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           + Y+H  G++HRD+K  N+LI +D  +K+ADFG+AR
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.9 bits (207), Expect = 8e-19
 Identities = 53/176 (30%), Positives = 90/176 (51%), Gaps = 11/176 (6%)

Query: 136 MGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
           +G    QGAFG++Y       G E+A+K ++     PE ++ +    + E+ +L  L H 
Sbjct: 6   LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEV-NALECEIQLLKNLLHE 64

Query: 194 NIVRFIGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
            IV++ G  R PM     I  E+  GGS++  L  +   ++   +  K    +  G++Y+
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYL 122

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 303
           H   ++HRD+K  N+L  S  ++K+ DFG ++    I +   GM   TGT  WM+P
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 83.8 bits (207), Expect = 1e-18
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 25/161 (15%)

Query: 158 VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VA+K+L    N   +       F +E+ +++ LK PNI+R +  C      C++TEY + 
Sbjct: 49  VAVKMLREDANKNAR-----NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103

Query: 218 GSVRQFLTKRQNRSVPLKLAVK---------QALDVARGMAYVHRLGLIHRDLKSDNLLI 268
           G + QFL++ + +    K  V           A  +A GM Y+  L  +HRDL + N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163

Query: 269 FSDKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 302
             + +IKIADFG++R         +Q   + P     RWM+
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP----IRWMS 200

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 83.8 bits (207), Expect = 1e-18
 Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 12/175 (6%)

Query: 132 RKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT 189
           +K    +   QGA G +Y       G+EVAIK +   +  P+K  ++      E++++  
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII-----NEILVMRE 72

Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
            KHPNIV ++ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 73  NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALE 129

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHRD+KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.9 bits (205), Expect = 1e-18
 Identities = 45/167 (26%), Positives = 89/167 (53%), Gaps = 11/167 (6%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPE-NDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +GAFG+  LYR T +   V  K +     ++ E+   +      E+++L+ L+HPNI+ +
Sbjct: 10  KGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-----NEIVILSLLQHPNIIAY 64

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
                      I  EYA GG++   + +++ +    ++ +     +   ++Y+H+ G++H
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           RD+K+ N+ +     IK+ DFG+++I + +E    ET  GT  +M+P
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVVGTPYYMSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 14/147 (9%)

Query: 142 QGAFGKLY--RGTYNGEEVAIK-ILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +GA+G +   R    GE VAIK   E  +++  K   +     +EV +L  L+H NIV  
Sbjct: 11  EGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-----REVKVLRQLRHENIVNL 65

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYVHRLGL 256
             A R+     +V EY    ++ + L        P  ++  + Q L   + +AY H   +
Sbjct: 66  KEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLL---QAIAYCHSHNI 121

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR 283
           IHRD+K +N+L+     +K+ DFG AR
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.0 bits (205), Expect = 1e-18
 Identities = 53/171 (30%), Positives = 87/171 (50%), Gaps = 19/171 (11%)

Query: 142 QGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA 201
           +G +G +Y       +V I I E PE D    Q +     +E+ + + LKH NIV+++G+
Sbjct: 18  KGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL----HEEIALHSYLKHRNIVQYLGS 73

Query: 202 CRKPMVWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
             +   + I  E   GGS+   L  +    ++    +    KQ L+   G+ Y+H   ++
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE---GLKYLHDNQIV 130

Query: 258 HRDLKSDNLLIFSDKSI-KIADFG----VARIEVQTEGMTPETGTYRWMAP 303
           HRD+K DN+L+ +   + KI+DFG    +A I   TE     TGT ++MAP
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 82.5 bits (204), Expect = 3e-18
 Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 31/180 (17%)

Query: 142 QGAFGKLYRGTYN------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           +G FG +    Y+      GE VA+K L+        A+ + + F++E+ +L +L+H NI
Sbjct: 14  KGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHL-RDFEREIEILKSLQHDNI 67

Query: 196 VRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           V++ G C    R+ +   +V EY   GS+R +L K + R    KL +  A  + +GM Y+
Sbjct: 68  VKYKGVCYSAGRRNLR--LVMEYLPYGSLRDYLQKHRERLDHRKL-LLYASQICKGMEYL 124

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 303
                +HRDL + N+L+ S+  +KI DFG+ ++        +V+  G +P      W AP
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP----IFWYAP 180

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.4 bits (203), Expect = 4e-18
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 38/207 (18%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAQVME 177
           W     KL +G    +G FG++      G +         VA+K+L+    + + + ++ 
Sbjct: 10  WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS 69

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
           +      MM    KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 70  EM----EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125

Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                +  +  K  V     VARGM Y+     IHRDL + N+L+  +  +KIADFG+AR
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 186 DVNNIDYYKKTTNGRLP----VKWMAP 208

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.4 bits (201), Expect = 4e-18
 Identities = 54/181 (29%), Positives = 92/181 (50%), Gaps = 17/181 (9%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           I+  +L        G FG ++ G +  + +VAIK +        +  + E+ F +E  ++
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN-------EGAMSEEDFIEEAKVM 53

Query: 188 ATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALDV 244
             L HP +V+  G C  +KP+   IVTE+ + G +  +L +RQ + S  + L++ Q  DV
Sbjct: 54  MKLSHPKLVQLYGVCTQQKPLY--IVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ--DV 109

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMA 302
             GM Y+ R   IHRDL + N L+ S   +K++DFG+ R  +  E  +     +  +W  
Sbjct: 110 CEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSP 169

Query: 303 P 303
           P
Sbjct: 170 P 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 82.0 bits (202), Expect = 5e-18
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 33/201 (16%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRG----TYNGEE---VAIKILERPENDPEKAQV-MEQQF 180
           I+L  +   +   +  FGK+Y+G    T  GE+   VAIK L+      +KA+  + ++F
Sbjct: 2   INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK------DKAEGPLREEF 55

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR----SVPLKL 236
           + E MM + L+HPNIV  +G   K     ++  Y     + +FL  R       S     
Sbjct: 56  KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115

Query: 237 AVKQALD----------VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV 286
            VK  L+          +A GM ++    ++H+DL + N+L+F   ++KI+D G+ R EV
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR-EV 174

Query: 287 QTEGMTPETGT----YRWMAP 303
                    G      RWM+P
Sbjct: 175 YAADYYKLMGNSLLPIRWMSP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 81.4 bits (201), Expect = 5e-18
 Identities = 42/167 (25%), Positives = 83/167 (49%), Gaps = 9/167 (5%)

Query: 141 AQGAFGKLYRGTY--NGEEVAIKILE-RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            +G+FG +++     +    A+K ++    N  E+ + ++     E  +LA L    I+R
Sbjct: 9   GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-----EARVLAKLDSSYIIR 63

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
           +  +        IV EYA+ G + + L  ++ R +P     +  + +  G+A++H   ++
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 303
           HRD+KS NL + +  ++KI D GVA++    T       GT  +++P
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 81.6 bits (201), Expect = 6e-18
 Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 37/194 (19%)

Query: 138 DAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK 191
           +   + AFGK+Y+G        + + VAIK L +  N+P++      +FQQE  ++A L 
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWG----EFQQEASLMAELH 65

Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-----SVPLKLAVKQALD--- 243
           HPNIV  +G   +    C++ EY   G + +FL  R        S      VK +LD   
Sbjct: 66  HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125

Query: 244 -------VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-------IEVQTE 289
                  +A GM Y+     +H+DL + N+LI     +KI+D G++R         VQ +
Sbjct: 126 FLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 290 GMTPETGTYRWMAP 303
            + P     RWM P
Sbjct: 186 SLLP----IRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.2 bits (201), Expect = 6e-18
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)

Query: 158 VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAK 216
           +A+K +    N+  + Q++     +E+ +L     P IV F GA      +  I  EY  
Sbjct: 29  MAVKTIRLEINEAIQKQIL-----RELDILHKCNSPYIVGFYGAFYNNGDIS-ICMEYMD 82

Query: 217 GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIK 275
           GGS+ + L K     +P ++  K A+ V +G+ Y+H    +IHRD+K  N+L+ S   IK
Sbjct: 83  GGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIK 141

Query: 276 IADFGVARIEVQTEGMTPETGTYRWMAP 303
           + DFGV+   V +   T   GT  +MAP
Sbjct: 142 LCDFGVSGQLVNSLAKT-FVGTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 81.6 bits (201), Expect = 7e-18
 Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 14/166 (8%)

Query: 143 GAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           GAFGK+Y+      G   A K++E       K++   + +  E+ +LAT  HP IV+ +G
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIE------TKSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           A        I+ E+  GG+V   + +  R      +++  +Q L+    + Y+H + +IH
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMKIIH 133

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           RDLK+ N+L+  D  IK+ADFGV+   V+T +      GT  WMAP
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.4 bits (202), Expect = 8e-18
 Identities = 55/171 (32%), Positives = 92/171 (53%), Gaps = 23/171 (13%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM----MLATLKHPNI 195
            G+FG+  L R   +G+  A+KIL        KA++++ +  + V+    +L +++HP +
Sbjct: 11  TGSFGRVMLVRHKGSGKYYALKILS-------KAKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           V   G+ +      +V EY  GG +   L  R++   P  +A   A  V   + Y+H L 
Sbjct: 64  VNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHSLD 121

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 303
           +++RDLK +NLL+ SD  IKI DFG A R++ +T  +  TPE     ++AP
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-----YLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 80.6 bits (199), Expect = 1e-17
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 23/175 (13%)

Query: 142 QGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
           +G FG +Y GT    +G+++  A+K L R  +  E  Q     F +E +++    HPN++
Sbjct: 5   KGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-----FLKEGIIMKDFSHPNVL 59

Query: 197 RFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
             +G C      P+V   V  Y K G +R F+      +  +K  +   L VA+GM Y+ 
Sbjct: 60  SLLGICLPSEGSPLV---VLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA 115

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YRWMA 302
               +HRDL + N ++    ++K+ADFG+AR     E  +    T      +WMA
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 28/173 (16%)

Query: 143 GAFGKLYRGTYNGEEV--AIKILE-RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           GAFGK+Y+  +    +  A KI++   E + E        F  E+ +L+  KHPNIV   
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELE-------DFMVEIDILSECKHPNIVGLY 68

Query: 200 GA-CRKPMVWCIVTEYAKGGSVRQF-------LTKRQNRSVPLKLAVKQALDVARGMAYV 251
            A   +  +W I+ E+  GG++          LT+ Q R V      +Q L+    + ++
Sbjct: 69  EAYFYENKLW-ILIEFCDGGALDSIMLELERGLTEPQIRYV-----CRQMLE---ALNFL 119

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           H   +IHRDLK+ N+L+  D  +K+ADFGV A+ +   +      GT  WMAP
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 23/173 (13%)

Query: 143 GAFGKLYRGTYNGEE----VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           G FG + +G Y  ++    VA+KIL+   NDP     ++ +  +E  ++  L +P IVR 
Sbjct: 6   GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP----ALKDELLREANVMQQLDNPYIVRM 61

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           IG C     W +V E A+ G + +FL K  N+ V  K   +    V+ GM Y+     +H
Sbjct: 62  IGICEAE-SWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 303
           RDL + N+L+ +    KI+DFG+++         + +T G  P     +W AP
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP----VKWYAP 167

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 17/154 (11%)

Query: 139 AFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQF-QQEVMMLATLKHPNI 195
              +G+FGK+Y  +   + E   IK     E D  K  V E++  ++EV++LA +KHPNI
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIK-----EIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL----DVARGMAYV 251
           V F  + ++     IV EY  GG     L KR NR   +  +  Q L     ++ G+ ++
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGD----LMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117

Query: 252 HRLGLIHRDLKSDNLLIFSDKSI-KIADFGVARI 284
           H   ++HRD+KS N+ +  +  + K+ DFG+AR 
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 57/191 (29%), Positives = 84/191 (43%), Gaps = 37/191 (19%)

Query: 140 FAQGAFGKLYRGT-------YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH 192
             +GAFGK++           +   VA+K L+      E ++   Q FQ+E  +L  L+H
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK------EASESARQDFQREAELLTVLQH 66

Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR--------QNRSVPL-KLAVKQAL- 242
            +IVRF G C +     +V EY + G + +FL               V   +L + Q L 
Sbjct: 67  QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 243 ---DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-------IEVQTEGMT 292
               +A GM Y+  L  +HRDL + N L+     +KI DFG++R         V    M 
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 293 PETGTYRWMAP 303
           P     RWM P
Sbjct: 187 P----IRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 80.5 bits (198), Expect = 1e-17
 Identities = 61/189 (32%), Positives = 90/189 (47%), Gaps = 29/189 (15%)

Query: 130 DLRKLNMGDAF------AQGAFGKLY--RGTYNGEEVAIKILE-RPENDPEKAQVMEQQF 180
           DL + N  + F        G +G +Y  R    GE  AIK+++  P  D    Q      
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ------ 54

Query: 181 QQEVMMLATLKHPNIVRFIGA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
            QE++M+   KH NIV + G+  R+  +W I  E+  GGS++          V   L+  
Sbjct: 55  -QEIIMMKDCKHSNIVAYFGSYLRRDKLW-ICMEFCGGGSLQDIY------HVTGPLSES 106

Query: 240 QALDVAR----GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPE 294
           Q   V+R    G+ Y+H  G +HRD+K  N+L+  +  +K+ADFGV A+I          
Sbjct: 107 QIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166

Query: 295 TGTYRWMAP 303
            GT  WMAP
Sbjct: 167 IGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.3 bits (198), Expect = 1e-17
 Identities = 53/153 (34%), Positives = 75/153 (49%), Gaps = 16/153 (10%)

Query: 158 VAIKILERPENDPEKAQVMEQQ---FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY 214
           VAIK L        KA   E+Q   F  E  ++    HPNI+   G   K     IVTEY
Sbjct: 35  VAIKTL--------KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86

Query: 215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI 274
            + GS+  FL K   +   ++L V     +A GM Y+  +G +HRDL + N+L+ S+   
Sbjct: 87  MENGSLDAFLRKHDGQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC 145

Query: 275 KIADFGVARI-EVQTEGMTPETG---TYRWMAP 303
           K++DFG++R+ E   E      G     RW AP
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 79.5 bits (197), Expect = 2e-17
 Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 34/178 (19%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQV----MEQQFQQEVMMLATLKHPNI 195
           +G+FGK+   R    G+  A+K+L+       K ++      +    E  +L+ + HP I
Sbjct: 3   KGSFGKVLLVRKKDTGKLYAMKVLK-------KKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 196 VRFIGACRKPMVWCI--------VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           V+        + +          V EYA GG +   L   +      + A   A ++   
Sbjct: 56  VK--------LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA 105

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           + Y+H LG+I+RDLK +N+L+ +D  IK+ DFG+A+     EG    T  GT  ++AP
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 53/170 (31%), Positives = 83/170 (48%), Gaps = 15/170 (8%)

Query: 143 GAFGKLYRGTYN--GEE---VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           G FG+++RG     G +   VAIK L+     P   +   Q F  E  ++    H NI+R
Sbjct: 16  GEFGEVFRGILKMPGRKEVAVAIKTLK-----PGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
             G   K     I+TEY + G++ ++L          +L V     +A GM Y+  +  +
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLSDMNYV 129

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG---TYRWMAP 303
           HRDL + N+L+ S+   K++DFG++R+ E   EG    +G     RW AP
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 57/170 (33%), Positives = 83/170 (48%), Gaps = 23/170 (13%)

Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           G +G +Y  R  + GE  A+KI++    D           QQE+ M+   KH NIV + G
Sbjct: 20  GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL------IQQEIFMVKECKHCNIVAYFG 73

Query: 201 A--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR----GMAYVHRL 254
           +   R+ +  C+  EY  GGS++          V   L+  Q   V R    G+AY+H  
Sbjct: 74  SYLSREKLWICM--EYCGGGSLQDIY------HVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           G +HRD+K  N+L+  +  +K+ADFGV A+I           GT  WMAP
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 51/162 (31%), Positives = 87/162 (53%), Gaps = 15/162 (9%)

Query: 140 FAQGAFGKLY------RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
             +G FGK+        G   GE+VA+K L +PE+            ++E+ +L  L H 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIA----DLKKEIEILRNLYHE 66

Query: 194 NIVRFIGACRKPMVWCI--VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           NIV++ G C +     I  + E+   GS++++L + +N+ + LK  +K A+ + +GM Y+
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYL 125

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMT 292
                +HRDL + N+L+ S+  +KI DFG+ + IE   E  T
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 79.7 bits (196), Expect = 3e-17
 Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 13/170 (7%)

Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           +   +G+FG++++G  N  +  VAIKI+     D E+A+   +  QQE+ +L+    P +
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            ++ G+  K     I+ EY  GGS    L         +   +K+ L   +G+ Y+H   
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEK 121

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
            IHRD+K+ N+L+     +K+ADFGVA     T+ +   T  GT  WMAP
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.5 bits (197), Expect = 3e-17
 Identities = 54/173 (31%), Positives = 88/173 (50%), Gaps = 17/173 (9%)

Query: 136 MGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQV-MEQQFQQEVMMLATLKH 192
            G    +G +  +Y+      G  VAIK ++    + ++A+  +     +E+ +L  LKH
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIK--LGERKEAKDGINFTALREIKLLQELKH 61

Query: 193 PNIVRFIGA-CRKPMVWCIVTEYAKGGSVRQFLTKR-QNRSVPLKLA-VKQ-ALDVARGM 248
           PNI+  +     K  +  +V E+ +       L K  +++S+ L  A +K   L   RG+
Sbjct: 62  PNIIGLLDVFGHKSNI-NLVFEFMETD-----LEKVIKDKSIVLTPADIKSYMLMTLRGL 115

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTPETGTYRW 300
            Y+H   ++HRDLK +NLLI SD  +K+ADFG+AR        MT +  T RW
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RW 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 60/173 (34%), Positives = 89/173 (51%), Gaps = 32/173 (18%)

Query: 143 GAFGKLY----RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           GA G +Y    R T  G   A+K++     D  + Q+      +E+ +L  + HPN+V+ 
Sbjct: 85  GAGGTVYKVIHRPT--GRLYALKVIYGNHEDTVRRQIC-----REIEILRDVNHPNVVKC 137

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL-DVAR----GMAYVHR 253
                      ++ E+  GGS+       +   +    A +Q L DVAR    G+AY+HR
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSL-------EGTHI----ADEQFLADVARQILSGIAYLHR 186

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP---ETGTYRWMAP 303
             ++HRD+K  NLLI S K++KIADFGV+RI  QT  M P     GT  +M+P
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSP 237

Length = 353

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 7e-17
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 25/168 (14%)

Query: 134 LNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAQVMEQQFQQEVMMLA 188
           L +G    +G FG +  G  + ++     VA+K ++   +         ++F  E   + 
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH----TYSEIEEFLSEAACMK 56

Query: 189 TLKHPNIVRFIGAC---------RKPMVWCIVTEYAKGGSVRQFL----TKRQNRSVPLK 235
              HPN+++ IG C          KPMV   +  + K G +  FL           +PL+
Sbjct: 57  DFDHPNVMKLIGVCFEASSLQKIPKPMV---ILPFMKHGDLHSFLLYSRLGGLPEKLPLQ 113

Query: 236 LAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
             +K  +D+A GM Y+     IHRDL + N ++  D ++ +ADFG+++
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.5 bits (193), Expect = 7e-17
 Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 21/185 (11%)

Query: 128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVM 185
             +LRKL +      G FG +++G +   G+ + I +  +   D    Q   Q+    ++
Sbjct: 6   ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF-QEITDHML 61

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALDV 244
            + +L H  IVR +G C    +  +VT+ +  GS+   +  RQ+R S+  +  +   + +
Sbjct: 62  AMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQI 118

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-------EVQTEGMTPETGT 297
           A+GM Y+    ++HR+L + N+L+ SD  ++IADFGVA +          +E  TP    
Sbjct: 119 AKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP---- 174

Query: 298 YRWMA 302
            +WMA
Sbjct: 175 IKWMA 179

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 78.6 bits (193), Expect = 8e-17
 Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 11/169 (6%)

Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           +   +G+FG++++G  N  +  VAIKI+     D E+A+   +  QQE+ +L+    P +
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            ++ G+  K     I+ EY  GGS    L         +   +++ L   +G+ Y+H   
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEK 121

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 303
            IHRD+K+ N+L+     +K+ADFGVA     T+       GT  WMAP
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 8e-17
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 23/158 (14%)

Query: 141 AQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---HPNI 195
            +GA+G +Y+      G  VA+K +  P ++    + +     +E+ +L  L+   HPNI
Sbjct: 8   GEGAYGTVYKARDLNTGRFVALKKVRVPLSE----EGIPLSTLREIALLKQLESFEHPNI 63

Query: 196 VRFIGACRKP-----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA----R 246
           VR +  C  P     +   +V E+     V Q L    ++     L  +   D+     R
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           G+ ++H   ++HRDLK  N+L+ SD  +KIADFG+ARI
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 78.4 bits (193), Expect = 8e-17
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 23/189 (12%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYN--GEE---VAIKILERPENDPEKAQVMEQQ---F 180
           ID+  + + +    G FG++ RG     G+    VAIK L        K+   E+Q   F
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--------KSGYTEKQRRDF 52

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
             E  ++    HPNI+   G   K     I+TE+ + G++  FL +   +   ++L V  
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VGM 111

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
              +A GM Y+  +  +HRDL + N+L+ S+   K++DFG++R           T +   
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 299 ----RWMAP 303
               RW AP
Sbjct: 172 KIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 78.2 bits (192), Expect = 9e-17
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 11/175 (6%)

Query: 137 GDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN 194
           G    QGAFG++Y       G E+A K ++     PE ++ +    + E+ +L  L+H  
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEV-SALECEIQLLKNLQHER 65

Query: 195 IVRFIGACRK--PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           IV++ G  R        I  EY  GGSV+  L  +   ++   +  K    +  GM+Y+H
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLH 123

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR----IEVQTEGMTPETGTYRWMAP 303
              ++HRD+K  N+L  S  ++K+ DFG ++    I +   G+   TGT  WM+P
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.7 bits (194), Expect = 9e-17
 Identities = 59/183 (32%), Positives = 88/183 (48%), Gaps = 30/183 (16%)

Query: 130 DLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           DLR++        G+FG +Y  R     E VAIK +       +++    Q   +EV  L
Sbjct: 19  DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69

Query: 188 ATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLT--KRQNRSVPLKLAVKQALD 243
             L+HPN + + G C  R+   W +V EY  G S    L   K+  + V +      AL 
Sbjct: 70  QQLRHPNTIEYKG-CYLREHTAW-LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQ 126

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---GTYRW 300
              G+AY+H    IHRD+K+ N+L+    ++K+ADFG A +      ++P     GT  W
Sbjct: 127 ---GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYW 177

Query: 301 MAP 303
           MAP
Sbjct: 178 MAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 78.2 bits (192), Expect = 1e-16
 Identities = 53/175 (30%), Positives = 90/175 (51%), Gaps = 12/175 (6%)

Query: 132 RKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT 189
           +K    +   QGA G ++       G+EVAIK +   +  P+K  ++      E++++  
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELII-----NEILVMKE 72

Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
           LK+PNIV F+ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALE 129

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHRD+KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 53/164 (32%), Positives = 84/164 (51%), Gaps = 10/164 (6%)

Query: 143 GAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC 202
           GAFGK+Y+   N E     +L   +    K++   + +  E+ +LA+  HPNIV+ + A 
Sbjct: 16  GAFGKVYKAQ-NKE---TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 203 RKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
                  I+ E+  GG+V   + +  R      +++  KQ L+    + Y+H   +IHRD
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHENKIIHRD 128

Query: 261 LKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           LK+ N+L   D  IK+ADFGV+    +T +      GT  WMAP
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 25/181 (13%)

Query: 138 DAFAQGAFGKLYRGTYNG----EEVAIKILERPENDPEKAQVMEQ-QFQQEVMMLATLKH 192
           D    G FGK+  G  +       V +K L         A   EQ  F QEV     L H
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELR------ASATPDEQLLFLQEVQPYRELNH 54

Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLK-LAVKQALDVARGMA 249
           PN+++ +G C + + + +V E+   G ++ +L   +     +  K +  + A +VA G+ 
Sbjct: 55  PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMA 302
           ++H+   IH DL   N  + +D S+KI D+G+A           +     P     RW+A
Sbjct: 115 WLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP----LRWLA 170

Query: 303 P 303
           P
Sbjct: 171 P 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 11/145 (7%)

Query: 140 FAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            ++GA+G+++  +    G+  AIK++++  +   K QV   Q   E  +L+  + P +V+
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKK-ADMIRKNQV--DQVLTERDILSQAQSPYVVK 57

Query: 198 FIGA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
              +   +K +   +V EY  GG +   L      S+   +A     ++   + Y+H  G
Sbjct: 58  LYYSFQGKKNL--YLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSNG 113

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFG 280
           +IHRDLK DN+LI S+  +K+ DFG
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFG 138

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.8 bits (189), Expect = 2e-16
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 7/165 (4%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GAFG ++  R   + + V IK +       +  +      Q E  +L  L HPNI+ + 
Sbjct: 10  RGAFGIVHLCRRKADQKLVIIKQI----PVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
               +     IV EYA GG++ +++ KR N  +     +   + +   + +VH   ++HR
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125

Query: 260 DLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK+ N+L+   K + KI DFG+++I           GT  +++P
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.0 bits (189), Expect = 3e-16
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 33/200 (16%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQ- 178
           W +   K+ M     QG+FG +Y G   G         VAIK +       E A + E+ 
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN------EAASMRERI 54

Query: 179 QFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV-- 232
           +F  E  ++      ++VR +G   +     ++ E    G ++ +L     + +N  V  
Sbjct: 55  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 233 --PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE- 289
              LK  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+ 
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174

Query: 290 ------GMTPETGTYRWMAP 303
                 G+ P     RWM+P
Sbjct: 175 YRKGGKGLLP----VRWMSP 190

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 8/161 (4%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G++G ++  R    G+ VAIK     E+DP    V+++   +E+ ML  LKHPN+V  I
Sbjct: 11  EGSYGVVFKCRNRETGQIVAIKKFVESEDDP----VIKKIALREIRMLKQLKHPNLVNLI 66

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
              R+     +V EY    +V   L K   R VP  L  K      + + + H+   IHR
Sbjct: 67  EVFRRKRKLHLVFEYCDH-TVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHR 124

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           D+K +N+LI     IK+ DFG ARI         +    RW
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW 165

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 76.6 bits (188), Expect = 5e-16
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 110 ALMDSNSPTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKIL 163
            L   NS   GLE+     D W I        +   +G +GK+Y+ T   +G   A+KIL
Sbjct: 3   GLFPYNSSMLGLESLGDPTDTWEII-------ETIGKGTYGKVYKVTNKKDGSLAAVKIL 55

Query: 164 ERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGA------CRKPMVWCIVTEYAK 216
           + P +D      ++++ + E  +L +L  HPN+V+F G            +W +V E   
Sbjct: 56  D-PISD------VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW-LVLELCN 107

Query: 217 GGSVRQFLTKRQNRSVPLKLAVKQAL--DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI 274
           GGSV + +         L  A+   +      G+ ++H   +IHRD+K +N+L+ ++  +
Sbjct: 108 GGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGV 167

Query: 275 KIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           K+ DFGV A++           GT  WMAP
Sbjct: 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 77.6 bits (191), Expect = 6e-16
 Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 7/151 (4%)

Query: 141 AQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           ++GAFGK+Y  R   N +  A+K++++ +   +    M  Q Q E   LA  K P IV  
Sbjct: 13  SRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN---MVHQVQAERDALALSKSPFIVHL 69

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
             + +      +V EY  GG V+  L         +  AVK   +VA  + Y+HR G+IH
Sbjct: 70  YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM--AVKYISEVALALDYLHRHGIIH 127

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           RDLK DN+LI ++  IK+ DFG++++ +  E
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.8 bits (186), Expect = 7e-16
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 19/172 (11%)

Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRFI 199
           G +G++Y+G +   G+  AIK+++  E++       E++ + E+ ML    H  NI  + 
Sbjct: 27  GTYGQVYKGRHVKTGQLAAIKVMDVTEDE-------EEEIKLEINMLKKYSHHRNIATYY 79

Query: 200 GACRKP-------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           GA  K         +W +V E+   GSV   +   +  ++          ++ RG+A++H
Sbjct: 80  GAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
              +IHRD+K  N+L+  +  +K+ DFGV A+++          GT  WMAP
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 28/211 (13%)

Query: 97  RVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGT--YN 154
           RVSH     AL + ++    P E L++F         + +G    +G+ G +   T  + 
Sbjct: 1   RVSHEQFRAAL-QLVVSPGDPREYLDSF---------IKIG----EGSTGIVCIATEKHT 46

Query: 155 GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY 214
           G++VA+K +     D  K Q  E  F  EV+++    H N+V    +        +V E+
Sbjct: 47  GKQVAVKKM-----DLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100

Query: 215 AKGGSVRQFLT-KRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS 273
            +GG++   +T  R N     ++A    L V R ++Y+H  G+IHRD+KSD++L+ SD  
Sbjct: 101 LEGGALTDIVTHTRMNEE---QIAT-VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR 156

Query: 274 IKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           IK++DFG  A++  +        GT  WMAP
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.0 bits (188), Expect = 8e-16
 Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 29/175 (16%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA+G +        G +VAIK +    +D   A+    +  +E+ +L  L+H NI+  +
Sbjct: 10  SGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK----RILREIKLLRHLRHENIIGLL 65

Query: 200 GACRKPMVWC-----IVTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVARGMA 249
              R P         IVTE      + + +   Q    PL     +  + Q L   RG+ 
Sbjct: 66  DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQ----PLTDDHIQYFLYQIL---RGLK 117

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI----EVQTEGMTPETGTYRW 300
           Y+H   +IHRDLK  N+L+ S+  +KI DFG+AR     E +   +T    T RW
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT-RW 171

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 51/179 (28%), Positives = 92/179 (51%), Gaps = 17/179 (9%)

Query: 136 MGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQ--QFQQEVMMLATLK 191
           +G    +GAFG++Y       G E+A+K   +   DP+  +  ++    + E+ +L  L+
Sbjct: 6   LGKLLGRGAFGEVYLCYDADTGRELAVK---QVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 192 HPNIVRFIGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
           H  IV++ G  R P      I  EY  GGS++  L  +   ++   +  +    + +G++
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-----EGMTPETGTYRWMAP 303
           Y+H   ++HRD+K  N+L  S  ++K+ DFG ++  +QT      G+   TGT  WM+P
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK-RIQTICMSGTGIKSVTGTPYWMSP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 38/175 (21%)

Query: 131 LRKLNMGDAFAQGAFGKLYRGTYN--GEEVAIK-ILERPEND--PEKAQVMEQQFQQEVM 185
           LR   +     +G FG++Y+      G  VA+K IL   E D  P  A        +E+ 
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-------REIK 59

Query: 186 MLATLKHPNIVRFI--------GACRKPMVWCIVTEYA--------KGGSVRQFLTKRQN 229
           +L  LKHPN+V  I         + RK     +VT Y         +  SV+  LT+ Q 
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQ- 116

Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
               +K  + Q L+   G+ Y+H   ++HRD+K+ N+LI +   +KIADFG+AR 
Sbjct: 117 ----IKCYMLQLLE---GINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 53/182 (29%), Positives = 97/182 (53%), Gaps = 19/182 (10%)

Query: 130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEE----VAIKILERPENDPEKAQVMEQQFQQE 183
           +L+K+ +      GAFG +Y+G +  +GE     VAIK+L   EN   KA    ++   E
Sbjct: 8   ELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR--ENTSPKAN---KEILDE 59

Query: 184 VMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
             ++A +  P + R +G C    V  +VT+    G +  ++ + ++R +  +  +   + 
Sbjct: 60  AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQ 117

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTY--RW 300
           +A+GM+Y+  + L+HRDL + N+L+ S   +KI DFG+AR +++       + G    +W
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177

Query: 301 MA 302
           MA
Sbjct: 178 MA 179

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 75.0 bits (184), Expect = 1e-15
 Identities = 62/190 (32%), Positives = 85/190 (44%), Gaps = 36/190 (18%)

Query: 138 DAFAQGAFGKLYRGTY----NGEEVAIKILER--PENDPEKAQVMEQQFQQEVMMLATL- 190
           D   +G FG++ R            AIK+L+    END        + F  E+ +L  L 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND-------HRDFAGELEVLCKLG 60

Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR----------QNRSVPLKLAVKQ 240
            HPNI+  +GAC       I  EYA  G++  FL K           +       L  +Q
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 241 ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE----VQTEGMT 292
               A DVA GM Y+     IHRDL + N+L+  + + KIADFG++R E     +T G  
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 293 PETGTYRWMA 302
           P     RWMA
Sbjct: 181 P----VRWMA 186

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.5 bits (183), Expect = 1e-15
 Identities = 40/145 (27%), Positives = 82/145 (56%), Gaps = 6/145 (4%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FGK  L +   +G++  IK +   +  P++     ++ ++EV +L+ +KHPNIV++ 
Sbjct: 10  EGSFGKAILVKSKEDGKQYVIKEINISKMSPKE----REESRKEVAVLSNMKHPNIVQYQ 65

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            +  +     IV +Y +GG + + +  ++    P    +   + +   + +VH   ++HR
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125

Query: 260 DLKSDNLLIFSDKSIKIADFGVARI 284
           D+KS N+ +  D +IK+ DFG+AR+
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARV 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 38/203 (18%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAQVMEQQFQ 181
           I  R + +     +GAFGK++         T +   VA+K L+ P     K       FQ
Sbjct: 2   IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK------DFQ 55

Query: 182 QEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR----------QNRS 231
           +E  +L  L+H +IV+F G C       +V EY K G + +FL             Q R 
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 232 VPLKLAVKQAL----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR---- 283
              +L + Q L     +A GM Y+     +HRDL + N L+ ++  +KI DFG++R    
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175

Query: 284 ---IEVQTEGMTPETGTYRWMAP 303
                V    M P     RWM P
Sbjct: 176 TDYYRVGGHTMLP----IRWMPP 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 74.8 bits (183), Expect = 2e-15
 Identities = 52/175 (29%), Positives = 89/175 (50%), Gaps = 12/175 (6%)

Query: 132 RKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT 189
           +K    +   QGA G +Y       G+EVAIK +   +  P+K  ++      E++++  
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII-----NEILVMRE 72

Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
            K+PNIV ++ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALD 129

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHRD+KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 74.3 bits (182), Expect = 2e-15
 Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 33/194 (17%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYR--GTYNGEEVAIKILERPENDPEKAQVMEQQFQQ 182
           D W I        +   +G +GK+++     NG + A+KIL+ P +D      ++++ + 
Sbjct: 18  DTWEII-------ETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHD------IDEEIEA 63

Query: 183 EVMMLATLK-HPNIVRFIGACRKPMV------WCIVTEYAKGGSV----RQFLTKRQNRS 231
           E  +L  L  HPN+V+F G   K  V      W +V E   GGSV    + FL + +   
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERME 122

Query: 232 VPL-KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV-ARIEVQTE 289
            P+    + +AL    G+ ++H    IHRD+K +N+L+ ++  +K+ DFGV A++     
Sbjct: 123 EPIIAYILHEAL---MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 290 GMTPETGTYRWMAP 303
                 GT  WMAP
Sbjct: 180 RRNTSVGTPFWMAP 193

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.8 bits (182), Expect = 3e-15
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 20/176 (11%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILE-RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +G+FG +   R   +G+ +  K ++     + EK     QQ   EV +L  LKHPNIVR+
Sbjct: 10  KGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-----QQLVSEVNILRELKHPNIVRY 64

Query: 199 IGAC--RKPMVWCIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
                 R      IV EY +GG + Q +   K++ + +  +   +    +   +   H  
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 255 G-----LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
                 ++HRDLK  N+ + ++ ++K+ DFG+A+I +  +    +T  GT  +M+P
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 44/160 (27%), Positives = 81/160 (50%), Gaps = 23/160 (14%)

Query: 141 AQGAFGKLY---RGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
            +G +G++Y   R     G+E AIK  +    D E+   + Q   +E+ +L  LKH N+V
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFK---GDKEQYTGISQSACREIALLRELKHENVV 65

Query: 197 RFIGACRKPM---VWCIVTEYAKG--GSVRQFLTKRQNRSVP---LKLAVKQALDVARGM 248
             +    +     V+ ++ +YA+     + +F  + +  S+P   +K  + Q L+   G+
Sbjct: 66  SLVEVFLEHADKSVY-LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN---GV 121

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKS----IKIADFGVARI 284
            Y+H   ++HRDLK  N+L+  +      +KI D G+AR+
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 14/156 (8%)

Query: 154 NGEEVAIK-ILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---MVWC 209
            G   A+K I   P  D +K      Q  +E+ +  + K P IV++ GA        +  
Sbjct: 25  TGMIFALKTITTDPNPDLQK------QILRELEINKSCKSPYIVKYYGAFLDESSSSIG- 77

Query: 210 IVTEYAKGGSVRQFLTKRQNRS--VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL 267
           I  EY +GGS+     K + R   +  K+  K A  V +G++Y+H   +IHRD+K  N+L
Sbjct: 78  IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL 137

Query: 268 IFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +     +K+ DFGV+   V +   T  TGT  +MAP
Sbjct: 138 LTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.0 bits (181), Expect = 3e-15
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 12/175 (6%)

Query: 132 RKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT 189
           +K    +   QGA G +Y       G+EVAI+ +   +  P+K  ++      E++++  
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII-----NEILVMRE 73

Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
            K+PNIV ++ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALE 130

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHRD+KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.8 bits (181), Expect = 3e-15
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 33/200 (16%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGT----YNGE---EVAIKILERPENDPEKAQVMEQ- 178
           W +   K+ +     QG+FG +Y G       GE    VA+K +       E A + E+ 
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERI 54

Query: 179 QFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL-------TKRQNRS 231
           +F  E  ++      ++VR +G   K     +V E    G ++ +L            R 
Sbjct: 55  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114

Query: 232 VP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE- 289
            P L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+ 
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174

Query: 290 ------GMTPETGTYRWMAP 303
                 G+ P     RWMAP
Sbjct: 175 YRKGGKGLLP----VRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.0 bits (182), Expect = 4e-15
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 32/176 (18%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QG FG+++  R     + VA+K +   EN+ E   +   +   E+ +L  LKH N+V  I
Sbjct: 22  QGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 77

Query: 200 GACRKP--------------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL--D 243
             CR                  +C   E+   G     L    N++V   L+  + +   
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFC---EHDLAG----LL---SNKNVKFTLSEIKKVMKM 127

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR 299
           +  G+ Y+HR  ++HRD+K+ N+LI  D  +K+ADFG+AR    ++   P   T R
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 73.2 bits (180), Expect = 5e-15
 Identities = 43/167 (25%), Positives = 83/167 (49%), Gaps = 8/167 (4%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G F  +Y+     +G  VA+K ++  E    KA+   Q   +E+ +L  L HPN+++++
Sbjct: 12  KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR---QDCLKEIDLLKQLDHPNVIKYL 68

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
            +  +     IV E A  G + + +   K+Q R +P +   K  + +   + ++H   ++
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 303
           HRD+K  N+ I +   +K+ D G+ R    +T       GT  +M+P
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 30/175 (17%)

Query: 128 TIDLRKLNMGDAFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQQ-- 179
            I   ++ + D   +G FG+++ G    E      EV +K +        K    E Q  
Sbjct: 2   AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV--------KDHASEIQVT 53

Query: 180 -FQQEVMMLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTK------RQ 228
              QE  +L  L H NI+  +  C      P V   +  Y   G+++ FL +        
Sbjct: 54  LLLQESCLLYGLSHQNILPILHVCIEDGEPPFV---LYPYMNWGNLKLFLQQCRLGEANN 110

Query: 229 NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            +++  +  V  A+ +A GM+Y+H+ G+IH+D+ + N +I  +  +KI D  ++R
Sbjct: 111 PQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 73.6 bits (180), Expect = 5e-15
 Identities = 55/183 (30%), Positives = 84/183 (45%), Gaps = 23/183 (12%)

Query: 140 FAQGAFGKLYRGT-YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
             +GAFGK++    YN      KIL   +   + +    + F +E  +L  L+H +IV+F
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV-------PLKLAVKQALDVAR----G 247
            G C +     +V EY K G + +FL      +V       P +L   Q L +A+    G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-------GMTPETGTYRW 300
           M Y+     +HRDL + N L+  +  +KI DFG++R    T+        M P     RW
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP----IRW 188

Query: 301 MAP 303
           M P
Sbjct: 189 MPP 191

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 73.2 bits (180), Expect = 5e-15
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 12/151 (7%)

Query: 155 GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA-CRKPMVWCIVTE 213
           G +VA+K +     D  K Q  E  F  EV+++   +HPNIV    +      +W +V E
Sbjct: 44  GRQVAVKKM-----DLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELW-VVME 96

Query: 214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS 273
           + +GG++   +T  +     +       L   + ++++H  G+IHRD+KSD++L+ SD  
Sbjct: 97  FLEGGALTDIVTHTRMNEEQIATVCLAVL---KALSFLHAQGVIHRDIKSDSILLTSDGR 153

Query: 274 IKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           +K++DFG  A++  +        GT  WMAP
Sbjct: 154 VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 47/173 (27%), Positives = 88/173 (50%), Gaps = 24/173 (13%)

Query: 143 GAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
           GAFG +Y+G +  E       VAIK L R    P+      ++   E  ++A++ +P++ 
Sbjct: 18  GAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK----ANKEILDEAYVMASVDNPHVC 72

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           R +G C    V  ++T+    G +  ++ + ++  +  +  +   + +A+GM Y+    L
Sbjct: 73  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEERRL 130

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARI------EVQTE-GMTPETGTYRWMA 302
           +HRDL + N+L+ + + +KI DFG+A++      E   E G  P     +WMA
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP----IKWMA 179

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 73.3 bits (180), Expect = 7e-15
 Identities = 61/181 (33%), Positives = 92/181 (50%), Gaps = 25/181 (13%)

Query: 129 IDLRKLNMGDAFAQGAFGKL--YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM 186
           +DL+ + MG      AFG +   R    G+ VAIK + +P + P    V+ ++  +E+ +
Sbjct: 13  VDLQPVGMG------AFGLVCSARDQLTGQNVAIKKIMKPFSTP----VLAKRTYRELKL 62

Query: 187 LATLKHPNIVRFIGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ--AL 242
           L  L+H NI+        P+  ++  VTE   G  + + LT R     PL+    Q    
Sbjct: 63  LKHLRHENIISLSDIFISPLEDIY-FVTELL-GTDLHRLLTSR-----PLEKQFIQYFLY 115

Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
            + RG+ YVH  G++HRDLK  N+LI  +  +KI DFG+ARI  Q   MT    T  + A
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMTGYVSTRYYRA 173

Query: 303 P 303
           P
Sbjct: 174 P 174

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 72.7 bits (178), Expect = 8e-15
 Identities = 44/173 (25%), Positives = 83/173 (47%), Gaps = 17/173 (9%)

Query: 142 QGAFGKLYRGT----YNGEEVAIKILERPENDPEKAQVMEQ-QFQQEVMMLATLKHPNIV 196
            G FGK+  G     Y   +V +K L         A V EQ +F +E     +L+H N++
Sbjct: 5   NGWFGKVILGEVNSGYTPAQVVVKELR------VSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLT---KRQNRSVPLKLAVKQALDVARGMAYVHR 253
           + +G C +   + +V E+   G ++ +L    K +  +       + A ++A G+ ++H+
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 303
              IH DL   N L+ +D ++KI D+G++  + + +        +   RW+AP
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 9e-15
 Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 16/163 (9%)

Query: 134 LNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
           L +G    +G FG +  G  N ++  +K+  +        +   + F  E + +    HP
Sbjct: 1   LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 194 NIVRFIGACRK---------PMVWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVKQ 240
           N++R IG C +         P+V   +  + K G +  FL         + +P ++ VK 
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVV---ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
             D+A GM Y+     IHRDL + N ++  + ++ +ADFG+++
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 47/174 (27%), Positives = 88/174 (50%), Gaps = 19/174 (10%)

Query: 141 AQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVR 197
             G +G++Y+G +   G+  AIK+++   ++       E++ +QE+ ML    H  NI  
Sbjct: 15  GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIAT 67

Query: 198 FIGACRKP-------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
           + GA  K         +W +V E+   GSV   +   +  ++  +       ++ RG+++
Sbjct: 68  YYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           +H+  +IHRD+K  N+L+  +  +K+ DFGV A+++          GT  WMAP
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 72.2 bits (177), Expect = 1e-14
 Identities = 43/169 (25%), Positives = 85/169 (50%), Gaps = 11/169 (6%)

Query: 140 FAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           F +    ++Y  T     V +K L+   +  E     + +F Q+      L+HPNI++ +
Sbjct: 8   FGKVLLSEIYTDT-GVARVVVKELKANASSKE-----QNEFLQQGDPYRILQHPNILQCL 61

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYVHRLGLI 257
           G C + + + +V EY + G ++ +L++ Q   R+  L L  + A ++A G+ ++H+   +
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY---RWMAP 303
           H DL   N  + SD ++K+ D+G+     + + +  E       RW+AP
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 58/190 (30%), Positives = 89/190 (46%), Gaps = 36/190 (18%)

Query: 138 DAFAQGAFGKLYRGTYNGE----EVAIKILER--PENDPEKAQVMEQQFQQEVMMLATL- 190
           D   +G FG++ +     +    + AIK ++    ++D        + F  E+ +L  L 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------HRDFAGELEVLCKLG 53

Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----------NRSVPLKLAVKQ 240
            HPNI+  +GAC       +  EYA  G++  FL K +            S    L+ +Q
Sbjct: 54  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113

Query: 241 AL----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE----VQTEGMT 292
            L    DVARGM Y+ +   IHRDL + N+L+  +   KIADFG++R +     +T G  
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 293 PETGTYRWMA 302
           P     RWMA
Sbjct: 174 P----VRWMA 179

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 1e-14
 Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 13/167 (7%)

Query: 141 AQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           ++GAFG +Y  +    G+  AIK+L++ +    K QV   + ++ +MM+     P + + 
Sbjct: 5   SKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGES-PYVAKL 62

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
             + +      +V EY  GG     +       +P   A +   +V  G+  +H+ G+IH
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 303
           RD+K +NLLI     +K+ DFG++R      G+  +   GT  ++AP
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 23/173 (13%)

Query: 143 GAFGKLYRGTYNGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           G FG + +G Y       +VAIK+L+   N+ EK+   E   + E+M    L +P IVR 
Sbjct: 6   GNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMH--QLDNPYIVRM 60

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           IG C    +  +V E A GG + +FL+ +++  + +   V+    V+ GM Y+     +H
Sbjct: 61  IGVCEAEALM-LVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 303
           RDL + N+L+ +    KI+DFG+++         + ++ G  P     +W AP
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP----LKWYAP 167

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 18/169 (10%)

Query: 141 AQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQ---QEVMMLATLKHPNI 195
             G+FG +Y  T  +  E VA+K +          +   +++Q   +EV  L  LKHPN 
Sbjct: 30  GHGSFGAVYFATNSHTNEVVAVKKMSY------SGKQTNEKWQDIIKEVKFLQQLKHPNT 83

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQF-LTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + + G   K     +V EY  G +     + K+  + V +      AL   +G+AY+H  
Sbjct: 84  IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH 140

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +IHRD+K+ N+L+     +K+ADFG A             GT  WMAP
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAP 186

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 41/130 (31%), Positives = 63/130 (48%), Gaps = 8/130 (6%)

Query: 155 GEEVAIKI-LERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTE 213
           G+ VAIK  LE  ++   K   M     +E+ ML  L+H N+V  I   R+     +V E
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80

Query: 214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS 273
           +    +V   L K  N  +      K    + RG+ + H   +IHRD+K +N+L+     
Sbjct: 81  FVDH-TVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV 138

Query: 274 IKIADFGVAR 283
           +K+ DFG AR
Sbjct: 139 VKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 56/175 (32%), Positives = 89/175 (50%), Gaps = 23/175 (13%)

Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---HPNIVR 197
           GA+G +Y  R  ++G  VA+K +    N+      +     +EV +L  L+   HPNIVR
Sbjct: 11  GAYGTVYKARDPHSGHFVALKSVRVQTNE----DGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 198 FIGAC------RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL---KLAVKQALDVARGM 248
            +  C      R+  V  +V E+     +R +L K     +P    K  ++Q L   RG+
Sbjct: 67  LMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGL 121

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            ++H   ++HRDLK +N+L+ S   +K+ADFG+ARI      +TP   T  + AP
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.0 bits (174), Expect = 4e-14
 Identities = 54/177 (30%), Positives = 86/177 (48%), Gaps = 13/177 (7%)

Query: 131 LRKLNMGDAFAQGAFGKL----YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM 186
           L    MG+    G+FG++    ++GT  GE  AIK L++ E    K QV  Q   QE  +
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMK-QV--QHVAQEKSI 71

Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           L  L HP IV  + + +       + E+  GG +  F   R+    P  +A     ++  
Sbjct: 72  LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVL 129

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
              Y+H   +I+RDLK +NLL+ +   +K+ DFG A+ +V  +      GT  ++AP
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KV-PDRTFTLCGTPEYLAP 184

Length = 329

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 52/165 (31%), Positives = 81/165 (49%), Gaps = 8/165 (4%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G +Y  R    GE VA+K +     D E   V     + E+ +L  L HPNIV+ +
Sbjct: 10  EGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIR-EISLLKELNHPNIVKLL 65

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
                     +V E+     +++F+       +PL L       + +G+A+ H   ++HR
Sbjct: 66  DVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124

Query: 260 DLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           DLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 55/172 (31%), Positives = 88/172 (51%), Gaps = 21/172 (12%)

Query: 142 QGAFGKL----YRGTYNGEEVAIKILER----PENDPEKAQVMEQQFQQEVMMLATLKHP 193
           +G+FGK+     +GT   E  A+K+L++     ++D E         ++ V+ LA  KHP
Sbjct: 5   KGSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMT-----EKRVLALAG-KHP 56

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            + +     +       V EY  GG +  F  +R  R      A   A ++  G+ ++H 
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDL-MFHIQRSGR-FDEPRARFYAAEIVLGLQFLHE 114

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
            G+I+RDLK DN+L+ S+  IKIADFG+ + E    G+T  T  GT  ++AP
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 69.6 bits (170), Expect = 7e-14
 Identities = 50/171 (29%), Positives = 90/171 (52%), Gaps = 15/171 (8%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKIL-ERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +G+FG +Y  +      E  +K+L E P  +    + +  Q  QE  +L+ L HP IV+F
Sbjct: 10  KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV--QANQEAQLLSKLDHPAIVKF 67

Query: 199 IGACRKPMVWCIVTEYAKGG----SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
             +  +   +CI+TEY +G      + +   K   +++      +  + +  G+ Y+H+ 
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEEL--KHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 255 GLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGM-TPETGTYRWMAP 303
            ++HRDLK+ N  IF   ++ KI DFGV+R+ + +  + T  TGT  +M+P
Sbjct: 126 RILHRDLKAKN--IFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 32/197 (16%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE----EVAIKILERPENDPEKAQVMEQQFQQEV 184
           ++   +   D   +G FG++ +     +    + AIK ++   +  +      + F  E+
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----HRDFAGEL 58

Query: 185 MMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----------NRSVP 233
            +L  L  HPNI+  +GAC       +  EYA  G++  FL K +            S  
Sbjct: 59  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118

Query: 234 LKLAVKQAL----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEV-- 286
             L+ +Q L    DVARGM Y+ +   IHRDL + N+L+  +   KIADFG++R  EV  
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178

Query: 287 -QTEGMTPETGTYRWMA 302
            +T G  P     RWMA
Sbjct: 179 KKTMGRLP----VRWMA 191

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.1 bits (171), Expect = 8e-14
 Identities = 56/180 (31%), Positives = 86/180 (47%), Gaps = 24/180 (13%)

Query: 130 DLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           DLR++        G+FG +Y  R   N E VAIK +       +++    Q   +EV  L
Sbjct: 19  DLREI------GHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQF-LTKRQNRSVPLKLAVKQALDVAR 246
             L+HPN +++ G   +     +V EY  G +     + K+  + V +      AL   +
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---Q 126

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 303
           G+AY+H   +IHRD+K+ N+L+     +K+ DFG A I      M P     GT  WMAP
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 47/169 (27%), Positives = 88/169 (52%), Gaps = 8/169 (4%)

Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
              +G++G+  L R   +G++  IK L        + +  EQ+ Q    +L+ LKHPNIV
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQ----LLSQLKHPNIV 62

Query: 197 RFIGACR-KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            +  +   +  +  IV  + +GG +   L +++ + +P    V+  + +A  + Y+H   
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETGTYRWMAP 303
           ++HRDLK+ N+ +     IK+ D G+AR+ E Q +  +   GT  +M+P
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.8 bits (168), Expect = 2e-13
 Identities = 40/145 (27%), Positives = 78/145 (53%), Gaps = 7/145 (4%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FG+  L +   + ++ A+K +  P     K+    +  ++E ++LA +KHPNIV F 
Sbjct: 10  EGSFGRALLVQHVNSDQKYAMKEIRLP-----KSSSAVEDSRKEAVLLAKMKHPNIVAFK 64

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            +        IV EY  GG + Q +  ++ +  P    ++  + +  G+ ++H   ++HR
Sbjct: 65  ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHR 124

Query: 260 DLKSDNLLIFSDKSIKIADFGVARI 284
           D+KS N+ +  +  +K+ DFG AR+
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARL 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 30/211 (14%)

Query: 98  VSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGK--LYRGTYNG 155
           V+H     AL R ++D   P   LEN+         + +G    +G+ G   + R  ++G
Sbjct: 1   VTHEQFKAAL-RMVVDQGDPRSLLENY---------IKIG----EGSTGIVCIAREKHSG 46

Query: 156 EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR-FIGACRKPMVWCIVTEY 214
            +VA+K++     D  K Q  E  F  EV+++   +H N+V  +        +W ++ E+
Sbjct: 47  RQVAVKMM-----DLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELW-VLMEF 99

Query: 215 AKGGSVRQFLTKRQNRSVPLKLA-VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS 273
            +GG++   ++  Q R    ++A V ++  V + + Y+H  G+IHRD+KSD++L+  D  
Sbjct: 100 LQGGALTDIVS--QTRLNEEQIATVCES--VLQALCYLHSQGVIHRDIKSDSILLTLDGR 155

Query: 274 IKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           +K++DFG  A+I           GT  WMAP
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 18/177 (10%)

Query: 134 LNMGDAFAQGAFGKLYRGTYNGEE---VAIKILERPENDPEKAQVMEQQFQQEVM----M 186
            N       G+FG++   TY  E+   VAIK  E       K+++++Q+    V     +
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKI 84

Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           L  + HP  V   G+ +      +V E+  GG    FL  R+N+  P  +    A  +  
Sbjct: 85  LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVL 142

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
              Y+  L +++RDLK +NLL+  D  IK+ DFG A++ V T   T   GT  ++AP
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT-LCGTPEYIAP 197

Length = 340

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 11/146 (7%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKI--LERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           +G +  +Y+G     GE VA+K   L+  E  P  A        +E+ ++  LKH NIVR
Sbjct: 10  EGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-------REISLMKELKHENIVR 62

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
                       +V EY      +   T     ++           + +G+A+ H   ++
Sbjct: 63  LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVAR 283
           HRDLK  NLLI     +K+ADFG+AR
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.0 bits (168), Expect = 2e-13
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 20/178 (11%)

Query: 130 DLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           DLR++        G+FG +Y  R     E VAIK +       +++    Q   +EV  L
Sbjct: 29  DLREI------GHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNEKWQDIIKEVKFL 79

Query: 188 ATLKHPNIVRFIGA-CRKPMVWCIVTEYAKGGSVRQF-LTKRQNRSVPLKLAVKQALDVA 245
             +KHPN + + G   R+   W +V EY  G +     + K+  + V +      AL   
Sbjct: 80  QRIKHPNSIEYKGCYLREHTAW-LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 135

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +G+AY+H   +IHRD+K+ N+L+     +K+ADFG A I           GT  WMAP
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAP 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.1 bits (166), Expect = 3e-13
 Identities = 45/168 (26%), Positives = 85/168 (50%), Gaps = 8/168 (4%)

Query: 141 AQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +G F ++YR T   + + VA+K ++  E    KA+   Q   +E+ +L  L HPN++++
Sbjct: 11  GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR---QDCVKEIDLLKQLNHPNVIKY 67

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLT--KRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           + +  +     IV E A  G + Q +   K+Q R +P +   K  + +   + ++H   +
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           +HRD+K  N+ I +   +K+ D G+ R    +T       GT  +M+P
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 54/172 (31%), Positives = 89/172 (51%), Gaps = 20/172 (11%)

Query: 143 GAFGKLYRGT--YNGEEVAIKILERPENDPEKAQ--VMEQQFQQEVMMLATLKHPNIVRF 198
           GAFG ++  T   +G+ VA+K +      P   Q  V  ++  +E+ ML   KH N++  
Sbjct: 11  GAFGVVWSVTDPRDGKRVALKKM------PNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64

Query: 199 IGACRKPMVWC-----IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
           +   + P +       +VTE  +    +  ++ +   S  +K+ + Q L   RG+ Y+H 
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKYLHS 121

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP 303
            G++HRD+K  NLL+ S+  +KI DFG+AR+E   E   MT E  T  + AP
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 8/145 (5%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G +Y+G     G+ VA+K + R E++ E    +     +E+ +L  L+HPNIV   
Sbjct: 10  EGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEG---VPSTAIREISLLKELQHPNIVCLQ 65

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL-DVARGMAYVHRLGLIH 258
               +     ++ E+      +   +  + + +  +L VK  L  + +G+ + H   ++H
Sbjct: 66  DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAEL-VKSYLYQILQGILFCHSRRVLH 124

Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR 283
           RDLK  NLLI +   IK+ADFG+AR
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 50/175 (28%), Positives = 86/175 (49%), Gaps = 27/175 (15%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM-----MLATLKHPN 194
           +G+FGK  L +   +G   A+K+L+       K  +++++ Q  +M     +L  LKHP 
Sbjct: 5   KGSFGKVLLAKRKSDGSFYAVKVLQ-------KKTILKKKEQNHIMAERNVLLKNLKHPF 57

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +V    + +       V +Y  GG +  F   ++ R      A   A +VA  + Y+H L
Sbjct: 58  LVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 303
            +I+RDLK +N+L+ S   + + DFG+ +     EG+ PE       GT  ++AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGVEPEETTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.4 bits (164), Expect = 5e-13
 Identities = 44/168 (26%), Positives = 83/168 (49%), Gaps = 8/168 (4%)

Query: 141 AQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +G F ++YR T   +G  VA+K ++  +    KA+       +E+ +L  L HPN++++
Sbjct: 11  GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQLNHPNVIKY 67

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLT--KRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
             +  +     IV E A  G + + +   K+Q R +P K   K  + +   + ++H   +
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           +HRD+K  N+ I +   +K+ D G+ R    +T       GT  +M+P
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 67.4 bits (165), Expect = 8e-13
 Identities = 60/179 (33%), Positives = 90/179 (50%), Gaps = 20/179 (11%)

Query: 133 KLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL 190
           KLN      +G +G +YR   T +GE VA+K + R +N+ +   +   +   E+ +L  L
Sbjct: 11  KLNR---IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLR---EITLLLNL 63

Query: 191 KHPNIVRF--IGACRKPMVWCIVTEYAKGGSVRQFLTKR-QNRSVPLKLA-VKQ-ALDVA 245
           +HPNIV    +   +      +V EY +     Q L     N   P   + VK   L + 
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCE-----QDLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           RG+ Y+H   +IHRDLK  NLL+     +KIADFG+AR   +  + MTP+  T  + AP
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 38/181 (20%)

Query: 142 QGAFGKL----YRGTYNGEEVAIKILERP---ENDPEKAQVMEQQFQQEVMMLATLKHPN 194
           +G FGK+    Y+ T  GE  AIK L++      D E   +M ++   E     + +HP 
Sbjct: 9   RGHFGKVLLAEYKKT--GELYAIKALKKGDIIARD-EVESLMCEKRIFETA--NSERHPF 63

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGM 248
           +V      +     C V EYA GG +        F   R         AV  A  V  G+
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR---------AVFYAACVVLGL 114

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMA 302
            Y+H   +++RDLK DNLL+ ++  +KIADFG+ +     EGM          GT  ++A
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFLA 169

Query: 303 P 303
           P
Sbjct: 170 P 170

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 54/172 (31%), Positives = 94/172 (54%), Gaps = 21/172 (12%)

Query: 142 QGAFGKLY----RGTYNGEEVAIKILERP---ENDPEKAQVMEQQFQQEVMMLATLKHPN 194
           +G+FGK+     +GT   E  AIKIL++    ++D  +  ++E++      +LA    P 
Sbjct: 10  KGSFGKVMLAERKGT--DELYAIKILKKDVVIQDDDVECTMVEKR------VLALQDKPP 61

Query: 195 IVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +  + +C + +     V EY  GG +   + +      P   AV  A +++ G+ ++HR
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ--AVFYAAEISVGLFFLHR 119

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
            G+I+RDLK DN+++ S+  IKIADFG+ + E   +G+T  T  GT  ++AP
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 17/152 (11%)

Query: 138 DAFAQGAFGKLYRGT--YNGEEVAIKI--LERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
           +   +G++  +Y+G    NG+ VA+K+  L+  E  P  A        +E  +L  LKH 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-------REASLLKGLKHA 63

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYV 251
           NIV             +V EY     + Q++ K      P  +KL + Q L   RG++Y+
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYI 119

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           H+  ++HRDLK  NLLI     +K+ADFG+AR
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 37/174 (21%)

Query: 134 LNMGDAFAQGAFG-------KLYRGTYNGEEVAIKILERPENDPEKAQVME----QQFQQ 182
             +G    +G FG       K   G+   ++VA+K+L        KA +      ++F +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGS--FQKVAVKML--------KADIFSSSDIEEFLR 50

Query: 183 EVMMLATLKHPNIVRFIGACRK---------PMVWCIVTEYAKGGSVRQFL----TKRQN 229
           E   +    HPN+++ IG   +         PMV   +  + K G +  FL       + 
Sbjct: 51  EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV---ILPFMKHGDLHTFLLMSRIGEEP 107

Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            ++PL+  V+  +D+A GM Y+     IHRDL + N ++  + ++ +ADFG+++
Sbjct: 108 FTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 16/163 (9%)

Query: 143 GAFGKLYRGTYNGEE--VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           G+ G+++  T  G+   V +KI ++         ++E       M+L  + HP+++R   
Sbjct: 77  GSEGRVFVATKPGQPDPVVLKIGQKG------TTLIE------AMLLQNVNHPSVIRMKD 124

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
                 + C+V  +     +  +LTKR +R +P+  A+     +  G+ Y+H   +IHRD
Sbjct: 125 TLVSGAITCMVLPHYSS-DLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRD 182

Query: 261 LKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +K++N+ I     + I D G A+  V         GT    AP
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225

Length = 357

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 10/152 (6%)

Query: 141 AQGAFGKLYRG---TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            +GA+GK+++       G  VA+K + R +   E   +   +    +  L T +HPN+VR
Sbjct: 10  GEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 198 FIGACR-----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
               C      +     +V E+     +  +L K     VP +        + RG+ ++H
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
              ++HRDLK  N+L+ S   IK+ADFG+ARI
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 20/176 (11%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRF 198
           +G +GK+Y  R    G+ VA+K   R E D E    +     +E+ +L  L     IVR 
Sbjct: 11  EGTYGKVYKARDKNTGKLVALK-KTRLEMDEEG---IPPTALREISLLQMLSESIYIVRL 66

Query: 199 IGA------CRKPMVWCIVTEYAKGGSVRQFLT---KRQNRSVPLKLAVKQALDVARGMA 249
           +          KP ++ +V EY     +++F+    +   R +P K        + +G+A
Sbjct: 67  LDVEHVEEKNGKPSLY-LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKS-IKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           + H+ G++HRDLK  NLL+   K  +KIAD G+ R   +  +  T E  T  + AP
Sbjct: 125 HCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 45/170 (26%), Positives = 86/170 (50%), Gaps = 17/170 (10%)

Query: 142 QGAFGKLYRGTYNGEEV--AIKILERPENDPEKAQVMEQQFQQEVM-----MLATLKHPN 194
           +G+FGK+    +  +    A+K+L+       K  +++++ Q+ +M     +L  +KHP 
Sbjct: 5   KGSFGKVLLAKHKADGKFYAVKVLQ-------KKAILKKKEQKHIMAERNVLLKNVKHPF 57

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +V    + +       V +Y  GG +  F   ++ RS P   A   A ++A  + Y+H L
Sbjct: 58  LVGLHYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSL 115

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
            +I+RDLK +N+L+ S   + + DFG+ +  ++    T    GT  ++AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 10/166 (6%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FGK  L R    G+  A+KIL++ E    K +V     +  V  L   +HP +    
Sbjct: 5   KGTFGKVILVREKATGKYYAMKILKK-EVIIAKDEVAHTLTESRV--LQNTRHPFLTALK 61

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            + +     C V EYA GG +  F    + R      A     ++   + Y+H   +++R
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           DLK +NL++  D  IKI DFG+ +  + ++G T +T  GT  ++AP
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 64.8 bits (158), Expect = 5e-12
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 12/146 (8%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G +++       E VA+K + R ++D E    +     +E+ +L  LKH NIVR  
Sbjct: 10  EGTYGTVFKAKNRETHEIVALKRV-RLDDDDEG---VPSSALREICLLKELKHKNIVRLY 65

Query: 200 GACRKPMVWCIVTEYAKGGSVRQF--LTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
                     +V EY      + F       +  + +K  + Q L   +G+A+ H   ++
Sbjct: 66  DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI-VKSFMFQLL---KGLAFCHSHNVL 121

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVAR 283
           HRDLK  NLLI  +  +K+ADFG+AR
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 57/180 (31%), Positives = 85/180 (47%), Gaps = 26/180 (14%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKI--LERPENDPEKAQVMEQQFQQEV 184
           ++L KL       +G++  +Y+G    NG+ VA+K+  ++  E  P  A        +E 
Sbjct: 8   LNLEKL------GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-------REA 54

Query: 185 MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQAL 242
            +L  LKH NIV              V EY     + Q++ +      P  ++L + Q L
Sbjct: 55  SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL 113

Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGTYR 299
              RG+AY+H   ++HRDLK  NLLI     +K+ADFG+AR   I  QT      T  YR
Sbjct: 114 ---RGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYR 170

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 6e-12
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 9/163 (5%)

Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           G FG+++  R   +    A+K++  PE    K    EQ    E  +L  + HP I+R   
Sbjct: 12  GTFGRVHLVRDRISEHYYALKVMAIPEVIRLK---QEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
                    ++ EY  GG +  +L  R +        +  A ++   + Y+H   +++RD
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRD 126

Query: 261 LKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           LK +N+L+  +  IK+ DFG A+ +++    T   GT  ++AP
Sbjct: 127 LKPENILLDKEGHIKLTDFGFAK-KLRDRTWT-LCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 57/173 (32%), Positives = 81/173 (46%), Gaps = 19/173 (10%)

Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIK--ILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
           D   +G +  +Y+G     +  VA+K   LE  E  P  A        +EV +L  LKH 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-------REVSLLKDLKHA 64

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYV 251
           NIV             +V EY     ++Q+L    N      +KL + Q L   RG+ Y 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYC 120

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE-VQTEGMTPETGTYRWMAP 303
           HR  ++HRDLK  NLLI     +K+ADFG+AR + + T+  + E  T  W  P
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL-WYRP 172

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 7e-12
 Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 24/174 (13%)

Query: 142 QGAFGKLY-----RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM---MLATLKHP 193
           QG+FGK++      G   G+  A+K+L+       KA +  +   +  M   +LA + HP
Sbjct: 6   QGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEVNHP 58

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR---QNRSVPLKLAVKQALDVARGMAY 250
            IV+   A +      ++ ++ +GG +   L+K        V   LA     ++A  + +
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDH 113

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           +H LG+I+RDLK +N+L+  +  IK+ DFG+++  +  E       GT  +MAP
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 46/171 (26%), Positives = 89/171 (52%), Gaps = 17/171 (9%)

Query: 141 AQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM-----MLATLKHP 193
            +G+FGK  L +   +G+  A+K+L+       K  V+ ++ Q+ +M     +L  +KHP
Sbjct: 4   GKGSFGKVLLAKRKLDGKCYAVKVLQ-------KKIVLNRKEQKHIMAERNVLLKNVKHP 56

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +V    + +       V ++  GG +  F   ++ RS P   A   A ++A  + Y+H 
Sbjct: 57  FLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV-QTEGMTPETGTYRWMAP 303
           + +++RDLK +N+L+ S   + + DFG+ +  + Q++  T   GT  ++AP
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.1 bits (156), Expect = 8e-12
 Identities = 39/128 (30%), Positives = 66/128 (51%), Gaps = 7/128 (5%)

Query: 176 MEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK 235
           +++Q   E+ +L     P I+ F GA        I TE+  GGS+  +      R +P  
Sbjct: 42  LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEH 95

Query: 236 LAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET 295
           +  + A+ V +G+ Y+  L ++HRD+K  N+L+ +   +K+ DFGV+   V +   T   
Sbjct: 96  VLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-YV 154

Query: 296 GTYRWMAP 303
           GT  +MAP
Sbjct: 155 GTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 8e-12
 Identities = 53/160 (33%), Positives = 77/160 (48%), Gaps = 37/160 (23%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPEND----PEKAQVMEQQFQQEVMMLATLKHPNI 195
           +G +G +Y  R    GE VA+K + R E +    P  A        +E+ +L  L HPNI
Sbjct: 9   EGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAI-------REISLLKELNHPNI 60

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLT---KRQNRSVP--------LKLAVKQALDV 244
           VR +          +V    K   V +FL    K+   S P        +K  + Q L  
Sbjct: 61  VRLLD---------VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL-- 109

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +G+AY H   ++HRDLK  NLLI  + ++K+ADFG+AR 
Sbjct: 110 -QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 21/154 (13%)

Query: 138 DAFAQGAFGKLYRG--TYNGEEVAIKI--LERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
           D   +G++  +Y+G     G+ VA+K   LE  E  P  A        +E  +L  LKH 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-------REASLLKDLKHA 63

Query: 194 NIVRF--IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMA 249
           NIV    I   +K +   +V EY     ++Q++           ++L + Q L   RG+A
Sbjct: 64  NIVTLHDIIHTKKTLT--LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLA 117

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Y H+  ++HRDLK  NLLI     +K+ADFG+AR
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 21/172 (12%)

Query: 142 QGAFGKLYRGTYNGEE--VAIKILERPENDPEKAQVMEQQFQQEVMM-----LATLKHPN 194
           +G+FGK+      G +   AIKIL        K  V+ Q    E  M     LA    P 
Sbjct: 10  KGSFGKVMLAERKGTDELYAIKIL--------KKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 195 IVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +  + +C + M     V EY  GG +   + +      P   AV  A ++A G+ ++H 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH--AVFYAAEIAIGLFFLHS 119

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
            G+I+RDLK DN+++ ++  IKIADFG+ + E    G T  T  GT  ++AP
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 40/142 (28%), Positives = 77/142 (54%), Gaps = 9/142 (6%)

Query: 142 QGAFGKLY----RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           +G  G+++    +GT  G+  A+K+L++ E      +V     +QE+  LATL HP +  
Sbjct: 11  KGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRN-KVKRVLTEQEI--LATLDHPFLPT 65

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
              + +     C+V +Y  GG + + L ++  + +  ++A   A +V   + Y+H LG++
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125

Query: 258 HRDLKSDNLLIFSDKSIKIADF 279
           +RDLK +N+L+     I ++DF
Sbjct: 126 YRDLKPENILLHESGHIMLSDF 147

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 45/171 (26%), Positives = 86/171 (50%), Gaps = 17/171 (9%)

Query: 141 AQGAFGKLYRGTYNGEEV--AIKILERPENDPEKAQVMEQQFQQEVM-----MLATLKHP 193
            +G+FGK+    +  EE   A+K+L+       K  +++++ ++ +M     +L  +KHP
Sbjct: 4   GKGSFGKVLLARHKAEEKFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHP 56

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +V    + +       V +Y  GG +  F   ++ R      A   A ++A  + Y+H 
Sbjct: 57  FLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHS 114

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           L +++RDLK +N+L+ S   I + DFG+ +  ++  G T    GT  ++AP
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 15/169 (8%)

Query: 142 QGAFGKLYRGTYNG-EEV-AIKILERP---ENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
           +G+FGK+      G +EV AIK+L++    ++D     + E++    ++ LA  KHP + 
Sbjct: 5   KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKR----ILALAA-KHPFLT 59

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
                 +       V EY  GG +  F  +R +R      +   A +V   + ++HR G+
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDL-MFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGV 117

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           I+RDLK DN+L+ ++   K+ADFG+ + E    G+T  T  GT  ++AP
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 13/133 (9%)

Query: 155 GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI--GACRKPMVWCIVT 212
           G EVAIK+L    + PE+      +F++E  + A L HPNIV  +  G     +++  V 
Sbjct: 3   GHEVAIKLLR--TDAPEEEH-QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VF 58

Query: 213 EYAKGGSVRQFLTKRQNRSV-PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS- 270
           EY  G ++R+ L         P     +  L V   +A  H  G++HRDLK  N+++   
Sbjct: 59  EYVPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115

Query: 271 --DKSIKIADFGV 281
                 K+ DFG+
Sbjct: 116 GVRPHAKVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 40/161 (24%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQ----QEVMMLATLKHPNI 195
           +G +G +YR      GE VA+K   + + + EK     + F     +E+ +L  L+HPNI
Sbjct: 15  EGTYGVVYRARDKKTGEIVALK---KLKMEKEK-----EGFPITSLREINILLKLQHPNI 66

Query: 196 VRFIGACRKPMVW-------CIVTEYAKGGSVRQFL-----TKRQNRSVP-LKLAVKQAL 242
           V       K +V         +V EY     V   L     T +Q      +K  + Q L
Sbjct: 67  VTV-----KEVVVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLMLQLL 116

Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
               G+A++H   ++HRDLK+ NLL+ +   +KI DFG+AR
Sbjct: 117 ---SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 56/173 (32%), Positives = 82/173 (47%), Gaps = 19/173 (10%)

Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIK--ILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
           D   +G +  +++G     E  VA+K   LE  E  P  A        +EV +L  LKH 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKHA 63

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV--PLKLAVKQALDVARGMAYV 251
           NIV             +V EY     ++Q+L    N      +K+ + Q L   RG++Y 
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYC 119

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE-VQTEGMTPETGTYRWMAP 303
           H+  ++HRDLK  NLLI     +K+ADFG+AR + V T+  + E  T  W  P
Sbjct: 120 HKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL-WYRP 171

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 54/172 (31%), Positives = 92/172 (53%), Gaps = 17/172 (9%)

Query: 140 FAQGAFGKLYRGTYNG--EEVAIKILERP---ENDPEKAQVMEQQFQQEVMMLATLKHPN 194
             +G+FGK+      G  E  AIKIL++    ++D  +  ++E++      +LA    P 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKR------VLALSGKPP 61

Query: 195 IVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +  + +C + M     V EY  GG +   + +      P   AV  A ++A G+ ++H 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH--AVFYAAEIAIGLFFLHS 119

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
            G+I+RDLK DN+++ S+  IKIADFG+ + E   +G+T +T  GT  ++AP
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 34/178 (19%)

Query: 142 QGAFGKL--YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA+G++     T  G +VAIK L RP      A+    +  +E+ +L  + H N++  +
Sbjct: 25  SGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK----RTYRELRLLKHMDHENVIGLL 80

Query: 200 GACRKPMVWC------------IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
                  V+             +VT    G  +   +  ++     ++  V Q L   RG
Sbjct: 81  D------VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQIL---RG 130

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-MTPETGTYRW-MAP 303
           + Y+H  G+IHRDLK  N+ +  D  +KI DFG+AR    T+  MT    T RW  AP
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVAT-RWYRAP 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 13/147 (8%)

Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQ---EVMMLATLKHPNIVR 197
           GA+G +Y  R     +  A+K + +      +  ++  Q QQ   E  +L   ++P +V 
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINK------QNLILRNQIQQVFVERDILTFAENPFVVS 65

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
              +       C+V EY +GG     L  +   ++P+ +A     +    + Y+H  G++
Sbjct: 66  MFCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVLALEYLHNYGIV 123

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARI 284
           HRDLK DNLLI S   IK+ DFG+++I
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 13/168 (7%)

Query: 142 QGAFGKLYRGTYNG--EEVAIKILERP---ENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
           +G+FGK+      G  E  AIK L++    E+D  +  ++E++    V+ LA  +HP + 
Sbjct: 5   KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERR----VLALAW-EHPFLT 59

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
                 +       V EY  GG +   +  + +       A   A ++  G+ ++H+ G+
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           I+RDLK DN+L+  D  IKIADFG+ +  +  EG      GT  ++AP
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 16/154 (10%)

Query: 154 NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTE 213
           +G+ VA+K +     D  K Q  E  F  EV+++   +H N+V    +        +V E
Sbjct: 44  SGKLVAVKKM-----DLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVME 97

Query: 214 YAKGGSVRQFLT-KRQNRS--VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS 270
           + +GG++   +T  R N      + LAV +AL V      +H  G+IHRD+KSD++L+  
Sbjct: 98  FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV------LHAQGVIHRDIKSDSILLTH 151

Query: 271 DKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           D  +K++DFG  A++  +        GT  WMAP
Sbjct: 152 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)

Query: 140 FAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
             +G FGK  L R    G   A+KIL R E    K +V     +  V  L   +HP +  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKIL-RKEVIIAKDEVAHTVTESRV--LQNTRHPFLTA 59

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
              A +     C V EYA GG +  F    + R    + A     ++   + Y+H   ++
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           +RD+K +NL++  D  IKI DFG+ + E  ++G T +T  GT  ++AP
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 56/173 (32%), Positives = 82/173 (47%), Gaps = 19/173 (10%)

Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIK--ILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
           +   +G +  +++G     E  VA+K   LE  E  P  A        +EV +L  LKH 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKDLKHA 64

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYV 251
           NIV             +V EY     ++Q++    N      +K+ + Q L   RG+AY 
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYC 120

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE-VQTEGMTPETGTYRWMAP 303
           HR  ++HRDLK  NLLI     +K+ADFG+AR + V T+  + E  T  W  P
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL-WYRP 172

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.0 bits (151), Expect = 5e-11
 Identities = 33/146 (22%), Positives = 66/146 (45%), Gaps = 8/146 (5%)

Query: 136 MGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
           +G  F       L +       VA+K +   ++  ++     +  QQE++    L+HPNI
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINL-DSCSKE---DLKLLQQEIITSRQLQHPNI 61

Query: 196 VRFIGA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL-DVARGMAYVHR 253
           + ++ +      ++ +V+     GS    L       +P +LA+   L DV   + Y+H 
Sbjct: 62  LPYVTSFIVDSELY-VVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLNALDYIHS 119

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADF 279
            G IHR +K+ ++L+  D  + ++  
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 8e-11
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 15/148 (10%)

Query: 141 AQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM----MLATLKHPN 194
            +GAFG+  L R    G+  A+K+L        K+ ++++     V     +LA    P 
Sbjct: 10  GRGAFGEVWLVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRAERDILADADSPW 62

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           IV+   + +      +V EY  GG +   L ++     P + A     ++   +  VH+L
Sbjct: 63  IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL 120

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           G IHRD+K DN+LI +D  IK+ADFG+ 
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 40/129 (31%), Positives = 69/129 (53%), Gaps = 4/129 (3%)

Query: 176 MEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK 235
           +  Q  +E+ +L     P IV F GA        I  E+  GGS+ Q L  ++ + +P +
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEE 103

Query: 236 LAVKQALDVARGMAYV-HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE 294
           +  K ++ V RG+AY+  +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +  
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-F 162

Query: 295 TGTYRWMAP 303
            GT  +M+P
Sbjct: 163 VGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 17/148 (11%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQ-----QFQQEVMMLATLKHPN 194
           QG +G+++  +    GE VA+K +        K  ++ +         E  +L T K   
Sbjct: 11  QGGYGQVFLAKKKDTGEIVALKRM--------KKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +V+ + A +      +  EY  GG  R  L       +    A     ++   +  +H L
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           G IHRDLK +N LI +   IK+ DFG++
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 8/145 (5%)

Query: 141 AQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +GA+G +   R     E VAIK  +    D E+ + +++   +E+ ML TLK  NIV  
Sbjct: 10  GEGAYGVVLKCRHKETKEIVAIKKFK----DSEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
             A R+     +V EY +  ++ + L +  N   P K+       + + + + H+  ++H
Sbjct: 66  KEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKNDIVH 123

Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR 283
           RD+K +NLLI  +  +K+ DFG AR
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 26/176 (14%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GA+G +   T+   G +VAIK +      P + Q   Q+  +E+ +L   KH NI+  I
Sbjct: 15  EGAYGMVCSATHKPTGVKVAIKKIS-----PFEHQTFCQRTLREIKILRRFKHENIIG-I 68

Query: 200 GACRKPMVWC------IVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARGMAYVH 252
               +P  +       IV E  +    +  L K Q+ S   ++  + Q L   RG+ Y+H
Sbjct: 69  LDIIRPPSFESFNDVYIVQELMETDLYK--LIKTQHLSNDHIQYFLYQIL---RGLKYIH 123

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI----EVQTEGMTPETGTYRWM-AP 303
              ++HRDLK  NLL+ ++  +KI DFG+ARI       T  +T    T RW  AP
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RWYRAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 24/59 (40%), Positives = 35/59 (59%), Gaps = 1/59 (1%)

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 303
           RG+ Y+H   ++HRDLK  NLL+ ++  +KI DFG+AR   +    MT    T  + AP
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 45/193 (23%)

Query: 130 DLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT 189
           +L+ +  G   AQG     Y  T  G+ VAIK L RP  +   A+   + +++ V+M   
Sbjct: 20  NLKPIGSG---AQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMK-L 71

Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA-------- 241
           + H NI+  +              +    S+ +F      + V L + +  A        
Sbjct: 72  VNHKNIIGLLNV------------FTPQKSLEEF------QDVYLVMELMDANLCQVIQM 113

Query: 242 -LDVAR----------GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG 290
            LD  R          G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  
Sbjct: 114 DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173

Query: 291 MTPETGTYRWMAP 303
           MTP   T  + AP
Sbjct: 174 MTPYVVTRYYRAP 186

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)

Query: 101 ALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDA-------FAQGAFG--KLYRG 151
           AL  D    AL  + +    L  +++    + KL M            +GAFG  +L R 
Sbjct: 5   ALVYDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRH 64

Query: 152 TYNGEEVAIKILERPE--NDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC 209
             + +  A+K+L + E     + A      F +E  ++A      IV+   A +      
Sbjct: 65  KSSKQVYAMKLLSKFEMIKRSDSAF-----FWEERDIMAHANSEWIVQLHYAFQDDKYLY 119

Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V EY  GG +   ++   N  +P K A     +V   +  +H +G IHRD+K DN+L+ 
Sbjct: 120 MVMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 270 SDKSIKIADFGVARIEVQTEGM 291
               +K+ADFG   +++   GM
Sbjct: 177 KSGHLKLADFGTC-MKMDANGM 197

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 19/195 (9%)

Query: 121 LENFDEWTIDLRKLNMG-------DAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPE 171
           L  +++    +RKL M            +GAFG  +L R   + +  A+K+L + E    
Sbjct: 25  LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR 84

Query: 172 KAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
                   F +E  ++A    P +V+   A +      +V EY  GG +   ++   N  
Sbjct: 85  SDSAF---FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS---NYD 138

Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM 291
           VP K A     +V   +  +H +GLIHRD+K DN+L+     +K+ADFG   +++   GM
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGM 197

Query: 292 T---PETGTYRWMAP 303
                  GT  +++P
Sbjct: 198 VRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 16/133 (12%)

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
            Q  +E+ +L     P IV F GA        I  E+  GGS+ Q L K+  R +P  + 
Sbjct: 44  NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPENIL 101

Query: 238 VKQALDVARGMAYVH-RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET- 295
            K ++ V RG+ Y+  +  ++HRD+K  N+L+ S   IK+ DFGV+       G   ++ 
Sbjct: 102 GKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------GQLIDSM 154

Query: 296 -----GTYRWMAP 303
                GT  +M+P
Sbjct: 155 ANSFVGTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 45/147 (30%), Positives = 67/147 (45%), Gaps = 19/147 (12%)

Query: 143 GAFGKLYRGTY---NGEE--VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           G FG+L RG     +  E  VAI  L    +D ++     + F  E + L    H NIVR
Sbjct: 16  GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-----RGFLAEALTLGQFDHSNIVR 70

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD----VARGMAYVHR 253
             G   +     IVTEY   G++  FL K +      +L   Q +     +A GM Y+  
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSE 125

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +G +H+ L +  +L+ SD   KI+ F 
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 12/168 (7%)

Query: 141 AQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +GAFG  +L R     +  A+K+L + E            F +E  ++A    P +V+ 
Sbjct: 52  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---FWEERDIMAFANSPWVVQL 108

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
             A +      +V EY  GG +   ++   N  VP K A     +V   +  +H +G IH
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHSMGFIH 165

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT---PETGTYRWMAP 303
           RD+K DN+L+     +K+ADFG   +++  EGM       GT  +++P
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 49/183 (26%), Positives = 75/183 (40%), Gaps = 38/183 (20%)

Query: 142 QGAFGKL--YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA+G +     T +G++VAIK +    + P  A+    +  +E+ +L   KH NI+   
Sbjct: 15  SGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK----RTLRELKILRHFKHDNII--- 67

Query: 200 GACRKPMVWCIVTEYAKGGSV-----------RQFLTKRQNRSVPLKLAVKQAL--DVAR 246
               + +   +    A    V              +   Q    PL     +     + R
Sbjct: 68  --AIRDI---LRPPGADFKDVYVVMDLMESDLHHIIHSDQ----PLTEEHIRYFLYQLLR 118

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-----EVQTEGMTPETGTYRWM 301
           G+ Y+H   +IHRDLK  NLL+  D  ++I DFG+AR            MT    T RW 
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWY 177

Query: 302 -AP 303
            AP
Sbjct: 178 RAP 180

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 34/172 (19%)

Query: 133 KLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL 190
           K ++     +G +G++Y  R    GE VA+K + R +N+ E   +   +   E+ +L  L
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIR---EIKILRQL 63

Query: 191 KHPNIVRF----------IGACRKPMVWCIVTEYA--------KGGSVRQFLTKRQNRSV 232
            H NIV            +   +    + +V EY         + G V    ++   +S 
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--FSEDHIKSF 121

Query: 233 PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
                +KQ L+   G+ Y H+   +HRD+K  N+L+ +   IK+ADFG+AR+
Sbjct: 122 -----MKQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.1 bits (143), Expect = 4e-10
 Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 19/171 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPEND---PEKAQVMEQQFQQEVMMLATLKHPNIV 196
           +G +G +Y+       E +A+K +   + D   P  A        +E+ +L  ++H NIV
Sbjct: 12  EGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-------REISLLKEMQHGNIV 64

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           R            +V EY     +++ +    + +   +L       + RG+AY H   +
Sbjct: 65  RLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV 123

Query: 257 IHRDLKSDNLLI-FSDKSIKIADFGVAR---IEVQTEGMTPETGTYRWMAP 303
           +HRDLK  NLLI     ++K+ADFG+AR   I V+T   T E  T  + AP
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAP 172

Length = 294

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 58/254 (22%), Positives = 95/254 (37%), Gaps = 85/254 (33%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQ 178
           +W     +L +G     GAFGK+   +  G         VA+K+L+      E   +M  
Sbjct: 1   QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALM-- 58

Query: 179 QFQQEVMMLATL-KHPNIVRFIGACRKP----MVWCIVTEYAKGGSVRQFL-TKRQ---- 228
               E+ +L  +  H N+V  +GAC KP    MV   + E+ K G++  FL  KR+    
Sbjct: 59  ---SELKILIHIGNHLNVVNLLGACTKPNGPLMV---IVEFCKYGNLSNFLRAKREFFSP 112

Query: 229 --NRSVPLKLAVKQALDVAR---------------------------------------- 246
              +S   +   +  ++ +R                                        
Sbjct: 113 YREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLT 172

Query: 247 -------------GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
                        GM ++     IHRDL + N+L+  +  +KI DFG+AR ++  +    
Sbjct: 173 MEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYV 231

Query: 294 ETGTYR----WMAP 303
             G+ R    WMAP
Sbjct: 232 RKGSARLPLKWMAP 245

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 37/166 (22%)

Query: 155 GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY 214
           G  VA+K L RP  +    Q   ++  +E+++L  + H NI+  +              +
Sbjct: 46  GINVAVKKLSRPFQN----QTHAKRAYRELVLLKCVNHKNIISLLNV------------F 89

Query: 215 AKGGSVRQFLTKRQNRSVPLKL-------AVKQALDVAR----------GMAYVHRLGLI 257
               S+ +F    Q+  + ++L        +   LD  R          G+ ++H  G+I
Sbjct: 90  TPQKSLEEF----QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGII 145

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           HRDLK  N+++ SD ++KI DFG+AR       MTP   T  + AP
Sbjct: 146 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 64/253 (25%), Positives = 97/253 (38%), Gaps = 84/253 (33%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQ 178
           +W     +L +G    +GAFGK+ + +  G         VA+K+L+      E   +M  
Sbjct: 1   KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM-- 58

Query: 179 QFQQEVMMLATL-KHPNIVRFIGACRKP----MVWCIVTEYAKGG-------SVRQFLTK 226
               E+ +L  +  H N+V  +GAC KP    MV   + EY K G       S R+  + 
Sbjct: 59  ---TELKILIHIGHHLNVVNLLGACTKPGGPLMV---IVEYCKFGNLSNYLRSKRECFSP 112

Query: 227 RQNRSVPLKLAV-----KQALD-------------------------------------- 243
            +N+S   +        KQ LD                                      
Sbjct: 113 YRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL 172

Query: 244 ---------VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE 294
                    VARGM ++     IHRDL + N+L+  +  +KI DFG+AR ++  +     
Sbjct: 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVR 231

Query: 295 TGTYR----WMAP 303
            G  R    WMAP
Sbjct: 232 KGDARLPLKWMAP 244

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 58.7 bits (142), Expect = 6e-10
 Identities = 41/167 (24%), Positives = 74/167 (44%), Gaps = 11/167 (6%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FG++   +    G+  A K L++      K    EQ    E  +L  +    IV   
Sbjct: 3   KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVSLA 59

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A       C+V     GG ++  +        P   A+  A  +  G+ ++H+  +++R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 303
           DLK +N+L+    +++I+D G+A   V+ +G        GT  +MAP
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.9 bits (142), Expect = 7e-10
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 34/215 (15%)

Query: 90  HSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDL-------RKLNMGDAFAQ 142
           H  N+ G     ++D  L      S++   G +  +E  ID        +   +G+    
Sbjct: 18  HKANKGGSGKFEMNDKKLDE-EERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGN 76

Query: 143 GAFGKLYRGTY--NGEEVAIK-ILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF- 198
           G+FG +Y        E+VAIK +L+ P           Q   +E++++  L H NI+   
Sbjct: 77  GSFGVVYEAICIDTSEKVAIKKVLQDP-----------QYKNRELLIMKNLNHINIIFLK 125

Query: 199 -------IGACRKPMVWCIVTEYAKGGSVRQFLT--KRQNRSVPLKLAVKQALDVARGMA 249
                       K +   +V E+    +V +++    R N ++PL L    +  + R +A
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 250 YVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVAR 283
           Y+H   + HRDLK  NLLI  +  ++K+ DFG A+
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219

Length = 440

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 37/163 (22%)

Query: 158 VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VAIK L RP  +    Q   ++  +E++++  + H NI+  +              +   
Sbjct: 52  VAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQ 95

Query: 218 GSVRQFLTKRQNRSVPLKL-------AVKQALDVAR----------GMAYVHRLGLIHRD 260
            S+ +F    Q+  + ++L        ++  LD  R          G+ ++H  G+IHRD
Sbjct: 96  KSLEEF----QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151

Query: 261 LKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           LK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.4 bits (142), Expect = 9e-10
 Identities = 19/38 (50%), Positives = 28/38 (73%)

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           + + Y+H   +IHRDLK  N+L+ SD  +K+ADFG+AR
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 17/168 (10%)

Query: 143 GAFGKL----YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           GAFGK+     R T   +  A+K + + +   EK  V  +    E  +L  L HP +V  
Sbjct: 11  GAFGKVCIVQKRDT--KKMFAMKYMNKQKCV-EKGSV--RNVLNERRILQELNHPFLVNL 65

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ--ALDVARGMAYVHRLGL 256
             + +      +V +   GG +R  L+++    V       +    ++   + Y+H  G+
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 303
           IHRD+K DN+L+     + I DF +A   V  + +T  T GT  +MAP
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLTTSTSGTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 42/140 (30%), Positives = 73/140 (52%), Gaps = 10/140 (7%)

Query: 172 KAQVMEQQFQQEVMML----ATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTK 226
           +A V  Q+ ++ +M L     ++  P  V F GA  R+  VW I  E     S+ +F  K
Sbjct: 35  RATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW-ICMEVMDT-SLDKFYKK 92

Query: 227 --RQNRSVPLKLAVKQALDVARGMAYVH-RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              +  ++P  +  K A+ + + + Y+H +L +IHRD+K  N+LI  +  +K+ DFG++ 
Sbjct: 93  VYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152

Query: 284 IEVQTEGMTPETGTYRWMAP 303
             V +   T + G   +MAP
Sbjct: 153 YLVDSVAKTIDAGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 18/172 (10%)

Query: 140 FAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
             +G FGK  L R   +G+  A+KIL++ E    K +V     +  V  L   +HP +  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKK-EVIIAKDEVAHTLTESRV--LKNTRHPFLTS 59

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVKQALDVARGMAYVHR 253
              + +     C V EY  GG +   L++     ++R+      +  ALD      Y+H 
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD------YLHS 113

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
             +++RDLK +NL++  D  IKI DFG+ + E  T+  T +T  GT  ++AP
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 12/167 (7%)

Query: 141 AQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           AQG     Y    +   VAIK L RP  +    Q   ++  +E++++  + H NI+  + 
Sbjct: 29  AQGIVCAAYDAVLD-RNVAIKKLSRPFQN----QTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA----LDVARGMAYVHRLGL 256
                     + E+     V + +     + + ++L  ++       +  G+ ++H  G+
Sbjct: 84  VFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 15/171 (8%)

Query: 140 FAQGAFGKLYRGTYNG--EEVAIKILERP----ENDPEKAQVMEQQFQQEVMMLATLKHP 193
             +G+FGK++     G  +  AIK L++     ++D E   V     ++ V+ LA  +HP
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----EKRVLSLA-WEHP 56

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +       +       V EY  GG +   +       +P   A   A ++  G+ ++H 
Sbjct: 57  FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPR--ATFYAAEIICGLQFLHS 114

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
            G+++RDLK DN+L+ +D  IKIADFG+ +  +  +  T    GT  ++AP
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 17/136 (12%)

Query: 155 GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY 214
           GE+VAIK L RP     ++++  ++  +E+ +L  ++H N++  +      +      E+
Sbjct: 40  GEKVAIKKLSRPF----QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV---SGDEF 92

Query: 215 AKGGSVRQFLTKRQNRSVPLKLA-------VKQALDVARGMAYVHRLGLIHRDLKSDNLL 267
                V  ++     + +   L+       V Q L    G+ Y+H  G+IHRDLK  NL 
Sbjct: 93  QDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML---CGLKYIHSAGIIHRDLKPGNLA 149

Query: 268 IFSDKSIKIADFGVAR 283
           +  D  +KI DFG+AR
Sbjct: 150 VNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 30/124 (24%), Positives = 53/124 (42%), Gaps = 13/124 (10%)

Query: 169 DPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ 228
                      F +   +++ L H ++V+  G C +     +V EY K G +  FL  R+
Sbjct: 37  VLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL-HRE 94

Query: 229 NRSVPL--KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-------IKIADF 279
             +V L  KL V + L  A  + Y+    L+H ++   N+L+            IK++D 
Sbjct: 95  KNNVSLHWKLDVAKQL--ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152

Query: 280 GVAR 283
           G+  
Sbjct: 153 GIPI 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 13/162 (8%)

Query: 151 GTYNGEEVAIKILERPEN--------DPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC 202
           G  NG  V  K+  +P            E    +  Q  +E+ +L     P IV F GA 
Sbjct: 14  GAGNGG-VVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV-HRLGLIHRDL 261
                  I  E+  GGS+ Q L K     +P ++  K ++ V +G+ Y+  +  ++HRD+
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130

Query: 262 KSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 15/169 (8%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERP---ENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
           +G+FGK  L R   +G   A+K+L++    ++D  +  + E++    ++ LA   HP + 
Sbjct: 5   KGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKR----ILSLAR-NHPFLT 59

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           +     + P     V E+  GG +   + K  +R      A   A ++   + ++H  G+
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGI 117

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           I+RDLK DN+L+  +   K+ADFG+ +  +   G T  T  GT  ++AP
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 24/175 (13%)

Query: 142 QGAFGKLYR-----GTYNGEEVAIKILERPENDPEKAQVMEQQ-----FQQEVMMLATLK 191
           +G +GK+++     G   G+  A+K+L+       KA ++  Q      + E  +L  +K
Sbjct: 6   KGGYGKVFQVRKVTGADTGKIFAMKVLK-------KATIVRNQKDTAHTKAERNILEAVK 58

Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL-DVARGMAY 250
           HP IV  I A +      ++ EY  GG   +     +   + ++      L +++  + +
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGG---ELFMHLEREGIFMEDTACFYLSEISLALEH 115

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           +H+ G+I+RDLK +N+L+ +   +K+ DFG+ +  +  EG    T  GT  +MAP
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFCGTIEYMAP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 17/184 (9%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEV 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++ +  ++  +E+
Sbjct: 13  WEVPERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 67

Query: 185 MMLATLKHPNIVRFI-----GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
            +L  +KH N++  +         +      +  +  G  +   +  ++     ++  + 
Sbjct: 68  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR 299
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR     + MT    T  
Sbjct: 128 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRW 182

Query: 300 WMAP 303
           + AP
Sbjct: 183 YRAP 186

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 41/145 (28%), Positives = 64/145 (44%), Gaps = 15/145 (10%)

Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQ----FQQEVMMLATLKHPNIV 196
           GAFG+  L R        A+K L        KA V+ +      + E  +LA   +  +V
Sbjct: 12  GAFGEVCLVRKVDTNALYAMKTLR-------KADVLMRNQAAHVKAERDILAEADNEWVV 64

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           +   + +       V +Y  GG +   L +         LA     ++   +  VH++G 
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGF 122

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGV 281
           IHRD+K DN+LI  D  IK+ DFG+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.1 bits (133), Expect = 9e-09
 Identities = 29/134 (21%), Positives = 63/134 (47%), Gaps = 10/134 (7%)

Query: 148 LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR----FIGACR 203
           +Y+G +N +EV I+  ++        +V+    + E+  L  +   NI++     I    
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKG---HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92

Query: 204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLK 262
                 ++ EY   G +R+ L K ++ S   KL +  A+D  +G+  +++     +++L 
Sbjct: 93  DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM--AIDCCKGLYNLYKYTNKPYKNLT 150

Query: 263 SDNLLIFSDKSIKI 276
           S + L+  +  +KI
Sbjct: 151 SVSFLVTENYKLKI 164

Length = 283

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 25/63 (39%), Positives = 34/63 (53%), Gaps = 5/63 (7%)

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR----IEVQTEGMTPETGTYRWM 301
            G+ Y+H   ++HRDLK  NLL+ +D  +KI DFG+AR       +  G   E    RW 
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175

Query: 302 -AP 303
            AP
Sbjct: 176 RAP 178

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 18/173 (10%)

Query: 139 AFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
               GA+G +        G +VAIK L RP     ++++  ++  +E+ +L  +KH N++
Sbjct: 22  QVGSGAYGTVCSALDRRTGAKVAIKKLYRPF----QSELFAKRAYRELRLLKHMKHENVI 77

Query: 197 RFIGACRKPMVWCIVTEYA-----KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
             +      +      ++       G  + + +   +     ++  V Q L   +G+ Y+
Sbjct: 78  GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML---KGLKYI 134

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 303
           H  G+IHRDLK  NL +  D  +KI DFG+AR   QT+  MT    T  + AP
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 41/171 (23%), Positives = 87/171 (50%), Gaps = 16/171 (9%)

Query: 143 GAFGKLY-----RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           GA+GK++      G  +G+  A+K+L++     +KA+  E    +  ++    + P +V 
Sbjct: 11  GAYGKVFLVRKVSGHDSGKLYAMKVLKKA-TIVQKAKTTEHTRTERQVLEHIRQSPFLVT 69

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ---NRSVPLKLAVKQALDVARGMAYVHRL 254
              A +      ++ +Y  GG +   L++R+    + V +        ++   + ++H+L
Sbjct: 70  LHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-----EIVLALEHLHKL 124

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 303
           G+I+RD+K +N+L+ S+  + + DFG+++   E + E      GT  +MAP
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 19/169 (11%)

Query: 143 GAFGKLYRGTYNGEEV--AIKILERPENDPEKAQVMEQQFQQEVM----MLATLKHPNIV 196
           G FG++       +    A+K ++       K  ++E   Q+ +     +L    HP IV
Sbjct: 4   GGFGRVELVKVKSKNRTFALKCVK-------KRHIVETGQQEHIFSEKEILEECNHPFIV 56

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           +     +      ++ EY  GG +   L  R         A      V     Y+H  G+
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGI 114

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           I+RDLK +NLL+ S+  +K+ DFG A+ ++++   T  T  GT  ++AP
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKT-WTFCGTPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 39/132 (29%), Positives = 71/132 (53%), Gaps = 10/132 (7%)

Query: 176 MEQQFQQEVMMLATLKHPNIVRFIGA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
           + +Q  +E+ ++   + P IV F GA   +  + C+  E+   GS+ +    ++   +P+
Sbjct: 46  VRKQILRELQIMHECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSLDRIY--KKGGPIPV 102

Query: 235 KLAVKQALDVARGMAY---VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM 291
           ++  K A+ V  G+ Y   VHR+  +HRD+K  N+L+ S   IK+ DFGV+   + +   
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160

Query: 292 TPETGTYRWMAP 303
           T   GT  +M+P
Sbjct: 161 T-FVGTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 19/153 (12%)

Query: 157 EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAK 216
           +V  K L   + D +  Q  +  F+Q         HP +V      +       V EY  
Sbjct: 26  KVVKKELVNDDEDIDWVQTEKHVFEQ------ASNHPFLVGLHSCFQTESRLFFVIEYVN 79

Query: 217 GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI 276
           GG +  F  +RQ R +P + A   + +++  + Y+H  G+I+RDLK DN+L+ S+  IK+
Sbjct: 80  GGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKL 137

Query: 277 ADFGVARIEVQTEGMTPE------TGTYRWMAP 303
            D+G+ +     EG+ P        GT  ++AP
Sbjct: 138 TDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 11/169 (6%)

Query: 140 FAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
             +G FGK  L +    G   A+KIL++ E    K +V     +  V  L   +HP +  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRV--LQNSRHPFLTA 59

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGL 256
              + +     C V EYA GG +  F    + R      A     ++   + Y+H    +
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           ++RDLK +NL++  D  IKI DFG+ + E   +G T +T  GT  ++AP
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 23/187 (12%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEV 184
           W +  R  N+      GA+G +     T   ++VA+K L RP     ++ +  ++  +E+
Sbjct: 11  WEVPERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF----QSLIHARRTYREL 65

Query: 185 MMLATLKHPNIVRFIGACRKPM-------VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
            +L  +KH N++  +              V+ +      G  +   +  ++     ++  
Sbjct: 66  RLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN--LMGADLNNIVKCQKLSDEHVQFL 123

Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETG 296
           + Q L   RG+ Y+H  G+IHRDLK  N+ +  D  ++I DFG+AR   Q  + MT    
Sbjct: 124 IYQLL---RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVA 177

Query: 297 TYRWMAP 303
           T  + AP
Sbjct: 178 TRWYRAP 184

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 43/168 (25%), Positives = 74/168 (44%), Gaps = 9/168 (5%)

Query: 140 FAQGAFGKL----YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
             +G FG++     R T  G+  A K LE+      K + M    +Q   +L  +    +
Sbjct: 8   LGKGGFGEVCACQVRAT--GKMYACKRLEKKRIKKRKGESMALNEKQ---ILEKVNSQFV 62

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           V    A       C+V     GG ++  +    N     + A+  A ++  G+  +HR  
Sbjct: 63  VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            ++RDLK +N+L+     I+I+D G+A    + E +    GT  +MAP
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 38/177 (21%), Positives = 78/177 (44%), Gaps = 11/177 (6%)

Query: 138 DAFAQGAFGKLY--RGTYNGE------EVAIKILERPENDPEKAQVMEQQFQQEVMMLAT 189
           +    GAFG +Y  R   NG+      E+ +      ++  E+ + +     +  ++   
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLT--KRQNRSVPLKLAVKQALDVARG 247
           L+HPNIVR+     +     IV +  +G  + +     K + +    +      + +   
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 248 MAYVHRLG-LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           + Y+H+   ++HRDL  +N+++  D  + I DFG+A+ +     +T   GT  +  P
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 22/137 (16%)

Query: 182 QEVMMLATLKHPNIVRF--------------IGACRKPMVWCIVTEYAKGGSVRQFLTKR 227
           +E+ ++  L H NIV+               +G+  +     IV EY +   +   L + 
Sbjct: 51  REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG 109

Query: 228 QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI-KIADFGVARI-- 284
                  +L + Q L   RG+ Y+H   ++HRDLK  N+ I ++  + KI DFG+ARI  
Sbjct: 110 PLSEEHARLFMYQLL---RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166

Query: 285 -EVQTEGMTPETGTYRW 300
                +G   E    +W
Sbjct: 167 PHYSHKGYLSEGLVTKW 183

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 13/100 (13%)

Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V EY  GG +  F  +RQ R +P + A   A ++   + ++H  G+I+RDLK DN+L+ 
Sbjct: 73  LVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130

Query: 270 SDKSIKIADFGVARIEVQTEGMTPE------TGTYRWMAP 303
           +D  IK+ D+G+ +     EG+ P        GT  ++AP
Sbjct: 131 ADGHIKLTDYGMCK-----EGLGPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 34/206 (16%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIK---ILERPENDPEKAQVMEQ-- 178
            ++I  R +  G    +G +GK+ +   T  G+ VAIK   I+E   +  +  Q++    
Sbjct: 3   SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62

Query: 179 -QFQ--QEVMMLATLKHPNIVRFIGA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
             F   +E+ ++  +KH NI+  +        +  +V +          L K  +R + L
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI-NLVMDIMASD-----LKKVVDRKIRL 116

Query: 235 KLAVKQA--LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV------ 286
             +  +   L +  G+  +H+   +HRDL   N+ I S    KIADFG+AR         
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 287 ---------QTEGMTPETGTYRWMAP 303
                    + E MT +  T  + AP
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAP 202

Length = 335

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 15/171 (8%)

Query: 140 FAQGAFGKLYRGTYNG--EEVAIKILERP----ENDPEKAQVMEQQFQQEVMMLATLKHP 193
             +G+FGK+      G  E  A+K L++     ++D E   V     ++ V+ LA  ++P
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMV-----EKRVLALA-WENP 56

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +       +       V E+  GG +  F  + + R   L  A   A ++  G+ ++H 
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHS 114

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-MTPETGTYRWMAP 303
            G+I+RDLK DN+++  D  IKIADFG+ +  V  +   +   GT  ++AP
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 20/155 (12%)

Query: 142 QGAFGKLYRGTYN---GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +G  G++Y   Y+      VA+K   +   D  +  +++++F +E  + A L HP IV  
Sbjct: 12  KGGMGEVYLA-YDPVCSRRVALK---KIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQAL--------DVARGMA 249
              C           Y +G +++  L +  Q  S+  +LA K ++         +   + 
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 250 YVHRLGLIHRDLKSDNLLI--FSDKSIKIADFGVA 282
           YVH  G++HRDLK DN+L+  F +  + I D+G A
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGE--VVILDWGAA 160

Length = 932

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 7e-08
 Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 5/95 (5%)

Query: 211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS 270
           V E+  GG +  F  +RQ R +P + A   + +++  + ++H  G+I+RDLK DN+L+ +
Sbjct: 74  VIEFVSGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131

Query: 271 DKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           +  IK+ D+G+ + E    G T  T  GT  ++AP
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 45/172 (26%), Positives = 90/172 (52%), Gaps = 18/172 (10%)

Query: 143 GAFGKLY----RGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           GA+GK++     G ++ G+  A+K+L +     +KA+  E    +  ++ A  + P +V 
Sbjct: 11  GAYGKVFLVRKVGGHDAGKLYAMKVL-KKATIVQKAKTAEHTRTERQVLEAVRRCPFLVT 69

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN---RSVPLKLA-VKQALDVARGMAYVHR 253
              A +      ++ +Y  GG +   L +R++     V + +A +  ALD      ++H+
Sbjct: 70  LHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD------HLHQ 123

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           LG+I+RD+K +N+L+ S+  + + DFG+++  +  E     +  GT  +MAP
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 23/148 (15%)

Query: 143 GAFG--KLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           GAFG  +L +    G   A+K L + E   EK QV   + ++++  LA   +P +V+   
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDI--LAEADNPWVVKLYY 68

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR--------GMAYVH 252
           + +      ++ EY  GG +   L K+   +           +  R         +  +H
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE----------EETRFYIAETILAIDSIH 118

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +LG IHRD+K DNLL+ +   IK++DFG
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFG 146

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 41/169 (24%), Positives = 88/169 (52%), Gaps = 12/169 (7%)

Query: 143 GAFGKLY-----RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           GA+GK++      G   G+  A+K+L++     +KA+ +E    +  ++    + P +V 
Sbjct: 11  GAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-VQKAKTVEHTRTERNVLEHVRQSPFLVT 69

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK-QALDVARGMAYVHRLGL 256
              A +      ++ +Y  GG +   L +R N S   +  V+  + ++   + ++H+LG+
Sbjct: 70  LHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEIILALEHLHKLGI 126

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 303
           ++RD+K +N+L+ S+  + + DFG+++  +  + E      GT  +MAP
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)

Query: 141 AQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +GAFG  +L +    G   A+KIL R  +  EK QV   + ++++++ A      +V+ 
Sbjct: 10  GRGAFGEVRLVQKKDTGHVYAMKIL-RKADMLEKEQVGHIRAERDILVEA--DSLWVVKM 66

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQN---RSVPLKLAVKQALDVARGMAYVHRLG 255
             + +  +   ++ E+  GG +   L K+           +A     +    +  +H+LG
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-----ETVLAIDSIHQLG 121

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGV 281
            IHRD+K DNLL+ S   +K++DFG+
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 26/204 (12%)

Query: 84  DNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQG 143
           D+  V H+ +          +++L+        P E   + D  ++   + N+  +   G
Sbjct: 50  DSDDVTHATDYDA------DEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPG 103

Query: 144 AFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR 203
           + G+++  T +G+E   K++        KA    +   +E+ +L T+ H  I+  I A R
Sbjct: 104 SEGEVFVCTKHGDEQRKKVIV-------KAVTGGKTPGREIDILKTISHRAIINLIHAYR 156

Query: 204 -KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM----AYVHRLGLIH 258
            K  V  ++ +Y      +  L    +RS PL L  +QA+ + R +    AY+H  G+IH
Sbjct: 157 WKSTVCMVMPKY------KCDLFTYVDRSGPLPL--EQAITIQRRLLEALAYLHGRGIIH 208

Query: 259 RDLKSDNLLIFSDKSIKIADFGVA 282
           RD+K++N+ +   ++  + DFG A
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 9/168 (5%)

Query: 140 FAQGAFGKL----YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
             +G FG++     R T  G+  A K LE+      K + M    +Q   +L  +    +
Sbjct: 8   LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGESMALNEKQ---ILEKVNSRFV 62

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           V    A       C+V     GG ++  +            AV  A ++  G+  +H+  
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +++RDLK +N+L+     I+I+D G+A    + + +    GT  +MAP
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 44/151 (29%), Positives = 71/151 (47%), Gaps = 23/151 (15%)

Query: 142 QGAFG--KLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GAFG  +L +    G+  A+K L + E   +K Q+   + +++V  LA    P +V   
Sbjct: 11  KGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDV--LAESDSPWVVSLY 67

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR--------GMAYV 251
            + +      ++ E+  GG +   L K    S           DV R         +  V
Sbjct: 68  YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE----------DVTRFYMAECVLAIEAV 117

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           H+LG IHRD+K DN+LI     IK++DFG++
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 7/141 (4%)

Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           GAFG+  L          A+K L R ++   + QV   + ++++  LA   +  +V+   
Sbjct: 12  GAFGEVCLACKVDTHALYAMKTL-RKKDVLNRNQVAHVKAERDI--LAEADNEWVVKLYY 68

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +       V +Y  GG +   L + +    P  LA     ++   +  VH++G IHRD
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 261 LKSDNLLIFSDKSIKIADFGV 281
           +K DN+LI  D  IK+ DFG+
Sbjct: 127 IKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 27/100 (27%), Positives = 53/100 (53%), Gaps = 3/100 (3%)

Query: 183 EVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL 242
           E  +L  + HP+I++  G        C++    K   +  +L  ++N ++   LA++++ 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERS- 190

Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
            V R + Y+H   +IHRD+K++N+ I     + + DFG A
Sbjct: 191 -VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 29/133 (21%), Positives = 64/133 (48%), Gaps = 6/133 (4%)

Query: 171 EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR 230
           EK  ++E++      +L  +  P IV    A       C+V     GG ++  +     R
Sbjct: 37  EKMALLEKE------ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGER 90

Query: 231 SVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG 290
            + ++  +  +  +  G+ ++H + +++RD+K +N+L+    + +++D G+A      + 
Sbjct: 91  GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150

Query: 291 MTPETGTYRWMAP 303
           +T   GT  +MAP
Sbjct: 151 ITQRAGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 14/135 (10%)

Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--GEE-----VAIKILERPEND 169
           PT+   N ++W      L  G     GAFGK+   T    G+E     VA+K+L+   + 
Sbjct: 24  PTQLPYN-EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT 82

Query: 170 PEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ 228
            E+  +M      E+ +L+ L +H NIV  +GAC       ++TEY   G +  FL K+ 
Sbjct: 83  DEREALM-----SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137

Query: 229 NRSVPLKLAVKQALD 243
              +   +A+ +  +
Sbjct: 138 ETFLNFVMALPEISE 152

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 44/174 (25%), Positives = 84/174 (48%), Gaps = 25/174 (14%)

Query: 143 GAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRFI 199
           GAFG + +  +   G  +A+K + R   D EK Q   ++   ++ +++ +   P IV+F 
Sbjct: 15  GAFGTVNKMLHKPSGTIMAVKRI-RSTVD-EKEQ---KRLLMDLDVVMRSSDCPYIVKFY 69

Query: 200 GA---------CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
           GA         C + M   +   Y       +++ +     +P ++  K A+   + + Y
Sbjct: 70  GALFREGDCWICMELMDISLDKFY-------KYVYEVLKSVIPEEILGKIAVATVKALNY 122

Query: 251 VHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +   L +IHRD+K  N+L+  + +IK+ DFG++   V +   T + G   +MAP
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 42/153 (27%)

Query: 152 TYNGEEVAIK-ILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI 210
           T+ GE+VAIK I +  E+  +  +++     +E+ +L  L+HP+IV        P     
Sbjct: 22  THTGEKVAIKKINDVFEHVSDATRIL-----REIKLLRLLRHPDIVEIKHIMLPP----- 71

Query: 211 VTEYAKGGSVRQFLTKRQNRSVPLKL------AVKQALD-------------VARGMAYV 251
                   S R+F    ++  V  +L       V +A D             + R + Y+
Sbjct: 72  --------SRREF----KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           H   + HRDLK  N+L  +D  +KI DFG+AR+
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 7/141 (4%)

Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           GAFG+  L R        A+K L R ++   + QV   + ++++  LA   +  +VR   
Sbjct: 12  GAFGEVCLARKVDTKALYAMKTL-RKKDVLLRNQVAHVKAERDI--LAEADNEWVVRLYY 68

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +       V +Y  GG +   L +      P  LA     ++   +  VH++G IHRD
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 261 LKSDNLLIFSDKSIKIADFGV 281
           +K DN+LI  D  IK+ DFG+
Sbjct: 127 IKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 39/144 (27%), Positives = 74/144 (51%), Gaps = 9/144 (6%)

Query: 141 AQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +GAFG  +L +    G   A+KIL R  +  EK QV   + ++++++ A      +V+ 
Sbjct: 10  GRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEA--DGAWVVKM 66

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV-PLKLAVKQALDVARGMAYVHRLGLI 257
             + +      ++ E+  GG +   L K+   S    +  + + +     +  +H+LG I
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV---LAIDAIHQLGFI 123

Query: 258 HRDLKSDNLLIFSDKSIKIADFGV 281
           HRD+K DNLL+ +   +K++DFG+
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 3/89 (3%)

Query: 218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
             V+  L+   +  +     +     VARGM ++     +HRDL + N+L+   K +KI 
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKIC 279

Query: 278 DFGVARIEVQTEGMTPETGTY---RWMAP 303
           DFG+AR  +       +  T+   +WMAP
Sbjct: 280 DFGLARDIMHDSNYVSKGSTFLPVKWMAP 308

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 9/166 (5%)

Query: 142 QGAFGKL----YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           +G FG++     R T  G+  A K LE+      K + M    +Q   +L  +    +V 
Sbjct: 10  KGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALNEKQ---ILEKVNSRFVVS 64

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
              A       C+V     GG ++  +    N     + AV  A ++  G+  +HR  ++
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +RDLK +N+L+     I+I+D G+A    + E +    GT  +MAP
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 45/181 (24%), Positives = 83/181 (45%), Gaps = 15/181 (8%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMM 186
            DL  L        G  G++Y+  +   G  +A+K + R  N  E  +++      +V++
Sbjct: 12  ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL---MDLDVVL 68

Query: 187 LATLKH--PNIVRFIGA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
            +   H  P IV+  G       V+ I  E     +    L KR    +P  +  K  + 
Sbjct: 69  KS---HDCPYIVKCYGYFITDSDVF-ICME--LMSTCLDKLLKRIQGPIPEDILGKMTVA 122

Query: 244 VARGMAYV-HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
           + + + Y+  + G+IHRD+K  N+L+ +  ++K+ DFG++   V ++  T   G   +MA
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMA 182

Query: 303 P 303
           P
Sbjct: 183 P 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 24/63 (38%), Positives = 36/63 (57%), Gaps = 3/63 (4%)

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY---RW 300
           VA GM ++     +HRDL + N+LI   K +KI DFG+AR  ++      +  T+   +W
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307

Query: 301 MAP 303
           MAP
Sbjct: 308 MAP 310

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 20/110 (18%)

Query: 182 QEVMMLATLKHPNI-----VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
            E  +L  L HP +     VR +G      + C+V    +   +  +L  R     PL L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGG-----LTCLVLPKYRS-DLYTYLGARLR---PLGL 259

Query: 237 AVKQALDVAR----GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           A  Q   VAR     + Y+H  G+IHRD+K++N+L+   + I + DFG A
Sbjct: 260 A--QVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA 307

Length = 461

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 29/184 (15%)

Query: 138 DAFAQGAFGKLYRGTYN-----GE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLA 188
           ++  QG F K+++G        GE    EV +K+L     D       E  F+   MM +
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVL-----DKSHRNYSESFFEAASMM-S 54

Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALDVARG 247
            L H ++V   G C       +V EY K GS+  +L K +N  ++  KL V + L  A  
Sbjct: 55  QLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQL--AWA 112

Query: 248 MAYVHRLGLIHRDLKSDNLLIF---SDKS-----IKIADFGVARIEVQTEGMTPETGTYR 299
           + ++   GL H ++ + N+L+      K+     IK++D G++ I V  + +  E     
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLE--RIP 169

Query: 300 WMAP 303
           W+ P
Sbjct: 170 WVPP 173

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 40/127 (31%), Positives = 56/127 (44%), Gaps = 14/127 (11%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQQ 179
           W      L +G     GAFGK+  GT  G        +VA+K+L+      EK  +M   
Sbjct: 32  WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALM--- 88

Query: 180 FQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTK-RQNRSVPLKLA 237
              E+ ++  L  H NIV  +GAC K     I+TEY   G +  +L K R N        
Sbjct: 89  --SELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK 146

Query: 238 VKQALDV 244
            K+ LD+
Sbjct: 147 PKKDLDI 153

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 5/165 (3%)

Query: 141 AQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +G FG++Y  R    G+  A+K L++     ++ + +    +  + +++T   P IV  
Sbjct: 3   GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 62

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
             A   P   C + +   GG +   L+  Q+     K     A ++  G+ ++H   +++
Sbjct: 63  TYAFHTPDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           RDLK  N+L+     ++I+D G+A  +   +      GT+ +MAP
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 16/170 (9%)

Query: 142 QGAFG--KLYRGTYNGEEVAIKILERPENDPEKAQVMEQ----QFQQEVMMLATLKHPNI 195
           +G FG  ++ R    G+  A+K+++       K+ ++ Q     F++E  +L+    P I
Sbjct: 11  RGHFGEVQVVREKATGDIYAMKVMK-------KSVLLAQETVSFFEEERDILSISNSPWI 63

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            +   A +      +V EY  GG +   L + +++     +A     ++   +  VH++G
Sbjct: 64  PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQMG 122

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFG-VARIEV-QTEGMTPETGTYRWMAP 303
            +HRD+K +N+LI     IK+ADFG  AR+   +        GT  ++AP
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 14/172 (8%)

Query: 138 DAFAQGAFGKLYRGTYNGEEVAIKILE-RPENDPEKAQVMEQQFQQEVMMLATLKH---P 193
           D   +G +G +Y+  +    V + + E R E D       E +F Q +M L  L     P
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-------ESKFNQIIMELDILHKAVSP 59

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLT-KRQNRSVPLKLAVKQALDVARGMAYV- 251
            IV F GA        +  EY   GS+ +          +P  +  +    V +G+ ++ 
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
               +IHRD+K  N+L+  +  +K+ DFGV+   V +   T   G   +MAP
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-NIGCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 25/71 (35%), Positives = 44/71 (61%), Gaps = 1/71 (1%)

Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V +Y  GG +   L+K ++R +P  +A     ++   +  VH+LG +HRD+K DN+L+ 
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136

Query: 270 SDKSIKIADFG 280
            +  I++ADFG
Sbjct: 137 KNGHIRLADFG 147

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 24/64 (37%), Positives = 37/64 (57%), Gaps = 5/64 (7%)

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR---- 299
           VA+GM+++     IHRDL + N+L+   +  KI DFG+AR +++ +      G  R    
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-DIRNDSNYVVKGNARLPVK 281

Query: 300 WMAP 303
           WMAP
Sbjct: 282 WMAP 285

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 19/39 (48%), Positives = 28/39 (71%)

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           V  G+  +HR+G++HRD+K +NLL+  D  +KI DFG A
Sbjct: 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 3/96 (3%)

Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V +Y  GG +   L+K ++R +P  +A     ++   +  VH+L  +HRD+K DN+L+ 
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136

Query: 270 SDKSIKIADFG--VARIEVQTEGMTPETGTYRWMAP 303
            +  I++ADFG  +  +E  T   +   GT  +++P
Sbjct: 137 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 13/111 (11%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQQ 179
           W +    L +G     GAFG++   T +G        +VA+K+L+      EK  +M   
Sbjct: 32  WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALM--- 88

Query: 180 FQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
              E+ +++ L  H NIV  +GAC K     I+TEY + G +  +L + ++
Sbjct: 89  --SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 29/155 (18%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRF 198
           +G F ++ +      G+  AIK +++     E  QV   +   E+  L  L  HPNI+R 
Sbjct: 9   EGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLR---EIQALRRLSPHPNILRL 63

Query: 199 IGACRKPMVWCI----------VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
           I          +          + E  KG   R    KR      +K  + Q L   + +
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKG-RKRPLPEKR------VKSYMYQLL---KSL 113

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            ++HR G+ HRD+K +N+LI  D  +K+ADFG  R
Sbjct: 114 DHMHRNGIFHRDIKPENILI-KDDILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 9/168 (5%)

Query: 140 FAQGAFGKL----YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI 195
             +G FG++     R T  G+  A K LE+      K + M      E  +L  +    +
Sbjct: 8   LGKGGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMALN---EKRILEKVNSRFV 62

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           V    A       C+V     GG ++  +    N     + A+  A ++  G+  + R  
Sbjct: 63  VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +++RDLK +N+L+     I+I+D G+A    + E +    GT  +MAP
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 8/136 (5%)

Query: 150 RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC 209
           RG+   E+V  K +    ND  +A       + E+  LA   H  IV+     +      
Sbjct: 88  RGSDPKEKVVAKFVML--NDERQAAYA----RSELHCLAACDHFGIVKHFDDFKSDDKLL 141

Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL--DVARGMAYVHRLGLIHRDLKSDNLL 267
           ++ EY  GG + + + +R    +P +      L   +   +  VH   ++HRDLKS N+ 
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201

Query: 268 IFSDKSIKIADFGVAR 283
           +     IK+ DFG ++
Sbjct: 202 LMPTGIIKLGDFGFSK 217

Length = 478

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 31/119 (26%), Positives = 54/119 (45%), Gaps = 14/119 (11%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQ 178
           +W     +L +G    +GAFG++      G         VA+K+L+      E   +M  
Sbjct: 1   KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-- 58

Query: 179 QFQQEVMMLATL-KHPNIVRFIGACRKP-MVWCIVTEYAKGGSVRQFLTKRQNRSVPLK 235
               E+ +L  +  H N+V  +GAC KP     ++ E+ K G++  +L  ++   VP K
Sbjct: 59  ---SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK 114

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 24/67 (35%), Positives = 37/67 (55%), Gaps = 5/67 (7%)

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR- 299
           +  VA+GM ++     IHRDL + N+L+  +  +KI DFG+AR ++  +      G  R 
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL 243

Query: 300 ---WMAP 303
              WMAP
Sbjct: 244 PLKWMAP 250

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 27/81 (33%), Positives = 45/81 (55%), Gaps = 2/81 (2%)

Query: 210 IVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL 267
           +V +YA  G +RQ +  R   NR+     A    + V   + +VH   +IHRD+KS N+L
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175

Query: 268 IFSDKSIKIADFGVARIEVQT 288
           + S+  +K+ DFG +++   T
Sbjct: 176 LCSNGLVKLGDFGFSKMYAAT 196

Length = 496

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 13/112 (11%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQ 178
           +W     +L+ G     GAFGK+   T  G         VA+K+L+   +  E+  +M  
Sbjct: 29  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALM-- 86

Query: 179 QFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
               E+ +L+ L  H NIV  +GAC       ++TEY   G +  FL ++++
Sbjct: 87  ---SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.9 bits (106), Expect = 2e-05
 Identities = 37/164 (22%), Positives = 76/164 (46%), Gaps = 5/164 (3%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FG++Y  R    G+  A+K L++     ++ + +    +  + +++T   P IV   
Sbjct: 4   RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 63

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A   P     + +   GG +   L+  Q+           A ++  G+ ++H   +++R
Sbjct: 64  YAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK  N+L+     ++I+D G+A  +   +      GT+ +MAP
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 22/157 (14%)

Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAQV----MEQQFQQEVMMLATLKHPNIVR----F 198
           K+ RGTY     A +   + + D    Q+    +     +E+ +L  LKHPN++     F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 199 IG-ACRKPMVWCIVTEYAKGG--SVRQFLTKRQNRSVPLKLA---VKQAL-DVARGMAYV 251
           +  A RK  VW ++ +YA+     + +F    +    P++L    VK  L  +  G+ Y+
Sbjct: 68  LSHADRK--VW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 252 HRLGLIHRDLKSDNLLIFSD----KSIKIADFGVARI 284
           H   ++HRDLK  N+L+  +      +KIAD G AR+
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 2e-05
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 28/160 (17%)

Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAQVMEQ--------QFQQEVMMLATLKHPNIVR- 197
           K+ RGTY     A    +R +   EK   ++Q           +E+ +L  LKHPN++  
Sbjct: 8   KVGRGTYGHVYKA----KRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIAL 63

Query: 198 ---FIGACRKPMVWCIVTEYAKGG--SVRQFLTKRQNRSVPLKLA---VKQAL-DVARGM 248
              F+    +  VW ++ +YA+     + +F    +    P++L    VK  L  +  G+
Sbjct: 64  QKVFLSHSDRK-VW-LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 249 AYVHRLGLIHRDLKSDNLLIFSD----KSIKIADFGVARI 284
            Y+H   ++HRDLK  N+L+  +      +KIAD G AR+
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 23/67 (34%), Positives = 36/67 (53%), Gaps = 5/67 (7%)

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR- 299
           +  VA+GM ++     IHRD+ + N+L+   +  KI DFG+AR ++  +      G  R 
Sbjct: 218 SSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMNDSNYVVKGNARL 276

Query: 300 ---WMAP 303
              WMAP
Sbjct: 277 PVKWMAP 283

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 23/71 (32%), Positives = 43/71 (60%), Gaps = 1/71 (1%)

Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V +Y  GG +   L+K ++R +P  +A     ++   +  +H+L  +HRD+K DN+L+ 
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136

Query: 270 SDKSIKIADFG 280
            +  I++ADFG
Sbjct: 137 MNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 43.7 bits (103), Expect = 5e-05
 Identities = 30/102 (29%), Positives = 55/102 (53%), Gaps = 11/102 (10%)

Query: 209 CIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
           C+V     GG +R  +     +N   P   A      +  G+ ++H+  +I+RDLK +N+
Sbjct: 69  CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENV 128

Query: 267 LIFSDKSIKIADFGVARIEV-----QTEGMTPETGTYRWMAP 303
           L+ +D +++I+D G+A +E+     +T+G     GT  +MAP
Sbjct: 129 LLDNDGNVRISDLGLA-VELKDGQSKTKGY---AGTPGFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 32/129 (24%), Positives = 56/129 (43%), Gaps = 14/129 (10%)

Query: 148 LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF-----IGAC 202
           L R T  G  V ++I +      E  + +    Q EV++    +HPNI+        G+ 
Sbjct: 18  LARHTPTGTLVTVRITDLENCTEEHLKAL----QNEVVLSHFFRHPNIMTSWTVFTTGS- 72

Query: 203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLK 262
               +W +++ +   GS    L       +   L         RG+ Y+H+ G IHR++K
Sbjct: 73  ---WLW-VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK 128

Query: 263 SDNLLIFSD 271
           + ++LI  D
Sbjct: 129 ASHILISGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (102), Expect = 7e-05
 Identities = 38/166 (22%), Positives = 77/166 (46%), Gaps = 7/166 (4%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRF 198
           +G FG++Y  R        A+K+L + E    K +V     ++ +++   L   P IV  
Sbjct: 3   KGTFGQVYQVRKKDTRRIYAMKVLSKKE-IVAKKEVAHTIGERNILVRTLLDESPFIVGL 61

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
             + +      +VT+Y  GG +  F   ++        A     ++   + ++H+  +++
Sbjct: 62  KFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVY 119

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           RDLK +N+L+ +   I + DFG+++  +     T    GT  ++AP
Sbjct: 120 RDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 9e-04
 Identities = 54/254 (21%), Positives = 89/254 (35%), Gaps = 30/254 (11%)

Query: 53  SVAMSVDNSSVGSNESHTRI--LNHQGLRRRANDNYSVAH---SVNRRGRVSHALSDDAL 107
           S+         G++ +           + R   D ++ A    S       SH   D+A 
Sbjct: 67  SIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAP 126

Query: 108 ARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY---RGTYNGEEVAIKILE 164
             A          L++ DE+   L    + D    GAFGK++         E  A + + 
Sbjct: 127 PDAAGPVPLAQAKLKHDDEF---LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVN 183

Query: 165 RPENDPEKAQV-----------MEQQFQQEVMMLATLKHPNIVRFIGACRKP-MVWCIVT 212
                  K +               Q + E++ L  L H NI++     R     + I  
Sbjct: 184 STNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQ 243

Query: 213 EYAKGGSVRQFLTKRQNRSVPL----KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI 268
           +Y        +      +  PL    +  +KQ L     + Y+H   LIHRD+K +N+ +
Sbjct: 244 KYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLC---AVEYIHDKKLIHRDIKLENIFL 300

Query: 269 FSDKSIKIADFGVA 282
             D  I + DFG A
Sbjct: 301 NCDGKIVLGDFGTA 314

Length = 501

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.5 bits (93), Expect = 0.001
 Identities = 21/75 (28%), Positives = 36/75 (48%), Gaps = 7/75 (9%)

Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           IV EY +G  ++  +       + L      + ++ R +  +H  G+IH DL + N +I 
Sbjct: 76  IVMEYIEGEPLKDLINSNGMEELEL------SREIGRLVGKLHSAGIIHGDLTTSN-MIL 128

Query: 270 SDKSIKIADFGVARI 284
           S   I + DFG+A  
Sbjct: 129 SGGKIYLIDFGLAEF 143

Length = 211

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.5 bits (90), Expect = 0.001
 Identities = 31/155 (20%), Positives = 53/155 (34%), Gaps = 38/155 (24%)

Query: 143 GAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGA 201
           G   ++Y      E+  +KI    E             ++EV +L  L +    V     
Sbjct: 9   GLTNRVYLLGTKDEDYVLKINPSREKG--------ADREREVAILQLLARKGLPV----- 55

Query: 202 CRKPMVWC---------IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
              P V           ++ E+ +G    + L +              A  +A  +A +H
Sbjct: 56  ---PKVLASGESDGWSYLLMEWIEG----ETLDEVSEEEKE-----DIAEQLAELLAKLH 103

Query: 253 RL---GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           +L    L H DL   N+L+   K + I D+  A  
Sbjct: 104 QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 38.0 bits (89), Expect = 0.003
 Identities = 33/156 (21%), Positives = 57/156 (36%), Gaps = 32/156 (20%)

Query: 141 AQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
            QGA   +Y   + G    +K  ER        +    +  +++    T       R + 
Sbjct: 5   KQGAEAIIYLTDFLGLPAVVK--ERI-----PKRYRHPELDEKLRRERTR---REARILA 54

Query: 201 ACRK-----PMVW-------CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
             R+     P+V+        IV EY +G  ++  L           L  +    V +  
Sbjct: 55  KAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL-----EEARPDLLREVGRLVGK-- 107

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
             +H+ G++H DL + N +I S   I   DFG+   
Sbjct: 108 --LHKAGIVHGDLTTSN-IILSGGRIYFIDFGLGEF 140

Length = 204

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	303
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.98
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.98
KOG0578	550	consensus p21-activated serine/threonine protein k	99.98
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.98
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.96
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
KOG0610	459	consensus Putative serine/threonine protein kinase	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.96
KOG0589	426	consensus Serine/threonine protein kinase [General	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.96
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.96
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.96
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
KOG0584	632	consensus Serine/threonine protein kinase [General	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.95
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.95
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.95
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.95
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.95
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.95
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.95
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.95
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.94
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.94
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
PHA03210	501	serine/threonine kinase US3; Provisional	99.94
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.94
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.94
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.94
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.94
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.94
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.94
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.94
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.94
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.94
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.94
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.93
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.93
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.93
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.93
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.93
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.93
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.93
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.93
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.93
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.93
PHA02882	294	putative serine/threonine kinase; Provisional	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.93
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.93
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.93
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.93
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.93
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.93
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.92
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.92
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.92
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.92
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.92
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.92
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.92
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.91
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.91
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.91
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.91
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.91
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.91
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.9
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.9
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.9
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.9
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.89
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
PRK14879	211	serine/threonine protein kinase; Provisional	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.86
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.85
smart00090	237	RIO RIO-like kinase.	99.85
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.83
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.81
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.78
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.76
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
PLN00181	793	protein SPA1-RELATED; Provisional	99.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.65
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.58
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.57
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.57
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.51
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.51
KOG3087	229	consensus Serine/threonine protein kinase [General	99.5
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.44
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.33
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.33
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.31
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.26
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.22
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.21
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.19
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.15
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.12
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.1
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.96
KOG1243	690	consensus Protein kinase [General function predict	98.96
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.93
PRK09902	216	hypothetical protein; Provisional	98.89
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.84
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.82
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.79
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.76
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.74
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.65
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.56
PF01636	239	APH: Phosphotransferase enzyme family This family	98.55
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.44
PLN02876	822	acyl-CoA dehydrogenase	98.42
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.4
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
PRK10593	297	hypothetical protein; Provisional	98.05
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.99
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.89
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.84
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.83
COG4248	637	Uncharacterized protein with protein kinase and he	97.78
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.77
PRK05231	319	homoserine kinase; Provisional	97.71
KOG2270	520	consensus Serine/threonine protein kinase involved	97.58
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.53
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.41
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.3
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.26
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.23
PLN02756	418	S-methyl-5-thioribose kinase	97.15
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.11
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.06
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.97
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.86
PRK12396	409	5-methylribose kinase; Reviewed	96.85
PLN02236	344	choline kinase	96.83
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.47
PTZ00384	383	choline kinase; Provisional	96.46
PRK11768	325	serine/threonine protein kinase; Provisional	96.2
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.19
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.09
KOG2137	700	consensus Protein kinase [Signal transduction mech	95.72
PRK06148	1013	hypothetical protein; Provisional	95.64
PTZ00296	442	choline kinase; Provisional	95.53
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.03
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	94.92
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.67
PRK10271	188	thiK thiamine kinase; Provisional	94.49
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.05
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	93.94

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=354.84  Aligned_cols=254  Identities=29%  Similarity=0.495  Sum_probs=218.0

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCee--eeeeccCC---CCccc-cCChHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYS--VAHSVNRR---GRVSH-ALSDDA  106 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~--i~~~~~~~---~~~~~-~~~~~~  106 (303)
                      ||++++.+|      ++..|+|++|+++...+...   ..|+||+|+..+.+.++  ++....+.   .++.| +...++
T Consensus       104 ~G~flvR~s------e~~~g~yslsv~~~~~~~~~---~~v~hyri~~~~~~~~~~~~~~~~~F~~l~~lv~~~~~~~~g  174 (468)
T KOG0197|consen  104 EGAFLVRES------ESDKGDYSLSVREGDSGGLG---AKVKHYRIRQLDGGGLYPYIDERELFSSLQQLVNYYSKNADG  174 (468)
T ss_pred             ccceeeecc------cCCcCCeeEEEEeccccCCc---cceeeeeeeEcCCCCeecCCCHHHhhhhHHHHHhhhhccCcc
Confidence            477887766      57899999999998766632   48999999999999877  66554443   35555 788899


Q ss_pred             HHHHhcCCCCC-----CcCCC-CCCcceeecCCccccceecccCceEEEEEEECCe-EEEEEEeeCCCCChHHHHHHHHH
Q 046106          107 LARALMDSNSP-----TEGLE-NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQ  179 (303)
Q Consensus       107 ~~~~l~~~~~~-----~~~~~-~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~~  179 (303)
                      ++..+..|+..     +...+ ..+.|+++++.+++.+.||+|.||.||.|.|+++ .||+|.++...+..       +.
T Consensus       175 l~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~-------~~  247 (468)
T KOG0197|consen  175 LCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP-------EA  247 (468)
T ss_pred             hhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh-------hH
Confidence            99999998863     11112 2789999999999999999999999999999877 99999999876654       57


Q ss_pred             HHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 046106          180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR  259 (303)
Q Consensus       180 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHr  259 (303)
                      |.+|+.+|++|+|++||+++++|..+.++|||||||+.|+|.+||+...+..+...+++.++.|||+||+||+++++|||
T Consensus       248 f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHR  327 (468)
T KOG0197|consen  248 FLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHR  327 (468)
T ss_pred             HHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccch
Confidence            88999999999999999999999998899999999999999999998777789999999999999999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCC---CCcccCC
Q 046106          260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG---TYRWMAP  303 (303)
Q Consensus       260 Dlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~g---t~~y~AP  303 (303)
                      ||.++||||+++..+||+||||||...++. ++...|   .++|+||
T Consensus       328 DLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~~~~~~kfPIkWtAP  373 (468)
T KOG0197|consen  328 DLAARNILVDEDLVVKISDFGLARLIGDDE-YTASEGGKFPIKWTAP  373 (468)
T ss_pred             hhhhhheeeccCceEEEcccccccccCCCc-eeecCCCCCCceecCH
Confidence            999999999999999999999999554443 444444   4899998

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=296.04  Aligned_cols=166  Identities=30%  Similarity=0.541  Sum_probs=150.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      .+|.+.+.||.|+|++||+|++  ++..||||.+.+......    ..+.+..|+.+|+.++|||||+|++++..++.+|
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k----~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKK----LVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHH----HHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence            4677788899999999999998  678999999987654332    2367889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC------CcEEEeccCCce
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD------KSIKIADFGVAR  283 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~------~~vKl~DFGla~  283 (303)
                      +|||||.||+|.+|++.+  +.+++..+..++.||+.||++||+++||||||||+|||++..      -.+||+|||+||
T Consensus        86 lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999999999986  469999999999999999999999999999999999999875      468999999999


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...+.....+.||+|.||||
T Consensus       164 ~L~~~~~a~tlcGSplYMAP  183 (429)
T KOG0595|consen  164 FLQPGSMAETLCGSPLYMAP  183 (429)
T ss_pred             hCCchhHHHHhhCCccccCH
Confidence            98877777888999999999

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=296.17  Aligned_cols=177  Identities=47%  Similarity=0.884  Sum_probs=160.5

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEECCeE-EEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ....|+++...+.+.+.||.|+||+||+|.|.|+. ||||++.....+...    .+.|.+|+.+|.+++|||||+++|+
T Consensus        32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~f~G~  107 (362)
T KOG0192|consen   32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES----RKAFRREASLLSRLRHPNIVQFYGA  107 (362)
T ss_pred             cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH----HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            45789999999999999999999999999999998 999999877665544    5799999999999999999999999


Q ss_pred             EEcCC-eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCcEEEcCCC-cEEEec
Q 046106          202 CRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG-LIHRDLKSDNLLIFSDK-SIKIAD  278 (303)
Q Consensus       202 ~~~~~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-iiHrDlkp~NILv~~~~-~vKl~D  278 (303)
                      |.++. .++||||||++|+|.+++.......+++..++.++.||+.||+|||+++ ||||||||+||||+.++ ++||+|
T Consensus       108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D  187 (362)
T KOG0192|consen  108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD  187 (362)
T ss_pred             EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence            99987 7899999999999999998754568999999999999999999999999 99999999999999997 999999


Q ss_pred             cCCceeeecC-CCccCCCCCCcccCC
Q 046106          279 FGVARIEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      ||+++..... ...+...||+.||||
T Consensus       188 FGlsr~~~~~~~~~~~~~GT~~wMAP  213 (362)
T KOG0192|consen  188 FGLSREKVISKTSMTSVAGTYRWMAP  213 (362)
T ss_pred             CccceeeccccccccCCCCCccccCh
Confidence            9999976654 344557899999999

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-38  Score=284.68  Aligned_cols=172  Identities=28%  Similarity=0.431  Sum_probs=150.7

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHH-HHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKA-QVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      -.+.|.+.+.||+|+||.|-+|..  +++.||||++.+......+. ........+|+++|++|+|||||++++++..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            345677889999999999999976  78999999998765544222 111234679999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccCCce
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR  283 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---~~vKl~DFGla~  283 (303)
                      ..|+|||||.||+|.+++...  +.+.+..-..++.|++.|+.|||++||+||||||+|||+..+   -.+||+|||+|+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            999999999999999999875  457777888899999999999999999999999999999776   679999999999


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +......+.+.||||.|.||
T Consensus       328 ~~g~~sfm~TlCGTpsYvAP  347 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAP  347 (475)
T ss_pred             ccccceehhhhcCCccccCh
Confidence            98877788899999999999

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-39  Score=300.05  Aligned_cols=250  Identities=25%  Similarity=0.462  Sum_probs=208.6

Q ss_pred             ecccCCCeEEEEEeecCCCCC---CcCccccccccccccCCCCeeeeeeccCC---CCccc-cCChHHHHHHhcCCCCCC
Q 046106           46 QTSNGGGSVAMSVDNSSVGSN---ESHTRILNHQGLRRRANDNYSVAHSVNRR---GRVSH-ALSDDALARALMDSNSPT  118 (303)
Q Consensus        46 ~~~~~~g~~~~s~~~~~~~~~---~~~~~~v~h~~i~~~~~~~~~i~~~~~~~---~~~~~-~~~~~~~~~~l~~~~~~~  118 (303)
                      .++...|+|.+.-.+++.|.-   -.+.+.|.||+|.....+..|++....++   .+|.| +.-.|++...|..|.+..
T Consensus       168 LsSgInGSFLVRESEsSpgQ~sISlRyeGRVyHYRINt~~dgK~yvt~EsrF~TLaELVHHHStvADGLittLhYPApK~  247 (1157)
T KOG4278|consen  168 LSSGINGSFLVRESESSPGQYSISLRYEGRVYHYRINTDNDGKMYVTQESRFRTLAELVHHHSTVADGLITTLHYPAPKK  247 (1157)
T ss_pred             hhcCcccceEEeeccCCCcceeEEEEecceEEEEEeeccCCccEEEeehhhhhHHHHHHhhccccccceeEeeeccCccC
Confidence            344556666666666665542   22456899999999999999998755444   35655 778889998888876542


Q ss_pred             cC------CCCCCcceeecCCccccceecccCceEEEEEEECC--eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC
Q 046106          119 EG------LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG--EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL  190 (303)
Q Consensus       119 ~~------~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l  190 (303)
                      ..      .++.++|++++.++.+..+||-|.||.||.|.|+.  -.||||.++...+.       .+.|+.|+.+|+.+
T Consensus       248 nKptvygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-------veEFLkEAAvMKei  320 (1157)
T KOG4278|consen  248 NKPTVYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEI  320 (1157)
T ss_pred             CCCceeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-------HHHHHHHHHHHHhh
Confidence            21      24679999999999999999999999999999954  58999999875543       36899999999999


Q ss_pred             CCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 046106          191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS  270 (303)
Q Consensus       191 ~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~  270 (303)
                      +|||+|+|+|+|..+.++|||+|||..|+|.+||++-....++.-.++.|+.||..||+||..+++|||||.++|+||.+
T Consensus       321 kHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgE  400 (1157)
T KOG4278|consen  321 KHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE  400 (1157)
T ss_pred             cCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccc
Confidence            99999999999999999999999999999999999876666788889999999999999999999999999999999999


Q ss_pred             CCcEEEeccCCceeeecCCCccCCCC---CCcccCC
Q 046106          271 DKSIKIADFGVARIEVQTEGMTPETG---TYRWMAP  303 (303)
Q Consensus       271 ~~~vKl~DFGla~~~~~~~~~~~~~g---t~~y~AP  303 (303)
                      +..|||+|||+++++..+. ++.-.|   .+.|+||
T Consensus       401 nhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAP  435 (1157)
T KOG4278|consen  401 NHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAP  435 (1157)
T ss_pred             cceEEeeccchhhhhcCCc-eecccCccCcccccCc
Confidence            9999999999999876543 555555   4899998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=273.94  Aligned_cols=171  Identities=25%  Similarity=0.438  Sum_probs=151.3

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .+..++|++++.||+|+||+|+.++.  +++.+|+|++++......+   ..+....|..||..++||+||+++-.|++.
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~---e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK---EVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh---hHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            35567889999999999999999986  7889999999876544321   235788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+|+|+||+.||.|.-.|.+.  +.+++..+.-++++|+.||.|||++|||||||||+|||+|.+|+++|+|||+|+..
T Consensus        98 ~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999999999864  56999999999999999999999999999999999999999999999999999964


Q ss_pred             ec-CCCccCCCCCCcccCC
Q 046106          286 VQ-TEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~-~~~~~~~~gt~~y~AP  303 (303)
                      .. .....+.|||+.||||
T Consensus       176 ~~~~~~t~tfcGT~eYmAP  194 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAP  194 (357)
T ss_pred             ccCCCccccccCCccccCh
Confidence            33 3445667999999999

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-36  Score=281.13  Aligned_cols=167  Identities=31%  Similarity=0.489  Sum_probs=152.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      .+|..++.||+|+|+.||+++.  +|+.||+|++.+.......   ..+.+.+|++|.++|+|||||+++++|++.+.+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~---~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY   94 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK---QREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY   94 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc---hHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence            6788899999999999999987  7899999999875443322   2468889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-  288 (303)
                      ||+|+|+.++|..+++.+  +.+++.+++.++.||+.||.|||+++|||||||..|+|++++.+|||+|||||.....+ 
T Consensus        95 ivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999999999855  57999999999999999999999999999999999999999999999999999887755 


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      +...+.||||.|.||
T Consensus       173 Erk~TlCGTPNYIAP  187 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAP  187 (592)
T ss_pred             cccceecCCCcccCh
Confidence            667788999999999

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=266.99  Aligned_cols=168  Identities=33%  Similarity=0.505  Sum_probs=150.0

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .+...+++.++.||+|..|.||++++  +++.+|+|++.... ++    ...+++.+|+++++.++||+||++||.|..+
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-~~----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-DP----ALQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-CH----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            45667888889999999999999998  68899999994332 22    2347899999999999999999999999998


Q ss_pred             C-eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          206 M-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       206 ~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      . .++|+||||.+|+|.+++...  +.+++..+.+++.+|++||.|||+ ++||||||||+||||+..|.|||||||.++
T Consensus       150 ~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  150 GEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             CceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence            8 599999999999999999876  569999999999999999999995 899999999999999999999999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...+. ...+.+||..||||
T Consensus       228 ~lvnS-~a~tfvGT~~YMsP  246 (364)
T KOG0581|consen  228 ILVNS-IANTFVGTSAYMSP  246 (364)
T ss_pred             Hhhhh-hcccccccccccCh
Confidence            87765 45678999999999

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-35  Score=272.63  Aligned_cols=173  Identities=24%  Similarity=0.391  Sum_probs=150.3

Q ss_pred             Ccce-eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          125 DEWT-IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       125 ~~~~-i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ..|. .....|+.+++||+|+||.||+|+.  +|+.||+|.++.........    .-..+|+.||++|.||||++|.+.
T Consensus       109 ~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~----~t~~REI~ILr~l~HpNIikL~ei  184 (560)
T KOG0600|consen  109 HGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFP----ITAIREIKILRRLDHPNIIKLEEI  184 (560)
T ss_pred             ccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcch----HHHHHHHHHHHhcCCCcccceeeE
Confidence            3443 3456788999999999999999997  88999999998877655443    456799999999999999999999


Q ss_pred             EEcC--CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          202 CRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       202 ~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      ..+.  ..+|+|+|||++ +|.-++.. .+..|++.++..++.|++.||+|||++||+|||||.+|||||.+|.+||+||
T Consensus       185 vt~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  185 VTSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             EEecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccc
Confidence            8876  689999999976 88887765 3457999999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCC--CccCCCCCCcccCC
Q 046106          280 GVARIEVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~--~~~~~~gt~~y~AP  303 (303)
                      |||++.....  .++..+-|.+|+||
T Consensus       263 GLAr~y~~~~~~~~T~rVvTLWYRpP  288 (560)
T KOG0600|consen  263 GLARFYTPSGSAPYTSRVVTLWYRPP  288 (560)
T ss_pred             cceeeccCCCCcccccceEEeeccCh
Confidence            9999765443  47778889999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.3e-36  Score=260.92  Aligned_cols=166  Identities=30%  Similarity=0.471  Sum_probs=147.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|+.+.++|+|+||.||+|+.  +|+.||||.+.....++    ...+-..+|+.+|++++|||+|.|+.+|.....++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~----~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh   77 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP----VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH   77 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH----HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence            3567778899999999999987  89999999998766554    33467789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee-cC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV-QT  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~-~~  288 (303)
                      +|+|||+. ++.+-|...+ ..++...+..++.|++.|+.|||++++|||||||+||||+.+|.+||||||+|+... ++
T Consensus        78 LVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   78 LVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             EEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99999976 6666676655 358999999999999999999999999999999999999999999999999999876 67


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      +.++..+.|.+|+||
T Consensus       156 d~YTDYVATRWYRaP  170 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAP  170 (396)
T ss_pred             chhhhhhhhhhccCh
Confidence            778888999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=271.29  Aligned_cols=176  Identities=30%  Similarity=0.568  Sum_probs=150.3

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--C-C---eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--N-G---EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR  197 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  197 (303)
                      ...|++.-+++.+.++||+|+||.||+|++  . +   ..||||..+....   ........|.+|+++|++++|||||+
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~---~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE---LTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc---ccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            467999999999999999999999999987  2 2   2389999875221   12334578999999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       198 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                      +||++....+++||||+|+||+|.+||+..++ .++..+.+.++.+.+.||+|||++++|||||.++|+|++.++.+||+
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence            99999999999999999999999999998753 68999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCCcc-CCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMT-PETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~-~~~gt~~y~AP  303 (303)
                      |||+++......... ...-..+|+||
T Consensus       305 DFGLs~~~~~~~~~~~~~klPirWLAP  331 (474)
T KOG0194|consen  305 DFGLSRAGSQYVMKKFLKKLPIRWLAP  331 (474)
T ss_pred             ccccccCCcceeeccccccCcceecCh
Confidence            999998654222112 11246899998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=270.65  Aligned_cols=175  Identities=33%  Similarity=0.618  Sum_probs=147.9

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      .+++..-..++|.-...||+|+||.||+|.. +++.||||.+.......      .++|.+|+.++.+++|||+|+|+|+
T Consensus        66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~------~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG------EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             eHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc------hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            3445555567787778999999999999998 55899999876544321      1469999999999999999999999


Q ss_pred             EEcCC-eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCcEEEcCCCcEEEe
Q 046106          202 CRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG---LIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       202 ~~~~~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g---iiHrDlkp~NILv~~~~~vKl~  277 (303)
                      |.+.. ..+||+|||++|+|.++|+......++|..+++||.++|+||+|||...   ||||||||+|||+|++..+||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99888 5899999999999999999764337899999999999999999999753   9999999999999999999999


Q ss_pred             ccCCceeeec-CCCccCC-CCCCcccCC
Q 046106          278 DFGVARIEVQ-TEGMTPE-TGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~-~~~~~~~-~gt~~y~AP  303 (303)
                      |||+|+.... ....... .||..|+||
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~P  247 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAP  247 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCCh
Confidence            9999976543 3222233 799999998

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=253.46  Aligned_cols=168  Identities=27%  Similarity=0.421  Sum_probs=149.1

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      ....+|+.++.||.|+||+|.+++.  +|.-+|+|++.+...-..+   ..+...+|..+|+.+.||+++++++.|.+..
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklK---QveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLK---QVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHH---HHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            4456788889999999999999987  7789999999765432221   2356789999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+||||++||.|..+|+..  ++++++.+..+|+||+.||+|||+.+|++|||||+|||+|.+|.+||+|||+|+...
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999999999875  569999999999999999999999999999999999999999999999999998654


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      .  .+.+.||||.|+||
T Consensus       196 ~--rT~TlCGTPeYLAP  210 (355)
T KOG0616|consen  196 G--RTWTLCGTPEYLAP  210 (355)
T ss_pred             C--cEEEecCCccccCh
Confidence            3  36678999999999

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=268.34  Aligned_cols=172  Identities=30%  Similarity=0.567  Sum_probs=152.0

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKP  205 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~  205 (303)
                      .....|.+++.||+|+||+|+.|+.  +++.||+|++.+....... ....+.+.+|+.+++.++ ||||++++.++..+
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            4456888999999999999999987  7899999988765322122 223456779999999999 99999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCcee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVARI  284 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~~  284 (303)
                      ..+|+||||+.+|+|.+++...  +++.+..+..++.|++.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999999983  568999999999999999999999999999999999999999 9999999999998


Q ss_pred             e-ecCCCccCCCCCCcccCC
Q 046106          285 E-VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~-~~~~~~~~~~gt~~y~AP  303 (303)
                      . .......+.|||+.|+||
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aP  190 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAP  190 (370)
T ss_pred             cCCCCCcccCCCCCcccCCH
Confidence            7 456677888999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-36  Score=259.41  Aligned_cols=172  Identities=27%  Similarity=0.457  Sum_probs=147.8

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE-EEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG-ACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~  204 (303)
                      .....+|.++++||.|+||.||+++.  +|..||.|.++-..++...    .+.+..|+.+|++|+|||||++++ .+..
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~----rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKA----RQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHH----HHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            34456788999999999999999986  8999999999866555433    478999999999999999999999 3433


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeCCCCCCcEEEcCCCcEEEe
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHR--LG--LIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~--~g--iiHrDlkp~NILv~~~~~vKl~  277 (303)
                       ...++|||||+.+|+|.+.++..  +.+.+|+..+++++.|++.||+.||.  .+  |+||||||.||+++.+|.+||.
T Consensus        91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence             44589999999999999999743  44679999999999999999999998  55  9999999999999999999999


Q ss_pred             ccCCceeeecCCC-ccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEG-MTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~-~~~~~gt~~y~AP  303 (303)
                      |||++++...... ..+.+|||.||+|
T Consensus       171 DfGL~r~l~s~~tfA~S~VGTPyYMSP  197 (375)
T KOG0591|consen  171 DFGLGRFLSSKTTFAHSLVGTPYYMSP  197 (375)
T ss_pred             cchhHhHhcchhHHHHhhcCCCcccCH
Confidence            9999998765443 3456899999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=268.18  Aligned_cols=166  Identities=31%  Similarity=0.451  Sum_probs=150.9

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCC-
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPM-  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~-  206 (303)
                      .++|.+.++||.|+||.||+|+.  ++..||||.+++....-+..     .-+||+..|++++ |||||+|..++.+.+ 
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-----~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-----MNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-----HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            46788999999999999999986  78899999998765543332     3468999999998 999999999999887 


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+|||||+ .+|+++++.+ ++.+++..+..|+.||+.||+|+|.+|+.||||||+||||..+..+||+|||+||.+.
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence            9999999995 5999999988 6889999999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ....++..+.|.+|+||
T Consensus       162 SkpPYTeYVSTRWYRAP  178 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAP  178 (538)
T ss_pred             cCCCcchhhhcccccch
Confidence            88888888999999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-34  Score=260.27  Aligned_cols=168  Identities=26%  Similarity=0.479  Sum_probs=154.9

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ..+|++.+.||+|.||+|-+++.  .|+.||||.+++.....++.   .-.+.+|++||..|+||||+++|.+|...+.+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD---lvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD---LVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH---HHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            45788899999999999999975  78999999999877655433   24788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      .|||||..+|.|++|+.++  +.+++.....+++||.+|+.|||.++++|||||.+|||+|.|+++||+|||++....+.
T Consensus       129 vivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999999999987  46999999999999999999999999999999999999999999999999999988888


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      ...+++||+|.|.+|
T Consensus       207 kfLqTFCGSPLYASP  221 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASP  221 (668)
T ss_pred             cHHHHhcCCcccCCc
Confidence            888999999999988

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=265.30  Aligned_cols=171  Identities=29%  Similarity=0.434  Sum_probs=148.3

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  204 (303)
                      .....+|.+++.||+|+|++|++|+.  +++.+|||++.+.-...++.   ..-+.+|-.+|.+| .||.|++|+-.|++
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K---vkYV~~Ek~~l~~L~~hPgivkLy~TFQD  145 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK---VKYVTREKEALTQLSGHPGIVKLYFTFQD  145 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc---cchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence            34567899999999999999999987  78899999997654333222   24566788899999 79999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +..+|+|+||+++|+|.+++.+.  +.+.+.....+++||+.||+|||++|||||||||+|||++.++++||+|||.|++
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999999986  5799999999999999999999999999999999999999999999999999987


Q ss_pred             eecCCC--------------ccCCCCCCcccCC
Q 046106          285 EVQTEG--------------MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~--------------~~~~~gt~~y~AP  303 (303)
                      +.+...              ..+++||..|.+|
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSP  256 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSP  256 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCH
Confidence            643221              1347899999988

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.7e-33  Score=241.27  Aligned_cols=166  Identities=28%  Similarity=0.422  Sum_probs=144.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      .+|...+.||+|+||.||+|++  +|+.||||.++.......-    .....+|+..|+.++||||+.|+++|.....+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi----~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~   77 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI----NRTALREIKLLQELKHPNIIELIDVFPHKSNLS   77 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc----cHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence            3567788999999999999998  7899999999876433211    146779999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      ||+|||+ .+|...++... ..+...++..++.++++|++|||++.|+||||||.|+||+++|.+||+|||+|+......
T Consensus        78 lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   78 LVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9999996 49998888654 568899999999999999999999999999999999999999999999999999865433


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ..+..+-|-+|+||
T Consensus       156 ~~~~~~V~TRWYRAP  170 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAP  170 (318)
T ss_pred             cccccceeeeeccCh
Confidence             34445788999998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-34  Score=242.94  Aligned_cols=173  Identities=28%  Similarity=0.463  Sum_probs=153.8

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..|+  .++|++++.||+|.||.||.|+.  ++-.||+|++.+.+...   ....+++.+|++|-..|+||||+++|++|
T Consensus        17 ~~~~--l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~---~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWT--LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK---TQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccc--hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH---hcchhhhhheeEeecccCCccHHhhhhhe
Confidence            4455  46899999999999999999997  55689999997655322   22357899999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .+...+|+++||.++|+++..|+..+...+.+.....+..|+|.|+.|||.++||||||||+|+|++.++.+||+|||.+
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            99999999999999999999999888888999999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .... .....+.|||..|.+|
T Consensus       172 V~~p-~~kR~tlcgt~dyl~p  191 (281)
T KOG0580|consen  172 VHAP-SNKRKTLCGTLDYLPP  191 (281)
T ss_pred             eecC-CCCceeeecccccCCH
Confidence            7644 3445677999999998

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=248.61  Aligned_cols=166  Identities=30%  Similarity=0.589  Sum_probs=142.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM--  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--  206 (303)
                      ..++..++.||+|+||.||++..  +|...|||.+.......      .+.+.+|+.+|.+++|||||+++|......  
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~   89 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------SESLEREIRILSRLNHPNIVQYYGSSSSREND   89 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------HHHHHHHHHHHHhCCCCCEEeeCCccccccCe
Confidence            34566778899999999999998  47899999987652111      357889999999999999999999744433  


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccCCceee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFGVARIE  285 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-~~~vKl~DFGla~~~  285 (303)
                      .++|+|||+++|+|.+++....+ .+++..+..+++||+.||+|||++|||||||||+||||+. ++.+||+|||+++..
T Consensus        90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            68999999999999999998765 7999999999999999999999999999999999999999 799999999999865


Q ss_pred             ec----CCCccCCCCCCcccCC
Q 046106          286 VQ----TEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~----~~~~~~~~gt~~y~AP  303 (303)
                      ..    ........||+.||||
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maP  190 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAP  190 (313)
T ss_pred             ccccccccccccccCCccccCc
Confidence            53    1223356899999999

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-33  Score=260.53  Aligned_cols=175  Identities=28%  Similarity=0.586  Sum_probs=152.6

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEEC----Ce--EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN----GE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI  195 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~----~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni  195 (303)
                      +....+++++..+.+.+.||.|.||.||+|.++    |+  .||||+.+...... +    .+.|.+|+.+|+.++||||
T Consensus       379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~----tekflqEa~iMrnfdHphI  453 (974)
T KOG4257|consen  379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-D----TEKFLQEASIMRNFDHPHI  453 (974)
T ss_pred             CCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-h----HHHHHHHHHHHHhCCCcch
Confidence            344677888999999999999999999999872    32  58999887643322 2    2689999999999999999


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vK  275 (303)
                      ++|+|+|.+.. .|||||+++-|.|..||+..+ ..++...+..++.||+.||+|||+.++|||||.++||||.....||
T Consensus       454 ikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  454 IKLIGVCVEQP-MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             hheeeeeeccc-eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence            99999998765 589999999999999999765 4689999999999999999999999999999999999999999999


Q ss_pred             EeccCCceeeecCCCccCCCC--CCcccCC
Q 046106          276 IADFGVARIEVQTEGMTPETG--TYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~~~~~~~~g--t~~y~AP  303 (303)
                      |+|||++|.+.+...+....|  .++||||
T Consensus       532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaP  561 (974)
T KOG4257|consen  532 LADFGLSRYLEDDAYYKASRGKLPIKWMAP  561 (974)
T ss_pred             ecccchhhhccccchhhccccccceeecCc
Confidence            999999999887776665555  5899998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=262.12  Aligned_cols=174  Identities=35%  Similarity=0.745  Sum_probs=155.6

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ...+|+|..+++.++..||+|.||+||+|.|.| .||||+++.....++.    .+.|++|+..+++-+|-||+-+.|+|
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~q----lqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQ----LQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHH----HHHHHHHHHHHhhcchhhheeeehhh
Confidence            347999999999999999999999999999977 6899999988777653    47999999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ..+.. .||+.+|+|.+|+.+|+... ..+.....++|++||+.||.|||.++|||||||..||++.+++.|||+|||+|
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence            99887 89999999999999998654 45888999999999999999999999999999999999999999999999999


Q ss_pred             eeeec---CCCccCCCCCCcccCC
Q 046106          283 RIEVQ---TEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~---~~~~~~~~gt~~y~AP  303 (303)
                      .....   ........|...||||
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAP  559 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAP  559 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcH
Confidence            76432   2334455788999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-32  Score=247.08  Aligned_cols=175  Identities=27%  Similarity=0.430  Sum_probs=155.3

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ...|-++.+.|++.+.||.|..+.||+|+.  .+..||||++.....+.     ....+.+|+..|..++||||++++..
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-----~ld~l~kE~~~msl~~HPNIv~~~~s   92 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-----DLDALRKEVQTMSLIDHPNIVTYHCS   92 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-----hHHHHHHHHHHhhhcCCCCcceEEEE
Confidence            467888999999999999999999999987  77899999997654433     34688999999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      |..+..+|+||.||.+|++.+.++..-...+++..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.
T Consensus        93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence            99999999999999999999999977666799999999999999999999999999999999999999999999999998


Q ss_pred             ceeeecCC-C----ccCCCCCCcccCC
Q 046106          282 ARIEVQTE-G----MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~-~----~~~~~gt~~y~AP  303 (303)
                      +..+.... .    ..+.+||+.||||
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAP  199 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAP  199 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccCh
Confidence            65443322 1    1445899999999

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-32  Score=245.04  Aligned_cols=168  Identities=29%  Similarity=0.484  Sum_probs=145.2

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC-eeeeeEEEEcCC-
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN-IVRFIGACRKPM-  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~-  206 (303)
                      ...|...++||+|+||+||+|+.  +|+.||+|.++..... +-   ......+|+.+|+.++|+| |+.|++++.+.. 
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cC---CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            45567778899999999999987  7899999999876542 11   1135679999999999999 999999998877 


Q ss_pred             -----eEEEEEeecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          207 -----VWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       207 -----~~~iv~E~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                           .+++|+||+. -+|..|+.....  ..++...+..++.||+.||+|||+++|+||||||.||||+++|.+||+||
T Consensus        86 ~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             ccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence                 8999999995 599999987653  35777899999999999999999999999999999999999999999999


Q ss_pred             CCceeee-cCCCccCCCCCCcccCC
Q 046106          280 GVARIEV-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~-~~~~~~~~~gt~~y~AP  303 (303)
                      |+|+... +...+++.++|.+|+||
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaP  189 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAP  189 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCH
Confidence            9998655 44558888999999998

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-33  Score=263.02  Aligned_cols=165  Identities=27%  Similarity=0.519  Sum_probs=150.6

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |++++.||.|+.|.|-.|++  +|+.+|||++.+.....+.   ....+.+|+-||+.+.||||++||++|.....+|+|
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s---~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSS---QPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccc---cccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            45788999999999999997  8999999999876322222   125788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      .||+++|.|++|+...  +++++.++++++.||+.|+.|||..+|+||||||+|+|++..+.+||+|||+|.....+...
T Consensus        91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            9999999999999875  57999999999999999999999999999999999999999999999999999988888888


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      .+.||.|.|.||
T Consensus       169 eTSCGSPHYA~P  180 (786)
T KOG0588|consen  169 ETSCGSPHYAAP  180 (786)
T ss_pred             cccCCCcccCCc
Confidence            999999999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=251.64  Aligned_cols=172  Identities=31%  Similarity=0.497  Sum_probs=141.7

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHH--------HHHHHHHHHHHHHHHcCCCCCeeee
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKA--------QVMEQQFQQEVMMLATLKHPNIVRF  198 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~--------~~~~~~~~~E~~il~~l~hpniv~l  198 (303)
                      ...++|++.+.||+|+||+|-+|+.  +++.||||++.+........        ..-.++..+|+.||++|.|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3467899999999999999999997  78899999997654322111        1113578899999999999999999


Q ss_pred             eEEEEcC--CeEEEEEeecCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 046106          199 IGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       199 ~~~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vK  275 (303)
                      +.+..++  +.+|||+|||..|.+...-   .... +.+.++++++++++.||+|||.+|||||||||+|+||+++|++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence            9999775  5689999999888774322   2334 88999999999999999999999999999999999999999999


Q ss_pred             EeccCCceee------ecCCCccCCCCCCcccCC
Q 046106          276 IADFGVARIE------VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~------~~~~~~~~~~gt~~y~AP  303 (303)
                      |+|||.+...      ..+......+|||.|+||
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP  284 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP  284 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccch
Confidence            9999998754      222234456899999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.98  E-value=8e-33  Score=257.54  Aligned_cols=165  Identities=30%  Similarity=0.532  Sum_probs=146.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|+.  +.+.||+|.+.+.....    ...+.+.+|++|++.++|||||.++++|++...+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~----k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~   77 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE----KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLW   77 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch----HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEE
Confidence            4677788999999999999986  67899999998765443    23468899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-  288 (303)
                      +|+||+.| +|..+|...  ..+|++.+..++.+++.||.|||+.+|+|||+||.|||++.++.+|++|||+|+.+..+ 
T Consensus        78 vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   78 VVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             EEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            99999976 999999865  56999999999999999999999999999999999999999999999999999976543 


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      ...+...|||.||||
T Consensus       155 ~vltsikGtPlYmAP  169 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAP  169 (808)
T ss_pred             eeeeeccCcccccCH
Confidence            345566899999998

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=260.00  Aligned_cols=171  Identities=26%  Similarity=0.415  Sum_probs=146.2

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACR  203 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  203 (303)
                      -.+...+|++++.||+|.||+|+++..  +++.+|||++++...-...   ..+....|.+|+... +||.++.|+..|+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d---~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ  439 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD---EVESLMCEKRIFELANRHPFLVNLFSCFQ  439 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc---cHHHHHHHHHHHHHhccCCeEeecccccc
Confidence            356678999999999999999999988  6679999999987542211   124566777777776 4999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ++..+|+||||+.||++..+.+   ...+++..+.-+++.|+.||.|||++|||+||||.+|||+|.+|.+||+|||+|+
T Consensus       440 T~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             cCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999999443333   2569999999999999999999999999999999999999999999999999999


Q ss_pred             eee-cCCCccCCCCCCcccCC
Q 046106          284 IEV-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~-~~~~~~~~~gt~~y~AP  303 (303)
                      ..- ....+++.||||.||||
T Consensus       517 e~m~~g~~TsTfCGTpey~aP  537 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAP  537 (694)
T ss_pred             ccCCCCCccccccCChhhcCh
Confidence            754 45567788999999999

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-32  Score=254.97  Aligned_cols=164  Identities=31%  Similarity=0.508  Sum_probs=145.8

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ...|..-++||+|+.|.||.++.  +++.||||.+.......      ++.+.+|+.+|+..+|+|||.+++.+...+.+
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~------keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK------KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc------hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            44566778899999999999986  77899999997654332      35788999999999999999999999888999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+|||||++|+|.+.+...   .+.+.++..|+++++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+...
T Consensus       346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999999999864   4899999999999999999999999999999999999999999999999999876554


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ..++.+|||.||||
T Consensus       423 ~~KR~TmVGTPYWMAP  438 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAP  438 (550)
T ss_pred             cCccccccCCCCccch
Confidence            4 45667999999998

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.98  E-value=3e-31  Score=238.72  Aligned_cols=167  Identities=23%  Similarity=0.324  Sum_probs=143.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |+..+.||+|+||.||++.+  +++.||+|.+.+......   .....+.+|+.++..++||+|+++++++.....+++|
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh---hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence            55678899999999999987  688999999875432211   1124678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      |||+++++|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||+++++.+||+|||++.........
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence            99999999998887654456899999999999999999999999999999999999999999999999999875444444


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ....||+.|+||
T Consensus       159 ~~~~g~~~y~aP  170 (285)
T cd05631         159 RGRVGTVGYMAP  170 (285)
T ss_pred             cCCCCCCCccCH
Confidence            556799999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=2.8e-31  Score=247.17  Aligned_cols=149  Identities=23%  Similarity=0.365  Sum_probs=131.5

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||+||++..  +++.||||++++....   .......+.+|+.++..++||+|+++++.+.+...+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML---EKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEE
Confidence            3577889999999999999987  6789999999753221   1122357788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus        78 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            999999999999999764  46899999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=2.7e-31  Score=244.48  Aligned_cols=173  Identities=29%  Similarity=0.572  Sum_probs=142.2

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeee
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVR  197 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~  197 (303)
                      .|+++.++|++.+.||+|+||.||+|.+       .++.||||+++......     ..+.+.+|+.++..+ +||||++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~   75 (338)
T cd05102           1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS-----EHKALMSELKILIHIGNHLNVVN   75 (338)
T ss_pred             CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH-----HHHHHHHHHHHHHHhccCcceee
Confidence            4889999999999999999999999974       23579999987543221     125788999999999 8999999


Q ss_pred             eeEEEEcC-CeEEEEEeecCCCCHHHHHHhcC------------------------------------------------
Q 046106          198 FIGACRKP-MVWCIVTEYAKGGSVRQFLTKRQ------------------------------------------------  228 (303)
Q Consensus       198 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~------------------------------------------------  228 (303)
                      ++++|... ..+++||||+++|+|.+++....                                                
T Consensus        76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (338)
T cd05102          76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG  155 (338)
T ss_pred             EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence            99998764 45899999999999999997532                                                


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc---cC
Q 046106          229 ------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM---TP  293 (303)
Q Consensus       229 ------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~---~~  293 (303)
                                  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........   ..
T Consensus       156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~  235 (338)
T cd05102         156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS  235 (338)
T ss_pred             ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence                        124678888999999999999999999999999999999999999999999999865332211   12


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      ..+++.|+||
T Consensus       236 ~~~~~~y~aP  245 (338)
T cd05102         236 ARLPLKWMAP  245 (338)
T ss_pred             CCCCccccCc
Confidence            2456789998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=5e-32  Score=263.13  Aligned_cols=176  Identities=31%  Similarity=0.555  Sum_probs=150.5

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI  195 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni  195 (303)
                      .....++.+.++.+.+.||+|+||+||+|...       .+.||||.++.....     .+.++|.+|+++|..++||||
T Consensus       477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-----~~~~dF~REaeLla~l~H~nI  551 (774)
T KOG1026|consen  477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-----QARQDFRREAELLAELQHPNI  551 (774)
T ss_pred             ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-----HHHHHHHHHHHHHHhccCCCe
Confidence            34567889999999999999999999999862       247999999764332     234799999999999999999


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------NRS----VPLKLAVKQALDVARGMAYVHRLGLIHRDLKS  263 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~----~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp  263 (303)
                      |+|+|+|..++++|+|+|||..|+|.+||+...        +.+    +...+.+.||.|||.||+||-++.+|||||.+
T Consensus       552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT  631 (774)
T KOG1026|consen  552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT  631 (774)
T ss_pred             EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence            999999999999999999999999999998532        122    77899999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeccCCceeeecCCCccCCC---CCCcccCC
Q 046106          264 DNLLIFSDKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP  303 (303)
Q Consensus       264 ~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~---gt~~y~AP  303 (303)
                      +|+||.++..|||+||||+|.+-..+.+....   -.++||||
T Consensus       632 RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMpp  674 (774)
T KOG1026|consen  632 RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPP  674 (774)
T ss_pred             hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCH
Confidence            99999999999999999999765444443322   24899998

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=4.8e-31  Score=243.82  Aligned_cols=172  Identities=27%  Similarity=0.415  Sum_probs=147.0

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC---CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN---GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ..+.+..++|.+.+.||+|+||.||+|.+.   +..||+|++.......   ....+.+.+|+.+++.++||||++++++
T Consensus        23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~Iv~~~~~   99 (340)
T PTZ00426         23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK---QKQVDHVFSERKILNYINHPFCVNLYGS   99 (340)
T ss_pred             cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence            445667788999999999999999999862   3589999986532211   1123568899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +..+..+|+||||+++|+|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        100 FKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCC
Confidence            99999999999999999999999765  4589999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCCccCCCCCCcccCC
Q 046106          282 ARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+....  .....+||+.|+||
T Consensus       178 a~~~~~--~~~~~~gt~~y~aP  197 (340)
T PTZ00426        178 AKVVDT--RTYTLCGTPEYIAP  197 (340)
T ss_pred             CeecCC--CcceecCChhhcCH
Confidence            986532  23345799999998

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=3.7e-31  Score=247.31  Aligned_cols=173  Identities=25%  Similarity=0.379  Sum_probs=146.8

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ....+..++|++.+.||+|+||.||++++  +++.+|+|++.+.....   ....+.+.+|+.+++.++||||+++++++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFCAF  112 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34455667888999999999999999998  57799999996532211   11234678899999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ..+..+|+||||+++|+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         113 QDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            9999999999999999999999753   4789999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC--ccCCCCCCcccCC
Q 046106          283 RIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      +.......  ....+||+.|+||
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aP  212 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISP  212 (370)
T ss_pred             eecccCCceecccCCCCcccCCH
Confidence            86543222  2345799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=3.8e-31  Score=243.17  Aligned_cols=166  Identities=29%  Similarity=0.429  Sum_probs=144.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ..+|.+.+.||+|+||.||+|++  +++.||+|+++......   ....+.+.+|+.+++.++||||+++++++..+..+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK---MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            46788889999999999999998  67899999997532211   11235788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        94 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999999999864  45889999999999999999999999999999999999999999999999999865332


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                        ....+||+.|+||
T Consensus       172 --~~~~~gt~~y~aP  184 (329)
T PTZ00263        172 --TFTLCGTPEYLAP  184 (329)
T ss_pred             --cceecCChhhcCH
Confidence              2345799999998

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-32  Score=252.10  Aligned_cols=172  Identities=32%  Similarity=0.548  Sum_probs=148.9

Q ss_pred             ceeecCCccccceecccCceEEEEEEECC-eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG-EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      -+++++.+.+.++||+|.||+|.+|...+ ..||||.++.......     ...|.+|+.+|.+|+||||+.|+|+|..+
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~-----r~~F~kEIkiLsqLkhPNIveLvGVC~~D  607 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA-----RNDFLKEIKILSRLKHPNIVELLGVCVQD  607 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH-----HHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence            45778899999999999999999999866 8999999987655433     47899999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      +++|+|+|||++|+|.+|+....-.........+|+.||+.||+||.+.++|||||.++|+|++.++++||+|||++|..
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence            99999999999999999999874333455667789999999999999999999999999999999999999999999965


Q ss_pred             ecCCCccCC---CCCCcccCC
Q 046106          286 VQTEGMTPE---TGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~---~gt~~y~AP  303 (303)
                      -..+.+..+   +-.++||||
T Consensus       688 ysg~yy~vqgr~vlpiRwmaw  708 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAW  708 (807)
T ss_pred             ccCCceeeecceeeeeeehhH
Confidence            444433322   346899986

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.3e-31  Score=245.67  Aligned_cols=149  Identities=25%  Similarity=0.364  Sum_probs=131.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||.||+++.  +++.||||+++......   ......+.+|+.+|+.++||||+++++++.++..+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE---KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLY   77 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEE
Confidence            3677889999999999999998  67899999997532211   122356788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        78 lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             EEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            999999999999999764  45899999999999999999999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=6.4e-31  Score=240.95  Aligned_cols=161  Identities=27%  Similarity=0.402  Sum_probs=137.8

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      +.||+|+||.||+++.  +++.||||++++.....   ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA---KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence            3599999999999987  67899999997532211   122356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccCC
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTPE  294 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~~  294 (303)
                      ++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... .......
T Consensus        78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            999999998764  4689999999999999999999999999999999999999999999999999975322 2233445


Q ss_pred             CCCCcccCC
Q 046106          295 TGTYRWMAP  303 (303)
Q Consensus       295 ~gt~~y~AP  303 (303)
                      +||+.|+||
T Consensus       156 ~gt~~y~aP  164 (323)
T cd05571         156 CGTPEYLAP  164 (323)
T ss_pred             ecCccccCh
Confidence            799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=8.7e-31  Score=245.47  Aligned_cols=147  Identities=25%  Similarity=0.349  Sum_probs=130.3

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      .|.+++.||+|+||+||+|+.  +++.||||++++.....   ......+.+|+.+++.++||||+++++++.++..+|+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l   78 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN---RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence            567788999999999999987  67899999997543221   1223578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.||+||||||+||||+.++.+||+|||+++.
T Consensus        79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          79 VMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            99999999999999764  4588999999999999999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.4e-31  Score=241.31  Aligned_cols=165  Identities=26%  Similarity=0.378  Sum_probs=143.1

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|++  +++.||||++++.....   ....+.+.+|+.++..++||||+++++++......|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEE
Confidence            3577889999999999999998  57899999997532211   112357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....  
T Consensus        78 lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             EEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999999764  4588999999999999999999999999999999999999999999999999976443  


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      .....+||+.|+||
T Consensus       154 ~~~~~~gt~~y~aP  167 (333)
T cd05600         154 YANSVVGSPDYMAP  167 (333)
T ss_pred             ccCCcccCccccCh
Confidence            23445799999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.8e-31  Score=245.32  Aligned_cols=146  Identities=25%  Similarity=0.375  Sum_probs=129.8

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||++..  +++.||||++.+....   .....+.+.+|+.+++.++||||+++++++.++..+|+
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   78 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF---KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL   78 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH---HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence            577889999999999999987  7789999998653211   11223578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        79 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          79 IMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence            99999999999999764  468899999999999999999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-32  Score=252.82  Aligned_cols=166  Identities=33%  Similarity=0.592  Sum_probs=151.0

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      .-+.|+|+++.+.-++-||.|+-|.||+|++.++.||||.++.             .-..++.-|++|+||||+.+.|+|
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e-------------lkETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE-------------LKETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh-------------hhhhhHHHHHhccCcceeeEeeee
Confidence            3468999999999999999999999999999999999998742             223578889999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .....+|||||||+.|.|.+.|+..  ..+....+..+..+||.||.|||.+.|||||||.-||||+.+..|||+|||.+
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence            9999999999999999999999876  46888999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +........-.++||..||||
T Consensus       260 ~e~~~~STkMSFaGTVaWMAP  280 (904)
T KOG4721|consen  260 KELSDKSTKMSFAGTVAWMAP  280 (904)
T ss_pred             HhhhhhhhhhhhhhhHhhhCH
Confidence            876655555567999999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=1.3e-31  Score=236.08  Aligned_cols=166  Identities=27%  Similarity=0.370  Sum_probs=141.1

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCe
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--PMV  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~  207 (303)
                      ++|+.+..|++|+||.||+|++  +++.||+|.++......- .   --.-++|+.+|.+++|||||.+-.+...  -+.
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-F---PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-F---PITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-C---cchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            4677788999999999999998  678999999976432110 0   0234689999999999999999887754  356


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +|||||||+. +|...+.... .++...++..++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+||....
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            8999999976 8998888654 6799999999999999999999999999999999999999999999999999997654


Q ss_pred             C-CCccCCCCCCcccCC
Q 046106          288 T-EGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~-~~~~~~~gt~~y~AP  303 (303)
                      . ..+++.+-|.+|+||
T Consensus       230 p~k~~T~lVVTLWYRaP  246 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAP  246 (419)
T ss_pred             CcccCcceEEEeeecCH
Confidence            3 457778889999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.4e-31  Score=238.43  Aligned_cols=164  Identities=24%  Similarity=0.375  Sum_probs=142.1

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||++.+  +++.||+|++.......   ....+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   78 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR---LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM   78 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence            577888999999999999998  57899999997532211   1123568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          79 LMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999999999999765  45889999999999999999999999999999999999999999999999999865432  


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      ....+||+.|+||
T Consensus       155 ~~~~~gt~~y~aP  167 (291)
T cd05612         155 TWTLCGTPEYLAP  167 (291)
T ss_pred             cccccCChhhcCH
Confidence            2345799999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=1.2e-30  Score=244.38  Aligned_cols=146  Identities=26%  Similarity=0.369  Sum_probs=129.6

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      .|.+.+.||+|+||.||+|+.  +++.||+|++.+....   .....+.+.+|+.+++.++||||+++++.+.++..+|+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~---~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l   78 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL---LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF   78 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence            477888999999999999987  6789999998753221   12224578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        79 v~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~  149 (382)
T cd05625          79 VMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (382)
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence            99999999999999764  458899999999999999999999999999999999999999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=1.9e-30  Score=242.61  Aligned_cols=146  Identities=25%  Similarity=0.347  Sum_probs=129.3

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||+++.  +++.||||++.+....   .......+.+|+.+|+.++||||+++++.+..+..+|+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l   78 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF   78 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH---hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence            678889999999999999987  6789999998643211   11223568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus        79 v~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          79 VMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            99999999999999764  458899999999999999999999999999999999999999999999999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=1.2e-30  Score=243.93  Aligned_cols=174  Identities=24%  Similarity=0.365  Sum_probs=148.3

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ...+.+..++|.+.+.||+|+||.||++++  +++.+|+|++.+.....   ....+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFYA  111 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            345667778999999999999999999998  67899999986532211   1123467889999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +..+..+|+||||+++++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         112 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            99999999999999999999998753   478899999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCC--ccCCCCCCcccCC
Q 046106          282 ARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      |+.......  ....+||+.|+||
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aP  212 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISP  212 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCH
Confidence            986543322  2345799999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=1e-30  Score=244.23  Aligned_cols=174  Identities=24%  Similarity=0.349  Sum_probs=147.4

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ...+.+..++|.+.+.||+|+||.||+++.  +++.||+|++++.....   ......+.+|+.+++.++||||++++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~h~~iv~~~~~  111 (370)
T cd05596          35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK---RSDSAFFWEERDIMAHANSEWIVQLHYA  111 (370)
T ss_pred             hccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            345566778899999999999999999987  67899999996532111   1122457789999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +.++..+|+||||+++|+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999999999999999998753   478899999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCC--ccCCCCCCcccCC
Q 046106          282 ARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      ++.......  ....+||+.|+||
T Consensus       189 ~~~~~~~~~~~~~~~~gt~~y~aP  212 (370)
T cd05596         189 CMKMDANGMVRCDTAVGTPDYISP  212 (370)
T ss_pred             eeeccCCCcccCCCCCCCcCeECH
Confidence            986543321  2345799999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=256.17  Aligned_cols=171  Identities=30%  Similarity=0.528  Sum_probs=150.9

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CC---eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NG---EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      -+|+...+.+.+.||.|.||+|++|++  .+   ..||||.++......     .+.+|+.|+.||.++.||||++|.|+
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek-----qrrdFL~EAsIMGQFdHPNIIrLEGV  698 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIRLEGV  698 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH-----HHhhhhhhhhhcccCCCCcEEEEEEE
Confidence            357788889999999999999999987  33   479999998765432     23789999999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      .....++.||+|||++|+|..||+.+. +.+.+.++..|++.|+.||.||-+.|+|||||.++||||+.+-.+|++|||+
T Consensus       699 VTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL  777 (996)
T KOG0196|consen  699 VTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL  777 (996)
T ss_pred             EecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence            999999999999999999999999876 4599999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCC--CccCCCC--CCcccCC
Q 046106          282 ARIEVQTE--GMTPETG--TYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~--~~~~~~g--t~~y~AP  303 (303)
                      +|+..++.  .+++.-|  ..+|+||
T Consensus       778 SRvledd~~~~ytt~GGKIPiRWTAP  803 (996)
T KOG0196|consen  778 SRVLEDDPEAAYTTLGGKIPIRWTAP  803 (996)
T ss_pred             eeecccCCCccccccCCccceeecCh
Confidence            99886554  2333334  4899998

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=2.3e-30  Score=237.87  Aligned_cols=161  Identities=25%  Similarity=0.391  Sum_probs=137.7

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      +.||+|+||.||++..  +++.||+|++++.....   ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA---KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence            3589999999999987  67899999997643221   112357788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccCC
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTPE  294 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~~  294 (303)
                      ++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus        78 ~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          78 NGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            999999988754  4589999999999999999999999999999999999999999999999999975332 2223445


Q ss_pred             CCCCcccCC
Q 046106          295 TGTYRWMAP  303 (303)
Q Consensus       295 ~gt~~y~AP  303 (303)
                      +||+.|+||
T Consensus       156 ~gt~~y~aP  164 (328)
T cd05593         156 CGTPEYLAP  164 (328)
T ss_pred             cCCcCccCh
Confidence            799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=241.61  Aligned_cols=167  Identities=31%  Similarity=0.523  Sum_probs=148.8

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~  207 (303)
                      ...|.+.+.||.|.||.||+++.  +|+.+|+|++.+.......   ....+.+|+.+|+++. |||||.+++++.+...
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---DREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            34677889999999999999987  6889999999876553322   2257889999999998 9999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC----CcEEEeccCCce
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD----KSIKIADFGVAR  283 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~----~~vKl~DFGla~  283 (303)
                      +++|||++.||.|.+.+...   .+++..+..++.|++.++.|||+.||+||||||+|+|+...    +.+|++|||+|.
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999999876   38999999999999999999999999999999999999654    479999999999


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........+||+.|+||
T Consensus       188 ~~~~~~~~~~~~Gtp~y~AP  207 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAP  207 (382)
T ss_pred             EccCCceEeeecCCccccCc
Confidence            88776667778999999999

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=1.9e-30  Score=237.87  Aligned_cols=161  Identities=27%  Similarity=0.398  Sum_probs=137.2

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      +.||+|+||.||+++.  +++.||+|+++......   ......+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence            3699999999999987  67899999997532211   112356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccCC
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTPE  294 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~~  294 (303)
                      ++++|..++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .......
T Consensus        78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          78 NGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            999999888754  4689999999999999999999999999999999999999999999999999875322 2223345


Q ss_pred             CCCCcccCC
Q 046106          295 TGTYRWMAP  303 (303)
Q Consensus       295 ~gt~~y~AP  303 (303)
                      +||+.|+||
T Consensus       156 ~gt~~y~aP  164 (323)
T cd05595         156 CGTPEYLAP  164 (323)
T ss_pred             cCCcCcCCc
Confidence            799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=4.4e-30  Score=232.90  Aligned_cols=170  Identities=32%  Similarity=0.525  Sum_probs=140.0

Q ss_pred             eecCCccccceecccCceEEEEEEEC------------------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYN------------------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL  190 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l  190 (303)
                      ++..+|.+.++||+|+||.||+|.+.                  +..||+|+++.....     .....+.+|+.+|..+
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l   76 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-----NARNDFLKEVKILSRL   76 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-----HHHHHHHHHHHHHhhc
Confidence            34567888899999999999999752                  236999998764321     1235788999999999


Q ss_pred             CCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 046106          191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN-----------------RSVPLKLAVKQALDVARGMAYVHR  253 (303)
Q Consensus       191 ~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~  253 (303)
                      +||||+++++++......++||||+++++|.+++.....                 ..+++..++.++.||+.||+|||+
T Consensus        77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~  156 (304)
T cd05096          77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS  156 (304)
T ss_pred             CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999998899999999999999999865321                 236778899999999999999999


Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      .||+||||||+|||++.++.+||+|||+++.......   .....+++.|+||
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW  209 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCH
Confidence            9999999999999999999999999999975433221   1223457889998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.9e-30  Score=230.79  Aligned_cols=167  Identities=25%  Similarity=0.337  Sum_probs=143.3

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |++.+.||+|+||.||++..  +++.||+|++.......   ......+.+|+.+++.++||||+++++.+..+..+|+|
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh---hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence            56678899999999999987  67899999997533221   11234677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            99999999999887654456899999999999999999999999999999999999999999999999999875444444


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ...+|++.|+||
T Consensus       159 ~~~~~~~~y~aP  170 (285)
T cd05605         159 RGRVGTVGYMAP  170 (285)
T ss_pred             ccccCCCCccCc
Confidence            455789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.6e-31  Score=230.22  Aligned_cols=170  Identities=25%  Similarity=0.400  Sum_probs=151.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCC--CChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCC
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPE--NDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPM  206 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~--~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~  206 (303)
                      ..|.-.+.||.|..+.|.++..  +++++|+|++....  ...+....+.+.-.+|+.||+++. ||+|+++.+++.++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            3455567799999999998876  78899999986542  233445566778889999999985 999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+++|+|.|+.|.|.|||...  ..++++...+++.|+..|++|||.++||||||||+|||++++.++||+|||+|..+.
T Consensus        97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            999999999999999999875  568999999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ..+.....||||.|+||
T Consensus       175 ~GekLrelCGTPgYLAP  191 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAP  191 (411)
T ss_pred             CchhHHHhcCCCcccCh
Confidence            88888889999999999

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=235.23  Aligned_cols=159  Identities=22%  Similarity=0.364  Sum_probs=136.4

Q ss_pred             ecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCC
Q 046106          140 FAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       140 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      ||+|+||.||++++  +++.||+|++++.....   ......+.+|+.+++.++||||+++++++..+..+|+||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS---RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence            69999999999998  57799999997532211   12235678899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccCCCC
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTPETG  296 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~~~g  296 (303)
                      ++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... .......+|
T Consensus        78 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          78 GELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            9999999764  4589999999999999999999999999999999999999999999999999985432 222344579


Q ss_pred             CCcccCC
Q 046106          297 TYRWMAP  303 (303)
Q Consensus       297 t~~y~AP  303 (303)
                      |+.|+||
T Consensus       156 t~~y~aP  162 (312)
T cd05585         156 TPEYLAP  162 (312)
T ss_pred             CcccCCH
Confidence            9999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=3.3e-30  Score=239.67  Aligned_cols=148  Identities=22%  Similarity=0.361  Sum_probs=130.6

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||+++.  +++.||+|+++.....   .......+.+|+.++..++||+|+++++.+.....+|+
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   78 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML---EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL   78 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            577788999999999999987  6789999999753211   11223578889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        79 v~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          79 IMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            99999999999999764  45899999999999999999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.3e-30  Score=235.74  Aligned_cols=168  Identities=25%  Similarity=0.363  Sum_probs=142.4

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||.||+++.  +++.||+|++.+....   .....+.+.+|+.++..++||||+++++++..+..+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML---KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLY   77 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEE
Confidence            3678889999999999999987  5789999999642211   1122356889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            9999999999999997542 458999999999999999999999999999999999999999999999999997654322


Q ss_pred             C--ccCCCCCCcccCC
Q 046106          290 G--MTPETGTYRWMAP  303 (303)
Q Consensus       290 ~--~~~~~gt~~y~AP  303 (303)
                      .  ....+||+.|+||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (331)
T cd05597         157 TVQSNVAVGTPDYISP  172 (331)
T ss_pred             CccccceeccccccCH
Confidence            2  1224699999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=2.1e-30  Score=240.50  Aligned_cols=151  Identities=27%  Similarity=0.457  Sum_probs=137.5

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .+..++|++++.||+|+||.||+|+-  +|..+|+|++++..+....   ....+..|-.+|....+|.||+||-.|++.
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~---Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKN---QVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhh---hHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            45677899999999999999999985  8899999999987654322   235778899999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ..+||||||++||++..+|...  ..+++..+..++++++.|++-||+.|+|||||||+|+|||..|++||+|||||.
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999999999865  579999999999999999999999999999999999999999999999999984

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=5.3e-30  Score=239.86  Aligned_cols=176  Identities=30%  Similarity=0.499  Sum_probs=146.2

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCC
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPN  194 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn  194 (303)
                      ....|.++.++|.+.+.||+|+||.||+|++       ++..||||+++.......     .+.+.+|+.+|..+ +|||
T Consensus        26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~Ei~il~~l~~Hpn  100 (375)
T cd05104          26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-----REALMSELKVLSYLGNHIN  100 (375)
T ss_pred             CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-----HHHHHHHHHHHHHhcCCcc
Confidence            3457889999999999999999999999974       345899999975433221     25788999999999 8999


Q ss_pred             eeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC----------------------------------------------
Q 046106          195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----------------------------------------------  228 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~----------------------------------------------  228 (303)
                      |++++++|......++||||+++|+|.+++....                                              
T Consensus       101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  180 (375)
T cd05104         101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP  180 (375)
T ss_pred             eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence            9999999999999999999999999999997532                                              


Q ss_pred             ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          229 ---------------------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       229 ---------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                                                 ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~  260 (375)
T cd05104         181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL  260 (375)
T ss_pred             cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCcc
Confidence                                       12467888999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCCcc---CCCCCCcccCC
Q 046106          282 ARIEVQTEGMT---PETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~~~---~~~gt~~y~AP  303 (303)
                      ++.........   ...+++.|+||
T Consensus       261 a~~~~~~~~~~~~~~~~~~~~y~aP  285 (375)
T cd05104         261 ARDIRNDSNYVVKGNARLPVKWMAP  285 (375)
T ss_pred             ceeccCcccccccCCCCCCcceeCh
Confidence            98654332211   12345679998

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=6.7e-30  Score=234.33  Aligned_cols=161  Identities=27%  Similarity=0.399  Sum_probs=136.6

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      +.||+|+||.||+++.  +++.||+|++++.....   ......+.+|+.++..++||||+++++++.....+|+||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence            3589999999999987  67899999997643211   112346778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      ++++|.+++...  ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+.... ......
T Consensus        78 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          78 NGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            999999888754  458999999999999999999997 7999999999999999999999999999975332 222334


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (325)
T cd05594         156 FCGTPEYLAP  165 (325)
T ss_pred             ccCCcccCCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=7.5e-30  Score=231.43  Aligned_cols=166  Identities=27%  Similarity=0.439  Sum_probs=140.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||+|+.  +++.||||+++.......     ...+.+|+.+++.++||||+++++++..+...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----PFTAIREASLLKGLKHANIVLLHDIIHTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence            35788889999999999999998  678999999975432211     13567899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            99999995 68888887643 45889999999999999999999999999999999999999999999999999754322


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       .......||+.|+||
T Consensus       157 ~~~~~~~~~~~~y~aP  172 (303)
T cd07869         157 SHTYSNEVVTLWYRPP  172 (303)
T ss_pred             CccCCCCcccCCCCCh
Confidence             223445789999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-30  Score=239.42  Aligned_cols=151  Identities=28%  Similarity=0.443  Sum_probs=133.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|++  +++.||||+++......   ......+.+|+.++..++||||+++++++.++..+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK---RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEE
Confidence            3577889999999999999998  58899999997532211   122357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus        78 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999999875  4689999999999999999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=9.2e-30  Score=234.14  Aligned_cols=168  Identities=24%  Similarity=0.337  Sum_probs=142.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+++.  +++.||+|++.+...   ........+.+|..++..++||+|+++++++..+...|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM---LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH---HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            3678889999999999999987  567899999865221   11122356788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        78 lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999999998643 468899999999999999999999999999999999999999999999999997654332


Q ss_pred             Cc--cCCCCCCcccCC
Q 046106          290 GM--TPETGTYRWMAP  303 (303)
Q Consensus       290 ~~--~~~~gt~~y~AP  303 (303)
                      ..  ...+||+.|+||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (331)
T cd05624         157 TVQSSVAVGTPDYISP  172 (331)
T ss_pred             ceeeccccCCcccCCH
Confidence            22  234799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=5e-30  Score=235.39  Aligned_cols=168  Identities=25%  Similarity=0.371  Sum_probs=143.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||++..  +++.||+|+++.....   .....+.+.+|+.+++.++||||+++++++.....+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL---AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLY   77 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEE
Confidence            3577889999999999999987  6789999999764321   1123457889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+|+......
T Consensus        78 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             EEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999999998653 468999999999999999999999999999999999999999999999999998654333


Q ss_pred             Cc--cCCCCCCcccCC
Q 046106          290 GM--TPETGTYRWMAP  303 (303)
Q Consensus       290 ~~--~~~~gt~~y~AP  303 (303)
                      ..  ....||+.|+||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (330)
T cd05601         157 MVNSKLPVGTPDYIAP  172 (330)
T ss_pred             ceeeecccCCccccCH
Confidence            22  234789999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=8.8e-30  Score=229.48  Aligned_cols=166  Identities=27%  Similarity=0.428  Sum_probs=140.2

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||.|+||.||+|..  +++.||+|+++.......     ...+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-----chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            45688889999999999999987  678999999875432211     13567899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        79 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            99999997 49999887543 45789999999999999999999999999999999999999999999999999764322


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......+|+.|+||
T Consensus       157 ~~~~~~~~~~~~y~aP  172 (288)
T cd07871         157 TKTYSNEVVTLWYRPP  172 (288)
T ss_pred             CccccCceecccccCh
Confidence            2 23345688999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.6e-30  Score=242.34  Aligned_cols=168  Identities=30%  Similarity=0.484  Sum_probs=153.6

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ....|.+.++||+|.|++|..++.  ++..||||++.+...+....    +.+.+|+.+|+.++|||||+++.+...+..
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~----~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR----QKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH----HHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            345677889999999999999987  78999999999887766442    458899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +|+||||+.+|.+.+|+...  ..+.+..+..++.|+.+|++|||+++|+|||||++|||++.+..+||+|||++.+...
T Consensus       130 lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             eEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999999999876  4567788999999999999999999999999999999999999999999999999888


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                      .....+.||++.|.||
T Consensus       208 ~~~lqt~cgsppyAaP  223 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAP  223 (596)
T ss_pred             cccccccCCCCCccCh
Confidence            8888889999999998

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=6.7e-30  Score=234.88  Aligned_cols=161  Identities=22%  Similarity=0.389  Sum_probs=137.2

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||++++  +++.||+|++++......   .....+.+|..++..+ +||||+++++++.....+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~   77 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD---EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF   77 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence            3689999999999987  678999999976432211   1235678899999888 699999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee-cCCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV-QTEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~-~~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        78 ~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          78 VSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9999999988754  468999999999999999999999999999999999999999999999999997532 2233345


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (329)
T cd05588         156 FCGTPNYIAP  165 (329)
T ss_pred             ccCCccccCH
Confidence            6899999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=6.3e-30  Score=239.27  Aligned_cols=178  Identities=30%  Similarity=0.506  Sum_probs=147.4

Q ss_pred             CCCCCcceeecCCccccceecccCceEEEEEEE--C-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CC
Q 046106          121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--N-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KH  192 (303)
Q Consensus       121 ~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h  192 (303)
                      .+....|.++.++|++.+.||+|+||.||++++  .     +..||+|+++......     ....+.+|+.+++.+ +|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~il~~l~~h  101 (374)
T cd05106          27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-----EREALMSELKILSHLGQH  101 (374)
T ss_pred             ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-----HHHHHHHHHHHHHhhccC
Confidence            445578999999999999999999999999885  2     2479999997644322     125688999999999 89


Q ss_pred             CCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------------------------------------------
Q 046106          193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------------------------------------  228 (303)
Q Consensus       193 pniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------------------------------------  228 (303)
                      |||++++++|.....+|+||||+++|+|.+++....                                            
T Consensus       102 ~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (374)
T cd05106         102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY  181 (374)
T ss_pred             CceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccc
Confidence            999999999999999999999999999999986421                                            


Q ss_pred             ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          229 ------------------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       229 ------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                                              ...+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~  261 (374)
T cd05106         182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARD  261 (374)
T ss_pred             cccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeee
Confidence                                    12467888999999999999999999999999999999999999999999999976


Q ss_pred             eecCCCcc---CCCCCCcccCC
Q 046106          285 EVQTEGMT---PETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~---~~~gt~~y~AP  303 (303)
                      ........   ...+++.|+||
T Consensus       262 ~~~~~~~~~~~~~~~~~~y~aP  283 (374)
T cd05106         262 IMNDSNYVVKGNARLPVKWMAP  283 (374)
T ss_pred             ccCCcceeeccCCCCccceeCH
Confidence            54332211   12345779998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=1.5e-29  Score=227.53  Aligned_cols=167  Identities=29%  Similarity=0.478  Sum_probs=137.2

Q ss_pred             CCccccceecccCceEEEEEEE---CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC---CCCCeeeeeEEEEc-
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL---KHPNIVRFIGACRK-  204 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~-  204 (303)
                      .+|++.+.||+|+||.||+|++   .++.||+|+++.........    ..+.+|+.+++.+   +||||++++++|.. 
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~   76 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS   76 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch----HHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence            3678889999999999999986   35789999987654332111    2445666666655   69999999999852 


Q ss_pred             ----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          205 ----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       205 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                          ...+++||||+. ++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence                346899999996 699999987655668999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +++............||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aP  178 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAP  178 (290)
T ss_pred             ceEeccCCcccccccccccccCh
Confidence            99876544444456789999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=9.2e-30  Score=233.30  Aligned_cols=162  Identities=25%  Similarity=0.406  Sum_probs=136.4

Q ss_pred             ceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          138 DAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      +.||+|+||.||+++.     .++.||||+++......  .......+.+|+.+|+.++||||+++++++..+..+|+||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR--NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh--hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence            5799999999999975     46789999997532211  1112346778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-Cc
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GM  291 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~~  291 (303)
                      ||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          80 EYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             eCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcc
Confidence            999999999999764  457888999999999999999999999999999999999999999999999997543222 23


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ...+||+.|+||
T Consensus       158 ~~~~gt~~y~aP  169 (323)
T cd05584         158 HTFCGTIEYMAP  169 (323)
T ss_pred             cccCCCccccCh
Confidence            345799999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=7e-30  Score=234.09  Aligned_cols=164  Identities=29%  Similarity=0.424  Sum_probs=135.7

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHH---HcCCCCCeeeeeEEEEcCCeE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML---ATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il---~~l~hpniv~l~~~~~~~~~~  208 (303)
                      |++.+.||+|+||.||++.+  +++.||||++++......   ...+.+.+|+.++   ..++||||+++++++......
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---DEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV   77 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEE
Confidence            45678899999999999987  678999999975422111   1124566666554   567899999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-  287 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-  287 (303)
                      |+||||+++++|..++..   ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.... 
T Consensus        78 ~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999999888764   3589999999999999999999999999999999999999999999999999875332 


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                      .......+||+.|+||
T Consensus       155 ~~~~~~~~g~~~y~aP  170 (324)
T cd05589         155 GDRTSTFCGTPEFLAP  170 (324)
T ss_pred             CCcccccccCccccCH
Confidence            2223445799999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=8.8e-31  Score=233.64  Aligned_cols=159  Identities=30%  Similarity=0.473  Sum_probs=133.3

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----C
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP-----M  206 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----~  206 (303)
                      +.-.+.+|.|+||.||+|..  ++++||||..-....-          -.+|+++|+.+.|||||+|.-+|...     -
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            34456799999999999987  6679999987553321          22799999999999999999888542     2


Q ss_pred             eEEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCce
Q 046106          207 VWCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVAR  283 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~  283 (303)
                      .+.+||||||. +|.++++..  .+..++...+.-++.||++||+|||+.||+||||||.|+|||.+ |.+||||||.|+
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            45689999975 999999842  34568888899999999999999999999999999999999987 999999999999


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ....++...+-.-|-.|+||
T Consensus       175 ~L~~~epniSYicSRyYRaP  194 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAP  194 (364)
T ss_pred             eeccCCCceeEEEeccccCH
Confidence            98877766666668889988

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=1.3e-29  Score=232.93  Aligned_cols=167  Identities=22%  Similarity=0.367  Sum_probs=140.1

Q ss_pred             CccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCC
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPM  206 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~  206 (303)
                      +|++.+.||+|+||.||+++.     +++.||+|++++.....  .....+.+.+|+.+++.++ ||+|+++++++....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ--KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence            367788999999999999875     46789999997532111  1112356788999999995 899999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+++||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999999999999765  458999999999999999999999999999999999999999999999999997543


Q ss_pred             cCC--CccCCCCCCcccCC
Q 046106          287 QTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~--~~~~~~gt~~y~AP  303 (303)
                      ...  .....+||+.|+||
T Consensus       157 ~~~~~~~~~~~gt~~y~aP  175 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAP  175 (332)
T ss_pred             ccCCCccccccCCccccCH
Confidence            322  22345799999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=2.4e-29  Score=231.38  Aligned_cols=168  Identities=24%  Similarity=0.345  Sum_probs=141.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||++++  +++.+|+|++.+...   ........+.+|+.++..++||+|+++++++..+..+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM---LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH---HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEE
Confidence            3677889999999999999988  567899999864211   11122346788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus        78 lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999999999998643 458999999999999999999999999999999999999999999999999997543322


Q ss_pred             C--ccCCCCCCcccCC
Q 046106          290 G--MTPETGTYRWMAP  303 (303)
Q Consensus       290 ~--~~~~~gt~~y~AP  303 (303)
                      .  ....+||+.|+||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (332)
T cd05623         157 TVQSSVAVGTPDYISP  172 (332)
T ss_pred             cceecccccCccccCH
Confidence            2  2235799999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-30  Score=236.67  Aligned_cols=162  Identities=27%  Similarity=0.482  Sum_probs=143.4

Q ss_pred             cceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          137 GDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .+.||+|.||+||-|.+  +|+.||||++.+......+.    ..+.+|+.||+++.||.||.|...|++++.+++|||-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe----sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK  644 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE----SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK  644 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchH----HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence            46799999999999986  89999999998765544332    5788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccCCceeeecCCCc
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---~~vKl~DFGla~~~~~~~~~  291 (303)
                      + +|+..+.+-....+++++.....+..||+.||.|||.++|+|+||||+|||+.+.   ..+||||||+||++....-.
T Consensus       645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            9 5677777766666789999999999999999999999999999999999999765   47999999999998877766


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      .+.+|||.|+||
T Consensus       724 rsVVGTPAYLaP  735 (888)
T KOG4236|consen  724 RSVVGTPAYLAP  735 (888)
T ss_pred             hhhcCCccccCH
Confidence            777999999998

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.2e-29  Score=231.92  Aligned_cols=160  Identities=26%  Similarity=0.405  Sum_probs=136.9

Q ss_pred             ceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          138 DAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      +.||+|+||.||+++.     +++.+|+|+++......    .....+.+|+.++++++||||+++++++..+..+|+||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   77 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV----RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL   77 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh----hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence            5799999999999864     56899999997533211    11245778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-CCc
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGM  291 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-~~~  291 (303)
                      ||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus        78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            999999999999754  45899999999999999999999999999999999999999999999999999765433 223


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ...+||+.|+||
T Consensus       156 ~~~~g~~~y~aP  167 (318)
T cd05582         156 YSFCGTVEYMAP  167 (318)
T ss_pred             ecccCChhhcCH
Confidence            345789999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-30  Score=258.02  Aligned_cols=171  Identities=33%  Similarity=0.605  Sum_probs=144.9

Q ss_pred             eeecCCccccceecccCceEEEEEEE---CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY---NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      .+....+.+.+.||+|+||.||+|+.   .+.    .||||.+++.....     ...+|.+|+.+|+.++|||||+++|
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~-----~~~~Fl~Ea~~m~~f~HpNiv~liG  762 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ-----EVSDFLKEALLMSKFDHPNIVSLIG  762 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCcceeeEEE
Confidence            35578888999999999999999987   332    48999887654322     2368999999999999999999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQ-----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vK  275 (303)
                      +|.+....+|++|||++|+|..||++.+     ...+....++.++.|||+||.||+++.+|||||.++|+|+++...+|
T Consensus       763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEE
Confidence            9999989999999999999999999752     24578899999999999999999999999999999999999999999


Q ss_pred             EeccCCceeeecCCCccCC---CCCCcccCC
Q 046106          276 IADFGVARIEVQTEGMTPE---TGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~~~~~~~---~gt~~y~AP  303 (303)
                      |+|||+|+.+...+.+...   .-..+||||
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~P  873 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPP  873 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCH
Confidence            9999999955443332221   124899998

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=2.8e-29  Score=236.82  Aligned_cols=175  Identities=31%  Similarity=0.511  Sum_probs=146.4

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCe
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNI  195 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpni  195 (303)
                      ...|+++.++|.+++.||+|+||.||+|++.       +..||||+++......     ..+.+.+|+.+|+.+. ||||
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-----~~~~~~~Ei~~l~~l~~HpnI  103 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS-----EKQALMSELKIMTHLGPHLNI  103 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhcCCCCCe
Confidence            3689999999999999999999999999862       2369999997643321     1257889999999996 9999


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC-----------------------------------------------
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-----------------------------------------------  228 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-----------------------------------------------  228 (303)
                      ++++++|.....+||||||+++|+|.+++....                                               
T Consensus       104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (400)
T cd05105         104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA  183 (400)
T ss_pred             eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence            999999999999999999999999999986531                                               


Q ss_pred             -----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 046106          229 -----------------------------------------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDL  261 (303)
Q Consensus       229 -----------------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDl  261 (303)
                                                                     ...+++..++.++.||+.||+|||+.+|+||||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di  263 (400)
T cd05105         184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL  263 (400)
T ss_pred             cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence                                                           124778888999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeccCCceeeecCCCc---cCCCCCCcccCC
Q 046106          262 KSDNLLIFSDKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       262 kp~NILv~~~~~vKl~DFGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      ||+|||++.++.+||+|||+++........   ....+++.|+||
T Consensus       264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  308 (400)
T cd05105         264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAP  308 (400)
T ss_pred             ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceECh
Confidence            999999999999999999999865432221   123467889998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=1.5e-29  Score=231.70  Aligned_cols=161  Identities=27%  Similarity=0.460  Sum_probs=133.2

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHH-HHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||+||+|++  +++.||||++.+......   .....+.+|. .+++.++||||+++++.+.....+|+||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh---hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence            3699999999999998  678999999975322111   1113344444 456889999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9999999998764  4689999999999999999999999999999999999999999999999999975322 223344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (323)
T cd05575         156 FCGTPEYLAP  165 (323)
T ss_pred             ccCChhhcCh
Confidence            5799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=1.7e-29  Score=231.54  Aligned_cols=166  Identities=27%  Similarity=0.353  Sum_probs=138.4

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCC-CeeeeeEEEEcCCeEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP-NIVRFIGACRKPMVWC  209 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-niv~l~~~~~~~~~~~  209 (303)
                      +|.+.+.||+|+||.||+|++  +++.||||++++.....   ....+.+..|+.++..+.|+ +|+++++++...+.+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   77 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ---DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   77 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEE
Confidence            467788999999999999988  56789999997532211   11235677899999999764 6888999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee-cC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV-QT  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~-~~  288 (303)
                      +||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ..
T Consensus        78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          78 FVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999999999998764  458899999999999999999999999999999999999999999999999987532 22


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      ......+||+.|+||
T Consensus       156 ~~~~~~~gt~~y~aP  170 (324)
T cd05587         156 KTTRTFCGTPDYIAP  170 (324)
T ss_pred             CceeeecCCccccCh
Confidence            223345799999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=1.9e-29  Score=231.99  Aligned_cols=161  Identities=23%  Similarity=0.398  Sum_probs=136.0

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||+++.  +++.||+|++++......   .....+.+|+.++.++ +||||+++++++.....+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   77 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   77 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch---hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence            3699999999999987  677999999986432211   1234677888888776 799999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|..++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        78 ~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          78 VNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9999999888754  4689999999999999999999999999999999999999999999999999975322 222344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (329)
T cd05618         156 FCGTPNYIAP  165 (329)
T ss_pred             ccCCccccCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=3.9e-29  Score=224.95  Aligned_cols=167  Identities=24%  Similarity=0.329  Sum_probs=142.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |...+.||+|+||+||++.+  +++.+|+|++........   .....+.+|+.+|+.++|++|+.+++.+..++.+|++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR---KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV   78 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh---hHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence            45567899999999999988  678999999876432211   1124577899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||++.........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            99999999999887654456999999999999999999999999999999999999999999999999999765433334


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ....|++.|+||
T Consensus       159 ~~~~g~~~~~aP  170 (285)
T cd05632         159 RGRVGTVGYMAP  170 (285)
T ss_pred             cCCCCCcCccCh
Confidence            455789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=2.2e-29  Score=230.64  Aligned_cols=166  Identities=28%  Similarity=0.344  Sum_probs=138.5

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~  209 (303)
                      +|.+.+.||+|+||.||+|..  +++.||||++++.....   ....+.+..|..++..+ .||+|+++++++.....+|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~   77 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLY   77 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEE
Confidence            467788999999999999987  56799999997643211   11124566778888777 5899999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-C
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-T  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~  288 (303)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.... .
T Consensus        78 lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          78 FVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999999999998764  4588999999999999999999999999999999999999999999999999975432 2


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      ......+||+.|+||
T Consensus       156 ~~~~~~~gt~~y~aP  170 (323)
T cd05616         156 VTTKTFCGTPDYIAP  170 (323)
T ss_pred             CccccCCCChhhcCH
Confidence            223445799999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=2e-29  Score=230.70  Aligned_cols=161  Identities=28%  Similarity=0.441  Sum_probs=132.9

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHH-HHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||++++  +++.||+|++.+......   .....+.+|. .+++.++||||+++++++.....+|+||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK---KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh---hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence            3699999999999998  678999999975322111   1123444454 467889999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|..++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ......
T Consensus        78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          78 VNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            9999999888754  4588999999999999999999999999999999999999999999999999975322 222344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (321)
T cd05603         156 FCGTPEYLAP  165 (321)
T ss_pred             ccCCcccCCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=1.9e-29  Score=230.97  Aligned_cols=161  Identities=27%  Similarity=0.365  Sum_probs=135.1

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||+|++  +++.||||++++.....   ....+.+..|..++..+ +||||+++++++..+..+|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~   77 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ---DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY   77 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh---hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence            3589999999999988  56799999997532211   11224567888888765 799999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ......
T Consensus        78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          78 VNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9999999998764  4588999999999999999999999999999999999999999999999999975432 222344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (321)
T cd05591         156 FCGTPDYIAP  165 (321)
T ss_pred             cccCccccCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=2.1e-29  Score=230.95  Aligned_cols=161  Identities=25%  Similarity=0.449  Sum_probs=133.2

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHH-HHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||+||+++.  +++.+|+|++.+......   .....+..|. .+++.++||||+++++++..+..+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR---KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence            3589999999999987  688999999975322111   1123444454 457889999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|..++...  ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        78 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          78 VNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9999999888754  4689999999999999999999999999999999999999999999999999975322 223344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (325)
T cd05604         156 FCGTPEYLAP  165 (325)
T ss_pred             ccCChhhCCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=2.6e-29  Score=230.73  Aligned_cols=161  Identities=23%  Similarity=0.389  Sum_probs=137.0

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||+||+++.  +++.||+|++++.....   ....+.+.+|+.++.++ +||+|+++++++.....+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD---DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY   77 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence            3699999999999987  66899999997643221   12235678899999888 599999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee-cCCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV-QTEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~-~~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          78 VNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9999999988754  468999999999999999999999999999999999999999999999999997532 2223345


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (327)
T cd05617         156 FCGTPNYIAP  165 (327)
T ss_pred             ccCCcccCCH
Confidence            6799999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2.3e-29  Score=236.87  Aligned_cols=160  Identities=25%  Similarity=0.383  Sum_probs=138.7

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +...+|.+.+.||+|+||.||++.+  +++.||+|....            ..+.+|+.+|+.++||||+++++++....
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~  156 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------------GGTATEAHILRAINHPSIIQLKGTFTYNK  156 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence            4556799999999999999999987  678999996532            35678999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ..|+|+|++. ++|..++...  ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus       157 ~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        157 FTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             eeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            9999999995 6899888764  458899999999999999999999999999999999999999999999999997533


Q ss_pred             cC--CCccCCCCCCcccCC
Q 046106          287 QT--EGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~--~~~~~~~gt~~y~AP  303 (303)
                      ..  ......+||+.|+||
T Consensus       234 ~~~~~~~~~~~gt~~y~aP  252 (391)
T PHA03212        234 DINANKYYGWAGTIATNAP  252 (391)
T ss_pred             cccccccccccCccCCCCh
Confidence            22  223345799999998

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=2.7e-29  Score=222.33  Aligned_cols=170  Identities=33%  Similarity=0.545  Sum_probs=146.8

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |.+..++|++.++||+|+||.||+|.. ++..||+|.+......       .+.+.+|+.+++.++||||+++++.+...
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-------VQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh-------HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            788899999999999999999999987 5678999988653321       25788999999999999999999999998


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...++++||+++++|.+++.......+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++..
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence            88999999999999999998765567899999999999999999999999999999999999999999999999999865


Q ss_pred             ecCCC--ccCCCCCCcccCC
Q 046106          286 VQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~--~~~~~gt~~y~AP  303 (303)
                      .....  .....++..|+||
T Consensus       154 ~~~~~~~~~~~~~~~~y~aP  173 (261)
T cd05072         154 EDNEYTAREGAKFPIKWTAP  173 (261)
T ss_pred             CCCceeccCCCccceecCCH
Confidence            43221  1222356778887

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.96  E-value=2.5e-29  Score=229.82  Aligned_cols=161  Identities=27%  Similarity=0.380  Sum_probs=132.9

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHc-CCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT-LKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||+|++  +++.||||+++.......   ...+.+..|..++.. .+||||+++++++.....+|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~   77 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence            3699999999999987  567899999976322111   112344556666654 4899999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.... ......
T Consensus        78 ~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          78 LNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9999999998764  4589999999999999999999999999999999999999999999999999976432 223344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (316)
T cd05592         156 FCGTPDYIAP  165 (316)
T ss_pred             ccCCccccCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.96  E-value=1.8e-29  Score=231.17  Aligned_cols=161  Identities=25%  Similarity=0.381  Sum_probs=135.1

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||+++.  +++.||||++++.....   ....+.+..|..++..+ +||||+++++++.....+|+||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey   77 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ---DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF   77 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence            3689999999999987  57899999997532111   11224667788888776 699999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        78 ~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          78 VNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9999999988764  4589999999999999999999999999999999999999999999999999875322 223344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (320)
T cd05590         156 FCGTPDYIAP  165 (320)
T ss_pred             cccCccccCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=2.5e-29  Score=230.47  Aligned_cols=161  Identities=25%  Similarity=0.416  Sum_probs=132.2

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHH-HHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQE-VMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E-~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||++++  +++.||+|++.+......   .....+..| ..+++.++||||+++++++.....+|+||||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh---hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence            3699999999999998  567899999975322111   111233344 4457889999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ......
T Consensus        78 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          78 INGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9999999999764  4578888999999999999999999999999999999999999999999999975332 223344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (325)
T cd05602         156 FCGTPEYLAP  165 (325)
T ss_pred             ccCCccccCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=6.4e-29  Score=223.65  Aligned_cols=167  Identities=23%  Similarity=0.325  Sum_probs=142.7

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |+..+.||+|+||.||++.+  +++.+|+|.+........   .....+.+|+.+++.++|++|+.+++.+.....+|+|
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   78 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV   78 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence            45667899999999999988  678999999876433221   1124567899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.........
T Consensus        79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            99999999999997655456899999999999999999999999999999999999999999999999999765444333


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ....||+.|+||
T Consensus       159 ~~~~g~~~y~aP  170 (285)
T cd05630         159 KGRVGTVGYMAP  170 (285)
T ss_pred             cCCCCCccccCh
Confidence            445789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=5.2e-29  Score=223.23  Aligned_cols=161  Identities=22%  Similarity=0.387  Sum_probs=137.2

Q ss_pred             ecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCC
Q 046106          140 FAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       140 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      ||+|+||.||++..  +++.+|+|++.......   ......+..|+++++.++||||+++++++..+..+|+||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK---KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc---chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence            69999999999987  68899999986432211   11123556799999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCC
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT  297 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt  297 (303)
                      ++|.+++.......+++..+..++.|++.||+|||+.||+||||||+|||+++++.+||+|||++.............||
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT  157 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence            99999887655556889999999999999999999999999999999999999999999999999866544434455789


Q ss_pred             CcccCC
Q 046106          298 YRWMAP  303 (303)
Q Consensus       298 ~~y~AP  303 (303)
                      +.|+||
T Consensus       158 ~~y~aP  163 (277)
T cd05607         158 NGYMAP  163 (277)
T ss_pred             CCccCH
Confidence            999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=6e-29  Score=228.67  Aligned_cols=167  Identities=27%  Similarity=0.404  Sum_probs=144.3

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +..++|++.+.||+|+||.||++++  ++..+|+|++.....     ......+.+|+.+|+.++||||+++++++..+.
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            3457888899999999999999998  577899999875321     122357899999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      .+++||||+++++|.+++...  ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          77 EISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            999999999999999999764  3589999999999999999999986 6999999999999999999999999999755


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ... ......||+.|+||
T Consensus       155 ~~~-~~~~~~g~~~y~aP  171 (331)
T cd06649         155 IDS-MANSFVGTRSYMSP  171 (331)
T ss_pred             ccc-ccccCCCCcCcCCH
Confidence            332 23445789999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=3.7e-29  Score=229.72  Aligned_cols=164  Identities=25%  Similarity=0.413  Sum_probs=136.0

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP-----  205 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----  205 (303)
                      +|.+.+.||+|+||.||+|+.  +++.||||.++........    ...+.+|+.+++.++||||+++++++...     
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   76 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD----ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF   76 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh----HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCC
Confidence            467788999999999999987  6789999998753222111    24678999999999999999999988643     


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+|+||||+. ++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          77 KDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             ceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            24799999995 6899988754  35899999999999999999999999999999999999999999999999999754


Q ss_pred             ecCCC----ccCCCCCCcccCC
Q 046106          286 VQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~----~~~~~gt~~y~AP  303 (303)
                      .....    .....||+.|+||
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aP  175 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAP  175 (338)
T ss_pred             ccccCccccccCCCCCCCcCCH
Confidence            32211    2335789999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.96  E-value=7.5e-29  Score=233.94  Aligned_cols=176  Identities=31%  Similarity=0.532  Sum_probs=146.7

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCC
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPN  194 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpn  194 (303)
                      ....|+++.+++.+++.||+|+||.||+|++.       +..||+|+++.......     .+.+.+|+.+|..+. |||
T Consensus        28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----~~~~~~E~~~l~~l~~H~n  102 (401)
T cd05107          28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-----KQALMSELKIMSHLGPHLN  102 (401)
T ss_pred             CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-----HHHHHHHHHHHHhcCCCCC
Confidence            34579999999999999999999999999863       25799999976433221     246889999999997 999


Q ss_pred             eeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC---------------------------------------------
Q 046106          195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN---------------------------------------------  229 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------------------------------------------  229 (303)
                      |++++++|.....+++||||+++|+|.++++....                                             
T Consensus       103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (401)
T cd05107         103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS  182 (401)
T ss_pred             eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence            99999999998899999999999999999975321                                             


Q ss_pred             ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 046106          230 ---------------------------------------------------RSVPLKLAVKQALDVARGMAYVHRLGLIH  258 (303)
Q Consensus       230 ---------------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~giiH  258 (303)
                                                                         ..+++..++.++.|++.||+|||+.+++|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH  262 (401)
T cd05107         183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVH  262 (401)
T ss_pred             CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCc
Confidence                                                               13567778899999999999999999999


Q ss_pred             CCCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       259 rDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |||||+|||+++++.+||+|||+++.......   .....+++.|+||
T Consensus       263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP  310 (401)
T cd05107         263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP  310 (401)
T ss_pred             ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeCh
Confidence            99999999999999999999999986433221   1223567889988

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=4.1e-29  Score=222.35  Aligned_cols=169  Identities=28%  Similarity=0.450  Sum_probs=141.4

Q ss_pred             eecCCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ++..+|++.+.||+|+||.||+|.+     .+..||+|.++......     ....+.+|+.++..++||||+++++++.
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~   76 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-----QRRGFLAEALTLGQFDHSNIVRLEGVIT   76 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-----HHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence            4567888999999999999999976     24589999987643221     2257889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .+...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+.
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          77 RGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             cCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            9999999999999999999998643 468999999999999999999999999999999999999999999999999876


Q ss_pred             eeecCCCcc--CCCCCCcccCC
Q 046106          284 IEVQTEGMT--PETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~--~~~gt~~y~AP  303 (303)
                      .........  ...++..|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aP  177 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAP  177 (266)
T ss_pred             cccccchhcccCCCCceeecCH
Confidence            533222111  22346789988

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.6e-29  Score=228.39  Aligned_cols=156  Identities=24%  Similarity=0.424  Sum_probs=141.7

Q ss_pred             CcceeecCCccccceecccCceEEEEEEECC--eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG--EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ....+..+.|++++.||+|.-|.||++...+  ..+|+|++.+.....   +....+...|-+||+.+.||.++.||+.+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~---rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f  146 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS---RKKLKRAQTEREILSLLDHPFLPTLYASF  146 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh---hhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence            3456778899999999999999999999844  789999997754332   33356788899999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      +.+...|++||||+||+|..+++++.++.+++..+..++++|+.||+|||..|||+|||||+||||-++|++.|+||.|+
T Consensus       147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             e
Q 046106          283 R  283 (303)
Q Consensus       283 ~  283 (303)
                      .
T Consensus       227 ~  227 (459)
T KOG0610|consen  227 L  227 (459)
T ss_pred             c
Confidence            3

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=3.2e-29  Score=232.40  Aligned_cols=165  Identities=32%  Similarity=0.494  Sum_probs=139.3

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .....+|+..+.||+|+||.||++++  +++.||||++......     .....+.+|+.+++.++|+||+++++++...
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  144 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-----TVRRQICREIEILRDVNHPNVVKCHDMFDHN  144 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH-----HHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence            33456778889999999999999987  5789999998654321     2235788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+++||||+++++|.+.      ....+..+..++.||+.||+|||++||+||||||+||||++++.+||+|||+++..
T Consensus       145 ~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             CeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            999999999999988542      23567788899999999999999999999999999999999999999999999865


Q ss_pred             ecCC-CccCCCCCCcccCC
Q 046106          286 VQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~-~~~~~~gt~~y~AP  303 (303)
                      .... ......||..|+||
T Consensus       219 ~~~~~~~~~~~gt~~y~aP  237 (353)
T PLN00034        219 AQTMDPCNSSVGTIAYMSP  237 (353)
T ss_pred             ccccccccccccCccccCc
Confidence            4322 23345799999998

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=8.4e-29  Score=219.29  Aligned_cols=169  Identities=32%  Similarity=0.580  Sum_probs=145.5

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |+++.++|++.+.||+|++|.||+|.+ .++.||+|.++.....       .+.+.+|+.++++++||||+++++++...
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-------PKDFLAEAQIMKKLRHPKLIQLYAVCTLE   73 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc-------HHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence            678888999999999999999999987 5568999998764432       24688899999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...|++|||+++++|.+++....+..+++..+..++.|++.||.|||+.|++||||||+||++++++.+||+|||+++..
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            99999999999999999998765556899999999999999999999999999999999999999999999999999865


Q ss_pred             ecCCCccCCCC---CCcccCC
Q 046106          286 VQTEGMTPETG---TYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~g---t~~y~AP  303 (303)
                      .... .....|   +..|+||
T Consensus       154 ~~~~-~~~~~~~~~~~~y~aP  173 (261)
T cd05068         154 KEDI-YEAREGAKFPIKWTAP  173 (261)
T ss_pred             cCCc-ccccCCCcCceeccCc
Confidence            4222 111222   3578888

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=7.5e-29  Score=222.53  Aligned_cols=161  Identities=25%  Similarity=0.345  Sum_probs=135.5

Q ss_pred             ecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCC
Q 046106          140 FAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       140 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      ||+|+||+||++.+  +++.+|+|.+.......   ....+.+..|+.+++.++||||+++.+++.....+|+||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK---RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh---hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence            69999999999987  67899999987543221   11224677899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC-ccCC
Q 046106          218 GSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-MTPE  294 (303)
Q Consensus       218 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~-~~~~  294 (303)
                      ++|.+++...  ....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ....
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            9999887542  234689999999999999999999999999999999999999999999999999976543322 2334


Q ss_pred             CCCCcccCC
Q 046106          295 TGTYRWMAP  303 (303)
Q Consensus       295 ~gt~~y~AP  303 (303)
                      .||+.|+||
T Consensus       158 ~g~~~y~aP  166 (280)
T cd05608         158 AGTPGFMAP  166 (280)
T ss_pred             CCCcCccCH
Confidence            789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=8.5e-29  Score=238.75  Aligned_cols=167  Identities=20%  Similarity=0.292  Sum_probs=140.7

Q ss_pred             cCCccccceecccCceEEEEEEE--C-CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--N-GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ...|.+.+.||+|+||.||++..  + ++.||+|.+.....   .   ....+.+|+.+|+.++||||+++++++..+..
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~---~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---R---QAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---H---HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            44588889999999999999986  3 67889997644221   1   12467789999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          208 WCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      +||||||+++|+|.+++...  ....+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+..
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            99999999999999988643  2345889999999999999999999999999999999999999999999999999865


Q ss_pred             ecCCC---ccCCCCCCcccCC
Q 046106          286 VQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~---~~~~~gt~~y~AP  303 (303)
                      .....   ....+||+.|+||
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aP  240 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAP  240 (478)
T ss_pred             CCccccccccccCCCccccCH
Confidence            43221   3345799999998

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=8e-29  Score=228.17  Aligned_cols=167  Identities=26%  Similarity=0.410  Sum_probs=143.6

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +..++|++.++||+|+||.||++.+  ++..+|+|+++.....     .....+.+|+.+++.++||||+++++++....
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   76 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-----HHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence            4567889999999999999999998  5778999998764321     12357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      .+|+||||+++++|.+++...  ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            999999999999999999764  3588999999999999999999975 7999999999999999999999999999754


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ... ......||+.|+||
T Consensus       155 ~~~-~~~~~~~~~~y~aP  171 (333)
T cd06650         155 IDS-MANSFVGTRSYMSP  171 (333)
T ss_pred             hhh-ccccCCCCccccCH
Confidence            322 23345789999998

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.96  E-value=4.7e-29  Score=223.94  Aligned_cols=165  Identities=28%  Similarity=0.423  Sum_probs=138.4

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||++++  +++.||+|+++.......    ..+.+.+|+.+++.++||||+++++++.....+|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE----VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL   77 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc----chhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence            577889999999999999998  577999999976543221    22567889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-  289 (303)
                      ||||++++.+.. +... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+|+...... 
T Consensus        78 v~e~~~~~~l~~-~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          78 VFEYVEKNMLEL-LEEM-PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EEecCCCCHHHH-HHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            999998765554 4332 2468999999999999999999999999999999999999999999999999998654322 


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......||+.|+||
T Consensus       156 ~~~~~~~~~~~y~aP  170 (287)
T cd07848         156 ANYTEYVATRWYRSP  170 (287)
T ss_pred             ccccccccccccCCc
Confidence             22334689999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=6.8e-30  Score=236.44  Aligned_cols=168  Identities=26%  Similarity=0.443  Sum_probs=150.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe-E
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV-W  208 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~-~  208 (303)
                      ++|..++.+|+|+||.++..+.  .++.+++|.+.........    ++...+|+.++++++|||||.+.+.|..+.. +
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~----r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE----RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh----hHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence            5678889999999999988776  5678999999876654322    2467799999999999999999999998887 9


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ||||+|++||++.+.+...++.-++++.+..++.|++.|+.|||++.|+|||||+.||+++.++.|||.|||+|+.....
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999999999888788999999999999999999999999999999999999999999999999999988776


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ...+.+||+.||.|
T Consensus       160 ~~~a~tvvGTp~YmcP  175 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCP  175 (426)
T ss_pred             hhhhheecCCCcccCH
Confidence            6 55667899999988

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=241.74  Aligned_cols=162  Identities=30%  Similarity=0.465  Sum_probs=141.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |.-++.||.|+||.||.+++  +.+.||||.+.-....   .....+++..|+..|.+++|||++.+-|++..+...|+|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ---s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ---SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccc---cHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            44466799999999999997  6789999998764432   233458999999999999999999999999988888999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      ||||- |+-.|++.-.+ +++.+..+..|+.+.+.||+|||+.+.||||||+.|||+++.|.|||+|||.|.+..+   .
T Consensus       105 MEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---A  179 (948)
T KOG0577|consen  105 MEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---A  179 (948)
T ss_pred             HHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---h
Confidence            99994 68888887554 6789999999999999999999999999999999999999999999999999976442   3


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      .+++|||.||||
T Consensus       180 nsFvGTPywMAP  191 (948)
T KOG0577|consen  180 NSFVGTPYWMAP  191 (948)
T ss_pred             hcccCCccccch
Confidence            467999999999

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=226.27  Aligned_cols=164  Identities=29%  Similarity=0.417  Sum_probs=140.3

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-----C
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-----P  205 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~  205 (303)
                      .|...+.||.|+||.|+.+.+  +|+.||||.+.....+.    ...++..+|+.+|+.++|+||+.+.+++..     -
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~----~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ----IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch----HHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            444478899999999999987  78899999986543332    334688899999999999999999999865     2


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+|+|+|+| ..+|.+.++..  ..+...++..++.|++.||.|+|+.+|+||||||.|+|++.+..+||+|||+|+..
T Consensus        99 ~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence            4689999999 56999999875  35899999999999999999999999999999999999999999999999999987


Q ss_pred             ec---CCCccCCCCCCcccCC
Q 046106          286 VQ---TEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~---~~~~~~~~gt~~y~AP  303 (303)
                      ..   ...++..+.|-+|+||
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAP  196 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAP  196 (359)
T ss_pred             cccCcccchhcceeeeeecCH
Confidence            53   3345666789999998

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.96  E-value=7.5e-29  Score=227.36  Aligned_cols=165  Identities=28%  Similarity=0.361  Sum_probs=137.5

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~i  210 (303)
                      |+..+.||+|+||.||++..  +++.||+|++++.....   ....+.+..|..++..+. ||+|+++++++.....+|+
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            56778899999999999987  67899999997532111   112346778888888886 5788889999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-  289 (303)
                      ||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        79 v~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          79 VMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             EEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            99999999999998764  458999999999999999999999999999999999999999999999999997543222 


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      .....+||+.|+||
T Consensus       157 ~~~~~~gt~~y~aP  170 (323)
T cd05615         157 TTRTFCGTPDYIAP  170 (323)
T ss_pred             cccCccCCccccCH
Confidence            23345799999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-30  Score=244.17  Aligned_cols=162  Identities=30%  Similarity=0.528  Sum_probs=139.8

Q ss_pred             cceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC------eE
Q 046106          137 GDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM------VW  208 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~------~~  208 (303)
                      .+.||+|+||.||+|+.  +|+.||||.+++......     .....+|+++|++++|||||+++++-.+..      ..
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-----~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-----RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccch-----HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            46799999999999996  899999999987543222     256779999999999999999999765433      45


Q ss_pred             EEEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc--CCC--cEEEeccCCce
Q 046106          209 CIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF--SDK--SIKIADFGVAR  283 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~--~~~--~vKl~DFGla~  283 (303)
                      .+|||||.+|+|...|.+..+ ..+|+..++.++.+++.||.|||++||+||||||.||++-  ++|  ..||+|||.|+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            799999999999999986443 4699999999999999999999999999999999999983  333  57999999999


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...++....+..||..|.||
T Consensus       173 el~d~s~~~S~vGT~~YLhP  192 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHP  192 (732)
T ss_pred             cCCCCCeeeeecCchhhcCh
Confidence            99888888889999999998

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=9.8e-29  Score=229.59  Aligned_cols=164  Identities=27%  Similarity=0.381  Sum_probs=137.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM--  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--  206 (303)
                      .++|.+.+.||+|+||.||++..  +++.||||++.........    ...+.+|+.+++.++||||+++++++....  
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH----AKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhH----HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            46788889999999999999987  6789999999765433221    256778999999999999999999986543  


Q ss_pred             ----eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          207 ----VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       207 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                          .+|+||||+.+ +|.+.+..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence                47999999964 67776643    4788999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +............||+.|+||
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aP  191 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAP  191 (359)
T ss_pred             cccccCccCCCCcccCCCCCc
Confidence            865444444556889999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.96  E-value=6.3e-29  Score=227.15  Aligned_cols=161  Identities=27%  Similarity=0.383  Sum_probs=133.8

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHc-CCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT-LKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||+|++  +++.||+|++++.....   ......+..|..++.. ++||+|+++++++.....+|+||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   77 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI---DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence            3699999999999998  67899999997632111   1112455667777765 4899999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        78 ~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          78 LNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9999999998764  4588999999999999999999999999999999999999999999999999875322 222345


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (316)
T cd05620         156 FCGTPDYIAP  165 (316)
T ss_pred             cCCCcCccCH
Confidence            6799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=1.3e-28  Score=221.69  Aligned_cols=170  Identities=18%  Similarity=0.297  Sum_probs=141.5

Q ss_pred             ceeecCCcccc--ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          127 WTIDLRKLNMG--DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       127 ~~i~~~~~~~~--~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      +.++.++++..  ..|++|++|.||+|.++|+.||||.++......   ....+.+.+|+.+|++++||||+++++++.+
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH---KVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc---HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            33444444444  569999999999999999999999997654322   2223678899999999999999999999876


Q ss_pred             ----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEecc
Q 046106          205 ----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       205 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                          ...+++||||+++|+|.+++...  ..+++...+.++.|++.||.|||+. +++||||||+|||+++++.+||+||
T Consensus        90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~df  167 (283)
T PHA02988         90 IVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICH  167 (283)
T ss_pred             cccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEccc
Confidence                34679999999999999999865  4688999999999999999999984 9999999999999999999999999


Q ss_pred             CCceeeecCCCccCCCCCCcccCC
Q 046106          280 GVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+++.....  .....||+.|+||
T Consensus       168 g~~~~~~~~--~~~~~~~~~y~aP  189 (283)
T PHA02988        168 GLEKILSSP--PFKNVNFMVYFSY  189 (283)
T ss_pred             chHhhhccc--cccccCcccccCH
Confidence            999864322  2345688999998

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.96  E-value=8.5e-29  Score=219.67  Aligned_cols=170  Identities=26%  Similarity=0.559  Sum_probs=145.1

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      |++...++.+.+.||+|+||.||+|.+  .++.||+|+++.....       ...+.+|+.+++.++||||+++++++..
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLLGVCTR   73 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH-------HHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence            678888899999999999999999987  5789999998653221       2468899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +..++++|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+|||+++.
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~  153 (263)
T cd05052          74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  153 (263)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence            99999999999999999999876555689999999999999999999999999999999999999999999999999976


Q ss_pred             eecCCCcc--CCCCCCcccCC
Q 046106          285 EVQTEGMT--PETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~--~~~gt~~y~AP  303 (303)
                      ........  ...+++.|+||
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aP  174 (263)
T cd05052         154 MTGDTYTAHAGAKFPIKWTAP  174 (263)
T ss_pred             cccceeeccCCCCCccccCCH
Confidence            54322111  11235678887

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=1.1e-28  Score=217.81  Aligned_cols=166  Identities=29%  Similarity=0.536  Sum_probs=140.0

Q ss_pred             ecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      +.++|++.+.||+|+||.||++.+ .+..+|+|.++.....       ...+.+|+.+++.++||||+++++++......
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL   74 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc-------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence            456788889999999999999998 4558999988654332       14688899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            99999999999999997643 35889999999999999999999999999999999999999999999999999764332


Q ss_pred             CCcc--CCCCCCcccCC
Q 046106          289 EGMT--PETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~--~~~gt~~y~AP  303 (303)
                      ....  ...++..|+||
T Consensus       154 ~~~~~~~~~~~~~y~aP  170 (256)
T cd05114         154 EYTSSSGAKFPVKWSPP  170 (256)
T ss_pred             ceeccCCCCCchhhCCh
Confidence            2211  22345678887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=8.8e-29  Score=226.28  Aligned_cols=161  Identities=26%  Similarity=0.380  Sum_probs=133.4

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHc-CCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT-LKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||+||+|++  +++.||||+++......   ......+..|..++.. ++||||+++++++.+...+|+||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey   77 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY   77 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence            3699999999999998  56789999997632111   1112345667777765 5899999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          78 LNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9999999999764  4588999999999999999999999999999999999999999999999999975322 223344


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (316)
T cd05619         156 FCGTPDYIAP  165 (316)
T ss_pred             ecCCccccCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2e-28  Score=216.05  Aligned_cols=168  Identities=34%  Similarity=0.635  Sum_probs=146.1

Q ss_pred             ceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      |.++.++|++.+.||+|+||.||++...++.||+|.++....       ..+++.+|+.+++.++||||+++++++....
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN   73 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence            566778899999999999999999999999999999975432       2367889999999999999999999999888


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++...
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence            89999999999999999987654568999999999999999999999999999999999999999999999999998653


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ...  .....+..|+||
T Consensus       154 ~~~--~~~~~~~~~~ap  168 (256)
T cd05039         154 QGQ--DSGKLPVKWTAP  168 (256)
T ss_pred             ccc--ccCCCcccccCc
Confidence            221  222345667777

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.6e-29  Score=227.33  Aligned_cols=159  Identities=23%  Similarity=0.346  Sum_probs=131.4

Q ss_pred             ecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC---CCCCeeeeeEEEEcCCeEEEEEee
Q 046106          140 FAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL---KHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       140 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      ||+|+||.||+|+.  +++.||||++.+......   .....+..|..++..+   .||+|+++++++..+..+|+||||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~   77 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK---KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY   77 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh---hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence            69999999999987  678999999865321111   1123445566666655   699999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        78 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          78 MSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             CCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9999999998754  4689999999999999999999999999999999999999999999999999875322 222345


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~gt~~y~aP  165 (330)
T cd05586         156 FCGTTEYLAP  165 (330)
T ss_pred             ccCCccccCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=1.2e-28  Score=225.05  Aligned_cols=168  Identities=25%  Similarity=0.508  Sum_probs=138.0

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +...+|++.+.||+|+||.||+|++  +++    .||+|+++.....     ...+.+.+|+.+++.++||||++++++|
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~g~~   78 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGIC   78 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3456788889999999999999987  343    4899998643221     1235788999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .... .++++||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~~~~-~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          79 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             cCCC-ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccc
Confidence            8764 579999999999999998653 35789999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCcc---CCCCCCcccCC
Q 046106          283 RIEVQTEGMT---PETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~---~~~gt~~y~AP  303 (303)
                      +.........   ...++..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~ap  180 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMAL  180 (316)
T ss_pred             ccccCCCcceeccCCccceeecCh
Confidence            8654333211   12345789988

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=9.2e-29  Score=226.19  Aligned_cols=161  Identities=27%  Similarity=0.382  Sum_probs=135.3

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||+||++.+  +++.||||++++.....   ......+.+|..++..+ +||||+++++++.....+|+||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~   77 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ---DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY   77 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh---hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence            3699999999999988  56799999997532111   11224667888888887 699999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-CCCccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-~~~~~~  293 (303)
                      +++++|..++...  ..+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+++.... ......
T Consensus        78 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          78 VNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9999999988764  4689999999999999999999999999999999999999999999999999975322 222334


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       156 ~~g~~~y~aP  165 (318)
T cd05570         156 FCGTPDYIAP  165 (318)
T ss_pred             eecCccccCH
Confidence            5799999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=1.7e-28  Score=219.39  Aligned_cols=172  Identities=27%  Similarity=0.481  Sum_probs=142.1

Q ss_pred             ceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      |++..++|++.+.||+|+||.||+|.+.       +..||||.+.......     ....+.+|+.+++.++||||++++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~iv~~~   75 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVVRLL   75 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence            7788899999999999999999998763       3579999885432211     125688999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQN--------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD  271 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~  271 (303)
                      +++......++||||+++++|.+++.....        ..+++..++.++.|++.||+|||+.|++||||||+|||++++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  155 (277)
T ss_pred             EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC
Confidence            999988899999999999999999975321        235678899999999999999999999999999999999999


Q ss_pred             CcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          272 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       272 ~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +.+||+|||+++.......   .....+++.|+||
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  190 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcCh
Confidence            9999999999875432221   1123457789998

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.96  E-value=1.3e-28  Score=235.07  Aligned_cols=163  Identities=27%  Similarity=0.461  Sum_probs=134.6

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--  205 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--  205 (303)
                      ...+|.+++.||+|+||.||+|..  +++.||||.+....          ....+|+.+|+.++||||+++++++...  
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~  133 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----------QYKNRELLIMKNLNHINIIFLKDYYYTECF  133 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----------chHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence            346788899999999999999987  67899999885422          1234799999999999999999887432  


Q ss_pred             ------CeEEEEEeecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEE
Q 046106          206 ------MVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKI  276 (303)
Q Consensus       206 ------~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl  276 (303)
                            ..+++||||++ ++|.+++..  .....+++..+..++.||+.||+|||++||+||||||+||||+.++ .+||
T Consensus       134 ~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL  212 (440)
T PTZ00036        134 KKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL  212 (440)
T ss_pred             ccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence                  24679999996 478777753  2345689999999999999999999999999999999999998764 7999


Q ss_pred             eccCCceeeecCCCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|||+|+...........+||+.|+||
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aP  239 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAP  239 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCH
Confidence            999999866544444456789999998

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=234.71  Aligned_cols=164  Identities=32%  Similarity=0.485  Sum_probs=144.0

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      .|...+.||+|+||.||+|.+  +++.||+|++.......+     ...+++|+.+|.+++++||.++|+.+..+..+||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-----Iediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-----hHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            344457899999999999998  678999999976544432     3678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      +||||.+|++.+.|...  ..+.+..+.-++++++.|+.|||.++.||||||+.||||..+|.+||+|||.+........
T Consensus        89 iMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999999999864  3457888888999999999999999999999999999999999999999999987655443


Q ss_pred             -ccCCCCCCcccCC
Q 046106          291 -MTPETGTYRWMAP  303 (303)
Q Consensus       291 -~~~~~gt~~y~AP  303 (303)
                       ..+++|||.||||
T Consensus       167 rr~tfvGTPfwMAP  180 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAP  180 (467)
T ss_pred             ccccccccccccch
Confidence             3677999999999

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=7.8e-29  Score=230.37  Aligned_cols=159  Identities=25%  Similarity=0.428  Sum_probs=137.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ...|.+.+.||+|+||.||+|++  +++.||+|+....            ....|+.+++.++||||+++++++......
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  132 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT  132 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence            44688899999999999999998  5568999985432            234689999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++|+|++. ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       133 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        133 CMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            99999994 68999887543 46899999999999999999999999999999999999999999999999999865444


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      .......||+.|+||
T Consensus       211 ~~~~~~~gt~~y~aP  225 (357)
T PHA03209        211 PAFLGLAGTVETNAP  225 (357)
T ss_pred             cccccccccccccCC
Confidence            444456799999998

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=2.2e-28  Score=217.18  Aligned_cols=169  Identities=34%  Similarity=0.570  Sum_probs=142.1

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |.+...+|.+.++||+|+||.||+|++ ....||+|+++......       ..+.+|+.+++.++||||+++++.+.. 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~-   72 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAVVSE-   72 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH-------HHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence            677888999999999999999999988 44579999987533322       467899999999999999999998754 


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...++||||+++++|.+++.......+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||.++..
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence            45689999999999999998655456889999999999999999999999999999999999999999999999999765


Q ss_pred             ecCCCcc--CCCCCCcccCC
Q 046106          286 VQTEGMT--PETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~--~~~gt~~y~AP  303 (303)
                      .......  ...++..|+||
T Consensus       153 ~~~~~~~~~~~~~~~~y~~P  172 (262)
T cd05071         153 EDNEYTARQGAKFPIKWTAP  172 (262)
T ss_pred             cccccccccCCcccceecCH
Confidence            4332211  22356679887

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=2e-28  Score=219.71  Aligned_cols=166  Identities=30%  Similarity=0.484  Sum_probs=135.8

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC---CCCCeeeeeEEEEc---
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL---KHPNIVRFIGACRK---  204 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~---  204 (303)
                      +|.+.+.||+|+||.||+|+.  +++.||+|.++.........    ..+.+|+.+++.+   +||||+++++++..   
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~   76 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP----LSTVREVALLKRLEAFDHPNIVRLMDVCATSRT   76 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc----hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence            467788999999999999987  67899999987643222111    2344666666554   79999999998864   


Q ss_pred             --CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          205 --PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       205 --~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                        ...+++++||++ ++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          77 DRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             CCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence              345799999996 58999988765556899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +............||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aP  176 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAP  176 (288)
T ss_pred             ccccCcccCCCccccccccCc
Confidence            876544444556789999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=2.7e-28  Score=221.82  Aligned_cols=165  Identities=26%  Similarity=0.412  Sum_probs=139.1

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|+.  +++.||+|.++.......     ...+.+|+.+++.++||||+++++++..+...+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence            5678889999999999999987  567899999975433221     135678999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            99999964 8988887543 457889999999999999999999999999999999999999999999999997543222


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......+|+.|+||
T Consensus       159 ~~~~~~~~~~~y~aP  173 (309)
T cd07872         159 KTYSNEVVTLWYRPP  173 (309)
T ss_pred             cccccccccccccCC
Confidence             22344678999998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.3e-28  Score=235.45  Aligned_cols=172  Identities=27%  Similarity=0.363  Sum_probs=143.7

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .....+|.+.+.||+|+||.||++++  +++.||||++.........    ...+.+|+.++..++|+||++++..+...
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD----KNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            34457899999999999999999987  7889999999776544322    35678999999999999999998877532


Q ss_pred             C--------eEEEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 046106          206 M--------VWCIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       206 ~--------~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vK  275 (303)
                      .        .+++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence            2        3689999999999999997532  34688999999999999999999999999999999999999999999


Q ss_pred             EeccCCceeeecC---CCccCCCCCCcccCC
Q 046106          276 IADFGVARIEVQT---EGMTPETGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~---~~~~~~~gt~~y~AP  303 (303)
                      |+|||+++.....   ......+||+.|+||
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP  214 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAP  214 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCH
Confidence            9999999864322   123345799999998

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=1.5e-28  Score=227.99  Aligned_cols=165  Identities=26%  Similarity=0.360  Sum_probs=138.6

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--  205 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--  205 (303)
                      ..++|.+.+.||+|+||.||++..  .++.||||.+.........    ...+.+|+.+++.++||||+++++++...  
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   90 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKS   90 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH----HHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence            346788889999999999999987  6789999999765433222    25677899999999999999999988643  


Q ss_pred             ----CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          206 ----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       206 ----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                          ..+|+||||++ +++.+++..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          91 LEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence                34699999996 477777753    378899999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCCccCCCCCCcccCC
Q 046106          282 ARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+............||+.|+||
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aP  187 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAP  187 (355)
T ss_pred             cccCCCccccCCccccCCccCH
Confidence            9865544444556899999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.9e-28  Score=215.44  Aligned_cols=166  Identities=30%  Similarity=0.533  Sum_probs=139.6

Q ss_pred             ecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      +..+|.+.+.||+|+||.||++.+ .+..+|+|++.......       ..+.+|+.+++.++||||+++++++......
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI   74 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH-------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence            455678889999999999999988 44589999986544322       3677899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||++++++.+||+|||+++.....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          75 FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            99999999999999998654 36899999999999999999999999999999999999999999999999999865432


Q ss_pred             CCcc--CCCCCCcccCC
Q 046106          289 EGMT--PETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~--~~~gt~~y~AP  303 (303)
                      ....  ...++..|+||
T Consensus       154 ~~~~~~~~~~~~~y~~P  170 (256)
T cd05059         154 QYTSSQGTKFPVKWAPP  170 (256)
T ss_pred             cccccCCCCCCccccCH
Confidence            2111  11234578887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=3.3e-28  Score=244.88  Aligned_cols=169  Identities=24%  Similarity=0.370  Sum_probs=140.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      .+|.+.++||+|+||.||+|++  +++.||||+++......   ....+++.+|+.+++.++||||+++++++.++...|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~---e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ly   78 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN---PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVY   78 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC---HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEE
Confidence            4678889999999999999987  57899999997543222   223467899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          210 IVTEYAKGGSVRQFLTKRQ---------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      ++|||+++++|.+++....         ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999999987421         1235567788999999999999999999999999999999999999999999


Q ss_pred             CceeeecCC-------------------CccCCCCCCcccCC
Q 046106          281 VARIEVQTE-------------------GMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~-------------------~~~~~~gt~~y~AP  303 (303)
                      +|+......                   .....+||+.|+||
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence            998652110                   01124699999998

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=2.5e-28  Score=215.68  Aligned_cols=167  Identities=29%  Similarity=0.571  Sum_probs=143.1

Q ss_pred             ceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE-cC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR-KP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~  205 (303)
                      |.++.++|.+.+.||+|+||.||++...+..+|+|.++....        .+.+.+|+.+++.++||+++++++++. ..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK   72 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch--------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence            667888999999999999999999999999999999864321        246889999999999999999999764 45


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...++++||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||+++..
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence            66899999999999999998765556889999999999999999999999999999999999999999999999999754


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ....  ....++..|+||
T Consensus       153 ~~~~--~~~~~~~~y~aP  168 (256)
T cd05082         153 SSTQ--DTGKLPVKWTAP  168 (256)
T ss_pred             cccC--CCCccceeecCH
Confidence            3222  223445678887

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=1.8e-28  Score=216.12  Aligned_cols=164  Identities=32%  Similarity=0.619  Sum_probs=140.9

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |++.+.||+|+||.||++..  +++.+|+|++.........    .....+|+.++++++||||+++++++......++|
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE----REENIREIKILRRLRHPNIVQILDVFQDDNYLYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH----HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc----cchhhhhhhcccccccccccccccccccccccccc
Confidence            45678999999999999998  5678999999875433222    23445699999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee-ecCCC
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE-VQTEG  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~-~~~~~  290 (303)
                      ||++++++|.+++...  ..+++..+..++.|++.||++||+.+++|+||||+||++++++.++|+|||.+... .....
T Consensus        77 ~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             EEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             cccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999988999999843  45899999999999999999999999999999999999999999999999999753 23334


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....+|+.|+||
T Consensus       155 ~~~~~~~~~y~aP  167 (260)
T PF00069_consen  155 FNPFVGTPEYMAP  167 (260)
T ss_dssp             BSSSSSSGGGSCH
T ss_pred             ccccccccccccc
Confidence            4556789999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=4.2e-28  Score=214.70  Aligned_cols=169  Identities=34%  Similarity=0.582  Sum_probs=143.3

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |.+..++|++.+.||+|+||.||++.+ .+..+|+|.++......       +.+.+|+.++++++||+++++++++.. 
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~E~~~l~~l~~~~i~~~~~~~~~-   72 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-------ESFLEEAQIMKKLRHDKLVQLYAVVSE-   72 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH-------HHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence            778888999999999999999999987 55689999987654432       468899999999999999999998854 


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||++...
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~  152 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence            45789999999999999998755556899999999999999999999999999999999999999999999999999765


Q ss_pred             ecCCCcc--CCCCCCcccCC
Q 046106          286 VQTEGMT--PETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~--~~~gt~~y~AP  303 (303)
                      .......  ...++..|+||
T Consensus       153 ~~~~~~~~~~~~~~~~y~aP  172 (260)
T cd05070         153 EDNEYTARQGAKFPIKWTAP  172 (260)
T ss_pred             cCcccccccCCCCCccccCh
Confidence            4332111  12345679988

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=205.65  Aligned_cols=165  Identities=25%  Similarity=0.438  Sum_probs=142.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +++-.++||+|.+|+||+++.  +++.||+|.++....+..-    .....+|+.+++.++|.|||+++++...+..+-+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv----pssalreicllkelkhknivrl~dvlhsdkkltl   78 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL   78 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC----cHHHHHHHHHHHHhhhcceeehhhhhccCceeEE
Confidence            345567899999999999986  6789999999876554311    1456799999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee-cCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV-QTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~-~~~  289 (303)
                      |+||| ..+|..|..... +.+..+.+..++.|+++||.|||++++.||||||.|.||..+|.+||+|||+|+-.. +..
T Consensus        79 vfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   79 VFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             eHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            99999 569999988754 578899999999999999999999999999999999999999999999999998543 333


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      .++..+-|.+|++|
T Consensus       157 cysaevvtlwyrpp  170 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPP  170 (292)
T ss_pred             eeeceeeeeeccCc
Confidence            56777888999887

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=1.7e-28  Score=226.46  Aligned_cols=173  Identities=29%  Similarity=0.556  Sum_probs=142.0

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeee
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVR  197 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~  197 (303)
                      .|.++.++|++.+.||+|+||.||+|.+       +++.||+|+++......     ..+.+.+|+.++..+ +||||++
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~E~~~~~~l~~h~niv~   75 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-----EYKALMTELKILIHIGHHLNVVN   75 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-----HHHHHHHHHHHHHhhccCcchhh
Confidence            4889999999999999999999999964       23689999987543221     124677899999999 7999999


Q ss_pred             eeEEEEc-CCeEEEEEeecCCCCHHHHHHhcCC-----------------------------------------------
Q 046106          198 FIGACRK-PMVWCIVTEYAKGGSVRQFLTKRQN-----------------------------------------------  229 (303)
Q Consensus       198 l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~-----------------------------------------------  229 (303)
                      ++++|.. ...+++++||+++++|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (337)
T cd05054          76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD  155 (337)
T ss_pred             eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence            9998865 4568899999999999999864321                                               


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCC
Q 046106          230 ------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPE  294 (303)
Q Consensus       230 ------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~  294 (303)
                                  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   ....
T Consensus       156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~  235 (337)
T cd05054         156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  235 (337)
T ss_pred             cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence                        2578999999999999999999999999999999999999999999999999986533221   1122


Q ss_pred             CCCCcccCC
Q 046106          295 TGTYRWMAP  303 (303)
Q Consensus       295 ~gt~~y~AP  303 (303)
                      .++..|+||
T Consensus       236 ~~~~~y~aP  244 (337)
T cd05054         236 RLPLKWMAP  244 (337)
T ss_pred             CCCccccCc
Confidence            456789998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=1.3e-28  Score=218.58  Aligned_cols=164  Identities=30%  Similarity=0.609  Sum_probs=134.4

Q ss_pred             cccceecccCceEEEEEEEC------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          135 NMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ++.+.||.|+||.||+|.+.      +..|+||.++... ..+    ..+.+.+|++++++++||||+++++++......
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEE----EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPL   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHH----HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccc----cceeeeecccccccccccccccccccccccccc
Confidence            35678999999999999986      5789999995532 221    136889999999999999999999999988889


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++|+||+++|+|.++|.......+++..++.++.||+.||.|||+++++|+||+++|||++.++.+||+|||+++.....
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999875567899999999999999999999999999999999999999999999999999865222


Q ss_pred             CCc---cCCCCCCcccCC
Q 046106          289 EGM---TPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~---~~~~gt~~y~AP  303 (303)
                      ...   ........|+||
T Consensus       157 ~~~~~~~~~~~~~~~~aP  174 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAP  174 (259)
T ss_dssp             SSEEESTTSESGGGGS-H
T ss_pred             cccccccccccccccccc
Confidence            111   223456788887

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.8e-28  Score=217.43  Aligned_cols=172  Identities=27%  Similarity=0.475  Sum_probs=144.1

Q ss_pred             ceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      |+++.++|.+.+.||+|+||.||+|.+.       +..||+|.+.......     ....+.+|+.+++.++||||++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~   75 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-----ERIEFLNEASVMKEFNCHHVVRLL   75 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH-----HHHHHHHHHHHHHhCCCCceeEEE
Confidence            6788899999999999999999999863       2579999986543221     124678999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQN--------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD  271 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~  271 (303)
                      +++......++||||+++++|.+++.....        ..+++..++.++.|++.||.|||+.+++||||||+|||++.+
T Consensus        76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~  155 (277)
T cd05032          76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED  155 (277)
T ss_pred             EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC
Confidence            999999999999999999999999975321        236788999999999999999999999999999999999999


Q ss_pred             CcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          272 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       272 ~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +.+||+|||+++.......   .....+|..|+||
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05032         156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (277)
T ss_pred             CCEEECCcccchhhccCcccccCCCCCccccccCH
Confidence            9999999999976543321   2233567889988

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.96  E-value=3.8e-28  Score=218.58  Aligned_cols=172  Identities=27%  Similarity=0.470  Sum_probs=141.2

Q ss_pred             ceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      |+++..+|.+.+.||+|+||.||+|...       +..||+|.++......     ....+.+|+.+++.++||||++++
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~   75 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-----ERIEFLNEASVMKGFTCHHVVRLL   75 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH-----HHHHHHHHHHHHHhCCCCCeeeEE
Confidence            8889999999999999999999999752       3479999886543221     124678899999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQN--------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD  271 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~  271 (303)
                      +++......|+||||+++++|.+++.....        ....+..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~  155 (288)
T cd05061          76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC
Confidence            999998889999999999999999975321        234567888999999999999999999999999999999999


Q ss_pred             CcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          272 KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       272 ~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +.+||+|||+++.......   .....++..|+||
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~p  190 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP  190 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCH
Confidence            9999999999975432221   1122346778887

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=3e-28  Score=215.56  Aligned_cols=166  Identities=29%  Similarity=0.525  Sum_probs=139.8

Q ss_pred             ecCCccccceecccCceEEEEEEECC-eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTYNG-EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      +.++|.+.+.||+|+||.||.+.+.+ ..+|+|.++......       ..+.+|+.+++.++||||+++++++.....+
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI   74 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccH-------HHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence            45678888999999999999999854 469999987543321       4688999999999999999999999988889


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||.++.....
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            99999999999999997643 36899999999999999999999999999999999999999999999999998865433


Q ss_pred             CCcc--CCCCCCcccCC
Q 046106          289 EGMT--PETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~--~~~gt~~y~AP  303 (303)
                      ....  ...++..|+||
T Consensus       154 ~~~~~~~~~~~~~y~~p  170 (256)
T cd05113         154 EYTSSVGSKFPVRWSPP  170 (256)
T ss_pred             ceeecCCCccChhhCCH
Confidence            2111  12345678887

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=7.5e-28  Score=211.88  Aligned_cols=166  Identities=23%  Similarity=0.412  Sum_probs=143.6

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |.+.+.||+|++|.||++++  +++.|++|.+........    ....+.+|+.+++.++||||+++++++......|+|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR----EREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHH----HHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            56678899999999999988  678999999876443322    235788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC-
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~-  290 (303)
                      |||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||++++++.+||+|||+++....... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999999876556789999999999999999999999999999999999999999999999999986544332 


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....|++.|+||
T Consensus       158 ~~~~~~~~~y~aP  170 (256)
T cd08529         158 ANTIVGTPYYLSP  170 (256)
T ss_pred             hhccccCccccCH
Confidence            2334688899988

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.7e-28  Score=214.14  Aligned_cols=170  Identities=33%  Similarity=0.571  Sum_probs=145.6

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |+++.++|.+.+.||.|+||.||++.+ .++.+|||.+.......       ..+.+|+.+++.++||||+++++++...
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-------EAFLQEAQIMKKLRHDKLVQLYAVCSEE   73 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCH-------HHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence            778899999999999999999999987 45689999987644332       4688999999999999999999999988


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++++++.+||+|||+++..
T Consensus        74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence            88999999999999999998765567899999999999999999999999999999999999999999999999998765


Q ss_pred             ecCCCc--cCCCCCCcccCC
Q 046106          286 VQTEGM--TPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~--~~~~gt~~y~AP  303 (303)
                      ......  ....++..|+||
T Consensus       154 ~~~~~~~~~~~~~~~~y~~P  173 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTAP  173 (261)
T ss_pred             cchhhhhhhccCCCccccCH
Confidence            422111  112234678887

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=3e-28  Score=227.43  Aligned_cols=164  Identities=29%  Similarity=0.453  Sum_probs=137.8

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM----  206 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~----  206 (303)
                      +|.+.+.||+|+||.||++..  +++.||||.+.....+..    ..+.+.+|+.+++.++||||+++++++..+.    
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   76 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPF   76 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH----HHHHHHHHHHHHHhCCCCCcCCHhheecCCCcccc
Confidence            367788999999999999986  688999999865432222    1257889999999999999999999998776    


Q ss_pred             -eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 -VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                       .+|+|+||+. ++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          77 EEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             ceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence             7899999996 5888887653  46899999999999999999999999999999999999999999999999999865


Q ss_pred             ecCC--CccCCCCCCcccCC
Q 046106          286 VQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~--~~~~~~gt~~y~AP  303 (303)
                      ....  ......+|+.|+||
T Consensus       154 ~~~~~~~~~~~~~~~~y~aP  173 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAP  173 (372)
T ss_pred             ccCccccCCCCCcCCCcCCH
Confidence            4322  22334678999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=2.8e-28  Score=225.32  Aligned_cols=173  Identities=28%  Similarity=0.561  Sum_probs=140.6

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeee
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVR  197 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~  197 (303)
                      .|.++.++|++.+.||+|+||.||+|.+       +++.||||+++......     ..+.+.+|+.++..+ +||||++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~   75 (343)
T cd05103           1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNVVN   75 (343)
T ss_pred             CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH-----HHHHHHHHHHHHHhccCCccHhh
Confidence            4888889999999999999999999974       45789999997543221     125688999999999 6899999


Q ss_pred             eeEEEEcC-CeEEEEEeecCCCCHHHHHHhcCC-----------------------------------------------
Q 046106          198 FIGACRKP-MVWCIVTEYAKGGSVRQFLTKRQN-----------------------------------------------  229 (303)
Q Consensus       198 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~~-----------------------------------------------  229 (303)
                      +++++... ..+++||||+++|+|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (343)
T cd05103          76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE  155 (343)
T ss_pred             hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence            99988654 567899999999999999875321                                               


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          230 ------------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       230 ------------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                                        ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  235 (343)
T cd05103         156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY  235 (343)
T ss_pred             CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence                              23678888999999999999999999999999999999999999999999999764322211


Q ss_pred             ---cCCCCCCcccCC
Q 046106          292 ---TPETGTYRWMAP  303 (303)
Q Consensus       292 ---~~~~gt~~y~AP  303 (303)
                         ....+++.|+||
T Consensus       236 ~~~~~~~~~~~y~aP  250 (343)
T cd05103         236 VRKGDARLPLKWMAP  250 (343)
T ss_pred             hhcCCCCCCcceECc
Confidence               112345779888

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=4.7e-28  Score=214.37  Aligned_cols=169  Identities=31%  Similarity=0.575  Sum_probs=144.3

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |++..++|++.++||+|+||.||+|.. +++.||+|.+.......       ..+.+|+.+++.++||||+++++++.. 
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~-   72 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP-------EAFLAEANLMKQLQHPRLVRLYAVVTQ-   72 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH-------HHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence            778889999999999999999999987 67899999987654432       467899999999999999999998754 


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...+++|||+++++|.+++....+..+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++...
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            45799999999999999998765567899999999999999999999999999999999999999999999999999765


Q ss_pred             ecCCCc--cCCCCCCcccCC
Q 046106          286 VQTEGM--TPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~--~~~~gt~~y~AP  303 (303)
                      ......  ....++..|+||
T Consensus       153 ~~~~~~~~~~~~~~~~y~~p  172 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAP  172 (260)
T ss_pred             CCCCcccccCCcccccccCH
Confidence            422211  122456778887

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=5.8e-28  Score=219.44  Aligned_cols=175  Identities=32%  Similarity=0.547  Sum_probs=144.9

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCC
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHP  193 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp  193 (303)
                      .+.|++..++|.+.+.||+|+||.||++.+.         ...+|+|.++......     ....+.+|+.+++.+ +||
T Consensus        10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~h~   84 (307)
T cd05098          10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-----DLSDLISEMEMMKMIGKHK   84 (307)
T ss_pred             CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH-----HHHHHHHHHHHHHHhcCCC
Confidence            4678999999999999999999999999762         2469999987542211     125688899999999 799


Q ss_pred             CeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 046106          194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--------------RSVPLKLAVKQALDVARGMAYVHRLGLIHR  259 (303)
Q Consensus       194 niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHr  259 (303)
                      ||+++++++......|+||||+++++|.+++.....              ..+++..++.++.|++.||+|||+.|++||
T Consensus        85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~  164 (307)
T cd05098          85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR  164 (307)
T ss_pred             CEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            999999999999999999999999999999986421              247889999999999999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       260 Dlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||||+|||++.++.+||+|||+++.......   .....+++.|+||
T Consensus       165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  211 (307)
T cd05098         165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  211 (307)
T ss_pred             cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeCh
Confidence            9999999999999999999999975432211   1112345689998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.96  E-value=3.3e-28  Score=226.44  Aligned_cols=164  Identities=27%  Similarity=0.367  Sum_probs=138.1

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  205 (303)
                      .++|.+.+.||+|+||.||++..  .++.||||++.........    .+.+.+|+.+++.++||||+++++++...   
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh----HHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            46788889999999999999987  6789999999765433222    24677899999999999999999988543   


Q ss_pred             ---CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          206 ---MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       206 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                         ..+|+||||++ ++|.+++..    .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875          99 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             cccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence               35799999996 578877753    3788999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +............||+.|+||
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aP  194 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAP  194 (364)
T ss_pred             cccCCCCcccCCcccCCcCCH
Confidence            875544444556889999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-27  Score=211.18  Aligned_cols=169  Identities=30%  Similarity=0.493  Sum_probs=142.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      +.|.+.+.||+|++|.||++..  +++++|+|.+......... ....+.+.+|+.++++++||||+++++++..+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET-KKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh-HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence            4577889999999999999986  6789999998765433222 222357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +|+||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.+||+|||+++......
T Consensus        81 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            999999999999999765  458899999999999999999999999999999999999999999999999997543221


Q ss_pred             Cc----cCCCCCCcccCC
Q 046106          290 GM----TPETGTYRWMAP  303 (303)
Q Consensus       290 ~~----~~~~gt~~y~AP  303 (303)
                      ..    ....|+..|+||
T Consensus       159 ~~~~~~~~~~~~~~y~aP  176 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSP  176 (263)
T ss_pred             cccccccCCCcCccccCc
Confidence            11    234678889998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=5e-28  Score=216.97  Aligned_cols=170  Identities=31%  Similarity=0.526  Sum_probs=139.9

Q ss_pred             eecCCccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ++.+++++.+.||+|+||.||+|++      .+..||+|.++.....     .....+.+|+.+++.++||||+++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~   76 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-----QQWGEFQQEASLMAELHHPNIVCLLGVV   76 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-----HHHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence            3456788889999999999999985      3468999998753321     1125788999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQ---------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL  267 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NIL  267 (303)
                      ......|+||||+++++|.+++....               ...+++..++.++.|++.||+|||++|++||||||+|||
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil  156 (283)
T cd05090          77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL  156 (283)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence            99999999999999999999986432               124788899999999999999999999999999999999


Q ss_pred             EcCCCcEEEeccCCceeeecCC---CccCCCCCCcccCC
Q 046106          268 IFSDKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       268 v~~~~~vKl~DFGla~~~~~~~---~~~~~~gt~~y~AP  303 (303)
                      +++++.+||+|||+++......   ......++..|+||
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP  195 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecCh
Confidence            9999999999999997643322   12223456778887

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=1.2e-27  Score=211.05  Aligned_cols=166  Identities=25%  Similarity=0.448  Sum_probs=142.4

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||++.+  +++.+|+|.++......     ..+.+.+|+.+++.++||||+++++.+..+..+|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-----AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence            366778999999999999987  67899999987543221     12577889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ++||+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||++++++.++|+|||+++.......
T Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999999999999765556689999999999999999999999999999999999999999999999999976543222


Q ss_pred             -ccCCCCCCcccCC
Q 046106          291 -MTPETGTYRWMAP  303 (303)
Q Consensus       291 -~~~~~gt~~y~AP  303 (303)
                       .....|++.|+||
T Consensus       156 ~~~~~~~~~~~~aP  169 (255)
T cd08219         156 YACTYVGTPYYVPP  169 (255)
T ss_pred             ccccccCCccccCH
Confidence             2334688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=9.8e-28  Score=212.98  Aligned_cols=166  Identities=30%  Similarity=0.479  Sum_probs=142.2

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ..++|++.+.||+|+||.||+|++  +++.||+|++.......      ...+.+|+.+++.++||||+++++++..+..
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~   80 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------FSLIQQEIFMVKECKHCNIVAYFGSYLSREK   80 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Confidence            345788899999999999999997  67899999997543221      1357789999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +++||||+++++|.+++...  ..+++..+..++.|++.||+|||+.||+||||+|+||+++.++.+||+|||+++....
T Consensus        81 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999999999998754  4588999999999999999999999999999999999999999999999999986532


Q ss_pred             CC-CccCCCCCCcccCC
Q 046106          288 TE-GMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~-~~~~~~gt~~y~AP  303 (303)
                      .. ......|++.|+||
T Consensus       159 ~~~~~~~~~~~~~y~~P  175 (267)
T cd06646         159 TIAKRKSFIGTPYWMAP  175 (267)
T ss_pred             cccccCccccCccccCH
Confidence            22 22344688899988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=6.5e-28  Score=218.69  Aligned_cols=175  Identities=31%  Similarity=0.556  Sum_probs=144.7

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE---------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCC
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY---------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHP  193 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp  193 (303)
                      ...|++...+|.+.+.||+|+||.||++++         .+..||+|.++.....     ...+.+.+|+.+++.+ +||
T Consensus         7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~   81 (304)
T cd05101           7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIGKHK   81 (304)
T ss_pred             CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch-----HHHHHHHHHHHHHHhhccCC
Confidence            346888899999999999999999999974         2347999988643221     1135788999999999 799


Q ss_pred             CeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 046106          194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHR  259 (303)
Q Consensus       194 niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHr  259 (303)
                      ||+++++.+......|++|||+++++|.+++....              ...+++..++.++.||+.||+|||++|++||
T Consensus        82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~  161 (304)
T cd05101          82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR  161 (304)
T ss_pred             CchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            99999999999999999999999999999997642              1347888899999999999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       260 Dlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||||+|||++.++.+||+|||+++.......   .....+++.|+||
T Consensus       162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aP  208 (304)
T cd05101         162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP  208 (304)
T ss_pred             ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCc
Confidence            9999999999999999999999986533221   1223456789998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=220.62  Aligned_cols=167  Identities=28%  Similarity=0.424  Sum_probs=144.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .+.|.+.+.||+|.|+.|+++..  +|+.+|+|++.........    .+.+.+|+.|-+.|+||||++|.+.+.+....
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~----~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFH   85 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc----HHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence            35677888999999999999876  8899999998654433322    36788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---~~vKl~DFGla~~~  285 (303)
                      |+|+|+|.|++|..-+-.+  .-+++..+-..++||+.+|.|||.+||||||+||+|+|+.+.   ..+||+|||+|...
T Consensus        86 ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999999998776655  347888889999999999999999999999999999999653   46999999999987


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ........++|||.||||
T Consensus       164 ~~g~~~~G~~GtP~fmaP  181 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSP  181 (355)
T ss_pred             CCccccccccCCCcccCH
Confidence            766566677999999998

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=2.1e-28  Score=216.36  Aligned_cols=171  Identities=32%  Similarity=0.552  Sum_probs=145.4

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |+....+|.+.+.||.|+||.||+|.+ .+..+|+|++......      ....+.+|+.+++.++||||+++++++...
T Consensus         1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (261)
T cd05148           1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL------KQQDFQKEVQALKRLRHKHLISLFAVCSVG   74 (261)
T ss_pred             CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh------hHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence            556677899999999999999999998 5678999998754321      124688899999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+++||||+++++|.+++....+..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence            99999999999999999998766667899999999999999999999999999999999999999999999999999764


Q ss_pred             ecCCC-ccCCCCCCcccCC
Q 046106          286 VQTEG-MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~-~~~~~gt~~y~AP  303 (303)
                      ..... .....+++.|+||
T Consensus       155 ~~~~~~~~~~~~~~~~~~P  173 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAP  173 (261)
T ss_pred             CCccccccCCCCceEecCH
Confidence            32211 1122356678887

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=8.5e-28  Score=226.17  Aligned_cols=162  Identities=23%  Similarity=0.361  Sum_probs=137.3

Q ss_pred             eeecCCccccceecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .+...+|.+.+.||+|+||.||++..    .+..||+|.+...           ....+|+.+|+.++||||+++++++.
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------~~~~~E~~il~~l~h~~iv~~~~~~~  156 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------KTPGREIDILKTISHRAIINLIHAYR  156 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------ccHHHHHHHHHhcCCCCccceeeeEe
Confidence            34456799999999999999999975    3467999988542           13457999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ....+|++||++. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus       157 ~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        157 WKSTVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             eCCEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            9999999999995 6899988533  568999999999999999999999999999999999999999999999999997


Q ss_pred             eeecCCC---ccCCCCCCcccCC
Q 046106          284 IEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      .......   .....||+.|+||
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aP  256 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSP  256 (392)
T ss_pred             ccCcccccccccccccccCccCH
Confidence            5443221   1234689999998

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.96  E-value=7.8e-28  Score=213.13  Aligned_cols=169  Identities=34%  Similarity=0.554  Sum_probs=141.0

Q ss_pred             ceeecCCccccceecccCceEEEEEEEC-CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |+++..++.+.+.||+|+||.||++.+. +..+|+|.+......       .+.+.+|+.+++.++|||++++++++.. 
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   72 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-------PEAFLQEAQIMKKLRHDKLVPLYAVVSE-   72 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-------HHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence            6677788999999999999999999984 457999988654322       2467889999999999999999998854 


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||++++++.+||+|||+++..
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~  152 (260)
T cd05069          73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI  152 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence            45689999999999999998765556889999999999999999999999999999999999999999999999999765


Q ss_pred             ecCCCc--cCCCCCCcccCC
Q 046106          286 VQTEGM--TPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~--~~~~gt~~y~AP  303 (303)
                      ......  ....++..|+||
T Consensus       153 ~~~~~~~~~~~~~~~~y~~P  172 (260)
T cd05069         153 EDNEYTARQGAKFPIKWTAP  172 (260)
T ss_pred             cCCcccccCCCccchhhCCH
Confidence            433211  112356778887

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=7.7e-28  Score=213.70  Aligned_cols=168  Identities=30%  Similarity=0.519  Sum_probs=140.7

Q ss_pred             ecCCccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      +.++|++.+.||+|+||.||+|.+.     ...||||.++......     ....+.+|+.+++.++||||+++++.+..
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-----QRLDFLTEASIMGQFDHPNIIRLEGVVTK   76 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH-----HHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence            4567888999999999999999872     2479999987543222     23578899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ....+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++.
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            999999999999999999997644 3689999999999999999999999999999999999999999999999999986


Q ss_pred             eec-CCCccC--CCCCCcccCC
Q 046106          285 EVQ-TEGMTP--ETGTYRWMAP  303 (303)
Q Consensus       285 ~~~-~~~~~~--~~gt~~y~AP  303 (303)
                      ... ......  ..+++.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~P  177 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAP  177 (266)
T ss_pred             ccccccceeccCCCCCccccCh
Confidence            542 111111  2345778887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.96  E-value=7e-28  Score=217.03  Aligned_cols=164  Identities=29%  Similarity=0.443  Sum_probs=142.5

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||++.+  +++.+|+|+++......   ......+.+|+.+++++.||||+++++++.....+|+
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK---LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL   78 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh---hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence            577788999999999999988  67899999987533211   1223578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||||+.++.+||+|||+++.....  
T Consensus        79 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          79 VMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            99999999999999865  46899999999999999999999999999999999999999999999999999865433  


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      ....+|++.|+||
T Consensus       155 ~~~~~~~~~y~aP  167 (290)
T cd05580         155 TYTLCGTPEYLAP  167 (290)
T ss_pred             CCCCCCCccccCh
Confidence            3345788999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.96  E-value=1.3e-28  Score=233.55  Aligned_cols=161  Identities=30%  Similarity=0.467  Sum_probs=140.3

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-C-----CCeeeeeEEEEc
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-H-----PNIVRFIGACRK  204 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----pniv~l~~~~~~  204 (303)
                      +|.+++.||+|+||+|.+|.+  +++.||||+++....       ..++-..|+.+|..++ |     -|+|+++++|..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            778899999999999999987  788999999986432       2246678999999997 4     499999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC--CcEEEeccCCc
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD--KSIKIADFGVA  282 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~--~~vKl~DFGla  282 (303)
                      .+.+|||+|++ ..+|++|++..+...++...++.++.||+.||.+||+.||||+||||+|||+..-  ..|||+|||.|
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999999 5699999999888889999999999999999999999999999999999999664  47999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .+..... + +.+.+..|+||
T Consensus       339 c~~~q~v-y-tYiQSRfYRAP  357 (586)
T KOG0667|consen  339 CFESQRV-Y-TYIQSRFYRAP  357 (586)
T ss_pred             cccCCcc-e-eeeeccccccc
Confidence            8754332 2 55677888888

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=5e-28  Score=216.63  Aligned_cols=170  Identities=32%  Similarity=0.593  Sum_probs=141.3

Q ss_pred             eecCCccccceecccCceEEEEEEEC--C-----eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYN--G-----EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ++..+|++.+.||+|+||.||+|...  +     ..||+|.++.....     .....+.+|+.++..++||||++++++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~i~~~~~~   76 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQEFRQEAELMSDLQHPNIVCLLGV   76 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-----HHHHHHHHHHHHHHhcCCcccceEEEE
Confidence            34567888999999999999999862  2     46999998654321     223578899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQN--------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL  267 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NIL  267 (303)
                      +......|++|||+++++|.+++.....              ..+++..++.++.|++.||+|||++|++||||||+||+
T Consensus        77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil  156 (283)
T cd05048          77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL  156 (283)
T ss_pred             EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence            9988889999999999999999975421              34788899999999999999999999999999999999


Q ss_pred             EcCCCcEEEeccCCceeeecCC---CccCCCCCCcccCC
Q 046106          268 IFSDKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       268 v~~~~~vKl~DFGla~~~~~~~---~~~~~~gt~~y~AP  303 (303)
                      +++++.+||+|||+++......   ......+++.|+||
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP  195 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccccccCCCcccccccCH
Confidence            9999999999999997643222   12234567889998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=7.1e-28  Score=214.27  Aligned_cols=160  Identities=27%  Similarity=0.478  Sum_probs=129.7

Q ss_pred             eecccCceEEEEEEE-C---CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          139 AFAQGAFGKLYRGTY-N---GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~-~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .||+|+||.||+|.. +   ...+|+|.+......     .....+.+|+.+++.++||||+++++.+.....+|+||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-----DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh-----HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            589999999999975 2   346888877543221     1225688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC-
Q 046106          215 AKGGSVRQFLTKRQN---RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-  290 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~-  290 (303)
                      +++++|.+++.....   ...++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999999976432   2346778889999999999999999999999999999999999999999999875322211 


Q ss_pred             --ccCCCCCCcccCC
Q 046106          291 --MTPETGTYRWMAP  303 (303)
Q Consensus       291 --~~~~~gt~~y~AP  303 (303)
                        .....+++.|+||
T Consensus       157 ~~~~~~~~~~~y~aP  171 (269)
T cd05042         157 ITKDCHAVPLRWLAP  171 (269)
T ss_pred             eccCCCCCcccccCH
Confidence              1223456779887

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=1.4e-27  Score=211.67  Aligned_cols=169  Identities=31%  Similarity=0.572  Sum_probs=142.7

Q ss_pred             CccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      +|++.+.||+|+||.||+|.. +++.+|+|.++...............+.+|+++++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            356778999999999999987 7789999998765433333333346789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec----
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ----  287 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~----  287 (303)
                      +||+++++|.+++...  ..+++..+..++.|++.||+|||+.+++|+||+|+||++++++.+||+|||++.....    
T Consensus        81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999999999999764  3578999999999999999999999999999999999999999999999999875321    


Q ss_pred             ---CCCccCCCCCCcccCC
Q 046106          288 ---TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ---~~~~~~~~gt~~y~AP  303 (303)
                         ........|++.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~p  177 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAP  177 (265)
T ss_pred             ccccccccccCCCccccCh
Confidence               1112234678889988

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=1.1e-27  Score=212.52  Aligned_cols=169  Identities=24%  Similarity=0.422  Sum_probs=142.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|++  +++.||||.++........   ....+.+|+.+++.++||||+++++++......+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK---ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN   78 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHH---HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEE
Confidence            4677889999999999999987  6789999988754332221   2357889999999999999999999999989999


Q ss_pred             EEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          210 IVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +++||+++++|.+++....  ...+++..+..++.|++.||+|||+++++|+||||+|||++.++.++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999999886432  24578899999999999999999999999999999999999999999999999986543


Q ss_pred             CCC-ccCCCCCCcccCC
Q 046106          288 TEG-MTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~-~~~~~gt~~y~AP  303 (303)
                      ... .....|++.|+||
T Consensus       159 ~~~~~~~~~~~~~~~aP  175 (267)
T cd08228         159 KTTAAHSLVGTPYYMSP  175 (267)
T ss_pred             hhHHHhcCCCCccccCh
Confidence            221 2234688899998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=224.24  Aligned_cols=162  Identities=28%  Similarity=0.460  Sum_probs=143.8

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      -|.++++||+|+||.||++.+  .|+.+|||.+....        -.+.+..|+.||.+++.|+||++||.+.....+||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            356788999999999999976  78999999885422        23688999999999999999999999988888999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      |||||-.|++.+.++.+. +++.+..+..++...++||+|||...-||||||+.|||+..+|..||+|||.|-...+...
T Consensus       106 VMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             ehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            999999999999998764 6899999999999999999999999999999999999999999999999999976654432


Q ss_pred             -ccCCCCCCcccCC
Q 046106          291 -MTPETGTYRWMAP  303 (303)
Q Consensus       291 -~~~~~gt~~y~AP  303 (303)
                       ..+..|||.||||
T Consensus       185 KRNTVIGTPFWMAP  198 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAP  198 (502)
T ss_pred             hhCccccCcccccH
Confidence             3456899999998

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=2e-27  Score=209.51  Aligned_cols=167  Identities=22%  Similarity=0.388  Sum_probs=143.6

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|+..+.||.|+||.||.++.  +++.+++|.+.........    .+.+.+|+.++++++||||+++++++.....+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   76 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE----RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLI   76 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH----HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEE
Confidence            467788999999999988876  6789999998765443322    2567899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-  289 (303)
                      +|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++....... 
T Consensus        77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999999999987655668999999999999999999999999999999999999999999999999998654332 


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......|++.|+||
T Consensus       157 ~~~~~~~~~~y~ap  170 (256)
T cd08221         157 MAETVVGTPYYMSP  170 (256)
T ss_pred             cccccCCCccccCH
Confidence            22345688999988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-28  Score=227.55  Aligned_cols=166  Identities=25%  Similarity=0.484  Sum_probs=151.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      -|.+.+.||+|.|..|-++++  +|..||||++.+...+....    ..+.+|++.|+.++|||||+||.+..++..+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st----~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST----GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh----hHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            356678899999999999986  99999999999887765443    577899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCceeeecCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVARIEVQTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~~~~~~~  289 (303)
                      |+|+-.+|+|++|+.++. ..+.+....++++||+.|+.|||+.-+|||||||+|+.+-+. |-|||+|||++....+..
T Consensus        95 iLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999998765 458999999999999999999999999999999999988665 999999999998888888


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ..++.||...|-||
T Consensus       174 kL~TsCGSLAYSAP  187 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAP  187 (864)
T ss_pred             hhhcccchhhccCc
Confidence            89999999999998

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=8.1e-28  Score=243.14  Aligned_cols=176  Identities=23%  Similarity=0.345  Sum_probs=145.9

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ++..+....+|.+++.||.|+||.||++++  .++.+|+|++.........    ...+..|+.+|+.++|||||+++++
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~----~~~~~~EI~IL~~L~HPNIVrl~d~   80 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE----KSQLVIEVNVMRELKHKNIVRYIDR   80 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHH----HHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            445566677899999999999999999998  5678999999765443322    3578899999999999999999998


Q ss_pred             EEc--CCeEEEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeCCCCCCcEEEcC
Q 046106          202 CRK--PMVWCIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRL-------GLIHRDLKSDNLLIFS  270 (303)
Q Consensus       202 ~~~--~~~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-------giiHrDlkp~NILv~~  270 (303)
                      |..  ...+||||||+++++|.++|....  ...+++..++.|+.||+.||+|||+.       +||||||||+||||+.
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            854  456899999999999999997532  24689999999999999999999984       4999999999999964


Q ss_pred             -----------------CCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          271 -----------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       271 -----------------~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                                       .+.+||+|||+++...........+||+.|+||
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAP  210 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSP  210 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCH
Confidence                             245999999999865544444455799999998

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=9.6e-28  Score=216.03  Aligned_cols=174  Identities=33%  Similarity=0.572  Sum_probs=145.0

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIV  196 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv  196 (303)
                      ..|+++..+|++.+.||+|+||.||++.+.       ...+|+|.++......     ....+.+|+.+++.+ +||||+
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~   79 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-----DLSDLVSEMEMMKMIGKHKNII   79 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-----HHHHHHHHHHHHHhhcCCCCee
Confidence            478889999999999999999999999863       2579999987543221     124688999999999 799999


Q ss_pred             eeeEEEEcCCeEEEEEeecCCCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 046106          197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKR--------------QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLK  262 (303)
Q Consensus       197 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlk  262 (303)
                      ++++++..+..++++|||+++++|.+++...              ....+++..++.++.|++.||+|||+.+|+|||||
T Consensus        80 ~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk  159 (293)
T cd05053          80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA  159 (293)
T ss_pred             eEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            9999999999999999999999999999752              23468899999999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          263 SDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       263 p~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |+|||++.++.+||+|||+++.......   .....+++.|+||
T Consensus       160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  203 (293)
T cd05053         160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAP  203 (293)
T ss_pred             eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCH
Confidence            9999999999999999999986543221   1112345678887

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=1.1e-27  Score=212.15  Aligned_cols=169  Identities=30%  Similarity=0.524  Sum_probs=143.4

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      |++..+++.+.+.||+|+||.||++.+ .+..+|+|.++....       ..+.+.+|+.+++.++|+||+++++.+.. 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   72 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-------SVEAFLAEANVMKTLQHDKLVKLHAVVTK-   72 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-------HHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence            788899999999999999999999987 556799998865321       12578899999999999999999999887 


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence            66799999999999999998765566889999999999999999999999999999999999999999999999999765


Q ss_pred             ecCCCc--cCCCCCCcccCC
Q 046106          286 VQTEGM--TPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~--~~~~gt~~y~AP  303 (303)
                      ......  ....++..|+||
T Consensus       153 ~~~~~~~~~~~~~~~~y~~P  172 (260)
T cd05073         153 EDNEYTAREGAKFPIKWTAP  172 (260)
T ss_pred             cCCCcccccCCcccccccCH
Confidence            432211  122345678887

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=1.6e-27  Score=216.92  Aligned_cols=163  Identities=28%  Similarity=0.403  Sum_probs=140.7

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||++.+  ++..+|+|.++....     .....++.+|++++++++||||+++++++..+..+|+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-----PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence            577889999999999999987  677899999865322     1123568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++...... 
T Consensus        77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            99999999999999765  458999999999999999999997 59999999999999999999999999998754322 


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      .....+|++.|+||
T Consensus       154 ~~~~~~~~~~~~aP  167 (308)
T cd06615         154 MANSFVGTRSYMSP  167 (308)
T ss_pred             ccccCCCCcCccCh
Confidence            23445788999998

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-29  Score=221.49  Aligned_cols=171  Identities=26%  Similarity=0.393  Sum_probs=148.0

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .+..++|..++.||+|.||+|-+++-  +++.+|+|++++......   .....-+.|-++|+..+||.+..|-=.|+..
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak---dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK---DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh---HHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            45567889999999999999999986  788999999987643321   1123556789999999999999998889999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      +.+|+||||+.||.|.-.|...  +.+++.....+-..|+.||.|||+++||.||||.+|.|+|.+|++||+|||+|+..
T Consensus       241 drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999999998777654  56899999999999999999999999999999999999999999999999999864


Q ss_pred             -ecCCCccCCCCCCcccCC
Q 046106          286 -VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 -~~~~~~~~~~gt~~y~AP  303 (303)
                       .....+.+.||||.|+||
T Consensus       319 I~~g~t~kTFCGTPEYLAP  337 (516)
T KOG0690|consen  319 IKYGDTTKTFCGTPEYLAP  337 (516)
T ss_pred             ccccceeccccCChhhcCc
Confidence             444557788999999999

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=5.6e-28  Score=216.49  Aligned_cols=170  Identities=28%  Similarity=0.530  Sum_probs=140.3

Q ss_pred             eecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ++..+|.+.+.||+|+||.||+|++.       ++.||+|+++.....     .....+.+|+.++..++||||++++++
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~   76 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-----PLREEFKHEAMMRSRLQHPNIVCLLGV   76 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            44567888899999999999999862       368999998754321     123578899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL  267 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NIL  267 (303)
                      +......++++||+++++|.+++....              ...+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil  156 (283)
T cd05091          77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL  156 (283)
T ss_pred             EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence            999989999999999999999986321              134788889999999999999999999999999999999


Q ss_pred             EcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          268 IFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       268 v~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +++++.+||+|||+++.......   .....+++.|+||
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP  195 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCH
Confidence            99999999999999875432221   1223456789998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=6.1e-29  Score=234.48  Aligned_cols=166  Identities=30%  Similarity=0.515  Sum_probs=136.9

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--eE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM--VW  208 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--~~  208 (303)
                      -+++...||+|+|-+||+|.+  +|-+||--.++...  ..+.....++|..|+.+|+.|+||||+++|..|.+..  .+
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d--~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD--VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHHH--hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            346677899999999999987  56677643332211  1112223479999999999999999999999998765  47


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCC-CcEEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSD-KSIKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~~~-~~vKl~DFGla~~~  285 (303)
                      -+|+|++..|+|..|+++.  +.+....+..+++||++||.|||++.  |||||||.+||+|+-+ |.|||+|+|||...
T Consensus       119 n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            8999999999999999987  45888999999999999999999985  9999999999999765 99999999999876


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ..... ....|||.||||
T Consensus       197 r~s~a-ksvIGTPEFMAP  213 (632)
T KOG0584|consen  197 RKSHA-KSVIGTPEFMAP  213 (632)
T ss_pred             hcccc-ceeccCccccCh
Confidence            65543 347899999999

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=1.2e-27  Score=217.96  Aligned_cols=158  Identities=24%  Similarity=0.429  Sum_probs=129.0

Q ss_pred             cceecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEE
Q 046106          137 GDAFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--PMVWCI  210 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~~i  210 (303)
                      +++||+|+||.||+|+.    +++.+|+|.++.....        ..+.+|+.+|+.++||||+++++++..  +..+|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL   77 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence            45799999999999986    3468999998754322        346689999999999999999999854  456899


Q ss_pred             EEeecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEecc
Q 046106          211 VTEYAKGGSVRQFLTKRQ-------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI----FSDKSIKIADF  279 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv----~~~~~vKl~DF  279 (303)
                      ++||+. ++|.+++....       ...+++..+..++.||+.||+|||++||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          78 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            999995 58888876321       2358899999999999999999999999999999999999    45578999999


Q ss_pred             CCceeeecCC----CccCCCCCCcccCC
Q 046106          280 GVARIEVQTE----GMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~----~~~~~~gt~~y~AP  303 (303)
                      |+|+......    ......||+.|+||
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCC
Confidence            9998654321    22345789999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=2.1e-27  Score=212.79  Aligned_cols=159  Identities=26%  Similarity=0.461  Sum_probs=136.8

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||+|.+  +++.||+|++......     ...+.+.+|+.++++++||||+++++.+..+...++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-----ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh-----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence            567788999999999999987  6789999998754321     122578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ||||+++++|..+.      .+++..+..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||++...... .
T Consensus        77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~  149 (279)
T cd06619          77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-I  149 (279)
T ss_pred             EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-c
Confidence            99999999986542      3688899999999999999999999999999999999999999999999999765432 2


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....||+.|+||
T Consensus       150 ~~~~~~~~~y~aP  162 (279)
T cd06619         150 AKTYVGTNAYMAP  162 (279)
T ss_pred             ccCCCCChhhcCc
Confidence            3445789999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-28  Score=222.52  Aligned_cols=161  Identities=35%  Similarity=0.597  Sum_probs=137.7

Q ss_pred             cCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHc--CCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT--LKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~~---  205 (303)
                      .+++.+.+.||+|.||+||+|.|.|+.||||++....         ++.+.+|.+|.+.  |+|+||+.+++.-..+   
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccc---------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            3577888999999999999999999999999996432         1467788888876  5999999999976543   


Q ss_pred             -CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----C---CceeCCCCCCcEEEcCCCcEEE
Q 046106          206 -MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-----L---GLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       206 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-----~---giiHrDlkp~NILv~~~~~vKl  276 (303)
                       .++|+|++|-+.|||+|||..   ..+.....++++..++.||+|||.     +   .|.|||||..||||..++.+.|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             368999999999999999987   358899999999999999999994     2   4999999999999999999999


Q ss_pred             eccCCceeeecC-----CCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQT-----EGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~-----~~~~~~~gt~~y~AP  303 (303)
                      +|+|||-.....     ....+.+||.+||||
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAP  389 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAP  389 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccCh
Confidence            999999654432     124567999999999

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.95  E-value=1.3e-27  Score=216.98  Aligned_cols=174  Identities=30%  Similarity=0.525  Sum_probs=145.1

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIV  196 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv  196 (303)
                      ..|.+..++|.+.+.||+|+||.||++++       .+..||+|+++......     ..+.+.+|+.+++++ +||||+
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~iv  102 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS-----EREALMSELKIMSHLGNHENIV  102 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH-----HHHHHHHHHHHHHhccCCCCcc
Confidence            35777888899999999999999999975       23479999987543221     125788999999999 799999


Q ss_pred             eeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       197 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      ++++.+......|++|||+++++|.+++.......+++..+..++.|++.||+|||+++++|+||||+|||++.++.+||
T Consensus       103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEE
Confidence            99999999999999999999999999998654444899999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +|||+++.......   .....+++.|+||
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  212 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAP  212 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCH
Confidence            99999975433221   1122456789988

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=1.3e-27  Score=238.89  Aligned_cols=168  Identities=33%  Similarity=0.483  Sum_probs=143.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.++||+|+||.||+|.+  .++.||||+++.......   .....+.+|+.+++.++||||+++++++.....+
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   79 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK---NMVHQVQAERDALALSKSPFIVHLYYSLQSANNV   79 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCH---HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEE
Confidence            35678889999999999999998  478999999976443221   2235788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ||||||+++++|.+++...  ..+++..++.++.||+.||+|||.++||||||||+||||+.++.+||+|||+++.....
T Consensus        80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~  157 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR  157 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence            9999999999999999764  35789999999999999999999999999999999999999999999999999875433


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......+|+.|+||
T Consensus       158 ~~~~~~~~~t~~~~~p  173 (669)
T cd05610         158 ELNMMDILTTPSMAKP  173 (669)
T ss_pred             cccccccccCccccCc
Confidence            2 23344678888876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-28  Score=223.95  Aligned_cols=163  Identities=33%  Similarity=0.537  Sum_probs=139.7

Q ss_pred             eecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHc--CCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT--LKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~~~  206 (303)
                      .....+.+.+.||+|.||.||+|+++++.||||++...         ..+.|++|-.|.+.  ++|+||++++++-....
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t  277 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT  277 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhccCceeEEEecCHH---------HHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence            34566788899999999999999999999999999541         12578888887765  57999999999876544


Q ss_pred             ----eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeCCCCCCcEEEcCCCc
Q 046106          207 ----VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR---------LGLIHRDLKSDNLLIFSDKS  273 (303)
Q Consensus       207 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---------~giiHrDlkp~NILv~~~~~  273 (303)
                          .++||+||-+.|+|.+||+..   .++|....+|+..++.||+|||+         ..|+|||||.+||||.+|++
T Consensus       278 ~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT  354 (534)
T KOG3653|consen  278 ADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT  354 (534)
T ss_pred             ccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence                789999999999999999975   58999999999999999999995         35999999999999999999


Q ss_pred             EEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          274 IKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       274 vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +.|+|||+|........   ...++||.+||||
T Consensus       355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAP  387 (534)
T KOG3653|consen  355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAP  387 (534)
T ss_pred             EEeeccceeEEecCCCCCcchhhhhhhhhhcCH
Confidence            99999999987654332   2336899999999

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=1.3e-27  Score=212.20  Aligned_cols=165  Identities=28%  Similarity=0.484  Sum_probs=142.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||++++  +++.||+|+++......      ...+.+|+.+++.++||||+++++.+.....+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence            45778888999999999999987  67899999987643221      13577899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+|+||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999999998764  46899999999999999999999999999999999999999999999999998754322


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......|++.|+||
T Consensus       160 ~~~~~~~~~~~~y~aP  175 (267)
T cd06645         160 IAKRKSFIGTPYWMAP  175 (267)
T ss_pred             ccccccccCcccccCh
Confidence            2 22345789999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=1.9e-27  Score=214.25  Aligned_cols=169  Identities=33%  Similarity=0.556  Sum_probs=141.1

Q ss_pred             ecCCccccceecccCceEEEEEEECC------------------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTYNG------------------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK  191 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------------------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~  191 (303)
                      ...+|++.+.||+|+||.||++++..                  ..||+|.+......     .....+.+|+.++++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~   77 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-----NAREDFLKEVKILSRLS   77 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhcC
Confidence            45678899999999999999987622                  45899998754332     22357889999999999


Q ss_pred             CCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 046106          192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ---------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLK  262 (303)
Q Consensus       192 hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlk  262 (303)
                      ||||+++++++..+..+++++|++++++|.+++....         ...+++..++.++.|++.||+|||++|++|||||
T Consensus        78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk  157 (296)
T cd05051          78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA  157 (296)
T ss_pred             CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            9999999999999889999999999999999997643         1258899999999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          263 SDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       263 p~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |+||+++.++.+||+|||+++.......   .....+++.|+||
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence            9999999999999999999975433221   1233467789998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=2e-27  Score=211.59  Aligned_cols=160  Identities=24%  Similarity=0.434  Sum_probs=131.3

Q ss_pred             eecccCceEEEEEEEC----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          139 AFAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .||+|+||.||+|.+.    +..+|+|.++......     ....+.+|+.+++.++||||+++++.+.+...+++||||
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ-----EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            5899999999999862    3578999886543221     124688899999999999999999999988889999999


Q ss_pred             cCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC-
Q 046106          215 AKGGSVRQFLTKRQN---RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-  290 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~-  290 (303)
                      +++++|.+++.....   ...++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++....... 
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999999975321   2456777889999999999999999999999999999999999999999999975432221 


Q ss_pred             --ccCCCCCCcccCC
Q 046106          291 --MTPETGTYRWMAP  303 (303)
Q Consensus       291 --~~~~~gt~~y~AP  303 (303)
                        .....+++.|+||
T Consensus       157 ~~~~~~~~~~~y~aP  171 (269)
T cd05087         157 VTPDQLWVPLRWIAP  171 (269)
T ss_pred             ecCCCcCCcccccCH
Confidence              1223567889998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=1.5e-27  Score=212.03  Aligned_cols=168  Identities=30%  Similarity=0.506  Sum_probs=139.0

Q ss_pred             ecCCccccceecccCceEEEEEEE--C---CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--N---GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      +..+|++.+.||+|+||.||+|.+  +   +..+|+|.++......     ..+.+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-----QRRDFLSEASIMGQFDHPNIIHLEGVVTK   76 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            456778889999999999999986  2   2379999986543221     23578899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +...|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            999999999999999999997643 4579999999999999999999999999999999999999999999999999986


Q ss_pred             eecCCC--c--cCCCCCCcccCC
Q 046106          285 EVQTEG--M--TPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~--~--~~~~gt~~y~AP  303 (303)
                      ......  .  ....++..|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~p  178 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAP  178 (267)
T ss_pred             cccccceeeecCCCccceeecCH
Confidence            543221  1  112235678887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=1.8e-27  Score=213.03  Aligned_cols=166  Identities=26%  Similarity=0.414  Sum_probs=138.9

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|++|.||+|+.  +++.||+|.++.......    ....+.+|+.+++.++||||+++++++..+..+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG----VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYL   76 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC----chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEE
Confidence            366778999999999999987  678999999875433221    12467789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          211 VTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      ||||++ ++|.+++..... ..+++..+..++.|++.||+|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus        77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            999997 689888875432 568999999999999999999999999999999999999999999999999997543221


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......+++.|+||
T Consensus       156 ~~~~~~~~~~~y~aP  170 (285)
T cd07861         156 RVYTHEVVTLWYRAP  170 (285)
T ss_pred             ccccCCcccccccCh
Confidence             22334678889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6.8e-28  Score=222.40  Aligned_cols=167  Identities=25%  Similarity=0.419  Sum_probs=138.6

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .|++ .++|.+.+.||+|+||.||+|..  +++.||||.+.......    ...+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07878          10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL----IHARRTYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh----HHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence            3444 36788899999999999999987  67799999987543221    12346778999999999999999999875


Q ss_pred             cC------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          204 KP------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       204 ~~------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                      ..      ...|+++|++ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          85 PATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             ccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEc
Confidence            43      3468999998 7899888764   358999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||+++....  .....+||+.|+||
T Consensus       161 Dfg~~~~~~~--~~~~~~~t~~y~aP  184 (343)
T cd07878         161 DFGLARQADD--EMTGYVATRWYRAP  184 (343)
T ss_pred             CCccceecCC--CcCCccccccccCc
Confidence            9999986433  23445789999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=1.5e-27  Score=216.59  Aligned_cols=170  Identities=31%  Similarity=0.527  Sum_probs=136.8

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCe--EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACR  203 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  203 (303)
                      +..++|.+.+.||+|+||.||+|.+  ++.  .+|+|.++....     ......+.+|+.++.++ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~   78 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-----KDDHRDFAGELEVLCKLGHHPNIINLLGACE   78 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC-----HHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence            4456788889999999999999987  444  457776653221     12235788999999999 8999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF  269 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~  269 (303)
                      ....+|+||||+++++|.+++....              ...+++..++.++.|++.||+|||++|++||||||+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~  158 (303)
T cd05088          79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG  158 (303)
T ss_pred             CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence            9999999999999999999997542              12578999999999999999999999999999999999999


Q ss_pred             CCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          270 SDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       270 ~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .++.+||+|||+++............++..|+||
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  192 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI  192 (303)
T ss_pred             CCCcEEeCccccCcccchhhhcccCCCcccccCH
Confidence            9999999999998643221111222345678887

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.95  E-value=1.8e-27  Score=217.02  Aligned_cols=174  Identities=32%  Similarity=0.574  Sum_probs=143.3

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE---------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCC
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY---------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPN  194 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn  194 (303)
                      ..|.+...+|.+.+.||+|+||.||+++.         ....+|+|+++......     ....+.+|+.+++.+ +|||
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~   79 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-----DLADLISEMELMKLIGKHKN   79 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChH-----HHHHHHHHHHHHHhccCCCC
Confidence            46888889999999999999999999975         23469999987533221     125688899999999 6999


Q ss_pred             eeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 046106          195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRD  260 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrD  260 (303)
                      |+++++++.....+|++|||+++++|.+++....              ...+++..+..++.|++.||.|||++|++|||
T Consensus        80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d  159 (314)
T cd05099          80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD  159 (314)
T ss_pred             eeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            9999999998888999999999999999997642              13478899999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          261 LKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       261 lkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |||+|||++.++.+||+|||+++.......   .....+++.|+||
T Consensus       160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (314)
T cd05099         160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP  205 (314)
T ss_pred             ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCH
Confidence            999999999999999999999976432211   1122344679988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.95  E-value=9.8e-28  Score=211.61  Aligned_cols=166  Identities=33%  Similarity=0.617  Sum_probs=141.0

Q ss_pred             ceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      |-++.++|.+.+.||+|+||.||++..+++.||+|.++....        .+.+.+|+.+++.++||||+++++++....
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   72 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--------AQAFLEETAVMTKLHHKNLVRLLGVILHNG   72 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch--------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence            556677889999999999999999999999999999864321        246889999999999999999999987655


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                       .+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++...
T Consensus        73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecc
Confidence             6899999999999999987655568999999999999999999999999999999999999999999999999997543


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ..  ......+..|+||
T Consensus       152 ~~--~~~~~~~~~y~~p  166 (254)
T cd05083         152 MG--VDNSKLPVKWTAP  166 (254)
T ss_pred             cc--CCCCCCCceecCH
Confidence            21  1222345667777

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=3.1e-27  Score=209.66  Aligned_cols=169  Identities=30%  Similarity=0.519  Sum_probs=139.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--Ce
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--MV  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~  207 (303)
                      .+|.+.+.||+|+||.||.+..  +++.||||.+......... ....+.+.+|+.+++.++||||+++++++.++  ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET-SKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc-HHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            4677889999999999999987  5789999998653322111 12235788999999999999999999998763  46


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      ++++|||+++++|.+++...  ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            78999999999999999764  3478889999999999999999999999999999999999999999999999875432


Q ss_pred             C----CCccCCCCCCcccCC
Q 046106          288 T----EGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~----~~~~~~~gt~~y~AP  303 (303)
                      .    .......|+..|+||
T Consensus       159 ~~~~~~~~~~~~~~~~y~aP  178 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSP  178 (265)
T ss_pred             ccccccccccCCCCccccCh
Confidence            1    122334688899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=1.9e-27  Score=218.76  Aligned_cols=174  Identities=33%  Similarity=0.571  Sum_probs=144.0

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCC
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPN  194 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn  194 (303)
                      ..|++...+|++++.||+|+||.||++++.         ...||+|+++......     ..+.+.+|+.+++++ +|||
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~   79 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-----DLSDLVSEMEMMKMIGKHKN   79 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHH-----HHHHHHHHHHHHHhhcCCCC
Confidence            678999999999999999999999999751         2368999886432221     235788999999999 7999


Q ss_pred             eeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 046106          195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRD  260 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrD  260 (303)
                      |++++++|.....+++++||+++++|.+++....              ...+++..++.++.|++.||+|||++|++|||
T Consensus        80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d  159 (334)
T cd05100          80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD  159 (334)
T ss_pred             eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence            9999999999888999999999999999997532              23477888999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          261 LKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       261 lkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |||+|||++.++.+||+|||+++.......   .....++..|+||
T Consensus       160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  205 (334)
T cd05100         160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP  205 (334)
T ss_pred             cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCH
Confidence            999999999999999999999986543221   1122345679988

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.2e-27  Score=229.20  Aligned_cols=159  Identities=23%  Similarity=0.323  Sum_probs=136.1

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ...|.+.+.||+|+||.||++.+  .++.||||....            ..+.+|+.+|++++||||+++++++......
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            34688889999999999999998  567899996421            2456899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+|||++. ++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus       236 ~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        236 CLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            99999994 69999987643 46899999999999999999999999999999999999999999999999999865332


Q ss_pred             CC---ccCCCCCCcccCC
Q 046106          289 EG---MTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~---~~~~~gt~~y~AP  303 (303)
                      ..   ....+||+.|+||
T Consensus       314 ~~~~~~~~~~GT~~Y~AP  331 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAP  331 (461)
T ss_pred             cccccccccCCCcCCcCH
Confidence            21   1234699999998

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=233.43  Aligned_cols=173  Identities=29%  Similarity=0.481  Sum_probs=148.9

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC---Ce--EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN---GE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      ..-.|..+++++.++||+|.||.|++|.|+   |+  .||||+++......     ....|++|+.+|.+|+|||+++||
T Consensus       103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-----~mddflrEas~M~~L~H~hliRLy  177 (1039)
T KOG0199|consen  103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-----IMDDFLREASHMLKLQHPHLIRLY  177 (1039)
T ss_pred             cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-----hHHHHHHHHHHHHhccCcceeEEe
Confidence            455678889999999999999999999993   33  79999998765543     236899999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      |+..+ ....+|+|+++.|+|.+.|+......+....+..++.||+.||.||.++++|||||.++|+|+.....|||+||
T Consensus       178 GvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DF  256 (1039)
T KOG0199|consen  178 GVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDF  256 (1039)
T ss_pred             eeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecc
Confidence            99987 55689999999999999999866677889999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCCccCC----CCCCcccCC
Q 046106          280 GVARIEVQTEGMTPE----TGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~----~gt~~y~AP  303 (303)
                      ||.|-...++.+-..    .-.+.|+||
T Consensus       257 GLmRaLg~ned~Yvm~p~rkvPfAWCaP  284 (1039)
T KOG0199|consen  257 GLMRALGENEDMYVMAPQRKVPFAWCAP  284 (1039)
T ss_pred             cceeccCCCCcceEecCCCcCcccccCH
Confidence            999976655543322    234678887

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.95  E-value=2.4e-27  Score=210.82  Aligned_cols=166  Identities=28%  Similarity=0.514  Sum_probs=139.9

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcC--
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP--  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~--  205 (303)
                      ...|.+.+.||+|+||.||+|.+  .++.||+|++......       ...+.+|+.++..+ +||||+++++++...  
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            34677788899999999999987  6779999998754322       14677899999988 699999999998653  


Q ss_pred             ----CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          206 ----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       206 ----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                          ..+|++|||+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||+
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence                4579999999999999999876556789999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecC-CCccCCCCCCcccCC
Q 046106          282 ARIEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      ++..... .......|++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aP  180 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAP  180 (272)
T ss_pred             ceecccccccCCcccccccccCH
Confidence            9764332 223345788999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.95  E-value=3.6e-27  Score=207.55  Aligned_cols=167  Identities=26%  Similarity=0.395  Sum_probs=143.6

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||++..  +++.+|+|.+.........    .+.+.+|+.+++.++||||+++++.+.....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE----RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMI   76 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH----HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEE
Confidence            466778999999999999887  6789999999765443322    3578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCceeeecCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVARIEVQTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~~~~~~~  289 (303)
                      |+||+++++|.+++.......+++..+..++.|++.+|+|||++|++|+||+|+||+++++ +.+||+|||++.......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999999999987655668999999999999999999999999999999999999865 568999999998765444


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......|++.|+||
T Consensus       157 ~~~~~~~~~~y~aP  170 (256)
T cd08220         157 KAYTVVGTPCYISP  170 (256)
T ss_pred             cccccccCCcccCc
Confidence            33445788999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=2.4e-27  Score=212.17  Aligned_cols=168  Identities=27%  Similarity=0.522  Sum_probs=137.7

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +...+|++.+.||+|+||.||+|++  +++    .||+|+++......     ....+.+|+.+++.+.||||+++++++
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-----ANKEILDEAYVMAGVGSPYVCRLLGIC   78 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH-----HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            3456788889999999999999987  444    48999987543221     235788999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .... .++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus        79 ~~~~-~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          79 LTST-VQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             cCCC-cEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCce
Confidence            7654 578999999999999997643 45899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCc---cCCCCCCcccCC
Q 046106          283 RIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      +........   ....+++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMAL  180 (279)
T ss_pred             eecccccceeecCCCccchhhCCH
Confidence            865432221   112345779887

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=2.8e-27  Score=208.26  Aligned_cols=160  Identities=31%  Similarity=0.526  Sum_probs=132.6

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      +.||+|+||.||+|++  +++.+|+|.+......     .....+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence            3689999999999987  7889999988643221     12257889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCcc---
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT---  292 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~---  292 (303)
                      ++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.........   
T Consensus        76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9999999997542 458899999999999999999999999999999999999999999999999987543221111   


Q ss_pred             CCCCCCcccCC
Q 046106          293 PETGTYRWMAP  303 (303)
Q Consensus       293 ~~~gt~~y~AP  303 (303)
                      ....+..|+||
T Consensus       155 ~~~~~~~y~aP  165 (252)
T cd05084         155 MKQIPVKWTAP  165 (252)
T ss_pred             CCCCceeecCc
Confidence            11224568887

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=1.8e-27  Score=212.54  Aligned_cols=169  Identities=30%  Similarity=0.511  Sum_probs=141.2

Q ss_pred             ecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ...+|.+.+.||+|+||.||+|++.       ++.||||+++.....     ...+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~   77 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-----DARKDFEREAELLTNFQHENIVKFYGVC   77 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-----HHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence            4567888899999999999999762       368999998754332     1236888999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQ------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS  270 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~  270 (303)
                      .....+++||||+++++|.+++....            ...+++..+..++.|++.|++|||++|++||||||+||+++.
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~  157 (280)
T cd05049          78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY  157 (280)
T ss_pred             ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence            99999999999999999999997542            234788899999999999999999999999999999999999


Q ss_pred             CCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          271 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       271 ~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ++.+||+|||+++.......   .....+++.|+||
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP  193 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecCh
Confidence            99999999999975432221   1223456889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=2.7e-27  Score=214.31  Aligned_cols=166  Identities=28%  Similarity=0.433  Sum_probs=139.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||+|.++.......     ...+.+|+.+++.++||||+++++++..+..+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc-----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            45678889999999999999987  578999999875433221     13567899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+|||+++++.+||+|||++......
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            99999996 59999887643 45889999999999999999999999999999999999999999999999999754322


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......+++.|+||
T Consensus       158 ~~~~~~~~~~~~y~~P  173 (301)
T cd07873         158 TKTYSNEVVTLWYRPP  173 (301)
T ss_pred             CCcccccceeecccCc
Confidence            2 22334578889998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=6.1e-27  Score=206.38  Aligned_cols=167  Identities=25%  Similarity=0.437  Sum_probs=141.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-PMVWC  209 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~~  209 (303)
                      .|++.+.||.|++|.||++..  +++.||+|.+........    ..+.+.+|+.++++++|||++++++.+.. ...+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR----ERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH----HHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEE
Confidence            367788999999999999987  567899999876443322    23567889999999999999999998764 44679


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +++||+++++|.+++.......+++..++.++.|++.|+++||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999999999987655678999999999999999999999999999999999999999999999999998664332


Q ss_pred             C-ccCCCCCCcccCC
Q 046106          290 G-MTPETGTYRWMAP  303 (303)
Q Consensus       290 ~-~~~~~gt~~y~AP  303 (303)
                      . .....+++.|+||
T Consensus       157 ~~~~~~~~~~~y~aP  171 (257)
T cd08223         157 DMASTLIGTPYYMSP  171 (257)
T ss_pred             CccccccCCcCccCh
Confidence            2 2334688999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=4e-27  Score=207.28  Aligned_cols=167  Identities=31%  Similarity=0.547  Sum_probs=142.7

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |...+.||+|+||+||+|..  +++.|++|.+......... +...+.+.+|+.+++.++||||+++++++.....++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG-QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccc-hHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            55668899999999999987  5789999998765432211 22236788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      +||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence            9999999999999764  35789999999999999999999999999999999999999999999999999875544334


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ....|++.|+||
T Consensus       159 ~~~~~~~~y~~p  170 (258)
T cd06632         159 KSFKGSPYWMAP  170 (258)
T ss_pred             cccCCCcceeCH
Confidence            455688889987

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=6.2e-27  Score=207.31  Aligned_cols=169  Identities=24%  Similarity=0.427  Sum_probs=143.1

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|..  +++.||+|.++........   ....+.+|+.++++++|++|+++++.+......+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK---ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN   78 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh---hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            4678889999999999999998  6889999998754332221   2357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          210 IVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +||||+++++|.+++...  ....+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||+++....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999999998753  234588999999999999999999999999999999999999999999999999976543


Q ss_pred             CC-CccCCCCCCcccCC
Q 046106          288 TE-GMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~-~~~~~~gt~~y~AP  303 (303)
                      .. ......+++.|+||
T Consensus       159 ~~~~~~~~~~~~~y~ap  175 (267)
T cd08224         159 KTTAAHSLVGTPYYMSP  175 (267)
T ss_pred             CCcccceecCCccccCH
Confidence            22 22334688889888

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.1e-27  Score=214.46  Aligned_cols=170  Identities=32%  Similarity=0.558  Sum_probs=138.7

Q ss_pred             eecCCccccceecccCceEEEEEEECC----------------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYNG----------------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH  192 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h  192 (303)
                      ++..+|++.+.||+|+||.||+++..+                ..||+|.++.....     .....+.+|++++++++|
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~ei~~l~~l~h   76 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-----TARNDFLKEIKIMSRLKN   76 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-----HHHHHHHHHHHHHHhCCC
Confidence            445688899999999999999987521                25899998754221     123578899999999999


Q ss_pred             CCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 046106          193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN----------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLK  262 (303)
Q Consensus       193 pniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlk  262 (303)
                      |||+++++++.....+++||||+++++|.+++.....          ..+++..++.++.|++.||+|||+.|++|||||
T Consensus        77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk  156 (295)
T cd05097          77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA  156 (295)
T ss_pred             CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence            9999999999999999999999999999999965321          236788999999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          263 SDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       263 p~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |+|||+++++.+||+|||+++.......   .....+++.|+||
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  200 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW  200 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecCh
Confidence            9999999999999999999975432221   1122346789888

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=6.4e-27  Score=207.56  Aligned_cols=168  Identities=31%  Similarity=0.543  Sum_probs=141.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChH---HHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPE---KAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~---~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      |.+...||+|+||.||+|..  +++.+|+|.+........   ......+.+.+|+.+++.++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            55678899999999999987  578999999876544322   2233346788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++++||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++||||+|+||++++++.+||+|||+++.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            9999999999999999765  45889999999999999999999999999999999999999999999999998765421


Q ss_pred             CC-------ccCCCCCCcccCC
Q 046106          289 EG-------MTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~-------~~~~~gt~~y~AP  303 (303)
                      ..       .....|++.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~p  181 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAP  181 (267)
T ss_pred             cccCCccccccccCCCcCccCh
Confidence            11       1123578889988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=4.8e-27  Score=211.64  Aligned_cols=172  Identities=30%  Similarity=0.457  Sum_probs=145.1

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..|..+.+.|++.+.||.|+||.||+|+.  +++.+|+|++.....      ...+.+.+|+.+++.++||||+++++.+
T Consensus         5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (292)
T cd06644           5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------EELEDYMVEIEILATCNHPYIVKLLGAF   78 (292)
T ss_pred             hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence            45556667899999999999999999987  578999999865321      1235788899999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ..+..+|+||||+++++|..++.... ..+++..+..++.|++.+|+|||+.+++||||||+||+++.++.+||+|||++
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  157 (292)
T cd06644          79 YWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS  157 (292)
T ss_pred             EeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence            99999999999999999988876543 45899999999999999999999999999999999999999999999999998


Q ss_pred             eeeecCC-CccCCCCCCcccCC
Q 046106          283 RIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      ....... ......+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aP  179 (292)
T cd06644         158 AKNVKTLQRRDSFIGTPYWMAP  179 (292)
T ss_pred             eeccccccccceecCCccccCc
Confidence            7533221 12334678889988

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=2.9e-27  Score=209.75  Aligned_cols=169  Identities=24%  Similarity=0.413  Sum_probs=142.4

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      .+|.+.+.||+|+||.||++++  +++.+|||.+........   .....+.+|+.+++.++||||+++++++..+...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN   78 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhH---HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEE
Confidence            4677788999999999999986  788999998875433221   12357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          210 IVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      ++|||+++++|.+++...  ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999999998742  234589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-ccCCCCCCcccCC
Q 046106          288 TEG-MTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~-~~~~~gt~~y~AP  303 (303)
                      ... .....|+..|+||
T Consensus       159 ~~~~~~~~~~~~~~~ap  175 (267)
T cd08229         159 KTTAAHSLVGTPYYMSP  175 (267)
T ss_pred             CCcccccccCCcCccCH
Confidence            221 2234688899988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.95  E-value=4.5e-27  Score=210.77  Aligned_cols=173  Identities=27%  Similarity=0.477  Sum_probs=142.6

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIG  200 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~  200 (303)
                      ++.+....++|.+.+.||+|+||.||++..  +++.+|+|+++.....       ...+.+|+.++..+ +||||+++++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~e~~~l~~l~~h~~i~~~~~   82 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------DEEIEAEYNILKALSDHPNVVKFYG   82 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------HHHHHHHHHHHHHHhcCCCeeeeee
Confidence            455556677889999999999999999987  6789999988643211       14677899999998 6999999999


Q ss_pred             EEE-----cCCeEEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc
Q 046106          201 ACR-----KPMVWCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS  273 (303)
Q Consensus       201 ~~~-----~~~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~  273 (303)
                      ++.     ....+++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.+++||||||+||++++++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC
Confidence            884     345689999999999999988642  2345888999999999999999999999999999999999999999


Q ss_pred             EEEeccCCceeeecCC-CccCCCCCCcccCC
Q 046106          274 IKIADFGVARIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       274 vKl~DFGla~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      +||+|||+++...... ......|++.|+||
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP  193 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP  193 (286)
T ss_pred             EEEccCCceeecccCCCccccccCCCcccCh
Confidence            9999999998654322 22334688999998

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-29  Score=236.22  Aligned_cols=162  Identities=28%  Similarity=0.465  Sum_probs=137.3

Q ss_pred             cccceecccCceEEEEEEEC--CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          135 NMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      ++...||.|+||+||++...  +-..|.|++...      ......++.-|++||..+.||+||+|++.++.++.+||+.
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk------seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhccc------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            44677999999999999873  345677887542      2333568899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee-cCCCc
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV-QTEGM  291 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~-~~~~~  291 (303)
                      |||.||-+...+-.. +..+.+.++.-++.|++.||.|||+++|||||||+.|||++-+|.++|+|||.+.... .-...
T Consensus       109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence            999999988887765 3679999999999999999999999999999999999999999999999999864322 22234


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      .++.|||.||||
T Consensus       188 DsFIGTPYWMAP  199 (1187)
T KOG0579|consen  188 DSFIGTPYWMAP  199 (1187)
T ss_pred             ccccCCcccccc
Confidence            467899999999

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=5.1e-27  Score=210.09  Aligned_cols=165  Identities=31%  Similarity=0.489  Sum_probs=138.4

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||++++  +++.||+|++........    ..+.+.+|+.+++.++||||+++++++..+...++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~   77 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL   77 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc----ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence            577788999999999999998  578999999875432221    12467899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-  289 (303)
                      ||||++++.|..++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++....... 
T Consensus        78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          78 VFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99999987777666543  358999999999999999999999999999999999999999999999999998654332 


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......++..|+||
T Consensus       156 ~~~~~~~~~~~~aP  169 (286)
T cd07847         156 DYTDYVATRWYRAP  169 (286)
T ss_pred             cccCcccccccCCH
Confidence            22234577888887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=4.9e-27  Score=210.51  Aligned_cols=167  Identities=26%  Similarity=0.496  Sum_probs=135.0

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ...+|++.+.||+|+||.||+|.+  +++    .+++|.+.....     ......+..|+.+++.+.||||+++++++.
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~   79 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-----RQTFQEITDHMLAMGSLDHAYIVRLLGICP   79 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-----hHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence            345778889999999999999998  454    467777643211     122356778898999999999999999886


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .. ..++++||+++++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+|||+++++.+||+|||+++
T Consensus        80 ~~-~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          80 GA-SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             CC-ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence            54 4678999999999999997643 468999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCC---ccCCCCCCcccCC
Q 046106          284 IEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      .......   .+...++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~p  180 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMAL  180 (279)
T ss_pred             eccCCCcccccCCCCCcccccCH
Confidence            6533221   1223466789887

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=4.9e-27  Score=208.24  Aligned_cols=168  Identities=30%  Similarity=0.499  Sum_probs=141.3

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |...+.||+|++|.||++..  +++.+|+|+++.............+.+.+|+.+++.++||||+++++++.....+++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            55678899999999999986  7789999999765443333333457889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccCCceeeecCCC
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVARIEVQTEG  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl~DFGla~~~~~~~~  290 (303)
                      +||+++++|.+++...  ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus        82 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          82 VEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999764  4688999999999999999999999999999999999998775 699999999876543211


Q ss_pred             -----ccCCCCCCcccCC
Q 046106          291 -----MTPETGTYRWMAP  303 (303)
Q Consensus       291 -----~~~~~gt~~y~AP  303 (303)
                           .....||..|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~P  177 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAP  177 (268)
T ss_pred             cCCccccccccccceeCH
Confidence                 1123578889987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=5e-27  Score=215.35  Aligned_cols=164  Identities=18%  Similarity=0.312  Sum_probs=135.4

Q ss_pred             ccceeccc--CceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          136 MGDAFAQG--AFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       136 ~~~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      ++++||+|  +|++||+++.  +++.||+|+++.......    ..+.+.+|+.+++.++||||+++++++..+...|+|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE----MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEE
Confidence            45789999  7789999987  678999999976443322    235677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC-
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~-  290 (303)
                      |||+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++||+.+........ 
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999999999765445689999999999999999999999999999999999999999999999986543211110 


Q ss_pred             -------ccCCCCCCcccCC
Q 046106          291 -------MTPETGTYRWMAP  303 (303)
Q Consensus       291 -------~~~~~gt~~y~AP  303 (303)
                             .....++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~y~aP  177 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSP  177 (327)
T ss_pred             ccccccccccccceecccCh
Confidence                   1122466778888

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=5.6e-27  Score=208.51  Aligned_cols=165  Identities=25%  Similarity=0.494  Sum_probs=132.0

Q ss_pred             cccceecccCceEEEEEEEC--Ce--EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----
Q 046106          135 NMGDAFAQGAFGKLYRGTYN--GE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP-----  205 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----  205 (303)
                      .+++.||+|+||.||+|++.  ++  .+|+|.++........    .+.+.+|+.+++.++||||+++++++...     
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   77 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE----MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG   77 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence            46788999999999999873  32  6899998765433222    35788999999999999999999987532     


Q ss_pred             -CeEEEEEeecCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          206 -MVWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       206 -~~~~iv~E~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                       ...++++||+++++|.+++...    ....+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus        78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence             2468999999999999988532    12347899999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCC---ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +++.......   .....+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~p  183 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAI  183 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCH
Confidence            9986543221   1122456778876

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=6.2e-27  Score=206.99  Aligned_cols=158  Identities=33%  Similarity=0.622  Sum_probs=131.4

Q ss_pred             eecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          139 AFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .||+|+||.||+|.+    ++..+|+|+++....+..    ..+.+.+|+.+++.++||||+++++++.. ..+++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPA----LKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHH----HHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence            589999999999975    467899999876543322    23678899999999999999999998864 456899999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC----
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG----  290 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~----  290 (303)
                      +++++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+|||+++++.+||+|||+++.......    
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999999999754  4589999999999999999999999999999999999999999999999999976543321    


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....+++.|+||
T Consensus       155 ~~~~~~~~~y~aP  167 (257)
T cd05116         155 KTHGKWPVKWYAP  167 (257)
T ss_pred             cCCCCCCccccCH
Confidence            1122345789887

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.8e-27  Score=213.00  Aligned_cols=150  Identities=24%  Similarity=0.462  Sum_probs=133.6

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||++..  +++.+|+|.+.+.....   ....+.+.+|+.+++.++||||+++++.+......|+
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   78 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK---RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL   78 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch---HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence            577888999999999999988  57899999997654332   1123578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+|+.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            999999999999998765567899999999999999999999999999999999999999999999999998643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=5.3e-27  Score=210.26  Aligned_cols=166  Identities=31%  Similarity=0.556  Sum_probs=135.4

Q ss_pred             cCCccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      ..++++.+.||+|+||.||++.+      +++.||+|.+.....      ...+.+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------EHLRDFEREIEILKSLQHDNIVKYKGVCYS   76 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence            34677889999999999999974      467899999865321      113578899999999999999999998754


Q ss_pred             C--CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          205 P--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       205 ~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .  ..+++|+||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||++
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          77 AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             CCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccc
Confidence            3  46799999999999999997543 35899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCc----cCCCCCCcccCC
Q 046106          283 RIEVQTEGM----TPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~----~~~~gt~~y~AP  303 (303)
                      +........    ....++..|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aP  180 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAP  180 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCH
Confidence            865432211    111234558887

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.95  E-value=5e-27  Score=209.97  Aligned_cols=161  Identities=24%  Similarity=0.343  Sum_probs=137.1

Q ss_pred             ecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCC
Q 046106          140 FAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       140 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      ||+|+||+||++..  +++.+|+|++.......   ....+.+..|+.+++.++||||+++++++......|+||||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK---RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh---hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence            68999999999986  67899999987543221   11235667899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCC
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT  297 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt  297 (303)
                      ++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||++++++.+||+|||++.............++
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT  157 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence            99999998765456899999999999999999999999999999999999999999999999999765443333344677


Q ss_pred             CcccCC
Q 046106          298 YRWMAP  303 (303)
Q Consensus       298 ~~y~AP  303 (303)
                      ..|+||
T Consensus       158 ~~y~~P  163 (277)
T cd05577         158 PGYMAP  163 (277)
T ss_pred             CCcCCH
Confidence            888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=5.7e-27  Score=209.75  Aligned_cols=165  Identities=28%  Similarity=0.469  Sum_probs=142.7

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||+|++  +++.||+|++........    ....+.+|+.+++.++||||+++++++..+...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   76 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVL   76 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEE
Confidence            467788999999999999997  678999999976543221    12578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-  289 (303)
                      |+||+ +++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||++++++.++|+|||++....... 
T Consensus        77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            99999 999999987643 568999999999999999999999999999999999999999999999999998654332 


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......|+..|+||
T Consensus       155 ~~~~~~~~~~~y~aP  169 (286)
T cd07832         155 RLYSHQVATRWYRAP  169 (286)
T ss_pred             CccccccCcccccCc
Confidence             13445788999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-29  Score=246.66  Aligned_cols=174  Identities=24%  Similarity=0.330  Sum_probs=150.6

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      .+..+..++|.+++.||+|+||.|..++.  +++.+|+|++++..+...   ....-|..|-.+|.-...+-|++|+=.|
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr---~~tA~F~EERDimv~~ns~Wiv~LhyAF  144 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR---AETACFREERDIMVFGNSEWIVQLHYAF  144 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc---hhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence            34456788999999999999999999987  677999999977443211   1124688999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      +++..+|+|||||+||+|..++....  .+|+..+..+++.|+.||.-||+.|+|||||||+|||+|..|++||+|||.|
T Consensus       145 QD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  145 QDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999999998864  6999999999999999999999999999999999999999999999999998


Q ss_pred             eeeecCC-C-ccCCCCCCcccCC
Q 046106          283 RIEVQTE-G-MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~-~-~~~~~gt~~y~AP  303 (303)
                      -.+..+. . ....+|||.|.+|
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISP  245 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISP  245 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCH
Confidence            6554333 2 3455899999998

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.95  E-value=7.9e-27  Score=206.74  Aligned_cols=158  Identities=28%  Similarity=0.579  Sum_probs=129.4

Q ss_pred             eecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          139 AFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .||+|+||.||+|.+    .+..||+|++.....     ....+.+.+|+.++++++||||+++++++..+ ..++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-----KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-ALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-----hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-CeEEEEEe
Confidence            389999999999976    244699999865432     11235788999999999999999999998654 57899999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC----
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG----  290 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~----  290 (303)
                      +++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++.......    
T Consensus        76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99999999997543 4689999999999999999999999999999999999999999999999999975433221    


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .+...+++.|+||
T Consensus       155 ~~~~~~~~~y~aP  167 (257)
T cd05115         155 RSAGKWPLKWYAP  167 (257)
T ss_pred             cCCCCCCcccCCH
Confidence            1112235789888

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.95  E-value=6.4e-27  Score=209.28  Aligned_cols=165  Identities=25%  Similarity=0.441  Sum_probs=135.8

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHH-HHcCCCCCeeeeeEEEEcCCeEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-LATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      +|.+.+.||+|+||.||++++  +++.||+|+++........     ..+..|+.+ ++.+.||||+++++++..+...|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-----KRLLMDLDISMRSVDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-----HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence            577788999999999999998  6889999999765432221     244455554 67778999999999999998999


Q ss_pred             EEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          210 IVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ++|||++ ++|.+++...  ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus        77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9999996 6898888653  234689999999999999999999997 99999999999999999999999999998654


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      .....+...|+..|+||
T Consensus       156 ~~~~~~~~~~~~~y~aP  172 (283)
T cd06617         156 DSVAKTIDAGCKPYMAP  172 (283)
T ss_pred             cccccccccCCccccCh
Confidence            43333445688889888

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=5.7e-27  Score=210.38  Aligned_cols=166  Identities=29%  Similarity=0.522  Sum_probs=137.7

Q ss_pred             CCccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      +-|++.+.||+|+||.||++++      .+..||+|.++.....     .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-----NHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            4567888999999999999974      4668999998654321     1125788999999999999999999998775


Q ss_pred             --CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          206 --MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       206 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                        ..+++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence              56899999999999999997543 358999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCC----ccCCCCCCcccCC
Q 046106          284 IEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      .......    .....++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~ap  181 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAP  181 (284)
T ss_pred             ccccCccceeecCCCCCCccccCH
Confidence            6543222    1233566778887

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=7.2e-27  Score=205.49  Aligned_cols=161  Identities=34%  Similarity=0.632  Sum_probs=139.0

Q ss_pred             ceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          138 DAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      +.||+|+||.||++.+.     +..+|+|+++......     ..+.+.+|+.++..++||||+++++++.....+++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEE
Confidence            36899999999999984     6789999997654432     2367889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          213 EYAKGGSVRQFLTKRQ-------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ||+++++|.+++....       ...+++..++.++.|++.||+|||+++++||||+|+||+++.++.+||+|||.++..
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence            9999999999998752       356899999999999999999999999999999999999999999999999999865


Q ss_pred             ecCC---CccCCCCCCcccCC
Q 046106          286 VQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~---~~~~~~gt~~y~AP  303 (303)
                      ....   ......+++.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aP  176 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAP  176 (262)
T ss_pred             ccccccccccCCCcCccccCH
Confidence            4432   12334578899998

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=6.3e-27  Score=209.42  Aligned_cols=167  Identities=27%  Similarity=0.537  Sum_probs=138.0

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ...+|++.+.||+|+||.||+|.+  ++.    .+|+|.++....     ......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-----PKANKEILDEAYVMASVDHPHVVRLLGICL   79 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-----HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            456788889999999999999986  332    689998865543     122357889999999999999999999998


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      . ...++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|||++.++.+||+|||+++
T Consensus        80 ~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          80 S-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             c-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence            7 66799999999999999998653 358999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCCccC---CCCCCcccCC
Q 046106          284 IEVQTEGMTP---ETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~---~~gt~~y~AP  303 (303)
                      ..........   ..+++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~P  180 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMAL  180 (279)
T ss_pred             cccCcccceecCCCcccccccCH
Confidence            6543222111   1235678887

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.4e-27  Score=211.13  Aligned_cols=166  Identities=29%  Similarity=0.431  Sum_probs=141.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||.|+||.||++.+  +++.+|+|+++....      ...+.+.+|+.+++.++||||+++++.+..+...
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE------EELEDFMVEIDILSECKHPNIVGLYEAYFYENKL   77 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH------HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence            45688889999999999999987  578999999865321      1225788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          78 WILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999999999987643 46899999999999999999999999999999999999999999999999998654322


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......+|+.|+||
T Consensus       157 ~~~~~~~~~~~~y~~P  172 (280)
T cd06611         157 LQKRDTFIGTPYWMAP  172 (280)
T ss_pred             ccccceeecchhhcCH
Confidence            1 22334678889887

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.95  E-value=7.7e-27  Score=205.26  Aligned_cols=165  Identities=36%  Similarity=0.663  Sum_probs=139.8

Q ss_pred             ccccceecccCceEEEEEEECC------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          134 LNMGDAFAQGAFGKLYRGTYNG------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      +.+.+.||.|+||.||++.+..      ..||+|+++......     ..+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence            3467889999999999999843      789999996654321     23578899999999999999999999999899


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      .+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||+++....
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999999999865433389999999999999999999999999999999999999999999999999986554


Q ss_pred             CCCccC--CCCCCcccCC
Q 046106          288 TEGMTP--ETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~--~~gt~~y~AP  303 (303)
                      ......  ..+++.|+||
T Consensus       156 ~~~~~~~~~~~~~~y~~P  173 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAP  173 (258)
T ss_pred             ccccccccCCCcccccCh
Confidence            322221  2367889988

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=6e-27  Score=210.82  Aligned_cols=166  Identities=30%  Similarity=0.568  Sum_probs=136.0

Q ss_pred             CccccceecccCceEEEEEEECC-------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          133 KLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      +|.+.+.||+|+||.||+|+...       ..+|+|.+......     ...+.+.+|+.+++.++||||+++++.+...
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-----SELRDLLSEFNLLKQVNHPHVIKLYGACSQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-----HHHHHHHHHHHHHhhCCCCCEeeEEEEEecC
Confidence            36678899999999999998632       46899988653321     1125788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQ----------------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKS  263 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp  263 (303)
                      ...++++||+++++|.+++....                      ...+++..++.++.|++.||+|||+.+++||||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp  155 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA  155 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence            89999999999999999987532                      12478899999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          264 DNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       264 ~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +|||+++++.+||+|||+++.......   .....++..|+||
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ap  198 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAI  198 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCH
Confidence            999999999999999999975432221   1223456788887

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.95  E-value=1.2e-26  Score=208.21  Aligned_cols=159  Identities=24%  Similarity=0.358  Sum_probs=129.7

Q ss_pred             eecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHH---HHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 046106          139 AFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVM---MLATLKHPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~---il~~l~hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      .||+|+||.||++..  +++.+|+|++.+.........   ..+.+|..   ++....||+|+.+++++..++..++|||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   77 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD   77 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH---HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence            389999999999987  578999999976543322211   22334443   3444579999999999999889999999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccC
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP  293 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~  293 (303)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||+.+++||||||+|||+++++.+||+|||++...... ....
T Consensus        78 ~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~  154 (279)
T cd05633          78 LMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA  154 (279)
T ss_pred             cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence            99999999998764  45899999999999999999999999999999999999999999999999998754322 2233


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      ..||+.|+||
T Consensus       155 ~~~~~~y~aP  164 (279)
T cd05633         155 SVGTHGYMAP  164 (279)
T ss_pred             cCCCcCccCH
Confidence            4789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=6.6e-27  Score=210.38  Aligned_cols=165  Identities=27%  Similarity=0.437  Sum_probs=137.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|++|.||+|+.  +++.||||.+.........     ..+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-----FTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCc-----hhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            5677889999999999999987  6789999998764322111     34668999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++......
T Consensus        80 lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9999997 49999887653 368899999999999999999999999999999999999999999999999987532211


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......+++.|+||
T Consensus       158 ~~~~~~~~~~~~~aP  172 (291)
T cd07844         158 KTYSNEVVTLWYRPP  172 (291)
T ss_pred             ccccccccccccCCc
Confidence             12223467888887

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=8.1e-27  Score=207.79  Aligned_cols=160  Identities=26%  Similarity=0.510  Sum_probs=129.4

Q ss_pred             eecccCceEEEEEEE-CCe---EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          139 AFAQGAFGKLYRGTY-NGE---EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~-~~~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .||+|+||.||++.. ++.   .+++|.++.....     ...+.+.+|+.+++.++||||+++++.|......|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-----KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-----HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence            589999999999975 332   4566766543221     1235789999999999999999999999999899999999


Q ss_pred             cCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC---
Q 046106          215 AKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE---  289 (303)
Q Consensus       215 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~---  289 (303)
                      +++++|.+++....  ....++..+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||++.......   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            99999999998642  2345677788999999999999999999999999999999999999999999986432211   


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      .....++++.|+||
T Consensus       157 ~~~~~~~~~~y~aP  170 (268)
T cd05086         157 TEDDKCVPLRWLAP  170 (268)
T ss_pred             cccCCcCcccccCc
Confidence            12234678889988

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=5.7e-27  Score=210.89  Aligned_cols=169  Identities=29%  Similarity=0.490  Sum_probs=140.1

Q ss_pred             eecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      |...+|.+.+.||+|+||+||++..       ++..+|+|.++....      ...+.+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~   75 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD------NARKDFHREAELLTNLQHEHIVKFYGV   75 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            4556788899999999999999974       234689998865321      123578899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQ-----------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS  270 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~  270 (303)
                      +.....+++|+||+++++|.+++....           ...+++..++.++.|++.||+|||++|++||||||+|||+++
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~  155 (288)
T cd05093          76 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  155 (288)
T ss_pred             EecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999999997532           124899999999999999999999999999999999999999


Q ss_pred             CCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          271 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       271 ~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ++.+||+|||+++.......   .....+++.|+||
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  191 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  191 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCCCCCccccccCH
Confidence            99999999999975432221   1223456789998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1e-26  Score=205.34  Aligned_cols=166  Identities=33%  Similarity=0.526  Sum_probs=142.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||++..  +++.+|+|++......      ..+.+.+|+.+++.++||||+++++++.....+
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   75 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD------DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKL   75 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh------hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEE
Confidence            45778889999999999999987  5678999999764332      235788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |++|||+++++|.+++.... ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.+||+|||++......
T Consensus        76 ~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          76 WIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            99999999999999987642 45899999999999999999999999999999999999999999999999998764432


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......++..|+||
T Consensus       155 ~~~~~~~~~~~~y~~P  170 (262)
T cd06613         155 IAKRKSFIGTPYWMAP  170 (262)
T ss_pred             hhccccccCCccccCc
Confidence            2 22344678889988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.1e-26  Score=206.43  Aligned_cols=166  Identities=25%  Similarity=0.491  Sum_probs=134.4

Q ss_pred             ccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe-
Q 046106          134 LNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV-  207 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~-  207 (303)
                      |.+++.||+|+||.||+|...     +..||+|.++.......    ....+.+|+.+++.++||||+++++++..... 
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   76 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS----EIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL   76 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH----HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence            457788999999999999862     25799999876443322    13578899999999999999999998866543 


Q ss_pred             -----EEEEEeecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          208 -----WCIVTEYAKGGSVRQFLTKRQ----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       208 -----~~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                           .++++||+++++|..++....    ...+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus        77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECC
Confidence                 799999999999999986432    23588999999999999999999999999999999999999999999999


Q ss_pred             cCCceeeecCCCc---cCCCCCCcccCC
Q 046106          279 FGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      ||+++........   ....++..|+||
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             ccceeeccccccccccccccCCccccCH
Confidence            9999865433211   112345678877

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=7.7e-27  Score=212.44  Aligned_cols=158  Identities=25%  Similarity=0.433  Sum_probs=128.1

Q ss_pred             cceecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEE
Q 046106          137 GDAFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--PMVWCI  210 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~~i  210 (303)
                      +.+||+|+||.||+|+.    ++..||+|.++.....        ..+.+|+.+++.++||||+++++++..  +..+|+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            35799999999999986    3368999998654322        356789999999999999999999853  567899


Q ss_pred             EEeecCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEecc
Q 046106          211 VTEYAKGGSVRQFLTKR-------QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI----FSDKSIKIADF  279 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv----~~~~~vKl~DF  279 (303)
                      |+||+. ++|.+++...       ....+++..+..++.||+.||+|||+.||+||||||+|||+    +.++.+||+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            999996 5888887532       12357889999999999999999999999999999999999    55679999999


Q ss_pred             CCceeeecCC----CccCCCCCCcccCC
Q 046106          280 GVARIEVQTE----GMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~----~~~~~~gt~~y~AP  303 (303)
                      |+|+......    ......||+.|+||
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aP  184 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAP  184 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCc
Confidence            9998654322    12334689999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.95  E-value=7.2e-27  Score=211.27  Aligned_cols=167  Identities=34%  Similarity=0.530  Sum_probs=134.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCe--EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPM  206 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~  206 (303)
                      ++|.+.+.||+|+||.||+|.+  ++.  .+++|.++.....     ...+.+.+|+.++.++ +||||+++++++....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-----NDHRDFAGELEVLCKLGHHPNIINLLGACENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-----HHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence            5678888999999999999987  333  4788887642221     1125788999999999 7999999999999988


Q ss_pred             eEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK  272 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~  272 (303)
                      .+|+++||+++++|.+++....              ...+++..++.++.|++.||+|||++|++||||||+|||++.++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence            8999999999999999997532              12478899999999999999999999999999999999999999


Q ss_pred             cEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          273 SIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       273 ~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .+||+|||++..............+..|+||
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  187 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAI  187 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCc
Confidence            9999999998643221111122334678887

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=1.1e-26  Score=209.09  Aligned_cols=165  Identities=27%  Similarity=0.403  Sum_probs=137.5

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|..  +++.||+|+++.......     ...+.+|+.+++.++|+||+++++++..+...|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC-----cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            5677889999999999999987  678999999865432221     135678999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +|+||+. +++.+++.... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus        80 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             EEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9999995 68888876543 457888899999999999999999999999999999999999999999999997543221


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......+++.|+||
T Consensus       158 ~~~~~~~~~~~y~aP  172 (291)
T cd07870         158 QTYSSEVVTLWYRPP  172 (291)
T ss_pred             CCCCCccccccccCC
Confidence             22334578899998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.95  E-value=5.7e-27  Score=208.45  Aligned_cols=150  Identities=28%  Similarity=0.501  Sum_probs=130.6

Q ss_pred             cCCccccceecccCceEEEEEEE--CC---eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NG---EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      ...+++.+.||+|+||.||+|.+  ++   ..||||+++.... .    .....|..|+.+++.++||||+++++++..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   77 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-E----KQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-H----HHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence            45677889999999999999987  23   3699999865422 1    1235789999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            99999999999999999997643 45889999999999999999999999999999999999999999999999998765


Q ss_pred             e
Q 046106          286 V  286 (303)
Q Consensus       286 ~  286 (303)
                      .
T Consensus       157 ~  157 (269)
T cd05065         157 E  157 (269)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=232.49  Aligned_cols=173  Identities=27%  Similarity=0.454  Sum_probs=143.3

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE-CC-eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NG-EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGA  201 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~  201 (303)
                      ..+++...++++.+.|.+|+|+.||.++. .+ ..+|+|++-..  +    +...+.+.+|+++|+.|+ |||||.+++.
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--d----e~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--D----EEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--C----HHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            56778888999999999999999999998 44 79999988553  2    223478899999999998 9999999993


Q ss_pred             E-Ec------CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCC
Q 046106          202 C-RK------PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDK  272 (303)
Q Consensus       202 ~-~~------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~~~~  272 (303)
                      . ..      .-.++|+||||++|.|.||+..+....+.+.++++|+.|++.|+++||...  |||||||.+||||+.+|
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence            2 11      135789999999999999999776677999999999999999999999987  99999999999999999


Q ss_pred             cEEEeccCCceeeecCCCcc----------CCCCCCcccCC
Q 046106          273 SIKIADFGVARIEVQTEGMT----------PETGTYRWMAP  303 (303)
Q Consensus       273 ~vKl~DFGla~~~~~~~~~~----------~~~gt~~y~AP  303 (303)
                      ..||||||.|.-........          ....|+-|+||
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsP  224 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSP  224 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence            99999999986432222111          11358999998

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=1.1e-26  Score=210.24  Aligned_cols=163  Identities=29%  Similarity=0.471  Sum_probs=140.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      .+|.+.+.||+|+||.||++..  +++.||+|.+.......      .+.+.+|+.+++.++||||+++++.+..+...|
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            5777888999999999999986  68899999987543321      246788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++++|.+++..   ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus        93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            99999999999999865   347899999999999999999999999999999999999999999999999997654332


Q ss_pred             C-ccCCCCCCcccCC
Q 046106          290 G-MTPETGTYRWMAP  303 (303)
Q Consensus       290 ~-~~~~~gt~~y~AP  303 (303)
                      . .....+++.|+||
T Consensus       170 ~~~~~~~~~~~y~aP  184 (297)
T cd06656         170 SKRSTMVGTPYWMAP  184 (297)
T ss_pred             cCcCcccCCccccCH
Confidence            2 2334678889987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=1.3e-26  Score=207.84  Aligned_cols=162  Identities=33%  Similarity=0.526  Sum_probs=133.2

Q ss_pred             ccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--
Q 046106          134 LNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--  205 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--  205 (303)
                      +.+.+.||+|+||+||++.+      +++.||+|+++......     ....+.+|+.+++.++||||+++++++...  
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-----NTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            47788999999999988753      45689999987643211     125678899999999999999999988653  


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..++++|||+++++|.+++...   .+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            4679999999999999999753   4899999999999999999999999999999999999999999999999999865


Q ss_pred             ecCCC----ccCCCCCCcccCC
Q 046106          286 VQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~----~~~~~gt~~y~AP  303 (303)
                      .....    .....++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~P  179 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAV  179 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCH
Confidence            43221    1122345678887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=1.1e-26  Score=210.26  Aligned_cols=164  Identities=28%  Similarity=0.461  Sum_probs=140.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ..+|.+.+.||+|+||.||+|..  +++.+|+|.+.......      ...+.+|+.+++.+.||||+++++.+..+...
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch------HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            35777788999999999999987  67899999987644322      14678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++++|.+++...   .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            9999999999999998653   4789999999999999999999999999999999999999999999999998754332


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......|++.|+||
T Consensus       170 ~~~~~~~~~~~~y~aP  185 (296)
T cd06654         170 QSKRSTMVGTPYWMAP  185 (296)
T ss_pred             ccccCcccCCccccCH
Confidence            2 12334788999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=6.1e-27  Score=210.07  Aligned_cols=166  Identities=24%  Similarity=0.420  Sum_probs=140.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++++.||+|+||.||++.+  +++.+|+|.++......     ....+.+|+.++++++||||+++++.+..+..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-----KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH-----HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence            3577889999999999999998  57899999986532211     1257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          210 IVTEYAKGGSVRQFLTKRQ-NRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +||||+++++|..++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            9999999999999887531 2368999999999999999999997 5999999999999999999999999999975432


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                      . ......+++.|+||
T Consensus       156 ~-~~~~~~~~~~y~aP  170 (286)
T cd06622         156 S-LAKTNIGCQSYMAP  170 (286)
T ss_pred             C-ccccCCCccCccCc
Confidence            2 23334678889988

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=9e-27  Score=210.43  Aligned_cols=169  Identities=29%  Similarity=0.529  Sum_probs=137.3

Q ss_pred             ecCCccccceecccCceEEEEEEEC------------------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTYN------------------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK  191 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~  191 (303)
                      +.++|++.+.||+|+||.||++.+.                  ...+|+|+++.....     .....+.+|+.+++.++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~E~~~l~~l~   77 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-----NARNDFLKEIKIMSRLK   77 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-----HHHHHHHHHHHHHHhCC
Confidence            4567888999999999999998542                  236899998754221     22357889999999999


Q ss_pred             CCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 046106          192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN---------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLK  262 (303)
Q Consensus       192 hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlk  262 (303)
                      ||||+++++++......+++|||+++++|.+++.....         ..+++..+..++.|++.||+|||+.|++|||||
T Consensus        78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk  157 (296)
T cd05095          78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA  157 (296)
T ss_pred             CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            99999999999999999999999999999999976421         236778899999999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          263 SDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       263 p~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |+|||++.++.+||+|||+++.......   .....+++.|+||
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  201 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW  201 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence            9999999999999999999975432221   1112335678876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=7.4e-27  Score=210.75  Aligned_cols=168  Identities=29%  Similarity=0.428  Sum_probs=140.8

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||+|.+  +++.||||.++........ ......+..|+.+++.++||||+++++++......++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK-DGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccccc-chhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence            366778899999999999997  5789999999765433111 1223567789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-C
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-E  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-~  289 (303)
                      ||||+ +++|.+++.... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||+++..... .
T Consensus        80 v~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             EEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            99999 889999997643 36899999999999999999999999999999999999999999999999999865433 2


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......+++.|+||
T Consensus       158 ~~~~~~~~~~y~aP  171 (298)
T cd07841         158 KMTHQVVTRWYRAP  171 (298)
T ss_pred             cccccccceeeeCH
Confidence            23334567888887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=9.4e-27  Score=208.65  Aligned_cols=169  Identities=32%  Similarity=0.518  Sum_probs=139.9

Q ss_pred             eecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      +..+++.+.++||+|+||.||++..       ++..+|+|.++....      .....+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~   75 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQDFQREAELLTVLQHQHIVRFYGV   75 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH------HHHHHHHHHHHHHhcCCCCCCceEEEE
Confidence            4567888899999999999999964       345789998764321      123578999999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQN-------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI  268 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv  268 (303)
                      +......+++|||+++++|.+++.....             ..+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~  155 (280)
T cd05092          76 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV  155 (280)
T ss_pred             EecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence            9999999999999999999999976421             247889999999999999999999999999999999999


Q ss_pred             cCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          269 FSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       269 ~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ++++.+||+|||+++.......   .....+++.|+||
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  193 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence            9999999999999975432221   1122346789888

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=1.6e-26  Score=205.39  Aligned_cols=169  Identities=25%  Similarity=0.433  Sum_probs=138.9

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      +++...+.....||+|+||.||+|++  ++..||+|.+......      ..+.+.+|+.+++.++||||+++++++..+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   77 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR------YVQPLHEEIALHSYLKHRNIVQYLGSDSEN   77 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH------HHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence            34445555556899999999999987  5678999988654321      125788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccCCc
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSV--PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFGVA  282 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-~~~vKl~DFGla  282 (303)
                      ...++|+||+++++|.+++.... ..+  ++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            99999999999999999998642 234  78888999999999999999999999999999999986 679999999998


Q ss_pred             eeeecC-CCccCCCCCCcccCC
Q 046106          283 RIEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      ...... .......|++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~aP  178 (268)
T cd06624         157 KRLAGINPCTETFTGTLQYMAP  178 (268)
T ss_pred             eecccCCCccccCCCCccccCh
Confidence            764322 222334678899988

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=6.4e-27  Score=206.31  Aligned_cols=154  Identities=25%  Similarity=0.487  Sum_probs=128.9

Q ss_pred             ceecccCceEEEEEEEC--C----------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          138 DAFAQGAFGKLYRGTYN--G----------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~--~----------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      +.||+|+||.||+|.+.  +          ..+++|++......       ...+.+|+.+++.++||||+++++++.. 
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------SLAFFETASLMSQLSHKHLVKLYGVCVR-   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------HHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence            36899999999999883  2          24788877543221       2578899999999999999999999988 


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-------cEEEec
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-------SIKIAD  278 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-------~vKl~D  278 (303)
                      ...++|+||+++++|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++       .+||+|
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          73 DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence            667999999999999999986542 689999999999999999999999999999999999999888       799999


Q ss_pred             cCCceeeecCCCccCCCCCCcccCC
Q 046106          279 FGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ||+++....   .....++..|+||
T Consensus       152 fg~a~~~~~---~~~~~~~~~y~aP  173 (259)
T cd05037         152 PGIPITVLS---REERVERIPWIAP  173 (259)
T ss_pred             CCccccccc---ccccccCCCccCh
Confidence            999986433   2233566778887

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=1.8e-26  Score=204.07  Aligned_cols=167  Identities=28%  Similarity=0.451  Sum_probs=143.0

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||.|+||.||+|.+  ++..+|+|++.......     ..+.+.+|+.+++.++||||+++++.+..+...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEE
Confidence            3677889999999999999987  67799999987544332     2357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          210 IVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      +|+|++++++|.+++..... ..+++..+..++.|++.||+|||+.|++||||+|+||++++++.+||+|||++......
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            99999999999999976432 46899999999999999999999999999999999999999999999999998765433


Q ss_pred             CCc-----cCCCCCCcccCC
Q 046106          289 EGM-----TPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~-----~~~~gt~~y~AP  303 (303)
                      ...     ....|++.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~y~~P  175 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAP  175 (267)
T ss_pred             ccccccccccccCChhhcCh
Confidence            222     234688899988

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=1.6e-26  Score=203.81  Aligned_cols=166  Identities=27%  Similarity=0.539  Sum_probs=139.8

Q ss_pred             ecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      +..+|.+.+.||+|+||.||++.+ ++..+|+|.++......       ..+.+|+.+++.++||+++++++++......
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-------EDFIEEAQVMMKLSHPKLVQLYGVCTERSPI   74 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH-------HHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence            455777889999999999999988 47789999987544332       4678899999999999999999999998899


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            99999999999999987543 35789999999999999999999999999999999999999999999999999765332


Q ss_pred             CCc--cCCCCCCcccCC
Q 046106          289 EGM--TPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~--~~~~gt~~y~AP  303 (303)
                      ...  ....++..|+||
T Consensus       154 ~~~~~~~~~~~~~~~aP  170 (256)
T cd05112         154 QYTSSTGTKFPVKWSSP  170 (256)
T ss_pred             cccccCCCccchhhcCH
Confidence            211  122345678887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=4.3e-27  Score=207.83  Aligned_cols=166  Identities=23%  Similarity=0.364  Sum_probs=142.9

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||++.+  +++.||+|++.+......   ...+.+.+|+.++++++||||+++++.+..+...++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK---GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYL   77 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch---hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEE
Confidence            366788999999999999998  578999999976433221   123678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      |+||+++++|.+++...  ..+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          78 VVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence            99999999999999765  4688999999999999999999999999999999999999999999999999876544333


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....|+..|+||
T Consensus       156 ~~~~~~~~~y~~P  168 (258)
T cd05578         156 TTSTSGTPGYMAP  168 (258)
T ss_pred             ccccCCChhhcCH
Confidence            3445678888887

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.1e-28  Score=220.15  Aligned_cols=174  Identities=22%  Similarity=0.335  Sum_probs=152.3

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      +-+..+.|..-+.||+|+||.||-++.  +|+.+|.|.+.+....   .+..+...++|-.||.++..|.||.+-=.+.+
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK---kr~ge~maLnEk~iL~kV~s~FiVslaYAfeT  256 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK---KRKGETMALNEKQILEKVSSPFIVSLAYAFET  256 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH---HhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence            345667777788899999999997764  8899999988654322   22234567789999999999999999888999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ++.+|+|+..|.||+|.-+|....+..+++..++.++++|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|..
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence            99999999999999998888877767899999999999999999999999999999999999999999999999999998


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      +.........+||..||||
T Consensus       337 i~~g~~~~~rvGT~GYMAP  355 (591)
T KOG0986|consen  337 IPEGKPIRGRVGTVGYMAP  355 (591)
T ss_pred             cCCCCccccccCcccccCH
Confidence            8777767777999999999

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=1.9e-26  Score=209.35  Aligned_cols=147  Identities=28%  Similarity=0.460  Sum_probs=129.9

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||++..  .++.||+|.+.......   ......+.+|+.+++.++||||+++++.+..+..+++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   78 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL---RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM   78 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh---HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence            567788999999999999987  56799999987643211   1223578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||+++.
T Consensus        79 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          79 VMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            99999999999999764  4589999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=9.4e-27  Score=209.71  Aligned_cols=166  Identities=27%  Similarity=0.367  Sum_probs=139.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--Ce
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--MV  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~  207 (303)
                      ++|.+.+.||+|.||.||+|.+  +++.+|+|.++.......    ....+.+|+.++++++||||+++++++..+  ..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----FPITSLREINILLKLQHPNIVTVKEVVVGSNLDK   80 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc----chhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence            4677888999999999999998  578999999976543321    124567899999999999999999998877  78


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      .|+|+||++ ++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+|||+++++.+||+|||+++....
T Consensus        81 ~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          81 IYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999999996 59999887643 3689999999999999999999999999999999999999999999999999986544


Q ss_pred             C-CCccCCCCCCcccCC
Q 046106          288 T-EGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~-~~~~~~~gt~~y~AP  303 (303)
                      . .......+++.|+||
T Consensus       159 ~~~~~~~~~~~~~~~aP  175 (293)
T cd07843         159 PLKPYTQLVVTLWYRAP  175 (293)
T ss_pred             CccccccccccccccCc
Confidence            3 223344678889998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=1.6e-26  Score=207.06  Aligned_cols=163  Identities=30%  Similarity=0.483  Sum_probs=138.2

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |++.+.||+|+||.||++.+  ++..+|+|.+.....      ...+.+.+|+.+++.++||||+++++.+..+...++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH------HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            46678899999999999998  567889998854321      1235788899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-C
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-G  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~  290 (303)
                      +||+++++|..++.... ..+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++....... .
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          81 IEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            99999999988876532 468999999999999999999999999999999999999999999999999987543221 2


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....+|+.|+||
T Consensus       160 ~~~~~~~~~y~aP  172 (282)
T cd06643         160 RDSFIGTPYWMAP  172 (282)
T ss_pred             cccccccccccCH
Confidence            2344688999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=9.1e-27  Score=207.04  Aligned_cols=156  Identities=21%  Similarity=0.422  Sum_probs=129.3

Q ss_pred             ceecccCceEEEEEEEC--------------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          138 DAFAQGAFGKLYRGTYN--------------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~--------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      +.||+|+||.||+|++.              ...||+|++.....      .....+.+|+.++..++||||+++++++.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~~~~~~~~~~~~l~~l~hp~iv~~~~~~~   74 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR------DISLAFFETASMMRQVSHKHIVLLYGVCV   74 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh------hHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            35899999999999852              12588888754321      22357888999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc-------EEE
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-------IKI  276 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~-------vKl  276 (303)
                      .+...++||||+++++|..++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.       +|+
T Consensus        75 ~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          75 RDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             cCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence            9888899999999999998887543 45899999999999999999999999999999999999987664       899


Q ss_pred             eccCCceeeecCCCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|||++.....   .....++..|+||
T Consensus       154 ~d~g~~~~~~~---~~~~~~~~~y~aP  177 (262)
T cd05077         154 SDPGIPITVLS---RQECVERIPWIAP  177 (262)
T ss_pred             CCCCCCccccC---cccccccccccCh
Confidence            99999875432   2234578889998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=1.9e-26  Score=202.62  Aligned_cols=160  Identities=34%  Similarity=0.564  Sum_probs=133.4

Q ss_pred             ceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecC
Q 046106          138 DAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAK  216 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~  216 (303)
                      +.||+|+||.||+|.. +++.+|+|.++.....     .....+.+|+.+++.++||||+++++++......++||||++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-----ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCH-----HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence            3689999999999987 6678999998654321     122468899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc--cCC
Q 046106          217 GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM--TPE  294 (303)
Q Consensus       217 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~--~~~  294 (303)
                      +++|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++.........  ...
T Consensus        76 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          76 GGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            999999987543 45789999999999999999999999999999999999999999999999999754322211  112


Q ss_pred             CCCCcccCC
Q 046106          295 TGTYRWMAP  303 (303)
Q Consensus       295 ~gt~~y~AP  303 (303)
                      .+++.|+||
T Consensus       155 ~~~~~y~aP  163 (250)
T cd05085         155 QIPIKWTAP  163 (250)
T ss_pred             CCcccccCH
Confidence            345678887

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=1.3e-26  Score=207.45  Aligned_cols=155  Identities=21%  Similarity=0.401  Sum_probs=127.2

Q ss_pred             eecccCceEEEEEEEC--------------------------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC
Q 046106          139 AFAQGAFGKLYRGTYN--------------------------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH  192 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~~--------------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h  192 (303)
                      .||+|+||.||+|.+.                          ...||+|++....      ......+.+|+.+++.++|
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------~~~~~~~~~~~~~~~~l~h   75 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------RDIALAFFETASLMSQVSH   75 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------HHHHHHHHHHHHHHhcCCC
Confidence            5999999999998741                          1258888885421      1223578889999999999


Q ss_pred             CCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC
Q 046106          193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK  272 (303)
Q Consensus       193 pniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~  272 (303)
                      |||++++++|......++||||+++++|..++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus        76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence            999999999999988999999999999999987543 4689999999999999999999999999999999999997654


Q ss_pred             -------cEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          273 -------SIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       273 -------~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                             .+|++|||++.....   .....+++.|+||
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aP  189 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAP  189 (274)
T ss_pred             cccCccceeeecCCcccccccc---ccccccCCcccCc
Confidence                   489999999864322   1223567888888

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=1.6e-26  Score=203.83  Aligned_cols=167  Identities=26%  Similarity=0.457  Sum_probs=142.0

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||.++.  +++.||+|.+.........    ...+.+|+.+++.++||||+++++++......++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE----REESRKEVAVLSNMKHPNIVQYQESFEENGNLYI   76 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH----HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEE
Confidence            467788999999999999987  6789999998764333221    2578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      |+||+++++|.+++.......+++..++.++.|++.||+|||+++++|+||+|+|||++.++.++|+|||++........
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999999999875555688999999999999999999999999999999999999999999999999976543222


Q ss_pred             -ccCCCCCCcccCC
Q 046106          291 -MTPETGTYRWMAP  303 (303)
Q Consensus       291 -~~~~~gt~~y~AP  303 (303)
                       .....|++.|+||
T Consensus       157 ~~~~~~~~~~~~~p  170 (256)
T cd08218         157 LARTCIGTPYYLSP  170 (256)
T ss_pred             hhhhccCCccccCH
Confidence             1223578888887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=9.7e-27  Score=207.46  Aligned_cols=170  Identities=25%  Similarity=0.491  Sum_probs=139.9

Q ss_pred             eecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      +..++|.+.+.||.|+||.||+|+..       .+.+|+|.+......     .....+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~   76 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-----NLQSEFRRELDMFRKLSHKNVVRLLGL   76 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-----HHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence            34567888899999999999999862       357999987543221     123578899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNR-------SVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI  274 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~v  274 (303)
                      +......|+||||+++++|.+++......       .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          77 CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             ECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcE
Confidence            99888899999999999999999865421       58999999999999999999999999999999999999999999


Q ss_pred             EEeccCCceeeecCC--CccCCCCCCcccCC
Q 046106          275 KIADFGVARIEVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       275 Kl~DFGla~~~~~~~--~~~~~~gt~~y~AP  303 (303)
                      ||+|||+++......  ......++..|+||
T Consensus       157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~P  187 (275)
T cd05046         157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAP  187 (275)
T ss_pred             EEcccccccccCcccccccCCceeEEeecCh
Confidence            999999987543222  12223456778887

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=1.7e-26  Score=205.48  Aligned_cols=169  Identities=32%  Similarity=0.518  Sum_probs=140.4

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCCh----HHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDP----EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~----~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +|.+.+.||+|+||.||+|..  +++.+|+|.++......    .......+.+.+|+.+++.++||||+++++++..+.
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            355678899999999999986  67899999986542211    112223457889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+++|+||+++++|.+++...  ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||+++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            999999999999999999765  468899999999999999999999999999999999999999999999999997543


Q ss_pred             cCC---CccCCCCCCcccCC
Q 046106          287 QTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~---~~~~~~gt~~y~AP  303 (303)
                      ...   ......|+..|+||
T Consensus       160 ~~~~~~~~~~~~~~~~y~~P  179 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAP  179 (272)
T ss_pred             ccccccccccccCCccccCH
Confidence            211   12234578889887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.5e-26  Score=203.93  Aligned_cols=169  Identities=28%  Similarity=0.523  Sum_probs=139.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--Ce
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--MV  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~  207 (303)
                      .+|.+.+.||+|+||.||+++.  +++.||+|.+........ .......+.+|+.+++.++||||+++++.+.+.  ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE-TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch-hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence            4677889999999999999987  678999998854321111 122336788999999999999999999998764  46


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +++++||+++++|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            88999999999999999764  3478999999999999999999999999999999999999999999999999975432


Q ss_pred             C----CCccCCCCCCcccCC
Q 046106          288 T----EGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~----~~~~~~~gt~~y~AP  303 (303)
                      .    ...+...++..|+||
T Consensus       159 ~~~~~~~~~~~~~~~~y~aP  178 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSP  178 (264)
T ss_pred             ccccCccccccCCcccccCH
Confidence            1    112334688899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=3.4e-26  Score=203.24  Aligned_cols=168  Identities=31%  Similarity=0.522  Sum_probs=139.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--PMVW  208 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~  208 (303)
                      +|...+.||+|+||.||++..  ++..||+|.++......... .....+.+|+.+++.++||||+++++.+..  ...+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETS-KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhH-HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            567788999999999999987  67899999987654333222 223578899999999999999999998875  3567


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++++||+++++|.+++...  ..+++...+.++.|++.||+|||+.+++||||+|+||+++.++.+||+|||+++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            8999999999999999764  35789999999999999999999999999999999999999999999999998754321


Q ss_pred             ----CCccCCCCCCcccCC
Q 046106          289 ----EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ----~~~~~~~gt~~y~AP  303 (303)
                          .......++..|+||
T Consensus       160 ~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             cccCCccccCCccccccCH
Confidence                112234578899998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.95  E-value=2.7e-26  Score=205.75  Aligned_cols=159  Identities=23%  Similarity=0.324  Sum_probs=129.5

Q ss_pred             eecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHH---HHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 046106          139 AFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQE---VMMLATLKHPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E---~~il~~l~hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      .||+|+||.||++..  +++.||+|++.+.........   ..+..|   ..++....||+|+++++++.....+|+|||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD   77 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence            389999999999987  678999999876543321111   122233   344555689999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccC
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP  293 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~  293 (303)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++..... ....
T Consensus        78 ~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~  154 (278)
T cd05606          78 LMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA  154 (278)
T ss_pred             cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcC
Confidence            99999999988753  46899999999999999999999999999999999999999999999999998754322 2234


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+|+..|+||
T Consensus       155 ~~~~~~y~aP  164 (278)
T cd05606         155 SVGTHGYMAP  164 (278)
T ss_pred             cCCCcCCcCc
Confidence            5789999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=5.5e-27  Score=210.00  Aligned_cols=165  Identities=25%  Similarity=0.446  Sum_probs=138.5

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||+|++  +|+.+|+|.++.......    ....+.+|+.++++++||||+++++++.+...+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~----~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL   76 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc----CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEE
Confidence            366778899999999999998  678999999976433211    12457789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-C
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-E  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-~  289 (303)
                      ++||+. ++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..... .
T Consensus        77 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          77 VFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             EEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            999996 58888887543 45899999999999999999999999999999999999999999999999999754322 2


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......+++.|+||
T Consensus       155 ~~~~~~~~~~y~aP  168 (284)
T cd07839         155 CYSAEVVTLWYRPP  168 (284)
T ss_pred             CcCCCccccCCcCh
Confidence            22344678899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=1.2e-26  Score=209.22  Aligned_cols=168  Identities=31%  Similarity=0.517  Sum_probs=138.9

Q ss_pred             ecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ...+|.+.+.||+|+||.||++.+       ++..+++|.++....      ...+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL------AARKDFQREAELLTNLQHEHIVKFYGVC   76 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH------HHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence            345677888999999999999975       234688998754321      1225688999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI  268 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv  268 (303)
                      ......++||||+++++|.+++....              ...+++..++.++.||+.||+|||++|++||||||+|||+
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~  156 (291)
T cd05094          77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV  156 (291)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence            99999999999999999999997532              2347899999999999999999999999999999999999


Q ss_pred             cCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          269 FSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       269 ~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +.++.+||+|||+++.......   .....+++.|+||
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  194 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  194 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecCh
Confidence            9999999999999975433221   1223467889998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.95  E-value=1.2e-26  Score=208.59  Aligned_cols=170  Identities=31%  Similarity=0.530  Sum_probs=139.7

Q ss_pred             eecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ++.++|++.+.||+|+||.||++.+       .+..||+|++......     ...+.+.+|+.+++.+.||||++++++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~ei~~l~~l~h~~iv~~~~~   76 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDHPNIVKLLGV   76 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-----HHHHHHHHHHHHHHhcCCCchheEEEE
Confidence            4566788899999999999999986       3468999998654321     123578899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQN--------------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDL  261 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDl  261 (303)
                      +......++++||+++++|.+++.....                    ..+++..++.++.|++.||+|||+++++||||
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl  156 (288)
T cd05050          77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL  156 (288)
T ss_pred             EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence            9998889999999999999999975321                    24678889999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          262 KSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       262 kp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||+|||++.++.+||+|||+++.......   ......++.|+||
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP  201 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCH
Confidence            99999999999999999999875432221   1122345678887

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.5e-26  Score=204.81  Aligned_cols=163  Identities=30%  Similarity=0.510  Sum_probs=141.5

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||.|+||.||+|.+  +++.||+|++.......     ....+.+|+.+++.++||||+++++.+..+..+|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED-----EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch-----HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence            567788999999999999987  67899999987543211     12467899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-C
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-E  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-~  289 (303)
                      |+||+++++|.+++...   .+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||+++..... .
T Consensus        77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999999999998764   6899999999999999999999999999999999999999999999999999876543 2


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......+++.|+||
T Consensus       154 ~~~~~~~~~~y~~P  167 (274)
T cd06609         154 KRNTFVGTPFWMAP  167 (274)
T ss_pred             ccccccCCccccCh
Confidence            23345688889998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.95  E-value=2e-26  Score=204.67  Aligned_cols=169  Identities=29%  Similarity=0.490  Sum_probs=138.7

Q ss_pred             eecCCccccceecccCceEEEEEEE--CC---eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NG---EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      |...+|+..+.||+|+||.||+|+.  ++   ..+|+|.++......     ..+.+.+|+.+++.++||||+++.+++.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-----QRQDFLSEASIMGQFSHHNIIRLEGVVT   76 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-----HHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence            3455677788999999999999987  33   369999986543221     1357889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          77 KFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccce
Confidence            9999999999999999999997643 468999999999999999999999999999999999999999999999999997


Q ss_pred             eeecCCCc--c--CCCCCCcccCC
Q 046106          284 IEVQTEGM--T--PETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~--~--~~~gt~~y~AP  303 (303)
                      ........  .  ....++.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~P  179 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAP  179 (268)
T ss_pred             ecccccccceeccCCCcCceecCH
Confidence            65332211  1  11234578887

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=1.6e-26  Score=207.97  Aligned_cols=166  Identities=22%  Similarity=0.380  Sum_probs=138.5

Q ss_pred             ccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCe
Q 046106          134 LNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMV  207 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~  207 (303)
                      |++.+.||+|+||.||+++.     +++.||+|+++......  .....+.+.+|+.+++.+ +||+|+++++++..+..
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ--KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK   79 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh--cchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence            56778999999999999986     57889999987532211  111235678899999999 58999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      .|+|+||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||+++....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          80 LHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999999999764  4578999999999999999999999999999999999999999999999999976543


Q ss_pred             CC--CccCCCCCCcccCC
Q 046106          288 TE--GMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~--~~~~~~gt~~y~AP  303 (303)
                      ..  ......|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~y~aP  175 (290)
T cd05613         158 DEVERAYSFCGTIEYMAP  175 (290)
T ss_pred             ccccccccccCCcccCCh
Confidence            22  12234688899988

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=2.9e-26  Score=202.67  Aligned_cols=165  Identities=30%  Similarity=0.532  Sum_probs=141.6

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||+|..  +++.+|+|.++.....    ....+.+.+|+.+++.++||||+++++.+.....+++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYI   76 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEE
Confidence            466778999999999999987  6789999999876543    2234688999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      |+||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++........
T Consensus        77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999999999764  3478899999999999999999999999999999999999999999999999876543222


Q ss_pred             cc-----CCCCCCcccCC
Q 046106          291 MT-----PETGTYRWMAP  303 (303)
Q Consensus       291 ~~-----~~~gt~~y~AP  303 (303)
                      ..     ...+++.|+||
T Consensus       155 ~~~~~~~~~~~~~~~~~P  172 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAP  172 (264)
T ss_pred             cccccccCCcCCcCccCh
Confidence            11     23577889887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.95  E-value=2.2e-26  Score=203.73  Aligned_cols=159  Identities=25%  Similarity=0.346  Sum_probs=137.3

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCC
Q 046106          140 FAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       140 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      ||.|+||.||+++..  ++.+|+|++.+......   ...+.+.+|+.+++.++||||+++++.+..+..+++++||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET---GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh---hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence            689999999999984  78999999976443221   2236788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCC
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT  297 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt  297 (303)
                      ++|.+++...  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.+||+|||+++............++
T Consensus        78 ~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          78 GELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             CcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            9999999764  35889999999999999999999999999999999999999999999999999866543333344688


Q ss_pred             CcccCC
Q 046106          298 YRWMAP  303 (303)
Q Consensus       298 ~~y~AP  303 (303)
                      +.|+||
T Consensus       156 ~~~~~P  161 (262)
T cd05572         156 PEYVAP  161 (262)
T ss_pred             cCccCh
Confidence            899988

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=2.6e-26  Score=204.61  Aligned_cols=160  Identities=33%  Similarity=0.528  Sum_probs=129.0

Q ss_pred             eecccCceEEEEEEE--CCe--EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEEe
Q 046106          139 AFAQGAFGKLYRGTY--NGE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      .||+|+||.||+|++  ++.  .+|+|.++.....     ...+.+.+|+.++.++ +||||+++++++.....+|++||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-----DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH-----HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            589999999999987  333  5788887643211     1125788999999999 79999999999999888999999


Q ss_pred             ecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          214 YAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      |+++++|.+++....              ...+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence            999999999997532              124789999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCCccCCCCCCcccCC
Q 046106          280 GVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+++.............++.|+||
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~ap  180 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAI  180 (270)
T ss_pred             CCccccchhhhccCCCCccccCCh
Confidence            998632211111122335678887

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.6e-26  Score=207.39  Aligned_cols=166  Identities=25%  Similarity=0.423  Sum_probs=142.1

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ..++|++.+.||+|+||.||++.+  +++.||+|++......     .....+.+|+++++.++||||+++++.+.....
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-----SVRKQILRELQIMHECRSPYIVSFYGAFLNENN   77 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc-----hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence            456788899999999999999998  5889999998654221     123578899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      +++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++....
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            99999999999999988764  468999999999999999999997 699999999999999999999999999987543


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      .. ......|+..|+||
T Consensus       156 ~~-~~~~~~~~~~~~aP  171 (284)
T cd06620         156 NS-IADTFVGTSTYMSP  171 (284)
T ss_pred             hh-ccCccccCcccCCH
Confidence            22 22345788999988

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.94  E-value=3.7e-26  Score=206.87  Aligned_cols=164  Identities=29%  Similarity=0.478  Sum_probs=141.2

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ..+|.+.+.||.|+||.||++..  +++.||+|.+.......      .+.+.+|+.+++.++||||+++++.+.....+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK------KELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch------HHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            35678888999999999999986  78899999986543221      24678899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+|+||+++++|.+++...   .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            9999999999999988753   4899999999999999999999999999999999999999999999999998764433


Q ss_pred             CC-ccCCCCCCcccCC
Q 046106          289 EG-MTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~-~~~~~gt~~y~AP  303 (303)
                      .. .....+++.|+||
T Consensus       169 ~~~~~~~~~~~~y~aP  184 (296)
T cd06655         169 QSKRSTMVGTPYWMAP  184 (296)
T ss_pred             cccCCCcCCCccccCc
Confidence            22 2334688899998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=2.6e-26  Score=205.42  Aligned_cols=171  Identities=25%  Similarity=0.447  Sum_probs=140.2

Q ss_pred             eeecCCccccceecccCceEEEEEEEC------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      .+..++|.+.+.||+|+||.||+|.+.      +..|++|.++.....     .....+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~   76 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE-----IQVTLLLQESCLLYGLSHQNILPILHV   76 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356778889999999999999999873      478999988643221     123578899999999999999999998


Q ss_pred             EEc-CCeEEEEEeecCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 046106          202 CRK-PMVWCIVTEYAKGGSVRQFLTKRQN------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI  274 (303)
Q Consensus       202 ~~~-~~~~~iv~E~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~v  274 (303)
                      +.. +...++++||+++++|.+++.....      ..+++..++.++.|++.||+|||+.+++||||||+||++++++.+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             EecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcE
Confidence            876 4667899999999999999976432      358899999999999999999999999999999999999999999


Q ss_pred             EEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          275 KIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       275 Kl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||+|||+++.......   .....++..|+||
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence            9999999985432221   1123456778887

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.5e-29  Score=227.95  Aligned_cols=171  Identities=26%  Similarity=0.338  Sum_probs=154.0

Q ss_pred             eeecCCccccceecccCceEEEEEEECCeE--EEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .+...+++....||.|+||.|-++..+++.  +|+|++++...-..+.   .+.+..|-.||..++.|.||+||..|.++
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ---qeHv~sEr~Im~~~~s~fIvrLYrTfrd~  492 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ---QEHVFSERNIMMECRSDFIVRLYRTFRDS  492 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH---HHHHHhHHHHHHhcCchHHHHHHHHhccc
Confidence            355677888889999999999999887665  8999998765433332   25678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+|++||-|-||.|+..|+.+  +.+.......++..++.|++|||++|||+|||||+|++++.+|-+||.|||+|+.+
T Consensus       493 kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999999999887  56888999999999999999999999999999999999999999999999999999


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      .....+.++||||.|.||
T Consensus       571 ~~g~KTwTFcGTpEYVAP  588 (732)
T KOG0614|consen  571 GSGRKTWTFCGTPEYVAP  588 (732)
T ss_pred             ccCCceeeecCCcccccc
Confidence            988889999999999999

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=2.6e-26  Score=204.36  Aligned_cols=169  Identities=28%  Similarity=0.529  Sum_probs=138.0

Q ss_pred             eeecCCccccceecccCceEEEEEEECC-----eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTYNG-----EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ++...++.+.+.||+|+||.||+|.+..     ..||||....... .    ...+.+.+|+.+++.++||||+++++++
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~   76 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-P----SVREKFLQEAYIMRQFDHPHIVKLIGVI   76 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-H----HHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence            4566778888999999999999998722     3689998864332 1    1235788999999999999999999998


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .... .|+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~-~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          77 TENP-VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             cCCC-cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence            7654 689999999999999997643 35899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCcc--CCCCCCcccCC
Q 046106          283 RIEVQTEGMT--PETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~--~~~gt~~y~AP  303 (303)
                      +.........  ...+++.|+||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aP  177 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAP  177 (270)
T ss_pred             eecccccceecCCCCccccccCh
Confidence            8654332211  12334678887

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=3e-26  Score=202.12  Aligned_cols=160  Identities=31%  Similarity=0.500  Sum_probs=135.0

Q ss_pred             ceecccCceEEEEEEEC---C--eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          138 DAFAQGAFGKLYRGTYN---G--EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      +.||+|++|.||+|.+.   +  ..||||.++.....     ...+.+.+|+.++++++||||+++++.+.. ...++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEE
Confidence            35899999999999872   2  36999999765443     234688999999999999999999999988 8889999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC--
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG--  290 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~--  290 (303)
                      ||+++++|.+++.......+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||+++.......  
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999999999875434689999999999999999999999999999999999999999999999999986543211  


Q ss_pred             --ccCCCCCCcccCC
Q 046106          291 --MTPETGTYRWMAP  303 (303)
Q Consensus       291 --~~~~~gt~~y~AP  303 (303)
                        .....++..|+||
T Consensus       155 ~~~~~~~~~~~y~~p  169 (257)
T cd05040         155 VMEEHLKVPFAWCAP  169 (257)
T ss_pred             ecccCCCCCceecCH
Confidence              1123467788887

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.94  E-value=2.4e-26  Score=213.06  Aligned_cols=164  Identities=27%  Similarity=0.384  Sum_probs=137.3

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  205 (303)
                      .++|...+.||+|+||.||+++.  +++.||||++.........    ...+.+|+.+++.++||||+++++++...   
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH----AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhH----HHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence            46788889999999999999987  7789999998754333222    24567899999999999999999988643   


Q ss_pred             ---CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          206 ---MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       206 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                         ...|+||||+. ++|.+++...    ++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence               34699999995 5888887642    788999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +............+|+.|+||
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aP  186 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRAP  186 (353)
T ss_pred             eeCCCCCCCCCCcccccccCH
Confidence            875544333445688999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=2.2e-26  Score=221.29  Aligned_cols=164  Identities=19%  Similarity=0.331  Sum_probs=131.1

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC------CCCeeeee
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK------HPNIVRFI  199 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~------hpniv~l~  199 (303)
                      .+...+|++.+.||+|+||+||+|.+  .++.||||+++.....       .+.+..|+.+++.++      |+++++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~  197 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-------TRDAKIEIQFMEKVRQADPADRFPLMKIQ  197 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-------HHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence            34457899999999999999999987  6789999999642211       133455666666654      45689999


Q ss_pred             EEEEcC-CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCC-----
Q 046106          200 GACRKP-MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDK-----  272 (303)
Q Consensus       200 ~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~-----  272 (303)
                      +++..+ ..+|||||++ +++|.+++...  ..+++..+..++.||+.||+|||+ .|||||||||+|||++.++     
T Consensus       198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        198 RYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence            988764 5789999998 77999998764  468999999999999999999998 5999999999999998765     


Q ss_pred             -----------cEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          273 -----------SIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       273 -----------~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                                 .+||+|||++....  ...+..+||+.|+||
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~AP  314 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSP  314 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc--cccccccCCccccCc
Confidence                       49999999986422  233456899999999

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=2.7e-26  Score=205.24  Aligned_cols=170  Identities=31%  Similarity=0.513  Sum_probs=136.9

Q ss_pred             eecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      +..++|.+.+.||+|+||.||+|.+.       +..||+|.++.....     .....+.+|+.+++.++||||++++++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~   77 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-----QDESDFLMEALIMSKFNHQNIVRLIGV   77 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34567888899999999999999883       357899987643221     112568899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---c
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQN-----RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK---S  273 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~---~  273 (303)
                      +.+....++||||+++++|.+++.....     ..+++..++.++.||+.||+|||+++++||||||+|||++.++   .
T Consensus        78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence            9988888999999999999999976432     2588999999999999999999999999999999999998765   6


Q ss_pred             EEEeccCCceeeecCCCc---cCCCCCCcccCC
Q 046106          274 IKIADFGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       274 vKl~DFGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      +||+|||+++........   .....++.|+||
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  190 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPP  190 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCH
Confidence            999999999865322111   111234678887

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=4.6e-26  Score=200.92  Aligned_cols=167  Identities=26%  Similarity=0.442  Sum_probs=140.5

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--PMVW  208 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~  208 (303)
                      +|++.+.||.|+||.||++..  +++.+|+|++.........    .+.+.+|+.+++.++||||+++++.+..  ....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTL   76 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH----HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEE
Confidence            366778899999999999987  6789999998765443322    2578899999999999999999998754  4568


Q ss_pred             EEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          209 CIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVH-----RLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH-----~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      |++|||+++++|.+++...  ....+++..++.++.|++.||+|||     +.+++|+||+|+||++++++.+||+|||+
T Consensus        77 ~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          77 YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             EEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccc
Confidence            9999999999999999753  2356899999999999999999999     89999999999999999999999999999


Q ss_pred             ceeeecCCC-ccCCCCCCcccCC
Q 046106          282 ARIEVQTEG-MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~-~~~~~gt~~y~AP  303 (303)
                      +........ .....+++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~p  179 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSP  179 (265)
T ss_pred             cccccCCcccccccccCCCccCh
Confidence            987654332 3344688899988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=3.6e-26  Score=201.15  Aligned_cols=164  Identities=29%  Similarity=0.487  Sum_probs=142.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.+|+|.++....        .+.+.+|+.+++.++||||+++++.+......
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   73 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL   73 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence            35778889999999999999998  468999999865321        36888999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++......
T Consensus        74 ~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            99999999999999997543 46899999999999999999999999999999999999999999999999999865433


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......++..|+||
T Consensus       153 ~~~~~~~~~~~~y~~P  168 (256)
T cd06612         153 MAKRNTVIGTPFWMAP  168 (256)
T ss_pred             ccccccccCCccccCH
Confidence            2 22334578889988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=4.2e-26  Score=205.57  Aligned_cols=167  Identities=26%  Similarity=0.425  Sum_probs=137.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|.+|.||+|.+  +++.||+|.++.......    ....+.+|+.++++++||||+++++++.....+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG----VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLY   77 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc----chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEE
Confidence            4677888999999999999987  678999999866433221    1246778999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccCCceeeecC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFGVARIEVQT  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-~~~vKl~DFGla~~~~~~  288 (303)
                      +||||++ ++|.+++.......+++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++......
T Consensus        78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9999995 58888887655555688889999999999999999999999999999999985 467999999999754322


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       ...+...+++.|+||
T Consensus       157 ~~~~~~~~~~~~y~~P  172 (294)
T PLN00009        157 VRTFTHEVVTLWYRAP  172 (294)
T ss_pred             ccccccCceeecccCH
Confidence             122334567888887

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.3e-26  Score=203.12  Aligned_cols=166  Identities=31%  Similarity=0.528  Sum_probs=140.3

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC-
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPM-  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-  206 (303)
                      .++|.+.+.||+|+||.||+|..  +++.+++|++......       ...+.+|+.+++++ .||||+++++++.... 
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-------HHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            46788899999999999999998  5678999998764321       24688999999999 6999999999997644 


Q ss_pred             -----eEEEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          207 -----VWCIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       207 -----~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                           .+|+||||+++++|.+++....  +..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence                 4899999999999999987543  457899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCC-CccCCCCCCcccCC
Q 046106          280 GVARIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      |++....... ......|++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aP  182 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAP  182 (275)
T ss_pred             ccceecccchhhhcCccccccccCH
Confidence            9987643322 22334688889988

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=1.4e-26  Score=205.01  Aligned_cols=164  Identities=31%  Similarity=0.473  Sum_probs=141.5

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||.|+||.||++.+  +++.+|+|.+......     .....+.+|+.+++.++||||+++++.+.....+++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence            567778899999999999998  4789999998765432     223578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      ++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||++++++.+||+|||.+.......
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            999999999999998654 568999999999999999999999 999999999999999999999999999987653322


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      .. ...++..|+||
T Consensus       156 ~~-~~~~~~~y~~P  168 (265)
T cd06605         156 AK-TFVGTSSYMAP  168 (265)
T ss_pred             hh-cccCChhccCH
Confidence            22 25788889887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.94  E-value=2.1e-26  Score=206.20  Aligned_cols=165  Identities=28%  Similarity=0.487  Sum_probs=139.5

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |+..+.||.|+||.||+|++  +++.||||.++.......    ....+.+|+.++++++||||+++++++......++|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   77 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc----cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence            66778899999999999987  678999999865432221    124688899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-C
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-G  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~  290 (303)
                      |||+. ++|.+++.......+++..+..++.|++.||+|||+.+++||||+|+||+++.++.+||+|||+++...... .
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence            99995 689999887655678999999999999999999999999999999999999999999999999987543221 2


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....+++.|+||
T Consensus       157 ~~~~~~~~~y~aP  169 (284)
T cd07860         157 YTHEVVTLWYRAP  169 (284)
T ss_pred             cccccccccccCC
Confidence            2334567889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.94  E-value=1.5e-26  Score=207.15  Aligned_cols=165  Identities=26%  Similarity=0.412  Sum_probs=139.1

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||+|.+  +++.||+|++.......    ...+.+.+|+.+++.++||||+++++++..+..+|+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   77 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL   77 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence            567788999999999999998  57899999986544322    122467889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-C
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-E  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-~  289 (303)
                      |+||+++++|..+....  ..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++...... .
T Consensus        78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          78 VFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            99999988887766543  34899999999999999999999999999999999999999999999999998765332 2


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......++..|+||
T Consensus       156 ~~~~~~~~~~y~aP  169 (286)
T cd07846         156 VYTDYVATRWYRAP  169 (286)
T ss_pred             ccCcccceeeccCc
Confidence            23334678889888

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-27  Score=195.41  Aligned_cols=171  Identities=26%  Similarity=0.414  Sum_probs=146.4

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACR  203 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  203 (303)
                      ++++.+.+..+..||+|++|.|-+.++  +|+..|+|.++..-.+.+.     .+++.|+.+..+. ..|.+|.+||...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q-----~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ-----KRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH-----HHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            667777888888999999998876665  8999999999876664433     4677788776554 6999999999998


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      ....+||.||.| ..+|..|.++  .+++.+|+..+-+|+..++.||.|||++ .+||||+||+||||+.+|++|+||||
T Consensus       116 regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  116 REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence            888899999999 4699888764  3457899999999999999999999987 79999999999999999999999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .+-+..+.-..+...|...||||
T Consensus       195 IsG~L~dSiAkt~daGCkpYmaP  217 (282)
T KOG0984|consen  195 ISGYLVDSIAKTMDAGCKPYMAP  217 (282)
T ss_pred             cceeehhhhHHHHhcCCCccCCh
Confidence            99988777666667899999998

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.2e-26  Score=202.95  Aligned_cols=163  Identities=34%  Similarity=0.596  Sum_probs=138.8

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCe
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---HPNIVRFIGACRKPMV  207 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~  207 (303)
                      .|+..+.||+|+||.||+|.+  +++.+|+|.++.......     ...+.+|+.+++.++   |||++++++++.....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-----VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-----HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence            356678899999999999997  678999999876433221     246778999999886   9999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      .|+||||+++++|.+++...   .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            99999999999999998653   588999999999999999999999999999999999999999999999999976543


Q ss_pred             CC-CccCCCCCCcccCC
Q 046106          288 TE-GMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~-~~~~~~gt~~y~AP  303 (303)
                      .. ......|+..|+||
T Consensus       154 ~~~~~~~~~~~~~y~aP  170 (277)
T cd06917         154 NSSKRSTFVGTPYWMAP  170 (277)
T ss_pred             CccccccccCCcceeCH
Confidence            32 22334688899988

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.94  E-value=2.5e-26  Score=205.84  Aligned_cols=165  Identities=28%  Similarity=0.416  Sum_probs=138.1

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||+|.+  +++.||+|.++......    .....+.+|+.+++.++||||+++++++..+..+++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i   77 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE----DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL   77 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc----cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence            577888999999999999988  57899999987543322    123578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-  289 (303)
                      ++||++++.+..+....  ..+++..+..++.||+.||+|||+.+++||||+|+||++++++.+||+|||++....... 
T Consensus        78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          78 VFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99999876555544432  458999999999999999999999999999999999999999999999999987654433 


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......++..|+||
T Consensus       156 ~~~~~~~~~~~~~~P  170 (288)
T cd07833         156 SPLTDYVATRWYRAP  170 (288)
T ss_pred             ccccCcccccCCcCC
Confidence             23334678889998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=4.8e-26  Score=203.71  Aligned_cols=165  Identities=25%  Similarity=0.429  Sum_probs=138.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||.|++|.||+|++  +++.||||+++.......     ...+.+|+.+++.++||||+++++++.....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-----PSTAIREISLMKELKHENIVRLHDVIHTENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc-----hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence            366788999999999999998  678999999976543211     1356789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          211 VTEYAKGGSVRQFLTKRQ-NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      ||||+++ +|.+++.... ...+++..+..++.|++.||+|||+.|++||||+|+||++++++.+||+|||+++......
T Consensus        76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9999974 8988887543 2458999999999999999999999999999999999999999999999999997543221


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......+++.|+||
T Consensus       155 ~~~~~~~~~~~y~~P  169 (284)
T cd07836         155 NTFSNEVVTLWYRAP  169 (284)
T ss_pred             cccccccccccccCh
Confidence             22334578889887

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.94  E-value=3e-26  Score=207.95  Aligned_cols=167  Identities=31%  Similarity=0.605  Sum_probs=135.6

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ...+|+..+.||+|+||.||+|.+  ++.    .||+|.+.......     ....+.+|+.+++.++||||++++++|.
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~~~~l~h~niv~~~~~~~   79 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK-----ANVEFMDEALIMASMDHPHLVRLLGVCL   79 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH-----HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            345677888999999999999987  444    57889886543211     1246889999999999999999999997


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .+. .++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~-~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          80 SPT-IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             CCC-ceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence            654 578999999999999987643 358899999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCC---ccCCCCCCcccCC
Q 046106          284 IEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      .......   .....++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~P  180 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMAL  180 (303)
T ss_pred             cccCcccccccCCCccccccCCH
Confidence            6543221   1122346789887

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=6.2e-26  Score=202.66  Aligned_cols=167  Identities=32%  Similarity=0.607  Sum_probs=138.6

Q ss_pred             cCCccccceecccCceEEEEEEEC------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      .+.|.+.+.||+|+||.||+++++      +..+|||+++.....     ...+.+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~   77 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----QHRSDFEREIEILRTLDHENIVKYKGVCEK   77 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence            456778889999999999999863      578999999765443     223678999999999999999999999877


Q ss_pred             --CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          205 --PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       205 --~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                        ....+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          78 PGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             CCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence              557899999999999999998653 35899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCc----cCCCCCCcccCC
Q 046106          283 RIEVQTEGM----TPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~----~~~~gt~~y~AP  303 (303)
                      .........    ....++..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~P  181 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAP  181 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCc
Confidence            865422211    112344567777

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=207.68  Aligned_cols=158  Identities=26%  Similarity=0.437  Sum_probs=135.6

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+++.|-.+..  ++.++|||++.+...      ..+.+..+|++++.+++ |+||++|+.+|.++..+|+|||-
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g------HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG------HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCc------hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            5699999999988875  899999999977532      22367889999999997 99999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEeccCCceeeec----
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK---SIKIADFGVARIEVQ----  287 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~---~vKl~DFGla~~~~~----  287 (303)
                      |.||+|...+.++  +-+++.++.++..+|+.||.|||.+||.||||||+|||.....   -|||+||.++.-+.-    
T Consensus       158 m~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  158 MRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            9999999999887  4689999999999999999999999999999999999996654   589999998743221    


Q ss_pred             ----CCCccCCCCCCcccCC
Q 046106          288 ----TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ----~~~~~~~~gt~~y~AP  303 (303)
                          .+...+.+|+..||||
T Consensus       236 spastP~L~tPvGSAEfMAP  255 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAP  255 (463)
T ss_pred             CCCCCccccCcccchhhcch
Confidence                1223445899999999

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=7.4e-26  Score=202.41  Aligned_cols=163  Identities=29%  Similarity=0.476  Sum_probs=139.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      .|...+.||.|+||.||+|.+  +++.||+|++......     .....+.+|+.+++.+.||||+++++.+.....+|+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            456677899999999999987  5789999998754322     123678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ||||+++++|.+++..   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus        80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999999999875   3578899999999999999999999999999999999999999999999999976543321


Q ss_pred             -ccCCCCCCcccCC
Q 046106          291 -MTPETGTYRWMAP  303 (303)
Q Consensus       291 -~~~~~gt~~y~AP  303 (303)
                       .....++..|+||
T Consensus       157 ~~~~~~~~~~y~ap  170 (277)
T cd06640         157 KRNTFVGTPFWMAP  170 (277)
T ss_pred             ccccccCcccccCH
Confidence             2234578888887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.94  E-value=3.6e-26  Score=204.66  Aligned_cols=167  Identities=28%  Similarity=0.497  Sum_probs=139.0

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEc--
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRK--  204 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~--  204 (303)
                      ....|++.+.||.|+||.||+|.+  +++.+|+|++.....       ....+..|+.++..+ +||||+++++++..  
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-------HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            345677788999999999999998  678999999865321       124677899999888 69999999999853  


Q ss_pred             ----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          205 ----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       205 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                          ...+|++|||+++++|.+++.......+++..+..++.|++.||+|||+.||+||||+|+||++++++.+||+|||
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg  166 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG  166 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence                4578999999999999999987665668899999999999999999999999999999999999999999999999


Q ss_pred             CceeeecC-CCccCCCCCCcccCC
Q 046106          281 VARIEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      ++...... .......|++.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aP  190 (282)
T cd06636         167 VSAQLDRTVGRRNTFIGTPYWMAP  190 (282)
T ss_pred             chhhhhccccCCCcccccccccCH
Confidence            98754321 123345688899988

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=8e-26  Score=199.74  Aligned_cols=158  Identities=33%  Similarity=0.585  Sum_probs=130.8

Q ss_pred             ceecccCceEEEEEEE--CC---eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          138 DAFAQGAFGKLYRGTY--NG---EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      ++||+|+||.||+|.+  .+   ..+|+|.++.....     ...+.+.+|+.+++.+.||||+++++++... ..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----AGKKEFLREASVMAQLDHPCIVRLIGVCKGE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-ceEEEE
Confidence            3699999999999987  22   57999998765443     1235788999999999999999999988654 568999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc-
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM-  291 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~-  291 (303)
                      ||+++++|.+++....  .+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++........ 
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999999998653  6899999999999999999999999999999999999999999999999999865433221 


Q ss_pred             c---CCCCCCcccCC
Q 046106          292 T---PETGTYRWMAP  303 (303)
Q Consensus       292 ~---~~~gt~~y~AP  303 (303)
                      .   ...++..|+||
T Consensus       153 ~~~~~~~~~~~y~aP  167 (257)
T cd05060         153 RATTAGRWPLKWYAP  167 (257)
T ss_pred             ccccCccccccccCH
Confidence            1   11234678887

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=7.9e-26  Score=202.23  Aligned_cols=162  Identities=30%  Similarity=0.498  Sum_probs=138.1

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |.+.+.||.|+||.||+|.+  +++.+|||++......     .....+.+|+.+++.++||||+++++.+..+...|+|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            55678899999999999987  6789999998653322     1235788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-C
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-G  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~  290 (303)
                      |||+++++|.+++..   ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        81 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          81 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            999999999999864   358899999999999999999999999999999999999999999999999987643322 2


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....++..|+||
T Consensus       158 ~~~~~~~~~y~~P  170 (277)
T cd06641         158 RNTFVGTPFWMAP  170 (277)
T ss_pred             hccccCCccccCh
Confidence            2334678888887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.3e-26  Score=224.66  Aligned_cols=172  Identities=23%  Similarity=0.297  Sum_probs=130.3

Q ss_pred             cCCccccceecccCceEEEEEEEC---CeEEEEEEeeCCCCC-----------hHHHHHHHHHHHHHHHHHHcCCCCCee
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTYN---GEEVAIKILERPEND-----------PEKAQVMEQQFQQEVMMLATLKHPNIV  196 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~-----------~~~~~~~~~~~~~E~~il~~l~hpniv  196 (303)
                      ..+|++.+.||+|+||+||++.+.   +...++|.+......           ..........+.+|+.+|+.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            467999999999999999998752   222232311100000           000112235688999999999999999


Q ss_pred             eeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc
Q 046106          197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ---NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS  273 (303)
Q Consensus       197 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~  273 (303)
                      ++++++..+...|+|+|++ .++|.+++....   ........+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            9999999999999999999 468888876422   112345667889999999999999999999999999999999999


Q ss_pred             EEEeccCCceeeecCCC--ccCCCCCCcccCC
Q 046106          274 IKIADFGVARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       274 vKl~DFGla~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      +||+|||+|+.......  ....+||+.|+||
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aP  337 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSP  337 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCc
Confidence            99999999986543322  2235799999998

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.94  E-value=8.3e-26  Score=198.27  Aligned_cols=167  Identities=26%  Similarity=0.508  Sum_probs=143.0

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||.|+||.||++.+  +++.+|+|++.........    ...+.+|+++++.++|||++++++.+......++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~l   76 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE----REDALNEVKILKKLNHPNIIKYYESFEEKGKLCI   76 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH----HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEE
Confidence            366778899999999999998  4789999999765543222    2568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          211 VTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||+++++|.+++....  ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.+||+|||++......
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999999998753  356899999999999999999999999999999999999999999999999999765433


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......|++.|+||
T Consensus       157 ~~~~~~~~~~~~y~~p  172 (258)
T cd08215         157 VDLAKTVVGTPYYLSP  172 (258)
T ss_pred             cceecceeeeecccCh
Confidence            2 22234678889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=2e-26  Score=206.00  Aligned_cols=163  Identities=32%  Similarity=0.508  Sum_probs=138.4

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      .|...+.||+|+||.||+|.+  +++.||+|.++......     ..+.+.+|+.+++.++||||+++++.+..+..+|+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH-----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence            455667899999999999987  57899999987543222     23578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      |+||+++++|.+++..   ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999999999998864   3588999999999999999999999999999999999999999999999999976543221


Q ss_pred             -ccCCCCCCcccCC
Q 046106          291 -MTPETGTYRWMAP  303 (303)
Q Consensus       291 -~~~~~gt~~y~AP  303 (303)
                       .....|+..|+||
T Consensus       157 ~~~~~~~~~~y~aP  170 (277)
T cd06642         157 KRNTFVGTPFWMAP  170 (277)
T ss_pred             hhhcccCcccccCH
Confidence             2234578888887

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=4.1e-26  Score=207.23  Aligned_cols=167  Identities=25%  Similarity=0.449  Sum_probs=135.8

Q ss_pred             CccccceecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--C
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--M  206 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~  206 (303)
                      +|.+.+.||+|+||.||+|.+    .++.||+|.+........   ...+.+.+|+.+++.++||||+++++++...  .
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLRELKHENVVSLVEVFLEHADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc---CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence            366778899999999999997    467999999986432111   1124667899999999999999999999888  7


Q ss_pred             eEEEEEeecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC----CCcEEEecc
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQ---NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADF  279 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~----~~~vKl~DF  279 (303)
                      .+|+||||++ ++|.+++....   ...+++..+..++.|++.||+|||+.+|+||||||+|||++.    ++.+||+||
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          78 SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            8999999996 47877775332   236889999999999999999999999999999999999999    899999999


Q ss_pred             CCceeeecCCC----ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      |+++.......    .....+|+.|+||
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aP  184 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAP  184 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCH
Confidence            99986433221    2234678889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-26  Score=221.19  Aligned_cols=166  Identities=30%  Similarity=0.521  Sum_probs=143.6

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEc---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRK---  204 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~---  204 (303)
                      ...+++.+.||.|.+|+||+++.  +++.+|+|+........       ..+..|.+||+.+. |||++.+|+++..   
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-------eEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-------EEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-------HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            34455668899999999999875  88999999987654333       35667899998875 9999999999853   


Q ss_pred             --CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          205 --PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       205 --~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                        ++.+|||||||.+|+..|+++...+..+.|..+..|++.++.|+.+||...+||||||-.|||++.++.|||+|||.+
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence              568999999999999999999888889999999999999999999999999999999999999999999999999998


Q ss_pred             eeeecCC-CccCCCCCCcccCC
Q 046106          283 RIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      ....... ...+.+|||.||||
T Consensus       171 aQldsT~grRnT~iGtP~WMAP  192 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAP  192 (953)
T ss_pred             eeeecccccccCcCCCcccccc
Confidence            7665443 34456899999999

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=1.5e-25  Score=203.50  Aligned_cols=164  Identities=29%  Similarity=0.454  Sum_probs=138.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      +.|...+.||+|+||.||+|+.  +++.||+|++........   ...+.+.+|+.+++.++||||+++++++..+...|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH---HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            4577788999999999999987  678999999865433221   12357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +|+||++ +++.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...... 
T Consensus        92 lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          92 LVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9999996 58888776433 45899999999999999999999999999999999999999999999999999764322 


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                        ....+++.|+||
T Consensus       169 --~~~~~~~~y~aP  180 (307)
T cd06607         169 --NSFVGTPYWMAP  180 (307)
T ss_pred             --CCccCCccccCc
Confidence              234678889988

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.94  E-value=1e-25  Score=202.72  Aligned_cols=167  Identities=28%  Similarity=0.492  Sum_probs=138.2

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcC-
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP-  205 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-  205 (303)
                      ...+|.+.+.||+|+||.||++..  +++.+|+|++......       ...+.+|+.++.++ +|||++++++++... 
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------DEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------HHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            356788888999999999999987  6789999998653221       14567889999988 799999999998753 


Q ss_pred             ----CeEEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          206 ----MVWCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       206 ----~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                          ..+|+|+||+++++|.+++...  ....+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df  172 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF  172 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence                3579999999999999988642  2346899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCC-CccCCCCCCcccCC
Q 046106          280 GVARIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      |+++...... ......|+..|+||
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~y~aP  197 (291)
T cd06639         173 GVSAQLTSTRLRRNTSVGTPFWMAP  197 (291)
T ss_pred             ccchhcccccccccCccCCccccCh
Confidence            9987644322 12234678889988

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=4.6e-26  Score=203.73  Aligned_cols=164  Identities=31%  Similarity=0.455  Sum_probs=139.9

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~i  210 (303)
                      |.+.+.||+|+||.||+|+.  +++.||||.+.........     ....+|+..+++++ ||||+++++++..+...++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~-----~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE-----CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhH-----HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence            45678899999999999998  5678999998654332211     24457899999999 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ||||+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||++++++.++|+|||+++.......
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            99999 78999999876545689999999999999999999999999999999999999999999999999987654444


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~aP  167 (283)
T cd07830         155 YTDYVSTRWYRAP  167 (283)
T ss_pred             cCCCCCcccccCc
Confidence            4455688889988

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=3.1e-26  Score=205.67  Aligned_cols=166  Identities=24%  Similarity=0.388  Sum_probs=136.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVW  208 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~  208 (303)
                      +++...+.||+|+||.||++.+  +++.+|+|.+......     .....+.+|+.++.++. ||||+++++++..+...
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            4566678899999999999988  6789999998754332     12357889999999996 99999999999988888


Q ss_pred             EEEEeecCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          209 CIVTEYAKGGSVRQFLT---KRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +++|||+. +++.++..   ......+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            99999985 46655432   23335689999999999999999999974 999999999999999999999999999976


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........|++.|+||
T Consensus       158 ~~~~~~~~~~~~~~~y~aP  176 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAP  176 (288)
T ss_pred             hccCCccccccCccCccCH
Confidence            5444333445688899998

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3.5e-26  Score=211.51  Aligned_cols=163  Identities=17%  Similarity=0.182  Sum_probs=122.3

Q ss_pred             ceeecCCccccceecccCceEEEEEEE---CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee-eeEEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR-FIGAC  202 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~-l~~~~  202 (303)
                      ...-...|.+.+.||+|+||+||+|++   +++.+|||++....... ......+.+.+|+.+|+.++|+|++. +++. 
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWW-SKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccc-ccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            344456788999999999999999987   46778999875321100 01122357899999999999999984 5442 


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCcEEEcCCCcEEEeccCC
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDL-KSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDl-kp~NILv~~~~~vKl~DFGl  281 (303)
                         ...|+||||+++++|.. +..     ..   ...++.|++.+|+|||++||+|||| ||+|||++.++.+||+|||+
T Consensus        91 ---~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             ---CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence               34699999999998862 211     11   1467889999999999999999999 99999999999999999999


Q ss_pred             ceeeecCCC---------ccCCCCCCcccCC
Q 046106          282 ARIEVQTEG---------MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~---------~~~~~gt~~y~AP  303 (303)
                      |+.......         .+...+++.|+||
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~p  189 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAP  189 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCc
Confidence            986543221         1234567778877

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.94  E-value=6.7e-26  Score=204.70  Aligned_cols=172  Identities=24%  Similarity=0.443  Sum_probs=141.6

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC--CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGA  201 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~  201 (303)
                      ..|.++.++|.+.+.||+|+||.||+|.+.  ++.||||.++.......     ...+.+|+.++... .||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~e~~~~~~~~~~~~i~~~~~~   82 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----NKRILMDLDVVLKSHDCPYIVKCYGY   82 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----HHHHHHHHHHHHhccCCCchHhhhee
Confidence            456777888999999999999999999984  88999999976543222     13555677666665 49999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      +......|++|||+. +++.+++.... ..+++..+..++.|++.||+|||+ .||+||||+|+||++++++.+||+|||
T Consensus        83 ~~~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          83 FITDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             eecCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence            999999999999995 57877776543 468999999999999999999997 599999999999999999999999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ++.............+++.|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aP  183 (296)
T cd06618         161 ISGRLVDSKAKTRSAGCAAYMAP  183 (296)
T ss_pred             cchhccCCCcccCCCCCccccCH
Confidence            99765443333444678889887

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=1e-25  Score=199.25  Aligned_cols=160  Identities=30%  Similarity=0.491  Sum_probs=128.1

Q ss_pred             ceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeEEEE
Q 046106          138 DAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-PMVWCIV  211 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~~iv  211 (303)
                      +.||+|+||.||+|.+     ....||+|.+......     ...+.+.+|+.+++.++||||+++++++.. +...+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH-----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEE
Confidence            3589999999999986     1347999987542211     113578889999999999999999998764 4567899


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC-
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~-  290 (303)
                      +||+++++|.+++.... ...++..+..++.|++.||+|||+.+++||||||+|||+++++.+||+|||+++....... 
T Consensus        76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999999999997643 3457788889999999999999999999999999999999999999999999975432211 


Q ss_pred             ----ccCCCCCCcccCC
Q 046106          291 ----MTPETGTYRWMAP  303 (303)
Q Consensus       291 ----~~~~~gt~~y~AP  303 (303)
                          .....+++.|+||
T Consensus       155 ~~~~~~~~~~~~~y~aP  171 (262)
T cd05058         155 SVHNHTGAKLPVKWMAL  171 (262)
T ss_pred             eecccccCcCCccccCh
Confidence                1123456789988

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=7.7e-26  Score=203.67  Aligned_cols=166  Identities=27%  Similarity=0.417  Sum_probs=135.0

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCe--
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMV--  207 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~--  207 (303)
                      +|++.+.||+|+||.||+|.+  +++.||||.++.......    ....+.+|+.+++.+. ||||+++++++.....  
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~   77 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG   77 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC----CchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence            577788999999999999997  678999999865432211    1246778999999995 6999999999876655  


Q ss_pred             ---EEEEEeecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccC
Q 046106          208 ---WCIVTEYAKGGSVRQFLTKRQ---NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFG  280 (303)
Q Consensus       208 ---~~iv~E~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-~~~vKl~DFG  280 (303)
                         +|+||||+++ +|.+++....   ...+++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||
T Consensus        78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence               8999999975 8998887542   235799999999999999999999999999999999999999 8999999999


Q ss_pred             CceeeecC-CCccCCCCCCcccCC
Q 046106          281 VARIEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      +++..... .......+++.|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aP  180 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAP  180 (295)
T ss_pred             cceecCCCccccCCcccccCCCCh
Confidence            99754322 222334567889887

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.94  E-value=9.8e-26  Score=201.36  Aligned_cols=162  Identities=26%  Similarity=0.390  Sum_probs=135.0

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcC--CeE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKP--MVW  208 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~--~~~  208 (303)
                      |++.+.||+|+||.||++..  +++.+|+|.++........     ....+|+.++.++. ||||+++++++.++  ..+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   75 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-----VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL   75 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-----hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence            45677899999999999987  6789999998764332221     23457888888885 99999999999887  889


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++|+||++ ++|.+++.... ..+++..+..++.|++.||+|||+.|++||||+|+||+++. +.+||+|||+++.....
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          76 ALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            99999996 58888887643 46899999999999999999999999999999999999999 99999999999866544


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      .......+++.|+||
T Consensus       153 ~~~~~~~~~~~y~aP  167 (282)
T cd07831         153 PPYTEYISTRWYRAP  167 (282)
T ss_pred             CCcCCCCCCcccCCh
Confidence            434445678899998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=7.6e-26  Score=205.60  Aligned_cols=167  Identities=29%  Similarity=0.431  Sum_probs=137.6

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--C
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--M  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~  206 (303)
                      .++|++.+.||+|+||.||+|.+  +++.||+|.++........    ...+.+|+.++++++||||+++++++...  .
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI----PISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC----cchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            45788889999999999999997  6789999998754332211    12456799999999999999999998754  5


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||++++++.+||+|||++....
T Consensus        82 ~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          82 SIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             eEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            6899999996 58988887543 468999999999999999999999999999999999999999999999999998654


Q ss_pred             cCC-CccCCCCCCcccCC
Q 046106          287 QTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~-~~~~~~gt~~y~AP  303 (303)
                      ... ..+...+++.|+||
T Consensus       160 ~~~~~~~~~~~~~~y~aP  177 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAP  177 (309)
T ss_pred             CccCCCCcccccccccCh
Confidence            332 22333567889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=1.4e-25  Score=198.06  Aligned_cols=164  Identities=31%  Similarity=0.488  Sum_probs=142.3

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|++|.||+++.  +++.||+|++......     ...+.+.+|+.++..++||||+++++++..+...++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence            567788999999999999988  5789999998765432     223678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      |+||+++++|.+++...  ..+++..++.++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus        77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999999999999865  468999999999999999999999 999999999999999999999999999998654333


Q ss_pred             Ccc-CCCCCCcccCC
Q 046106          290 GMT-PETGTYRWMAP  303 (303)
Q Consensus       290 ~~~-~~~gt~~y~AP  303 (303)
                      ... ...++..|+||
T Consensus       155 ~~~~~~~~~~~y~~p  169 (264)
T cd06623         155 DQCNTFVGTVTYMSP  169 (264)
T ss_pred             CcccceeecccccCH
Confidence            222 34577888887

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.94  E-value=2.3e-26  Score=207.77  Aligned_cols=159  Identities=28%  Similarity=0.445  Sum_probs=135.1

Q ss_pred             ccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 046106          136 MGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      ....||+|+||.||++..  ++..||||.+.....      .....+.+|+.+++.++||||+++++.+..+...|+|||
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ------QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH------HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            345699999999999987  678999999864321      123568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-Ccc
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMT  292 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~~~  292 (303)
                      |+++++|.+++..   ..+++..+..++.||+.||+|||+++++||||||+||++++++.+||+|||++....... ...
T Consensus       100 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658         100 FLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             CCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence            9999999998854   347899999999999999999999999999999999999999999999999987543222 223


Q ss_pred             CCCCCCcccCC
Q 046106          293 PETGTYRWMAP  303 (303)
Q Consensus       293 ~~~gt~~y~AP  303 (303)
                      ...|++.|+||
T Consensus       177 ~~~~~~~y~aP  187 (292)
T cd06658         177 SLVGTPYWMAP  187 (292)
T ss_pred             eeecCccccCH
Confidence            34688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.94  E-value=8.4e-27  Score=201.12  Aligned_cols=172  Identities=23%  Similarity=0.431  Sum_probs=146.4

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGA  201 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~  201 (303)
                      .....+.++++.+..||.|+.|.||++++  +|..+|||.+++..+..+.     ++++..+.++... ..|.||+.+|+
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~-----kRILmDldvv~~s~dcpyIV~c~Gy  159 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN-----KRILMDLDVVLKSHDCPYIVQCFGY  159 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH-----HHHHHhhhHHhhccCCCeeeeeeeE
Confidence            34456677888889999999999999998  6689999999887765443     4666777776555 48999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      |..+..++|.||.|. ..+..+++.. .+++|+..+-++...+++||.||.+ +||||||+||+|||+|+.|.+||||||
T Consensus       160 Fi~n~dV~IcMelMs-~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  160 FITNTDVFICMELMS-TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             EeeCchHHHHHHHHH-HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence            999888899999994 4666666654 4679999999999999999999996 589999999999999999999999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .+-...+....+...|.+.||||
T Consensus       238 IsGrlvdSkAhtrsAGC~~YMaP  260 (391)
T KOG0983|consen  238 ISGRLVDSKAHTRSAGCAAYMAP  260 (391)
T ss_pred             ccceeecccccccccCCccccCc
Confidence            99888888878888999999998

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.94  E-value=6.1e-26  Score=199.83  Aligned_cols=167  Identities=25%  Similarity=0.458  Sum_probs=140.5

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||++.+  ++..+|+|.+........    ..+.+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~l   76 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK----EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFI   76 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch----hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEE
Confidence            366778899999999999988  578999999876432221    12467789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccCCceeeecCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVARIEVQTE  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl~DFGla~~~~~~~  289 (303)
                      |+||+++++|.+++.......+++..+..++.|++.||+|||+.+++|+||+|+||++++++ .+||+|||.+.......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999999999876555689999999999999999999999999999999999999885 56999999987654332


Q ss_pred             C-ccCCCCCCcccCC
Q 046106          290 G-MTPETGTYRWMAP  303 (303)
Q Consensus       290 ~-~~~~~gt~~y~AP  303 (303)
                      . .....|++.|+||
T Consensus       157 ~~~~~~~~~~~~~ap  171 (257)
T cd08225         157 ELAYTCVGTPYYLSP  171 (257)
T ss_pred             ccccccCCCccccCH
Confidence            2 2233588889987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=9.7e-26  Score=204.06  Aligned_cols=168  Identities=27%  Similarity=0.445  Sum_probs=136.3

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM-  206 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-  206 (303)
                      ..++|++.+.||+|+||.||++..  +++.||||.+........    ....+.+|+.++++++||||+++++++.... 
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC----chhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            345788889999999999999987  678999999865432211    1134568999999999999999999987643 


Q ss_pred             -------eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          207 -------VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       207 -------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                             ..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence                   3599999995 58888886543 46899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCC-----ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~-----~~~~~gt~~y~AP  303 (303)
                      |++........     .....++..|+||
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aP  192 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPP  192 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCc
Confidence            99976433221     1234567889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.6e-25  Score=195.09  Aligned_cols=165  Identities=38%  Similarity=0.621  Sum_probs=142.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|++|.||+++.  .++.+|+|.+.......    .....+.+|++++.+++|||++++++++..+...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE----EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYI   76 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH----HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEE
Confidence            366778999999999999987  56799999997654331    223578999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ++||+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus        77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999999999765  4689999999999999999999999999999999999999999999999999986543322


Q ss_pred             -ccCCCCCCcccCC
Q 046106          291 -MTPETGTYRWMAP  303 (303)
Q Consensus       291 -~~~~~gt~~y~AP  303 (303)
                       .....++..|+||
T Consensus       155 ~~~~~~~~~~y~~p  168 (254)
T cd06627         155 DDASVVGTPYWMAP  168 (254)
T ss_pred             cccccccchhhcCH
Confidence             2334678889887

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.94  E-value=4e-26  Score=206.69  Aligned_cols=158  Identities=23%  Similarity=0.428  Sum_probs=135.0

Q ss_pred             cceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          137 GDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      ...||+|+||.||++..  +++.||+|++.......      .+.+.+|+.++..++||||+++++.+..+...|+++||
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            44699999999999987  67899999986533221      24678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-CccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~~~~  293 (303)
                      +++++|.+++..   ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++....... ....
T Consensus       100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            999999988765   358899999999999999999999999999999999999999999999999987543222 2233


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      ..|++.|+||
T Consensus       177 ~~~~~~y~aP  186 (297)
T cd06659         177 LVGTPYWMAP  186 (297)
T ss_pred             eecCccccCH
Confidence            4688999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.94  E-value=1.4e-25  Score=199.40  Aligned_cols=170  Identities=21%  Similarity=0.376  Sum_probs=139.7

Q ss_pred             ccccceecccCceEEEEEEEC---CeEEEEEEeeCCCCChH----HHHHHHHHHHHHHHHHHc-CCCCCeeeeeEEEEcC
Q 046106          134 LNMGDAFAQGAFGKLYRGTYN---GEEVAIKILERPENDPE----KAQVMEQQFQQEVMMLAT-LKHPNIVRFIGACRKP  205 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~----~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~~  205 (303)
                      |.+.+.||+|+||.||++.+.   ++.+|+|.+........    .......++.+|+.++.+ ++||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            567788999999999999983   47899998865432211    112233567788888865 7999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ...+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+ .+++|+||+|+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence            9999999999999999988642  23468899999999999999999996 78999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .............|+..|+||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~P  182 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCP  182 (269)
T ss_pred             eecccccccccccCcccCcCh
Confidence            876554444455788899988

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.94  E-value=6.8e-26  Score=208.60  Aligned_cols=163  Identities=28%  Similarity=0.435  Sum_probs=134.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP----  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----  205 (303)
                      ++|.+.+.||+|+||.||+|.+  +++.||||++......     .....+.+|+.+++.++||||+++++++...    
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-----hhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            5788889999999999999987  6789999998643221     1224677899999999999999999987654    


Q ss_pred             -CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          206 -MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       206 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                       ...|+++||+. ++|.+++..   ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence             34799999996 588877754   3589999999999999999999999999999999999999999999999999976


Q ss_pred             eecCCC----ccCCCCCCcccCC
Q 046106          285 EVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~----~~~~~gt~~y~AP  303 (303)
                      ......    .....||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aP  178 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAP  178 (336)
T ss_pred             ccccccccCCcCCcCcCCCccCh
Confidence            433221    1234688999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=2.5e-25  Score=200.11  Aligned_cols=165  Identities=30%  Similarity=0.430  Sum_probs=137.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--MVW  208 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~  208 (303)
                      +|...+.||.|++|.||++..  +++.+|+|++......     .....+.+|+++++.++||||+++++++...  ..+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   76 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI   76 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence            566778999999999999998  6789999998764332     1235788999999999999999999998653  468


Q ss_pred             EEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          209 CIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      |+||||+++++|.+++...  ....+++..+..++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            9999999999999987642  23457889999999999999999999999999999999999999999999999987543


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ... .....++..|+||
T Consensus       157 ~~~-~~~~~~~~~y~~p  172 (287)
T cd06621         157 NSL-AGTFTGTSFYMAP  172 (287)
T ss_pred             ccc-cccccCCccccCH
Confidence            221 2234577888887

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=1.1e-25  Score=203.29  Aligned_cols=164  Identities=29%  Similarity=0.471  Sum_probs=139.6

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ..+|.+.+.||+|+||.||++..  +++.||+|.+.......      .+.+.+|+.+++.++||||+++++.+......
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK------KELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH------HHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            35777888999999999999986  67899999986432211      25678999999999999999999999998899


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+|+||+++++|.+++...   .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++......
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            9999999999999998753   4789999999999999999999999999999999999999999999999998754332


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......|++.|+||
T Consensus       169 ~~~~~~~~~~~~y~~P  184 (293)
T cd06647         169 QSKRSTMVGTPYWMAP  184 (293)
T ss_pred             ccccccccCChhhcCc
Confidence            2 22234688889998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=8e-26  Score=204.22  Aligned_cols=168  Identities=24%  Similarity=0.398  Sum_probs=137.6

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM-  206 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-  206 (303)
                      ...+|.+.+.||+|+||.||+|.+  +++.||+|.++.......    ....+.+|+.+++.++||||+++++++.... 
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~   80 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----FPITAIREIKILRQLNHRNIVNLKEIVTDKQD   80 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC----chHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence            345788889999999999999998  578999999976432211    1246678999999999999999999987654 


Q ss_pred             ---------eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          207 ---------VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       207 ---------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                               .+|+|+||+++ ++.+++... ...+++..+..++.|++.||+|||+.||+|+||||+||++++++.+||+
T Consensus        81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             hhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence                     78999999975 788877654 2468999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCC--ccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      |||++........  .....++..|+||
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~P  186 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPP  186 (302)
T ss_pred             cccccccccCCcccccccceeccCccCh
Confidence            9999976543321  2223457788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-25  Score=200.11  Aligned_cols=164  Identities=26%  Similarity=0.422  Sum_probs=137.8

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--MVWC  209 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~~  209 (303)
                      |.+.+.||+|+||.||+|.+  +++.+|+|.+........    ..+.+.+|+.+++.++|||++++++++...  ...+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   76 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY   76 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc----chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEE
Confidence            45678899999999999998  568999999987542211    124678899999999999999999999887  7899


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +|+||++ ++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++.......
T Consensus        77 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          77 MVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             EEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9999997 48988887543 468999999999999999999999999999999999999999999999999998654432


Q ss_pred             --CccCCCCCCcccCC
Q 046106          290 --GMTPETGTYRWMAP  303 (303)
Q Consensus       290 --~~~~~~gt~~y~AP  303 (303)
                        ..+...++..|+||
T Consensus       155 ~~~~~~~~~~~~y~~P  170 (287)
T cd07840         155 SADYTNRVITLWYRPP  170 (287)
T ss_pred             cccccccccccccCCc
Confidence              12334567889988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.94  E-value=7.4e-26  Score=199.59  Aligned_cols=159  Identities=26%  Similarity=0.464  Sum_probs=135.3

Q ss_pred             ecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCC
Q 046106          140 FAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       140 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      ||.|+||.||++.+  +++.+|+|++.......   ....+.+.+|+.+++.++||||+++++.+......|+++||+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR---KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh---hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence            68999999999998  48899999987543321   22346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC--------
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE--------  289 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~--------  289 (303)
                      ++|.+++....  .+++..+..++.||+.||+|||+.+++|+||+|+||++++++.+||+|||++.......        
T Consensus        78 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          78 GDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99999998653  68999999999999999999999999999999999999999999999999987543321        


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       ......++..|+||
T Consensus       156 ~~~~~~~~~~~~~~P  170 (265)
T cd05579         156 KEDKRIVGTPDYIAP  170 (265)
T ss_pred             ccccCcccCccccCH
Confidence             12233577888887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.94  E-value=3.7e-25  Score=193.94  Aligned_cols=164  Identities=35%  Similarity=0.591  Sum_probs=142.5

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--CeEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--MVWC  209 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~~  209 (303)
                      |...+.||+|++|.||+|..  +++.|++|++.......    ...+.+.+|+.++++++||||+++++.+...  ...+
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE----EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN   77 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccch----HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence            55678899999999999998  47899999997655431    2236888999999999999999999999988  8899


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +++||+++++|.+++....  .+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999999998753  68999999999999999999999999999999999999999999999999998765443


Q ss_pred             C---ccCCCCCCcccCC
Q 046106          290 G---MTPETGTYRWMAP  303 (303)
Q Consensus       290 ~---~~~~~gt~~y~AP  303 (303)
                      .   .....++..|+||
T Consensus       156 ~~~~~~~~~~~~~y~~p  172 (260)
T cd06606         156 TGEGTGSVRGTPYWMAP  172 (260)
T ss_pred             ccccccCCCCCccccCH
Confidence            2   3445678889887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-27  Score=218.45  Aligned_cols=176  Identities=23%  Similarity=0.325  Sum_probs=144.9

Q ss_pred             Ccceee---cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHH-H-HHHHHHHHHHHHHHHcCC---CCC
Q 046106          125 DEWTID---LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEK-A-QVMEQQFQQEVMMLATLK---HPN  194 (303)
Q Consensus       125 ~~~~i~---~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~-~-~~~~~~~~~E~~il~~l~---hpn  194 (303)
                      ..|+..   ..+|..++.+|.|+||+|+.|.+  +...|+||.+.+...-... . +...-.+.-|++||..++   |+|
T Consensus       551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N  630 (772)
T KOG1152|consen  551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN  630 (772)
T ss_pred             ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence            345554   34568889999999999999998  5568999998764321100 0 001124557999999998   999


Q ss_pred             eeeeeEEEEcCCeEEEEEeec-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc
Q 046106          195 IVRFIGACRKPMVWCIVTEYA-KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS  273 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~  273 (303)
                      |++++++|++++.+||+||-- ++.+|++|+...  ..+.+..+..|+.||+.|+++||++||||||||-+|+.|+.+|.
T Consensus       631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             hhhhhheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe
Confidence            999999999999999999964 567999999865  45899999999999999999999999999999999999999999


Q ss_pred             EEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          274 IKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       274 vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +||+|||.|....+. ....++||..|.||
T Consensus       709 ~klidfgsaa~~ksg-pfd~f~gtv~~aap  737 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSG-PFDVFVGTVDYAAP  737 (772)
T ss_pred             EEEeeccchhhhcCC-Ccceeeeeccccch
Confidence            999999999876544 35677999999998

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=5.2e-26  Score=224.69  Aligned_cols=174  Identities=34%  Similarity=0.611  Sum_probs=149.3

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCC
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPN  194 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn  194 (303)
                      +.|+++.+++.+.+.||+|+||+|++|...         ...||||.++......+     .+.+..|+.+|+.+ +|||
T Consensus       289 ~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~-----~~~~~~El~~m~~~g~H~n  363 (609)
T KOG0200|consen  289 PKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSE-----KKDLMSELNVLKELGKHPN  363 (609)
T ss_pred             CceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHH-----HHHHHHHHHHHHHhcCCcc
Confidence            389999999999999999999999999741         34799999987655432     36899999999998 5999


Q ss_pred             eeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 046106          195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ------------N--RSVPLKLAVKQALDVARGMAYVHRLGLIHRD  260 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~qi~~~l~~LH~~giiHrD  260 (303)
                      |+.++|+|.+...+++|+||+..|+|.+||+..+            .  ..++...++.++.||+.||+||++..+||||
T Consensus       364 iv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRD  443 (609)
T KOG0200|consen  364 IVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRD  443 (609)
T ss_pred             hhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchh
Confidence            9999999999989999999999999999999765            0  1388899999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCceeeecCCCccCC--C--CCCcccCC
Q 046106          261 LKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--T--GTYRWMAP  303 (303)
Q Consensus       261 lkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~--~--gt~~y~AP  303 (303)
                      |.++||||.++..+||+|||+|+...+...+...  .  -..+||||
T Consensus       444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP  490 (609)
T ss_pred             hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH
Confidence            9999999999999999999999965554444322  2  24679998

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.1e-25  Score=196.10  Aligned_cols=160  Identities=34%  Similarity=0.573  Sum_probs=133.5

Q ss_pred             ceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecC
Q 046106          138 DAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAK  216 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~  216 (303)
                      ++||+|+||.||++.+ .++.||+|.++.....     .....+.+|+.++++++||||+++++++......++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence            3689999999999987 4789999998765432     123578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc---cC
Q 046106          217 GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM---TP  293 (303)
Q Consensus       217 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~---~~  293 (303)
                      +++|.+++.... ..+++..+..++.|++.+|+|||+++++||||+|+|||++.++.+||+|||+++........   ..
T Consensus        76 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          76 GGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            999999997643 35789999999999999999999999999999999999999999999999999754321111   11


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      ...+..|+||
T Consensus       155 ~~~~~~y~~P  164 (251)
T cd05041         155 KQIPIKWTAP  164 (251)
T ss_pred             CcceeccCCh
Confidence            2234568877

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.5e-25  Score=196.80  Aligned_cols=158  Identities=26%  Similarity=0.458  Sum_probs=129.9

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHH-HHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-LATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.||+|+||.||+|+.  +++.||+|++++......   .....+..|..+ ....+|||++++++++.....+|+|+||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   78 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK---NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY   78 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH---HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence            5689999999999987  678999999875432211   111234455444 4556899999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE  294 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~  294 (303)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.+||+|||+++....   ....
T Consensus        79 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          79 LNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence            9999999999764  3589999999999999999999999999999999999999999999999999875432   2234


Q ss_pred             CCCCcccCC
Q 046106          295 TGTYRWMAP  303 (303)
Q Consensus       295 ~gt~~y~AP  303 (303)
                      .+++.|+||
T Consensus       154 ~~~~~y~~p  162 (260)
T cd05611         154 VGTPDYLAP  162 (260)
T ss_pred             CCCcCccCh
Confidence            678888887

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.94  E-value=1.4e-25  Score=200.72  Aligned_cols=165  Identities=28%  Similarity=0.449  Sum_probs=138.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |++.+.||.|++|.||+|.+  +++.||+|++........    ....+.+|+.+++.++|||++++++++..+...|++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv   76 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLV   76 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEE
Confidence            45678899999999999987  688999999875432211    124677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-CC
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-EG  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-~~  290 (303)
                      +||++ ++|.+++.......+++..+..++.|++.||+|||+++++||||+|+||++++++.+||+|||+++..... ..
T Consensus        77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          77 FEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             EeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            99995 69999998765446899999999999999999999999999999999999999999999999999754322 12


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....+++.|+||
T Consensus       156 ~~~~~~~~~~~aP  168 (283)
T cd07835         156 YTHEVVTLWYRAP  168 (283)
T ss_pred             cCccccccCCCCC
Confidence            2334568889998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.94  E-value=1.5e-25  Score=203.81  Aligned_cols=165  Identities=20%  Similarity=0.323  Sum_probs=136.3

Q ss_pred             cccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          135 NMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .+++.+|.|+++.|+++..+++.||||+++........    ...+.+|+.+++.++||||+++++++......+++|||
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKED----LKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhH----HHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence            34555666677777777778999999999865333222    35788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC----
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG----  290 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~----  290 (303)
                      +++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+........    
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999999999876555689999999999999999999999999999999999999999999999999865432211    


Q ss_pred             ----ccCCCCCCcccCC
Q 046106          291 ----MTPETGTYRWMAP  303 (303)
Q Consensus       291 ----~~~~~gt~~y~AP  303 (303)
                          .....++..|+||
T Consensus       161 ~~~~~~~~~~~~~y~aP  177 (314)
T cd08216         161 VHDFPKSSVKNLPWLSP  177 (314)
T ss_pred             cccccccccccccccCH
Confidence                1223467788887

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.93  E-value=2.5e-25  Score=197.93  Aligned_cols=166  Identities=23%  Similarity=0.479  Sum_probs=131.8

Q ss_pred             ccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--
Q 046106          134 LNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM--  206 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--  206 (303)
                      |.+.+.||+|+||.||+|.+     +++.||||+++........    .+.+.+|+.+++.++||||+++++++....  
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   76 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD----IEEFLREAACMKEFDHPNVIKLIGVSLRSRAK   76 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH----HHHHHHHHHHHhcCCCCCcceEEEEEccCCCC
Confidence            45677899999999999985     3578999999765443322    256889999999999999999999886532  


Q ss_pred             ----eEEEEEeecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          207 ----VWCIVTEYAKGGSVRQFLTKRQ----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       207 ----~~~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                          ..++++||+++++|.+++....    ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECc
Confidence                3478899999999998875321    12478899999999999999999999999999999999999999999999


Q ss_pred             cCCceeeecCCC---ccCCCCCCcccCC
Q 046106          279 FGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||+++.......   .....+++.|++|
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLAL  184 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCH
Confidence            999986432221   1122345667776

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=5.5e-26  Score=201.17  Aligned_cols=156  Identities=24%  Similarity=0.459  Sum_probs=129.1

Q ss_pred             ceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          138 DAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      +.||.|+||.||+|.+.         ...+|+|.+....      ....+.+.+|+.+++.+.||||+++++++..+...
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~   74 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDES   74 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCc
Confidence            36899999999999762         2248888774321      12235788899999999999999999999988888


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc--------EEEeccC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS--------IKIADFG  280 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~--------vKl~DFG  280 (303)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.        +|++|||
T Consensus        75 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          75 IMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             EEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            99999999999999998653 35889999999999999999999999999999999999987765        6999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ++.....   .....+++.|+||
T Consensus       154 ~~~~~~~---~~~~~~~~~y~aP  173 (258)
T cd05078         154 ISITVLP---KEILLERIPWVPP  173 (258)
T ss_pred             cccccCC---chhccccCCccCc
Confidence            9865432   2234678889988

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.93  E-value=1.1e-25  Score=199.96  Aligned_cols=160  Identities=33%  Similarity=0.582  Sum_probs=130.8

Q ss_pred             eecccCceEEEEEEECC--------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          139 AFAQGAFGKLYRGTYNG--------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      .||+|+||.||+|++..        +.+|||.+.......     ....+.+|+.+++.++||||+++++++......++
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-----EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI   76 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchh-----hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence            58999999999998632        579999886543211     12478899999999999999999999998888999


Q ss_pred             EEeecCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-----cEEEeccC
Q 046106          211 VTEYAKGGSVRQFLTKRQ-----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-----SIKIADFG  280 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-----~vKl~DFG  280 (303)
                      ||||+++++|.+++....     ...+++..++.++.|++.||+|||+.+++|+||||+||+++.++     .+||+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999999997532     23478899999999999999999999999999999999999887     89999999


Q ss_pred             CceeeecCCC---ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +++.......   .....++..|+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             cccccccccccccCcccCCCccccCH
Confidence            9975432221   1122446788887

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=8.2e-26  Score=201.29  Aligned_cols=150  Identities=30%  Similarity=0.459  Sum_probs=132.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVW  208 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~  208 (303)
                      ++|.+.+.||+|+||.||+++.  +++.||+|++.+......   ...+.+.+|+.++++++ ||||+++++++..+...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   77 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE---KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENL   77 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch---HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceE
Confidence            3577888999999999999987  688999999876432221   12357889999999998 99999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ++|||++++++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          78 YFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999999999865  368999999999999999999999999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=224.05  Aligned_cols=163  Identities=30%  Similarity=0.593  Sum_probs=138.1

Q ss_pred             CccccceecccCceEEEEEEE--CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      .++..++||+|+||.||+|.|  .++    +||||++.........     ..+++|+-+|.+++|||+++|+++|....
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s-----~e~LdeAl~masldHpnl~RLLgvc~~s~  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKAS-----IELLDEALRMASLDHPNLLRLLGVCMLST  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhh-----HHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence            456678899999999999998  443    7999998765443222     57899999999999999999999998876


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                       +.||++||+.|+|.+|++..+ ..+-.+..+.++.||++||.|||.++++||||.++|+||.+-..+||.|||+|+...
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence             679999999999999999865 468889999999999999999999999999999999999999999999999999765


Q ss_pred             cCC-CccCCCC--CCcccC
Q 046106          287 QTE-GMTPETG--TYRWMA  302 (303)
Q Consensus       287 ~~~-~~~~~~g--t~~y~A  302 (303)
                      .++ .++...|  .+.|||
T Consensus       850 ~d~~ey~~~~gK~pikwma  868 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMA  868 (1177)
T ss_pred             cccccccccccccCcHHHH
Confidence            543 2333333  367775

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.93  E-value=6.2e-25  Score=200.64  Aligned_cols=163  Identities=29%  Similarity=0.464  Sum_probs=137.4

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      .|...+.||+|+||.||++++  +++.+|+|.+........   .....+.+|+.+++.++|||++++++++..+...++
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch---HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            356678899999999999987  678999999876433222   123578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ||||++ ++|.+++.... ..+++..+..++.|++.||.|||+++++||||+|+||+++.++.+||+|||++.....   
T Consensus       103 v~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         103 VMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             EEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            999996 58888876543 4589999999999999999999999999999999999999999999999999875332   


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....|++.|+||
T Consensus       178 ~~~~~~~~~y~aP  190 (317)
T cd06635         178 ANSFVGTPYWMAP  190 (317)
T ss_pred             cccccCCccccCh
Confidence            2334688889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.93  E-value=2.1e-25  Score=204.66  Aligned_cols=142  Identities=20%  Similarity=0.341  Sum_probs=124.9

Q ss_pred             ceeccc--CceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 046106          138 DAFAQG--AFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       138 ~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      ..||.|  +||+||++.+  .++.||+|++........    ..+.+.+|+.+++.++||||+++++++..+...|+|+|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e   79 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE----HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP   79 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence            356666  9999999988  789999999876544332    23578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      |+.+++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.+|++||+.+.
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            9999999999987654568999999999999999999999999999999999999999999999998653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=3.4e-25  Score=198.17  Aligned_cols=165  Identities=30%  Similarity=0.506  Sum_probs=135.6

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC---CCCCeeeeeEEEEcCCe-
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL---KHPNIVRFIGACRKPMV-  207 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~~~~-  207 (303)
                      |++.+.||+|+||.||+|++  +++.+|+|.++........    ...+.+|+.+++.+   +||||+++++++..... 
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   76 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI----PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD   76 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh----hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence            45677899999999999998  4789999999765432211    13455677776655   59999999999987766 


Q ss_pred             ----EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          208 ----WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       208 ----~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                          ++++|||+. ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++.
T Consensus        77 ~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          77 RELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             CCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence                899999996 589999876544568999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ............+++.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~P  175 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAP  175 (287)
T ss_pred             eccCCcccccccccccccCh
Confidence            76444333444678889988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=205.49  Aligned_cols=174  Identities=20%  Similarity=0.365  Sum_probs=149.8

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGA  201 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~  201 (303)
                      ..|.+...+|.+++.||+|+|.+|..++.  +.+.+|+|++++...+...   -....+.|-.+..+. +||.+|.|+.+
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde---didwvqtek~vfe~asn~pflvglhsc  319 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNNPFLVGLHSC  319 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc---cchhHHhhHHHHHhccCCCeEEehhhh
Confidence            46788899999999999999999999987  6679999999876433211   124566777777665 69999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      |+++..+++|.||++||+|.-.++..  +.+|++.+..+...|+.||.|||++|||.||||.+|+|++..|++||+|+|+
T Consensus       320 fqtesrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  320 FQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             hcccceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence            99999999999999999997666544  5699999999999999999999999999999999999999999999999999


Q ss_pred             ceeee-cCCCccCCCCCCcccCC
Q 046106          282 ARIEV-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~-~~~~~~~~~gt~~y~AP  303 (303)
                      ++... +...+++.||||.|.||
T Consensus       398 cke~l~~gd~tstfcgtpnyiap  420 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAP  420 (593)
T ss_pred             hhcCCCCCcccccccCCCcccch
Confidence            98753 44556778999999998

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=1.9e-25  Score=196.42  Aligned_cols=166  Identities=26%  Similarity=0.490  Sum_probs=141.3

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|++.+.||+|+||.||++..  +++.+|+|.+........    ....+.+|+.+++.++||||+++++++......++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK----EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCI   76 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH----HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEE
Confidence            366778899999999999987  677999999876543322    12567789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          211 VTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||+++++|.+++....  ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999999987632  246889999999999999999999999999999999999999999999999999865543


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                       ......+++.|+||
T Consensus       157 -~~~~~~~~~~~~~P  170 (256)
T cd08530         157 -MAKTQIGTPHYMAP  170 (256)
T ss_pred             -CcccccCCccccCH
Confidence             33345678888887

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2.4e-25  Score=205.76  Aligned_cols=167  Identities=26%  Similarity=0.452  Sum_probs=137.5

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .|++ .++|.+.+.||+|+||.||++..  +++.||||++.......    .....+.+|+.+|+.++||||+++++++.
T Consensus        10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07880          10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence            3444 45688889999999999999987  67899999986543221    12346789999999999999999999987


Q ss_pred             cCC------eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          204 KPM------VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       204 ~~~------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                      ...      .+++|+||+ +++|.+++..   ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+
T Consensus        85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             CCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEe
Confidence            543      358999999 7799888764   358999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||++......  .....+++.|+||
T Consensus       161 dfg~~~~~~~~--~~~~~~~~~y~aP  184 (343)
T cd07880         161 DFGLARQTDSE--MTGYVVTRWYRAP  184 (343)
T ss_pred             ecccccccccC--ccccccCCcccCH
Confidence            99999754322  2334678889887

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=5.5e-25  Score=192.03  Aligned_cols=163  Identities=31%  Similarity=0.600  Sum_probs=141.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |.+.+.||+|++|.||++.+  +++.+++|++.....      ...+.+.+|+.+++.++||+|+++++.+......+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            56678899999999999998  478999999976443      1235788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      +||+++++|.+++.... ..+++..+..++.|++.||++||+.|++|+||+|+||++++++.+||+|||.+.........
T Consensus        76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  154 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR  154 (253)
T ss_pred             EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccc
Confidence            99999999999988653 46899999999999999999999999999999999999999999999999999865543323


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ....++..|+||
T Consensus       155 ~~~~~~~~~~~P  166 (253)
T cd05122         155 NTMVGTPYWMAP  166 (253)
T ss_pred             cceecCCcccCH
Confidence            445678888887

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.2e-27  Score=212.08  Aligned_cols=171  Identities=29%  Similarity=0.396  Sum_probs=141.7

Q ss_pred             eeecCCccccceecccCceEEEEEEECC--eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTYNG--EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  204 (303)
                      .+...+|+++..||+|+||+|.++...|  +.+|||++++.-......   .+--..|-++|... +-|.+++++.++++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD---vectm~EKrvLAL~~kppFL~qlHScFQT  421 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD---VECTMVEKRVLALPGKPPFLVQLHSCFQT  421 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc---ccceehhhhheecCCCCchHHHHHHHhhh
Confidence            6778899999999999999999998744  579999998763211110   01222455566555 57899999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .+.+|+||||+.||+|--.+++.  +.+.++.++.+|++|+.||-|||++|||+||||.+|||++.+|++||+|||+++.
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc
Confidence            99999999999999998777765  5688999999999999999999999999999999999999999999999999986


Q ss_pred             ee-cCCCccCCCCCCcccCC
Q 046106          285 EV-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~-~~~~~~~~~gt~~y~AP  303 (303)
                      .. ....+.+.||||.|+||
T Consensus       500 ni~~~~TTkTFCGTPdYiAP  519 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAP  519 (683)
T ss_pred             cccCCcceeeecCCCccccc
Confidence            43 33345567999999999

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.93  E-value=2.3e-25  Score=200.23  Aligned_cols=166  Identities=22%  Similarity=0.378  Sum_probs=137.9

Q ss_pred             ccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCe
Q 046106          134 LNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMV  207 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~  207 (303)
                      |.+.+.||+|+||.||+++.     +++.||||++++....  ......+.+.+|+.++.++ .||+|+++++.+.....
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~   79 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV--QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK   79 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH--hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence            56778899999999999875     4578999998753221  1122235788999999999 59999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +|+||||+++++|.+++...  ..+++..+..++.|++.+|+|||+.+++||||+|+||+++.++.++|+|||+++....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999999998754  4588999999999999999999999999999999999999999999999999876443


Q ss_pred             CCC--ccCCCCCCcccCC
Q 046106          288 TEG--MTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~--~~~~~gt~~y~AP  303 (303)
                      ...  .....|++.|+||
T Consensus       158 ~~~~~~~~~~~~~~y~aP  175 (288)
T cd05583         158 EEEERAYSFCGTIEYMAP  175 (288)
T ss_pred             ccccccccccCCccccCH
Confidence            322  1223578889987

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=1.8e-25  Score=205.99  Aligned_cols=165  Identities=26%  Similarity=0.383  Sum_probs=136.4

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP----  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----  205 (303)
                      .+|.+.+.||+|+||.||+++.  +++.||||.++........    ...+.+|+.+++.++||||+++++++...    
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID----AKRTLREIKLLRHLDHENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch----hHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence            3678888999999999999987  6789999998754322211    24567899999999999999999988654    


Q ss_pred             -CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          206 -MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       206 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                       ...|+|+||+. ++|.+++...  ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          81 FNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             cCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence             24799999995 6899888754  4689999999999999999999999999999999999999999999999999976


Q ss_pred             eecC-CCccCCCCCCcccCC
Q 046106          285 EVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~-~~~~~~~gt~~y~AP  303 (303)
                      .... .......++..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~y~aP  177 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAP  177 (337)
T ss_pred             cCCCcccccccccccCccCh
Confidence            5432 122334678899998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.93  E-value=5.3e-27  Score=201.62  Aligned_cols=175  Identities=23%  Similarity=0.345  Sum_probs=146.6

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHH-HcCCCCCeeeee
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML-ATLKHPNIVRFI  199 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~  199 (303)
                      .-..|++...+++-+..||.|+||.|++..+  .|+.+|||.++......++     ++++.|.+.. +.-+.||||++|
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq-----~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ-----KRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH-----HHHHHHHHHHHhhcCCcHHHHHh
Confidence            3456888888998899999999999999987  7889999999876653332     5677777655 555799999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEE
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLT---KRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vK  275 (303)
                      |.+..+..-||.||+| ..+|..+.+   ..++..+|+..+-.|+...+.||+||... .|||||+||+|||++..|.+|
T Consensus       130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence            9998888889999999 457765543   44556799999999999999999999964 899999999999999999999


Q ss_pred             EeccCCceeeecCCCccCCCCCCcccCC
Q 046106          276 IADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||||.+-...+.-..+...|...||||
T Consensus       209 LCDFGIcGqLv~SiAkT~daGCrpYmAP  236 (361)
T KOG1006|consen  209 LCDFGICGQLVDSIAKTVDAGCRPYMAP  236 (361)
T ss_pred             eecccchHhHHHHHHhhhccCCccccCh
Confidence            9999999877666666777899999998

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.93  E-value=1.4e-25  Score=206.38  Aligned_cols=165  Identities=25%  Similarity=0.396  Sum_probs=136.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc----C
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK----P  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~  205 (303)
                      .+|.+.+.||+|+||.||+|..  +++.||+|++........    ..+.+.+|+.+|+.++||||+++++++..    .
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT----LAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc----chHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            5677788999999999999987  688999999875432221    12467789999999999999999998753    3


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+++|+||+. ++|.+++...  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            46899999995 6898888654  45899999999999999999999999999999999999999999999999999765


Q ss_pred             ecCCC-----ccCCCCCCcccCC
Q 046106          286 VQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~-----~~~~~gt~~y~AP  303 (303)
                      .....     .....|+..|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~P  180 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAP  180 (334)
T ss_pred             cccCcCCCcccccccccccccCh
Confidence            43221     1234678889988

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.93  E-value=4.1e-25  Score=203.13  Aligned_cols=166  Identities=24%  Similarity=0.354  Sum_probs=135.0

Q ss_pred             cccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHH--------HHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQV--------MEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~--------~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      .+.+.||.|+||.||+|.+  .++.||||+++...........        ....+.+|+.+++.++||||+++++++..
T Consensus        12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence            3457799999999999986  6789999998765432211000        01257789999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ...+|+||||+. ++|.+++...  ..+++.....++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||+++.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceee
Confidence            999999999996 6999998754  4589999999999999999999999999999999999999999999999999875


Q ss_pred             eec---------------CCCccCCCCCCcccCC
Q 046106          285 EVQ---------------TEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~---------------~~~~~~~~gt~~y~AP  303 (303)
                      ...               ........+++.|+||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  202 (335)
T PTZ00024        169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP  202 (335)
T ss_pred             cccccccccccccccccccccccccccccCCCCC
Confidence            431               1112233567889888

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.93  E-value=6.2e-25  Score=197.60  Aligned_cols=161  Identities=27%  Similarity=0.462  Sum_probs=135.7

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      +...+.||+|++|.||++..  +++.+|+|.+......      ..+.+.+|+.+++.+.||||+++++++......|++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence            33346799999999999986  5678999988643221      124678999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-C
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-G  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~  290 (303)
                      +||+++++|.+++..   ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++....... .
T Consensus        95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            999999999999876   358899999999999999999999999999999999999999999999999886543221 1


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....|++.|+||
T Consensus       172 ~~~~~~~~~y~aP  184 (285)
T cd06648         172 RKSLVGTPYWMAP  184 (285)
T ss_pred             cccccCCccccCH
Confidence            2234688899987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.93  E-value=4.9e-25  Score=203.84  Aligned_cols=163  Identities=26%  Similarity=0.387  Sum_probs=135.3

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  205 (303)
                      .++|.+.+.||+|+||.||++..  +++.||+|+++.......    ..+.+.+|+.++++++||||+++++++...   
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH----HHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            36788899999999999999986  678999999876432221    124677899999999999999999988543   


Q ss_pred             ---CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          206 ---MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       206 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                         ...|++++++ +++|.+++..   ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence               3468888887 7899888764   34899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +....  ......+++.|+||
T Consensus       168 ~~~~~--~~~~~~~~~~y~aP  186 (345)
T cd07877         168 RHTDD--EMTGYVATRWYRAP  186 (345)
T ss_pred             ccccc--cccccccCCCccCH
Confidence            75432  22344678889988

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=9.1e-27  Score=233.71  Aligned_cols=163  Identities=31%  Similarity=0.493  Sum_probs=139.5

Q ss_pred             cccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      .-+..||.|.||+||.|..  +|...|+|.++.....    ......+.+|..++..++|||+|++||+=.+.+..+|+|
T Consensus      1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~----~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD----HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc----cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3456799999999999986  8889999998765443    122357789999999999999999999998888889999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC--
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG--  290 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~--  290 (303)
                      |||++|+|.+.+...  +..++.....+..|++.|++|||++|||||||||.||+++.+|.+|+.|||.|..+..+..  
T Consensus      1314 EyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            999999999999864  3466777778899999999999999999999999999999999999999999987655431  


Q ss_pred             ---ccCCCCCCcccCC
Q 046106          291 ---MTPETGTYRWMAP  303 (303)
Q Consensus       291 ---~~~~~gt~~y~AP  303 (303)
                         .....||+.||||
T Consensus      1392 ~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAP 1407 (1509)
T ss_pred             CHHHHhhcCCchhcCc
Confidence               2334799999999

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.93  E-value=8.3e-25  Score=197.82  Aligned_cols=172  Identities=16%  Similarity=0.237  Sum_probs=125.8

Q ss_pred             eecCCccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHH-----HHHHHHHHHHHHHcCCCCCeeee
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQV-----MEQQFQQEVMMLATLKHPNIVRF  198 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~-----~~~~~~~E~~il~~l~hpniv~l  198 (303)
                      +..++|.+.+.||+|+||.||+|.+.     +..+|+|+.............     .......+...+..+.|++++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            45578889999999999999999873     346777765433221111000     01223344455667889999999


Q ss_pred             eEEEEcCC----eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 046106          199 IGACRKPM----VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI  274 (303)
Q Consensus       199 ~~~~~~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~v  274 (303)
                      ++++....    ..++++|++. .++.+.+...  ...++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            99776543    3467888874 4777776653  236788899999999999999999999999999999999999999


Q ss_pred             EEeccCCceeeecCC--------CccCCCCCCcccCC
Q 046106          275 KIADFGVARIEVQTE--------GMTPETGTYRWMAP  303 (303)
Q Consensus       275 Kl~DFGla~~~~~~~--------~~~~~~gt~~y~AP  303 (303)
                      ||+|||+|+......        ......||+.|+||
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap  202 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL  202 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence            999999998653221        11234699999997

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.93  E-value=3.6e-25  Score=203.73  Aligned_cols=164  Identities=28%  Similarity=0.426  Sum_probs=135.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcC--C
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP--M  206 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~--~  206 (303)
                      .+|.+.+.||+|+||.||+|.+  +++.+|+|.+.........    ...+.+|+.+++++ +||||+++++++...  .
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD----AQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh----hhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            5678889999999999999987  5789999988653322221    24567899999999 999999999998653  4


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+||||++ ++|.+++...   .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            6899999996 5999888753   57888999999999999999999999999999999999999999999999997643


Q ss_pred             cCC------CccCCCCCCcccCC
Q 046106          287 QTE------GMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~------~~~~~~gt~~y~AP  303 (303)
                      ...      ......||+.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aP  181 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAP  181 (337)
T ss_pred             cccccccCcchhcccccccccCc
Confidence            322      12234678899998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-26  Score=199.39  Aligned_cols=155  Identities=25%  Similarity=0.392  Sum_probs=133.7

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEc----CCeEEE
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRK----PMVWCI  210 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~----~~~~~i  210 (303)
                      ++||-|-.|+|..+..  +++.+|+|++..    .       +...+|+++--.. .|||||++++++..    ...+.|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D----s-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD----S-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhc----C-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            5799999999999976  788999999853    1       2344677764433 69999999999854    356889


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccCCceeeec
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEVQ  287 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---~~vKl~DFGla~~~~~  287 (303)
                      |||.|+||.|++-++.+....+++.++..|+.||+.|+.|||+.+|.||||||+|+|....   ..+||+|||+|+....
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999999999999888889999999999999999999999999999999999999654   5799999999998766


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                      .....+.|-||.|.||
T Consensus       217 ~~~L~TPc~TPyYvaP  232 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAP  232 (400)
T ss_pred             CccccCCcccccccCH
Confidence            6667778999999998

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.93  E-value=4.1e-26  Score=228.00  Aligned_cols=166  Identities=30%  Similarity=0.502  Sum_probs=133.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE------
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR------  203 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~------  203 (303)
                      .+|+.++.||+|+||.||+++.  +|+.+|||.|....     .+..-.++.+|+..|.+|+|||||+++..|.      
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            4677788999999999999987  99999999997644     2233368899999999999999999865430      


Q ss_pred             --------------------------------------------------c-----------------------------
Q 046106          204 --------------------------------------------------K-----------------------------  204 (303)
Q Consensus       204 --------------------------------------------------~-----------------------------  204 (303)
                                                                        .                             
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                              0                             


Q ss_pred             --------------------------C--------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 046106          205 --------------------------P--------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY  250 (303)
Q Consensus       205 --------------------------~--------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~  250 (303)
                                                +        ..+||-||||+...+.+++....-.. .....+++++||+.||+|
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHH
Confidence                                      0        23588899999877777776543111 367789999999999999


Q ss_pred             HHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee-------------------cCCCccCCCCCCcccCC
Q 046106          251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV-------------------QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       251 LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~-------------------~~~~~~~~~gt~~y~AP  303 (303)
                      +|++|+|||||||.||++++++.|||+|||+|....                   +....+..+||..|+||
T Consensus       713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            999999999999999999999999999999997511                   11134566899999999

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.93  E-value=1.1e-24  Score=195.57  Aligned_cols=165  Identities=32%  Similarity=0.499  Sum_probs=141.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ...|...+.||+|.+|.||++.+  .++.+|+|++.....       ....+.+|+++++.++||||+++++.+......
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            34567778899999999999998  478999999975433       225788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+++||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999999999998754 36899999999999999999999999999999999999999999999999998654322


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......+++.|+||
T Consensus       170 ~~~~~~~~~~~~y~~P  185 (286)
T cd06614         170 KSKRNSVVGTPYWMAP  185 (286)
T ss_pred             hhhhccccCCcccCCH
Confidence            1 12334577888887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2.6e-25  Score=203.75  Aligned_cols=164  Identities=28%  Similarity=0.424  Sum_probs=138.7

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM----  206 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~----  206 (303)
                      +|.+.+.||.|+||.||+|+.  +++.||||.+.......    ...+.+.+|+.+++.++||||+++++++....    
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL----IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF   76 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc----hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccc
Confidence            467788999999999999997  47899999987643322    12357889999999999999999999998765    


Q ss_pred             -eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 -VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                       .+|++|||++ ++|.+++...  ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++...
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          77 NDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             cceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence             7899999997 5898888754  36899999999999999999999999999999999999999999999999999875


Q ss_pred             ecCC----CccCCCCCCcccCC
Q 046106          286 VQTE----GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~----~~~~~~gt~~y~AP  303 (303)
                      ....    ......+|+.|+||
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aP  175 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAP  175 (330)
T ss_pred             cccccccccccccccccCcCCc
Confidence            5432    23344678889998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=5.8e-25  Score=198.71  Aligned_cols=158  Identities=25%  Similarity=0.414  Sum_probs=134.3

Q ss_pred             cceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          137 GDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      ..+||+|+||.||++..  +++.||||.+.....      .....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            35699999999999987  678999998754221      1235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-CccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~~~~  293 (303)
                      +++++|.+++..   ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++....... ....
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657          99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            999999998754   347899999999999999999999999999999999999999999999999987543322 2233


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      ..|++.|+||
T Consensus       176 ~~~~~~y~~p  185 (292)
T cd06657         176 LVGTPYWMAP  185 (292)
T ss_pred             cccCccccCH
Confidence            4678889987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=2.1e-24  Score=196.93  Aligned_cols=162  Identities=30%  Similarity=0.469  Sum_probs=135.9

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      +...+.||+|+||.||+|+.  +++.||+|.+.........   ..+.+.+|+.+++.++|||++++++++.+....|+|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE---KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            44456799999999999987  6789999998764432221   225678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      |||+. +++.+++.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++....   ..
T Consensus       100 ~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~  174 (313)
T cd06633         100 MEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PA  174 (313)
T ss_pred             EecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CC
Confidence            99995 58888876543 468999999999999999999999999999999999999999999999999986422   22


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ....|+..|+||
T Consensus       175 ~~~~~~~~y~aP  186 (313)
T cd06633         175 NSFVGTPYWMAP  186 (313)
T ss_pred             CCccccccccCh
Confidence            345688889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.93  E-value=7.5e-25  Score=201.31  Aligned_cols=164  Identities=25%  Similarity=0.360  Sum_probs=132.4

Q ss_pred             CccccceecccCceEEEEEEE--C--CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcC--
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--N--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP--  205 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~--  205 (303)
                      +|.+.+.||+|+||.||++++  .  +..||+|.+.......    ...+.+.+|+.+++.+ .||||+++++.+...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK----ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc----hhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            356778899999999999998  3  6689999986533221    1235677899999999 499999999976432  


Q ss_pred             --CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          206 --MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       206 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                        ..+++++||+. ++|.+++...  ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++
T Consensus        77 ~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          77 NFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             cCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence              45788999985 6899988654  468999999999999999999999999999999999999999999999999997


Q ss_pred             eeecCCC-----ccCCCCCCcccCC
Q 046106          284 IEVQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~-----~~~~~gt~~y~AP  303 (303)
                      .......     .....||+.|+||
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aP  178 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAP  178 (332)
T ss_pred             ecccccccccccccCcccCccccCc
Confidence            6432211     2234688999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.93  E-value=1.9e-26  Score=201.95  Aligned_cols=168  Identities=25%  Similarity=0.436  Sum_probs=135.9

Q ss_pred             cCCccccceecccCceEEEEEEE---C---CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY---N---GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~---~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      ...|+....||+|+||.||++..   +   ...+|||.++-...-.--    -....+|+.+++.++||||+.|..++.+
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi----S~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI----SMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc----CHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            44677788999999999999954   1   237899998765211100    1355689999999999999999999877


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC----CcEEE
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKR---QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD----KSIKI  276 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~----~~vKl  276 (303)
                       +..+|+++||.+. +|++.++..   ..+.+|...+..++.||+.|+.|||++=|+||||||.||||.-+    |.|||
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence             7789999999986 899888743   23568999999999999999999999999999999999999877    89999


Q ss_pred             eccCCceeeecCC----CccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTE----GMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~----~~~~~~gt~~y~AP  303 (303)
                      +|||+||...+.-    ...+.+-|.+|+||
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAP  208 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAP  208 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecCh
Confidence            9999999765322    12334668999998

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.2e-24  Score=190.67  Aligned_cols=159  Identities=30%  Similarity=0.436  Sum_probs=136.4

Q ss_pred             ecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCC
Q 046106          140 FAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       140 lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      ||+|+||.||++.+  +++.+|+|+++.......   .....+..|+.+++.++||||+++++.+..+...|++|||+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch---HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence            68999999999998  478999999876543221   1235788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-CCccCCCC
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETG  296 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-~~~~~~~g  296 (303)
                      ++|.+++...  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus        78 ~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          78 GELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            9999999865  35899999999999999999999999999999999999999999999999999765433 22334567


Q ss_pred             CCcccCC
Q 046106          297 TYRWMAP  303 (303)
Q Consensus       297 t~~y~AP  303 (303)
                      +..|+||
T Consensus       156 ~~~~~~P  162 (250)
T cd05123         156 TPEYLAP  162 (250)
T ss_pred             CccccCh
Confidence            8889887

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.93  E-value=5.5e-25  Score=199.22  Aligned_cols=167  Identities=27%  Similarity=0.390  Sum_probs=134.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  205 (303)
                      .++|.+.+.||+|+||.||+|++  +++.+|||++.........    ...+.+|+++++.++||||+++++++...   
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF----PITALREIKILKKLKHPNVVPLIDMAVERPDK   82 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc----chhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence            46788889999999999999998  5789999998754332211    13566899999999999999999987543   


Q ss_pred             -----CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          206 -----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       206 -----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                           ..+++|+||+. ++|...+... ...+++..+..++.|++.||+|||++|++||||||+|||+++++.+||+|||
T Consensus        83 ~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          83 SKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             ccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence                 34699999996 4787777643 3468999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCC------------ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG------------MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~------------~~~~~gt~~y~AP  303 (303)
                      +++.......            .+...+++.|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPP  195 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCCh
Confidence            9975432211            1223467889988

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=9.4e-25  Score=194.92  Aligned_cols=164  Identities=29%  Similarity=0.474  Sum_probs=138.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |.+.+.||+|++|.||++..  +++.+|+|.++.......    ....+.+|+.+++.++||||+++++++..+...++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   76 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLV   76 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEE
Confidence            34567899999999999987  678999999876544321    225778899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-C
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-G  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~  290 (303)
                      +||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.+||+|||.+....... .
T Consensus        77 ~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          77 FEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             EeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence            999965 8988887643 468999999999999999999999999999999999999999999999999997654432 2


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~~P  167 (283)
T cd05118         155 YTHYVVTRWYRAP  167 (283)
T ss_pred             ccCccCcccccCc
Confidence            2334577888887

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.92  E-value=2e-24  Score=198.45  Aligned_cols=163  Identities=31%  Similarity=0.470  Sum_probs=135.1

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-PMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  207 (303)
                      .++|.+.+.||.|+||.||++..  +++.||||++.+......    ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV----LAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc----hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            45688889999999999999986  678999998865433221    12567789999999999999999999865 456


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      .|+++||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+|+||||+|+|||+++++.+||+|||++.....
T Consensus        85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            78999999 5689888864   3478888899999999999999999999999999999999999999999999975322


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                        ......+++.|+||
T Consensus       161 --~~~~~~~~~~y~aP  174 (328)
T cd07856         161 --QMTGYVSTRYYRAP  174 (328)
T ss_pred             --CcCCCcccccccCc
Confidence              22334677888887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.92  E-value=2.4e-24  Score=192.07  Aligned_cols=155  Identities=20%  Similarity=0.328  Sum_probs=126.6

Q ss_pred             Cccccce--ecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCe
Q 046106          133 KLNMGDA--FAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMV  207 (303)
Q Consensus       133 ~~~~~~~--lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~  207 (303)
                      ++.+.+.  ||+|+||.||+++.  ++..+|+|++.......           .|+.....+ +||||+++++.+..+..
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------IEPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            3344444  59999999999986  67889999987543221           122222222 69999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccCCceeee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVARIEV  286 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl~DFGla~~~~  286 (303)
                      +|+||||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            99999999999999999865  3689999999999999999999999999999999999999998 99999999997653


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ..   ....+++.|+||
T Consensus       162 ~~---~~~~~~~~y~aP  175 (267)
T PHA03390        162 TP---SCYDGTLDYFSP  175 (267)
T ss_pred             CC---ccCCCCCcccCh
Confidence            22   234688899998

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=204.88  Aligned_cols=172  Identities=24%  Similarity=0.425  Sum_probs=145.7

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCC-CCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-C
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERP-ENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-P  205 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~-~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  205 (303)
                      -.++|-++..||+|+|+.||++.+  ..+-||||+-... .+..++...+.+...+|..|-+.|.||.||++|+++.- .
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            346778889999999999999987  5678999987543 34556666677888999999999999999999999964 5


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCcEEEcCC---CcEEEeccC
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL--GLIHRDLKSDNLLIFSD---KSIKIADFG  280 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--giiHrDlkp~NILv~~~---~~vKl~DFG  280 (303)
                      +.+|-|+|||+|.+|.-||+..  +.+++..+..|+-||+.||.||...  .|||=||||.|||+.+.   |.+||+|||
T Consensus       541 dsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            6789999999999999899876  5689999999999999999999976  59999999999999553   789999999


Q ss_pred             CceeeecCCC--------ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~--------~~~~~gt~~y~AP  303 (303)
                      +++++..+..        ++...||++|++|
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPP  649 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPP  649 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCc
Confidence            9998765432        2345799999998

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.92  E-value=2.4e-24  Score=195.91  Aligned_cols=164  Identities=29%  Similarity=0.468  Sum_probs=137.1

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ..|...+.||+|+||.||+|+.  +++.+|+|.+........   ...+.+.+|+.+++.++|||++++++++..+...+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence            3466677899999999999997  677899999875322221   12356788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +|+||+. +++.+++.... ..+++..+..++.|++.||.|||+.+++||||+|+|||++.++.+||+|||++.....  
T Consensus        92 lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--
Confidence            9999996 68888776543 4588999999999999999999999999999999999999999999999999876432  


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                       .....+++.|+||
T Consensus       168 -~~~~~~~~~y~aP  180 (308)
T cd06634         168 -ANXFVGTPYWMAP  180 (308)
T ss_pred             -cccccCCccccCH
Confidence             2234678889988

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.9e-25  Score=209.42  Aligned_cols=154  Identities=25%  Similarity=0.329  Sum_probs=133.7

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..-.++.+-|..++.||-|+||+|.+++.  +...+|+|.+++...-.   +......+.|-.||.....+-||+||-.|
T Consensus       622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~---rnQvaHVKAERDILAEADn~WVVrLyySF  698 (1034)
T KOG0608|consen  622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM---RNQVAHVKAERDILAEADNEWVVRLYYSF  698 (1034)
T ss_pred             HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh---hhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence            34456777788889999999999999875  55689999997643221   11124567899999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ++.+.+|+||||++||++-.+|.+.  +-|++..+..+++++.+|+++.|..|+|||||||+|||||.+|++||+|||||
T Consensus       699 QDkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  699 QDKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             ccCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence            9999999999999999999999865  46889999999999999999999999999999999999999999999999998


Q ss_pred             e
Q 046106          283 R  283 (303)
Q Consensus       283 ~  283 (303)
                      .
T Consensus       777 T  777 (1034)
T KOG0608|consen  777 T  777 (1034)
T ss_pred             c
Confidence            4

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=1.1e-24  Score=194.45  Aligned_cols=164  Identities=30%  Similarity=0.493  Sum_probs=137.3

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |...+.||+|.+|.||+|+.  +++.+|+|++........    ..+.+..|+.+++.++||||+++++++.....+++|
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v   76 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLV   76 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc----ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEE
Confidence            34567899999999999998  578999999976542211    124677899999999999999999999998999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-C
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-G  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~  290 (303)
                      +||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||+|+||++++++.+||+|||+++...... .
T Consensus        77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            99997 59999998653 358999999999999999999999999999999999999999999999999997654322 2


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....++..|+||
T Consensus       155 ~~~~~~~~~~~aP  167 (282)
T cd07829         155 YTHEVVTLWYRAP  167 (282)
T ss_pred             cCccccCcCcCCh
Confidence            3334567788887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.7e-25  Score=210.48  Aligned_cols=158  Identities=27%  Similarity=0.483  Sum_probs=135.5

Q ss_pred             eecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecC
Q 046106          139 AFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAK  216 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~  216 (303)
                      .||+|.||+||-|++  +...+|||-+.....      ...+-+.+|+.+-+.|+|.|||+++|.|.++..+-|+||-++
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds------r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS------REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc------hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            699999999999998  444789998854322      123578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccCCceeeec-CCCcc
Q 046106          217 GGSVRQFLTKRQNRSV--PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFGVARIEVQ-TEGMT  292 (303)
Q Consensus       217 ~gsL~~~l~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-~~~vKl~DFGla~~~~~-~~~~~  292 (303)
                      ||+|.++|+.. -+++  .+..+-.+..||+.||.|||++.|||||||-+|+||.. .|.+||+|||.++.... ++.+.
T Consensus       656 GGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  656 GGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             CCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            99999999864 2455  67888899999999999999999999999999999966 59999999998876432 44566


Q ss_pred             CCCCCCcccCC
Q 046106          293 PETGTYRWMAP  303 (303)
Q Consensus       293 ~~~gt~~y~AP  303 (303)
                      +++||.-||||
T Consensus       735 TFTGTLQYMAP  745 (1226)
T KOG4279|consen  735 TFTGTLQYMAP  745 (1226)
T ss_pred             ccccchhhhCh
Confidence            78999999999

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.3e-24  Score=184.84  Aligned_cols=144  Identities=23%  Similarity=0.196  Sum_probs=110.2

Q ss_pred             cceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHH--------------------HHHHHHHHHHHHHHHHcCCCCCe
Q 046106          137 GDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEK--------------------AQVMEQQFQQEVMMLATLKHPNI  195 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~--------------------~~~~~~~~~~E~~il~~l~hpni  195 (303)
                      ...||+|+||.||+|.. +|++||||+++........                    .........+|+.++..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999987 7899999999865322111                    00112334569999999988777


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCCcEEEcCCCcE
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV-HRLGLIHRDLKSDNLLIFSDKSI  274 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~giiHrDlkp~NILv~~~~~v  274 (303)
                      .....+....  .+|||||++++++.......  ..++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.+
T Consensus        82 ~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          82 PCPEPILLKS--HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCcEEEecC--CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence            5444333222  27999999887765543222  4688999999999999999999 799999999999999998 5789


Q ss_pred             EEeccCCceee
Q 046106          275 KIADFGVARIE  285 (303)
Q Consensus       275 Kl~DFGla~~~  285 (303)
                      +|+|||+|...
T Consensus       157 ~LiDFG~a~~~  167 (190)
T cd05147         157 YIIDVSQSVEH  167 (190)
T ss_pred             EEEEccccccC
Confidence            99999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.2e-24  Score=201.02  Aligned_cols=166  Identities=27%  Similarity=0.464  Sum_probs=135.0

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .|++. .+|.+.+.||+|+||.||+|++  +++.||||.+.+.....    .....+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE----IFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc----cchhHHHHHHHHHHhcCCCCccchhheec
Confidence            45553 4788889999999999999987  67899999987643221    11246788999999999999999999986


Q ss_pred             cC------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          204 KP------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       204 ~~------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                      ..      ..+|+|+||+. .+|..++.    ..+++..+..++.|++.||+|||+.+++||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~  159 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL  159 (342)
T ss_pred             ccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence            54      24689999995 47766552    358999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||+++....  ......+|+.|+||
T Consensus       160 dfg~~~~~~~--~~~~~~~~~~y~aP  183 (342)
T cd07879         160 DFGLARHADA--EMTGYVVTRWYRAP  183 (342)
T ss_pred             eCCCCcCCCC--CCCCceeeecccCh
Confidence            9999975422  22334678889988

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=6.8e-25  Score=204.42  Aligned_cols=171  Identities=20%  Similarity=0.304  Sum_probs=145.3

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~  203 (303)
                      .+.+..+.|.++++||+|+.++||++.. +.+.+|+|.+.....+..    ...-+.+|+..|.+|+ |.+||+||++-.
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~q----tl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQ----TLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHH----HHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            4677888999999999999999999987 567888888776555543    3478999999999997 899999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .+..+|+|||+= ..+|..+|..... .++.-.+..+..|++.++.++|++||||.||||.|+|+ -.|.+||+|||.|.
T Consensus       431 ~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~  507 (677)
T KOG0596|consen  431 TDGYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN  507 (677)
T ss_pred             cCceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence            999999999987 4599999987643 34434788899999999999999999999999999999 56899999999998


Q ss_pred             eeecCCC---ccCCCCCCcccCC
Q 046106          284 IEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      .+..+..   ....+||+.||+|
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsP  530 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSP  530 (677)
T ss_pred             ccCccccceeeccccCcccccCH
Confidence            7654432   2356899999998

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.3e-24  Score=200.83  Aligned_cols=167  Identities=26%  Similarity=0.438  Sum_probs=138.3

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .|++ .++|.+.+.||+|+||.||+|++  +++.||||++........    ..+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07851          10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMDHENVIGLLDVFT   84 (343)
T ss_pred             eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh----HHHHHHHHHHHHHhccCCCHHHHHHHhh
Confidence            3444 34688889999999999999998  578999999865432221    1246778999999999999999999876


Q ss_pred             cCCe------EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          204 KPMV------WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       204 ~~~~------~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                      ....      .++|+||+ +++|.+++..   ..+++..+..++.|++.||+|||+.||+||||||+||++++++.+||+
T Consensus        85 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          85 PASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEc
Confidence            6544      89999999 6799998875   358999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||++......  .....++..|+||
T Consensus       161 dfg~~~~~~~~--~~~~~~~~~y~aP  184 (343)
T cd07851         161 DFGLARHTDDE--MTGYVATRWYRAP  184 (343)
T ss_pred             ccccccccccc--ccCCcccccccCH
Confidence            99999764322  3344678889887

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2.6e-24  Score=206.90  Aligned_cols=176  Identities=21%  Similarity=0.329  Sum_probs=129.7

Q ss_pred             eeecCCccccceecccCceEEEEEEE------------------CCeEEEEEEeeCCCCChHHH--------HHHHHHHH
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY------------------NGEEVAIKILERPENDPEKA--------QVMEQQFQ  181 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~------------------~~~~vAvK~~~~~~~~~~~~--------~~~~~~~~  181 (303)
                      ....++|.+.++||+|+||.||+|.+                  .++.||||.+..........        ....+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            34678999999999999999999964                  24579999986532211000        00112344


Q ss_pred             HHHHHHHcCCCCCe-----eeeeEEEEc--------CCeEEEEEeecCCCCHHHHHHhcCC-------------------
Q 046106          182 QEVMMLATLKHPNI-----VRFIGACRK--------PMVWCIVTEYAKGGSVRQFLTKRQN-------------------  229 (303)
Q Consensus       182 ~E~~il~~l~hpni-----v~l~~~~~~--------~~~~~iv~E~~~~gsL~~~l~~~~~-------------------  229 (303)
                      .|+.++.+++|.++     ++++++|..        ....|+||||+++++|.+++....+                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            57777777776654     567777643        3457999999999999999874211                   


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCC--CCCCcccCC
Q 046106          230 ---RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP  303 (303)
Q Consensus       230 ---~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~--~gt~~y~AP  303 (303)
                         ..+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||+++...........  .+|+.|+||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence               12356778899999999999999999999999999999999999999999999754433322332  347899998

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.92  E-value=1.4e-24  Score=191.87  Aligned_cols=169  Identities=27%  Similarity=0.462  Sum_probs=134.1

Q ss_pred             CccccceecccCceEEEEEEEC--CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      +|.+.+.||+|+||.||++.+.  +..+++|+++......... .....+.+|+.+++.++||||+++++++.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-NETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc-chHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEE
Confidence            4677889999999999999873  4456667665432211111 111356678999999999999999999998888999


Q ss_pred             EEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          211 VTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||+++++|.+++...  ....+++..++.++.|++.||+|||+.|++|+||+|+||+++. +.+||+|||+++.....
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            99999999999988742  2346899999999999999999999999999999999999975 67999999999765432


Q ss_pred             CC-ccCCCCCCcccCC
Q 046106          289 EG-MTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~-~~~~~gt~~y~AP  303 (303)
                      .. .....|++.|+||
T Consensus       159 ~~~~~~~~~~~~~~~p  174 (260)
T cd08222         159 CDLATTFTGTPYYMSP  174 (260)
T ss_pred             cccccCCCCCcCccCH
Confidence            22 2344678889887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.92  E-value=3.4e-24  Score=197.91  Aligned_cols=162  Identities=24%  Similarity=0.354  Sum_probs=132.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP----  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----  205 (303)
                      .+|.+.+.||.|+||.||+|..  +++.||+|.+.......      .+.+.+|+.+++.++||||+++++++...    
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~------~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------VKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch------HHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence            5788889999999999999987  67899999987654321      24677899999999999999999876543    


Q ss_pred             ----------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcE
Q 046106          206 ----------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSI  274 (303)
Q Consensus       206 ----------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-~~~v  274 (303)
                                ...|+|+||++ ++|.+++..   ..+++..+..++.||+.||+|||+.||+||||||+||+++. ++.+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence                      35789999996 589888864   35889999999999999999999999999999999999974 5679


Q ss_pred             EEeccCCceeeecCCC----ccCCCCCCcccCC
Q 046106          275 KIADFGVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       275 Kl~DFGla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      ||+|||+++.......    .+...++..|+||
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  187 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP  187 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCH
Confidence            9999999976432211    1223578889988

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=7.5e-24  Score=180.11  Aligned_cols=145  Identities=20%  Similarity=0.173  Sum_probs=113.4

Q ss_pred             cceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHH--------------------HHHHHHHHHHHHHHHHcCCCCCe
Q 046106          137 GDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEK--------------------AQVMEQQFQQEVMMLATLKHPNI  195 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~--------------------~~~~~~~~~~E~~il~~l~hpni  195 (303)
                      ...||+|+||.||+|+. +|+.||||++++.......                    .......+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999987 6999999999876422111                    11112345689999999999988


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCc
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQF-LTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKS  273 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~  273 (303)
                      .....+....  .++||||++++++... +..   ..++......++.|++.+|.+||. .||+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence            5555444333  3799999988755433 332   357788899999999999999999 9999999999999998 899


Q ss_pred             EEEeccCCceeeec
Q 046106          274 IKIADFGVARIEVQ  287 (303)
Q Consensus       274 vKl~DFGla~~~~~  287 (303)
                      ++|+|||+|+....
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.91  E-value=6.8e-25  Score=186.91  Aligned_cols=154  Identities=18%  Similarity=0.242  Sum_probs=134.4

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ...-|+.++|.+.+.||+|+|+.||.++.  ++..+|+|.+.......      .+...+|++.-++++||||+++++++
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~------~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED------IEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH------HHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            45668899999999999999999999985  78899999987755221      25778999999999999999999987


Q ss_pred             EcC-----CeEEEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCc
Q 046106          203 RKP-----MVWCIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKS  273 (303)
Q Consensus       203 ~~~-----~~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~~~~~  273 (303)
                      ..+     ...||+++|...|+|.+.+....  +..+++.+++.++.+|++||++||+..  +.||||||.|||+++.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            433     35899999999999999998543  346899999999999999999999998  999999999999999999


Q ss_pred             EEEeccCCcee
Q 046106          274 IKIADFGVARI  284 (303)
Q Consensus       274 vKl~DFGla~~  284 (303)
                      ++|.|||.+..
T Consensus       168 ~vl~D~GS~~~  178 (302)
T KOG2345|consen  168 PVLMDLGSATQ  178 (302)
T ss_pred             eEEEeccCccc
Confidence            99999998853

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.91  E-value=8.5e-24  Score=185.17  Aligned_cols=146  Identities=19%  Similarity=0.263  Sum_probs=122.6

Q ss_pred             cCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCH
Q 046106          143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV  220 (303)
Q Consensus       143 G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL  220 (303)
                      |.||.||++++  +++.+|+|.++...           .+.+|...+....||||+++++++.....+|++|||+++++|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            89999999987  77899999996532           223444555566799999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCCCcc
Q 046106          221 RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW  300 (303)
Q Consensus       221 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y  300 (303)
                      .+++...  ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......  .....++..|
T Consensus        73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y  148 (237)
T cd05576          73 WSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMY  148 (237)
T ss_pred             HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccc
Confidence            9999765  35899999999999999999999999999999999999999999999999987654322  2233456778


Q ss_pred             cCC
Q 046106          301 MAP  303 (303)
Q Consensus       301 ~AP  303 (303)
                      +||
T Consensus       149 ~aP  151 (237)
T cd05576         149 CAP  151 (237)
T ss_pred             cCC
Confidence            887

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-25  Score=212.29  Aligned_cols=166  Identities=30%  Similarity=0.493  Sum_probs=144.6

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      +..+|.++..+|.|++|.||++++  +++..|+|+++....+..      .-+.+|+-+++.++|||||.+++.+...+.
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~------~~iqqei~~~~dc~h~nivay~gsylr~dk   86 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF------SGIQQEIGMLRDCRHPNIVAYFGSYLRRDK   86 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc------cccccceeeeecCCCcChHHHHhhhhhhcC
Confidence            456788889999999999999997  788999999987655443      356789999999999999999999999889


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +||.||||-+|+|.+..+-.  +++++.++..+++..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus        87 lwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999999999877643  5788999999999999999999999999999999999999999999999998754432


Q ss_pred             C-CCccCCCCCCcccCC
Q 046106          288 T-EGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~-~~~~~~~gt~~y~AP  303 (303)
                      . .....+.||+.||||
T Consensus       165 ti~KrksfiGtpywmap  181 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAP  181 (829)
T ss_pred             hhhhhhcccCCccccch
Confidence            2 223457899999998

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.3e-26  Score=196.81  Aligned_cols=161  Identities=26%  Similarity=0.426  Sum_probs=132.8

Q ss_pred             ccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-----eE
Q 046106          136 MGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM-----VW  208 (303)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-----~~  208 (303)
                      -.+.||-|+||.||.+++  +|+.||+|.+........    .-+++.+|+.+|..++|.|++.+++....+.     .+
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~----s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLA----SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHH----HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            346799999999999998  789999998754332222    2367889999999999999999999876543     36


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+++|+|. .+|...+-..  +.++.+.+.-+..||++||.|||+.+|.||||||.|.||+.|..+||+|||+|+....+
T Consensus       133 YV~TELmQ-SDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHHHH-hhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            78999995 4787777654  46888899999999999999999999999999999999999999999999999986544


Q ss_pred             C--CccCCCCCCcccCC
Q 046106          289 E--GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~--~~~~~~gt~~y~AP  303 (303)
                      +  .++..+-|..|+||
T Consensus       210 ~~~hMTqEVVTQYYRAP  226 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAP  226 (449)
T ss_pred             hhhhhHHHHHHHHhccH
Confidence            3  34555678888887

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.91  E-value=9.7e-25  Score=184.24  Aligned_cols=154  Identities=19%  Similarity=0.457  Sum_probs=130.8

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcC-
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKP-  205 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~-  205 (303)
                      ..++|++.+++|+|.+++||.|..  +++.++||++++..         .+.+.+|+.||..|+ ||||++|+++..++ 
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~  106 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---------KKKIKREIKILQNLRGGPNIIKLLDIVKDPE  106 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---------HHHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence            467889999999999999999985  77899999997622         368899999999998 99999999999775 


Q ss_pred             -CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCce
Q 046106          206 -MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVAR  283 (303)
Q Consensus       206 -~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~  283 (303)
                       ....+|+||+.+.++..+..     .++...+..++.++++||.|||+.||+|||+||.|++|+.. ..++|+|||+|.
T Consensus       107 SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             ccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence             34679999998887766654     36777889999999999999999999999999999999876 579999999998


Q ss_pred             eeecCCCccCCCCC
Q 046106          284 IEVQTEGMTPETGT  297 (303)
Q Consensus       284 ~~~~~~~~~~~~gt  297 (303)
                      +..+...+...+.+
T Consensus       182 FYHp~~eYnVRVAS  195 (338)
T KOG0668|consen  182 FYHPGKEYNVRVAS  195 (338)
T ss_pred             hcCCCceeeeeeeh
Confidence            87666655554433

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.91  E-value=6e-24  Score=190.66  Aligned_cols=164  Identities=26%  Similarity=0.396  Sum_probs=138.7

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC--C----CeeeeeEE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH--P----NIVRFIGA  201 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p----niv~l~~~  201 (303)
                      -..+|.+..++|+|.||+|.++.+  .+..||||+++.       ...+.+...-|+++|.++.+  |    .+|++.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            367899999999999999999987  567899999964       23334566679999999842  2    46778888


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-----------
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-----------  270 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-----------  270 (303)
                      |.-....|||+|.+ |-++.+||......++|..++..|+.|++.+++|||+.+++|.||||+|||+.+           
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence            88889999999999 779999999988889999999999999999999999999999999999999843           


Q ss_pred             ---------CCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          271 ---------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       271 ---------~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                               +..|||+|||.|++....  .++.+.|..|+||
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAP  278 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAP  278 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCc
Confidence                     235999999999875433  3666889999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=6.7e-26  Score=193.60  Aligned_cols=169  Identities=28%  Similarity=0.475  Sum_probs=133.8

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--  204 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--  204 (303)
                      +.-+.|.-..+||+|.||+||+++.  .++.||+|.+--..   ++.. .-....+|+.+|..++|+|++.++..|..  
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen---eKeG-fpitalreikiL~~lkHenv~nliEic~tk~   89 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN---EKEG-FPITALREIKILQLLKHENVVNLIEICRTKA   89 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc---cccC-CcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence            3445666678899999999999986  66788987653211   0000 01345689999999999999999998853  


Q ss_pred             ------CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          205 ------PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       205 ------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                            ...+|+|+.+|+. +|.-+|.... ..++..++.+++.++..||.|+|...|+|||+||.|+||+.+|.+||+|
T Consensus        90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             CCcccccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeec
Confidence                  2348999999976 8888887653 5689999999999999999999999999999999999999999999999


Q ss_pred             cCCceeeecC-----CCccCCCCCCcccCC
Q 046106          279 FGVARIEVQT-----EGMTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~-----~~~~~~~gt~~y~AP  303 (303)
                      ||+|+.....     ..++..+.|.+|++|
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCH
Confidence            9999764322     224455668888876

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.90  E-value=2.9e-23  Score=203.50  Aligned_cols=168  Identities=17%  Similarity=0.231  Sum_probs=118.2

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--C----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--N----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      .+....++|.+.+.||+|+||.||+|++  +    +..||||.+.......        ....|  .+....+.++..++
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--------~~~~e--~l~~~~~~~~~~~~  195 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--------IWMNE--RVRRACPNSCADFV  195 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--------HHHHH--HHHhhchhhHHHHH
Confidence            3455678899999999999999999998  4    6799999875432110        11111  11111122222111


Q ss_pred             EE------EEcCCeEEEEEeecCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 046106          200 GA------CRKPMVWCIVTEYAKGGSVRQFLTKRQNR------------------SVPLKLAVKQALDVARGMAYVHRLG  255 (303)
Q Consensus       200 ~~------~~~~~~~~iv~E~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~g  255 (303)
                      ..      +.....+++|+||+.+++|.+++......                  ......+..++.||+.||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g  275 (566)
T PLN03225        196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG  275 (566)
T ss_pred             HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence            11      24556789999999999999998753210                  0113346679999999999999999


Q ss_pred             ceeCCCCCCcEEEcC-CCcEEEeccCCceeeecCC--CccCCCCCCcccCC
Q 046106          256 LIHRDLKSDNLLIFS-DKSIKIADFGVARIEVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       256 iiHrDlkp~NILv~~-~~~vKl~DFGla~~~~~~~--~~~~~~gt~~y~AP  303 (303)
                      |+||||||+|||++. ++.+||+|||+|+......  .....++|+.|+||
T Consensus       276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~AP  326 (566)
T PLN03225        276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAP  326 (566)
T ss_pred             EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccCh
Confidence            999999999999986 5899999999998643322  22345789999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.90  E-value=2e-22  Score=173.18  Aligned_cols=164  Identities=34%  Similarity=0.617  Sum_probs=139.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |.+.+.||.|++|.||++..  +++.+|+|.+......     ...+.+.+|+..++.++|+|++++++.+......+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence            34567899999999999998  3689999999765433     1236888999999999999999999999988889999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC--
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE--  289 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~--  289 (303)
                      +|++++++|.+++..... .+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+.......  
T Consensus        76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            999999999999986532 27899999999999999999999999999999999999999999999999998764432  


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......++..|++|
T Consensus       155 ~~~~~~~~~~~~~p  168 (225)
T smart00221      155 LLKTVKGTPFYLAP  168 (225)
T ss_pred             cccceeccCCcCCH
Confidence            22344677888887

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.90  E-value=7.1e-23  Score=212.96  Aligned_cols=152  Identities=21%  Similarity=0.402  Sum_probs=127.2

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      .+...+.||+|+||.||+|++  ++..||||.++.....          ..+|+.++++++|||||+++++|.++...|+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            345567899999999999986  6789999998643221          1246888999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH---RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      ||||+++|+|.++++.     +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+++. ||.+.....
T Consensus       761 v~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        761 IHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            9999999999999963     789999999999999999999   6699999999999999999988876 776543221


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                         .....||+.|+||
T Consensus       835 ---~~~~~~t~~y~aP  847 (968)
T PLN00113        835 ---DTKCFISSAYVAP  847 (968)
T ss_pred             ---CCCccccccccCc
Confidence               1233688999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.89  E-value=2.6e-23  Score=201.56  Aligned_cols=160  Identities=28%  Similarity=0.473  Sum_probs=127.9

Q ss_pred             ccccceecccCce-EEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFG-KLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg-~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv  211 (303)
                      |.-.+.+|.|+.| .||+|.+.+++||||.+-....         ....+|+..|+.- +|||||++|+.-.++...||.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~---------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa  581 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF---------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA  581 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH---------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence            3445668899988 6899999999999998854221         3456899999877 599999999999999999999


Q ss_pred             EeecCCCCHHHHHHhc-CCCCCCH-HHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---C--CcEEEeccCCcee
Q 046106          212 TEYAKGGSVRQFLTKR-QNRSVPL-KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---D--KSIKIADFGVARI  284 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~-~~~~~~~-~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---~--~~vKl~DFGla~~  284 (303)
                      .|+|. .+|.+++... ....... ...+.+..|+++||++||+.+||||||||.||||+.   +  .+++|+|||+++.
T Consensus       582 lELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  582 LELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             ehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            99995 5999999863 1111111 345778899999999999999999999999999976   3  4799999999987


Q ss_pred             eecCCC----ccCCCCCCcccCC
Q 046106          285 EVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~----~~~~~gt~~y~AP  303 (303)
                      ...+..    .+...||-.|+||
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~AP  683 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAP  683 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCH
Confidence            654332    3345799999999

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.89  E-value=9.3e-22  Score=165.84  Aligned_cols=158  Identities=32%  Similarity=0.635  Sum_probs=134.0

Q ss_pred             ecccCceEEEEEEEC--CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCC
Q 046106          140 FAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       140 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      ||+|.+|.||++...  ++.+++|++.......     ..+.+.+|+..++.++|++|+++++++......++++|++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence            689999999999985  8899999997654432     235788999999999999999999999998899999999998


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEeccCCceeeecCC-CccCCC
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFGVARIEVQTE-GMTPET  295 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-~~~vKl~DFGla~~~~~~~-~~~~~~  295 (303)
                      ++|.+++.... ..+++..++.++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+....... ......
T Consensus        76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence            99999998642 35789999999999999999999999999999999999999 8999999999998654322 122234


Q ss_pred             CCCcccCC
Q 046106          296 GTYRWMAP  303 (303)
Q Consensus       296 gt~~y~AP  303 (303)
                      +...|++|
T Consensus       155 ~~~~~~~p  162 (215)
T cd00180         155 GTPAYMAP  162 (215)
T ss_pred             CCCCccCh
Confidence            56777766

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.88  E-value=4.9e-22  Score=172.01  Aligned_cols=153  Identities=35%  Similarity=0.557  Sum_probs=133.1

Q ss_pred             CceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHH
Q 046106          144 AFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR  221 (303)
Q Consensus       144 ~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~  221 (303)
                      +||.||+|.+  +++.+|+|++........     .+.+.+|+..+++++|+||+++++.+......++++||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence            5899999998  468999999976544321     368889999999999999999999999988999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCCCccc
Q 046106          222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWM  301 (303)
Q Consensus       222 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~  301 (303)
                      +++....  .+++..++.++.+++.++.+||+.+++|+||+|+||++++++.++|+|||.+.............+++.|+
T Consensus        76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  153 (244)
T smart00220       76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM  153 (244)
T ss_pred             HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence            9997643  37899999999999999999999999999999999999999999999999998765543445567888898


Q ss_pred             CC
Q 046106          302 AP  303 (303)
Q Consensus       302 AP  303 (303)
                      ||
T Consensus       154 ~p  155 (244)
T smart00220      154 AP  155 (244)
T ss_pred             CH
Confidence            87

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=7.5e-22  Score=174.66  Aligned_cols=167  Identities=27%  Similarity=0.349  Sum_probs=138.1

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGAC  202 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~  202 (303)
                      ...+-.-.|+++++||+|+||.++.|+.  ++++||||.-......        .++..|....+.|. .++|...|=+.
T Consensus        22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--------PQLrdEYr~YKlL~g~~GIP~vYYFG   93 (449)
T KOG1165|consen   22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--------PQLRDEYRTYKLLGGTEGIPQVYYFG   93 (449)
T ss_pred             CceEecccceeccccccCcceeeecccccccCceEEEEeccccCCc--------chHHHHHHHHHHHcCCCCCCceeeec
Confidence            4455666899999999999999999985  9999999986554433        35677888888886 68999888777


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-----CcEEEe
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-----KSIKIA  277 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-----~~vKl~  277 (303)
                      ..+..-.+|+|++ |-+|.|++. .+++.++.+.+..+|.|++.-|+|+|++.+|.|||||+|+||...     ..+.|+
T Consensus        94 qeG~~NiLVidLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen   94 QEGKYNILVIDLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             cccchhhhhhhhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence            7777778999999 889988765 567889999999999999999999999999999999999999764     469999


Q ss_pred             ccCCceeeecCCC--------ccCCCCCCcccC
Q 046106          278 DFGVARIEVQTEG--------MTPETGTYRWMA  302 (303)
Q Consensus       278 DFGla~~~~~~~~--------~~~~~gt~~y~A  302 (303)
                      |||+|+..-+...        .....||.+||+
T Consensus       172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMS  204 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMS  204 (449)
T ss_pred             eccchhhhcCccccccCccccccccccceeeeE
Confidence            9999987544322        234579999996

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.8e-21  Score=167.60  Aligned_cols=136  Identities=16%  Similarity=0.289  Sum_probs=104.4

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-----CCCCeeeeeEEEEcCC---e-
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-----KHPNIVRFIGACRKPM---V-  207 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~~~~~~~~---~-  207 (303)
                      .+.||+|+||.||.-..++.. +||++.......      .+.+.+|+.+++.+     .||||+++++++.++.   . 
T Consensus         7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGG------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cceecCCCceEEEECCCCcCe-EEEEEeccccch------HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            357999999999962224334 688886543221      25688999999999     5799999999998863   3 


Q ss_pred             EEEEEee--cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeCCCCCCcEEEcCC----CcEEEec-c
Q 046106          208 WCIVTEY--AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM-AYVHRLGLIHRDLKSDNLLIFSD----KSIKIAD-F  279 (303)
Q Consensus       208 ~~iv~E~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~giiHrDlkp~NILv~~~----~~vKl~D-F  279 (303)
                      +.+|+||  +++++|.+++...   .+++.  ..++.|++.++ +|||+++|+||||||+|||++.+    ..++|+| |
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            4478999  5578999999753   35555  35678888787 99999999999999999999743    3799999 5


Q ss_pred             CCcee
Q 046106          280 GVARI  284 (303)
Q Consensus       280 Gla~~  284 (303)
                      |.+..
T Consensus       155 G~~~~  159 (210)
T PRK10345        155 GESTF  159 (210)
T ss_pred             CCcce
Confidence            55443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=2.2e-21  Score=166.90  Aligned_cols=140  Identities=19%  Similarity=0.362  Sum_probs=117.4

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChH--HHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPE--KAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      +.||+|++|.||+|.+.+..|++|+.........  ........+.+|+.++..++|++|+....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            5699999999999999999999998765432211  11222356889999999999999988777777777779999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +|++|.+++....     . .+..++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.++.
T Consensus        82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999986531     2 7889999999999999999999999999999999 88999999999875

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=8.1e-22  Score=167.73  Aligned_cols=165  Identities=26%  Similarity=0.337  Sum_probs=135.3

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC-CCeeeeeEEEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRFIGACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~  204 (303)
                      .+...+|.+.++||+|+||.+|.|..  .|..||||+-+.....        .++..|..+.+.|++ ..|+.+..+..+
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--------pqL~yEskvY~iL~~g~GiP~i~~y~~e   82 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--------PQLLYESKVYRILQGGVGIPHIRHYGTE   82 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--------cchhHHHHHHHHhccCCCCchhhhhccc
Confidence            45667899999999999999999987  8899999987654433        367789999999985 788888888888


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccCC
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGV  281 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---~~vKl~DFGl  281 (303)
                      ...-.+|||++ |.+|.+++.- ..+.++...++.++-|++.-++|+|.+++|||||||+|+|..-+   ..+.|+|||+
T Consensus        83 ~~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   83 KDYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             cccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence            88888999999 8899887763 34679999999999999999999999999999999999998654   5689999999


Q ss_pred             ceeeecCCC--------ccCCCCCCcccC
Q 046106          282 ARIEVQTEG--------MTPETGTYRWMA  302 (303)
Q Consensus       282 a~~~~~~~~--------~~~~~gt~~y~A  302 (303)
                      |+...+...        ....+||.+|.+
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYAS  189 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehh
Confidence            975433221        122468888864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.86  E-value=5.1e-22  Score=184.10  Aligned_cols=164  Identities=26%  Similarity=0.400  Sum_probs=135.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC------CCeeeeeEEE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH------PNIVRFIGAC  202 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h------pniv~l~~~~  202 (303)
                      ..+|.+....|+|-|+.|.+|.+  .|+.||||+|+...       .+.+.=++|++||++|+.      -++++|+..|
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-------~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-------VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-------HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            45677777889999999999987  67799999997632       334566789999999963      4889999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccC
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQ-NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFG  280 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFG  280 (303)
                      ...+++|+|+|-+ .-+|.+.|+... +..+....+..++.|+..||..|-.+||+|.||||+||||.+. ..+||||||
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence            9999999999988 569999998653 3457889999999999999999999999999999999999887 678999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .|.+...++ .++...+-.|.||
T Consensus       583 SA~~~~ene-itPYLVSRFYRaP  604 (752)
T KOG0670|consen  583 SASFASENE-ITPYLVSRFYRAP  604 (752)
T ss_pred             ccccccccc-ccHHHHHHhccCc
Confidence            998766554 3333444566666

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.86  E-value=5e-21  Score=163.32  Aligned_cols=137  Identities=20%  Similarity=0.344  Sum_probs=110.9

Q ss_pred             eecccCceEEEEEEECCeEEEEEEeeCCCCCh--HHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecC
Q 046106          139 AFAQGAFGKLYRGTYNGEEVAIKILERPENDP--EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAK  216 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~  216 (303)
                      .||+|+||.||+|.+++..|++|+........  ........++.+|+.++..++|+++.....++......++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            38999999999999999999999965433211  1122224678899999999998876655555556666689999999


Q ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          217 GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       217 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      |++|.+++....     .    .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||+++..
T Consensus        81 g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998876421     1    7889999999999999999999999999999 899999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-21  Score=185.76  Aligned_cols=158  Identities=22%  Similarity=0.357  Sum_probs=130.6

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~  207 (303)
                      ...|.+...+|.|+|+.|-++..  +++..++|++.+...          +..+|+.++... +||||+++.+++.++..
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~  390 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE  390 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----------ccccccchhhhhcCCCcceeecceecCCce
Confidence            55677778899999999999887  778999999977532          233567666555 69999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE-cCCCcEEEeccCCceeee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI-FSDKSIKIADFGVARIEV  286 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv-~~~~~vKl~DFGla~~~~  286 (303)
                      .|+|||++.++-+.+-+...+   .....+..|+++|+.|+.|||++|+|||||||+|||+ ++.++++|+|||.++...
T Consensus       391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999999999998877776532   3336778899999999999999999999999999999 588999999999998654


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ..  ..+.|-|..|.||
T Consensus       468 ~~--~~tp~~t~~y~AP  482 (612)
T KOG0603|consen  468 RS--CDTPALTLQYVAP  482 (612)
T ss_pred             hh--hcccchhhcccCh
Confidence            43  3344667888887

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=6e-21  Score=175.22  Aligned_cols=164  Identities=21%  Similarity=0.367  Sum_probs=130.9

Q ss_pred             CccccceecccCceEEEEEEECC---eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC----CCeeeeeEEE-Ec
Q 046106          133 KLNMGDAFAQGAFGKLYRGTYNG---EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH----PNIVRFIGAC-RK  204 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h----pniv~l~~~~-~~  204 (303)
                      +|.+.++||+|+||.||.+....   ..+|+|+.........      ..+..|+.++..+..    +++..+++.. ..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~   92 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST   92 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------ccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence            78889999999999999999733   4789998765432211      146678888888762    6889999998 47


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-----CcEEEecc
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-----KSIKIADF  279 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-----~~vKl~DF  279 (303)
                      +...||||+.+ |.+|.++......+.++....+.++.|++.+|++||+.|+|||||||.|+++...     ..+.|.||
T Consensus        93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            77789999998 8899998877666789999999999999999999999999999999999999865     46999999


Q ss_pred             CCce--eeecCCC---------ccCCCCCCcccCC
Q 046106          280 GVAR--IEVQTEG---------MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~--~~~~~~~---------~~~~~gt~~y~AP  303 (303)
                      |+|+  .......         .....||.+|+++
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~  206 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASI  206 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccH
Confidence            9998  3211110         1223499999874

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.85  E-value=1e-20  Score=184.94  Aligned_cols=141  Identities=21%  Similarity=0.325  Sum_probs=115.0

Q ss_pred             cccceecccCceEEEEEEECCeEEEEEEeeCCCC-Ch-HHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          135 NMGDAFAQGAFGKLYRGTYNGEEVAIKILERPEN-DP-EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~-~~-~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      ...+.||+|+||.||+|.+.+..+++|....... .. .......+++.+|+.+++.++|++++.+..++..+...++||
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            4578899999999999999777666665433211 11 112223467889999999999999998888877777778999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ||+++++|.+++.          ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+|+...
T Consensus       416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            9999999998885          246789999999999999999999999999999 67899999999998643

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=8.6e-21  Score=166.69  Aligned_cols=147  Identities=19%  Similarity=0.214  Sum_probs=111.9

Q ss_pred             CccccceecccCceEEEEEE-E--CCeEEEEEEeeCCCCChH------------------HHHHHHHHHHHHHHHHHcCC
Q 046106          133 KLNMGDAFAQGAFGKLYRGT-Y--NGEEVAIKILERPENDPE------------------KAQVMEQQFQQEVMMLATLK  191 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~-~--~~~~vAvK~~~~~~~~~~------------------~~~~~~~~~~~E~~il~~l~  191 (303)
                      -|.+.+.||+|+||.||+|. .  +|+.||||+++.......                  ..+.....+..|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35677899999999999998 3  789999999986532110                  01112345678999999997


Q ss_pred             CC--CeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCcEEE
Q 046106          192 HP--NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG-LIHRDLKSDNLLI  268 (303)
Q Consensus       192 hp--niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-iiHrDlkp~NILv  268 (303)
                      +.  .++++++.   . ..++||||+++.+|..+....  ..........++.|++.+|++||+.| ++||||||+||++
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            53  34444443   2 247999999987876654222  33556667899999999999999999 9999999999999


Q ss_pred             cCCCcEEEeccCCceeee
Q 046106          269 FSDKSIKIADFGVARIEV  286 (303)
Q Consensus       269 ~~~~~vKl~DFGla~~~~  286 (303)
                      + ++.++|+|||.|....
T Consensus       183 ~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             E-CCCEEEEEChhhhccC
Confidence            9 8899999999997543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=172.67  Aligned_cols=162  Identities=27%  Similarity=0.353  Sum_probs=132.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP----  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----  205 (303)
                      .+|.-+..+|.|+- .|.-+-+  .+++||+|.+..+..+...    .++..+|..+|..++|+||++++.++...    
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~----akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH----AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc----chhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            45555677888887 5666655  7889999988766433222    25677999999999999999999999643    


Q ss_pred             --CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          206 --MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       206 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                        ...|+|||+| ..+|.+.+...    +.-..+..+..|++.|+.|||+.||+||||||+||+|..+..+||.|||+|+
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence              3469999999 56999888732    5667788999999999999999999999999999999999999999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ....+-..++.+.|-.|.||
T Consensus       167 ~e~~~~~mtpyVvtRyyrap  186 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAP  186 (369)
T ss_pred             ccCcccccCchhheeeccCc
Confidence            76555456777889999998

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.4e-20  Score=163.30  Aligned_cols=144  Identities=10%  Similarity=0.160  Sum_probs=116.1

Q ss_pred             cCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHH---HHHHHHHHHHHHcCCCCCeeeeeEEEEcC--
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVM---EQQFQQEVMMLATLKHPNIVRFIGACRKP--  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~---~~~~~~E~~il~~l~hpniv~l~~~~~~~--  205 (303)
                      ..+|+..+.||.|+||.||+...++..+|||++++.....+.....   ...+.+|+..+.++.||+|..+.+++...  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            5688899999999999999977777799999998665444322110   12267999999999999999999886532  


Q ss_pred             ------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          206 ------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       206 ------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                            ...+|+|||++|.+|.++..      ++.    ....+++.+|..||+.|++|||++|+||++++++ ++|+||
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                  35789999999999987732      233    2456899999999999999999999999999999 999999


Q ss_pred             CCceee
Q 046106          280 GVARIE  285 (303)
Q Consensus       280 Gla~~~  285 (303)
                      |..+..
T Consensus       179 g~~~~~  184 (232)
T PRK10359        179 SGKRCT  184 (232)
T ss_pred             CCcccc
Confidence            988654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2.6e-21  Score=167.10  Aligned_cols=143  Identities=24%  Similarity=0.439  Sum_probs=119.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEE-EEcCCe
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGA-CRKPMV  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~-~~~~~~  207 (303)
                      +.|.+.+.||+|.||++.++.+  ..+.+++|.+.++...       ..+|.+|..----| .|.||+.-|++ |++.+.
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-------QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-------HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            3567888999999999999998  5568999998765432       36899998766556 48999998885 566678


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--CCcEEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS--DKSIKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~--~~~vKl~DFGla~~  284 (303)
                      +.+++||++.|+|..-+..   ..+-+.....++.|+++|+.|+|++++||||||.+||||-+  ..+|||||||+.+.
T Consensus        97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence            8899999999999887765   34778888999999999999999999999999999999943  35899999999864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.1e-19  Score=154.83  Aligned_cols=135  Identities=20%  Similarity=0.194  Sum_probs=106.3

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEeec
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      ...|++|.||+|+.+...+.+++.+.+.....-..  ......+.+|+++|+++. |+++++++++    ...+++|||+
T Consensus         7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~--~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLR--GVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             ceeecCCCcceEEEeecCCceeeecccccchhhhh--hHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            45799999999998877888888777765433211  111236889999999996 5889999886    2358999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCcEEEcCCCcEEEeccCCceeee
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDL-KSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDl-kp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .|.+|.+.+..        . ...++.|++.+|++||++||+|||| ||.|||++.++.++|+|||+|....
T Consensus        81 ~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         81 AGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             cCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            99888654321        1 1356789999999999999999999 7999999999999999999998543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.83  E-value=5.1e-20  Score=157.37  Aligned_cols=140  Identities=20%  Similarity=0.223  Sum_probs=107.3

Q ss_pred             ccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHH----------------HHHHHHHHHHHHHHHcCCCC--C
Q 046106          134 LNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKA----------------QVMEQQFQQEVMMLATLKHP--N  194 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~----------------~~~~~~~~~E~~il~~l~hp--n  194 (303)
                      +.+.+.||+|+||.||++.. +++.||||+++.........                .........|..++..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            45567899999999999988 78999999987643211110                01123467889999998877  4


Q ss_pred             eeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 046106          195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI  274 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~v  274 (303)
                      ++..++.    ...++||||+++++|.+....        .....++.+++.++.++|+.||+||||||+||++++++.+
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence            4555442    234899999999888654321        2346788999999999999999999999999999999999


Q ss_pred             EEeccCCceee
Q 046106          275 KIADFGVARIE  285 (303)
Q Consensus       275 Kl~DFGla~~~  285 (303)
                      +|+|||+|...
T Consensus       165 ~liDfg~~~~~  175 (198)
T cd05144         165 YIIDWPQMVST  175 (198)
T ss_pred             EEEECCccccC
Confidence            99999999643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=7.1e-20  Score=168.90  Aligned_cols=135  Identities=24%  Similarity=0.428  Sum_probs=117.4

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-----C---CCeeee
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-----H---PNIVRF  198 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---pniv~l  198 (303)
                      +...+|.+.++||-|.|++||++.+  ..+.||+|+.+.       ++.+.+....|+.+|++++     |   ..||+|
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            3457899999999999999999988  567899999964       4555667789999999874     2   479999


Q ss_pred             eEEEEc----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCC
Q 046106          199 IGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSD  271 (303)
Q Consensus       199 ~~~~~~----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~  271 (303)
                      ++.|..    +..+|+|+|++ |.+|..++.....+.+|...+..|+.||+.||.|||. .||||.||||+|||+..+
T Consensus       148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence            999964    46899999999 8899999998877889999999999999999999995 599999999999999654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.81  E-value=8.9e-19  Score=156.01  Aligned_cols=166  Identities=29%  Similarity=0.499  Sum_probs=139.1

Q ss_pred             ccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCC-CeeeeeEEEEcCCeEEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP-NIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-niv~l~~~~~~~~~~~iv~  212 (303)
                      |.+.+.||.|+||.||.+.+. ..+++|.+........   .....+.+|+.++..+.|+ +++++++.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS---KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch---hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            456678999999999999988 7889999977654432   1236889999999999988 7999999998877789999


Q ss_pred             eecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccCCceeeecCC-
Q 046106          213 EYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVARIEVQTE-  289 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl~DFGla~~~~~~~-  289 (303)
                      +++.++++.+++..... ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++...... 
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            99999999977765421 1588999999999999999999999999999999999999998 79999999997543322 


Q ss_pred             ------CccCCCCCCcccCC
Q 046106          290 ------GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ------~~~~~~gt~~y~AP  303 (303)
                            ......||..|+||
T Consensus       158 ~~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             cccccccccccccccccCCH
Confidence                  23556899999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.80  E-value=8.4e-20  Score=165.84  Aligned_cols=139  Identities=24%  Similarity=0.396  Sum_probs=123.3

Q ss_pred             CCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcC
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKP  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~  205 (303)
                      ..|...++||+|.|+.||++++     ..+.||+|.+......        .++.+|+++|..+. +.||+++.+++...
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--------~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--------SRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--------hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            4566778999999999999976     3458999998765432        46889999999996 89999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCce
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVAR  283 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~  283 (303)
                      +..++|+||+++....+++..     ++...+..++..++.||+++|.+|||||||||.|+|.+.. +.-.|+|||+|.
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence            999999999999999999875     5788899999999999999999999999999999999876 778999999996

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.78  E-value=1.8e-18  Score=146.01  Aligned_cols=141  Identities=22%  Similarity=0.223  Sum_probs=99.5

Q ss_pred             cceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHH------------------HHHHHHHHHHHHcCCCC--Ce
Q 046106          137 GDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVM------------------EQQFQQEVMMLATLKHP--NI  195 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~------------------~~~~~~E~~il~~l~hp--ni  195 (303)
                      ++.||+|+||.||+|.. ++++||||+++............                  ......|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988 58899999987654332211110                  01123566666666543  34


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCc
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQ-FLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKS  273 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~  273 (303)
                      .+++++.    ..++||||++++.+.. .+....   .. .....++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus        82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CceEecC----CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence            4454432    2489999998854321 122110   11 5678899999999999999 9999999999999999 999


Q ss_pred             EEEeccCCceeee
Q 046106          274 IKIADFGVARIEV  286 (303)
Q Consensus       274 vKl~DFGla~~~~  286 (303)
                      ++|+|||.|....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.78  E-value=3e-18  Score=150.81  Aligned_cols=141  Identities=18%  Similarity=0.178  Sum_probs=107.8

Q ss_pred             ceec-ccCceEEEEEEECCeEEEEEEeeCCCCChH-------HHHHHHHHHHHHHHHHHcCCCCCe--eeeeEEEEcCC-
Q 046106          138 DAFA-QGAFGKLYRGTYNGEEVAIKILERPENDPE-------KAQVMEQQFQQEVMMLATLKHPNI--VRFIGACRKPM-  206 (303)
Q Consensus       138 ~~lG-~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~-------~~~~~~~~~~~E~~il~~l~hpni--v~l~~~~~~~~-  206 (303)
                      ..|| .|+.|.||.+...+..++||.+.....-..       .......++.+|+.++..++|++|  +.++++..... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4577 788899999888889999999865432000       001223578899999999998775  67777654322 


Q ss_pred             ---eEEEEEeecCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          207 ---VWCIVTEYAKG-GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       207 ---~~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                         ..++|||++++ .+|.+++...   .++..    .+.|++.+|.+||++||+||||||.|||++.++.++|+|||.+
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence               12599999997 6898887642   34544    3578999999999999999999999999999999999999999


Q ss_pred             eee
Q 046106          283 RIE  285 (303)
Q Consensus       283 ~~~  285 (303)
                      +..
T Consensus       190 ~~~  192 (239)
T PRK01723        190 ELR  192 (239)
T ss_pred             ccC
Confidence            764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.76  E-value=7.5e-18  Score=135.52  Aligned_cols=131  Identities=21%  Similarity=0.246  Sum_probs=111.5

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC--CCeeeeeEEEEcCCeEEEEEee
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH--PNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .+.||+|.++.||++..++..+++|+.+....        ...+.+|+.+++.++|  +.+++++.+...+...++++||
T Consensus         3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             ceecccccccceEEEEecCCeEEEEecCCCCc--------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46799999999999999888999999865432        1467889999999976  5899999888877788999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL---GLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +++..+..+         +......++.+++.+|++||..   +++|+|++|+||++++.+.++++|||.++.
T Consensus        75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            988766543         4556677889999999999985   799999999999999989999999999975

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.74  E-value=2.5e-18  Score=155.23  Aligned_cols=174  Identities=24%  Similarity=0.398  Sum_probs=137.8

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR  197 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  197 (303)
                      .+.++.+.++++...+-+|.||.||+|.|       +.+.|-+|.++.     ...+.....++.|..++..+.|||+..
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-----~AS~iQv~~~L~es~lly~~sH~nll~  351 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-----HASQIQVNLLLQESMLLYGASHPNLLS  351 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-----cccHHHHHHHHHHHHHHhcCcCCCccc
Confidence            35567778888888999999999999966       224567777753     223344578999999999999999999


Q ss_pred             eeEEEEcC-CeEEEEEeecCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 046106          198 FIGACRKP-MVWCIVTEYAKGGSVRQFLTKR------QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS  270 (303)
Q Consensus       198 l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~  270 (303)
                      +.+++... ...++++.++.-|+|..||..-      ..+.+...++..++.|++.||+|||++||||.||.++|++|++
T Consensus       352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh
Confidence            99998654 4567888999889999999821      2245778889999999999999999999999999999999999


Q ss_pred             CCcEEEeccCCceeeecCCCcc---CCCCCCcccCC
Q 046106          271 DKSIKIADFGVARIEVQTEGMT---PETGTYRWMAP  303 (303)
Q Consensus       271 ~~~vKl~DFGla~~~~~~~~~~---~~~gt~~y~AP  303 (303)
                      .-.+||+|=-++|...+.....   ..-...+||+|
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMsl  467 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSL  467 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCH
Confidence            9999999999998654432111   11235788885

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=4.4e-17  Score=164.23  Aligned_cols=152  Identities=25%  Similarity=0.401  Sum_probs=115.8

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC---CCCeee
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---HPNIVR  197 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~  197 (303)
                      ....+.++....|.+.+.||+|+||+||+|+. +++.||+|+-+++..-.         |.--.+++.+|+   -+.|..
T Consensus       688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---------fYI~~q~~~RLk~~~~~~~~~  758 (974)
T KOG1166|consen  688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---------FYICLQVMERLKPQMLPSIMH  758 (974)
T ss_pred             CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---------eeehHHHHHhhchhhhcchHH
Confidence            33456677788899999999999999999987 78999999987765321         111223333333   122333


Q ss_pred             eeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-------
Q 046106          198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-------  270 (303)
Q Consensus       198 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-------  270 (303)
                      +..+..-.+.-++|+||.+.|+|.+++..  .+.+++..++.++.|++..++.||..+|||+||||+|+||..       
T Consensus       759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  759 ISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             HHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence            33333333344799999999999999984  467999999999999999999999999999999999999953       


Q ss_pred             CCcEEEeccCCcee
Q 046106          271 DKSIKIADFGVARI  284 (303)
Q Consensus       271 ~~~vKl~DFGla~~  284 (303)
                      +.-++|+|||-+..
T Consensus       837 ~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  837 SKGLYLIDFGRSID  850 (974)
T ss_pred             ccceEEEeccccee
Confidence            24699999998854

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.66  E-value=5.1e-17  Score=165.88  Aligned_cols=93  Identities=19%  Similarity=0.258  Sum_probs=73.5

Q ss_pred             CCC-CCeeeeeEEE-------EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 046106          190 LKH-PNIVRFIGAC-------RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDL  261 (303)
Q Consensus       190 l~h-pniv~l~~~~-------~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDl  261 (303)
                      ++| +||.+++++|       .....+++++|++ +++|.++|... ...+++..++.++.||+.||+|||++|||||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            345 5777777776       2234567888988 56999999753 356899999999999999999999999999999


Q ss_pred             CCCcEEEcC-------------------CCcEEEeccCCcee
Q 046106          262 KSDNLLIFS-------------------DKSIKIADFGVARI  284 (303)
Q Consensus       262 kp~NILv~~-------------------~~~vKl~DFGla~~  284 (303)
                      ||+||||+.                   ++.+||+|||+++.
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~  148 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR  148 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence            999999954                   44566777777653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.65  E-value=9.4e-16  Score=146.07  Aligned_cols=144  Identities=21%  Similarity=0.315  Sum_probs=99.7

Q ss_pred             ceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHH----------------------------HHH------HHHHHH
Q 046106          138 DAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKA----------------------------QVM------EQQFQQ  182 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~----------------------------~~~------~~~~~~  182 (303)
                      +.||.|++|+||+|+. +|+.||||+.++.....-..                            +..      +-++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999998 89999999987653211110                            000      113556


Q ss_pred             HHHHHHcCC-----CCCeeeeeEEE-EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 046106          183 EVMMLATLK-----HPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR-GMAYVHRLG  255 (303)
Q Consensus       183 E~~il~~l~-----hpniv~l~~~~-~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~g  255 (303)
                      |+..+.+++     +++| .+-.++ .-....++||||++|++|.++...... ...   ...++.+++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence            666666653     3433 322222 222335899999999999888754221 122   2345555555 478899999


Q ss_pred             ceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       256 iiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ++|+|++|.||++++++.++|+|||++....
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.59  E-value=2.3e-16  Score=136.75  Aligned_cols=167  Identities=32%  Similarity=0.554  Sum_probs=136.1

Q ss_pred             eecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      |+.+++++..+|.+...|+.|+|+|.|..+++|++..........    +.|.+|...|+.+.||||+.+++.|..+..+
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~ris----rdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARIS----RDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhc----chhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            566778888899999999999999999999999987765554333    6899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeC-CCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG-LIHR-DLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-iiHr-Dlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .++..||+.|+|++.|++..+..+...++.+++.++++||+|||+.. +|-| -|....++||++-+.+|+ .+-+++..
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf  341 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF  341 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee
Confidence            99999999999999999887777788899999999999999999875 4444 688899999999887774 23333322


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      +..   ...=.|.||+|
T Consensus       342 qe~---gr~y~pawmsp  355 (448)
T KOG0195|consen  342 QEV---GRAYSPAWMSP  355 (448)
T ss_pred             ecc---ccccCcccCCH
Confidence            111   11224778887

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=1.6e-15  Score=149.26  Aligned_cols=166  Identities=23%  Similarity=0.307  Sum_probs=122.7

Q ss_pred             cccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      .....+|.|++|.|+....  .....+.|..+......+........+..|..+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4566799999997776654  33334444332110011122222234788999999999999988877776655555559


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC---
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE---  289 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~---  289 (303)
                      ||+++ +|..++...  ..+....+-.++.|++.|++|||+.||.|||||++|++++.+|.+||+|||.+.......   
T Consensus       401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            99998 999999864  347788889999999999999999999999999999999999999999999987643222   


Q ss_pred             --CccCCCCCCcccCC
Q 046106          290 --GMTPETGTYRWMAP  303 (303)
Q Consensus       290 --~~~~~~gt~~y~AP  303 (303)
                        .....+|+..|+||
T Consensus       478 ~~~~~g~~gS~pY~ap  493 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAP  493 (601)
T ss_pred             hhhhcCcccCCcCcCc
Confidence              12345788889988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.57  E-value=2.1e-16  Score=150.48  Aligned_cols=155  Identities=25%  Similarity=0.416  Sum_probs=127.6

Q ss_pred             ecccCceEEEEEE-----ECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEe
Q 046106          140 FAQGAFGKLYRGT-----YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       140 lG~G~fg~Vy~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      +|+|+||+|+.++     ..+..+|+|++++........    .....|..++..++ ||.++++.-.++.+...+++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~----~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR----THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccc----cccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            7899999999764     356678999887654322111    14456777888887 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccC
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP  293 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~  293 (303)
                      +..+|.|...+...  ..+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++|+.|||+.+.....+..  
T Consensus        78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99999997777654  34667777888899999999999999999999999999999999999999999876544332  


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                       |||..||||
T Consensus       154 -cgt~eymAp  162 (612)
T KOG0603|consen  154 -CGTYEYRAP  162 (612)
T ss_pred             -ccchhhhhh
Confidence             999999998

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.57  E-value=4.1e-15  Score=143.89  Aligned_cols=152  Identities=18%  Similarity=0.250  Sum_probs=93.7

Q ss_pred             cCCccccceecccCceEEEEEEE-C-CeEEEEEEeeCCCCCh----------------------------HHHHHHHH--
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY-N-GEEVAIKILERPENDP----------------------------EKAQVMEQ--  178 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~-~-~~~vAvK~~~~~~~~~----------------------------~~~~~~~~--  178 (303)
                      +.+|+. +.||.|++|+||+|+. + |+.||||++++.....                            +-.+...+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            455665 7899999999999998 4 8999999998653110                            00111112  


Q ss_pred             ----HHHHHHHHHHcCC----CCCeeeeeEEEEc-CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 046106          179 ----QFQQEVMMLATLK----HPNIVRFIGACRK-PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA  249 (303)
Q Consensus       179 ----~~~~E~~il~~l~----hpniv~l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~  249 (303)
                          ++.+|+..+.+++    +...+.+-.++.+ ....+|||||+.|+++.++..-.. .......+.....+  .-+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~v~--~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERGVE--VFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHHHH--HHHH
Confidence                3444555444442    3333333333321 223479999999999987532111 11222222111111  1122


Q ss_pred             HHHhCCceeCCCCCCcEEEcCCC----cEEEeccCCceeee
Q 046106          250 YVHRLGLIHRDLKSDNLLIFSDK----SIKIADFGVARIEV  286 (303)
Q Consensus       250 ~LH~~giiHrDlkp~NILv~~~~----~vKl~DFGla~~~~  286 (303)
                      -+...|++|+|+||.||+|+.++    .++++|||++....
T Consensus       275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            34468999999999999999988    99999999987553

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.57  E-value=1.6e-14  Score=119.63  Aligned_cols=127  Identities=16%  Similarity=0.153  Sum_probs=95.4

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEEeecC
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN-IVRFIGACRKPMVWCIVTEYAK  216 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~~~iv~E~~~  216 (303)
                      +.|+.|.++.||+++..+..+++|+.......       ...+.+|+.+++.+.+.+ +++++.....  ..++||||++
T Consensus         4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~-------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~   74 (170)
T cd05151           4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL-------LINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE   74 (170)
T ss_pred             eecCCcccCceEEEEECCeEEEEEeCCCCccc-------ccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence            45889999999999999999999997654311       124567888888876544 3455554432  2379999999


Q ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          217 GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL-----IHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       217 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~gi-----iHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +.++.+.  .     ..   ....+.+++.+|+.||+.++     +|+|++|.||+++ ++.++++|||.|..
T Consensus        75 G~~l~~~--~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9877542  0     11   12356789999999999885     9999999999998 67899999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.51  E-value=3.8e-13  Score=111.44  Aligned_cols=139  Identities=23%  Similarity=0.324  Sum_probs=106.6

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeC-CCCChHHHH-HHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILER-PENDPEKAQ-VMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~-~~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      ..+.+|+-+.++.+.|-|.++++|.-.+ .-..++-.+ ....+-.+|+.++.+++-..|...+-+..++..-.|+|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            3578999999999988887777776433 333333322 33567889999999987666665555566666667999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      +|..|.+++...         ...++..+-.-+.-||..||||+||.++||++...+ +.++||||+.+..
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            998888888764         245677777788889999999999999999996655 9999999998643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.51  E-value=3.9e-13  Score=114.20  Aligned_cols=142  Identities=15%  Similarity=0.154  Sum_probs=101.2

Q ss_pred             cceecccCceEEEEEEEC--------CeEEEEEEeeCCCCCh--------------------HHHHHHHHHHHHHHHHHH
Q 046106          137 GDAFAQGAFGKLYRGTYN--------GEEVAIKILERPENDP--------------------EKAQVMEQQFQQEVMMLA  188 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~--------~~~vAvK~~~~~~~~~--------------------~~~~~~~~~~~~E~~il~  188 (303)
                      ...||.|.=+.||.|...        +..+|||+.+.....-                    ...........+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            346899999999999753        3689999987543210                    011122234448999999


Q ss_pred             cCC--CCCeeeeeEEEEcCCeEEEEEeecCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCCC
Q 046106          189 TLK--HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQ-FLTKRQNRSVPLKLAVKQALDVARGMAYV-HRLGLIHRDLKSD  264 (303)
Q Consensus       189 ~l~--hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~giiHrDlkp~  264 (303)
                      ++.  .-++++++++  .  .-+|||||+.+..+.. .++.   ..++......+..+++.+|..| |+.||||+||++.
T Consensus        82 rl~~~Gv~vP~pi~~--~--~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~  154 (197)
T cd05146          82 RMQKAGIPCPEVVVL--K--KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY  154 (197)
T ss_pred             HHHHcCCCCCeEEEe--c--CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            986  3566777765  2  2379999996543321 2222   2345556677889999999999 8999999999999


Q ss_pred             cEEEcCCCcEEEeccCCceeee
Q 046106          265 NLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       265 NILv~~~~~vKl~DFGla~~~~  286 (303)
                      |||+. ++.+.|+|||.|....
T Consensus       155 NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeCC
Confidence            99996 5779999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.50  E-value=6.7e-13  Score=109.71  Aligned_cols=150  Identities=22%  Similarity=0.272  Sum_probs=112.9

Q ss_pred             ccceecccCceEEEEEEECCeEEEEEEeeCC-CCCh-HHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 046106          136 MGDAFAQGAFGKLYRGTYNGEEVAIKILERP-ENDP-EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~-~~~~-~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      .+..+-||+-+.|+++.+.|+...||.--.. -..+ -..+...++.++|+.+|.++.--.|....-++.+...-+|+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            3456889999999999999999888864222 2222 2334446788999999999875555544445555544579999


Q ss_pred             ecCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEeccCCceee
Q 046106          214 YAKG-GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK---SIKIADFGVARIE  285 (303)
Q Consensus       214 ~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~---~vKl~DFGla~~~  285 (303)
                      |+++ .++.+|+...............++.+|-..+.-||..+|||+||..+||++.+++   .+.++|||++...
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9965 4889998876544444444578899999999999999999999999999997664   4689999998653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.44  E-value=6.8e-13  Score=118.68  Aligned_cols=148  Identities=20%  Similarity=0.361  Sum_probs=95.1

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC----------CCeeeeeE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH----------PNIVRFIG  200 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h----------pniv~l~~  200 (303)
                      .+..+..||.|+++.||++++  +++++|+|+.........   ...+.+.+|......+.+          -.++..++
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~---~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d   89 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA---NEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD   89 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT---THHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch---HHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence            456677899999999999999  679999999877663222   123566666544444322          23333334


Q ss_pred             EEEc------------CCe-----EEEEEeecCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 046106          201 ACRK------------PMV-----WCIVTEYAKGGSVRQFLTK---RQNR--SVPLKLAVKQALDVARGMAYVHRLGLIH  258 (303)
Q Consensus       201 ~~~~------------~~~-----~~iv~E~~~~gsL~~~l~~---~~~~--~~~~~~~~~i~~qi~~~l~~LH~~giiH  258 (303)
                      ...-            ...     .+++|+-+. ++|.+++..   ....  .......+.+..|+++.+++||..|++|
T Consensus        90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVH  168 (288)
T PF14531_consen   90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVH  168 (288)
T ss_dssp             EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEe
Confidence            3321            111     367888884 588887652   2211  1223445566789999999999999999


Q ss_pred             CCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          259 RDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       259 rDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +||+|+|+|++++|.++|+||+....
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r  194 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVR  194 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEE
T ss_pred             cccceeeEEEcCCCCEEEcChHHHee
Confidence            99999999999999999999997754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.33  E-value=8.9e-12  Score=107.29  Aligned_cols=139  Identities=19%  Similarity=0.281  Sum_probs=102.8

Q ss_pred             ceecccCceEEEEEEECC-eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC--CCeeeeeEEEEcCC---eEEEE
Q 046106          138 DAFAQGAFGKLYRGTYNG-EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH--PNIVRFIGACRKPM---VWCIV  211 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~~---~~~iv  211 (303)
                      +.|+.|..+.||+++..+ +.+++|+........     ....+.+|+.+++.+++  ..+++++.+.....   ..++|
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~-----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v   78 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP-----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYV   78 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCc-----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEE
Confidence            458899999999998854 899999986543310     11467789999999875  44677777766532   56899


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR--------------------------------------  253 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------  253 (303)
                      |||++|.++.+.+..   ..++......++.+++.+|..||+                                      
T Consensus        79 ~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          79 MERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            999998877654421   135556666667777777777763                                      


Q ss_pred             ------------------CCceeCCCCCCcEEEcC--CCcEEEeccCCcee
Q 046106          254 ------------------LGLIHRDLKSDNLLIFS--DKSIKIADFGVARI  284 (303)
Q Consensus       254 ------------------~giiHrDlkp~NILv~~--~~~vKl~DFGla~~  284 (303)
                                        ..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                              24799999999999998  67789999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.33  E-value=2.1e-11  Score=103.15  Aligned_cols=130  Identities=22%  Similarity=0.283  Sum_probs=83.9

Q ss_pred             EEEEEEE-CCeEEEEEEeeCCCCCh--------------------HHHHHHHHHHHHHHHHHHcCCCC--CeeeeeEEEE
Q 046106          147 KLYRGTY-NGEEVAIKILERPENDP--------------------EKAQVMEQQFQQEVMMLATLKHP--NIVRFIGACR  203 (303)
Q Consensus       147 ~Vy~~~~-~~~~vAvK~~~~~~~~~--------------------~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~~~  203 (303)
                      .||.|.. ++..+|||+.+.....-                    ...........+|+..|.++...  ++++++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899987 78899999987542211                    11123346788999999999865  567777553 


Q ss_pred             cCCeEEEEEeecC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          204 KPMVWCIVTEYAK--GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY-VHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       204 ~~~~~~iv~E~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                       ..  +|||||++  |..+..+....    +.......++.+++..+.. +|..||||+||.+.|||++++ .+.|+|||
T Consensus        80 -~~--~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   80 -RN--VIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             -TT--EEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             -CC--EEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence             22  69999998  55554433221    1133345667777775555 579999999999999999887 99999999


Q ss_pred             Cceee
Q 046106          281 VARIE  285 (303)
Q Consensus       281 la~~~  285 (303)
                      .|...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            98653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.31  E-value=6.3e-11  Score=105.77  Aligned_cols=140  Identities=16%  Similarity=0.096  Sum_probs=98.6

Q ss_pred             CceEEEEEEECCeEEEEEEeeCCCCChHHHHH------HHHHHHHHHHHHHcCCCCCe--eeeeEEEEc-----CCeEEE
Q 046106          144 AFGKLYRGTYNGEEVAIKILERPENDPEKAQV------MEQQFQQEVMMLATLKHPNI--VRFIGACRK-----PMVWCI  210 (303)
Q Consensus       144 ~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~------~~~~~~~E~~il~~l~hpni--v~l~~~~~~-----~~~~~i  210 (303)
                      ....|.+..+.|+.+.||......... ....      -...+.+|...+..|...+|  +.++++...     ...-+|
T Consensus        34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         34 EGRRTLRFELAGKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CCceEEEEEECCEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            334577888899999999774433210 0000      00136788888887753333  344444432     123579


Q ss_pred             EEeecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-------CCcEEEeccCCc
Q 046106          211 VTEYAKGG-SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-------DKSIKIADFGVA  282 (303)
Q Consensus       211 v~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-------~~~vKl~DFGla  282 (303)
                      |||++++. +|.+++........+......++.+++..+.-||+.||+|+|+++.||||+.       +..+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99999875 7999886433334566777889999999999999999999999999999975       468999999988


Q ss_pred             ee
Q 046106          283 RI  284 (303)
Q Consensus       283 ~~  284 (303)
                      +.
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            64

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=1.1e-11  Score=112.83  Aligned_cols=89  Identities=33%  Similarity=0.521  Sum_probs=73.6

Q ss_pred             CCCCeeeeeEEEEc---------------------------CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Q 046106          191 KHPNIVRFIGACRK---------------------------PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD  243 (303)
Q Consensus       191 ~hpniv~l~~~~~~---------------------------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~q  243 (303)
                      +|||||++.+.|.+                           +..+|+||..++ .+|.+|+..+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence            69999999887632                           345799999885 4999999864   3566677788999


Q ss_pred             HHHHHHHHHhCCceeCCCCCCcEEE--cCCC--cEEEeccCCce
Q 046106          244 VARGMAYVHRLGLIHRDLKSDNLLI--FSDK--SIKIADFGVAR  283 (303)
Q Consensus       244 i~~~l~~LH~~giiHrDlkp~NILv--~~~~--~vKl~DFGla~  283 (303)
                      +++|+.|||.+||.|||+|.+||||  ++++  .+.|+|||.|-
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence            9999999999999999999999998  4443  57899999873

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.22  E-value=1.7e-12  Score=130.40  Aligned_cols=145  Identities=22%  Similarity=0.296  Sum_probs=112.6

Q ss_pred             CccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEE
Q 046106          133 KLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      ++...+.||.+.|=+|.+|++..-.|+||++-+......- +.. .+..+|+. ....++||.+.+..+..++.--|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL-~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL-RPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc-hHH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            5666788999999999999984444999998665422111 111 22334444 56678999999888877777778888


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      +|..+ +|+|.+..++.  +...+..-|+.|+++||.-||..||+|+|||.+||||+.=+-+.|+||-.=+
T Consensus       101 qyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             HHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC
Confidence            99965 99999987643  4556667789999999999999999999999999999998889999997543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.21  E-value=4.6e-11  Score=99.36  Aligned_cols=73  Identities=25%  Similarity=0.292  Sum_probs=63.6

Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCC
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT  297 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt  297 (303)
                      |+|.+++... +..+++..++.++.|++.||+|||+++      ||+|||++.++.+|+  ||+++......    ..||
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~   67 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVD   67 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCc
Confidence            6899999864 356999999999999999999999999      999999999999999  99998754322    3689


Q ss_pred             CcccCC
Q 046106          298 YRWMAP  303 (303)
Q Consensus       298 ~~y~AP  303 (303)
                      +.||||
T Consensus        68 ~~y~aP   73 (176)
T smart00750       68 PYFMAP   73 (176)
T ss_pred             ccccCh
Confidence            999998

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=2.3e-12  Score=126.98  Aligned_cols=169  Identities=22%  Similarity=0.379  Sum_probs=130.9

Q ss_pred             cCCccccceecccCceEEEEEEE---CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCC
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPM  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~  206 (303)
                      ...+.+.+.||+|+|+.|-....   ....+|+|.+........    .......|..+-+.+. |+|++.+++....+.
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~----~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~   94 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSED----SSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR   94 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccc----hhhhcCccccccccccccccccccCCccCCCc
Confidence            34556667799999999887655   233567776665542111    1235556888888887 999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCcEEEcCCC-cEEEeccCCcee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIHRDLKSDNLLIFSDK-SIKIADFGVARI  284 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~giiHrDlkp~NILv~~~~-~vKl~DFGla~~  284 (303)
                      ..++++++..++++.+-+........+......++.|+..++.|+| ..++.||||||+|.+++..+ .+|++|||+|..
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999999999988873222124667778889999999999999 99999999999999999999 999999999976


Q ss_pred             eec-CC---CccCCCC-CCcccCC
Q 046106          285 EVQ-TE---GMTPETG-TYRWMAP  303 (303)
Q Consensus       285 ~~~-~~---~~~~~~g-t~~y~AP  303 (303)
                      ... ..   .....+| ++.|+||
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~  198 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAP  198 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCc
Confidence            544 22   1234578 9999997

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.15  E-value=2.6e-11  Score=121.70  Aligned_cols=128  Identities=29%  Similarity=0.499  Sum_probs=87.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ..+|+.++.|-.|++|.||..++  +.+++|+|+-+. .           .+.+.  ++.....|.+|            
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~-----------lilRn--ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N-----------LILRN--ILTFAGNPFVV------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc-c-----------hhhhc--cccccCCccee------------
Confidence            34677778899999999999987  477899965322 1           11111  23333344433            


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                               |+-...++..  +.+|...        +.+++|||+.||+|||+||+|.||+.-|++|+.|||+.+.....
T Consensus       136 ---------gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ---------GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ---------chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                     3444444432  2344332        67899999999999999999999999999999999998653211


Q ss_pred             C----------------CccCCCCCCcccCC
Q 046106          289 E----------------GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~----------------~~~~~~gt~~y~AP  303 (303)
                      .                .....||||.|.||
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccCh
Confidence            0                01234899999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.13  E-value=5.9e-11  Score=112.88  Aligned_cols=99  Identities=29%  Similarity=0.467  Sum_probs=89.9

Q ss_pred             HHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeCCCCCCc
Q 046106          187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL-IHRDLKSDN  265 (303)
Q Consensus       187 l~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~gi-iHrDlkp~N  265 (303)
                      |+.+.|.|+.+++|.+..+...++|++|+..|+|.|.+... ...+.+--...+.++++.||+|||...| .|+.|+..|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            45789999999999999999999999999999999999874 3567888888999999999999998765 999999999


Q ss_pred             EEEcCCCcEEEeccCCceeee
Q 046106          266 LLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       266 ILv~~~~~vKl~DFGla~~~~  286 (303)
                      ++++....+||+|||+..+..
T Consensus        80 Clvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   80 CLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             ceeeeeEEEEechhhhccccc
Confidence            999999999999999987653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.12  E-value=7.5e-10  Score=97.14  Aligned_cols=140  Identities=21%  Similarity=0.246  Sum_probs=98.9

Q ss_pred             cccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHH----------------HHHHHHHHHHHHHHHHcCCCC--Ce
Q 046106          135 NMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEK----------------AQVMEQQFQQEVMMLATLKHP--NI  195 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~----------------~~~~~~~~~~E~~il~~l~hp--ni  195 (303)
                      .++.+||-|.-+.||.|.. +|.++|||.-+.....-.+                ....+....+|.++|.+|...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4567899999999999998 6999999976543221111                112234567899999999744  77


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vK  275 (303)
                      ++.+++-..    .+|||+++|..|...-       +.....-.++..|+.-+.-+-..||||+|+.+-||+|+++|.+.
T Consensus       174 P~P~~~nRH----aVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         174 PKPIAWNRH----AVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCccccccc----eeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            777775433    7999999886664322       11222333444444445545589999999999999999999999


Q ss_pred             EeccCCceee
Q 046106          276 IADFGVARIE  285 (303)
Q Consensus       276 l~DFGla~~~  285 (303)
                      ++||-.+...
T Consensus       243 vIDwPQ~v~~  252 (304)
T COG0478         243 VIDWPQAVPI  252 (304)
T ss_pred             EEeCcccccC
Confidence            9999887643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.10  E-value=9.6e-10  Score=94.58  Aligned_cols=106  Identities=20%  Similarity=0.259  Sum_probs=82.9

Q ss_pred             HHHHHHHHHHHcCCC--CCeeeeeEEEEcC----CeEEEEEeecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 046106          178 QQFQQEVMMLATLKH--PNIVRFIGACRKP----MVWCIVTEYAKGG-SVRQFLTKRQNRSVPLKLAVKQALDVARGMAY  250 (303)
Q Consensus       178 ~~~~~E~~il~~l~h--pniv~l~~~~~~~----~~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~  250 (303)
                      .+..+|...+..|..  -.+++++++....    ..-+||+|++++. +|.+++.....  .+......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            467778887777753  2345555655442    2347999999874 79998886432  5566778899999999999


Q ss_pred             HHhCCceeCCCCCCcEEEcCCC---cEEEeccCCceee
Q 046106          251 VHRLGLIHRDLKSDNLLIFSDK---SIKIADFGVARIE  285 (303)
Q Consensus       251 LH~~giiHrDlkp~NILv~~~~---~vKl~DFGla~~~  285 (303)
                      ||+.||+|+|+++.||||+.++   .+.|+||+-++..
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.96  E-value=1.2e-10  Score=109.43  Aligned_cols=94  Identities=30%  Similarity=0.520  Sum_probs=80.7

Q ss_pred             eEEEEEeecCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKR-QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      .+||.|+++.-.+|.+++..+ .....++.....++.|++.|++|   ++.+|||+||.||+...+..+||.|||+..-.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            478999999999999999743 33456788889999999999999   99999999999999999999999999998655


Q ss_pred             ecCC-------CccCCCCCCcccCC
Q 046106          286 VQTE-------GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~-------~~~~~~gt~~y~AP  303 (303)
                      ....       ..+..+||..||+|
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsP  431 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSP  431 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCH
Confidence            4444       34566899999998

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.96  E-value=3.7e-09  Score=102.28  Aligned_cols=118  Identities=17%  Similarity=0.339  Sum_probs=98.8

Q ss_pred             CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCC
Q 046106          154 NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP  233 (303)
Q Consensus       154 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~  233 (303)
                      ++.+|.|...+....  +.    .....+.+..|+.++||||+++++.+.....+|||+|.+.  .|..++.+..     
T Consensus        36 ~~~~vsVF~~~~~~~--~~----~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----  102 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG--EV----TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----  102 (690)
T ss_pred             cCCceEEEEEeCCCc--hh----hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence            667888888876543  11    2356678899999999999999999999999999999983  7888887642     


Q ss_pred             HHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          234 LKLAVKQALDVARGMAYVH-RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       234 ~~~~~~i~~qi~~~l~~LH-~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ...+.-.+.||+.||.||| +++++|++|..+.|+|++.|..||.+|.++..
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~  154 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSK  154 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEec
Confidence            4556667899999999998 66899999999999999999999999998743

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.93  E-value=7.4e-09  Score=100.02  Aligned_cols=156  Identities=17%  Similarity=0.239  Sum_probs=99.0

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHH----------------------------HHH-
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKA----------------------------QVM-  176 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~----------------------------~~~-  176 (303)
                      |+-.+.+|+- +.|+.++-|+||+|++ +|+.||||+.++.....-..                            +.. 
T Consensus       121 iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~  199 (517)
T COG0661         121 IEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE  199 (517)
T ss_pred             HHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence            3333444432 6799999999999999 69999999988754321111                            011 


Q ss_pred             -----HHHHHHHHHHHHcCC-----CCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH
Q 046106          177 -----EQQFQQEVMMLATLK-----HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR  246 (303)
Q Consensus       177 -----~~~~~~E~~il~~l~-----hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~  246 (303)
                           +=++.+|+.-+.+++     .|+|.-..-++.-...-.++|||++|..+.+...... ..++...+.....++. 
T Consensus       200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f-  277 (517)
T COG0661         200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF-  277 (517)
T ss_pred             HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH-
Confidence                 123445666565553     3444322222222223369999999999988854322 3355444433333222 


Q ss_pred             HHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       247 ~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                       +.-+=..|++|.|..|.||+|..+|.+.+.|||+.....
T Consensus       278 -~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         278 -LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             -HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence             333445899999999999999999999999999986543

>PRK09902 hypothetical protein; Provisional

Probab=98.89  E-value=2.4e-08  Score=85.48  Aligned_cols=144  Identities=12%  Similarity=0.091  Sum_probs=100.3

Q ss_pred             cccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC--CCeeeeeEEE--EcC--CeEEEEEee
Q 046106          141 AQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH--PNIVRFIGAC--RKP--MVWCIVTEY  214 (303)
Q Consensus       141 G~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~--~~~--~~~~iv~E~  214 (303)
                      |.|+-+-|++-...|+.+=+|.-.......-....-+..|.+|...+..+..  -.++++....  ..+  ..-+||+|-
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~  106 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED  106 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence            4577778998888777777776541100000000012578899999988853  2244444221  111  235799998


Q ss_pred             cCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc--EEEeccCCcee
Q 046106          215 AKG-GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVARI  284 (303)
Q Consensus       215 ~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~--vKl~DFGla~~  284 (303)
                      +.+ .+|.+++....-.+.+......+..+++..+.-||+.|+.|+|+-+.|||++.++.  ++++||.-++.
T Consensus       107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            853 58888887643334567777899999999999999999999999999999987776  99999987764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.84  E-value=3.6e-08  Score=85.78  Aligned_cols=141  Identities=20%  Similarity=0.194  Sum_probs=97.3

Q ss_pred             eecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHH------------------HHHHHHHHHHHHHHHcCC--CCCeee
Q 046106          139 AFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKA------------------QVMEQQFQQEVMMLATLK--HPNIVR  197 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~------------------~~~~~~~~~E~~il~~l~--hpniv~  197 (303)
                      .|.+|.-+.||+|.. ++..+|||+++.......+.                  +....+..+|..-|+++.  +-.+++
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            567788889999876 78899999998654432221                  122234556787787774  445556


Q ss_pred             eeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEE
Q 046106          198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       198 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      .+++...    .|||||+... - .---.....++.......+..+++..|.-|-. .++||+||..-|||+. ++.+.|
T Consensus       135 Pi~~~~n----VLvMEfIg~~-g-~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         135 PIAFRNN----VLVMEFIGDD-G-LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             ceeecCC----eEEEEeccCC-C-CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            6655432    6899999442 1 00001111223333577778888889888887 8999999999999998 889999


Q ss_pred             eccCCceeee
Q 046106          277 ADFGVARIEV  286 (303)
Q Consensus       277 ~DFGla~~~~  286 (303)
                      +|||.|....
T Consensus       208 ID~~QaV~~~  217 (268)
T COG1718         208 IDVSQAVTID  217 (268)
T ss_pred             EECccccccC
Confidence            9999986544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.82  E-value=3e-09  Score=101.59  Aligned_cols=166  Identities=21%  Similarity=0.289  Sum_probs=125.7

Q ss_pred             CCccccceecc--cCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEc
Q 046106          132 RKLNMGDAFAQ--GAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRK  204 (303)
Q Consensus       132 ~~~~~~~~lG~--G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~  204 (303)
                      ..+.....+|.  |.+|.||.+..    .+..+|+|.-+.....+...    ..=.+|+..-++++ |++.++.+..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~----~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS----KRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc----ccccchhhcccccCccccccccCccccc
Confidence            34556677899  99999998865    55688988754433322111    12235666666665 9999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeCCCCCCcEEEcCC-CcEEEecc
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR----GMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADF  279 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DF  279 (303)
                      .+..++-+|++ +.+|..+..... .-++...++....+...    |+.++|..+++|-|+||.||+...+ ..++++||
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence            99999999999 578888877653 34788888888888888    9999999999999999999999999 88999999


Q ss_pred             CCceeeecCCCc------cCCCCCCcccCC
Q 046106          280 GVARIEVQTEGM------TPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~------~~~~gt~~y~AP  303 (303)
                      |+...+....-.      ....|...|++|
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~k  297 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAK  297 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeCh
Confidence            998765443311      111456677775

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.79  E-value=5.5e-08  Score=80.44  Aligned_cols=137  Identities=23%  Similarity=0.333  Sum_probs=98.1

Q ss_pred             cCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI-VRFIGACRKPMVWC  209 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~  209 (303)
                      ....+..+.|++|.+|.||.|.|.|..+|+|+-+.+..        +..+..|+++|..++..++ .++|.+..+    +
T Consensus        21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--------r~~l~kEakiLeil~g~~~~p~vy~yg~~----~   88 (201)
T COG2112          21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--------RRNLEKEAKILEILAGEGVTPEVYFYGED----F   88 (201)
T ss_pred             chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc--------hhhHHHHHHHHHHhhhcCCCceEEEechh----h
Confidence            34456677899999999999999999999998765433        2578899999999986555 455555443    4


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC-CCcEEEcCCCcEEEeccCCceeeecC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLK-SDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlk-p~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      +.|||+.|.+|.+.-...     ...++    ..+++.---|-..||-|..|. |..++|..++.+.|+||.-|++...+
T Consensus        89 i~me~i~G~~L~~~~~~~-----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p  159 (201)
T COG2112          89 IRMEYIDGRPLGKLEIGG-----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP  159 (201)
T ss_pred             hhhhhhcCcchhhhhhcc-----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence            669999887887655421     22333    334444444667799999884 66666667779999999999854433

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.76  E-value=2.6e-07  Score=79.50  Aligned_cols=141  Identities=14%  Similarity=0.197  Sum_probs=86.4

Q ss_pred             CCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHH---HHHHHHHHHHHcCC---CCCeeeeeEEEE--
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVME---QQFQQEVMMLATLK---HPNIVRFIGACR--  203 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~---~~~~~E~~il~~l~---hpniv~l~~~~~--  203 (303)
                      .++...+.+-......|.+-..++..+++|..+......++.-...   ....+++..+..++   --....++.+..  
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            3455555565556666666667889999998876543332211100   01112233233332   222223233322  


Q ss_pred             ---cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          204 ---KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       204 ---~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                         -....+++|||++|..|.++..      +++    .++..+..+|.-||+.|+.|+|+.|.|+++++++ ++++||+
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~  179 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ  179 (229)
T ss_pred             eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence               1234568999999988866542      222    2445666789999999999999999999998555 9999998


Q ss_pred             Cce
Q 046106          281 VAR  283 (303)
Q Consensus       281 la~  283 (303)
                      ..+
T Consensus       180 ~k~  182 (229)
T PF06176_consen  180 GKR  182 (229)
T ss_pred             ccc
Confidence            765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.74  E-value=1.2e-07  Score=89.57  Aligned_cols=138  Identities=17%  Similarity=0.255  Sum_probs=107.7

Q ss_pred             eEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc----CCeEEEEEeecCC-C
Q 046106          146 GKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK----PMVWCIVTEYAKG-G  218 (303)
Q Consensus       146 g~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~~~~~iv~E~~~~-g  218 (303)
                      .+.|++..  +|..+++|++.-......      .....-+++++++.|+|||++..++..    +..+++|++|.++ +
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQST------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCc------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            46788875  889999999832211110      122345788999999999999998863    4578999999976 4


Q ss_pred             CHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          219 SVRQFLTKR-------------QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       219 sL~~~l~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      +|.++....             .+...++..+|.++.|+..||.++|+.|+.-+-|.+.+||++-+.+++|+..|...+.
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            777765421             2334778999999999999999999999999999999999999989999999988766


Q ss_pred             ecCC
Q 046106          286 VQTE  289 (303)
Q Consensus       286 ~~~~  289 (303)
                      ..+.
T Consensus       444 ~~d~  447 (655)
T KOG3741|consen  444 QEDP  447 (655)
T ss_pred             cCCC
Confidence            5544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.72  E-value=6.2e-09  Score=99.48  Aligned_cols=148  Identities=20%  Similarity=0.196  Sum_probs=117.3

Q ss_pred             ecCCccccceecccCceEEEEEEE---CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP  205 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~  205 (303)
                      ...+|.++..||.|.|+.|+....   ++..+++|.+.+........    ..-..|+.+...+ .|.+++..+..|...
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d----i~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD----IFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh----hcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            345788889999999999998764   45688888876654433221    2233566666555 488999988888888


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCce
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVAR  283 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~  283 (303)
                      ...||-.||++++++.......  ..+.+..++++..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+.
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence            8888999999998887666432  347778889999999999999999999999999999999886 788999999875

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=2.4e-07  Score=80.85  Aligned_cols=136  Identities=10%  Similarity=0.085  Sum_probs=84.3

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCC--CeeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP--NIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~~~~~~~~~iv~E~~  215 (303)
                      ..||+|..+.||+.  .+..+++|....... .       ....+|.++++.+..-  -+++.++++......++|||++
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~-~-------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD-K-------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCCC-H-------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence            46899999999984  355678888764321 1       2457899999887643  3477788887777788999999


Q ss_pred             CCCC-HH--------------HHHHh----cCC---CCCCHHHHHH-HHHH----------HHH-HHHHHH----hCCce
Q 046106          216 KGGS-VR--------------QFLTK----RQN---RSVPLKLAVK-QALD----------VAR-GMAYVH----RLGLI  257 (303)
Q Consensus       216 ~~gs-L~--------------~~l~~----~~~---~~~~~~~~~~-i~~q----------i~~-~l~~LH----~~gii  257 (303)
                      +|.+ +.              ..+..    ...   ...+...... +..+          +.. ...+|.    ...++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            8853 11              11111    110   1111111111 1000          111 122332    12478


Q ss_pred             eCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          258 HRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       258 HrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      |+|+.|.||++++++ +.|+||+.|..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=2.2e-07  Score=89.75  Aligned_cols=144  Identities=17%  Similarity=0.278  Sum_probs=94.2

Q ss_pred             ceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHH-------------------------HHH------HHHHHHHHH
Q 046106          138 DAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKA-------------------------QVM------EQQFQQEVM  185 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~-------------------------~~~------~~~~~~E~~  185 (303)
                      +.||.-+.|+|++|+. +|+.||||+-++........                         +..      +-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5699999999999998 88999999987654321111                         011      123455555


Q ss_pred             HHHcC----CCCC------eeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 046106          186 MLATL----KHPN------IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG  255 (303)
Q Consensus       186 il~~l----~hpn------iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g  255 (303)
                      -..++    +|-+      |+++|.-+....  .++||||+|..+.|.-.-.. ..++...+..-+.+...-  -+=..|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~R--VLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~--qIf~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKR--VLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLE--QIFKTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcce--EEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHH--HHHhcC
Confidence            44443    3544      555555554443  69999999987766543222 346666555444443222  223568


Q ss_pred             ceeCCCCCCcEEEcC----CCcEEEeccCCceeee
Q 046106          256 LIHRDLKSDNLLIFS----DKSIKIADFGVARIEV  286 (303)
Q Consensus       256 iiHrDlkp~NILv~~----~~~vKl~DFGla~~~~  286 (303)
                      ++|+|-.|.||+|..    ++.+.+-|||+...+.
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            999999999999984    5789999999987543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.56  E-value=8.6e-07  Score=77.92  Aligned_cols=137  Identities=15%  Similarity=0.103  Sum_probs=84.4

Q ss_pred             eecccCc-eEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEeecC
Q 046106          139 AFAQGAF-GKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVTEYAK  216 (303)
Q Consensus       139 ~lG~G~f-g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~iv~E~~~  216 (303)
                      .|-.|+. ..||+....+..+.+|+.....         ...+.+|+.+++.+. +--+++++++.......++|||+++
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   75 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP   75 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence            3445565 6899987766788889875432         024557888887774 3446677777766656789999999


Q ss_pred             CCCHHHHH----------------HhcCCC-----CCCH--HHHHHHHHH--------------------HHHHHHHHH-
Q 046106          217 GGSVRQFL----------------TKRQNR-----SVPL--KLAVKQALD--------------------VARGMAYVH-  252 (303)
Q Consensus       217 ~gsL~~~l----------------~~~~~~-----~~~~--~~~~~i~~q--------------------i~~~l~~LH-  252 (303)
                      |.++....                ......     .+..  .........                    +...+..|- 
T Consensus        76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  155 (244)
T cd05150          76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA  155 (244)
T ss_pred             CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence            87765431                111100     1110  000000000                    111122221 


Q ss_pred             ------hCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          253 ------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       253 ------~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                            ...++|+|+.|.|||+++++.+.|+||+.|.+
T Consensus       156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                  23499999999999999988889999999864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.55  E-value=1.5e-06  Score=74.93  Aligned_cols=140  Identities=20%  Similarity=0.218  Sum_probs=82.4

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCC--CeeeeeEEEEc---CCeEEEEE
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP--NIVRFIGACRK---PMVWCIVT  212 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~~~~---~~~~~iv~  212 (303)
                      +.|+.|..+.||+....+..+++|+....        .....+.+|..+++.+...  .+++++.....   ....+++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEESSSSEEEEEEETTSEEEEEEESSH--------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECCcEEEEEEeCCC--------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            46889999999999997789999997542        1124667888888777532  35666665433   33468999


Q ss_pred             eecCCCCHHH----------------HHHh---c--CCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 046106          213 EYAKGGSVRQ----------------FLTK---R--QNRSVPLKL---------AVKQ------------ALDVAR-GMA  249 (303)
Q Consensus       213 E~~~~gsL~~----------------~l~~---~--~~~~~~~~~---------~~~i------------~~qi~~-~l~  249 (303)
                      +++++..+..                .+..   .  .........         ....            ...+.. .++
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999887777                2211   1  001111100         0000            011122 233


Q ss_pred             HHHh-------CCceeCCCCCCcEEEc-CCCcEEEeccCCceee
Q 046106          250 YVHR-------LGLIHRDLKSDNLLIF-SDKSIKIADFGVARIE  285 (303)
Q Consensus       250 ~LH~-------~giiHrDlkp~NILv~-~~~~vKl~DFGla~~~  285 (303)
                      .+++       ..++|+|+.|.|||++ +++.+-|+||+.+...
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence            3332       3599999999999999 5676789999998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.49  E-value=3.3e-06  Score=71.85  Aligned_cols=133  Identities=20%  Similarity=0.346  Sum_probs=94.8

Q ss_pred             ecCCccccceecccCc-eEEEEEEECCeEEEEEEeeCC---CCC-----h-------HHHHHHHHHHHHHHHHHHcCC--
Q 046106          130 DLRKLNMGDAFAQGAF-GKLYRGTYNGEEVAIKILERP---END-----P-------EKAQVMEQQFQQEVMMLATLK--  191 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~f-g~Vy~~~~~~~~vAvK~~~~~---~~~-----~-------~~~~~~~~~~~~E~~il~~l~--  191 (303)
                      ...+++.++.||.|.- |.||++...|+.+|+|+++.-   ...     .       ........-|..|++...+|+  
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            3478889999999999 999999999999999994321   110     0       000123356888998888775  


Q ss_pred             -CCCe--eeeeEEEEcC------------------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 046106          192 -HPNI--VRFIGACRKP------------------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY  250 (303)
Q Consensus       192 -hpni--v~l~~~~~~~------------------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~  250 (303)
                       +.++  |+++|+..-.                  ..+.||.||++...           .+..    +-+.+|.+-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHH
Confidence             3455  9999987311                  23568888886543           1222    335667777889


Q ss_pred             HHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       251 LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      +|..||+=+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999999975     2478899865

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=2e-07  Score=83.72  Aligned_cols=91  Identities=29%  Similarity=0.454  Sum_probs=77.6

Q ss_pred             HHcCCCCCeeeeeEEEEcC-----CeEEEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ce
Q 046106          187 LATLKHPNIVRFIGACRKP-----MVWCIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLG--LI  257 (303)
Q Consensus       187 l~~l~hpniv~l~~~~~~~-----~~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g--ii  257 (303)
                      |-++.|.|||+++.+|.+.     ....+++|||..|++..||++..  ...+......+++.||+.||.|||+..  |+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            4455799999999999653     34678999999999999998532  346778888899999999999999885  99


Q ss_pred             eCCCCCCcEEEcCCCcEEEe
Q 046106          258 HRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       258 HrDlkp~NILv~~~~~vKl~  277 (303)
                      |+++..+-|++..+|-+|+.
T Consensus       201 hgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cCCcchhheeecCCceEEec
Confidence            99999999999999999874

>PLN02876 acyl-CoA dehydrogenase

Probab=98.42  E-value=2.6e-06  Score=87.78  Aligned_cols=77  Identities=13%  Similarity=0.202  Sum_probs=54.4

Q ss_pred             ceecccCceEEEEEEECC----eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCe--eeeeEEEEcC---Ce
Q 046106          138 DAFAQGAFGKLYRGTYNG----EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNI--VRFIGACRKP---MV  207 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpni--v~l~~~~~~~---~~  207 (303)
                      +.|+.|.+..+|+..+.+    ..+++|+.........     ...+.+|+.+|+.+. |+++  ++++.+|.+.   ..
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-----~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-----AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-----HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            468899999999987743    4677787544321111     136779999999985 6655  7788888764   34


Q ss_pred             EEEEEeecCCCC
Q 046106          208 WCIVTEYAKGGS  219 (303)
Q Consensus       208 ~~iv~E~~~~gs  219 (303)
                      .|+||||++|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            689999998754

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.40  E-value=9.8e-07  Score=74.77  Aligned_cols=99  Identities=22%  Similarity=0.332  Sum_probs=80.0

Q ss_pred             HHHHHHHHcCCC-CCeeeeeEEEEcCCeEEEEEeecCCCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---
Q 046106          181 QQEVMMLATLKH-PNIVRFIGACRKPMVWCIVTEYAKGGSVRQF---LTKRQNRSVPLKLAVKQALDVARGMAYVHR---  253 (303)
Q Consensus       181 ~~E~~il~~l~h-pniv~l~~~~~~~~~~~iv~E~~~~gsL~~~---l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---  253 (303)
                      ..|.-+|+.+++ +++++++|.|-.    ++|+||...+++...   +...  ...+|..+.++|.+++..+++|+.   
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            358888999986 699999999954    678999986655421   1111  236899999999999999999997   


Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+.-.|++|+|+.|++++.+|++|...+...
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            34888899999999999999999999987543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.21  E-value=4.9e-05  Score=64.88  Aligned_cols=134  Identities=17%  Similarity=0.293  Sum_probs=88.9

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCChHH----------HHHHHHHHHHHHHHHHcCC------CCCeeeeeE
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEK----------AQVMEQQFQQEVMMLATLK------HPNIVRFIG  200 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~----------~~~~~~~~~~E~~il~~l~------hpniv~l~~  200 (303)
                      ...||+|+.-.||.-- ......||+.+........          .....++..+|+.-...+.      +..|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            3469999998888533 3345678988765500000          0001134455555544444      889999999


Q ss_pred             EEEcCCeEEEEEeecCC------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC--
Q 046106          201 ACRKPMVWCIVTEYAKG------GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK--  272 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~--  272 (303)
                      +..++.-..+|+|.+.+      -+|.+++...   .++. .+...   +-.-..||-+.+|+.+||+|.||++..+.  
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            99999888999998743      3688888643   3444 33333   33345688899999999999999996542  


Q ss_pred             --cEEEec
Q 046106          273 --SIKIAD  278 (303)
Q Consensus       273 --~vKl~D  278 (303)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=1.5e-05  Score=69.72  Aligned_cols=31  Identities=29%  Similarity=0.445  Sum_probs=26.8

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .+++|+|+.+.|||++.++..-|+||+.|..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998776678999998865

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.05  E-value=9.9e-05  Score=67.11  Aligned_cols=76  Identities=16%  Similarity=0.110  Sum_probs=54.8

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC---CCeeeeeEEEEcC---CeEEE
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH---PNIVRFIGACRKP---MVWCI  210 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~~~~~~~---~~~~i  210 (303)
                      .+.||.|..+.||+-...+..+.+|..+... ..       ..+..|+..|+.+.-   ..+++++++|..+   ...+|
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~~-------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMARSFS-TP-------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEecccc-cc-------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            3469999999999987654567778754311 11       367789999988853   4678888887543   55799


Q ss_pred             EEeecCCCCH
Q 046106          211 VTEYAKGGSV  220 (303)
Q Consensus       211 v~E~~~~gsL  220 (303)
                      |||++++.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999988654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.99  E-value=5.6e-06  Score=74.89  Aligned_cols=137  Identities=19%  Similarity=0.252  Sum_probs=94.4

Q ss_pred             cccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHH--------------HHH--HHHHHHHHHHHHcCCC--CCe
Q 046106          135 NMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKA--------------QVM--EQQFQQEVMMLATLKH--PNI  195 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~--------------~~~--~~~~~~E~~il~~l~h--pni  195 (303)
                      .++..||-|.-+.||.+.+ .|++.++|+-+.....-...              ...  +-...+|...|+.|.-  --|
T Consensus        95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            4567899999999999988 69999999755432211111              111  2234578888888853  345


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vK  275 (303)
                      ++.++++..    |+|||++.+-+|.+.-+-     ...+   .+...+..-+--|-.+|+||+|..-=||+|++++.++
T Consensus       175 PkpiD~~RH----~Vvmelv~g~Pl~~v~~v-----~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  175 PKPIDHNRH----CVVMELVDGYPLRQVRHV-----EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCcccccce----eeHHHhhcccceeeeeec-----CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            666665543    899999988777543221     1222   2334444445667899999999999999999999999


Q ss_pred             EeccCCce
Q 046106          276 IADFGVAR  283 (303)
Q Consensus       276 l~DFGla~  283 (303)
                      ++||-.+.
T Consensus       243 vIDFPQmv  250 (465)
T KOG2268|consen  243 VIDFPQMV  250 (465)
T ss_pred             EeechHhh
Confidence            99998764

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.89  E-value=9.9e-05  Score=66.66  Aligned_cols=138  Identities=19%  Similarity=0.215  Sum_probs=82.0

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCC--CeeeeeEE------EEcCCeEE
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP--NIVRFIGA------CRKPMVWC  209 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~------~~~~~~~~  209 (303)
                      +.|..|....+|+....+..+++|+...  ...       ..+..|+.++..+.+.  .+++++..      ....+..+
T Consensus        20 ~~i~~G~~n~~y~v~~~~~~~vLr~~~~--~~~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          20 EGISAGIENTNYFVTTDSGRYVLTLFEK--VSA-------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             ecccCccccceEEEEeCCCcEEEEEcCC--CCh-------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            4577788789999877667899998764  111       2455677777766432  24444432      12234568


Q ss_pred             EEEeecCCCCHHH-----------HHHh---c-CCC--------CCCHHHHH----------HHHHHHHHHHHHHHh---
Q 046106          210 IVTEYAKGGSVRQ-----------FLTK---R-QNR--------SVPLKLAV----------KQALDVARGMAYVHR---  253 (303)
Q Consensus       210 iv~E~~~~gsL~~-----------~l~~---~-~~~--------~~~~~~~~----------~i~~qi~~~l~~LH~---  253 (303)
                      +|+++++|..+..           .+..   . ...        ...|....          .....+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999998865421           1110   0 000        00111100          011123334455553   


Q ss_pred             ----CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 ----LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ----~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                          .+++|+|+.|.|||+++++.+.|+||+.|..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                4799999999999999988889999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.84  E-value=0.00028  Score=64.32  Aligned_cols=139  Identities=17%  Similarity=0.205  Sum_probs=79.2

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCC--CeeeeeEEE------EcCCeE
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP--NIVRFIGAC------RKPMVW  208 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~~------~~~~~~  208 (303)
                      .+.++.|....+|+...++..+++|+...... .       ..+..|..++..|...  .+++++...      ......
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~-~-------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK-A-------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCCC-H-------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            34577777788998876555788898754211 1       1333455666555321  234444321      123456


Q ss_pred             EEEEeecCCCCHH-----------HHHH---hc-CCCC---------CCHHHHH------------HHHHHHHHHHHHHH
Q 046106          209 CIVTEYAKGGSVR-----------QFLT---KR-QNRS---------VPLKLAV------------KQALDVARGMAYVH  252 (303)
Q Consensus       209 ~iv~E~~~~gsL~-----------~~l~---~~-~~~~---------~~~~~~~------------~i~~qi~~~l~~LH  252 (303)
                      ++++||++|..+.           ..+.   .. .+..         -.|....            .....+...++++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            8999999875421           1111   10 0000         0111100            01112334555554


Q ss_pred             h-------CCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          253 R-------LGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       253 ~-------~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .       .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            2       589999999999999998878999999985

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.84  E-value=0.00018  Score=62.61  Aligned_cols=136  Identities=15%  Similarity=0.207  Sum_probs=78.1

Q ss_pred             ceecccCceEEEEEEEC---CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC-CCeeeeeEEEEcCCeEEEEEe
Q 046106          138 DAFAQGAFGKLYRGTYN---GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~~~~~iv~E  213 (303)
                      +.|..|-...+|+....   +..+++|+........       ....+|+.+++.+.. .-.++++..+.  .  .++||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-------~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e   72 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-------IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYE   72 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-------ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEE
Confidence            45777888899998864   5688999775432111       122367878877743 23345544432  2  47999


Q ss_pred             ecCCCCHHH--------------HHHhcCC--C----------CC-CHHHHHHHHH----------------------HH
Q 046106          214 YAKGGSVRQ--------------FLTKRQN--R----------SV-PLKLAVKQAL----------------------DV  244 (303)
Q Consensus       214 ~~~~gsL~~--------------~l~~~~~--~----------~~-~~~~~~~i~~----------------------qi  244 (303)
                      |++|.++..              .+.+...  .          .. .+..+..+..                      .+
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  152 (235)
T cd05157          73 FIPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQL  152 (235)
T ss_pred             eeCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHH
Confidence            998865421              1111000  0          01 1122112211                      11


Q ss_pred             HHHHHHH----Hh----CCceeCCCCCCcEEEcC-CCcEEEeccCCcee
Q 046106          245 ARGMAYV----HR----LGLIHRDLKSDNLLIFS-DKSIKIADFGVARI  284 (303)
Q Consensus       245 ~~~l~~L----H~----~giiHrDlkp~NILv~~-~~~vKl~DFGla~~  284 (303)
                      ...+..|    ..    .+++|+|+.+.|||++. ++.+.|+||..|..
T Consensus       153 ~~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         153 RDEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            1111222    11    35999999999999998 57899999998864

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.83  E-value=0.00039  Score=61.55  Aligned_cols=134  Identities=17%  Similarity=0.180  Sum_probs=77.3

Q ss_pred             ecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEEeecCCC
Q 046106          140 FAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN-IVRFIGACRKPMVWCIVTEYAKGG  218 (303)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~~~iv~E~~~~g  218 (303)
                      +..|-...+|+...++..+++|+.........      -...+|..+++.+.... .++++..+.  .  ++|+||++|.
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~i~~~~--~--~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALG------VDRQREYQILQALSALGLAPKPILVNE--H--WLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCccccccc------CcHHHHHHHHHHHHhcCCCCceEEEeC--C--EEEEEeccCc
Confidence            55678889999888888899997643221100      12356788888775332 244444432  2  6899999886


Q ss_pred             CHHH--------------HHHhcC-----CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeCCC
Q 046106          219 SVRQ--------------FLTKRQ-----NRSVPLK-LAVKQALDV---------ARGMAYVHR--------LGLIHRDL  261 (303)
Q Consensus       219 sL~~--------------~l~~~~-----~~~~~~~-~~~~i~~qi---------~~~l~~LH~--------~giiHrDl  261 (303)
                      .+..              .+.+..     +.++... .+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5431              122111     1111211 111211111         111222222        25899999


Q ss_pred             CCCcEEEcCCCcEEEeccCCcee
Q 046106          262 KSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       262 kp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .|.||++++++ +.|+||..|..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.78  E-value=0.00032  Score=65.57  Aligned_cols=159  Identities=19%  Similarity=0.249  Sum_probs=104.2

Q ss_pred             cccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHc-CCCCCeeeeeEEE-------EcCC
Q 046106          135 NMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT-LKHPNIVRFIGAC-------RKPM  206 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~-------~~~~  206 (303)
                      ..+..||+|+-+.+|---.-+..| -|++..+......         +.+..|.. -.||-+..-+.+-       ..+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~a---------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~   83 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQA---------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK   83 (637)
T ss_pred             CCCccccCCccceeeecchhhchh-heeecCCCchHHH---------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence            346679999999998543222234 4887766543221         12223333 3466544312211       1123


Q ss_pred             eEEEEEeecCCC-CHHHHHHh---c-CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          207 VWCIVTEYAKGG-SVRQFLTK---R-QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       207 ~~~iv~E~~~~g-sL~~~l~~---~-~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      .+.++|..+++. .+..++..   + ....+.|+-++++++.++.+.+-||..|.+-+|+.++|+||++++.|.|.|=..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            367888888654 34444432   1 112367899999999999999999999999999999999999999999998765


Q ss_pred             ceeeecCCCccCCCCCCcccCC
Q 046106          282 ARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      -.+..++......+|...|++|
T Consensus       164 fqi~~ng~~~~cpVg~~eftPP  185 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPP  185 (637)
T ss_pred             eeeccCCceEecccCccccCCH
Confidence            5444444445556788888876

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.77  E-value=0.00049  Score=64.94  Aligned_cols=79  Identities=13%  Similarity=0.028  Sum_probs=50.9

Q ss_pred             ceecccCceEEEEEEEC-C-eEEEEEEeeCCCCC-hHHHHHHHHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEE
Q 046106          138 DAFAQGAFGKLYRGTYN-G-EEVAIKILERPEND-PEKAQVMEQQFQQEVMMLATLK---HPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~-~-~~vAvK~~~~~~~~-~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~iv  211 (303)
                      +.||.|.+..||+.... | +.++||.-.+.... .+.-.....++..|.+.|+.+.   ...+++++.+..  ..-++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            46899999999999884 4 48999985422110 0000011245667788887753   356777877744  334799


Q ss_pred             EeecCCC
Q 046106          212 TEYAKGG  218 (303)
Q Consensus       212 ~E~~~~g  218 (303)
                      ||++++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999764

>PRK05231 homoserine kinase; Provisional

Probab=97.71  E-value=0.0011  Score=60.64  Aligned_cols=31  Identities=39%  Similarity=0.435  Sum_probs=27.0

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .++||+|+.|.|||++.+...-|+||+.|..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3799999999999998776678999998853

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.58  E-value=0.00074  Score=62.40  Aligned_cols=143  Identities=22%  Similarity=0.197  Sum_probs=96.6

Q ss_pred             cceecccCceEEEEEEE-CCeEEEEEEeeCCCC--------------------ChHHHHHHHHHHHHHHHHHHcCCCCCe
Q 046106          137 GDAFAQGAFGKLYRGTY-NGEEVAIKILERPEN--------------------DPEKAQVMEQQFQQEVMMLATLKHPNI  195 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~--------------------~~~~~~~~~~~~~~E~~il~~l~hpni  195 (303)
                      -..|..|.-+.||-++- +|..+|||+++....                    ......+..-+...|++-|+++....|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            34566777788999987 888999999874321                    011112334456678888888876665


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCcEEEcCCCcE
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIHRDLKSDNLLIFSDKSI  274 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~giiHrDlkp~NILv~~~~~v  274 (303)
                      +..--......  .|||+|+- .+=+-.- ..+...++...+..+-.|++.-|.-|- .+++||.||.--|+|+ .+|.+
T Consensus       229 P~PePIlLk~h--VLVM~FlG-rdgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  229 PCPEPILLKNH--VLVMEFLG-RDGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCceeeecc--eEeeeecc-CCCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            44332222222  58999993 3221111 122345777778888888888888776 5689999999999999 56789


Q ss_pred             EEeccCCcee
Q 046106          275 KIADFGVARI  284 (303)
Q Consensus       275 Kl~DFGla~~  284 (303)
                      .|+|-+.+..
T Consensus       304 yiIDVSQSVE  313 (520)
T KOG2270|consen  304 YIIDVSQSVE  313 (520)
T ss_pred             EEEEcccccc
Confidence            9999887754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.53  E-value=2.1e-05  Score=76.58  Aligned_cols=149  Identities=20%  Similarity=0.217  Sum_probs=102.8

Q ss_pred             ceecccCceEEEEEEECC-eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCeEEEEEeec
Q 046106          138 DAFAQGAFGKLYRGTYNG-EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN-IVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~~~iv~E~~  215 (303)
                      ..+++++.+++++.+... +....+.+...           ....-++++|.+++||| .+..++-+..+...+|+++++
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~-----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc-----------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            446789999999987633 23335655432           12335788999999999 677777777778889999999


Q ss_pred             CCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCC
Q 046106          216 KGG-SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE  294 (303)
Q Consensus       216 ~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~  294 (303)
                      .++ +...... ...-.+...+...+++.-++++++||+.--+|||    ||+..+ +..|..||+.+..........+.
T Consensus       317 s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~  390 (829)
T KOG0576|consen  317 STGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTA  390 (829)
T ss_pred             cCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccC
Confidence            766 2211111 0011233344555666677889999998778998    777754 78999999998766555445566


Q ss_pred             CCCCcccCC
Q 046106          295 TGTYRWMAP  303 (303)
Q Consensus       295 ~gt~~y~AP  303 (303)
                      .+|+.|+||
T Consensus       391 ~~~~~~~~p  399 (829)
T KOG0576|consen  391 IGTPEPLAP  399 (829)
T ss_pred             CCCCCCCCc
Confidence            799999998

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.41  E-value=0.0016  Score=59.04  Aligned_cols=30  Identities=30%  Similarity=0.531  Sum_probs=27.0

Q ss_pred             CceeCCCCCCcEEEcCC----CcEEEeccCCcee
Q 046106          255 GLIHRDLKSDNLLIFSD----KSIKIADFGVARI  284 (303)
Q Consensus       255 giiHrDlkp~NILv~~~----~~vKl~DFGla~~  284 (303)
                      .++|+|+.+.|||++.+    +.++|+||..|..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            58999999999999985    8899999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.30  E-value=0.0025  Score=58.27  Aligned_cols=140  Identities=17%  Similarity=0.260  Sum_probs=81.0

Q ss_pred             ccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC--CCeeeeeEEEEcCC--eEEEEEeecCC
Q 046106          142 QGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH--PNIVRFIGACRKPM--VWCIVTEYAKG  217 (303)
Q Consensus       142 ~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~~--~~~iv~E~~~~  217 (303)
                      .|..-.+|+...++++++++ ..........    .....+|..+|+.+.-  .-+...++.|..+.  ..|.||+|++|
T Consensus        35 ~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~----~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          35 GGWSNDTFRLGDTGQKYVLR-KPPRGDPVES----AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             CCcccceEEEecCCceEEEe-cCCccccchh----hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            34444566666668888888 3322222222    2456678888887753  23345566676655  56899999987


Q ss_pred             CC------------------HHHHHHhcC----------CC--CCCHHHHHHHHHH--------------HHHHHHHHHh
Q 046106          218 GS------------------VRQFLTKRQ----------NR--SVPLKLAVKQALD--------------VARGMAYVHR  253 (303)
Q Consensus       218 gs------------------L~~~l~~~~----------~~--~~~~~~~~~i~~q--------------i~~~l~~LH~  253 (303)
                      ..                  |.++|....          +.  .....++.....+              ...-..+|+.
T Consensus       110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~  189 (321)
T COG3173         110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA  189 (321)
T ss_pred             eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence            32                  222222110          00  0011111111111              1223455553


Q ss_pred             C--------CceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          254 L--------GLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       254 ~--------giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      +        .++|+|+.+.||+|+.++-+=|.||+++.+..
T Consensus       190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            2        48999999999999999889999999997644

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.26  E-value=0.0041  Score=56.40  Aligned_cols=30  Identities=27%  Similarity=0.506  Sum_probs=26.0

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            47999999999999987 6789999997753

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.23  E-value=0.0029  Score=56.90  Aligned_cols=31  Identities=29%  Similarity=0.468  Sum_probs=26.1

Q ss_pred             CceeCCCCCCcEEEcCCCc-EEEeccCCceee
Q 046106          255 GLIHRDLKSDNLLIFSDKS-IKIADFGVARIE  285 (303)
Q Consensus       255 giiHrDlkp~NILv~~~~~-vKl~DFGla~~~  285 (303)
                      .++|+|+.|.|||+++++. .-|+||+.|.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997554 579999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.15  E-value=0.0089  Score=56.52  Aligned_cols=78  Identities=12%  Similarity=-0.006  Sum_probs=49.9

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHH-HHHHHHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEEEe
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEK-AQVMEQQFQQEVMMLATLK---HPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~-~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      +.||.|....||+....+..++||.-.+....... -.....+-..|+..|+.+.   ...+++++.++.+..  +++||
T Consensus        38 ~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~--vlvME  115 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMA--LIGMR  115 (418)
T ss_pred             EEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC--EEEEe
Confidence            56899999999998877678999986522210000 0000123334566665553   357888999888554  68899


Q ss_pred             ecCC
Q 046106          214 YAKG  217 (303)
Q Consensus       214 ~~~~  217 (303)
                      ++++
T Consensus       116 ~L~~  119 (418)
T PLN02756        116 YLEP  119 (418)
T ss_pred             ecCC
Confidence            9966

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.11  E-value=5.2e-05  Score=77.36  Aligned_cols=150  Identities=19%  Similarity=0.230  Sum_probs=101.5

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      ......+.+.+.+-.|+++.++.+.-  .+...++|+..........   ..+....+-.++....+|.++...-.+...
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~---~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN---DYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccc---cccccCCccCccccCCCCceecccCCCCCC
Confidence            34455666777888999999987754  3434444444322111000   001222333344444567776655554455


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ...+++++|+.+++|...|+...  .............+..+.++||...++|||++|.|+|+..++..+++|||..
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccc
Confidence            66789999999999988887653  2344445566677888999999999999999999999999999999999943

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.06  E-value=0.0034  Score=58.35  Aligned_cols=77  Identities=12%  Similarity=0.004  Sum_probs=44.8

Q ss_pred             eecccCceEEEEEEECC--eEEEEEEeeCCCCC-hHHHHHHHHHHHHHHHHHHcCC--CC-CeeeeeEEEEcCCeEEEEE
Q 046106          139 AFAQGAFGKLYRGTYNG--EEVAIKILERPEND-PEKAQVMEQQFQQEVMMLATLK--HP-NIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~-~~~~~~~~~~~~~E~~il~~l~--hp-niv~l~~~~~~~~~~~iv~  212 (303)
                      .||.|....||++...+  +.|+||.-.+.... .+.-.....+..-|...|+...  -| .++++|.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            47999999999998743  57999975321110 0000011134446777776653  23 45555544  333446899


Q ss_pred             eecCC
Q 046106          213 EYAKG  217 (303)
Q Consensus       213 E~~~~  217 (303)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.97  E-value=0.0064  Score=56.11  Aligned_cols=135  Identities=13%  Similarity=0.183  Sum_probs=75.2

Q ss_pred             eecccCceEEEEEEECC-----eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEE
Q 046106          139 AFAQGAFGKLYRGTYNG-----EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI-VRFIGACRKPMVWCIVT  212 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~iv~  212 (303)
                      .|..|=...+|+....+     ..|++|+........       -...+|..+++.+...++ +++++++.. .   +|.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-------IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~   89 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-------IDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQ   89 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-------echHHHHHHHHHHHhcCCCCceeEEeCC-c---Eee
Confidence            35446667899887533     378899875532211       123467888877764444 455655532 2   578


Q ss_pred             eecCCCCHHH--------------HHHhcCCCC------C-CHHHHHHHHHHH----------------------HHHHH
Q 046106          213 EYAKGGSVRQ--------------FLTKRQNRS------V-PLKLAVKQALDV----------------------ARGMA  249 (303)
Q Consensus       213 E~~~~gsL~~--------------~l~~~~~~~------~-~~~~~~~i~~qi----------------------~~~l~  249 (303)
                      +|+++..+..              .++......      . .+..+..+..++                      ..-+.
T Consensus        90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  169 (330)
T PLN02421         90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV  169 (330)
T ss_pred             hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence            8887654321              111111111      1 123332222221                      11111


Q ss_pred             ----HHHhC----CceeCCCCCCcEEEcC-CCcEEEeccCCcee
Q 046106          250 ----YVHRL----GLIHRDLKSDNLLIFS-DKSIKIADFGVARI  284 (303)
Q Consensus       250 ----~LH~~----giiHrDlkp~NILv~~-~~~vKl~DFGla~~  284 (303)
                          .+...    -+.|.|+.+.|||+++ ++.++++||..|..
T Consensus       170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                22222    2899999999999975 47899999998854

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.86  E-value=0.0031  Score=57.01  Aligned_cols=73  Identities=16%  Similarity=0.184  Sum_probs=47.1

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEEEe
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---HPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      .+.++.|....+|+...+++.+.||+-.....         ..|..|+.-|+.|.   --.+++++++....+.-++|+|
T Consensus        22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~---------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDTDGGSYFVKVNSESGR---------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             EEEE--SSSSEEEEEETTS-EEEEEEEEGGGC---------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eEecCCCChhheEEEECCCccEEEEecChhhH---------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            35688899999999887888999998763221         35777888887773   4567888998877666699999


Q ss_pred             ecCCC
Q 046106          214 YAKGG  218 (303)
Q Consensus       214 ~~~~g  218 (303)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.85  E-value=0.0033  Score=59.11  Aligned_cols=78  Identities=13%  Similarity=0.133  Sum_probs=47.0

Q ss_pred             ceecccCceEEEEEEEC--CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC--CC-CeeeeeEEEEcCCeEEEEE
Q 046106          138 DAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK--HP-NIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp-niv~l~~~~~~~~~~~iv~  212 (303)
                      +.||.|.-.-||++.+.  ++.|+||.-.+.-...+.-.....+..-|.++|+...  -| .++++|.+-  +....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHHH
Confidence            46899999999999974  5689999753221111110111245556777777653  23 566666543  33346889


Q ss_pred             eecCC
Q 046106          213 EYAKG  217 (303)
Q Consensus       213 E~~~~  217 (303)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            98854

>PLN02236 choline kinase

Probab=96.83  E-value=0.0067  Score=56.31  Aligned_cols=135  Identities=14%  Similarity=0.226  Sum_probs=76.6

Q ss_pred             eecccCceEEEEEEEC------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEE
Q 046106          139 AFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI-VRFIGACRKPMVWCIV  211 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~iv  211 (303)
                      .|-.|-.-.+|+..+.      ++.+++|+........       -...+|..+++.+...++ +++++.+...    .|
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-------idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v  111 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-------FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RV  111 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-------echHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence            4545777899998752      2578999876532111       122467888777753333 4555655332    57


Q ss_pred             EeecCCCCHHHH--------------HHhcCCC-------CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 046106          212 TEYAKGGSVRQF--------------LTKRQNR-------SVPLKLAVKQALDV-----------------ARGMAYV--  251 (303)
Q Consensus       212 ~E~~~~gsL~~~--------------l~~~~~~-------~~~~~~~~~i~~qi-----------------~~~l~~L--  251 (303)
                      .||+++.++...              +.+....       ...+..+..+..++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            899877554311              1111000       11123332322111                 1112222  


Q ss_pred             --H----hCCceeCCCCCCcEEEcC-CCcEEEeccCCcee
Q 046106          252 --H----RLGLIHRDLKSDNLLIFS-DKSIKIADFGVARI  284 (303)
Q Consensus       252 --H----~~giiHrDlkp~NILv~~-~~~vKl~DFGla~~  284 (303)
                        .    ...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence              1    225899999999999986 47899999999864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.47  E-value=0.046  Score=49.76  Aligned_cols=30  Identities=20%  Similarity=0.231  Sum_probs=27.9

Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       255 giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +++|+|+.+.|+|++.++.+.|+||..|..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=96.46  E-value=0.035  Score=52.31  Aligned_cols=30  Identities=33%  Similarity=0.448  Sum_probs=25.0

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ..+.|.|+-+.|||.++ ..++++||..|..
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            46899999999999754 5699999998853

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.20  E-value=0.14  Score=47.16  Aligned_cols=29  Identities=31%  Similarity=0.378  Sum_probs=24.6

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .++||+|+.+.|||++ + .+.|+||+.|..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            3699999999999995 4 578999998853

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.19  E-value=0.037  Score=48.28  Aligned_cols=75  Identities=17%  Similarity=0.178  Sum_probs=54.3

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---HPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.+.-|..-..|+..+...++-||+-..         ...+.|..|+.-|..+.   .-.+.+.+.+.......|+|+||
T Consensus        22 ~~v~gG~inea~~v~dg~~~~FvK~n~~---------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~   92 (286)
T COG3001          22 EEVSGGDINEAWRLRDGTDPFFVKCNQR---------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY   92 (286)
T ss_pred             cccCCccccceeEeecCCcceEEEecch---------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence            4455666667777777778899997532         23357778877766664   45678888888888889999999


Q ss_pred             cCCCCHH
Q 046106          215 AKGGSVR  221 (303)
Q Consensus       215 ~~~gsL~  221 (303)
                      ++-+.+.
T Consensus        93 L~~~~~d   99 (286)
T COG3001          93 LPTGPLD   99 (286)
T ss_pred             ccCCCCC
Confidence            9876544

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.09  E-value=0.025  Score=52.50  Aligned_cols=71  Identities=15%  Similarity=0.272  Sum_probs=54.0

Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ...|++|++- |+++. .+     ....++++..++.+.+..++-+..+ .+=|||+.-.||||+ +|.|.|+||-+||.
T Consensus       299 ~y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3456777765 55552 11     1245788888888877777766654 689999999999999 99999999999984

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=95.72  E-value=0.008  Score=59.38  Aligned_cols=46  Identities=22%  Similarity=0.454  Sum_probs=39.7

Q ss_pred             HHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          241 ALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       241 ~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      +.+++.||.|+|.. ++||++|.|++|.++.++.+||+.|+++....
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~  151 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNAN  151 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccC
Confidence            34455899999965 79999999999999999999999999986543

>PRK06148 hypothetical protein; Provisional

Probab=95.64  E-value=0.15  Score=54.20  Aligned_cols=30  Identities=37%  Similarity=0.546  Sum_probs=25.8

Q ss_pred             CCceeCCCCCCcEEEcCCC--cEE-EeccCCce
Q 046106          254 LGLIHRDLKSDNLLIFSDK--SIK-IADFGVAR  283 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~--~vK-l~DFGla~  283 (303)
                      .++||.|+.+.|||++.++  .+. |+|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999999875  555 99999875

>PTZ00296 choline kinase; Provisional

Probab=95.53  E-value=0.13  Score=49.43  Aligned_cols=29  Identities=21%  Similarity=0.417  Sum_probs=24.7

Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       255 giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .++|.|+-+.|||.+.++ ++|+||..|..
T Consensus       285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~  313 (442)
T PTZ00296        285 VFCHNDLQENNIINTNKC-LRLIDFEYSGY  313 (442)
T ss_pred             eEEeCCCCccceeecCCC-EEEEeeccccc
Confidence            489999999999886544 99999998864

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.03  E-value=0.11  Score=46.04  Aligned_cols=77  Identities=14%  Similarity=0.129  Sum_probs=52.2

Q ss_pred             ceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeec-
Q 046106          138 DAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYA-  215 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~-  215 (303)
                      ..+..|..+.|+.++. +|+++++|+..+......       + ......|+..+-...|++++.-....  .+++|.+ 
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-------E-~~g~~~L~~w~G~GaVrll~~d~~~~--AlLLErl~   77 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-------E-ARGEAALRWWNGRGAVRLLAADPERG--ALLLERLD   77 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-------h-hhHHhHhheeCCCCceeeeccccccc--hhhhhhcc
Confidence            3456788999999976 889999999865432110       0 11225577888888899988764433  5788888 


Q ss_pred             CCCCHHHHH
Q 046106          216 KGGSVRQFL  224 (303)
Q Consensus       216 ~~gsL~~~l  224 (303)
                      ++.+|.+..
T Consensus        78 ~g~~L~~~~   86 (253)
T PF04655_consen   78 PGRSLASLP   86 (253)
T ss_pred             CCCchhhcc
Confidence            555666554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=94.92  E-value=0.091  Score=55.23  Aligned_cols=108  Identities=20%  Similarity=0.274  Sum_probs=82.3

Q ss_pred             HHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE----EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046106          178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVW----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR  253 (303)
Q Consensus       178 ~~~~~E~~il~~l~hpniv~l~~~~~~~~~~----~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  253 (303)
                      +...-|...+..+.|+|++.++.+.......    .+..|++...++...+...  ..++....+.+..+..+|++|+|+
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence            4555677788889999999999987654332    3445788888888888765  468889999999999999999999


Q ss_pred             CCceeCCCCCC---cEEEcCCCcEEEe--ccCCceeeec
Q 046106          254 LGLIHRDLKSD---NLLIFSDKSIKIA--DFGVARIEVQ  287 (303)
Q Consensus       254 ~giiHrDlkp~---NILv~~~~~vKl~--DFGla~~~~~  287 (303)
                      ....|.-|..+   +-.++..+.+.++  ||+..+....
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d  343 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD  343 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence            97777766666   5555666777777  8888765443

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.67  E-value=0.12  Score=48.74  Aligned_cols=60  Identities=27%  Similarity=0.315  Sum_probs=42.6

Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeCCCCCCcEEEcCC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY-VHRLGLIHRDLKSDNLLIFSD  271 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~giiHrDlkp~NILv~~~  271 (303)
                      .++-+|++|.++..++....   .|+....+++.-.+.|+-- |--.+++|.|+.|.||++--+
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            46667888999999998642   4555566666555555443 335689999999999999543

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.49  E-value=0.031  Score=47.20  Aligned_cols=29  Identities=21%  Similarity=0.349  Sum_probs=25.7

Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       255 giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      -.+|+|+.|.||++++++ ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            379999999999998877 89999999864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.05  E-value=0.13  Score=43.97  Aligned_cols=30  Identities=37%  Similarity=0.535  Sum_probs=21.9

Q ss_pred             CceeCCCCCCcEEE-cCCCcEEEeccCCcee
Q 046106          255 GLIHRDLKSDNLLI-FSDKSIKIADFGVARI  284 (303)
Q Consensus       255 giiHrDlkp~NILv-~~~~~vKl~DFGla~~  284 (303)
                      .+.|.||.|.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            49999999999999 8889999999999864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=93.94  E-value=0.31  Score=42.48  Aligned_cols=84  Identities=13%  Similarity=0.122  Sum_probs=55.6

Q ss_pred             HHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCc
Q 046106          179 QFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR--LGL  256 (303)
Q Consensus       179 ~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~gi  256 (303)
                      .+..+.++++++.  .|++|..=  ..-.+.++.|+|-..           +..+..   .+.+. +++|.-.|+  .+.
T Consensus       104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-----------~i~~~N---~i~ag-i~~L~~fH~~~~~~  164 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-----------KINFSN---FITAG-IKDLMDFHSENQHC  164 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-----------ccchhH---HHHHh-HHHHHHhhccCCCe
Confidence            5667788887764  46666521  233467899988321           111111   11111 456777884  469


Q ss_pred             eeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          257 IHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       257 iHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +|+|-.|+||+-|..|.+||.|=+.
T Consensus       165 lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  165 LHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ecCCCChhheeecCCCCEEecChhh
Confidence            9999999999999999999999874

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	303
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-16
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-14
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-14
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-14
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-14
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-12
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-12
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-11
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		8e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-10
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-07
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		6e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		8e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-05
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		4e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-05
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		8e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		1e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		1e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-04
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		2e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-04

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/187 (37%), Positives = 102/187 (54%), Gaps = 19/187 (10%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL- 187
           ID  +L + +    G FGK+YR  + G+EVA+K      +DP++              L 
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVK---AARHDPDEDISQTIENVRQEAKLF 60
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           A LKHPNI+   G C K    C+V E+A+GG + + L+ ++   +P  + V  A+ +ARG
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 248 MAYVHR---LGLIHRDLKSDNLLI--------FSDKSIKIADFGVARIEVQTEGMTPETG 296
           M Y+H    + +IHRDLKS N+LI         S+K +KI DFG+AR   +T  M+   G
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AAG 176
Query: 297 TYRWMAP 303
            Y WMAP
Sbjct: 177 AYAWMAP 183

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (250), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 100/189 (52%), Gaps = 8/189 (4%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXX 178
           +G  + D+  I    LN+ +    G+FG ++R  ++G +VA+KIL   +   E+      
Sbjct: 24  QGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLR 83
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLA 237
                   +  L+HPNIV F+GA  +P    IVTEY   GS+ + L K   R  +  +  
Sbjct: 84  EVAI----MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 238 VKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPE 294
           +  A DVA+GM Y+H     ++HR+LKS NLL+    ++K+ DFG++R++  T       
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 295 TGTYRWMAP 303
            GT  WMAP
Sbjct: 200 AGTPEWMAP 208

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 100/189 (52%), Gaps = 8/189 (4%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXX 178
           +G  + D+  I    LN+ +    G+FG ++R  ++G +VA+KIL   +   E+      
Sbjct: 24  QGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLR 83
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLA 237
                   +  L+HPNIV F+GA  +P    IVTEY   GS+ + L K   R  +  +  
Sbjct: 84  EVAI----MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 238 VKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE- 294
           +  A DVA+GM Y+H     ++HRDLKS NLL+    ++K+ DFG++R++      +   
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA 199
Query: 295 TGTYRWMAP 303
            GT  WMAP
Sbjct: 200 AGTPEWMAP 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 5   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 61
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +K  +  A   
Sbjct: 62  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQT 117
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           ARGM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G+  WM
Sbjct: 118 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 177
Query: 302 AP 303
           AP
Sbjct: 178 AP 179

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 24/268 (8%)
Query: 46  QTSNGGGSVAMSVDNSSVGSNESHTRI--LNHQGLRRRANDNYS-----VAHSVNRRGRV 98
           +T+ G   +++S  +++ G N  H +I  L+  G    +   +S     VA+       +
Sbjct: 98  ETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFSSLQQLVAYYSKHADGL 157
Query: 99  SHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-E 157
            H L++         S   T+GL   D W I    L +     QG FG+++ GT+NG   
Sbjct: 158 CHRLTN-----VCPTSKPQTQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR 211
Query: 158 VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VAIK L+     PE               +  L+H  +V+      +  ++ IVTEY   
Sbjct: 212 VAIKTLKPGNMSPE-------AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSK 263
Query: 218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
           GS+  FL     + + L   V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+A
Sbjct: 264 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 323
Query: 278 DFGVARIEVQTEGMTPETGTY--RWMAP 303
           DFG+ R+    E    +   +  +W AP
Sbjct: 324 DFGLGRLIEDNEYTARQGAKFPIKWTAP 351

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 96/182 (52%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 17  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 73
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +K  +  A   
Sbjct: 74  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQT 129
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           ARGM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A  + +  G       +G+  WM
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 302 AP 303
           AP
Sbjct: 190 AP 191

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 24/268 (8%)
Query: 46  QTSNGGGSVAMSVDNSSVGSNESHTRI--LNHQGLRRRANDNYS-----VAHSVNRRGRV 98
           +T+ G   +++S  +++ G N  H +I  L+  G    +   ++     VA+       +
Sbjct: 97  ETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGL 156
Query: 99  SHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-E 157
            H L+          S   T+GL   D W I    L +     QG FG+++ GT+NG   
Sbjct: 157 CHRLTT-----VCPTSKPQTQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR 210
Query: 158 VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VAIK L+     PE               +  L+H  +V+      +  ++ IVTEY   
Sbjct: 211 VAIKTLKPGTMSPE-------AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSK 262
Query: 218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
           GS+  FL     + + L   V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+A
Sbjct: 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 322
Query: 278 DFGVARIEVQTEGMTPETGTY--RWMAP 303
           DFG+AR+    E    +   +  +W AP
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAP 350

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 24/268 (8%)
Query: 46  QTSNGGGSVAMSVDNSSVGSNESHTRI--LNHQGLRRRANDNYS-----VAHSVNRRGRV 98
           +T+ G   +++S  +++ G N  H +I  L+  G    +   ++     VA+       +
Sbjct: 97  ETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGL 156
Query: 99  SHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-E 157
            H L+          S   T+GL   D W I    L +     QG FG+++ GT+NG   
Sbjct: 157 CHRLTT-----VCPTSKPQTQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR 210
Query: 158 VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VAIK L+     PE               +  L+H  +V+      +  ++ IVTEY   
Sbjct: 211 VAIKTLKPGTMSPE-------AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSK 262
Query: 218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
           GS+  FL     + + L   V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+A
Sbjct: 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 322
Query: 278 DFGVARIEVQTEGMTPETGTY--RWMAP 303
           DFG+AR+    E    +   +  +W AP
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAP 350

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 101/187 (54%), Gaps = 10/187 (5%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           G ++ D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++       
Sbjct: 1   GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNE 59
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL + 
Sbjct: 60  VGV----LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-ID 113
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETG 296
            A   A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G
Sbjct: 114 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 297 TYRWMAP 303
           +  WMAP
Sbjct: 174 SILWMAP 180

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 101/187 (54%), Gaps = 10/187 (5%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           G ++ D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++       
Sbjct: 1   GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNE 59
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL + 
Sbjct: 60  VGV----LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-ID 113
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETG 296
            A   A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G
Sbjct: 114 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 297 TYRWMAP 303
           +  WMAP
Sbjct: 174 SILWMAP 180

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 24/268 (8%)
Query: 46  QTSNGGGSVAMSVDNSSVGSNESHTRI--LNHQGLRRRANDNYS-----VAHSVNRRGRV 98
           +T+ G   +++S  +++ G N  H +I  L+  G    +   ++     VA+       +
Sbjct: 180 ETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGL 239
Query: 99  SHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-E 157
            H L+          S   T+GL   D W I    L +     QG FG+++ GT+NG   
Sbjct: 240 CHRLTT-----VCPTSKPQTQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR 293
Query: 158 VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VAIK L+     PE               +  L+H  +V+      +  ++ IVTEY   
Sbjct: 294 VAIKTLKPGTMSPE-------AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSK 345
Query: 218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
           GS+  FL     + + L   V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+A
Sbjct: 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 405
Query: 278 DFGVARIEVQTEGMTPETGTY--RWMAP 303
           DFG+AR+    E    +   +  +W AP
Sbjct: 406 DFGLARLIEDNEYTARQGAKFPIKWTAP 433

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 98/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 29  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 85
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL +  A   
Sbjct: 86  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQT 141
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G+  WM
Sbjct: 142 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 201
Query: 302 AP 303
           AP
Sbjct: 202 AP 203

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 98/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 3   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 59
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL +  A   
Sbjct: 60  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQT 115
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G+  WM
Sbjct: 116 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 175
Query: 302 AP 303
           AP
Sbjct: 176 AP 177

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 98/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 28  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 84
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL +  A   
Sbjct: 85  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQT 140
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G+  WM
Sbjct: 141 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 200
Query: 302 AP 303
           AP
Sbjct: 201 AP 202

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 98/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 57
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL +  A   
Sbjct: 58  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQT 113
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G+  WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 302 AP 303
           AP
Sbjct: 174 AP 175

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 97/184 (52%), Gaps = 25/184 (13%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ID +++ + +   +GAFG + +  +  ++VAIK +E        +             L+
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE--------SESERKAFIVELRQLS 57
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL-----AVKQALD 243
            + HPNIV+  GAC  P+  C+V EYA+GGS+   L   +    PL       A+   L 
Sbjct: 58  RVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAE----PLPYYTAAHAMSWCLQ 111
Query: 244 VARGMAYVHRL---GLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYR 299
            ++G+AY+H +    LIHRDLK  NLL+ +  ++ KI DFG A  ++QT  MT   G+  
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTH-MTNNKGSAA 169
Query: 300 WMAP 303
           WMAP
Sbjct: 170 WMAP 173

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/184 (34%), Positives = 97/184 (52%), Gaps = 25/184 (13%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ID +++ + +   +GAFG + +  +  ++VAIK +E        +             L+
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIE--------SESERKAFIVELRQLS 56
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL-----AVKQALD 243
            + HPNIV+  GAC  P+  C+V EYA+GGS+   L   +    PL       A+   L 
Sbjct: 57  RVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAE----PLPYYTAAHAMSWCLQ 110
Query: 244 VARGMAYVHRL---GLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYR 299
            ++G+AY+H +    LIHRDLK  NLL+ +  ++ KI DFG A  ++QT  MT   G+  
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQTH-MTNNKGSAA 168
Query: 300 WMAP 303
           WMAP
Sbjct: 169 WMAP 172

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 95/182 (52%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 17  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ----LQAFKNEV 71
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G    P +  IVT++ +G S+   L   + +   +K  +  A   
Sbjct: 72  GVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQT 129
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           ARGM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A  + +  G       +G+  WM
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 302 AP 303
           AP
Sbjct: 190 AP 191

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 121/268 (45%), Gaps = 24/268 (8%)
Query: 46  QTSNGGGSVAMSVDNSSVGSNESHTRI--LNHQGLRRRANDNYS-----VAHSVNRRGRV 98
           +T+ G   +++S  +++ G N  H +I  L+  G    +   ++     VA+       +
Sbjct: 97  ETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGL 156
Query: 99  SHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-E 157
            H L+          S   T+GL   D W I    L +     QG FG+++ GT+NG   
Sbjct: 157 CHRLTT-----VCPTSKPQTQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR 210
Query: 158 VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
           VAIK L+     PE               +  L+H  +V+      +  ++ IV EY   
Sbjct: 211 VAIKTLKPGTMSPE-------AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVGEYMSK 262
Query: 218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
           GS+  FL     + + L   V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+A
Sbjct: 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 322
Query: 278 DFGVARIEVQTEGMTPETGTY--RWMAP 303
           DFG+AR+    E    +   +  +W AP
Sbjct: 323 DFGLARLIEDNEYTARQGAKFPIKWTAP 350

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/184 (33%), Positives = 95/184 (51%), Gaps = 24/184 (13%)
Query: 137 GDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
           G+   +G FG+  + T+   GE + +K L R + + ++              +  L+HPN
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV------MRCLEHPN 68
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +++FIG   K      +TEY KGG++R  + K  +   P    V  A D+A GMAY+H +
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEV----QTEGM----TPE-------TGTYR 299
            +IHRDL S N L+  +K++ +ADFG+AR+ V    Q EG+     P+        G   
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 300 WMAP 303
           WMAP
Sbjct: 188 WMAP 191

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 29  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 85
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL +  A   
Sbjct: 86  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQT 141
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A  + +  G       +G+  WM
Sbjct: 142 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 302 AP 303
           AP
Sbjct: 202 AP 203

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/182 (34%), Positives = 90/182 (49%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           D W I    L +      G FG+++ GT+NG  +VAIK L+     PE            
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-------SFLEE 54
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  LKH  +V+      +  ++ IVTEY   GS+  FL   + R++ L   V  A  
Sbjct: 55  AQIMKKLKHDKLVQLYAVVSEEPIY-IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQ 113
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           VA GMAY+ R+  IHRDL+S N+L+ +    KIADFG+AR+    E    +   +  +W 
Sbjct: 114 VAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWT 173
Query: 302 AP 303
           AP
Sbjct: 174 AP 175

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 97/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 57
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G    P +  IVT++ +G S+   L   + +   +KL +  A   
Sbjct: 58  --LRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQT 113
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G+  WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 302 AP 303
           AP
Sbjct: 174 AP 175

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 21  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 77
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL +  A   
Sbjct: 78  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQT 133
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A  + +  G       +G+  WM
Sbjct: 134 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 193
Query: 302 AP 303
           AP
Sbjct: 194 AP 195

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 92/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 5   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 58
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L  
Sbjct: 59  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 116 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 176 KFPIKWTAP 184

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P++            
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGV-- 57
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L   +H NI+ F+G   KP +  IVT++ +G S+   L   + +   +KL +  A   
Sbjct: 58  --LRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQT 113
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A  + +  G       +G+  WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 173
Query: 302 AP 303
           AP
Sbjct: 174 AP 175

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 5   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 58
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  ++H  +V+      +  ++ IVTEY   GS+  FL     + + L  
Sbjct: 59  --AFLQEAQVMKKIRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 116 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 176 KFPIKWTAP 184

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 5   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 58
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L  
Sbjct: 59  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  A  +A GMAYV R+  +HRDL + N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 116 LVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 176 KFPIKWTAP 184

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 2   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 55
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L  
Sbjct: 56  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  +  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 113 LVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGA 172
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 173 KFPIKWTAP 181

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 5   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 58
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IVTEY   G +  FL     + + L  
Sbjct: 59  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGCLLDFLKGEMGKYLRLPQ 115
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 116 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 176 KFPIKWTAP 184

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 5   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 58
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IV EY   GS+  FL     + + L  
Sbjct: 59  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 116 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGA 175
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 176 KFPIKWTAP 184

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 2   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 55
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L  
Sbjct: 56  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  +  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 113 LVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 172
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 173 KFPIKWTAP 181

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           D W I    L +     QG FG+++ GT+NG   VAIK L+     PE            
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------AFLQE 54
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L   V  A  
Sbjct: 55  AQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ 113
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +   +  +W 
Sbjct: 114 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 173
Query: 302 AP 303
           AP
Sbjct: 174 AP 175

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 5   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 58
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IV EY   GS+  FL     + + L  
Sbjct: 59  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVCEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 116 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 176 KFPIKWTAP 184

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           D W I    L +     QG FG+++ GT+NG   VAIK L+     PE            
Sbjct: 4   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------AFLQE 56
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L   V  A  
Sbjct: 57  AQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 115
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +   +  +W 
Sbjct: 116 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 175
Query: 302 AP 303
           AP
Sbjct: 176 AP 177

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 5   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 58
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IV EY   GS+  FL     + + L  
Sbjct: 59  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 116 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 176 KFPIKWTAP 184

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 99/184 (53%), Gaps = 18/184 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
           W I+  ++ +      G+FG +Y+G ++G+ VA+KIL+  +  PE+              
Sbjct: 31  WEIEASEVMLSTRIGSGSFGTVYKGKWHGD-VAVKILKVVDPTPEQ----FQAFRNEVAV 85
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           L   +H NI+ F+G   K  +  IVT++ +G S+ + L  ++      K  + Q +D+AR
Sbjct: 86  LRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIAR 139
Query: 247 ----GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYR 299
               GM Y+H   +IHRD+KS+N+ +    ++KI DFG+A ++ +  G   +   TG+  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 300 WMAP 303
           WMAP
Sbjct: 200 WMAP 203

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 87/182 (47%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           D W I    L +     QG FG+++ GT+NG   VAIK L+     PE            
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------AFLQE 53
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +V+      +  +  IVTEY   GS+  FL     + + L   V  A  
Sbjct: 54  AQVMKKLRHEKLVQLYAVVSEEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 112
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +   +  +W 
Sbjct: 113 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT 172
Query: 302 AP 303
           AP
Sbjct: 173 AP 174

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXXXX 185
           W I    L +     QG FG+++ GT+NG   VAIK L+     PE              
Sbjct: 2   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-------AFLQEAQ 54
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            +  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L   V  A  +A
Sbjct: 55  VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 113
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +   +  +W AP
Sbjct: 114 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 173

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 90/189 (47%), Gaps = 12/189 (6%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L+     PE     
Sbjct: 5   TQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----- 58
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L+H  +V+      +  ++ IV EY   G +  FL     + + L  
Sbjct: 59  --AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVMEYMSKGCLLDFLKGEMGKYLRLPQ 115
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+    E    +  
Sbjct: 116 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 297 TY--RWMAP 303
            +  +W AP
Sbjct: 176 KFPIKWTAP 184

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 53
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 54  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 112
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 113 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 172
Query: 302 AP 303
           AP
Sbjct: 173 AP 174

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 60  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 118
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 119 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 178
Query: 302 AP 303
           AP
Sbjct: 179 AP 180

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 58
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 177
Query: 302 AP 303
           AP
Sbjct: 178 AP 179

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 66
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 67  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 125
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 126 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 185
Query: 302 AP 303
           AP
Sbjct: 186 AP 187

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 58
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 177
Query: 302 AP 303
           AP
Sbjct: 178 AP 179

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 60
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 61  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 119
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 120 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 179
Query: 302 AP 303
           AP
Sbjct: 180 AP 181

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 64
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 65  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 124 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 183
Query: 302 AP 303
           AP
Sbjct: 184 AP 185

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 58
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 302 AP 303
           AP
Sbjct: 178 AP 179

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 28/202 (13%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPEND 169
           MD +SP     N+D+W ++   + M      G +G++Y G +      VA+K L+    +
Sbjct: 3   MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            E+              +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   
Sbjct: 58  VEE-------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 110
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           + V   + +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+     
Sbjct: 111 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL----- 165
Query: 290 GMTPETGT--------YRWMAP 303
            MT +T T         +W AP
Sbjct: 166 -MTGDTYTAHAGAKFPIKWTAP 186

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 68
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 69  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 127
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 128 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 187
Query: 302 AP 303
           AP
Sbjct: 188 AP 189

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 64
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 65  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 123
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 124 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 183
Query: 302 AP 303
           AP
Sbjct: 184 AP 185

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 67
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 68  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 126
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 127 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 186
Query: 302 AP 303
           AP
Sbjct: 187 AP 188

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           DEW +    L + +    G FG+++ G YNG  +VA+K L++    P+            
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 63
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 64  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 122
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 123 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 182
Query: 302 AP 303
           AP
Sbjct: 183 AP 184

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 28/202 (13%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPEND 169
           MD +SP     N+D+W ++   + M      G +G++Y G +      VA+K L+    +
Sbjct: 3   MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            E+              +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   
Sbjct: 58  VEE-------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 110
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           + V   + +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+     
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL----- 165
Query: 290 GMTPETGT--------YRWMAP 303
            MT +T T         +W AP
Sbjct: 166 -MTGDTXTAHAGAKFPIKWTAP 186

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 28/202 (13%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPEND 169
           MD +SP     N+D+W ++   + M      G +G++Y G +      VA+K L+    +
Sbjct: 3   MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            E+              +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   
Sbjct: 58  VEE-------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 110
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           + V   + +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+     
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL----- 165
Query: 290 GMTPETGT--------YRWMAP 303
            MT +T T         +W AP
Sbjct: 166 -MTGDTYTAHAGAKFPIKWTAP 186

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 28/202 (13%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPEND 169
           MD +SP     N+D+W ++   + M      G +G++Y G +      VA+K L+    +
Sbjct: 3   MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            E+              +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   
Sbjct: 58  VEE-------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 110
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           + V   + +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+     
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL----- 165
Query: 290 GMTPETGT--------YRWMAP 303
            MT +T T         +W AP
Sbjct: 166 -MTGDTYTAHAGAKFPIKWTAP 186

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 86/182 (47%), Gaps = 13/182 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           +W ID  +L        G FG ++ G + N ++VAIK +       E             
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-------FIEEA 54
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             +  L HP +V+  G C +    C+VTE+ + G +  +L + Q      +  +   LDV
Sbjct: 55  EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDV 113
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWM 301
             GMAY+    +IHRDL + N L+  ++ IK++DFG+ R  V  +  T  TGT    +W 
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWA 172
Query: 302 AP 303
           +P
Sbjct: 173 SP 174

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 116/267 (43%), Gaps = 23/267 (8%)
Query: 46  QTSNGGGSVAMSVDNSSVGSNESHTRI--LNHQGLRRRANDNYSVAHSVNRRGRVSHALS 103
           +T+ G  S+++   +   G    H +I  L++ G        +S    +     V H   
Sbjct: 102 ETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQEL-----VDHYKK 156
Query: 104 -DDALARAL---MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EV 158
            +D L + L     S+ P +  E  D W I    L +      G FG+++  TYN   +V
Sbjct: 157 GNDGLCQKLSVPCMSSKPQKPWEK-DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV 215
Query: 159 AIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGG 218
           A+K ++                      + TL+H  +V+      K  ++ I+TE+   G
Sbjct: 216 AVKTMK-------PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKG 267
Query: 219 SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD 278
           S+  FL   +    PL   +  +  +A GMA++ +   IHRDL++ N+L+ +    KIAD
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD 327
Query: 279 FGVARIEVQTEGMTPETGTY--RWMAP 303
           FG+AR+    E    E   +  +W AP
Sbjct: 328 FGLARVIEDNEYTAREGAKFPIKWTAP 354

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 11/185 (5%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 58
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+        P    +  
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 178
Query: 299 RWMAP 303
           +W AP
Sbjct: 179 KWTAP 183

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 23/195 (11%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXX 176
           +G  N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+    
Sbjct: 13  QGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---- 68
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   +
Sbjct: 69  ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 125
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T 
Sbjct: 126 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTY 179
Query: 297 T--------YRWMAP 303
           T         +W AP
Sbjct: 180 TAHAGAKFPIKWTAP 194

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 11/185 (5%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 57
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+        P    +  
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 177
Query: 299 RWMAP 303
           +W AP
Sbjct: 178 KWTAP 182

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 23/194 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXX 177
           G  N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+     
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----- 55
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + 
Sbjct: 56  --FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T
Sbjct: 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYT 167
Query: 298 --------YRWMAP 303
                    +W AP
Sbjct: 168 AHAGAKFPIKWTAP 181

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 23/194 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXX 177
           G  N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+     
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----- 55
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + 
Sbjct: 56  --FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T
Sbjct: 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYT 167
Query: 298 --------YRWMAP 303
                    +W AP
Sbjct: 168 AHAGAKFPIKWTAP 181

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPEND 169
           MD +SP     N+D+W ++   + M      G +G++Y G +      VA+K L+    +
Sbjct: 3   MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            E+              +  +KHPN+V+ +G C +   + I+ E+   G++  +L +   
Sbjct: 58  VEE-------FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR 110
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           + V   + +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+     
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL----- 165
Query: 290 GMTPETGT--------YRWMAP 303
            MT +T T         +W AP
Sbjct: 166 -MTGDTYTAHAGAKFPIKWTAP 186

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 263
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHR+L + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHA 377
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 378 GAKFPIKWTAP 388

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 58
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHA 172
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 173 GAKFPIKWTAP 183

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 58
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHA 172
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 173 GAKFPIKWTAP 183

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 81/182 (44%), Gaps = 10/182 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           D W I    + +      G FG+++ G YN   +VA+K L+                   
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLK-------PGTMSVQAFLEE 58
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              + TL+H  +VR      +     I+TEY   GS+  FL   +   V L   +  +  
Sbjct: 59  ANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 118
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMAY+ R   IHRDL++ N+L+      KIADFG+AR+    E    E   +  +W 
Sbjct: 119 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 178
Query: 302 AP 303
           AP
Sbjct: 179 AP 180

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 11/181 (6%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXXX 184
           EW +    L + +    G FG+++ G YNG  +VA+K L++    P+             
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAEA 55
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  +
Sbjct: 56  NLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 114
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMA 302
           A GMA++     IHR+L++ N+L+    S KIADFG+AR+    E    E   +  +W A
Sbjct: 115 AEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 174
Query: 303 P 303
           P
Sbjct: 175 P 175

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 302
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 362
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHR+L + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 363 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHA 416
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 417 GAKFPIKWTAP 427

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 13/182 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           +W ID  +L        G FG ++ G + N ++VAIK +       E             
Sbjct: 4   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-------FIEEA 56
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             +  L HP +V+  G C +    C+V E+ + G +  +L + Q      +  +   LDV
Sbjct: 57  EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDV 115
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWM 301
             GMAY+    +IHRDL + N L+  ++ IK++DFG+ R  V  +  T  TGT    +W 
Sbjct: 116 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWA 174
Query: 302 AP 303
           +P
Sbjct: 175 SP 176

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 60
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 120
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHA 174
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 175 GAKFPIKWTAP 185

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 56
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHA 170
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 171 GAKFPIKWTAP 181

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 56
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYTAHA 170
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 171 GAKFPIKWTAP 181

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           + D+W ++   + M      G FG++Y G +      VA+K L+    + E+        
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 54
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTXTAHA 168
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 169 GAKFPIKWTAP 179

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 23/194 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXX 177
           G  N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+     
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----- 55
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    +  +KHPN+V+ +G C +   + I+ E+   G++  +L +   + V   + 
Sbjct: 56  --FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T
Sbjct: 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYT 167
Query: 298 --------YRWMAP 303
                    +W AP
Sbjct: 168 AHAGAKFPIKWTAP 181

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 23/194 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXX 177
           G  N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+     
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----- 55
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    +  +KHPN+V+ +G C +   + I+ E+   G++  +L +   + V   + 
Sbjct: 56  --FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T
Sbjct: 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTYT 167
Query: 298 --------YRWMAP 303
                    +W AP
Sbjct: 168 AHAGAKFPIKWTAP 181

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 21/246 (8%)
Query: 46  QTSNGGGSVAMSVDNSSVGSNESHTRI--LNHQGLRRRANDNYSVAHSVNRRGRVSHALS 103
           +T+ G  S+++   +   G    H +I  L++ G        +S    +     V H   
Sbjct: 96  ETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQEL-----VDHYKK 150
Query: 104 -DDALARAL---MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EV 158
            +D L + L     S+ P +  E  D W I    L +      G FG+++  TYN   +V
Sbjct: 151 GNDGLCQKLSVPCMSSKPQKPWEK-DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV 209
Query: 159 AIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGG 218
           A+K ++                      + TL+H  +V+      K  ++ I+TE+   G
Sbjct: 210 AVKTMK-------PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKG 261
Query: 219 SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD 278
           S+  FL   +    PL   +  +  +A GMA++ +   IHRDL++ N+L+ +    KIAD
Sbjct: 262 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD 321
Query: 279 FGVARI 284
           FG+AR+
Sbjct: 322 FGLARV 327

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           W I    + +      G FG+++ G YN   +VA+K L+                     
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-------PGTMSVQAFLEEAN 59
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            + TL+H  +VR      K     I+TE+   GS+  FL   +   V L   +  +  +A
Sbjct: 60  LMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 119
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            GMAY+ R   IHRDL++ N+L+      KIADFG+AR+    E    E   +  +W AP
Sbjct: 120 EGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 179

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           D W I    L +      G FG+++  TYN   +VA+K ++                   
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-------PGSMSVEAFLAE 60
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              + TL+H  +V+      K  ++ I+TE+   GS+  FL   +    PL   +  +  
Sbjct: 61  ANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 119
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++ +   IHRDL++ N+L+ +    KIADFG+AR+    E    E   +  +W 
Sbjct: 120 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 179
Query: 302 AP 303
           AP
Sbjct: 180 AP 181

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 84/167 (50%), Gaps = 19/167 (11%)
Query: 124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKIL--ERPENDPEKAXXXXXXXX 181
             EW I   +L +G+   +G FG++Y G ++GE VAI+++  ER   D  KA        
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAY 83
Query: 182 XXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ- 240
                    +H N+V F+GAC  P    I+T   KG ++   +     R   + L V + 
Sbjct: 84  RQT------RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-----RDAKIVLDVNKT 132
Query: 241 ---ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
              A ++ +GM Y+H  G++H+DLKS N+  + +  + I DFG+  I
Sbjct: 133 RQIAQEIVKGMGYLHAKGILHKDLKSKNVF-YDNGKVVITDFGLFSI 178

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 11/184 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W ++   L +G+   +G FG+++ G    +   + +    E  P              
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD---LKAKFLQEA 163
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L    HPNIVR IG C +     IV E  +GG    FL     R + +K  ++   D 
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDA 222
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR----- 299
           A GM Y+     IHRDL + N L+     +KI+DFG++R E   +G+   +G  R     
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE--ADGVXAASGGLRQVPVK 280
Query: 300 WMAP 303
           W AP
Sbjct: 281 WTAP 284

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 82/184 (44%), Gaps = 11/184 (5%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           D+W ++   L +G+   +G FG+++ G    +   + +    E  P              
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI- 165
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             L    HPNIVR IG C +     IV E  +GG    FL     R + +K  ++   D 
Sbjct: 166 --LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDA 222
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR----- 299
           A GM Y+     IHRDL + N L+     +KI+DFG++R E   +G+   +G  R     
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE--ADGVYAASGGLRQVPVK 280
Query: 300 WMAP 303
           W AP
Sbjct: 281 WTAP 284

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           N+D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 57
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+ E+   G++  +L +   + V   + +  
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTXTAHA 171
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 172 GAKFPIKWTAP 182

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 11/182 (6%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXX 183
           D W +    L + +    G  G+++ G YNG  +VA+K L++    P+            
Sbjct: 6   DAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-------AFLAE 58
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+    E    E   +  +W 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWT 177
Query: 302 AP 303
           AP
Sbjct: 178 AP 179

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXX 178
            ++ D+W ++   + M      G +G++Y G +      VA+K L+    + E+      
Sbjct: 21  FQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE------ 74
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV 238
                   +  +KHPN+V+ +G C     + IVTEY   G++  +L +     V   + +
Sbjct: 75  -FLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLL 133
Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT- 297
             A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T 
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRL------MTGDTYTA 187
Query: 298 -------YRWMAP 303
                   +W AP
Sbjct: 188 HAGAKFPIKWTAP 200

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           + D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 54
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+TE+   G++  +L +   + V   + +  
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTFTAHA 168
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 169 GAKFPIKWTAP 179

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 128 TIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
            ID  +L        G FG ++ G + N ++VAIK +       E               
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-------FIEEAEV 55
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +  L HP +V+  G C +    C+V E+ + G +  +L + Q      +  +   LDV  
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 114
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           GMAY+    +IHRDL + N L+  ++ IK++DFG+ R  V  +  T  TGT    +W +P
Sbjct: 115 GMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASP 173

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXX 180
           + D+W ++   + M      G +G++Y G +      VA+K L+    + E+        
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------F 54
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +  +KHPN+V+ +G C +   + I+ E+   G++  +L +   + V   + +  
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--- 297
           A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+      MT +T T   
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------MTGDTXTAHA 168
Query: 298 -----YRWMAP 303
                 +W AP
Sbjct: 169 GAKFPIKWTAP 179

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 128 TIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
            ID  +L        G FG ++ G + N ++VAIK +       E               
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-------FIEEAEV 55
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +  L HP +V+  G C +    C+V E+ + G +  +L + Q      +  +   LDV  
Sbjct: 56  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 114
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           GMAY+    +IHRDL + N L+  ++ IK++DFG+ R  V  +  T  TGT    +W +P
Sbjct: 115 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASP 173

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 128 TIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
            ID  +L        G FG ++ G + N ++VAIK +       E               
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-------FIEEAEV 53
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +  L HP +V+  G C +    C+V E+ + G +  +L + Q      +  +   LDV  
Sbjct: 54  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 112
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           GMAY+    +IHRDL + N L+  ++ IK++DFG+ R  V  +  T  TGT    +W +P
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASP 171

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 128 TIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
            ID  +L        G FG ++ G + N ++VAIK ++       +              
Sbjct: 23  VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIK-------EGSMSEDDFIEEAEV 75
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +  L HP +V+  G C +    C+V E+ + G +  +L + Q      +  +   LDV  
Sbjct: 76  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 134
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           GMAY+    +IHRDL + N L+  ++ IK++DFG+ R  V  +  T  TGT    +W +P
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASP 193

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 80
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 81  ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYN 138
Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 199 DIHHIDYYKKTTNGRLP----VKWMAP 221

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 64  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 121
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 122 ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 240 DIHHIDYYKKTTNGRLP----VKWMAP 262

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 80
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL--- 234
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+   +     
Sbjct: 81  ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFN 138
Query: 235 -----------KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                      K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 199 DIHHIDXXKKTTNGRLP----VKWMAP 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 80
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 81  ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 138
Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 199 DIHHIDYYKKTTNGRLP----VKWMAP 221

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 15  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 72
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 73  ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 130
Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 131 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 191 DIHHIDYYKKTTNGRLP----VKWMAP 213

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 12  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 69
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 70  ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 127
Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 128 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 188 DIHHIDYYKKTTNGRLP----VKWMAP 210

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 16  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 73
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 74  ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 131
Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 132 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 192 DIHHIDYYKKTTNGRLP----VKWMAP 214

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 80
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 81  ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 138
Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 139 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 199 DIHHIDYYKKTTNGRLP----VKWMAP 221

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 13/152 (8%)
Query: 139 AFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
               GAFG +Y+G +  E       VAIKIL   E    KA             +A++ H
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANVEFMDEALI---MASMDH 99
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           P++VR +G C  P +  +VT+    G + +++ + ++ ++  +L +   + +A+GM Y+ 
Sbjct: 100 PHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE 157
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
              L+HRDL + N+L+ S   +KI DFG+AR+
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 189

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 38/207 (18%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAXXXX 177
           W +   +L +G    +GAFG++      G          +VA+K+L+   +  EK     
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDL 65
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------- 228
                    +   KH NI+  +GAC +     ++ EYA  G++R++L  R+         
Sbjct: 66  ISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYN 123
Query: 229 -----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                   +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG+AR
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 284 -------IEVQTEGMTPETGTYRWMAP 303
                   +  T G  P     +WMAP
Sbjct: 184 DIHHIDYYKKTTNGRLP----VKWMAP 206

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 13/152 (8%)
Query: 139 AFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
               GAFG +Y+G +  E       VAIKIL   E    KA             +A++ H
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN--ETTGPKANVEFMDEALI---MASMDH 76
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           P++VR +G C  P +  +VT+    G + +++ + ++ ++  +L +   + +A+GM Y+ 
Sbjct: 77  PHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE 134
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
              L+HRDL + N+L+ S   +KI DFG+AR+
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 166

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  EK    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDYYKKTTNGRLP----VKWMAP 228

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  EK    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDXXKKTTNGRLP----VKWMAP 228

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  EK    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDXXKKTTNGRLP----VKWMAP 228

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  EK    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDYYKKTTNGRLP----VKWMAP 228

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
           W +++++L +     +G FG +  G Y G +VA+K ++   ND                 
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---ND-----ATAQAFLAEASV 67
Query: 187 LATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
           +  L+H N+V+ +G     K  ++ IVTEY   GS+  +L  R    +     +K +LDV
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMA 302
              M Y+     +HRDL + N+L+  D   K++DFG+ +    T+    +TG    +W A
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA 182
Query: 303 P 303
           P
Sbjct: 183 P 183

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  EK    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDYYKNTTNGRLP----VKWMAP 228

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 30/272 (11%)
Query: 42  FSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHA 101
           F   +++N  G   + V   S      H RI+ H        + Y      N    V H 
Sbjct: 104 FLVRESTNYPGDYTLCV---SCEGKVEHYRIMYHASKLSIDEEVYFE----NLMQLVEHY 156
Query: 102 LSD-DALARALMDSNSPTEGLENFDE-----WTIDLRKLNMGDAFAQGAFGKLYRGTYNG 155
            +D D L   L+        +   DE     W +++++L +     +G FG +  G Y G
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG 216
Query: 156 EEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGAC--RKPMVWCIVTE 213
            +VA+K ++   ND                 +  L+H N+V+ +G     K  ++ IVTE
Sbjct: 217 NKVAVKCIK---ND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY-IVTE 267
Query: 214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS 273
           Y   GS+  +L  R    +     +K +LDV   M Y+     +HRDL + N+L+  D  
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327
Query: 274 IKIADFGVAR--IEVQTEGMTPETGTYRWMAP 303
            K++DFG+ +     Q  G  P     +W AP
Sbjct: 328 AKVSDFGLTKEASSTQDTGKLP----VKWTAP 355

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
           W +++++L +     +G FG +  G Y G +VA+K ++   ND                 
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---ND-----ATAQAFLAEASV 58
Query: 187 LATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
           +  L+H N+V+ +G     K  ++ IVTEY   GS+  +L  R    +     +K +LDV
Sbjct: 59  MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 117
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMA 302
              M Y+     +HRDL + N+L+  D   K++DFG+ +    T+    +TG    +W A
Sbjct: 118 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA 173
Query: 303 P 303
           P
Sbjct: 174 P 174

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R + + ++  +G FG+++RG + GEEVA+KI    E                      L+
Sbjct: 4   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-------RSWFREAEIYQTVMLR 56
Query: 192 HPNIVRFIGACRK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI A  K       +W +V++Y + GS+  +L +    +V ++  +K AL  A 
Sbjct: 57  HENILGFIAADNKDNGTWTQLW-LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTAS 112
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTE--GMTP-- 293
           G+A++H        +  + HRDLKS N+L+  + +  IAD G+A R +  T+   + P  
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 172
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 173 RVGTKRYMAP 182

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R + + ++  +G FG+++RG + GEEVA+KI    E                      L+
Sbjct: 29  RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-------RSWFREAEIYQTVMLR 81
Query: 192 HPNIVRFIGACRK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI A  K       +W +V++Y + GS+  +L +    +V ++  +K AL  A 
Sbjct: 82  HENILGFIAADNKDNGTWTQLW-LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTAS 137
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEG--MTP-- 293
           G+A++H        +  + HRDLKS N+L+  + +  IAD G+A R +  T+   + P  
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 197
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 198 RVGTKRYMAP 207

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R + + ++  +G FG+++RG + GEEVA+KI    E                      L+
Sbjct: 9   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-------RSWFREAEIYQTVMLR 61
Query: 192 HPNIVRFIGACRK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI A  K       +W +V++Y + GS+  +L +    +V ++  +K AL  A 
Sbjct: 62  HENILGFIAADNKDNGTWTQLW-LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTAS 117
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEG--MTP-- 293
           G+A++H        +  + HRDLKS N+L+  + +  IAD G+A R +  T+   + P  
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 178 RVGTKRYMAP 187

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R + + ++  +G FG+++RG + GEEVA+KI    E                      L+
Sbjct: 6   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-------RSWFREAEIYQTVMLR 58
Query: 192 HPNIVRFIGACRK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI A  K       +W +V++Y + GS+  +L +    +V ++  +K AL  A 
Sbjct: 59  HENILGFIAADNKDNGTWTQLW-LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTAS 114
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTE--GMTP-- 293
           G+A++H        +  + HRDLKS N+L+  + +  IAD G+A R +  T+   + P  
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 174
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 175 RVGTKRYMAP 184

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
           W +++++L +     +G FG +  G Y G +VA+K ++   ND                 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK---ND-----ATAQAFLAEASV 52
Query: 187 LATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
           +  L+H N+V+ +G     K  ++ IVTEY   GS+  +L  R    +     +K +LDV
Sbjct: 53  MTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMA 302
              M Y+     +HRDL + N+L+  D   K++DFG+ +    T+    +TG    +W A
Sbjct: 112 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTA 167
Query: 303 P 303
           P
Sbjct: 168 P 168

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R + + ++  +G FG+++RG + GEEVA+KI    E                      L+
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-------RSWFREAEIYQTVMLR 55
Query: 192 HPNIVRFIGACRK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI A  K       +W +V++Y + GS+  +L +    +V ++  +K AL  A 
Sbjct: 56  HENILGFIAADNKDNGTWTQLW-LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTAS 111
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEG--MTP-- 293
           G+A++H        +  + HRDLKS N+L+  + +  IAD G+A R +  T+   + P  
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 172 RVGTKRYMAP 181

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R++ + +   +G +G+++RG ++GE VA+KI    +                      L+
Sbjct: 8   RQVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQ-------SWFRETEIYNTVLLR 60
Query: 192 HPNIVRFIGA-----CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI +          +W ++T Y + GS+  FL   Q +++   LA++ A+  A 
Sbjct: 61  HDNILGFIASDMTSRNSSTQLW-LITHYHEHGSLYDFL---QRQTLEPHLALRLAVSAAC 116
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-----GMTP 293
           G+A++H        +  + HRD KS N+L+ S+    IAD G+A +  Q       G  P
Sbjct: 117 GLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNP 176
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 177 RVGTKRYMAP 186

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R + + ++  +G FG+++RG + GEEVA+KI    E                      L+
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-------RSWFREAEIYQTVMLR 94
Query: 192 HPNIVRFIGACRK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI A  K       +W +V++Y + GS+  +L +    +V ++  +K AL  A 
Sbjct: 95  HENILGFIAADNKDNGTWTQLW-LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTAS 150
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTE--GMTP-- 293
           G+A++H        +  + HRDLKS N+L+  + +  IAD G+A R +  T+   + P  
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 211 RVGTKRYMAP 220

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  EK    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  ++IADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDYYKKTTNGRLP----VKWMAP 228

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +G FG++      G +         VA+K+L+  ++  EK    
Sbjct: 75  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 132
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 133 LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 191 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 250 ARDINNIDYYKKTTNGRLP----VKWMAP 274

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +G FG++      G +         VA+K+L+  ++  EK    
Sbjct: 21  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 78
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 79  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 136
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 137 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 195
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 196 ARDINNIDYYKKTTNGRLP----VKWMAP 220

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +G FG++      G +         VA+K+L+  ++  EK    
Sbjct: 18  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 75
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 76  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 133
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 134 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 192
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 193 ARDINNIDYYKKTTNGRLP----VKWMAP 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 94  RRGRVSHALS---DDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYR 150
           ++G  SH +S    D  A  + + ++ T  + +  ++ I   ++ +G    +G FG +++
Sbjct: 351 KQGVRSHTVSVSETDDYAEIIDEEDTYT--MPSTRDYEIQRERIELGRCIGEGQFGDVHQ 408
Query: 151 GTYNGEE-----VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKP 205
           G Y   E     VAIK  +   +D  +              +    HP+IV+ IG   + 
Sbjct: 409 GIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT-----MRQFDHPHIVKLIGVITEN 463
Query: 206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA--VKQALDVARGMAYVHRLGLIHRDLKS 263
            VW I+ E    G +R FL   Q R   L LA  +  A  ++  +AY+     +HRD+ +
Sbjct: 464 PVW-IIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 519
Query: 264 DNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
            N+L+ S+  +K+ DFG++R    +       G    +WMAP
Sbjct: 520 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 140 FAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
             +G FGK+    Y+      GE+VA+K L+     PE               L  L H 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 83
Query: 194 NIVRFIGACRKPMVWCI--VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           NIV++ G C +     I  + E+   GS++++L K +N+ + LK  +K A+ + +GM Y+
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL 142
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPE---TGTYRWMAP 303
                +HRDL + N+L+ S+  +KI DFG+ + IE   E  T +        W AP
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +G FG++      G +         VA+K+L+  ++  EK    
Sbjct: 16  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 73
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 74  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 131
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 132 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGL 190
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 191 ARDINNIDYYKKTTNGRLP----VKWMAP 215

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  E+    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEEDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++ EYA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDYYKKTTNGRLP----VKWMAP 228

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 7   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 67  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILY 119
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R    +       G    
Sbjct: 120 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 179
Query: 299 RWMAP 303
           +WMAP
Sbjct: 180 KWMAP 184

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 69  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILY 121
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R    +       G    
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 299 RWMAP 303
           +WMAP
Sbjct: 182 KWMAP 186

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 6   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 66  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILY 118
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R    +       G    
Sbjct: 119 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 178
Query: 299 RWMAP 303
           +WMAP
Sbjct: 179 KWMAP 183

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 32  DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 92  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILY 144
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R    +       G    
Sbjct: 145 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 204
Query: 299 RWMAP 303
           +WMAP
Sbjct: 205 KWMAP 209

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 140 FAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
             +G FGK+    Y+      GE+VA+K L+     PE               L  L H 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 71
Query: 194 NIVRFIGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           NIV++ G C +       ++ E+   GS++++L K +N+ + LK  +K A+ + +GM Y+
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYL 130
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPE---TGTYRWMAP 303
                +HRDL + N+L+ S+  +KI DFG+ + IE   E  T +        W AP
Sbjct: 131 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 64  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKF-SLDLASLILY 116
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R    +       G    
Sbjct: 117 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI 176
Query: 299 RWMAP 303
           +WMAP
Sbjct: 177 KWMAP 181

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 109 RALMDSNS---PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIK 161
           R  +D ++   PT+ +  F    D   I + K+     F +   G+L   +     VAIK
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 162 ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR 221
            L+    + ++              +    HPNI+R  G   K     IVTEY + GS+ 
Sbjct: 80  TLKVGYTEKQR-----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
            FL K   +   ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG+
Sbjct: 135 SFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 282 ARI-EVQTEGMTPETG---TYRWMAP 303
           AR+ E   E      G     RW +P
Sbjct: 194 ARVLEDDPEAAYTTRGGKIPIRWTSP 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R++ + +   +G +G+++RG++ GE VA+KI    +   EK+                L+
Sbjct: 37  RQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---EKSWFRETELYNT----VMLR 89
Query: 192 HPNIVRFIGA-----CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI +          +W ++T Y + GS+  +L   Q  ++     ++  L +A 
Sbjct: 90  HENILGFIASDMTSRHSSTQLW-LITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIAS 145
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-----GMTP 293
           G+A++H        +  + HRDLKS N+L+  +    IAD G+A +  Q+      G  P
Sbjct: 146 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 205
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 206 RVGTKRYMAP 215

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 64  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILY 116
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R    +       G    
Sbjct: 117 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 299 RWMAP 303
           +WMAP
Sbjct: 177 KWMAP 181

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 64  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILY 116
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R    +       G    
Sbjct: 117 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 299 RWMAP 303
           +WMAP
Sbjct: 177 KWMAP 181

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 13/176 (7%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXXXXXLATL 190
            ++ +      G FG +  G + G+ +VA+K+++       +              +  L
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-------EGSMSEDEFFQEAQTMMKL 60
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
            HP +V+F G C K     IVTEY   G +  +L        P +L ++   DV  GMA+
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-LEMCYDVCEGMAF 119
Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           +     IHRDL + N L+  D  +K++DFG+ R  V  +      GT    +W AP
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAP 174

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 61  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILY 113
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R    +       G    
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 299 RWMAP 303
           +WMAP
Sbjct: 174 KWMAP 178

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 31/204 (15%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 67
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   +    H N+V  +GAC KP     ++TE+ K G++  +L  ++N  VP K+A
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 238 --------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                         +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 284 IEVQTEGMTPETGTYR----WMAP 303
            ++  +      G  R    WMAP
Sbjct: 188 -DIXKDPDXVRKGDARLPLKWMAP 210

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 109 RALMDSNS---PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIK 161
           R  +D ++   PT+ +  F    D   I + K+     F +   G+L   +     VAIK
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 162 ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR 221
            L+    + ++              +    HPNI+R  G   K     IVTEY + GS+ 
Sbjct: 80  TLKVGYTEKQR-----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
            FL K   +   ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG+
Sbjct: 135 SFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGL 193
Query: 282 ARI-EVQTEGMTPETG---TYRWMAP 303
           +R+ E   E      G     RW +P
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSP 219

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  EK    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++  YA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDYYKKTTNGRLP----VKWMAP 228

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G EVAIKI+++ + +P                +  L HPNIV+         
Sbjct: 29  KLARHILTGREVAIKIIDKTQLNP----TSLQKLFREVRIMKILNHPNIVKLFEVIETEK 84
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              ++ EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 85  TLYLIMEYASGGEVFDYLV--AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 142
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 143 LLDADMNIKIADFGFS 158

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 37/207 (17%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 67
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKP----MVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   +    H N+V  +GAC KP    MV   +TE+ K G++  +L  ++N  VP 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMV---ITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 235 KLA--------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           K+A              +  +  VA+GM ++     IHRDL + N+L+     +KI DFG
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 184
Query: 281 VARIEVQTEGMTPETGTYR----WMAP 303
           +AR ++  +      G  R    WMAP
Sbjct: 185 LAR-DIYKDPDYVRKGDARLPLKWMAP 210

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 7/170 (4%)
Query: 136 MGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           +GD    G FGK+  G +   G +VA+KIL R +    ++             L   +HP
Sbjct: 20  LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI---RSLDVVGKIRREIQNLKLFRHP 76
Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
           +I++       P    +V EY  GG +  ++ K  N  +  K + +    +  G+ Y HR
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHR 134
Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK +N+L+ +  + KIADFG++ +    E +    G+  + AP
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAP 184

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 37/207 (17%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 67
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKP----MVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   +    H N+V  +GAC KP    MV   +TE+ K G++  +L  ++N  VP 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMV---ITEFCKFGNLSTYLRSKRNEFVPY 124
Query: 235 KLA--------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           K+A              +  +  VA+GM ++     IHRDL + N+L+     +KI DFG
Sbjct: 125 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 184
Query: 281 VARIEVQTEGMTPETGTYR----WMAP 303
           +AR ++  +      G  R    WMAP
Sbjct: 185 LAR-DIYKDPDYVRKGDARLPLKWMAP 210

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G EVAIKI+++ + +P                +  L HPNIV+         
Sbjct: 32  KLARHILTGREVAIKIIDKTQLNP----TSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              ++ EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 88  TLYLIMEYASGGEVFDYLV--AHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 146 LLDADMNIKIADFGFS 161

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 109 RALMDSNS---PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIK 161
           R  +D ++   PT+ +  F    D   I + K+     F +   G+L   +     VAIK
Sbjct: 20  RTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 162 ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR 221
            L+    + ++              +    HPNI+R  G   K     IVTEY + GS+ 
Sbjct: 80  TLKVGYTEKQR-----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
            FL K   +   ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG+
Sbjct: 135 SFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 282 ARI-EVQTEGMTPETG---TYRWMAP 303
           +R+ E   E      G     RW +P
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSP 219

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 109 RALMDSNS---PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIK 161
           R  +D ++   PT+ +  F    D   I + K+     F +   G+L   +     VAIK
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 162 ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR 221
            L+    + ++              +    HPNI+R  G   K     IVTEY + GS+ 
Sbjct: 80  TLKVGYTEKQR-----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
            FL K   +   ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG+
Sbjct: 135 SFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 282 ARI-EVQTEGMTPETG---TYRWMAP 303
           +R+ E   E      G     RW +P
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSP 219

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 11/192 (5%)
Query: 115 NSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKA 173
           N+P+     +  W ID + L        G FG +  G + G+ +VAIK+++       + 
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EG 59
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP 233
                        +  L H  +V+  G C K     I+TEY   G +  +L + ++R   
Sbjct: 60  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
            +L ++   DV   M Y+     +HRDL + N L+     +K++DFG++R  +  E  + 
Sbjct: 120 QQL-LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSS 178
Query: 294 ETGTY--RWMAP 303
               +  RW  P
Sbjct: 179 VGSKFPVRWSPP 190

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 13/193 (6%)
Query: 115 NSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKA 173
           N+P+     +  W ID + L        G FG +  G + G+ +VAIK+++       + 
Sbjct: 7   NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EG 59
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP 233
                        +  L H  +V+  G C K     I+TEY   G +  +L + ++R   
Sbjct: 60  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
            +L ++   DV   M Y+     +HRDL + N L+     +K++DFG++R  +  E  T 
Sbjct: 120 QQL-LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 177
Query: 294 ETGT---YRWMAP 303
             G+    RW  P
Sbjct: 178 SVGSKFPVRWSPP 190

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAXXX 176
           +W     KL +G    +GAFG++      G +         VA+K+L+  ++  EK    
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSD 86
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------- 228
                     +   KH NI+  +GAC +     ++  YA  G++R++L  R+        
Sbjct: 87  LVSEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSY 144
Query: 229 --NRSVP-----LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
             NR VP      K  V     +ARGM Y+     IHRDL + N+L+  +  +KIADFG+
Sbjct: 145 DINR-VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 282 AR-------IEVQTEGMTPETGTYRWMAP 303
           AR        +  T G  P     +WMAP
Sbjct: 204 ARDINNIDYYKKTTNGRLP----VKWMAP 228

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 67/136 (49%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G EVA+KI+++ + +P                +  L HPNIV+         
Sbjct: 32  KLARHVLTGREVAVKIIDKTQLNP----TSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              +V EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 88  TLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENL 145
Query: 267 LIFSDKSIKIADFGVA 282
           L+  D +IKIADFG +
Sbjct: 146 LLDGDMNIKIADFGFS 161

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 18/187 (9%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA--V 238
                 +    HP+IV+ IG   +  VW I+ E    G +R FL   Q R   L LA  +
Sbjct: 444 T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL---QVRKFSLDLASLI 494
Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY 298
             A  ++  +AY+     +HRD+ + N+L+ +   +K+ DFG++R    +       G  
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 299 --RWMAP 303
             +WMAP
Sbjct: 555 PIKWMAP 561

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 117 PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEK 172
           PT+ +  F    D   I + K+     F +   G+L   +     VAIK L+    + ++
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 173 AXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV 232
                         +    HPNI+R  G   K     IVTEY + GS+  FL K   +  
Sbjct: 91  -----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 233 PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGM 291
            ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG++R+ E   E  
Sbjct: 146 VIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 292 TPETG---TYRWMAP 303
               G     RW +P
Sbjct: 205 YTTRGGKIPIRWTSP 219

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 117 PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEK 172
           PT+ +  F    D   I + K+     F +   G+L   +     VAIK L+    + ++
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 173 AXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV 232
                         +    HPNI+R  G   K     IVTEY + GS+  FL K   +  
Sbjct: 91  -----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 233 PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGM 291
            ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG++R+ E   E  
Sbjct: 146 VIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 292 TPETG---TYRWMAP 303
               G     RW +P
Sbjct: 205 YTTRGGKIPIRWTSP 219

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 109 RALMDSNS---PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIK 161
           R  +D ++   PT+ +  F    D   I + K+     F +   G+L   +     VAIK
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 162 ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR 221
            L+    + ++              +    HPNI+R  G   K     IVTEY + GS+ 
Sbjct: 80  TLKVGYTEKQR-----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
            FL K   +   ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG+
Sbjct: 135 SFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 282 ARI-EVQTEGMTPETG---TYRWMAP 303
            R+ E   E      G     RW +P
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSP 219

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 29/190 (15%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           R + + +   +G +G+++RG++ GE VA+KI    +   EK+                L+
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---EKSWFRETELYNT----VMLR 60
Query: 192 HPNIVRFIGA-----CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+ FI +          +W ++T Y + GS+  +L   Q  ++     ++  L +A 
Sbjct: 61  HENILGFIASDMTSRHSSTQLW-LITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIAS 116
Query: 247 GMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-----GMTP 293
           G+A++H        +  + HRDLKS N+L+  +    IAD G+A +  Q+      G  P
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 294 ETGTYRWMAP 303
             GT R+MAP
Sbjct: 177 RVGTKRYMAP 186

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 14/195 (7%)
Query: 117 PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEK 172
           PT+ +  F    D   I + K+     F +   G+L   +     VAIK L+    + ++
Sbjct: 29  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 88
Query: 173 AXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV 232
                         +    HPNI+R  G   K     IVTEY + GS+  FL K   +  
Sbjct: 89  -----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 143
Query: 233 PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGM 291
            ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG++R+ E   E  
Sbjct: 144 VIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 292 TPETG---TYRWMAP 303
               G     RW +P
Sbjct: 203 YTTRGGKIPIRWTSP 217

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 27/200 (13%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +LN+G    +GAFG++          T     VA+K+L+      E       
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH----RA 76
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   +    H N+V  +GAC KP     ++ E+ K G++  +L  ++N  VP K  
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 238 VKQAL----------DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ 287
            K  L           VA+GM ++     IHRDL + N+L+     +KI DFG+AR ++ 
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR-DIY 195
Query: 288 TEGMTPETGTYR----WMAP 303
            +      G  R    WMAP
Sbjct: 196 KDPDYVRKGDARLPLKWMAP 215

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 67
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   +    H N+V  +GAC KP     ++ E+ K G++  +L  ++N  VP K+A
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 238 --------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                         +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 284 IEVQTEGMTPETGTYR----WMAP 303
            ++  +      G  R    WMAP
Sbjct: 188 -DIXKDPDXVRKGDARLPLKWMAP 210

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 86/187 (45%), Gaps = 34/187 (18%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGT---YNGE----EVAIKILERPENDPEKAXXXXX 178
           +W    + L +G    +G FGK+ + T     G      VA+K+L+   +  E       
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-----LR 71
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--------- 229
                   L  + HP++++  GAC +     ++ EYAK GS+R FL + +          
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 230 -------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI 276
                        R++ +   +  A  +++GM Y+  + L+HRDL + N+L+   + +KI
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKI 191
Query: 277 ADFGVAR 283
           +DFG++R
Sbjct: 192 SDFGLSR 198

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 30/203 (14%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +LN+G    +GAFG++          T     VA+K+L+      E       
Sbjct: 22  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 77
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   +    H N+V  +GAC KP     ++ E+ K G++  +L  ++N  VP K  
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 238 -------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
                        +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR- 196
Query: 285 EVQTEGMTPETGTYR----WMAP 303
           ++  +      G  R    WMAP
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAP 219

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 27/200 (13%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +LN+G    +GAFG++          T     VA+K+L+      E       
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH----RA 76
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   +    H N+V  +GAC KP     ++ E+ K G++  +L  ++N  VP K  
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 238 VKQAL----------DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ 287
            K  L           VA+GM ++     IHRDL + N+L+     +KI DFG+AR ++ 
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLAR-DIY 195
Query: 288 TEGMTPETGTYR----WMAP 303
            +      G  R    WMAP
Sbjct: 196 KDPDYVRKGDARLPLKWMAP 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 14/185 (7%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAXXXXXXX 180
           ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +        
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 181 XXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
                 +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 64  T-----MRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKF-SLDLASLILY 116
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY-- 298
           A  ++  +AY+     +HRD+ + N+L+ +   +K+ DFG++R    +       G    
Sbjct: 117 AYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPI 176
Query: 299 RWMAP 303
           +WMAP
Sbjct: 177 KWMAP 181

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 143 GAFGKLYRGTYNGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GAFGK+Y+       V  A K+++       K+             LA+  HPNIV+ + 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDT------KSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           A        I+ E+  GG+V   + +  R      +++  KQ LD    + Y+H   +IH
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD---ALNYLHDNKIIH 158
Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           RDLK+ N+L   D  IK+ADFGV+    +T +      GT  WMAP
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 37/207 (17%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 76
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKP----MVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   +    H N+V  +GAC KP    MV   + E+ K G++  +L  ++N  VP 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMV---IVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 235 KLA--------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           K+A              +  +  VA+GM ++     IHRDL + N+L+     +KI DFG
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 281 VARIEVQTEGMTPETGTYR----WMAP 303
           +AR ++  +      G  R    WMAP
Sbjct: 194 LAR-DIXKDPDXVRKGDARLPLKWMAP 219

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 133 KLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++ + +   +G +G+++RG++ GE VA+KI    +   EK+                L+H
Sbjct: 9   QITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---EKSWFRETELYNT----VMLRH 61
Query: 193 PNIVRFIGA-----CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
            NI+ FI +          +W ++T Y + GS+  +L   Q  ++     ++  L +A G
Sbjct: 62  ENILGFIASDMTSRHSSTQLW-LITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASG 117
Query: 248 MAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-----GMTPE 294
           +A++H        +  + HRDLKS N+L+  +    IAD G+A +  Q+      G  P 
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 295 TGTYRWMAP 303
            GT R+MAP
Sbjct: 178 VGTKRYMAP 186

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 136 MGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           +GD    G FGK+  G +   G +VA+KIL R +    ++             L   +HP
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHP 71
Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR-QNRSVPLKLAVKQALDVARGMAYVH 252
           +I++       P  + +V EY  GG +  ++ K  +   +  +   +Q L     + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDYCH 128
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           R  ++HRDLK +N+L+ +  + KIADFG++ +    E +    G+  + AP
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 34/187 (18%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAXXXXX 178
           +W    + L +G    +G FGK+ + T            VA+K+L+   +  E       
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-----LR 71
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--------- 229
                   L  + HP++++  GAC +     ++ EYAK GS+R FL + +          
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 230 -------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI 276
                        R++ +   +  A  +++GM Y+  + L+HRDL + N+L+   + +KI
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKI 191
Query: 277 ADFGVAR 283
           +DFG++R
Sbjct: 192 SDFGLSR 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 86/187 (45%), Gaps = 34/187 (18%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGT---YNGE----EVAIKILERPENDPEKAXXXXX 178
           +W    + L +G    +G FGK+ + T     G      VA+K+L+   +  E       
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-----LR 71
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--------- 229
                   L  + HP++++  GAC +     ++ EYAK GS+R FL + +          
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 230 -------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI 276
                        R++ +   +  A  +++GM Y+  + L+HRDL + N+L+   + +KI
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKI 191
Query: 277 ADFGVAR 283
           +DFG++R
Sbjct: 192 SDFGLSR 198

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 37/207 (17%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 76
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKP----MVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   +    H N+V  +GAC KP    MV   + E+ K G++  +L  ++N  VP 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMV---IVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 235 KLA--------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           K+A              +  +  VA+GM ++     IHRDL + N+L+     +KI DFG
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 281 VARIEVQTEGMTPETGTYR----WMAP 303
           +AR ++  +      G  R    WMAP
Sbjct: 194 LAR-DIYKDPDXVRKGDARLPLKWMAP 219

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 58  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 113
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   +    H N+V  +GAC KP     ++ E+ K G++  +L  ++N  VP K+A
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
Query: 238 --------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                         +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR
Sbjct: 174 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233
Query: 284 IEVQTEGMTPETGTYR----WMAP 303
            ++  +      G  R    WMAP
Sbjct: 234 -DIYKDPDYVRKGDARLPLKWMAP 256

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 136 MGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           +GD    G FGK+  G +   G +VA+KIL R +    ++             L   +HP
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHP 71
Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR-QNRSVPLKLAVKQALDVARGMAYVH 252
           +I++       P  + +V EY  GG +  ++ K  +   +  +   +Q L     + Y H
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS---AVDYCH 128
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           R  ++HRDLK +N+L+ +  + KIADFG++ +    E +    G+  + AP
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAP 179

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 18/198 (9%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-----EEVAIKILERPENDPE 171
           P E +  F +  ID+  + + +    G FG++ RG           VAIK L+    + +
Sbjct: 2   PNEAVREFAK-EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ 60
Query: 172 KAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
           +              +   +HPNI+R  G     M   I+TE+ + G++  FL     + 
Sbjct: 61  R-----REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQF 115
Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM 291
             ++L V     +A GM Y+  +  +HRDL + N+L+ S+   K++DFG++R   +    
Sbjct: 116 TVIQL-VGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD 174
Query: 292 TPETGTY------RWMAP 303
             ET +       RW AP
Sbjct: 175 PTETSSLGGKIPIRWTAP 192

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 10/189 (5%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXX 178
           E  +  D   I + K+     F +   G+L   +     VAIK L+    + ++      
Sbjct: 25  EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-----R 79
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV 238
                   +    HPNI+R  G   K     IVTEY + GS+  FL K   +   ++L V
Sbjct: 80  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-V 138
Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG- 296
                +A GM Y+  +G +HRDL + N+LI S+   K++DFG++R+ E   E      G 
Sbjct: 139 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 297 --TYRWMAP 303
               RW +P
Sbjct: 199 KIPIRWTSP 207

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 85/189 (44%), Gaps = 10/189 (5%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXX 178
           E  +  D   I + K+     F +   G+L   +     VAIK L+    + ++      
Sbjct: 8   EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-----R 62
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV 238
                   +    HPNI+R  G   K     IVTEY + GS+  FL K   +   ++L V
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-V 121
Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG- 296
                +A GM Y+  +G +HRDL + N+LI S+   K++DFG++R+ E   E      G 
Sbjct: 122 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 297 --TYRWMAP 303
               RW +P
Sbjct: 182 KIPIRWTSP 190

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 37/207 (17%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 21  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 76
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKP----MVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   +    H N+V  +GAC KP    MV   + E+ K G++  +L  ++N  VP 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMV---IVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 235 KLA--------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           K+A              +  +  VA+GM ++     IHRDL + N+L+     +KI DFG
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 281 VARIEVQTEGMTPETGTYR----WMAP 303
           +AR ++  +      G  R    WMAP
Sbjct: 194 LAR-DIYKDPDYVRKGDARLPLKWMAP 219

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 56
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 57  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 113
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 114 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 171
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 172 --VKWYAP 177

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 118 TEGLEN-FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-VAIKILERPENDPEKAXX 175
           +E L+N  ++  ID   L +G    +G FG +  G    E+  ++K+  +       +  
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 176 XXXXXXXXXXXLATLKHPNIVRFIGAC--------RKPMVWCIVTEYAKGGSVRQFLTKR 227
                      +    HPN++R +G C         KPMV   +  + K G +  +L   
Sbjct: 79  EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV---ILPFMKYGDLHTYLLYS 135
Query: 228 Q----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +     + +PL+  +K  +D+A GM Y+     +HRDL + N ++  D ++ +ADFG+++
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 420
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 421 ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 477
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 478 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 535
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 536 --VKWYAP 541

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 16/172 (9%)
Query: 140 FAQGAFGKLYRGTYN---GEE--VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
             +G FG++Y G Y    GE+  VA+K  ++     +               +  L HP+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKK-----DCTLDNKEKFMSEAVIMKNLDHPH 86
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           IV+ IG   +   W I+ E    G +  +L + +N S+ +   V  +L + + MAY+  +
Sbjct: 87  IVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESI 144
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
             +HRD+   N+L+ S + +K+ DFG++R  ++ E     + T    +WM+P
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSP 195

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 16/172 (9%)
Query: 140 FAQGAFGKLYRGTYN---GEE--VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
             +G FG++Y G Y    GE+  VA+K  ++     +               +  L HP+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKK-----DCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           IV+ IG   +   W I+ E    G +  +L + +N S+ +   V  +L + + MAY+  +
Sbjct: 75  IVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESI 132
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
             +HRD+   N+L+ S + +K+ DFG++R  ++ E     + T    +WM+P
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSP 183

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 366 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 421
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 422 ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 478
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 479 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 536
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 537 --VKWYAP 542

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G+EVA+KI+++ + +                 +  L HPNIV+         
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLN----SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEK 86
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              +V EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 87  TLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 145 LLDADMNIKIADFGFS 160

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G+EVA+KI+++ + +                 +  L HPNIV+         
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLN----SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEK 86
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              +V EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 87  TLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 145 LLDADMNIKIADFGFS 160

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 143 GAFGKLYRGTYNGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GAFGK+Y+       V  A K+++       K+             LA+  HPNIV+ + 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDT------KSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           A        I+ E+  GG+V   + +  R      +++  KQ LD    + Y+H   +IH
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD---ALNYLHDNKIIH 158
Query: 259 RDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           RDLK+ N+L   D  IK+ADFGV A+     +      GT  WMAP
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 58
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 115
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 173
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 174 --VKWYAP 179

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 21  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 76
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 77  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 133
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 134 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 191
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 192 --VKWYAP 197

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 62
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 63  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 119
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP-- 177
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 178 --VKWYAP 183

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G+EVA+KI+++ + +                 +  L HPNIV+         
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLN----SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEK 86
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              +V EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 87  TLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 145 LLDADMNIKIADFGFS 160

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 16/172 (9%)
Query: 140 FAQGAFGKLYRGTYN---GEE--VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
             +G FG++Y G Y    GE+  VA+K  ++     +               +  L HP+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKK-----DCTLDNKEKFMSEAVIMKNLDHPH 70
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           IV+ IG   +   W I+ E    G +  +L + +N S+ +   V  +L + + MAY+  +
Sbjct: 71  IVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESI 128
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
             +HRD+   N+L+ S + +K+ DFG++R  ++ E     + T    +WM+P
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSP 179

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 68
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 125
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 183
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 184 --VKWYAP 189

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 62
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 63  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 119
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 177
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 178 --VKWYAP 183

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 14/166 (8%)
Query: 143 GAFGKLYRGTYNGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GAFGK+Y+       V  A K+++       K+             LA+  HPNIV+ + 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDT------KSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           A        I+ E+  GG+V   + +  R      +++  KQ LD    + Y+H   +IH
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD---ALNYLHDNKIIH 158
Query: 259 RDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           RDLK+ N+L   D  IK+ADFGV A+     +      GT  WMAP
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GA+G +Y  R  ++G  VA+K +  P N  E               L   +HPN+VR + 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVP-NGEEGLPISTVREVALLRRLEAFEHPNVVRLMD 73
Query: 201 ACR-----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            C      + +   +V E+     +R +L K     +P +          RG+ ++H   
Sbjct: 74  VCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 132
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +N+L+ S  ++K+ADFG+ARI      + P   T  + AP
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 78
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 79  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 135
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 193
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 194 --VKWYAP 199

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 24/188 (12%)
Query: 129 IDLRKLNMGDA-FAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP             
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAE 78
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +  L +P IVR IG C     W +V E A+ G + ++L  +QNR V  K  ++    
Sbjct: 79  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQ 135
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--------IEVQTEGMTPET 295
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++         + QT G  P  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP-- 193
Query: 296 GTYRWMAP 303
              +W AP
Sbjct: 194 --VKWYAP 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 14/190 (7%)
Query: 118 TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXX 176
           T GL  +  W ID + L        G FG +  G + G+ +VAIK+++       +    
Sbjct: 2   TAGL-GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMS 53
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     +  L H  +V+  G C K     I+TEY   G +  +L + ++R    +L
Sbjct: 54  EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL 113
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETG 296
            ++   DV   M Y+     +HRDL + N L+     +K++DFG++R  +  E  T   G
Sbjct: 114 -LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVG 171
Query: 297 T---YRWMAP 303
           +    RW  P
Sbjct: 172 SKFPVRWSPP 181

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 11/180 (6%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXXXX 185
           W ID + L        G FG +  G + G+ +VAIK+++       +             
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAK 56
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            +  L H  +V+  G C K     I+TEY   G +  +L + ++R    +L ++   DV 
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVC 115
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY--RWMAP 303
             M Y+     +HRDL + N L+     +K++DFG++R  +  E  +     +  RW  P
Sbjct: 116 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPP 175

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GA+G +Y  R  ++G  VA+K +  P N  E               L   +HPN+VR + 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVP-NGEEGLPISTVREVALLRRLEAFEHPNVVRLMD 73
Query: 201 ACR-----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            C      + +   +V E+     +R +L K     +P +          RG+ ++H   
Sbjct: 74  VCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 132
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +N+L+ S  ++K+ADFG+ARI      + P   T  + AP
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 13/181 (7%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXXXX 185
           W ID + L        G FG +  G + G+ +VAIK+++       +             
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAK 56
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            +  L H  +V+  G C K     I+TEY   G +  +L + ++R    +L ++   DV 
Sbjct: 57  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVC 115
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 302
             M Y+     +HRDL + N L+     +K++DFG++R  +  E  T   G+    RW  
Sbjct: 116 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSP 174
Query: 303 P 303
           P
Sbjct: 175 P 175

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 29/202 (14%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH----RA 78
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVP---- 233
                   +    H N+V  +GAC KP     ++ E+ K G++  +L  ++N  VP    
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 234 --------LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE 285
                   L+  +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR +
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR-D 197
Query: 286 VQTEGMTPETGTYR----WMAP 303
           +  +      G  R    WMAP
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAP 219

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 13/181 (7%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXXXX 185
           W ID + L        G FG +  G + G+ +VAIK+++       +             
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAK 55
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            +  L H  +V+  G C K     I+TEY   G +  +L + ++R    +L ++   DV 
Sbjct: 56  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVC 114
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMA 302
             M Y+     +HRDL + N L+     +K++DFG++R  +  E  T   G+    RW  
Sbjct: 115 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSP 173
Query: 303 P 303
           P
Sbjct: 174 P 174

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 31/204 (15%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAXXXXX 178
           +W     +L +G    +GAFG++          T     VA+K+L+      E       
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RA 78
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   +    H N+V  +GAC KP     ++ E+ K G++  +L  ++N  VP K A
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 238 --------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
                         +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR
Sbjct: 139 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198
Query: 284 IEVQTEGMTPETGTYR----WMAP 303
            ++  +      G  R    WMAP
Sbjct: 199 -DIYKDPDYVRKGDARLPLKWMAP 221

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GA+G +Y  R  ++G  VA+K +  P N  E               L   +HPN+VR + 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVP-NGEEGLPISTVREVALLRRLEAFEHPNVVRLMD 73
Query: 201 ACR-----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            C      + +   +V E+     +R +L K     +P +          RG+ ++H   
Sbjct: 74  VCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC 132
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +N+L+ S  ++K+ADFG+ARI      + P   T  + AP
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 63/121 (52%), Gaps = 5/121 (4%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +    HPNI+R  G   +  +  IVTEY + GS+  FL     +   ++L V     V  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-VGMLRGVGA 162
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG---TYRWMA 302
           GM Y+  LG +HRDL + N+L+ S+   K++DFG++R+ E   +     TG     RW A
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTA 222
Query: 303 P 303
           P
Sbjct: 223 P 223

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 14/195 (7%)
Query: 117 PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEK 172
           PT+ +  F    D   I + K+     F +   G+L   +     VAIK L+    + ++
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 173 AXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV 232
                         +    HPNI+R  G   K     IVTE  + GS+  FL K   +  
Sbjct: 91  -----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 233 PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGM 291
            ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG++R+ E   E  
Sbjct: 146 VIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 292 TPETG---TYRWMAP 303
               G     RW +P
Sbjct: 205 YTTRGGKIPIRWTSP 219

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G+EVA++I+++ + +                 +  L HPNIV+         
Sbjct: 31  KLARHILTGKEVAVRIIDKTQLN----SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEK 86
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              +V EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 87  TLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 145 LLDADMNIKIADFGFS 160

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G+EVA+KI+++ + +                 +  L HPNIV+         
Sbjct: 24  KLARHILTGKEVAVKIIDKTQLN----SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEK 79
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              +V EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 80  TLYLVMEYASGGEVFDYLV--AHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 137
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 138 LLDADMNIKIADFGFS 153

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G+EVA++I+++ + +                 +  L HPNIV+         
Sbjct: 31  KLARHILTGKEVAVRIIDKTQLN----SSSLQKLFREVRIMKVLNHPNIVKLFEVIETEK 86
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              +V EYA GG V  +L    +  +  K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 87  TLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 145 LLDADMNIKIADFGFS 160

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 109 RALMDSNS---PTEGLENF----DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIK 161
           R  +D ++   PT+ +  F    D   I + K+     F +   G+L   +     VAIK
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 162 ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR 221
            L+    + ++              +    HPNI+R  G   K     IVTE  + GS+ 
Sbjct: 80  TLKVGYTEKQR-----RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
            FL K   +   ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG+
Sbjct: 135 SFLRKHDAQFTVIQL-VGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGL 193
Query: 282 ARI-EVQTEGMTPETG---TYRWMAP 303
           +R+ E   E      G     RW +P
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSP 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKA 173
           G E+ D    + R L       +G FG +    Y+      GE VA+K L+    +    
Sbjct: 1   GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---- 56
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
                        L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + 
Sbjct: 57  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKE 112
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           R   +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +
Sbjct: 113 RIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 290 GMT----PETGTYRWMAP 303
                  P      W AP
Sbjct: 172 EXXKVKEPGESPIFWYAP 189

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 63/121 (52%), Gaps = 5/121 (4%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +    HPNI+R  G   +  +  IVTEY + GS+  FL     +   ++L V     V  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-VGMLRGVGA 162
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG---TYRWMA 302
           GM Y+  LG +HRDL + N+L+ S+   K++DFG++R+ E   +     TG     RW A
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 303 P 303
           P
Sbjct: 223 P 223

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 129 IDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXX 183
           +D+      +   +G +G +Y  R    GE VA+K +      E  P  A          
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL---- 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              L  L HPNIV+ +          +V E+     +++F+       +PL L       
Sbjct: 60  ---LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMA 302
           + +G+A+ H   ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + A
Sbjct: 116 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 175
Query: 303 P 303
           P
Sbjct: 176 P 176

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPEND 169
           PT+   N ++W      L  G     GAFGK+   T  G        +VA+K+L+   + 
Sbjct: 24  PTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 82
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----- 224
            EK                  +H NIV  +GAC       ++TEY   G +  FL     
Sbjct: 83  DEKEALMSELKIMSHLG----QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 138
Query: 225 ---TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
               K   R + L+  +  +  VA+GMA++     IHRD+ + N+L+ +    KI DFG+
Sbjct: 139 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 198
Query: 282 ARIEVQTEGMTPETGTYR----WMAP 303
           AR ++  +      G  R    WMAP
Sbjct: 199 AR-DIMNDSNYIVKGNARLPVKWMAP 223

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 38/173 (21%)
Query: 142 QGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
           +GAFG++++    G         VA+K+L+      E +             +A   +PN
Sbjct: 57  EGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-----EASADMQADFQREAALMAEFDNPN 111
Query: 195 IVRFIGACR--KPMVWCIVTEYAKGGSVRQFLTKRQNRSV------------------PL 234
           IV+ +G C   KPM  C++ EY   G + +FL      +V                  P 
Sbjct: 112 IVKLLGVCAVGKPM--CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 235 KLAVKQALDVAR----GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            L+  + L +AR    GMAY+     +HRDL + N L+  +  +KIADFG++R
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 6/136 (4%)
Query: 147 KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           KL R    G+EVA+KI+++ + +                    L HPNIV+         
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLN----SSSLQKLFREVRIXKVLNHPNIVKLFEVIETEK 86
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
              +V EYA GG V  +L          K A  +   +   + Y H+  ++HRDLK++NL
Sbjct: 87  TLYLVXEYASGGEVFDYLVAHGRXKE--KEARAKFRQIVSAVQYCHQKFIVHRDLKAENL 144
Query: 267 LIFSDKSIKIADFGVA 282
           L+ +D +IKIADFG +
Sbjct: 145 LLDADXNIKIADFGFS 160

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPEND 169
           PT+   N ++W      L  G     GAFGK+   T  G        +VA+K+L+   + 
Sbjct: 32  PTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----- 224
            EK                  +H NIV  +GAC       ++TEY   G +  FL     
Sbjct: 91  DEKEALMSELKIMSHLG----QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 146
Query: 225 ---TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
               K   R + L+  +  +  VA+GMA++     IHRD+ + N+L+ +    KI DFG+
Sbjct: 147 ADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 206
Query: 282 ARIEVQTEGMTPETGTYR----WMAP 303
           AR ++  +      G  R    WMAP
Sbjct: 207 AR-DIMNDSNYIVKGNARLPVKWMAP 231

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKA 173
             E+ D    + R L       +G FG +    Y+      GE VA+K L+    +    
Sbjct: 5   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---- 60
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
                        L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + 
Sbjct: 61  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKE 116
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           R   +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +
Sbjct: 117 RIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 175
Query: 290 GMT----PETGTYRWMAP 303
                  P      W AP
Sbjct: 176 EXXKVKEPGESPIFWYAP 193

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKA 173
             E+ D    + R L       +G FG +    Y+      GE VA+K L+    +    
Sbjct: 3   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---- 58
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
                        L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + 
Sbjct: 59  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKE 114
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           R   +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +
Sbjct: 115 RIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 173
Query: 290 GMT----PETGTYRWMAP 303
                  P      W AP
Sbjct: 174 EXXKVKEPGESPIFWYAP 191

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKA 173
             E+ D    + R L       +G FG +    Y+      GE VA+K L+    +    
Sbjct: 4   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---- 59
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
                        L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + 
Sbjct: 60  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKE 115
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           R   +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +
Sbjct: 116 RIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 174
Query: 290 GMT----PETGTYRWMAP 303
                  P      W AP
Sbjct: 175 EXXKVKEPGESPIFWYAP 192

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 11/151 (7%)
Query: 140 FAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
             +G FGK+Y+G   +G  VA+K L+      E+              ++   H N++R 
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKE-----ERXQGGELQFQTEVEMISMAVHRNLLRL 100
Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ--ALDVARGMAYVHR--- 253
            G C  P    +V  Y   GSV   L +R     PL    +Q  AL  ARG+AY+H    
Sbjct: 101 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 160
Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
             +IHRD+K+ N+L+  +    + DFG+A++
Sbjct: 161 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 21/183 (11%)
Query: 130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           +LRKL +      G FG +++G +   GE + I +  +   D +               +
Sbjct: 32  ELRKLKV---LGSGVFGTVHKGVWIPEGESIKIPVCIKVIED-KSGRQSFQAVTDHMLAI 87
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALDVAR 246
            +L H +IVR +G C    +  +VT+Y   GS+   +  RQ+R ++  +L +   + +A+
Sbjct: 88  GSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAK 144
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-------EVQTEGMTPETGTYR 299
           GM Y+   G++HR+L + N+L+ S   +++ADFGVA +        + +E  TP     +
Sbjct: 145 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP----IK 200
Query: 300 WMA 302
           WMA
Sbjct: 201 WMA 203

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKA 173
             E+ D    + R L       +G FG +    Y+      GE VA+K L+    +    
Sbjct: 29  AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---- 84
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
                        L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + 
Sbjct: 85  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKE 140
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           R   +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +
Sbjct: 141 RIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
Query: 290 GMT----PETGTYRWMAP 303
                  P      W AP
Sbjct: 200 EXXKVKEPGESPIFWYAP 217

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 21/183 (11%)
Query: 130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           +LRKL +      G FG +++G +   GE + I +  +   D +               +
Sbjct: 14  ELRKLKV---LGSGVFGTVHKGVWIPEGESIKIPVCIKVIED-KSGRQSFQAVTDHMLAI 69
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALDVAR 246
            +L H +IVR +G C    +  +VT+Y   GS+   +  RQ+R ++  +L +   + +A+
Sbjct: 70  GSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAK 126
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-------EVQTEGMTPETGTYR 299
           GM Y+   G++HR+L + N+L+ S   +++ADFGVA +        + +E  TP     +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP----IK 182
Query: 300 WMA 302
           WMA
Sbjct: 183 WMA 185

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 11/151 (7%)
Query: 140 FAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
             +G FGK+Y+G   +G  VA+K L+      E+              ++   H N++R 
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKE-----ERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ--ALDVARGMAYVHR--- 253
            G C  P    +V  Y   GSV   L +R     PL    +Q  AL  ARG+AY+H    
Sbjct: 93  RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
             +IHRD+K+ N+L+  +    + DFG+A++
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/121 (34%), Positives = 62/121 (51%), Gaps = 5/121 (4%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +    HPNI+   G   K     IVTEY + GS+  FL K   +   ++L V     ++ 
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL-VGMLRGISA 135
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG---TYRWMA 302
           GM Y+  +G +HRDL + N+LI S+   K++DFG++R+ E   E      G     RW A
Sbjct: 136 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 195
Query: 303 P 303
           P
Sbjct: 196 P 196

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKA 173
             E+ D    + R L       +G FG +    Y+      GE VA+K L+    +    
Sbjct: 2   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---- 57
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
                        L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + 
Sbjct: 58  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKE 113
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           R   +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +
Sbjct: 114 RIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 172
Query: 290 GMT----PETGTYRWMAP 303
                  P      W AP
Sbjct: 173 EXXKVKEPGESPIFWYAP 190

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRG----TYNGE---EVAIKILERPENDPEKAXXXX 177
           DEW +   K+ +     QG+FG +Y G       GE    VA+K +    +  E+     
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 66
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------NR 230
                      T  H  +VR +G   K     +V E    G ++ +L   +        R
Sbjct: 67  EASVMKGF---TCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 121
Query: 231 SVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
             P L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 122 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 181
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWMAP
Sbjct: 182 XXRKGGKGLLP----VRWMAP 198

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRG----TYNGE---EVAIKILERPENDPEKAXXXX 177
           DEW +   K+ +     QG+FG +Y G       GE    VA+K +    +  E+     
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------NR 230
                      T  H  +VR +G   K     +V E    G ++ +L   +        R
Sbjct: 70  EASVMKGF---TCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 231 SVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
             P L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWMAP
Sbjct: 185 XXRKGGKGLLP----VRWMAP 201

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 16/171 (9%)
Query: 143 GAFGKLYRG---TYNGEE---VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
           G FG++Y+G   T +G++   VAIK L+    + ++              +    H NI+
Sbjct: 55  GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI-----MGQFSHHNII 109
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           R  G   K     I+TEY + G++ +FL ++      L+L V     +A GM Y+  +  
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-VGMLRGIAAGMKYLANMNY 168
Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG---TYRWMAP 303
           +HRDL + N+L+ S+   K++DFG++R+ E   E     +G     RW AP
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 138 DAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNI 195
           D   +G+FG++Y+G  N   E VAIKI+     D E+A             L+    P I
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            R+ G+  K     I+ EY  GGS    L         +   +++ L   +G+ Y+H   
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSER 136
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 303
            IHRD+K+ N+L+     +K+ADFGVA     T+       GT  WMAP
Sbjct: 137 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 185

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 72  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 186
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 187 XXRKGGKGLLP----VRWMSP 203

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRG----TYNGE---EVAIKILERPENDPEKAXXXX 177
           DEW +   K+ +     QG+FG +Y G       GE    VA+K +    +  E+     
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------NR 230
                      T  H  +VR +G   K     +V E    G ++ +L   +        R
Sbjct: 70  EASVMKGF---TCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 231 SVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
             P L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWMAP
Sbjct: 185 XXRKGGKGLLP----VRWMAP 201

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 100 EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 154
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 214
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 215 YYRKGGKGLLP----VRWMSP 231

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 72  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 186
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 187 YYRKGGKGLLP----VRWMSP 203

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 63  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 117
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 118 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 177
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 178 XXRKGGKGLLP----VRWMSP 194

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAX 174
           G+ENF +           +   +G +G +Y  R    GE VA+K +      E  P  A 
Sbjct: 1   GMENFQK----------VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI 50
Query: 175 XXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                       L  L HPNIV+ +          +V E+     +++F+       +PL
Sbjct: 51  REISL-------LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 102
Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTP 293
            L       + +G+A+ H   ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T 
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
Query: 294 ETGTYRWMAP 303
           E  T  + AP
Sbjct: 163 EVVTLWYRAP 172

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 10/189 (5%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXX 178
           E  +  D   I + K+     F +   G+L   +     VAIK L+    + ++      
Sbjct: 8   EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR-----R 62
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV 238
                   +    HPNI+R  G   K     IVTE  + GS+  FL K   +   ++L V
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL-V 121
Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG- 296
                +A GM Y+  +G +HRDL + N+LI S+   K++DFG++R+ E   E      G 
Sbjct: 122 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 297 --TYRWMAP 303
               RW +P
Sbjct: 182 KIPIRWTSP 190

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRG----TYNGE---EVAIKILERPENDPEKAXXXX 177
           DEW +   K+ +     QG+FG +Y G       GE    VA+K +    +  E+     
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------NR 230
                      T  H  +VR +G   K     +V E    G ++ +L   +        R
Sbjct: 70  EASVMKGF---TCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 231 SVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
             P L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWMAP
Sbjct: 185 YYRKGGKGLLP----VRWMAP 201

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 69  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 183
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 184 YYRKGGKGLLP----VRWMSP 200

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 65  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 179
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 180 YYRKGGKGLLP----VRWMSP 196

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 33/201 (16%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           E ++DL  L + +   +G +G +Y+G+ +   VA+K+          A            
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFS-------FANRQNFINEKNIY 59
Query: 186 XLATLKHPNIVRFIGACRKP-----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
            +  ++H NI RFI    +      M + +V EY   GS+ ++L+   +  V    + + 
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS---SCRL 116
Query: 241 ALDVARGMAYVH---------RLGLIHRDLKSDNLLIFSDKSIKIADFGVA--------- 282
           A  V RG+AY+H         +  + HRDL S N+L+ +D +  I+DFG++         
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 283 RIEVQTEGMTPETGTYRWMAP 303
           R   +      E GT R+MAP
Sbjct: 177 RPGEEDNAAISEVGTIRYMAP 197

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 71  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 185
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 186 YYRKGGKGLLP----VRWMSP 202

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 143 GAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXX--LATLKHPNIVRF 198
           GA+G +Y  R  ++G  VA+K +  P                      L   +HPN+VR 
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79
Query: 199 IGACR-----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
           +  C      + +   +V E+     +R +L K     +P +          RG+ ++H 
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 138
Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK +N+L+ S  ++K+ADFG+ARI      +TP   T  + AP
Sbjct: 139 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 71  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 185
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 186 YYRKGGKGLLP----VRWMSP 202

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRG----TYNGE---EVAIKILERPENDPEKAXXXX 177
           DEW +   K+ +     QG+FG +Y G       GE    VA+K +    +  E+     
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------NR 230
                      T  H  +VR +G   K     +V E    G ++ +L   +        R
Sbjct: 70  EASVMKGF---TCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 231 SVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT- 288
             P L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T 
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA 184
Query: 289 ------EGMTPETGTYRWMAP 303
                 +G+ P     RWMAP
Sbjct: 185 YYRKGGKGLLP----VRWMAP 201

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 23/193 (11%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      GE VA+K L+    +         
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLR 56
Query: 179 XXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R   +
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM--- 291
           KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +     
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 292 -TPETGTYRWMAP 303
             P      W AP
Sbjct: 174 KEPGESPIFWYAP 186

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 78  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 132
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 193 YYRKGGKGLLP----VRWMSP 209

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 143 GAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GAFGK+Y+      G   A K++E       K+             LAT  HP IV+ +G
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIET------KSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           A        I+ E+  GG+V   + +  R      +++  +Q L+    + ++H   +IH
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE---ALNFLHSKRIIH 140
Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           RDLK+ N+L+  +  I++ADFGV+   ++T +      GT  WMAP
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 143 GAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GAFGK+Y+      G   A K++E       K+             LAT  HP IV+ +G
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVIET------KSEEELEDYIVEIEILATCDHPYIVKLLG 75
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           A        I+ E+  GG+V   + +  R      +++  +Q L+    + ++H   +IH
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE---ALNFLHSKRIIH 132
Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           RDLK+ N+L+  +  I++ADFGV+   ++T +      GT  WMAP
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 178

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 23/198 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKA 173
             E+ D    + R L       +G FG +    Y+      GE VA+K L+    +    
Sbjct: 1   AFEDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---- 56
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
                        L +L+H NIV++ G C    R+ +   ++ E+   GS+R++L K + 
Sbjct: 57  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEFLPYGSLREYLQKHKE 112
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           R   +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +
Sbjct: 113 RIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 290 GMT----PETGTYRWMAP 303
                  P      W AP
Sbjct: 172 EXXKVKEPGESPIFWYAP 189

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 132 RKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLAT 189
           +K    +   QGA G +Y       G+EVAI+ +   +  P+K                 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIINEILVMREN---- 74
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
            K+PNIV ++ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 75  -KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALE 130
Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHRD+KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 16/196 (8%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--GEE---VAIKILERPENDPE 171
           P + +  F +  ID   + +      G FG++  G     G+    VAIK L+    D +
Sbjct: 15  PNQAVREFAK-EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 73
Query: 172 KAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
           +              +    HPNI+   G   K     I+TEY + GS+  FL K   R 
Sbjct: 74  R-----RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF 128
Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEG 290
             ++L V     +  GM Y+  +  +HRDL + N+L+ S+   K++DFG++R+ E   E 
Sbjct: 129 TVIQL-VGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 187
Query: 291 MTPETG---TYRWMAP 303
                G     RW AP
Sbjct: 188 AYTTRGGKIPIRWTAP 203

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 23/193 (11%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      GE VA+K L+    +         
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLR 56
Query: 179 XXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R   +
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT-- 292
           KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +     
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 293 --PETGTYRWMAP 303
             P      W AP
Sbjct: 174 KEPGESPIFWYAP 186

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 132 RKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLAT 189
           +K    +   QGA G +Y       G+EVAI+ +   +  P+K                 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIINEILVMREN---- 74
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
            K+PNIV ++ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 75  -KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALE 130
Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHRD+KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAP 185

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 62
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 173

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 23/186 (12%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           R L       +G FG +    Y+      GE VA+K L+    +                
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLRDFEREIE 81
Query: 186 XLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
            L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R   +KL ++  
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHIKL-LQYT 138
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT----PETGT 297
             + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +       P    
Sbjct: 139 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 298 YRWMAP 303
             W AP
Sbjct: 199 IFWYAP 204

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 12/186 (6%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXX 182
           NFDE  I +     G+   +G FG +Y+G  N   VA+K L    +   +          
Sbjct: 26  NFDERPISVG----GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE--ELKQQFDQ 79
Query: 183 XXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK--LAVKQ 240
               +A  +H N+V  +G        C+V  Y   GS+   L+   + + PL   +  K 
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKI 138
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE---VQTEGMTPETGT 297
           A   A G+ ++H    IHRD+KS N+L+    + KI+DFG+AR      QT   +   GT
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGT 198
Query: 298 YRWMAP 303
             +MAP
Sbjct: 199 TAYMAP 204

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 34/206 (16%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXXX 178
           +W     +L+ G     GAFGK+   T  G         VA+K+L+     P        
Sbjct: 17  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTERE 71
Query: 179 XXXXXXXXLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   L+ L  H NIV  +GAC       ++TEY   G +  FL ++++  +  K +
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 238 ----------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
                           +  +  VA+GMA++     IHRDL + N+L+   +  KI DFG+
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 282 ARIEVQTEGMTPETGTYR----WMAP 303
           AR +++ +      G  R    WMAP
Sbjct: 192 AR-DIKNDSNYVVKGNARLPVKWMAP 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 23/193 (11%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      GE VA+K L+    +         
Sbjct: 2   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLR 55
Query: 179 XXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R   +
Sbjct: 56  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHI 113
Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT-- 292
           KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +     
Sbjct: 114 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 293 --PETGTYRWMAP 303
             P      W AP
Sbjct: 173 KEPGESPIFWYAP 185

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 132 RKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLAT 189
           +K    +   QGA G +Y       G+EVAI+ +   +  P+K                 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIINEILVMREN---- 74
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
            K+PNIV ++ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 75  -KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALE 130
Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHRD+KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 185

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 23/193 (11%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      GE VA+K L+    +         
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLR 56
Query: 179 XXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R   +
Sbjct: 57  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHI 114
Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT-- 292
           KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +     
Sbjct: 115 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 293 --PETGTYRWMAP 303
             P      W AP
Sbjct: 174 KEPGESPIFWYAP 186

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 132 RKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLAT 189
           +K    +   QGA G +Y       G+EVAI+ +   +  P+K                 
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIINEILVMREN---- 75
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
            K+PNIV ++ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 76  -KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALE 131
Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHRD+KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 132 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 186

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 23/186 (12%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           R L       +G FG +    Y+      GE VA+K L+    +                
Sbjct: 28  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLRDFEREIE 81
Query: 186 XLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
            L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R   +KL ++  
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHIKL-LQYT 138
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT----PETGT 297
             + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +       P    
Sbjct: 139 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 298 YRWMAP 303
             W AP
Sbjct: 199 IFWYAP 204

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 24/191 (12%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKA 173
           E +ENF +           +   +G +G +Y  R    GE VA+K +      E  P  A
Sbjct: 7   EFMENFQK----------VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA 56
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP 233
                        L  L HPNIV+ +          +V E+     +++F+       +P
Sbjct: 57  IREISL-------LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIP 108
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMT 292
           L L       + +G+A+ H   ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T
Sbjct: 109 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 168
Query: 293 PETGTYRWMAP 303
            E  T  + AP
Sbjct: 169 HEVVTLWYRAP 179

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 60
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 24/191 (12%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKA 173
           E +ENF +           +   +G +G +Y  R    GE VA+K +      E  P  A
Sbjct: 7   EFMENFQK----------VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA 56
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP 233
                        L  L HPNIV+ +          +V E+     +++F+       +P
Sbjct: 57  IREISL-------LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIP 108
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMT 292
           L L       + +G+A+ H   ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T
Sbjct: 109 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 168
Query: 293 PETGTYRWMAP 303
            E  T  + AP
Sbjct: 169 HEVVTLWYRAP 179

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 60
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 23/193 (11%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      GE VA+K L+    +         
Sbjct: 1   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLR 54
Query: 179 XXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R   +
Sbjct: 55  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHI 112
Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT-- 292
           KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +     
Sbjct: 113 KL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 171
Query: 293 --PETGTYRWMAP 303
             P      W AP
Sbjct: 172 KEPGESPIFWYAP 184

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 10/170 (5%)
Query: 142 QGAFGKLYRG---TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
           +GA+GK+++       G  VA+K + R +   E               L T +HPN+VR 
Sbjct: 21  EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 79
Query: 199 IGACR-----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
              C      +     +V E+     +  +L K     VP +        + RG+ ++H 
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK  N+L+ S   IK+ADFG+ARI      +T    T  + AP
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 15/184 (8%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYN--GEE---VAIKILERPENDPEKAXXXXXXXXXX 183
           ID   + +      G FG++  G     G+    VAIK L+    D ++           
Sbjct: 11  IDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-----RDFLSE 65
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +    HPNI+   G   K     I+TEY + GS+  FL K   R   ++L V     
Sbjct: 66  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-VGMLRG 124
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG---TYR 299
           +  GM Y+  +  +HRDL + N+L+ S+   K++DFG++R+ E   E      G     R
Sbjct: 125 IGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 184
Query: 300 WMAP 303
           W AP
Sbjct: 185 WTAP 188

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 34/206 (16%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXXX 178
           +W     +L+ G     GAFGK+   T  G         VA+K+L+     P        
Sbjct: 33  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTERE 87
Query: 179 XXXXXXXXLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   L+ L  H NIV  +GAC       ++TEY   G +  FL ++++  +  K +
Sbjct: 88  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 147
Query: 238 ----------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
                           +  +  VA+GMA++     IHRDL + N+L+   +  KI DFG+
Sbjct: 148 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 207
Query: 282 ARIEVQTEGMTPETGTYR----WMAP 303
           AR +++ +      G  R    WMAP
Sbjct: 208 AR-DIKNDSNYVVKGNARLPVKWMAP 232

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRG----TYNGE---EVAIKILERPENDPEKAXXXX 177
           DEW +   K+ +     QG+FG +Y G       GE    VA+K +    +  E+     
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 70
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------NR 230
                      T  H  +VR +G   K     +V E    G ++ +L   +        R
Sbjct: 71  EASVMKGF---TCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 125
Query: 231 SVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
             P L+  ++ A ++A GMAY++    +HR+L + N ++  D ++KI DFG+ R   +T+
Sbjct: 126 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 185
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWMAP
Sbjct: 186 YYRKGGKGLLP----VRWMAP 202

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 15/184 (8%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYN--GEE---VAIKILERPENDPEKAXXXXXXXXXX 183
           ID   + +      G FG++  G     G+    VAIK L+    D ++           
Sbjct: 5   IDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-----RDFLSE 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +    HPNI+   G   K     I+TEY + GS+  FL K   R   ++L V     
Sbjct: 60  ASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-VGMLRG 118
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPETG---TYR 299
           +  GM Y+  +  +HRDL + N+L+ S+   K++DFG++R+ E   E      G     R
Sbjct: 119 IGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 178
Query: 300 WMAP 303
           W AP
Sbjct: 179 WTAP 182

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ID ++LN      +   G+L++G + G ++ +K+L+  +    K+             L 
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPR----LR 62
Query: 189 TLKHPNIVRFIGACRKPMVW--CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
              HPN++  +GAC+ P      ++T +   GS+   L +  N  V    AVK ALD+AR
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 247 GMAYVHRL-GLIHRD-LKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           GMA++H L  LI R  L S +++I  D + +I+   V +   Q+ G         W+AP
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV-KFSFQSPG---RMYAPAWVAP 177

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRG----TYNGE---EVAIKILERPENDPEKAXXXX 177
           DEW +   K+ +     QG+FG +Y G       GE    VA+K +    +  E+     
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN 69
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------NR 230
                      T  H  +VR +G   K     +V E    G ++ +L   +        R
Sbjct: 70  EASVMKGF---TCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 231 SVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
             P L+  ++ A ++A GMAY++    +HR+L + N ++  D ++KI DFG+ R   +T+
Sbjct: 125 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWMAP
Sbjct: 185 YYRKGGKGLLP----VRWMAP 201

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 10/170 (5%)
Query: 142 QGAFGKLYRG---TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
           +GA+GK+++       G  VA+K + R +   E               L T +HPN+VR 
Sbjct: 21  EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 79
Query: 199 IGACR-----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
              C      +     +V E+     +  +L K     VP +        + RG+ ++H 
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK  N+L+ S   IK+ADFG+ARI      +T    T  + AP
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL----TKRQNRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L     + +N  V 
Sbjct: 65  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N  +  D ++KI DFG+ R   +T+
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD 179
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 180 YYRKGGKGLLP----VRWMSP 196

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 34/206 (16%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXXX 178
           +W     +L+ G     GAFGK+   T  G         VA+K+L+     P        
Sbjct: 35  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTERE 89
Query: 179 XXXXXXXXLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   L+ L  H NIV  +GAC       ++TEY   G +  FL ++++  +  K +
Sbjct: 90  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 149
Query: 238 ----------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
                           +  +  VA+GMA++     IHRDL + N+L+   +  KI DFG+
Sbjct: 150 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 209
Query: 282 ARIEVQTEGMTPETGTYR----WMAP 303
           AR +++ +      G  R    WMAP
Sbjct: 210 AR-DIKNDSNYVVKGNARLPVKWMAP 234

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPEND 169
           PT+   N ++W      L  G     GAFGK+   T  G        +VA+K+L+   + 
Sbjct: 32  PTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ- 228
            EK                  +H NIV  +GAC       ++TEY   G +  FL ++  
Sbjct: 91  DEKEALMSELKIMSHLG----QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 229 -----------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
                      N ++  +  +  +  VA+GMA++     IHRD+ + N+L+ +    KI 
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 278 DFGVARIEVQTEGMTPETGTYR----WMAP 303
           DFG+AR ++  +      G  R    WMAP
Sbjct: 207 DFGLAR-DIMNDSNYIVKGNARLPVKWMAP 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 12/186 (6%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXX 182
           NFDE  I +     G+   +G FG +Y+G  N   VA+K L    +   +          
Sbjct: 26  NFDERPISVG----GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE--ELKQQFDQ 79
Query: 183 XXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK--LAVKQ 240
               +A  +H N+V  +G        C+V  Y   GS+   L+   + + PL   +  K 
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKI 138
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE---VQTEGMTPETGT 297
           A   A G+ ++H    IHRD+KS N+L+    + KI+DFG+AR      QT       GT
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGT 198
Query: 298 YRWMAP 303
             +MAP
Sbjct: 199 TAYMAP 204

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 10/170 (5%)
Query: 142 QGAFGKLYRG---TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
           +GA+GK+++       G  VA+K + R +   E               L T +HPN+VR 
Sbjct: 21  EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 79
Query: 199 IGACR-----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
              C      +     +V E+     +  +L K     VP +        + RG+ ++H 
Sbjct: 80  FDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK  N+L+ S   IK+ADFG+ARI      +T    T  + AP
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/129 (37%), Positives = 65/129 (50%), Gaps = 22/129 (17%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----------NRSVPLKLAVKQA 241
           HPNI+  +GAC       +  EYA  G++  FL K +            S    L+ +Q 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 242 L----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEV---QTEGMTP 293
           L    DVARGM Y+ +   IHRDL + N+L+  +   KIADFG++R  EV   +T G  P
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 294 ETGTYRWMA 302
                RWMA
Sbjct: 205 ----VRWMA 209

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 17/181 (9%)
Query: 131 LRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL- 187
           +    +G+   +G+F  +YR    + G EVAIK++++      KA             + 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDK------KAMYKAGMVQRVQNEVK 63
Query: 188 --ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL--D 243
               LKHP+I+             +V E    G + ++L   +NR  P      +     
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQ 120
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMA 302
           +  GM Y+H  G++HRDL   NLL+  + +IKIADFG+A ++++  E      GT  +++
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
Query: 303 P 303
           P
Sbjct: 181 P 181

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/129 (37%), Positives = 65/129 (50%), Gaps = 22/129 (17%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----------NRSVPLKLAVKQA 241
           HPNI+  +GAC       +  EYA  G++  FL K +            S    L+ +Q 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 242 L----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEV---QTEGMTP 293
           L    DVARGM Y+ +   IHRDL + N+L+  +   KIADFG++R  EV   +T G  P
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 294 ETGTYRWMA 302
                RWMA
Sbjct: 195 ----VRWMA 199

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 16/152 (10%)
Query: 140 FAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
             +G FGK+    Y+      GE VA+K L + +  P+               L TL H 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQH----RSGWKQEIDILRTLYHE 93
Query: 194 NIVRFIGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           +I+++ G C         +V EY   GS+R +L +       L L  +Q   +  GMAY+
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ---ICEGMAYL 150
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           H    IHRDL + N+L+ +D+ +KI DFG+A+
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 34/206 (16%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXXX 178
           +W     +L+ G     GAFGK+   T  G         VA+K+L+     P        
Sbjct: 40  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTERE 94
Query: 179 XXXXXXXXLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   L+ L  H NIV  +GAC       ++TEY   G +  FL ++++  +  K +
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 238 ----------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
                           +  +  VA+GMA++     IHRDL + N+L+   +  KI DFG+
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 214
Query: 282 ARIEVQTEGMTPETGTYR----WMAP 303
           AR +++ +      G  R    WMAP
Sbjct: 215 AR-DIKNDSNYVVKGNARLPVKWMAP 239

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 23/172 (13%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPE 171
           P   +ENF +           +   +G +G +Y  R    GE VA+K +      E  P 
Sbjct: 1   PLGSMENFQK----------VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS 50
Query: 172 KAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
            A             L  L HPNIV+ +          +V E+     +++F+       
Sbjct: 51  TAIREISL-------LKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTG 102
Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +PL L       + +G+A+ H   ++HRDLK +NLLI ++ +IK+ADFG+AR
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVA---IKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA   I++    E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVA---IKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA   I++    E  P  A             L  L H
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISL-------LKELNH 60
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 62
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK +NLLI ++ +IK+ADFG+AR
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----NRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L   +    N  V 
Sbjct: 68  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 182
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 183 YYRKGGKGLLP----VRWMSP 199

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 62
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK +NLLI ++ +IK+ADFG+AR
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 8/168 (4%)
Query: 138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNI 195
           +   +G+FGK+   T+    ++VA+K + R      K              L  L+HP+I
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISR---QLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           ++       P    +V EYA GG +  ++ +++  +        Q +  A  + Y HR  
Sbjct: 72  IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHRHK 128
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +NLL+  + ++KIADFG++ I      +    G+  + AP
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK +NLLI ++ +IK+ADFG+AR
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNG-----EEVAIKILERPENDPEKAXXXXXXXXXX 183
           ID+  + + +    G FG++ RG           VAIK L+    + ++           
Sbjct: 11  IDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-----REFLSE 65
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +   +HPNI+R  G     M   I+TE+ + G++  FL     +   ++L V     
Sbjct: 66  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-VGMLRG 124
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTY----- 298
           +A GM Y+  +  +HRDL + N+L+ S+   K++DFG++R   +       T +      
Sbjct: 125 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP 184
Query: 299 -RWMAP 303
            RW AP
Sbjct: 185 IRWTAP 190

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 77/172 (44%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 60
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     ++ F+       +PL L       + +G+A+ H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXX 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----NRSV- 232
                    +      ++VR +G   +     ++ E    G ++ +L   +    N  V 
Sbjct: 78  EASV-----MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 233 -PLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            P  L+  ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 290 -------GMTPETGTYRWMAP 303
                  G+ P     RWM+P
Sbjct: 193 YYRKGGKGLLP----VRWMSP 209

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FG+  L +    G+E A+K++ + +    K              L  L HPNI+
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQV---KQKTDKESLLREVQLLKQLDHPNIM 113
Query: 197 RFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           +          + +V E   GG +  + +++++   V     ++Q L    G+ Y+H+  
Sbjct: 114 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GITYMHKNK 170
Query: 256 LIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +NLL+ S   D +I+I DFG++     ++ M  + GT  ++AP
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 221

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 63/121 (52%), Gaps = 5/121 (4%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +    HPN+V   G   +     IV E+ + G++  FL K   +   ++L V     +A 
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL-VGMLRGIAA 156
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETG---TYRWMA 302
           GM Y+  +G +HRDL + N+L+ S+   K++DFG++R IE   E +   TG     RW A
Sbjct: 157 GMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTA 216
Query: 303 P 303
           P
Sbjct: 217 P 217

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 142 QGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
            G FGK+Y+G   +G +VA+K        PE +             L+  +HP++V  IG
Sbjct: 49  HGVFGKVYKGVLRDGAKVALK-----RRTPESSQGIEEFETEIET-LSFCRHPHLVSLIG 102
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
            C +     ++ +Y + G++++ L  +     S+  +  ++  +  ARG+ Y+H   +IH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR 283
           RD+KS N+L+  +   KI DFG+++
Sbjct: 163 RDVKSINILLDENFVPKITDFGISK 187

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 13/179 (7%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           ID + L        G FG +  G + G+ +VAIK+++       +              +
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L H  +V+  G C K     I+TEY   G +  +L + ++R    +L ++   DV   
Sbjct: 54  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEA 112
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YRWMAP 303
           M Y+     +HRDL + N L+     +K++DFG++R  +  E  T   G+    RW  P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 170

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FG+  L +    G+E A+K++ + +    K              L  L HPNI+
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQV---KQKTDKESLLREVQLLKQLDHPNIM 112
Query: 197 RFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           +          + +V E   GG +  + +++++   V     ++Q L    G+ Y+H+  
Sbjct: 113 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GITYMHKNK 169
Query: 256 LIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +NLL+ S   D +I+I DFG++     ++ M  + GT  ++AP
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 14/172 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+++ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
              ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T  + AP
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 29/210 (13%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPEND 169
           PT+   N ++W      L  G     GAFGK+   T  G        +VA+K+L+   + 
Sbjct: 32  PTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ- 228
            EK                  +H NIV  +GAC       ++TEY   G +  FL ++  
Sbjct: 91  DEKEALMSELKIMSHLG----QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 229 -----------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
                      N +   +  +  +  VA+GMA++     IHRD+ + N+L+ +    KI 
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 278 DFGVARIEVQTEGMTPETGTYR----WMAP 303
           DFG+AR ++  +      G  R    WMAP
Sbjct: 207 DFGLAR-DIMNDSNYIVKGNARLPVKWMAP 235

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILER 165
           M   +P + L    + T +LRK+ +      GAFG +Y+G +  +GE     VAIK+L  
Sbjct: 1   MSGAAPNQALLRILKET-ELRKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR- 55
Query: 166 PENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLT 225
            EN   KA             +A +  P + R +G C    V  +VT+    G +   + 
Sbjct: 56  -ENTSPKANKEILDEAYV---MAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVR 110
Query: 226 KRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           + + R     L +   + +A+GM+Y+  + L+HRDL + N+L+ S   +KI DFG+AR+
Sbjct: 111 ENRGRLGSQDL-LNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARL 168

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 142 QGAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
            G FGK+Y+G   +G +VA+K        PE +             L+  +HP++V  IG
Sbjct: 49  HGVFGKVYKGVLRDGAKVALK-----RRTPESSQGIEEFETEIET-LSFCRHPHLVSLIG 102
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
            C +     ++ +Y + G++++ L  +     S+  +  ++  +  ARG+ Y+H   +IH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR 283
           RD+KS N+L+  +   KI DFG+++
Sbjct: 163 RDVKSINILLDENFVPKITDFGISK 187

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FG+  L +    G+E A+K++ + +    K              L  L HPNI+
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQV---KQKTDKESLLREVQLLKQLDHPNIM 89
Query: 197 RFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           +          + +V E   GG +  + +++++   V     ++Q L    G+ Y+H+  
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GITYMHKNK 146
Query: 256 LIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +NLL+ S   D +I+I DFG++     ++ M  + GT  ++AP
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 31/177 (17%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKIL--------ERPENDPEKAXXXXXXXXXXXXXLATLK 191
           +G+FGK  L + T +G +  IK +        ER E+  E A             LA +K
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAV------------LANMK 81
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD----VARG 247
           HPNIV++  +  +     IV +Y +GG     L KR N    +     Q LD    +   
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGD----LFKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           + +VH   ++HRD+KS N+ +  D ++++ DFG+AR+   T E      GT  +++P
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 34/206 (16%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXXX 178
           +W     +L+ G     GAFGK+   T  G         VA+K+L+     P        
Sbjct: 40  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTERE 94
Query: 179 XXXXXXXXLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                   L+ L  H NIV  +GAC       ++TEY   G +  FL ++++  +  K +
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 238 ----------------VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
                           +  +  VA+GMA++     IHRDL + N+L+   +  KI DFG+
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 214
Query: 282 ARIEVQTEGMTPETGTYR----WMAP 303
           AR  ++ +      G  R    WMAP
Sbjct: 215 AR-HIKNDSNYVVKGNARLPVKWMAP 239

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKA 173
             E+ D    + R L       +G FG +    Y+      GE VA+K L+    +    
Sbjct: 1   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---- 56
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
                        L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L     
Sbjct: 57  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQAHAE 112
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           R   +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++  Q +
Sbjct: 113 RIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 290 GMT----PETGTYRWMAP 303
                  P      W AP
Sbjct: 172 EXXKVKEPGESPIFWYAP 189

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 23/172 (13%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPE 171
           P   +ENF +           +   +G +G +Y  R    GE VA+K +      E  P 
Sbjct: 2   PLGSMENFQK----------VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS 51
Query: 172 KAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
            A             L  L HPNIV+ +          +V E+     +++F+       
Sbjct: 52  TAIREISL-------LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 103
Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +PL L       + +G+A+ H   ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 104 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GA+G+  L R      E AIKI+ +       +             L  L HPNI++   
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSV----STSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 201 ACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
                  + +V E  KGG +  + + + +   V   + +KQ L    G+ Y+H+  ++HR
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHKHNIVHR 160
Query: 260 DLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK +NLL+ S   D  IKI DFG++ +    + M    GT  ++AP
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 23/172 (13%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPE 171
           P   +ENF +           +   +G +G +Y  R    GE VA+K +      E  P 
Sbjct: 1   PLGSMENFQK----------VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS 50
Query: 172 KAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
            A             L  L HPNIV+ +          +V E+     +++F+       
Sbjct: 51  TAIREISL-------LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG 102
Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +PL L       + +G+A+ H   ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 82/185 (44%), Gaps = 27/185 (14%)
Query: 140 FAQGAFGKLYRG-TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
             +GAFGK++    YN      KIL   +   + +             L  L+H +IV+F
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 199 IGACRK--PMVWCIVTEYAKGGSVRQFLTKRQNRSV-------PLKLAVKQALDVAR--- 246
            G C +  P++  +V EY K G + +FL      +V       P +L   Q L +A+   
Sbjct: 81  YGVCVEGDPLI--MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 247 -GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-------GMTPETGTY 298
            GM Y+     +HRDL + N L+  +  +KI DFG++R    T+        M P     
Sbjct: 139 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP----I 194
Query: 299 RWMAP 303
           RWM P
Sbjct: 195 RWMPP 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 62
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 62
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 31  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 85
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 86  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 141
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 142 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK 201
Query: 300 WMA 302
           WMA
Sbjct: 202 WMA 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     ++ F+       +PL L       + +G+A+ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK +NLLI ++ +IK+ADFG+AR
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 86/193 (44%), Gaps = 23/193 (11%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      GE VA+K L+    +         
Sbjct: 4   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------HLR 57
Query: 179 XXXXXXXXLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                   L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R   +
Sbjct: 58  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERIDHI 115
Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM--- 291
           KL ++    + +GM Y+     IHR+L + N+L+ ++  +KI DFG+ ++  Q +     
Sbjct: 116 KL-LQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 174
Query: 292 -TPETGTYRWMAP 303
             P      W AP
Sbjct: 175 KEPGESPIFWYAP 187

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 60
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 12/175 (6%)
Query: 132 RKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLAT 189
           +K    +   QGA G +Y       G+EVAI+ +   +  P+K                 
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIINEILVMREN---- 75
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
            K+PNIV ++ +        +V EY  GGS+   +T+       +    ++ L   + + 
Sbjct: 76  -KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALE 131
Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           ++H   +IHR++KSDN+L+  D S+K+ DFG  A+I  +    +   GT  WMAP
Sbjct: 132 FLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 61
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 91/183 (49%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 33  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 87
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 88  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 143
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGT---YR 299
           A+GM ++     +HRDL + N ++    ++K+ADFG+AR  ++ + + +  +TG     +
Sbjct: 144 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK 203
Query: 300 WMA 302
           WMA
Sbjct: 204 WMA 206

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 60
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     +++F+       +PL L       + +G+A+ H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 50  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 104
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 105 DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 160
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 161 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 220
Query: 300 WMA 302
           WMA
Sbjct: 221 WMA 223

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKL-------NMGDAFAQGAFGKLYRGTY--NGEEVAIKI 162
           M S+SP   L+      IDL  L        + +    G +G++Y+G +   G+  AIK+
Sbjct: 2   MASDSPARSLDE-----IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV 56
Query: 163 LERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKP-------MVWCIVTEYA 215
           ++   ++ E+                   H NI  + GA  K         +W +V E+ 
Sbjct: 57  MDVTGDEEEEIKQEINMLKKYSH------HRNIATYYGAFIKKNPPGMDDQLW-LVMEFC 109
Query: 216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK 275
             GSV   +   +  ++  +       ++ RG++++H+  +IHRD+K  N+L+  +  +K
Sbjct: 110 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169
Query: 276 IADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           + DFGV A+++          GT  WMAP
Sbjct: 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 23/172 (13%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPE 171
           P   +ENF +           +   +G +G +Y  R    GE VA+K +      E  P 
Sbjct: 1   PLGSMENFQK----------VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS 50
Query: 172 KAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
            A             L  L HPNIV+ +          +V E+     ++ F+       
Sbjct: 51  TAIREISL-------LKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTG 102
Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +PL L       + +G+A+ H   ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 103 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 30  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 84
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 85  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 140
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 141 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 200
Query: 300 WMA 302
           WMA
Sbjct: 201 WMA 203

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 86
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 87  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 142
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 143 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 300 WMA 302
           WMA
Sbjct: 203 WMA 205

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 11/176 (6%)
Query: 133 KLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATL 190
           + N+     +G+FG++ +       +E A+K++    N                  L  L
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI----NKASAKNKDTSTILREVELLKKL 78
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
            HPNI++          + IV E   GG +   + KR+  S     A +    V  G+ Y
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITY 136
Query: 251 VHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +H+  ++HRDLK +N+L+ S   D  IKI DFG++    Q   M    GT  ++AP
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     ++ F+       +PL L       + +G+A+ H
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 7/155 (4%)
Query: 131 LRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           L+   +      G+FG+  L R  +NG   A+K+L++   +                 L+
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK---EIVVRLKQVEHTNDERLMLS 61
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
            + HP I+R  G  +      ++ +Y +GG +   L  R+++  P  +A   A +V   +
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLAL 119
Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            Y+H   +I+RDLK +N+L+  +  IKI DFG A+
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 86
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 87  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 142
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 143 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 300 WMA 302
           WMA
Sbjct: 203 WMA 205

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 31  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 85
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 86  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 141
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 142 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 201
Query: 300 WMA 302
           WMA
Sbjct: 202 WMA 204

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 65/145 (44%), Gaps = 8/145 (5%)
Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G++G ++  R    G+ VAIK     E+DP                L  LKHPN+V  +
Sbjct: 13  EGSYGVVFKCRNRDTGQIVAIKKFLESEDDP----VIKKIALREIRMLKQLKHPNLVNLL 68
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
              R+     +V EY     + +    R  R VP  L         + + + H+   IHR
Sbjct: 69  EVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 260 DLKSDNLLIFSDKSIKIADFGVARI 284
           D+K +N+LI     IK+ DFG AR+
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARL 151

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 27  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 81
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 82  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 137
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 300 WMA 302
           WMA
Sbjct: 198 WMA 200

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 30/180 (16%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G FG++++  +  +G+   IK   R + + EKA             LA L H NIV + G
Sbjct: 22  GGFGQVFKAKHRIDGKTYVIK---RVKYNNEKAEREVKA-------LAKLDHVNIVHYNG 71
Query: 201 AC----------------RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
                              K     I  E+   G++ Q++ KR+   +   LA++    +
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET-GTYRWMAP 303
            +G+ Y+H   LI+RDLK  N+ +   K +KI DFG+    ++ +G    + GT R+M+P
Sbjct: 132 TKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRXRSKGTLRYMSP 190

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 51  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 105
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 106 DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 161
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 162 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 221
Query: 300 WMA 302
           WMA
Sbjct: 222 WMA 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 139 AFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
              +G +G +Y G     +V I I E PE D   +                LKH NIV++
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH----LKHKNIVQY 84
Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVKQALDVARGMAYVHRL 254
           +G+  +     I  E   GGS+   L  +    ++    +    KQ L+   G+ Y+H  
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE---GLKYLHDN 141
Query: 255 GLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPE----TGTYRWMAP 303
            ++HRD+K DN+LI +   + KI+DFG ++   +  G+ P     TGT ++MAP
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAP 192

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 13/151 (8%)
Query: 138 DAFAQGAFGKLY--RGTYNGEEVAIKILE---RPENDPEKAXXXXXXXXXXXXXLATLKH 192
           +   +G +G +Y  R    GE VA+K +      E  P  A             L  L H
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL-------LKELNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           PNIV+ +          +V E+     ++ F+       +PL L       + +G+A+ H
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
              ++HRDLK  NLLI ++ +IK+ADFG+AR
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 29  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 83
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 84  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 139
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 140 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 199
Query: 300 WMA 302
           WMA
Sbjct: 200 WMA 202

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 18/198 (9%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEE---VAIKILERPENDPE 171
           P E +  F +  ID+  + +      G FG++  G     G+    VAIK L+    + +
Sbjct: 19  PNEAVREFAK-EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 77
Query: 172 KAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
           +              +    HPN++   G   K     I+TE+ + GS+  FL +   + 
Sbjct: 78  R-----RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 132
Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEG 290
             ++L V     +A GM Y+  +  +HRDL + N+L+ S+   K++DFG++R +E  T  
Sbjct: 133 TVIQL-VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 191
Query: 291 MTPETG-----TYRWMAP 303
            T  +        RW AP
Sbjct: 192 PTYTSALGGKIPIRWTAP 209

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 140 FAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
             +G FGK+    Y+      GE VA+K L + +  P+               L TL H 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADCGPQH----RSGWKQEIDILRTLYHE 76
Query: 194 NIVRFIGACR----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
           +I+++ G C     K +   +V EY   GS+R +L +    S+ L   +  A  +  GMA
Sbjct: 77  HIIKYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMA 131
Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Y+H    IHR+L + N+L+ +D+ +KI DFG+A+
Sbjct: 132 YLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 94/188 (50%), Gaps = 29/188 (15%)
Query: 134 LNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           L + +  A+G FG +++     E VA+KI   P  D +               L  +KH 
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLNEYVAVKIF--PIQDKQS-----WQNEYEVYSLPGMKHE 78
Query: 194 NIVRFIGACRKPM-----VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
           NI++FIGA ++       +W ++T + + GS+  FL   +   V        A  +ARG+
Sbjct: 79  NILQFIGAEKRGTSVDVDLW-LITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGL 134
Query: 249 AYVH----------RLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEV-QTEGMTP-ET 295
           AY+H          +  + HRD+KS N+L+ ++ +  IADFG+A + E  ++ G T  + 
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 296 GTYRWMAP 303
           GT R+MAP
Sbjct: 195 GTRRYMAP 202

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 19/174 (10%)
Query: 139 AFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
              +G +G +Y G     +V I I E PE D   +                LKH NIV++
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKH----LKHKNIVQY 70
Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVKQALDVARGMAYVHRL 254
           +G+  +     I  E   GGS+   L  +    ++    +    KQ L+   G+ Y+H  
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE---GLKYLHDN 127
Query: 255 GLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPE----TGTYRWMAP 303
            ++HRD+K DN+LI +   + KI+DFG ++   +  G+ P     TGT ++MAP
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAP 178

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 90/219 (41%), Gaps = 38/219 (17%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPEND 169
           PT+ L   ++W      L  G     GAFGK+   T  G        +VA+K+L+   + 
Sbjct: 17  PTQ-LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 75
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EK                  +H NIV  +GAC       ++TEY   G +  FL ++  
Sbjct: 76  DEKEALMSELKIMSHLG----QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 131
Query: 230 RSVPLKLAVKQ---ALD------------------VARGMAYVHRLGLIHRDLKSDNLLI 268
             +   LA  Q    LD                  VA+GMA++     IHRD+ + N+L+
Sbjct: 132 AMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 191
Query: 269 FSDKSIKIADFGVARIEVQTEGMTPETGTYR----WMAP 303
            +    KI DFG+AR ++  +      G  R    WMAP
Sbjct: 192 TNGHVAKIGDFGLAR-DIMNDSNYIVKGNARLPVKWMAP 229

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 65/129 (50%), Gaps = 22/129 (17%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----------NRSVPLKLAVKQA 241
           HPNI+  +GAC       +  EYA  G++  FL K +            S    L+ +Q 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 242 L----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEV---QTEGMTP 293
           L    DVARGM Y+ +   IHR+L + N+L+  +   KIADFG++R  EV   +T G  P
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 294 ETGTYRWMA 302
                RWMA
Sbjct: 202 ----VRWMA 206

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 24  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 78
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 79  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 134
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-----YR 299
           A+GM Y+     +HRDL + N ++    ++K+ADFG+AR     E  +    T      +
Sbjct: 135 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 194
Query: 300 WMA 302
           WMA
Sbjct: 195 WMA 197

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 31/200 (15%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXXXXXX 181
           I L  +   +   +  FGK+Y+G   G       + VAIK L+     P +         
Sbjct: 23  ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 82
Query: 182 XXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS----VPLKLA 237
                 A L+HPN+V  +G   K     ++  Y   G + +FL  R   S          
Sbjct: 83  R-----ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 238 VKQALD----------VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ 287
           VK AL+          +A GM Y+    ++H+DL + N+L++   ++KI+D G+ R EV 
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-EVY 196
Query: 288 TEGMTPETG----TYRWMAP 303
                   G      RWMAP
Sbjct: 197 AADYYKLLGNSLLPIRWMAP 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 63/121 (52%), Gaps = 7/121 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVA 245
           L +L HPNI++          + +VTE+ +GG +  Q + + +         +KQ L   
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL--- 156
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMA 302
            G+ Y+H+  ++HRD+K +N+L+ +  S   IKI DFG++    +   +    GT  ++A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 303 P 303
           P
Sbjct: 217 P 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPEND 169
           PT+   N ++W      L  G     GAFGK+   T  G        +VA+K+L+   + 
Sbjct: 32  PTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EK                  +H NIV  +GAC       ++TEY   G +  FL +++ 
Sbjct: 91  DEKEALMSELKIMSHLG----QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRP 146
Query: 230 RSVPL----------KLAVKQAL----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK 275
             +            +L+ +  L     VA+GMA++     IHRD+ + N+L+ +    K
Sbjct: 147 PGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 206
Query: 276 IADFGVARIEVQTEGMTPETGTYR----WMAP 303
           I DFG+AR ++  +      G  R    WMAP
Sbjct: 207 IGDFGLAR-DIMNDSNYIVKGNARLPVKWMAP 237

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 31/200 (15%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAXXXXXXXX 181
           I L  +   +   +  FGK+Y+G   G       + VAIK L+     P +         
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 182 XXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS----VPLKLA 237
                 A L+HPN+V  +G   K     ++  Y   G + +FL  R   S          
Sbjct: 66  R-----ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 238 VKQALD----------VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ 287
           VK AL+          +A GM Y+    ++H+DL + N+L++   ++KI+D G+ R EV 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-EVY 179
Query: 288 TEGMTPETG----TYRWMAP 303
                   G      RWMAP
Sbjct: 180 AADYYKLLGNSLLPIRWMAP 199

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 140 FAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
             +G FGK+    Y+      GE VA+K L + +  P+               L TL H 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADCGPQH----RSGWKQEIDILRTLYHE 76
Query: 194 NIVRFIGACR----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
           +I+++ G C     K +   +V EY   GS+R +L +    S+ L   +  A  +  GMA
Sbjct: 77  HIIKYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMA 131
Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Y+H    IHR+L + N+L+ +D+ +KI DFG+A+
Sbjct: 132 YLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 113 DSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDP 170
           D   P+  L+      + L   N      +G+FGK+      G E   AIKIL++   D 
Sbjct: 5   DRKQPSNNLDR-----VKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKK---DV 56
Query: 171 EKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQN 229
                           LA L  P  +  + +C + +     V EY  GG +   + +   
Sbjct: 57  VIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK 116
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
              P   AV  A +++ G+ ++H+ G+I+RDLK DN+++ S+  IKIADFG+ + E   +
Sbjct: 117 FKEPQ--AVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMD 173
Query: 290 GMTPE--TGTYRWMAP 303
           G+T     GT  ++AP
Sbjct: 174 GVTTREFCGTPDYIAP 189

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 83/186 (44%), Gaps = 12/186 (6%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXX 182
           NFDE  I +     G+   +G FG +Y+G  N   VA+K L    +   +          
Sbjct: 20  NFDERPISVG----GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE--ELKQQFDQ 73
Query: 183 XXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK--LAVKQ 240
               +A  +H N+V  +G        C+V  Y   GS+   L+   + + PL   +  K 
Sbjct: 74  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKI 132
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE---VQTEGMTPETGT 297
           A   A G+ ++H    IHRD+KS N+L+    + KI+DFG+AR      Q        GT
Sbjct: 133 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGT 192
Query: 298 YRWMAP 303
             +MAP
Sbjct: 193 TAYMAP 198

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           I  E+   G++ Q++ KR+   +   LA++    + +G+ Y+H   LIHRDLK  N+ + 
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV 170
Query: 270 SDKSIKIADFGVARIEVQTEGM-TPETGTYRWMAP 303
             K +KI DFG+    ++ +G  T   GT R+M+P
Sbjct: 171 DTKQVKIGDFGLV-TSLKNDGKRTRSKGTLRYMSP 204

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 73/165 (44%), Gaps = 13/165 (7%)
Query: 143 GAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G FG  +L R   + E VA+K +ER E   E                 +L+HPNIVRF  
Sbjct: 29  GNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHR-------SLRHPNIVRFKE 81
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
               P    IV EYA GG + + +      S        Q L    G++Y H + + HRD
Sbjct: 82  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYCHAMQVCHRD 139
Query: 261 LKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           LK +N L+    +  +KI DFG ++  V         GT  ++AP
Sbjct: 140 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 184

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 26/197 (13%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRG-TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           I  R + +     +GAFGK++    YN      K+L   +   +               L
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR----------QNRSVPLKLA 237
             L+H +IV+F G C       +V EY K G + +FL             Q R    +L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 238 VKQAL----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE---- 289
           + Q L     +A GM Y+     +HRDL + N L+ ++  +KI DFG++R    T+    
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 290 ---GMTPETGTYRWMAP 303
               M P     RWM P
Sbjct: 192 GGHTMLP----IRWMPP 204

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 130 DLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           DLR++        G+FG +Y  R   N E VAIK +       +++             L
Sbjct: 58  DLREI------GHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 108
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQF-LTKRQNRSVPLKLAVKQALDVAR 246
             L+HPN +++ G   +     +V EY  G +     + K+  + V +      AL   +
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---Q 165
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAP 303
           G+AY+H   +IHRD+K+ N+L+     +K+ DFG A I      M P     GT  WMAP
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAP 219

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 68/126 (53%), Gaps = 17/126 (13%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQ 240
           L  +KH NIV        P    +V +   GG +      + F T++   ++     ++Q
Sbjct: 74  LRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL-----IRQ 128
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGT 297
            LD    + Y+HR+G++HRDLK +NLL +S   +  I I+DFG++++E + + M+   GT
Sbjct: 129 VLD---AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGT 185
Query: 298 YRWMAP 303
             ++AP
Sbjct: 186 PGYVAP 191

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 59/99 (59%), Gaps = 7/99 (7%)
Query: 207 VWCIVTEYAKGGSVRQFLT-KRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDN 265
           +W +V E+ +GG++   +T  R N     ++A    L V R ++Y+H  G+IHRD+KSD+
Sbjct: 117 LW-VVMEFLEGGALTDIVTHTRMNEE---QIATV-CLSVLRALSYLHNQGVIHRDIKSDS 171
Query: 266 LLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           +L+ SD  IK++DFG  A++  +        GT  WMAP
Sbjct: 172 ILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAP 210

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 73/165 (44%), Gaps = 13/165 (7%)
Query: 143 GAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G FG  +L R     E VA+K +ER E   E                 +L+HPNIVRF  
Sbjct: 30  GNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHR-------SLRHPNIVRFKE 82
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
               P    IV EYA GG + + +      S        Q L    G++Y H + + HRD
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYAHAMQVAHRD 140
Query: 261 LKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           LK +N L+    +  +KIADFG ++  V         GT  ++AP
Sbjct: 141 LKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAP 185

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 33  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 87
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 88  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 143
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGT---YR 299
           A+GM ++     +HRDL + N ++    ++K+ADFG+AR   + + + +  +TG     +
Sbjct: 144 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203
Query: 300 WMA 302
           WMA
Sbjct: 204 WMA 206

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 37  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 91
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 92  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 147
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGT---YR 299
           A+GM ++     +HRDL + N ++    ++K+ADFG+AR   + + + +  +TG     +
Sbjct: 148 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207
Query: 300 WMA 302
           WMA
Sbjct: 208 WMA 210

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 86
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 87  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 142
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGT---YR 299
           A+GM ++     +HRDL + N ++    ++K+ADFG+AR   + + + +  +TG     +
Sbjct: 143 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 300 WMA 302
           WMA
Sbjct: 203 WMA 205

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 92  VNRRGRVSHALSDDALARALMDS-NSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYR 150
           + R+  +   L +  L   L  S  +P + L    + T + +K+ +      GAFG +Y+
Sbjct: 12  IVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKET-EFKKIKV---LGSGAFGTVYK 67
Query: 151 GTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPM 206
           G +   GE+V I   I+E  E    KA             +A++ +P++ R +G C    
Sbjct: 68  GLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYV---MASVDNPHVCRLLGICLTST 124
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
           V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+    L+HRDL + N+
Sbjct: 125 VQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 182
Query: 267 LIFSDKSIKIADFGVARI 284
           L+ + + +KI DFG+A++
Sbjct: 183 LVKTPQHVKITDFGLAKL 200

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FG+  L +    G+E A+K++ + +    K              L  L HPNI+
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQV---KQKTDKESLLREVQLLKQLDHPNIM 95
Query: 197 RFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           +          + +V E   GG +  + +++++   V     ++Q L    G+ Y+H+  
Sbjct: 96  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GITYMHKNK 152
Query: 256 LIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +NLL+ S   D +I+I DFG++     ++ M  + GT  ++AP
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 203

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 30  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 84
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 85  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 140
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGT---YR 299
           A+GM ++     +HRDL + N ++    ++K+ADFG+AR   + + + +  +TG     +
Sbjct: 141 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 200
Query: 300 WMA 302
           WMA
Sbjct: 201 WMA 203

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 130 DLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           DLR++        G+FG +Y  R   N E VAIK +       +++             L
Sbjct: 19  DLREI------GHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSNEKWQDIIKEVRFL 69
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQF-LTKRQNRSVPLKLAVKQALDVAR 246
             L+HPN +++ G   +     +V EY  G +     + K+  + V +      AL   +
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---Q 126
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAP 303
           G+AY+H   +IHRD+K+ N+L+     +K+ DFG A I      M P     GT  WMAP
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAP 180

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 11/176 (6%)
Query: 133 KLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATL 190
           + N+     +G+FG++ +       +E A+K++    N                  L  L
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI----NKASAKNKDTSTILREVELLKKL 78
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
            HPNI++          + IV E   GG +   + KR+  S     A +    V  G+ Y
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITY 136
Query: 251 VHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +H+  ++HRDLK +N+L+ S   D  IKI DFG++    Q   M    GT  ++AP
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 37/210 (17%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXX 178
           +W      L  G     GAFGK+   T  G        +VA+K+L+   +  E+      
Sbjct: 39  KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRS------ 231
                        H NIV  +GAC       ++ EY   G +  +L +KR+  S      
Sbjct: 99  LKMMTQLG----SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 232 --------------VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
                         +  +  +  A  VA+GM ++     +HRDL + N+L+   K +KI 
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 278 DFGVARIEVQTEGMTPETGTYR----WMAP 303
           DFG+AR ++ ++      G  R    WMAP
Sbjct: 215 DFGLAR-DIMSDSNYVVRGNARLPVKWMAP 243

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 86
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 87  DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 142
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGT---YR 299
           A+GM ++     +HRDL + N ++    ++K+ADFG+AR   + + + +  +TG     +
Sbjct: 143 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 300 WMA 302
           WMA
Sbjct: 203 WMA 205

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 23/183 (12%)
Query: 134 LNMGDAFAQGAFGKLYRGTY---NGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ++  +   +G FG +Y GT    +G+++  A+K L R  +  E +             + 
Sbjct: 91  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII-----MK 145
Query: 189 TLKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              HPN++  +G C +    P+V   V  Y K G +R F+ + +  +  +K  +   L V
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLV---VLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 201
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMTPETGT---YR 299
           A+GM ++     +HRDL + N ++    ++K+ADFG+AR   + + + +  +TG     +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 300 WMA 302
           WMA
Sbjct: 262 WMA 264

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 11/176 (6%)
Query: 133 KLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATL 190
           + N+     +G+FG++ +       +E A+K++    N                  L  L
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI----NKASAKNKDTSTILREVELLKKL 78
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
            HPNI++          + IV E   GG +   + KR+  S     A +    V  G+ Y
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITY 136
Query: 251 VHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +H+  ++HRDLK +N+L+ S   D  IKI DFG++    Q   M    GT  ++AP
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 91/226 (40%), Gaps = 40/226 (17%)
Query: 114 SNSPTEG---------LENFDEWT------IDLRKLNMGDAFAQGAFGKLYRG-TYNGEE 157
           S SPTEG         +EN   ++      I  R + +     +GAFGK++    +N   
Sbjct: 8   SLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLP 67
Query: 158 VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKG 217
              K+L   +   E +             L  L+H +IVRF G C +     +V EY + 
Sbjct: 68  EQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRH 127
Query: 218 GSVRQFLTKRQNRS---------VPLKLAVKQAL----DVARGMAYVHRLGLIHRDLKSD 264
           G + +FL      +          P  L + Q L     VA GM Y+  L  +HRDL + 
Sbjct: 128 GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATR 187
Query: 265 NLLIFSDKSIKIADFGVAR-------IEVQTEGMTPETGTYRWMAP 303
           N L+     +KI DFG++R         V    M P     RWM P
Sbjct: 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP----IRWMPP 229

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +WT++    ++G    +G FG +Y  R   +   +A+K+L +     EKA          
Sbjct: 8   QWTLE--DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFK--TQLEKAGVEHQLRREV 63
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 64  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE--QRTATYITE 120
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S+  +KIADFG + +   +   T   GT  ++ P
Sbjct: 121 LANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 179

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 12/179 (6%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLA 188
           ID ++LN      +   G+L++G + G ++ +K+L+  +    K+             L 
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPR----LR 62
Query: 189 TLKHPNIVRFIGACRKPMVW--CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
              HPN++  +GAC+ P      ++T +   GS+   L +  N  V    AVK ALD AR
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXAR 122
Query: 247 GMAYVHRL-GLIHRD-LKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G A++H L  LI R  L S ++ I  D + +I+   V +   Q+ G         W+AP
Sbjct: 123 GXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADV-KFSFQSPG---RXYAPAWVAP 177

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 12/188 (6%)
Query: 120 GLENFDEWTIDLRKL-NMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXX 176
           G EN    ++D  +L    +   +G+FG++++G  N  +  VAIKI+     D E+A   
Sbjct: 14  GTENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-----DLEEAEDE 68
Query: 177 XXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                     L+    P + ++ G+  K     I+ EY  GGS    L         +  
Sbjct: 69  IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT 128
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTPET 295
            +++ L   +G+ Y+H    IHRD+K+ N+L+     +K+ADFGVA     T+       
Sbjct: 129 ILREIL---KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 185
Query: 296 GTYRWMAP 303
           GT  WMAP
Sbjct: 186 GTPFWMAP 193

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GA+G+  L +    G E AIKI+++                     L  L HPNI++   
Sbjct: 15  GAYGEVLLCKDKLTGAERAIKIIKKS---SVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYVHRLGLIHR 259
                  + +V E  +GG +   +  RQ  S V   + +KQ L    G  Y+H+  ++HR
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTYLHKHNIVHR 128
Query: 260 DLKSDNLLIFS---DKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           DLK +NLL+ S   D  IKI DFG+ A  EV  + M    GT  ++AP
Sbjct: 129 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAP 175

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 73/145 (50%), Gaps = 11/145 (7%)
Query: 143 GAFGKLYRGTYNGE----EVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF 198
           G FG + +G Y       +VAIK+L++     EKA             +  L +P IVR 
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQ---GTEKADTEEMMREAQI--MHQLDNPYIVRL 75
Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           IG C+   +  +V E A GG + +FL  ++   +P+    +    V+ GM Y+     +H
Sbjct: 76  IGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR 283
           RDL + N+L+ +    KI+DFG+++
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSK 158

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPE--NDPEKAXXXXXXXXXXX 184
           + L + +    G+FG + RG ++        VA+K L +P+  + PE             
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPE----AMDDFIREV 66
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             + +L H N++R  G    P +  +VTE A  GS+   L K Q   + L    + A+ V
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQV 124
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           A GM Y+     IHRDL + NLL+ +   +KI DFG+ R
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNI 195
           +   +G+FG++++G  N  +  VAIKI+     D E+A             L+    P +
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            ++ G+  K     I+ EY  GGS    L         +   +++ L   +G+ Y+H   
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEK 139
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 303
            IHRD+K+ N+L+     +K+ADFGVA     T+       GT  WMAP
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 188

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPE--NDPEKAXXXXXXXXXXX 184
           + L + +    G+FG + RG ++        VA+K L +P+  + PE             
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPE----AMDDFIREV 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             + +L H N++R  G    P +  +VTE A  GS+   L K Q   + L    + A+ V
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQV 130
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           A GM Y+     IHRDL + NLL+ +   +KI DFG+ R   Q +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 85
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++ L H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPE--NDPEKAXXXXXXXXXXX 184
           + L + +    G+FG + RG ++        VA+K L +P+  + PE             
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPE----AMDDFIREV 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             + +L H N++R  G    P +  +VTE A  GS+   L K Q   + L    + A+ V
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQV 130
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           A GM Y+     IHRDL + NLL+ +   +KI DFG+ R   Q +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPE--NDPEKAXXXXXXXXXXX 184
           + L + +    G+FG + RG ++        VA+K L +P+  + PE             
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPE----AMDDFIREV 66
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             + +L H N++R  G    P +  +VTE A  GS+   L K Q   + L    + A+ V
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQV 124
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           A GM Y+     IHRDL + NLL+ +   +KI DFG+ R   Q +
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 169

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 115 NSPTEGLENFDEWTIDLRKLNMGDAF---AQGAFGKLYRGTY--NGEEVAIKILERPEND 169
           N P   L+  DE ++  +   + D      +G++G +Y+  +   G+ VAIK +   E+D
Sbjct: 9   NPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-ESD 67
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            ++              +     P++V++ G+  K     IV EY   GSV   +  R N
Sbjct: 68  LQEIIKEISI-------MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-N 119
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQT 288
           +++             +G+ Y+H +  IHRD+K+ N+L+ ++   K+ADFGVA ++    
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXM 179
Query: 289 EGMTPETGTYRWMAP 303
                  GT  WMAP
Sbjct: 180 AKRNXVIGTPFWMAP 194

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 80/196 (40%), Gaps = 25/196 (12%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRG-TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           I  R + +     +GAFGK++    +N      K+L   +   E +             L
Sbjct: 9   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 68
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS---------VPLKLAV 238
             L+H +IVRF G C +     +V EY + G + +FL      +          P  L +
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 239 KQAL----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-------IEVQ 287
            Q L     VA GM Y+  L  +HRDL + N L+     +KI DFG++R         V 
Sbjct: 129 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 288 TEGMTPETGTYRWMAP 303
              M P     RWM P
Sbjct: 189 GRTMLP----IRWMPP 200

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 99
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++ L H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPE--NDPEKAXXXXXXXXXXX 184
           + L + +    G+FG + RG ++        VA+K L +P+  + PE             
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPE----AMDDFIREV 62
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             + +L H N++R  G    P +  +VTE A  GS+   L K Q   + L    + A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQV 120
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           A GM Y+     IHRDL + NLL+ +   +KI DFG+ R   Q +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNI 195
           +   +G+FG++++G  N  +  VAIKI+     D E+A             L+    P +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            ++ G+  K     I+ EY  GGS    L         +   +++ L   +G+ Y+H   
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEK 124
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 303
            IHRD+K+ N+L+     +K+ADFGVA     T+       GT  WMAP
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 173

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPE--NDPEKAXXXXXXXXXXX 184
           + L + +    G+FG + RG ++        VA+K L +P+  + PE             
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPE----AMDDFIREV 62
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             + +L H N++R  G    P +  +VTE A  GS+   L K Q   + L    + A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQV 120
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           A GM Y+     IHRDL + NLL+ +   +KI DFG+ R
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNI 195
           +   +G+FG++++G  N  +  VAIKI+     D E+A             L+    P +
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
            ++ G+  K     I+ EY  GGS    L         +   +++ L   +G+ Y+H   
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEK 124
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 303
            IHRD+K+ N+L+     +K+ADFGVA     T+       GT  WMAP
Sbjct: 125 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 173

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
             + GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 78
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 79  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
             + GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 85
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 86  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 72/165 (43%), Gaps = 13/165 (7%)
Query: 143 GAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G FG  +L R   + E VA+K +ER E                     +L+HPNIVRF  
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGEK-------IAANVKREIINHRSLRHPNIVRFKE 82
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
               P    IV EYA GG + + +      S        Q L    G++Y H + + HRD
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYCHAMQVCHRD 140
Query: 261 LKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           LK +N L+    +  +KI DFG ++  V         GT  ++AP
Sbjct: 141 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 185

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 12/171 (7%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FG+  L +    G+E A+K++ + +    K              L  L HPNI 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQV---KQKTDKESLLREVQLLKQLDHPNIX 89
Query: 197 RFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           +          + +V E   GG +  + +++++   V     ++Q L    G+ Y H+  
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL---SGITYXHKNK 146
Query: 256 LIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +NLL+ S   D +I+I DFG++     ++    + GT  ++AP
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAP 197

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPE--NDPEKAXXXXXXXXXXX 184
           + L + +    G+FG + RG ++        VA+K L +P+  + PE             
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPE----AMDDFIREV 62
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
             + +L H N++R  G    P +  +VTE A  GS+   L K Q   + L    + A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQV 120
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           A GM Y+     IHRDL + NLL+ +   +KI DFG+ R
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 80/196 (40%), Gaps = 25/196 (12%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRG-TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           I  R + +     +GAFGK++    +N      K+L   +   E +             L
Sbjct: 15  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 74
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS---------VPLKLAV 238
             L+H +IVRF G C +     +V EY + G + +FL      +          P  L +
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 239 KQAL----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-------IEVQ 287
            Q L     VA GM Y+  L  +HRDL + N L+     +KI DFG++R         V 
Sbjct: 135 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 288 TEGMTPETGTYRWMAP 303
              M P     RWM P
Sbjct: 195 GRTMLP----IRWMPP 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FGK  L   T  G++VA+KI+ +                     L  L+HP+I+
Sbjct: 21  TLGEGSFGKVKLAYHTTTGQKVALKIINK---KVLAKSDMQGRIEREISYLRLLRHPHII 77
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           +     +      +V EYA G  +  ++ +R   S   + A +    +   + Y HR  +
Sbjct: 78  KLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSE--QEARRFFQQIISAVEYCHRHKI 134
Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +HRDLK +NLL+    ++KIADFG++ I      +    G+  + AP
Sbjct: 135 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 181

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 103
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 104 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 161
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 191

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FGK  L   T  G++VA+KI+ +                     L  L+HP+I+
Sbjct: 20  TLGEGSFGKVKLAYHTTTGQKVALKIINK---KVLAKSDMQGRIEREISYLRLLRHPHII 76
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           +     +      +V EYA G  +  ++ +R   S   + A +    +   + Y HR  +
Sbjct: 77  KLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSE--QEARRFFQQIISAVEYCHRHKI 133
Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +HRDLK +NLL+    ++KIADFG++ I      +    G+  + AP
Sbjct: 134 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 180

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 84
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 85  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 142
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 172

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +WT++    ++G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 8   QWTLE--DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQL--EKAGVEHQLRREV 63
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 64  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE--QRTATYITE 120
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S+  +KIADFG
Sbjct: 121 LANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 25/191 (13%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 102
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 162
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEVQTEGMTPETG 296
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR ++   G   + G
Sbjct: 163 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRAGYYRKGG 221
Query: 297 T----YRWMAP 303
                 +WM P
Sbjct: 222 CAMLPVKWMPP 232

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 81
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 82  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 62/119 (52%), Gaps = 6/119 (5%)
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL-AVKQALDVAR 246
           + L H NIV  I    +   + +V EY +G ++ +++      SV   +    Q LD   
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD--- 122
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--EVQTEGMTPETGTYRWMAP 303
           G+ + H + ++HRD+K  N+LI S+K++KI DFG+A+   E          GT ++ +P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 25/191 (13%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 125
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEVQTEGMTPETG 296
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR ++   G   + G
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRAGYYRKGG 244
Query: 297 T----YRWMAP 303
                 +WM P
Sbjct: 245 CAMLPVKWMPP 255

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 80
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 81  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 23/193 (11%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---EEVAIKILERPENDPEKAXXXXXXXXXX 183
           W+I+     + +    GA   + +  Y     E+VAIK +     + EK           
Sbjct: 10  WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKE 63
Query: 184 XXXLATLKHPNIVRFIGA-CRKPMVWCIVTEYAKGGSV----RQFLTKRQNRSVPLKLAV 238
              ++   HPNIV +  +   K  +W +V +   GGSV    +  + K +++S  L  + 
Sbjct: 64  IQAMSQCHHPNIVSYYTSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 239 KQAL--DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-- 294
              +  +V  G+ Y+H+ G IHRD+K+ N+L+  D S++IADFGV+        +T    
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 295 ----TGTYRWMAP 303
                GT  WMAP
Sbjct: 183 RKTFVGTPCWMAP 195

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 81
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 82  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           R L       +G FGK+    Y+      GE VA+K L+       ++            
Sbjct: 9   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEI---- 64
Query: 186 XLATLKHPNIVRFIGACR----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
            L TL H +IV++ G C     K +   +V EY   GS+R +L +       L L  +Q 
Sbjct: 65  -LRTLYHEHIVKYKGCCEDQGEKSVQ--LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ- 120
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
             +  GMAY+H    IHR L + N+L+ +D+ +KI DFG+A+
Sbjct: 121 --ICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 81
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 82  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           R L       +G FGK+    Y+      GE VA+K L+       ++            
Sbjct: 8   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEI---- 63
Query: 186 XLATLKHPNIVRFIGACR----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
            L TL H +IV++ G C     K +   +V EY   GS+R +L +       L L  +Q 
Sbjct: 64  -LRTLYHEHIVKYKGCCEDQGEKSVQ--LVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQ- 119
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
             +  GMAY+H    IHR L + N+L+ +D+ +KI DFG+A+
Sbjct: 120 --ICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FGK  L   T  G++VA+KI+ +                     L  L+HP+I+
Sbjct: 15  TLGEGSFGKVKLAYHTTTGQKVALKIINK---KVLAKSDMQGRIEREISYLRLLRHPHII 71
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           +     +      +V EYA G  +  ++ +R   S   + A +    +   + Y HR  +
Sbjct: 72  KLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSE--QEARRFFQQIISAVEYCHRHKI 128
Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +HRDLK +NLL+    ++KIADFG++ I      +    G+  + AP
Sbjct: 129 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 175

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 85
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 86  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 78
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 79  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 72
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 73  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              +G+FGK  L   T  G++VA+KI+ +                     L  L+HP+I+
Sbjct: 11  TLGEGSFGKVKLAYHTTTGQKVALKIINK---KVLAKSDMQGRIEREISYLRLLRHPHII 67
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           +     +      +V EYA G  +  ++ +R   S   + A +    +   + Y HR  +
Sbjct: 68  KLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSE--QEARRFFQQIISAVEYCHRHKI 124
Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +HRDLK +NLL+    ++KIADFG++ I      +    G+  + AP
Sbjct: 125 VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 171

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 23/193 (11%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNG---EEVAIKILERPENDPEKAXXXXXXXXXX 183
           W+I+     + +    GA   + +  Y     E+VAIK +     + EK           
Sbjct: 5   WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKE 58
Query: 184 XXXLATLKHPNIVRFIGA-CRKPMVWCIVTEYAKGGSV----RQFLTKRQNRSVPLKLAV 238
              ++   HPNIV +  +   K  +W +V +   GGSV    +  + K +++S  L  + 
Sbjct: 59  IQAMSQCHHPNIVSYYTSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 239 KQAL--DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-- 294
              +  +V  G+ Y+H+ G IHRD+K+ N+L+  D S++IADFGV+        +T    
Sbjct: 118 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 177
Query: 295 ----TGTYRWMAP 303
                GT  WMAP
Sbjct: 178 RKTFVGTPCWMAP 190

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 78
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 79  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 14/168 (8%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GA+G+  L +    G E AIKI+++                     L  L HPNI++   
Sbjct: 32  GAYGEVLLCKDKLTGAERAIKIIKKSSVT---TTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYVHRLGLIHR 259
                  + +V E  +GG +   +  RQ  S V   + +KQ L    G  Y+H+  ++HR
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTYLHKHNIVHR 145
Query: 260 DLKSDNLLIFS---DKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           DLK +NLL+ S   D  IKI DFG+ A  EV  + M    GT  ++AP
Sbjct: 146 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAP 192

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 88
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 89  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 146
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 176

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 64/120 (53%), Gaps = 7/120 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDV 244
           L  L HPNIV  I          +V E+ +   +++ L + +   +   +K+ + Q L  
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL-- 129
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
            RG+A+ H+  ++HRDLK  NLLI SD ++K+ADFG+AR   +     T E  T  + AP
Sbjct: 130 -RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 64/120 (53%), Gaps = 7/120 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDV 244
           L  L HPNIV  I          +V E+ +   +++ L + +   +   +K+ + Q L  
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL-- 129
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
            RG+A+ H+  ++HRDLK  NLLI SD ++K+ADFG+AR   +     T E  T  + AP
Sbjct: 130 -RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 78
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 79  VCRLLGICLTSTV-QLITQLMPFGXLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 143 GAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G FG  +L R     E VA+K +ER     E                 +L+HPNIVRF  
Sbjct: 31  GNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHR-------SLRHPNIVRFKE 83
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV-PLKLAVKQALDVARGMAYVHRLGLIHR 259
               P    I+ EYA GG + + +      S    +   +Q L    G++Y H + + HR
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS---GVSYCHSMQICHR 140
Query: 260 DLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK +N L+    +  +KI DFG ++  V         GT  ++AP
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 186

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 99
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 85
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 72/165 (43%), Gaps = 13/165 (7%)
Query: 143 GAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G FG  +L R   + E VA+K +ER E   E                 +L+HPNIVRF  
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHR-------SLRHPNIVRFKE 82
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
               P    IV EYA GG + + +      S        Q L    G++Y H + + HRD
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYCHAMQVCHRD 140
Query: 261 LKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           LK +N L+    +  +KI  FG ++  V         GT  ++AP
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAP 185

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 115 NSPTEGLENFDEWTIDLRKLNMGDA---FAQGAFGKLYRGTYNGE----EVAIKILERPE 167
            SP    E   +  + L++ N+  A      G FG + +G Y       +VAIK+L++  
Sbjct: 316 ESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-- 373
Query: 168 NDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR 227
              EKA             +  L +P IVR IG C+   +  +V E A GG + +FL  +
Sbjct: 374 -GTEKADTEEMMREAQI--MHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK 429
Query: 228 QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +   +P+    +    V+ GM Y+     +HR+L + N+L+ +    KI+DFG+++
Sbjct: 430 RE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 111
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 171
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 172 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 91
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 151
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 152 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 12/148 (8%)
Query: 142 QGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
           +G FG +Y G Y     N  + AIK L R                     +  L HPN++
Sbjct: 31  KGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-----MQQVEAFLREGLLMRGLNHPNVL 85
Query: 197 RFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
             IG    P  +  ++  Y   G + QF+   Q R+  +K  +   L VARGM Y+    
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            +HRDL + N ++    ++K+ADFG+AR
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 72/165 (43%), Gaps = 13/165 (7%)
Query: 143 GAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G FG  +L R   + E VA+K +ER E   E                 +L+HPNIVRF  
Sbjct: 30  GNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHR-------SLRHPNIVRFKE 82
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
               P    IV EYA GG + + +      S        Q L    G++Y H + + HRD
Sbjct: 83  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVSYCHAMQVCHRD 140
Query: 261 LKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           LK +N L+    +  +KI  FG ++  V         GT  ++AP
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAP 185

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 101
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 161
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 162 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 84
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 76
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 136
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 137 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G++         E VA+KI+     D ++A              A L H
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINAMLNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 75
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A GM Y+   
Sbjct: 76  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAEGMNYLEDR 133
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 163

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVYSEQ---DELDFLMEA 99
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 31/193 (16%)
Query: 133 KLNMGDAFAQGAFGKLYRG----TYNGE---EVAIKILERPENDPEKAXXXXXXXXXXXX 185
           K+ +     QG+FG +Y G       GE    VA+K +    +  E+             
Sbjct: 17  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF 76
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------NRSVP-LKLA 237
              T  H  +VR +G   K     +V E    G ++ +L   +        R  P L+  
Sbjct: 77  ---TCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-------G 290
           ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R   +T+       G
Sbjct: 132 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 191
Query: 291 MTPETGTYRWMAP 303
           + P     RWMAP
Sbjct: 192 LLP----VRWMAP 200

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 62/129 (48%), Gaps = 14/129 (10%)
Query: 187 LATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTK----RQNRSVPLKLAVKQ 240
           L  LKHPNIVR+      R      IV EY +GG +   +TK    RQ       L V  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 241 ALDVARGMAYVHRLG-----LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE- 294
            L +A  +   HR       ++HRDLK  N+ +   +++K+ DFG+ARI    E    E 
Sbjct: 119 QLTLA--LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEF 176
Query: 295 TGTYRWMAP 303
            GT  +M+P
Sbjct: 177 VGTPYYMSP 185

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 84
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+AR
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 62/126 (49%), Gaps = 17/126 (13%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQ 240
           L  L HPNI++       P    +V E   GG +      + + ++R         AVKQ
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD-----AVKQ 156
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGT 297
            L+    +AY+H  G++HRDLK +NLL  +   D  +KIADFG+++I      M    GT
Sbjct: 157 ILE---AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGT 213
Query: 298 YRWMAP 303
             + AP
Sbjct: 214 PGYCAP 219

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPEND 169
           M+S      LE+F+          +G    +G FG +Y  R   +   +A+K+L + +  
Sbjct: 1   MESKKRQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL- 49
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EKA              + L+HPNI+R  G         ++ EYA  G+V + L K   
Sbjct: 50  -EKAGVEHQLRREVEIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
                +       ++A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   + 
Sbjct: 108 FDE--QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSS 164
Query: 290 GMTPETGTYRWMAP 303
             T   GT  ++ P
Sbjct: 165 RRTTLCGTLDYLPP 178

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPEND 169
           M+S      LE+F+          +G    +G FG +Y  R   +   +A+K+L + +  
Sbjct: 3   MESKKRQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL- 51
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EKA              + L+HPNI+R  G         ++ EYA  G+V + L K   
Sbjct: 52  -EKAGVEHQLRREVEIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 109
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
                +       ++A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   + 
Sbjct: 110 FDE--QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSS 166
Query: 290 GMTPETGTYRWMAP 303
             T   GT  ++ P
Sbjct: 167 RRTTLCGTLDYLPP 180

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 18/194 (9%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPEND 169
           M+S      LE+F+          +G    +G FG +Y  R   +   +A+K+L + +  
Sbjct: 3   MESKKRQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL- 51
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EKA              + L+HPNI+R  G         ++ EYA  G V + L K   
Sbjct: 52  -EKAGVEHQLRREVEIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK 109
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
                +       ++A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   + 
Sbjct: 110 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSS 166
Query: 290 GMTPETGTYRWMAP 303
             T   GT  ++ P
Sbjct: 167 RRTTLCGTLDYLPP 180

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 58/123 (47%), Gaps = 7/123 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL--DV 244
           L +L HPNI++            IV E  +GG + + +   Q R   L       L   +
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKS----IKIADFGVARIEVQTEGMTPETGTYRW 300
              +AY H   ++H+DLK +N+L F D S    IKI DFG+A +    E  T   GT  +
Sbjct: 134 MNALAYFHSQHVVHKDLKPENIL-FQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY 192
Query: 301 MAP 303
           MAP
Sbjct: 193 MAP 195

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 9   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 64
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 65  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 121
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 180

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPEND 169
           M+S      LE+F+          +G    +G FG +Y  R   +   +A+K+L + +  
Sbjct: 1   MESKKRQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL- 49
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EKA              + L+HPNI+R  G         ++ EYA  G+V + L K   
Sbjct: 50  -EKAGVEHQLRREVEIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
                +       ++A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   + 
Sbjct: 108 FDE--QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSS 164
Query: 290 GMTPETGTYRWMAP 303
             T   GT  ++ P
Sbjct: 165 RRTTLCGTLDYLPP 178

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 30  QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 85
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 86  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 142
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 201

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 7/165 (4%)
Query: 142 QGAFGKLYRGTYNGEEV--AIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G+FGK+    +  EEV  A+K+L++      K              L  +KHP +V   
Sbjct: 48  KGSFGKVLLARHKAEEVFYAVKVLQK--KAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            + +       V +Y  GG +  F   ++ R      A   A ++A  + Y+H L +++R
Sbjct: 106 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           DLK +N+L+ S   I + DFG+ +  ++    T    GT  ++AP
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 4   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 60  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 116
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 175

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 4   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 60  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 116
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPP 175

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 9   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 64
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 65  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 121
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 122 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPP 180

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 21  QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 76
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 77  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 133
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 134 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 192

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 80
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 81  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG A++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 8   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 63
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 64  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 120
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 121 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 179

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
             + GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 85
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 86  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 85
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 86  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 143
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG A++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKL 173

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 78
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++T+    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 79  VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG A++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKL 166

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 5   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 60
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 61  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 117
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPP 176

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 4   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 60  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 116
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPP 175

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 3   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 58
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 59  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 115
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 116 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 174

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 82/186 (44%), Gaps = 12/186 (6%)
Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXX 182
           NFDE  I +     G+   +G FG +Y+G  N   VA+K L    +   +          
Sbjct: 17  NFDERPISVG----GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEI 72
Query: 183 XXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK--LAVKQ 240
                A  +H N+V  +G        C+V  Y   GS+   L+   + + PL      K 
Sbjct: 73  KVX--AKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPPLSWHXRCKI 129
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE---VQTEGMTPETGT 297
           A   A G+ ++H    IHRD+KS N+L+    + KI+DFG+AR      Q    +   GT
Sbjct: 130 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGT 189
Query: 298 YRWMAP 303
             + AP
Sbjct: 190 TAYXAP 195

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 81
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 82  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 139
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 4   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 60  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 116
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPP 175

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYN--GEE---VAIKILERPENDPEKAXXXXXXXXXX 183
           ID+  + +      G FG++  G     G+    VAIK L+    + ++           
Sbjct: 4   IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR-----RDFLSE 58
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              +    HPN++   G   K     I+TE+ + GS+  FL +   +   ++L V     
Sbjct: 59  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL-VGMLRG 117
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETG-----T 297
           +A GM Y+  +  +HR L + N+L+ S+   K++DFG++R +E  T   T  +       
Sbjct: 118 IAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 177
Query: 298 YRWMAP 303
            RW AP
Sbjct: 178 IRWTAP 183

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 4   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 60  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 116
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPP 175

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 142 QGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G+FG++++G  N  +  VAIKI+     D E+A             L+      + ++ 
Sbjct: 33  KGSFGEVFKGIDNRTQQVVAIKII-----DLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
           G+  K     I+ EY  GGS    L         +   +K+ L   +G+ Y+H    IHR
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKKIHR 144
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP 303
           D+K+ N+L+     +K+ADFGVA     T+       GT  WMAP
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 80
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 81  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 82
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 83  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 170

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 5   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 60
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 61  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 117
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG +     +   T  +GT  ++ P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPP 176

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 79
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 80  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R       +A+K+L + +   EKA          
Sbjct: 1   QWALE--DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQL--EKAGVEHQLRREV 56
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 57  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 113
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG + +   +   T   GT  ++ P
Sbjct: 114 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPP 172

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 78
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 79  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 188 ATLKHPNIVRF--IGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           A L HP IV     G    P   +  IV EY  G ++R  +   +    P K A++   D
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTP-KRAIEVIAD 124
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYR 299
             + + + H+ G+IHRD+K  N+LI +  ++K+ DFG+AR    +     +T    GT +
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 300 WMAP 303
           +++P
Sbjct: 185 YLSP 188

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGE-------EVAIKILERPENDPEKAXXXXXXXXXXX 184
           + + +      GAFG++Y G  +G        +VA+K L  PE   E+            
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQ---DELDFLMEA 85
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQALD 243
             ++   H NIVR IG   + +   I+ E   GG ++ FL + + R S P  LA+   L 
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 244 VAR----GMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVAR 283
           VAR    G  Y+     IHRD+ + N L+      +  KI DFG+A+
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 7/120 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +A    P +V+   A +      +V EY  GG +   ++   N  VP K A     +V  
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVL 184
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT---PETGTYRWMAP 303
            +  +H +G IHRD+K DN+L+     +K+ADFG   +++  EGM       GT  +++P
Sbjct: 185 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 243

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 77/150 (51%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 79
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 80  VCRLLGICLTSTV-QLIMQLMPFGXLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 137
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG+A++
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 7/120 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +A    P +V+   A +      +V EY  GG +   ++   N  VP K A     +V  
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVL 179
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT---PETGTYRWMAP 303
            +  +H +G IHRD+K DN+L+     +K+ADFG   +++  EGM       GT  +++P
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 238

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 17/171 (9%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPEND 169
           M+S      LE+F+          +G    +G FG +Y  R   +   +A+K+L + +  
Sbjct: 3   MESKKRQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL- 51
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EKA              + L+HPNI+R  G         ++ EYA  G V + L K   
Sbjct: 52  -EKAGVEHQLRREVEIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK 109
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
                +       ++A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 110 FDE--QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G++         E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L R    G   A+KIL +   +   A             L   +HP +    
Sbjct: 18  KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 74
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A +     C V EYA GG +  F    + R    + A     ++   + Y+H   +++R
Sbjct: 75  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 132
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           D+K +NL++  D  IKI DFG+ + E  ++G T +T  GT  ++AP
Sbjct: 133 DIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 177

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +G+ HRD+K +NLL+    ++KI+DFG+A +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 62
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 135 NMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G++         E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +G+ HRD+K +NLL+    ++KI+DFG+A +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 7/120 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +A    P +V+   A +      +V EY  GG +   ++   N  VP K A     +V  
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVL 184
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT---PETGTYRWMAP 303
            +  +H +G IHRD+K DN+L+     +K+ADFG   +++  EGM       GT  +++P
Sbjct: 185 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 243

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L R    G   A+KIL +   +   A             L   +HP +    
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A +     C V EYA GG +  F    + R    + A     ++   + Y+H   +++R
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           D+K +NL++  D  IKI DFG+ + E  ++G T +T  GT  ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 174

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEIXINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +G+ HRD+K +NLL+    ++KI+DFG+A +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQ 240
           L  +KHPNIV             ++ +   GG +      + F T+R    +     + Q
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQ 124
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGT 297
            LD  +   Y+H LG++HRDLK +NLL +S   D  I I+DFG++++E     ++   GT
Sbjct: 125 VLDAVK---YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 181
Query: 298 YRWMAP 303
             ++AP
Sbjct: 182 PGYVAP 187

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L R    G   A+KIL +   +   A             L   +HP +    
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A +     C V EYA GG +  F    + R    + A     ++   + Y+H   +++R
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           D+K +NL++  D  IKI DFG+ + E  ++G T +T  GT  ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 174

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEIXINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 30  QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 85
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 86  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 142
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 17/171 (9%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPEND 169
           M+S      LE+F+          +G    +G FG +Y  R   +   +A+K+L + +  
Sbjct: 1   MESKKRQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL- 49
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EKA              + L+HPNI+R  G         ++ EYA  G+V + L K   
Sbjct: 50  -EKAGVEHQLRREVEIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
                +       ++A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 108 FDE--QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G++         E VA+KI+     D ++A                L H
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 7   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 62
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 63  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 119
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +G+ HRD+K +NLL+    ++KI+DFG+A +
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATV 153

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G++         E VA+KI+     D ++A                L H
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQ 240
           L  +KHPNIV             ++ +   GG +      + F T+R    +     + Q
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQ 124
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGT 297
            LD  +   Y+H LG++HRDLK +NLL +S   D  I I+DFG++++E     ++   GT
Sbjct: 125 VLDAVK---YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 181
Query: 298 YRWMAP 303
             ++AP
Sbjct: 182 PGYVAP 187

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 7   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 62
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 63  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 119
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA+G  +L       E VA+KI+     D ++A                L H
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEIXINKMLNH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +G+ HRD+K +NLL+    ++KI+DFG+A +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATV 154

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 111 LMDSNSPTEGL-ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILE 164
           ++DS   ++ L E  ++  I  ++  +G    +G FG +       E+     VA+K+L+
Sbjct: 1   MLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60
Query: 165 R---PENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRK---------PMVWCIVT 212
                 +D E+              +    HP++ + +G   +         PMV   + 
Sbjct: 61  ADIIASSDIEE-------FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV---IL 110
Query: 213 EYAKGGSVRQFLTKRQ----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI 268
            + K G +  FL   +      ++PL+  V+  +D+A GM Y+     IHRDL + N ++
Sbjct: 111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML 170
Query: 269 FSDKSIKIADFGVAR 283
             D ++ +ADFG++R
Sbjct: 171 AEDMTVCVADFGLSR 185

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPEND 169
           M+S      LE+F+          +G    +G FG +Y  R   +   +A+K+L + +  
Sbjct: 1   MESKKRQWALEDFE----------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL- 49
Query: 170 PEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
            EKA              + L+HPNI+R  G         ++ EYA  G+V + L K   
Sbjct: 50  -EKAGVEHQLRREVEIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
                +       ++A  ++Y H   +IHRD+K +NLL+ S   +KIA+FG + +   + 
Sbjct: 108 FDE--QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSS 164
Query: 290 GMTPETGTYRWMAP 303
             T   GT  ++ P
Sbjct: 165 RRTTLCGTLDYLPP 178

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 87/189 (46%), Gaps = 27/189 (14%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
           +++ M     +G +G+++ G + GE+VA+K+    E                      ++
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE-------ASWFRETEIYQTVLMR 89
Query: 192 HPNIVRFIGACRKPM-VWC---IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           H NI+ FI A  K    W    ++T+Y + GS+  +L   ++ ++  K  +K A     G
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSG 146
Query: 248 MAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPET- 295
           + ++H        +  + HRDLKS N+L+  + +  IAD G+A   +       + P T 
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 296 -GTYRWMAP 303
            GT R+M P
Sbjct: 207 VGTKRYMPP 215

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 61/124 (49%), Gaps = 14/124 (11%)
Query: 187 LATLKHPNIVRFIGACRKPMV--WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA--- 241
           L  L HPN+V+ +     P      +V E    G V +  T +        L+  QA   
Sbjct: 90  LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFY 142
Query: 242 -LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET-GTYR 299
             D+ +G+ Y+H   +IHRD+K  NLL+  D  IKIADFGV+     ++ +   T GT  
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA 202
Query: 300 WMAP 303
           +MAP
Sbjct: 203 FMAP 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y       +  +A+K+L + +   EKA          
Sbjct: 4   QWALE--DFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQL--EKAGVEHQLRREV 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 60  EIQ-SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 116
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 117 LANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 4   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 60  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 116
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQ 240
           L  +KHPNIV             ++ +   GG +      + F T+R    +     + Q
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQ 124
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGT 297
            LD  +   Y+H LG++HRDLK +NLL +S   D  I I+DFG++++E     ++   GT
Sbjct: 125 VLDAVK---YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 181
Query: 298 YRWMAP 303
             ++AP
Sbjct: 182 PGYVAP 187

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 62/112 (55%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L  ++ + +P ++  K ++ V RG+AY+ 
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +MAP
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMAP 182

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 6   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 61
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 62  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 118
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 5   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 60
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 61  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 117
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 64/121 (52%), Gaps = 9/121 (7%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR---QNRSVPLKLAVKQALD 243
           LA + HP +V+   A +      ++ ++ +GG +   L+K        V   LA     +
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----E 138
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMA 302
           +A G+ ++H LG+I+RDLK +N+L+  +  IK+ DFG+++  +  E       GT  +MA
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMA 198
Query: 303 P 303
           P
Sbjct: 199 P 199

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 188 ATLKHPNIVRF--IGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           A L HP IV     G    P   +  IV EY  G ++R  +   +    P K A++   D
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTP-KRAIEVIAD 124
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYR 299
             + + + H+ G+IHRD+K  N++I +  ++K+ DFG+AR    +     +T    GT +
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 300 WMAP 303
           +++P
Sbjct: 185 YLSP 188

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 9/157 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 4   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 59
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 60  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 116
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG
Sbjct: 117 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 188 ATLKHPNIVRF--IGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           A L HP IV     G    P   +  IV EY  G ++R  +   +    P K A++   D
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTP-KRAIEVIAD 124
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYR 299
             + + + H+ G+IHRD+K  N++I +  ++K+ DFG+AR    +     +T    GT +
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 300 WMAP 303
           +++P
Sbjct: 185 YLSP 188

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +W ++     +G    +G FG +Y  R   +   +A+K+L + +   EKA          
Sbjct: 6   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREV 61
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
               + L+HPNI+R  G         ++ EYA  G+V + L K        +       +
Sbjct: 62  EIQ-SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE--QRTATYITE 118
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIA+FG + +   +   T   GT  ++ P
Sbjct: 119 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPP 177

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 188 ATLKHPNIVRF--IGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           A L HP IV     G    P   +  IV EY  G ++R  +   +    P K A++   D
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTP-KRAIEVIAD 124
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYR 299
             + + + H+ G+IHRD+K  N++I +  ++K+ DFG+AR    +     +T    GT +
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 300 WMAP 303
           +++P
Sbjct: 185 YLSP 188

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 7/120 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           +A    P +V+   A +      +V EY  GG +   ++   N  VP K A     +V  
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVL 185
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT---PETGTYRWMAP 303
            +  +H +GLIHRD+K DN+L+     +K+ADFG   +++   GM       GT  +++P
Sbjct: 186 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAVGTPDYISP 244

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQ 240
           L  +KHPNIV             ++ +   GG +      + F T+R    +     + Q
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQ 124
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGT 297
            LD  +   Y+H LG++HRDLK +NLL +S   D  I I+DFG++++E     ++   GT
Sbjct: 125 VLDAVK---YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 181
Query: 298 YRWMAP 303
             ++AP
Sbjct: 182 PGYVAP 187

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 77/173 (44%), Gaps = 18/173 (10%)
Query: 138 DAFAQGAFGKLYRGTYNGEE--VAIKI--LERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           D   +G +  +Y+G     +  VA+K   LE  E  P  A             L  LKH 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSL-------LKDLKHA 60
Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYV 251
           NIV             +V EY     ++Q+L    N      +KL + Q L   RG+AY 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYC 116
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE-VQTEGMTPETGTYRWMAP 303
           HR  ++HRDLK  NLLI     +K+ADFG+AR + + T+    E  T  +  P
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 80
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 81  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG A++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 188 ATLKHPNIVRF--IGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           A L HP IV     G    P   +  IV EY  G ++R  +   +    P K A++   D
Sbjct: 67  AALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTP-KRAIEVIAD 124
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYR 299
             + + + H+ G+IHRD+K  N++I +  ++K+ DFG+AR    +     +T    GT +
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 300 WMAP 303
           +++P
Sbjct: 185 YLSP 188

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 12/150 (8%)
Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           QG FG++++  +   G++VA+K +   EN+ E               L  LKH N+V  I
Sbjct: 28  QGTFGEVFKARHRKTGQKVALKKVLM-ENEKE---GFPITALREIKILQLLKHENVVNLI 83
Query: 200 GACR---KPMVWCIVTEYAKGGSVRQFLT-KRQNRSVPLKLA-VKQALD-VARGMAYVHR 253
             CR    P   C  + Y         L     N  V   L+ +K+ +  +  G+ Y+HR
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 143
Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
             ++HRD+K+ N+LI  D  +K+ADFG+AR
Sbjct: 144 NKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 80
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 81  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 138
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG A++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 188 ATLKHPNIVRF--IGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           A L HP IV     G    P   +  IV EY  G ++R  +   +    P K A++   D
Sbjct: 84  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD-IVHTEGPMTP-KRAIEVIAD 141
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYR 299
             + + + H+ G+IHRD+K  N++I +  ++K+ DFG+AR    +     +T    GT +
Sbjct: 142 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 300 WMAP 303
           +++P
Sbjct: 202 YLSP 205

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 22/155 (14%)
Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           QG FG++++  +   G++VA+K +   EN+ E               L  LKH N+V  I
Sbjct: 28  QGTFGEVFKARHRKTGQKVALKKVLM-ENEKE---GFPITALREIKILQLLKHENVVNLI 83
Query: 200 GACR---KPMVWC-----IVTEYAK---GGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
             CR    P   C     +V ++ +    G +   L K     +  K  ++  L+   G+
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GL 138
Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            Y+HR  ++HRD+K+ N+LI  D  +K+ADFG+AR
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 67/126 (53%), Gaps = 16/126 (12%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK--QALDV 244
           ++ L HPNIV+  G    P    +V E+   G +   L    +++ P+K +VK    LD+
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDI 131
Query: 245 ARGMAYVHRLG--LIHRDLKSDNLLIFS-----DKSIKIADFGVARIEVQTEGMTPETGT 297
           A G+ Y+      ++HRDL+S N+ + S         K+ADFG+++  V +  ++   G 
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGN 189
Query: 298 YRWMAP 303
           ++WMAP
Sbjct: 190 FQWMAP 195

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 9/150 (6%)
Query: 139 AFAQGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHPN 194
               GAFG +Y+G +   GE+V I   I E  E    KA             +A++ +P+
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV---MASVDNPH 82
Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + R +G C    V  ++ +    G +  ++ + ++ ++  +  +   + +A+GM Y+   
Sbjct: 83  VCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR 140
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            L+HRDL + N+L+ + + +KI DFG A++
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGRAKL 170

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 207 VWCIVTEYAKGGSVRQFLT-KRQNRS--VPLKLAVKQALDVARGMAYVHRLGLIHRDLKS 263
           +W +V E+ +GG++   +T  R N      + LAV QAL V      +H  G+IHRD+KS
Sbjct: 96  LW-VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV------LHAQGVIHRDIKS 148
Query: 264 DNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           D++L+  D  +K++DFG  A++  +        GT  WMAP
Sbjct: 149 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 189

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 207 VWCIVTEYAKGGSVRQFLT-KRQNRS--VPLKLAVKQALDVARGMAYVHRLGLIHRDLKS 263
           +W +V E+ +GG++   +T  R N      + LAV QAL V      +H  G+IHRD+KS
Sbjct: 223 LW-VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV------LHAQGVIHRDIKS 275
Query: 264 DNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           D++L+  D  +K++DFG  A++  +        GT  WMAP
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 316

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 207 VWCIVTEYAKGGSVRQFLT-KRQNRS--VPLKLAVKQALDVARGMAYVHRLGLIHRDLKS 263
           +W +V E+ +GG++   +T  R N      + LAV QAL V      +H  G+IHRD+KS
Sbjct: 146 LW-VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV------LHAQGVIHRDIKS 198
Query: 264 DNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           D++L+  D  +K++DFG  A++  +        GT  WMAP
Sbjct: 199 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 239

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 22/155 (14%)
Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           QG FG++++  +   G++VA+K +   EN+ E               L  LKH N+V  I
Sbjct: 28  QGTFGEVFKARHRKTGQKVALKKVLM-ENEKE---GFPITALREIKILQLLKHENVVNLI 83
Query: 200 GACR---KPMVWC-----IVTEYAK---GGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
             CR    P   C     +V ++ +    G +   L K     +  K  ++  L+   G+
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GL 138
Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            Y+HR  ++HRD+K+ N+LI  D  +K+ADFG+AR
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 22/155 (14%)
Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           QG FG++++  +   G++VA+K +   EN+ E               L  LKH N+V  I
Sbjct: 27  QGTFGEVFKARHRKTGQKVALKKVLM-ENEKE---GFPITALREIKILQLLKHENVVNLI 82
Query: 200 GACR---KPMVWC-----IVTEYAK---GGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
             CR    P   C     +V ++ +    G +   L K     +  K  ++  L+   G+
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GL 137
Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            Y+HR  ++HRD+K+ N+LI  D  +K+ADFG+AR
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 207 VWCIVTEYAKGGSVRQFLT-KRQNRS--VPLKLAVKQALDVARGMAYVHRLGLIHRDLKS 263
           +W +V E+ +GG++   +T  R N      + LAV QAL V      +H  G+IHRD+KS
Sbjct: 103 LW-VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV------LHAQGVIHRDIKS 155
Query: 264 DNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           D++L+  D  +K++DFG  A++  +        GT  WMAP
Sbjct: 156 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 196

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 207 VWCIVTEYAKGGSVRQFLT-KRQNRS--VPLKLAVKQALDVARGMAYVHRLGLIHRDLKS 263
           +W +V E+ +GG++   +T  R N      + LAV QAL V      +H  G+IHRD+KS
Sbjct: 92  LW-VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV------LHAQGVIHRDIKS 144
Query: 264 DNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           D++L+  D  +K++DFG  A++  +        GT  WMAP
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 185

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/57 (45%), Positives = 38/57 (66%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTPE  T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAP 194

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 207 VWCIVTEYAKGGSVRQFLT-KRQNRS--VPLKLAVKQALDVARGMAYVHRLGLIHRDLKS 263
           +W +V E+ +GG++   +T  R N      + LAV QAL V      +H  G+IHRD+KS
Sbjct: 101 LW-VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV------LHAQGVIHRDIKS 153
Query: 264 DNLLIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           D++L+  D  +K++DFG  A++  +        GT  WMAP
Sbjct: 154 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 194

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 66/126 (52%), Gaps = 16/126 (12%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK--QALDV 244
           ++ L HPNIV+  G    P    +V E+   G +   L    +++ P+K +VK    LD+
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDI 131
Query: 245 ARGMAYVHRLG--LIHRDLKSDNLLIFS-----DKSIKIADFGVARIEVQTEGMTPETGT 297
           A G+ Y+      ++HRDL+S N+ + S         K+ADFG ++  V +  ++   G 
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHS--VSGLLGN 189
Query: 298 YRWMAP 303
           ++WMAP
Sbjct: 190 FQWMAP 195

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 135 NMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
            M +    G FG + R  +   GE+VAIK   R E  P+               +  L H
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKN----RERWCLEIQIMKKLNH 72
Query: 193 PNIV---------RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN----RSVPLKLAVK 239
           PN+V         + +     P+   +  EY +GG +R++L + +N    +  P++  + 
Sbjct: 73  PNVVSAREVPDGLQKLAPNDLPL---LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 129
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI---KIADFGVARIEVQTEGMTPETG 296
              D++  + Y+H   +IHRDLK +N+++         KI D G A+   Q E  T   G
Sbjct: 130 ---DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 186
Query: 297 TYRWMAP 303
           T +++AP
Sbjct: 187 TLQYLAP 193

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 29/187 (15%)
Query: 135 NMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
            M +    G FG + R  +   GE+VAIK   R E  P+               +  L H
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-RQELSPKN----RERWCLEIQIMKKLNH 71
Query: 193 PNIV---------RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN----RSVPLKLAVK 239
           PN+V         + +     P+   +  EY +GG +R++L + +N    +  P++  + 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPL---LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI---KIADFGVARIEVQTEGMTPETG 296
              D++  + Y+H   +IHRDLK +N+++         KI D G A+   Q E  T   G
Sbjct: 129 ---DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 297 TYRWMAP 303
           T +++AP
Sbjct: 186 TLQYLAP 192

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 10/166 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L R    G   A+KIL +   +   A             L   +HP +    
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A +     C V EYA GG +  F    + R    + A     ++   + Y+H   +++R
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 303
           D+K +NL++  D  IKI DFG+ + E  ++G T +   GT  ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAP 174

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 10/166 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L R    G   A+KIL +   +   A             L   +HP +    
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A +     C V EYA GG +  F    + R    + A     ++   + Y+H   +++R
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 303
           D+K +NL++  D  IKI DFG+ + E  ++G T +   GT  ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAP 174

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 61/118 (51%), Gaps = 13/118 (11%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP +V      +       V EY  GG +  F  +RQ R +P + A   + +++  + Y+
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYL 169
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP------ETGTYRWMAP 303
           H  G+I+RDLK DN+L+ S+  IK+ D+G+ +     EG+ P        GT  ++AP
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 222

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 10/166 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L R    G   A+KIL +   +   A             L   +HP +    
Sbjct: 20  KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 76
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A +     C V EYA GG +  F    + R    + A     ++   + Y+H   +++R
Sbjct: 77  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 134
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 303
           D+K +NL++  D  IKI DFG+ + E  ++G T +   GT  ++AP
Sbjct: 135 DIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAP 179

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 10/166 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L R    G   A+KIL +   +   A             L   +HP +    
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A +     C V EYA GG +  F    + R    + A     ++   + Y+H   +++R
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 303
           D+K +NL++  D  IKI DFG+ + E  ++G T +   GT  ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAP 174

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 61/118 (51%), Gaps = 13/118 (11%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP +V      +       V EY  GG +  F  +RQ R +P + A   + +++  + Y+
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYL 137
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP------ETGTYRWMAP 303
           H  G+I+RDLK DN+L+ S+  IK+ D+G+ +     EG+ P        GT  ++AP
Sbjct: 138 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAP 190

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 61/118 (51%), Gaps = 13/118 (11%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP +V      +       V EY  GG +  F  +RQ R +P + A   + +++  + Y+
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYL 122
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP------ETGTYRWMAP 303
           H  G+I+RDLK DN+L+ S+  IK+ D+G+ +     EG+ P        GT  ++AP
Sbjct: 123 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAP 175

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 12/174 (6%)
Query: 135 NMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++     +GA G  +L       E VA+KI+     D ++A                L H
Sbjct: 9   DLVQTLGEGAAGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            N+V+F G  R+  +  +  EY  GG +  F     +  +P   A +    +  G+ Y+H
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVA---RIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K +NLL+    ++KI+DFG+A   R   +   +    GT  ++AP
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++ +   +GAF  + R  +   G E A KI+    N  + +                L+H
Sbjct: 32  DVKEELGKGAFSVVRRCVHKTTGLEFAAKII----NTKKLSARDFQKLEREARICRKLQH 87
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYV 251
           PNIVR   + ++     +V +   GG + + +  R+  S       ++Q L+    +AY 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SIAYC 144
Query: 252 HRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEV-QTEGMTPETGTYRWMAP 303
           H  G++HR+LK +NLL+ S     ++K+ADFG+A IEV  +E      GT  +++P
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSP 199

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 61/118 (51%), Gaps = 13/118 (11%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP +V      +       V EY  GG +  F  +RQ R +P + A   + +++  + Y+
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQ-RKLPEEHARFYSAEISLALNYL 126
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP------ETGTYRWMAP 303
           H  G+I+RDLK DN+L+ S+  IK+ D+G+ +     EG+ P        GT  ++AP
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXFCGTPNYIAP 179

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 59/116 (50%), Gaps = 10/116 (8%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HPNI++          + +V +  K G +  +LT++      + L+ K+   + R +  V
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEV 136
Query: 252 ----HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
               H+L ++HRDLK +N+L+  D +IK+ DFG +      E +    GT  ++AP
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAP 192

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 59/116 (50%), Gaps = 10/116 (8%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HPNI++          + +V +  K G +  +LT++      + L+ K+   + R +  V
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEV 136
Query: 252 ----HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
               H+L ++HRDLK +N+L+  D +IK+ DFG +      E +    GT  ++AP
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 61/129 (47%), Gaps = 14/129 (10%)
Query: 187 LATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTK----RQNRSVPLKLAVKQ 240
           L  LKHPNIVR+      R      IV EY +GG +   +TK    RQ       L V  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 241 ALDVARGMAYVHRLG-----LIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPE 294
            L +A  +   HR       ++HRDLK  N+ +   +++K+ DFG+ARI    T      
Sbjct: 119 QLTLA--LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF 176
Query: 295 TGTYRWMAP 303
            GT  +M+P
Sbjct: 177 VGTPYYMSP 185

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 61/129 (47%), Gaps = 14/129 (10%)
Query: 187 LATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTK----RQNRSVPLKLAVKQ 240
           L  LKHPNIVR+      R      IV EY +GG +   +TK    RQ       L V  
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 241 ALDVARGMAYVHRLG-----LIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQTEGMTPE 294
            L +A  +   HR       ++HRDLK  N+ +   +++K+ DFG+ARI    T      
Sbjct: 119 QLTLA--LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF 176
Query: 295 TGTYRWMAP 303
            GT  +M+P
Sbjct: 177 VGTPYYMSP 185

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLY-----RGTYNGEEVAIKILERPENDPEKA 173
           EG E  D    +L K+       QG+FGK++      G+   +  A+K+L++        
Sbjct: 17  EGHEKADPSQFELLKV-----LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL----K 67
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR---QNR 230
                        L  + HP IV+   A +      ++ ++ +GG +   L+K       
Sbjct: 68  VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 127
Query: 231 SVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG 290
            V   LA     ++A  + ++H LG+I+RDLK +N+L+  +  IK+ DFG+++  +  E 
Sbjct: 128 DVKFYLA-----ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 182
Query: 291 MTPE-TGTYRWMAP 303
                 GT  +MAP
Sbjct: 183 KAYSFCGTVEYMAP 196

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLY-----RGTYNGEEVAIKILERPENDPEKA 173
           EG E  D    +L K+       QG+FGK++      G+   +  A+K+L++        
Sbjct: 16  EGHEKADPSQFELLKV-----LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL----K 66
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR---QNR 230
                        L  + HP IV+   A +      ++ ++ +GG +   L+K       
Sbjct: 67  VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 126
Query: 231 SVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG 290
            V   LA     ++A  + ++H LG+I+RDLK +N+L+  +  IK+ DFG+++  +  E 
Sbjct: 127 DVKFYLA-----ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 291 MTPE-TGTYRWMAP 303
                 GT  +MAP
Sbjct: 182 KAYSFCGTVEYMAP 195

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 59/116 (50%), Gaps = 10/116 (8%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HPNI++          + +V +  K G +  +LT++      + L+ K+   + R +  V
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEV 123
Query: 252 ----HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
               H+L ++HRDLK +N+L+  D +IK+ DFG +      E +    GT  ++AP
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 179

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNG--EEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
           + L   N      +G+FGK+      G  E  A+KIL++   D                 
Sbjct: 17  MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK---DVVIQDDDVECTMVEKRV 73
Query: 187 LATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           LA    P  +  + +C + M     V EY  GG +   + +      P   AV  A ++A
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH--AVFYAAEIA 131
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 303
            G+ ++   G+I+RDLK DN+++ S+  IKIADFG+ +  +  +G+T +   GT  ++AP
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKXFCGTPDYIAP 190

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNG--EEVAIKILERPENDPEKAXXXXXXXXXXXXX 186
           + L   N      +G+FGK+      G  E  A+KIL++   D                 
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK---DVVIQDDDVECTMVEKRV 394
Query: 187 LATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           LA    P  +  + +C + M     V EY  GG +   + +      P   AV  A ++A
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH--AVFYAAEIA 452
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 303
            G+ ++   G+I+RDLK DN+++ S+  IKIADFG+ +  +  +G+T +   GT  ++AP
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKXFCGTPDYIAP 511

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 23/194 (11%)
Query: 119 EGLENFDEWTIDLRKLNMGDAFAQGAFGKLY-----RGTYNGEEVAIKILERPENDPEKA 173
           EG E  D    +L K+       QG+FGK++      G+   +  A+K+L++        
Sbjct: 16  EGHEKADPSQFELLKV-----LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL----K 66
Query: 174 XXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR---QNR 230
                        L  + HP IV+   A +      ++ ++ +GG +   L+K       
Sbjct: 67  VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 126
Query: 231 SVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG 290
            V   LA     ++A  + ++H LG+I+RDLK +N+L+  +  IK+ DFG+++  +  E 
Sbjct: 127 DVKFYLA-----ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181
Query: 291 MTPE-TGTYRWMAP 303
                 GT  +MAP
Sbjct: 182 KAYSFCGTVEYMAP 195

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 32/160 (20%)
Query: 157 EVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAK 216
           E A+KI+++ + DP +              L   +HPNI+             +VTE  K
Sbjct: 49  EFAVKIIDKSKRDPTEEIEIL---------LRYGQHPNIITLKDVYDDGKYVYVVTELMK 99
Query: 217 GGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS 270
           GG +      ++F ++R+  +V           + + + Y+H  G++HRDLK  N+L   
Sbjct: 100 GGELLDKILRQKFFSEREASAV--------LFTITKTVEYLHAQGVVHRDLKPSNILYVD 151
Query: 271 D----KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 303
           +    +SI+I DFG A+ +++ E    MTP   T  ++AP
Sbjct: 152 ESGNPESIRICDFGFAK-QLRAENGLLMTP-CYTANFVAP 189

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 3/118 (2%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           L  L+H N+V  +  C+K   W +V E+    ++   L    N  +  ++  K    +  
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN-GLDYQVVQKYLFQIIN 135
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           G+ + H   +IHRD+K +N+L+     +K+ DFG AR +    E    E  T  + AP
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      G  VA+K L+    D ++      
Sbjct: 3   DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR------ 56
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                   L  L    IV++ G    P      +V EY   G +R FL + + R    +L
Sbjct: 57  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 116
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +  +  + +GM Y+     +HRDL + N+L+ S+  +KIADFG+A++
Sbjct: 117 LLYSS-QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 163

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
           +W ++ E+ +GG++   +++ +     +    +  L   + +AY+H  G+IHRD+KSD++
Sbjct: 117 LW-VLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QALAYLHAQGVIHRDIKSDSI 172
Query: 267 LIFSDKSIKIADFG-VARIEVQTEGMTPETGTYRWMAP 303
           L+  D  +K++DFG  A+I           GT  WMAP
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAP 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      G  VA+K L+    D ++      
Sbjct: 16  DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR------ 69
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                   L  L    IV++ G    P      +V EY   G +R FL + + R    +L
Sbjct: 70  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 129
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +  +  + +GM Y+     +HRDL + N+L+ S+  +KIADFG+A++
Sbjct: 130 LLYSS-QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 23/176 (13%)
Query: 123 NFDEWTIDL--RKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXX 178
           +F   T++L   +L +    A+G F  +Y      +G E A+K L   E +  +A     
Sbjct: 17  DFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEV 76
Query: 179 XXXXXXXXLATLKHPNIVRFIGACR--------KPMVWCIVTEYAKGGSVRQFLTKRQNR 230
                        HPNIV+F  A              + ++TE  KG  V +FL K ++R
Sbjct: 77  CFMKKLSG-----HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLV-EFLKKMESR 130
Query: 231 SVPLKL--AVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADFGVA 282
             PL     +K      R + ++HR    +IHRDLK +NLL+ +  +IK+ DFG A
Sbjct: 131 G-PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 15/168 (8%)
Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAXXXXX 178
           D    + R L       +G FG +    Y+      G  VA+K L+    D ++      
Sbjct: 4   DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR------ 57
Query: 179 XXXXXXXXLATLKHPNIVRFIGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
                   L  L    IV++ G    P      +V EY   G +R FL + + R    +L
Sbjct: 58  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 117
Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +  +  + +GM Y+     +HRDL + N+L+ S+  +KIADFG+A++
Sbjct: 118 LLYSS-QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 164

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 36/57 (63%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR       MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 194

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++ +   +GAF  + R  +   G E A KI+    N  + +                L+H
Sbjct: 8   DVKEELGKGAFSVVRRCVHKTTGLEFAAKII----NTKKLSARDFQKLEREARICRKLQH 63
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYV 251
           PNIVR   + ++     +V +   GG + + +  R+  S       ++Q L+    +AY 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SIAYC 120
Query: 252 HRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEV-QTEGMTPETGTYRWMAP 303
           H  G++HR+LK +NLL+ S     ++K+ADFG+A IEV  +E      GT  +++P
Sbjct: 121 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSP 175

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++ +   +GAF  + R  +   G E A KI+    N  + +                L+H
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKII----NTKKLSARDFQKLEREARICRKLQH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYV 251
           PNIVR   + ++     +V +   GG + + +  R+  S       ++Q L+    +AY 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SIAYC 121
Query: 252 HRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEV-QTEGMTPETGTYRWMAP 303
           H  G++HR+LK +NLL+ S     ++K+ADFG+A IEV  +E      GT  +++P
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSP 176

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 66/126 (52%), Gaps = 16/126 (12%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK--QALDV 244
           ++ L HPNIV+  G    P    +V E+   G +   L    +++ P+K +VK    LD+
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDI 131
Query: 245 ARGMAYVHRLG--LIHRDLKSDNLLIFS-----DKSIKIADFGVARIEVQTEGMTPETGT 297
           A G+ Y+      ++HRDL+S N+ + S         K+ADF +++  V +  ++   G 
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS--VSGLLGN 189
Query: 298 YRWMAP 303
           ++WMAP
Sbjct: 190 FQWMAP 195

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 36/192 (18%)
Query: 134 LNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           L + +  A+G FG +++     + VA+KI   P  D +                  +KH 
Sbjct: 17  LQLLEIKARGRFGCVWKAQLMNDFVAVKIF--PLQDKQSWQSEREIFST-----PGMKHE 69
Query: 194 NIVRFIGACRK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGM 248
           N+++FI A ++       +W ++T +   GS+  +L   +   +        A  ++RG+
Sbjct: 70  NLLQFIAAEKRGSNLEVELW-LITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGL 125
Query: 249 AYVH-----------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP---- 293
           +Y+H           +  + HRD KS N+L+ SD +  +ADFG+A   V+ E   P    
Sbjct: 126 SYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA---VRFEPGKPPGDT 182
Query: 294 --ETGTYRWMAP 303
             + GT R+MAP
Sbjct: 183 HGQVGTRRYMAP 194

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 138 DAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
           +   +G +G +Y+   N GE  A+K +   + D                 L  LKH NIV
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKED----EGIPSTTIREISILKELKHSNIV 63
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYVHRL 254
           +            +V E+     +++ L   +    SV  K  + Q L+   G+AY H  
Sbjct: 64  KLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN---GIAYCHDR 119
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
            ++HRDLK  NLLI  +  +KIADFG+AR   +     T E  T  + AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 15/182 (8%)
Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERP----ENDPEKAXXXXXXXXX 182
           + +    +     +G+FGK++   +    +  AIK L++     ++D E           
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS- 73
Query: 183 XXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL 242
                   +HP +       +       V EY  GG +   +  +      L  A   A 
Sbjct: 74  -----LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 126
Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWM 301
           ++  G+ ++H  G+++RDLK DN+L+  D  IKIADFG+ +  +  +  T E  GT  ++
Sbjct: 127 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYI 186
Query: 302 AP 303
           AP
Sbjct: 187 AP 188

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 27/137 (19%)
Query: 157 EVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAK 216
           E A+KI+++ + DP +              L   +HPNI+             +VTE  K
Sbjct: 49  EFAVKIIDKSKRDPTE---------EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXK 99
Query: 217 GGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS 270
           GG +      ++F ++R+  +V           + + + Y+H  G++HRDLK  N+L   
Sbjct: 100 GGELLDKILRQKFFSEREASAV--------LFTITKTVEYLHAQGVVHRDLKPSNILYVD 151
Query: 271 D----KSIKIADFGVAR 283
           +    +SI+I DFG A+
Sbjct: 152 ESGNPESIRICDFGFAK 168

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 138 DAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
           +   +G +G +Y+   N GE  A+K +   + D                 L  LKH NIV
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKED----EGIPSTTIREISILKELKHSNIV 63
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYVHRL 254
           +            +V E+     +++ L   +    SV  K  + Q L+   G+AY H  
Sbjct: 64  KLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN---GIAYCHDR 119
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
            ++HRDLK  NLLI  +  +KIADFG+AR   +     T E  T  + AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
           ++ +   +GAF  + R  +   G E A KI+    N  + +                L+H
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKII----NTKKLSARDFQKLEREARICRKLQH 64
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYV 251
           PNIVR   + ++     +V +   GG + + +  R+  S       ++Q L+    +AY 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SIAYC 121
Query: 252 HRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEV-QTEGMTPETGTYRWMAP 303
           H  G++HR+LK +NLL+ S     ++K+ADFG+A IEV  +E      GT  +++P
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSP 176

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  M PE  T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 75/170 (44%), Gaps = 12/170 (7%)
Query: 138 DAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
           +   +G +G +Y+   N GE  A+K +   + D                 L  LKH NIV
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKED----EGIPSTTIREISILKELKHSNIV 63
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYVHRL 254
           +            +V E+     +++ L   +    SV  K  + Q L+   G+AY H  
Sbjct: 64  KLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN---GIAYCHDR 119
Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
            ++HRDLK  NLLI  +  +KIADFG+AR   +     T E  T  + AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 90
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANSFVGTAQYVS 202
Query: 303 P 303
           P
Sbjct: 203 P 203

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  M PE  T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAP 194

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 135 NMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
            + +   +GAF  + R      G+E A KI+    N  + +                LKH
Sbjct: 25  QLFEELGKGAFSVVRRCVKVLAGQEYAAKII----NTKKLSARDHQKLEREARICRLLKH 80
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYV 251
           PNIVR   +  +     ++ +   GG + + +  R+  S       ++Q L+    + + 
Sbjct: 81  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE---AVLHC 137
Query: 252 HRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEVQTE 289
           H++G++HRDLK +NLL+ S     ++K+ADFG+A IEV+ E
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGE 177

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G F ++YR     +G  VA+K ++  +    KA             L  L HPN++++ 
Sbjct: 42  RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL---LKQLNHPNVIKYY 98
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLT--KRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
            +  +     IV E A  G + + +   K+Q R +P +   K  + +   + ++H   ++
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 258 HRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           HRD+K  N+ I +   +K+ D G+ R    +T       GT  +M+P
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 90
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 202
Query: 303 P 303
           P
Sbjct: 203 P 203

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 227 RQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFGVARIE 285
           R  RS+P+ L       + R + ++H LG+ HRD+K  NLL+ S D ++K+ DFG A+  
Sbjct: 133 RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192
Query: 286 VQTEGMTPETGTYRWMAP 303
           + +E       +  + AP
Sbjct: 193 IPSEPSVAXICSRFYRAP 210

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 91
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 149
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANSFVGTAQYVS 203
Query: 303 P 303
           P
Sbjct: 204 P 204

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 70/163 (42%), Gaps = 29/163 (17%)
Query: 139 AFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              QGAFG++   R   +    AIK +   E                   LA+L H  +V
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-------KLSTILSEVMLLASLNHQYVV 65
Query: 197 RF-------------IGACRKPMVWCIVTEYAKGGSVRQFLTKR---QNRSVPLKLAVKQ 240
           R+             + A +K     I  EY + G++   +      Q R    +L  +Q
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL-FRQ 124
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            L+    ++Y+H  G+IHRDLK  N+ I   +++KI DFG+A+
Sbjct: 125 ILE---ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 45/75 (60%), Gaps = 1/75 (1%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V EY   G +R FL + + R    +L +  +  + +GM Y+     +HRDL + N+L+ 
Sbjct: 87  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSS-QICKGMEYLGSRRCVHRDLAARNILVE 145
Query: 270 SDKSIKIADFGVARI 284
           S+  +KIADFG+A++
Sbjct: 146 SEAHVKIADFGLAKL 160

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 87
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 145
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 146 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANSFVGTAQYVS 199
Query: 303 P 303
           P
Sbjct: 200 P 200

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 90
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 202
Query: 303 P 303
           P
Sbjct: 203 P 203

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 90
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 202
Query: 303 P 303
           P
Sbjct: 203 P 203

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 88
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 146
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 200
Query: 303 P 303
           P
Sbjct: 201 P 201

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 139 AFAQGAFGKLYR-----GTYNGEEVAIKILERP---ENDPEKAXXXXXXXXXXXXXLATL 190
              +G +GK+++     G   G+  A+K+L++     N  + A             L  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI-----LEEV 78
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
           KHP IV  I A +      ++ EY  GG +  F+   +        A     +++  + +
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           +H+ G+I+RDLK +N+++     +K+ DFG+ +  +    +T    GT  +MAP
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 95
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 96  HPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 153
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 154 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 207
Query: 303 P 303
           P
Sbjct: 208 P 208

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 139 AFAQGAFGKLYR-----GTYNGEEVAIKILERP---ENDPEKAXXXXXXXXXXXXXLATL 190
              +G +GK+++     G   G+  A+K+L++     N  + A             L  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI-----LEEV 78
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
           KHP IV  I A +      ++ EY  GG +  F+   +        A     +++  + +
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           +H+ G+I+RDLK +N+++     +K+ DFG+ +  +    +T    GT  +MAP
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 88
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 146
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANAFVGTAQYVS 200
Query: 303 P 303
           P
Sbjct: 201 P 201

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 90
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 202
Query: 303 P 303
           P
Sbjct: 203 P 203

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 88
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 146
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 200
Query: 303 P 303
           P
Sbjct: 201 P 201

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 7/121 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVA 245
           + +L HPNI+R            +V E   GG +  + + KR  R      A +   DV 
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD---AARIMKDVL 133
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
             +AY H+L + HRDLK +N L  +   D  +K+ DFG+A      + M  + GT  +++
Sbjct: 134 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 193
Query: 303 P 303
           P
Sbjct: 194 P 194

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 79/178 (44%), Gaps = 13/178 (7%)
Query: 131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERP-ENDPEKAXXXXXXXXXXXXXL 187
           L   ++ +    GAFG ++R T    G   A K +  P E+D E               +
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT-------M 102
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           + L+HP +V    A        ++ E+  GG + + +    N+ +    AV+    V +G
Sbjct: 103 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKG 161
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           + ++H    +H DLK +N++  + +S  +K+ DFG+       + +   TGT  + AP
Sbjct: 162 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 219

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 93
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 94  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 151
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 152 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 205
Query: 303 P 303
           P
Sbjct: 206 P 206

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 88
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 146
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 200
Query: 303 P 303
           P
Sbjct: 201 P 201

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLD 91
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 149
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 203
Query: 303 P 303
           P
Sbjct: 204 P 204

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 143 GAFGKLYRG--TYNGEEVAIKILE-RPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           G FG++++   T  G ++A KI++ R   D E+              +  L H N+++  
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISV-------MNQLDHANLIQLY 152
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK--LAVKQALDVARGMAYVHRLGLI 257
            A        +V EY  GG +   +         L   L +KQ   +  G+ ++H++ ++
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ---ICEGIRHMHQMYIL 209
Query: 258 HRDLKSDNLLIFS--DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           H DLK +N+L  +   K IKI DFG+AR     E +    GT  ++AP
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 143 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 199

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 90
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 148
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 202
Query: 303 P 303
           P
Sbjct: 203 P 203

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 124
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+  ++  E      GT  +M+P
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDEMANEFVGTRSYMSP 175

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 137 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 193

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 7/121 (5%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVA 245
           + +L HPNI+R            +V E   GG +  + + KR  R      A +   DV 
Sbjct: 60  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD---AARIMKDVL 116
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
             +AY H+L + HRDLK +N L  +   D  +K+ DFG+A      + M  + GT  +++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 303 P 303
           P
Sbjct: 177 P 177

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 72
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 73  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 130
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 131 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 184
Query: 303 P 303
           P
Sbjct: 185 P 185

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 87
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 145
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 146 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 199
Query: 303 P 303
           P
Sbjct: 200 P 200

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/57 (43%), Positives = 36/57 (63%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR       MTP   T  + AP
Sbjct: 136 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAP 192

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 79/178 (44%), Gaps = 13/178 (7%)
Query: 131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERP-ENDPEKAXXXXXXXXXXXXXL 187
           L   ++ +    GAFG ++R T    G   A K +  P E+D E               +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT-------M 208
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           + L+HP +V    A        ++ E+  GG + + +    N+ +    AV+    V +G
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKG 267
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           + ++H    +H DLK +N++  + +S  +K+ DFG+       + +   TGT  + AP
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 27/71 (38%), Positives = 42/71 (59%), Gaps = 1/71 (1%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V EY  GG +   L+K   R +P ++A     ++   +  VHRLG +HRD+K DN+L+ 
Sbjct: 138 LVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD 196
Query: 270 SDKSIKIADFG 280
               I++ADFG
Sbjct: 197 RCGHIRLADFG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 66
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 124
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 178
Query: 303 P 303
           P
Sbjct: 179 P 179

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 17/175 (9%)
Query: 138 DAFAQGAFGKLYRG--TYNGEEVAIK--ILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           +    G +  +Y+G     G  VA+K   L+  E  P  A             +  LKH 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISL-------MKELKHE 63
Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----NRSVPLKLAVKQALDVARGMA 249
           NIVR            +V E+     +++++  R      R + L L       + +G+A
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           + H   ++HRDLK  NLLI     +K+ DFG+AR   +     + E  T  + AP
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 67
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 68  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 125
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 126 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 179
Query: 303 P 303
           P
Sbjct: 180 P 180

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 62/121 (51%), Gaps = 8/121 (6%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVA 245
           L  L HP I++ I        + IV E  +GG +  + +  ++ +    KL   Q L   
Sbjct: 208 LKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML--- 263
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
             + Y+H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT  ++A
Sbjct: 264 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 323
Query: 303 P 303
           P
Sbjct: 324 P 324

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 65
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 66  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 123
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 124 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 177
Query: 303 P 303
           P
Sbjct: 178 P 178

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 15/165 (9%)
Query: 130 DLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLAT 189
           D R L       +G+F  +Y+G      V +   E    D +               L  
Sbjct: 24  DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEXLKG 81
Query: 190 LKHPNIVRFIGAC------RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           L+HPNIVRF  +       +K +V  +VTE    G+++ +L  ++ +   +K+       
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIV--LVTELXTSGTLKTYL--KRFKVXKIKVLRSWCRQ 137
Query: 244 VARGMAYVHRLG--LIHRDLKSDNLLIFSDK-SIKIADFGVARIE 285
           + +G+ ++H     +IHRDLK DN+ I     S+KI D G+A ++
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 62/121 (51%), Gaps = 8/121 (6%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQALDVA 245
           L  L HP I++ I        + IV E  +GG +  + +  ++ +    KL   Q L   
Sbjct: 194 LKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML--- 249
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
             + Y+H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT  ++A
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 303 P 303
           P
Sbjct: 310 P 310

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 136 MGDAFAQGAFG--KLYRGTYNGEEVAIKILERP--------ENDPEKAXXXXXXXXXXXX 185
           M      GA G  KL       ++VAIKI+ +         E DP               
Sbjct: 20  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP------ALNVETEIE 73
Query: 186 XLATLKHPNIVR---FIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQA 241
            L  L HP I++   F  A      + IV E  +GG +  + +  ++ +    KL   Q 
Sbjct: 74  ILKKLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTY 298
           L     + Y+H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT 
Sbjct: 130 L---LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 299 RWMAP 303
            ++AP
Sbjct: 187 TYLAP 191

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 90/191 (47%), Gaps = 20/191 (10%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLY-----RGTYNGEEVAIKILERPENDPEKAX 174
           G+ENF+          +      GA+GK++      G   G+  A+K+L++     +KA 
Sbjct: 52  GIENFE----------LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA-TIVQKAK 100
Query: 175 XXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                           + P +V    A +      ++ +Y  GG +   L++R+ R    
Sbjct: 101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEH 159
Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGMT 292
           ++ +    ++   + ++H+LG+I+RD+K +N+L+ S+  + + DFG+++  +  +TE   
Sbjct: 160 EVQIYVG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 293 PETGTYRWMAP 303
              GT  +MAP
Sbjct: 219 DFCGTIEYMAP 229

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 136 MGDAFAQGAFG--KLYRGTYNGEEVAIKILERP--------ENDPEKAXXXXXXXXXXXX 185
           M      GA G  KL       ++VAIKI+ +         E DP               
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP------ALNVETEIE 67
Query: 186 XLATLKHPNIVR---FIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQA 241
            L  L HP I++   F  A      + IV E  +GG +  + +  ++ +    KL   Q 
Sbjct: 68  ILKKLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTY 298
           L     + Y+H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT 
Sbjct: 124 L---LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 299 RWMAP 303
            ++AP
Sbjct: 181 TYLAP 185

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 22/181 (12%)
Query: 134 LNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
              G    +G+F    L R      E AIKILE+     E               ++ L 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV---MSRLD 68
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP  V+     +          YAK G + +++  R+  S           ++   + Y+
Sbjct: 69  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYL 126
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---------GTYRWMA 302
           H  G+IHRDLK +N+L+  D  I+I DFG A++      ++PE+         GT ++++
Sbjct: 127 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKV------LSPESKQARANXFVGTAQYVS 180
Query: 303 P 303
           P
Sbjct: 181 P 181

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 136 MGDAFAQGAFG--KLYRGTYNGEEVAIKILERP--------ENDPEKAXXXXXXXXXXXX 185
           M      GA G  KL       ++VAIKI+ +         E DP               
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP------ALNVETEIE 67
Query: 186 XLATLKHPNIVR---FIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQA 241
            L  L HP I++   F  A      + IV E  +GG +  + +  ++ +    KL   Q 
Sbjct: 68  ILKKLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTY 298
           L     + Y+H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT 
Sbjct: 124 L---LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 299 RWMAP 303
            ++AP
Sbjct: 181 TYLAP 185

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 136 MGDAFAQGAFG--KLYRGTYNGEEVAIKILERP--------ENDPEKAXXXXXXXXXXXX 185
           M      GA G  KL       ++VAIKI+ +         E DP               
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP------ALNVETEIE 67
Query: 186 XLATLKHPNIVR---FIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQA 241
            L  L HP I++   F  A      + IV E  +GG +  + +  ++ +    KL   Q 
Sbjct: 68  ILKKLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTY 298
           L     + Y+H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT 
Sbjct: 124 L---LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 299 RWMAP 303
            ++AP
Sbjct: 181 TYLAP 185

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 136 MGDAFAQGAFG--KLYRGTYNGEEVAIKILERP--------ENDPEKAXXXXXXXXXXXX 185
           M      GA G  KL       ++VAIKI+ +         E DP               
Sbjct: 13  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADP------ALNVETEIE 66
Query: 186 XLATLKHPNIVR---FIGACRKPMVWCIVTEYAKGGSV-RQFLTKRQNRSVPLKLAVKQA 241
            L  L HP I++   F  A      + IV E  +GG +  + +  ++ +    KL   Q 
Sbjct: 67  ILKKLNHPCIIKIKNFFDA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTY 298
           L     + Y+H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT 
Sbjct: 123 L---LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 299 RWMAP 303
            ++AP
Sbjct: 180 TYLAP 184

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 183
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V EYA GG +   L +    S P   A   A  +     Y+H L LI+RDLK +NLLI 
Sbjct: 119 MVLEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 270 SDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               IK+ADFG A R++ +T  +    GT  ++AP
Sbjct: 177 QQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 172

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 172

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
            + +   +GAF  + R      G+E A KI+    N  + +                LKH
Sbjct: 7   QLFEELGKGAFSVVRRCMKIPTGQEYAAKII----NTKKLSARDHQKLEREARICRLLKH 62
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYV 251
           PNIVR   +  +     +V +   GG + + +  R+  S       ++Q L+    + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE---SVNHC 119
Query: 252 HRLGLIHRDLKSDNLLIFSDK---SIKIADFGVARIEVQ 287
           H  G++HRDLK +NLL+ S     ++K+ADFG+A IEVQ
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQ 157

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           ++TID    ++G    +G FG +Y  R   N   +A+K+L + + + E            
Sbjct: 11  KFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 68
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVK 239
               + L+HPNI+R            ++ E+A  G + + L K     + RS        
Sbjct: 69  Q---SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF----- 120
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
              ++A  + Y H   +IHRD+K +NLL+     +KIADFG
Sbjct: 121 -MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 172

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 172

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 140
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +       GT  +M+P
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSP 191

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 26/60 (43%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLLI +   +KI DFG+ARI   E    G   E    RW
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 121
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 172

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKL--YRGTYNGEEVAIKILERPENDPEKAXXXX 177
           G +NF+    DL  +       +GA+G +   R   +G+ +A+K +    N  E+     
Sbjct: 42  GNQNFEVKADDLEPIM---ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLM 98
Query: 178 XXXXXXXXXLATLKHPNIVRFIGAC-RKPMVW-CI-VTEYAKGGSVRQFLTKRQNRSVPL 234
                    + T+  P  V F GA  R+  VW C+ + + +     +Q + K Q  ++P 
Sbjct: 99  DLDIS----MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ--TIPE 152
Query: 235 KLAVKQALDVARGMAYVH-RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
            +  K A+ + + + ++H +L +IHRD+K  N+LI +   +K+ DFG++   V +   T 
Sbjct: 153 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTI 212
Query: 294 ETGTYRWMAP 303
           + G   +MAP
Sbjct: 213 DAGCKPYMAP 222

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV- 251
           P IV F GA        I  E+  GGS+ Q L K+  R +P ++  K ++ V +G+ Y+ 
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLR 148
Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +  ++HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 199

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 62/117 (52%), Gaps = 8/117 (6%)
Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HPNIV+        +   +V E   GG + + + K+++ S      + + L     ++++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL--VSAVSHM 122
Query: 252 HRLGLIHRDLKSDNLLIFSDKS----IKIADFGVARIE-VQTEGMTPETGTYRWMAP 303
           H +G++HRDLK +NLL F+D++    IKI DFG AR++    + +     T  + AP
Sbjct: 123 HDVGVVHRDLKPENLL-FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     IK+ADFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 142 QGAFGKLYRGTY--NGEEVAIKILERP----ENDPEKAXXXXXXXXXXXXXLATLKHPNI 195
           +G+FGK++   +    +  AIK L++     ++D E                   +HP +
Sbjct: 27  KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS------LAWEHPFL 80
Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
                  +       V EY  GG +   +  +      L  A   A ++  G+ ++H  G
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           +++RDLK DN+L+  D  IKIADFG+ +  +  +  T    GT  ++AP
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 135 NMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKH 192
            + +   +GAF  + R      G+E A KI+    N  + +                LKH
Sbjct: 7   QLFEELGKGAFSVVRRCMKIPTGQEYAAKII----NTKKLSARDHQKLEREARICRLLKH 62
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYV 251
           PNIVR   +  +     +V +   GG + + +  R+  S       ++Q L+    + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE---SVNHC 119
Query: 252 HRLGLIHRDLKSDNLLIFSDK---SIKIADFGVARIEVQ 287
           H  G++HRDLK +NLL+ S     ++K+ADFG+A IEVQ
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQ 157

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 60/104 (57%), Gaps = 8/104 (7%)
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGM 248
           LKHPNIVR   +  +     ++ +   GG + + +  R+  S       ++Q L+    +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE---AV 123
Query: 249 AYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEVQTE 289
            + H++G++HR+LK +NLL+ S     ++K+ADFG+A IEV+ E
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGE 166

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 36/57 (63%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  M P   T  + AP
Sbjct: 140 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAP 196

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 112 MDSNSPTEGLENFDEWTIDLRKLNM---GDAFAQGAFGKLYRGT-------YNGEEVAIK 161
           + S+  +  L+   +  +D R +     G    +G F K Y  T       + G+ V   
Sbjct: 3   LGSDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKS 62
Query: 162 ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVR 221
           +L +P    + +               +L +P++V F G         +V E  +  S+ 
Sbjct: 63  MLLKPHQKEKMSTEIAIH--------KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLL 114
Query: 222 QFLTKRQNRSVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           +   +R+  + P  +  ++Q +   +G+ Y+H   +IHRDLK  NL +  D  +KI DFG
Sbjct: 115 ELHKRRKAVTEPEARYFMRQTI---QGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFG 171
Query: 281 VA-RIEVQTEGMTPETGTYRWMAP 303
           +A +IE   E      GT  ++AP
Sbjct: 172 LATKIEFDGERKKDLCGTPNYIAP 195

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 17/173 (9%)
Query: 139 AFAQGAFGK--LYRGTYNGEEVAIKILER----PENDPEKAXXXXXXXXXXXXXLATLKH 192
              +G+FGK  L R    G+  A+K+L++     ++D E                    H
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR------NH 83
Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           P + +     + P     V E+  GG +   + K  +R      A   A ++   + ++H
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLH 141
Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
             G+I+RDLK DN+L+  +   K+ADFG+ + E    G+T  T  GT  ++AP
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAP 193

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 8/102 (7%)
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGM 248
           LKH NIVR   +  +     +V +   GG + + +  R+  S       ++Q L+    +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE---AV 116
Query: 249 AYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEVQ 287
            + H++G++HRDLK +NLL+ S     ++K+ADFG+A IEVQ
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQ 157

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI---LQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EYA GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NL+I     IK+ DFG+A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL---CGTPEYLAP 207

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 8/104 (7%)
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGM 248
           LKHPNIVR   +  +     +V +   GG + + +  R+  S       + Q L+    +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE---SV 143
Query: 249 AYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEVQTE 289
            ++H+  ++HRDLK +NLL+ S     ++K+ADFG+A IEVQ E
Sbjct: 144 NHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGE 186

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     IK+ADFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     IK+ADFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 58/104 (55%), Gaps = 11/104 (10%)
Query: 187 LATLKHPNIVRFIGACRKP-----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
           LA + HP+IV+              V  IV EY  G    Q L + + + +P+  A+   
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG----QSLKRSKGQKLPVAEAIAYL 188
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG-VARI 284
           L++   ++Y+H +GL++ DLK +N+++ +++ +K+ D G V+RI
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRI 231

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EYA GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NL+I     IK+ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 34/147 (23%)
Query: 187 LATLKHPNIVRFIGACRK-----------PMVWC-IVTEYAKGGSVRQFLTKR-----QN 229
           LA L+HP IVR+  A  +           P V+  I  +  +  +++ ++  R     + 
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           RSV L +     L +A  + ++H  GL+HRDLK  N+    D  +K+ DFG+     Q E
Sbjct: 117 RSVCLHIF----LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 290 G----MTP---------ETGTYRWMAP 303
                +TP         + GT  +M+P
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSP 199

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 29/163 (17%)
Query: 139 AFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              QGAFG++   R   +    AIK +   E                   LA+L H  +V
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-------KLSTILSEVMLLASLNHQYVV 65
Query: 197 RF-------------IGACRKPMVWCIVTEYAKGGSVRQFLTKR---QNRSVPLKLAVKQ 240
           R+             + A +K     I  EY +  ++   +      Q R    +L  +Q
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL-FRQ 124
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            L+    ++Y+H  G+IHRDLK  N+ I   +++KI DFG+A+
Sbjct: 125 ILE---ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 20/182 (10%)
Query: 131 LRKLNMGDAFAQGAFGKLYRGT-------YNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +++   G    +G F K Y  T       + G+ V   +L +P    EK           
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIH--- 96
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQAL 242
                +L +P++V F G         +V E  +  S+ +   +R+  + P  +  ++Q +
Sbjct: 97  ----KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWM 301
              +G+ Y+H   +IHRDLK  NL +  D  +KI DFG+A +IE   E      GT  ++
Sbjct: 153 ---QGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYI 209
Query: 302 AP 303
           AP
Sbjct: 210 AP 211

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 20/182 (10%)
Query: 131 LRKLNMGDAFAQGAFGKLYRGT-------YNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +++   G    +G F K Y  T       + G+ V   +L +P    EK           
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIH--- 96
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQAL 242
                +L +P++V F G         +V E  +  S+ +   +R+  + P  +  ++Q +
Sbjct: 97  ----KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWM 301
              +G+ Y+H   +IHRDLK  NL +  D  +KI DFG+A +IE   E      GT  ++
Sbjct: 153 ---QGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYI 209
Query: 302 AP 303
           AP
Sbjct: 210 AP 211

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EYA GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NL+I     IK+ DFG A R++ +T  +    GT  ++AP
Sbjct: 168 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 20/182 (10%)
Query: 131 LRKLNMGDAFAQGAFGKLYRGT-------YNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           +++   G    +G F K Y  T       + G+ V   +L +P    EK           
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIH--- 96
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQAL 242
                +L +P++V F G         +V E  +  S+ +   +R+  + P  +  ++Q +
Sbjct: 97  ----KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWM 301
              +G+ Y+H   +IHRDLK  NL +  D  +KI DFG+A +IE   E      GT  ++
Sbjct: 153 ---QGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYI 209
Query: 302 AP 303
           AP
Sbjct: 210 AP 211

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 81/181 (44%), Gaps = 15/181 (8%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPEN--DPEKAXXXXXXXXXXXXXL 187
           +K +  D   +G    + R  +   G E A+KI+E       PE+              L
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 188 ATLK-HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
             +  HP+I+  I +        +V +  + G +  +LT++      + L+ K+   + R
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK------VALSEKETRSIMR 207
Query: 247 GM----AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
            +    +++H   ++HRDLK +N+L+  +  I+++DFG +      E +    GT  ++A
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 303 P 303
           P
Sbjct: 268 P 268

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 130 DLRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXL 187
           D+ KL   +   +GA+ K+       NG+E A+KI+E+      +A             L
Sbjct: 12  DMYKLT-SELLGEGAYAKVQGAVSLQNGKEYAVKIIEK------QAGHSRSRVFREVETL 64
Query: 188 ATLK-HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
              + + NI+  I        + +V E  +GGS+   + K+++ +   + A +   DVA 
Sbjct: 65  YQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNE--REASRVVRDVAA 122
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGV--------ARIEVQTEGMTPET 295
            + ++H  G+ HRDLK +N+L  S +    +KI DF +        +   + T  +T   
Sbjct: 123 ALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 296 GTYRWMAP 303
           G+  +MAP
Sbjct: 183 GSAEYMAP 190

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V EYA GG +   L +    S P   A   A  +     Y+H L LI+RDLK +NL+I 
Sbjct: 119 MVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID 176
Query: 270 SDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               IK+ DFG A R++ +T  +    GT  ++AP
Sbjct: 177 QQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 38  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 92
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 152
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 153 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 24  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 78
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 139 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V EYA GG +   L +    S P   A   A  +     Y+H L LI+RDLK +NL+I 
Sbjct: 119 MVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID 176
Query: 270 SDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               IK+ DFG A R++ +T  +    GT  ++AP
Sbjct: 177 QQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 37  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 91
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 151
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 152 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 38  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 92
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 152
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 153 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 34/58 (58%), Gaps = 2/58 (3%)
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           RG+ Y+H  G+IHRDLK  N+ +  D  ++I DFG+AR     E MT    T  + AP
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAP 197

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI---LQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EYA GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NL+I     I++ DFG+A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 34/58 (58%), Gaps = 2/58 (3%)
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           RG+ Y+H  G+IHRDLK  N+ +  D  ++I DFG+AR     E MT    T  + AP
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAP 197

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L +    G   A+KIL++   +   A             L   +HP +    
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIH 258
            + +     C V EYA GG +  F    + R      A     ++   + Y+H    +++
Sbjct: 215 YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           RDLK +NL++  D  IKI DFG+ +  ++ +G T +T  GT  ++AP
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFCGTPEYLAP 318

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 8/121 (6%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVA 245
           L  +KH NIV           + +V +   GG +   + +R   +     L ++Q L   
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
           +   Y+H  G++HRDLK +NLL  +   +  I I DFG++++E Q   M+   GT  ++A
Sbjct: 120 K---YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVA 175
Query: 303 P 303
           P
Sbjct: 176 P 176

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 28  WEVPERYQNLA-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 82
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 83  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 142
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 143 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L +    G   A+KIL++   +   A             L   +HP +    
Sbjct: 161 KGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIH 258
            + +     C V EYA GG +  F    + R      A     ++   + Y+H    +++
Sbjct: 218 YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           RDLK +NL++  D  IKI DFG+ +  ++ +G T +T  GT  ++AP
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFCGTPEYLAP 321

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 14/124 (11%)
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV-----KQALDV 244
           LKHP+IV  +       +  +V E+  G  +   + KR +       AV     +Q L+ 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTP--ETGTYR 299
            R   Y H   +IHRD+K +N+L+ S ++   +K+ DFGVA I++   G+      GT  
Sbjct: 143 LR---YCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVAGGRVGTPH 198
Query: 300 WMAP 303
           +MAP
Sbjct: 199 FMAP 202

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 20  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 74
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 135 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 13/171 (7%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXX 177
           G+E F +  ++    ++G+    G F   K  R    G E A K +++ ++   +     
Sbjct: 1   GMETFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR 59
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    L  + HPNI+             ++ E   GG +  FL ++++ S     +
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 238 -VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADFGVA 282
            +KQ LD   G+ Y+H   + H DLK +N+++  DK+     IK+ DFG+A
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLA 166

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 23  WEVPERYQNLS-PIGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 77
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 138 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 24  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 78
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 139 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARG 247
           +L H ++V F G         +V E  +  S+ +   +R+  + P  +  ++Q   +  G
Sbjct: 73  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---IVLG 129
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
             Y+HR  +IHRDLK  NL +  D  +KI DFG+A ++E   E      GT  ++AP
Sbjct: 130 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 93
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAP 207

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 94
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 95  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EYA GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NL+I     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 38  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 95
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 96  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 152
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARG 247
           +L H ++V F G         +V E  +  S+ +   +R+  + P  +  ++Q   +  G
Sbjct: 73  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---IVLG 129
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
             Y+HR  +IHRDLK  NL +  D  +KI DFG+A ++E   E      GT  ++AP
Sbjct: 130 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 94
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 95  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 93
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 93
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 114
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 172
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT-PETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A+   + +G T    GT  ++AP
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGATWTLCGTPEYLAP 228

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARG 247
           +L H ++V F G         +V E  +  S+ +   +R+  + P  +  ++Q   +  G
Sbjct: 77  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---IVLG 133
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
             Y+HR  +IHRDLK  NL +  D  +KI DFG+A ++E   E      GT  ++AP
Sbjct: 134 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 14  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 68
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 129 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 93
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 23/172 (13%)
Query: 143 GAFGKLYRGTY-NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI-- 199
           G+FG +++      +EVAIK          K              +  +KHPN+V     
Sbjct: 51  GSFGVVFQAKLVESDEVAIK----------KVLQDKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 200 ----GACRKPMVWCIVTEYAKGG---SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
               G  +  +   +V EY       + R +   +Q  ++P+ L       + R +AY+H
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ--TMPMLLIKLYMYQLLRSLAYIH 158
Query: 253 RLGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +G+ HRD+K  NLL+     + K+ DFG A+I +  E       +  + AP
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAP 210

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 14  WEVPERYQNLSPV-GSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 68
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 129 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 94
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 95  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAP 207

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 29  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 83
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 143
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 144 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 12/176 (6%)
Query: 136 MGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           MG+    G F   +  R    G+E A K +++      +              L  ++HP
Sbjct: 30  MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHP 89
Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV-PLKLAVKQALDVARGMAYVH 252
           NI+             ++ E   GG +  FL ++++ +       +KQ LD   G+ Y+H
Sbjct: 90  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLH 146
Query: 253 RLGLIHRDLKSDNLLIFS----DKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
              + H DLK +N+++      +  IK+ DFG+A +IE   E      GT  ++AP
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAP 201

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 94
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 95  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 94
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 95  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 23  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 77
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 138 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/58 (43%), Positives = 34/58 (58%), Gaps = 2/58 (3%)
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           RG+ Y+H  G+IHRDLK  N+ +  D  ++I DFG+AR     E MT    T  + AP
Sbjct: 134 RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAP 189

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 12/176 (6%)
Query: 136 MGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           MG+    G F   +  R    G+E A K +++      +              L  ++HP
Sbjct: 9   MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV-PLKLAVKQALDVARGMAYVH 252
           NI+             ++ E   GG +  FL ++++ +       +KQ LD   G+ Y+H
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLH 125
Query: 253 RLGLIHRDLKSDNLLIFS----DKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
              + H DLK +N+++      +  IK+ DFG+A +IE   E      GT  ++AP
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAP 180

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 20/37 (54%), Positives = 27/37 (72%)
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           G+ YVH  G++HRDLK  N L+  D S+K+ DFG+AR
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 9/166 (5%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L +    G   A+KIL++   +   A             L   +HP +    
Sbjct: 18  KGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIH 258
            + +     C V EYA GG +  F    + R      A     ++   + Y+H    +++
Sbjct: 75  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           RDLK +NL++  D  IKI DFG+ +  ++    M    GT  ++AP
Sbjct: 133 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 178

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 24  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 81
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 82  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 138
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 194

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARG 247
           +L H ++V F G         +V E  +  S+ +   +R+  + P  +  ++Q   +  G
Sbjct: 95  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---IVLG 151
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
             Y+HR  +IHRDLK  NL +  D  +KI DFG+A ++E   E      GT  ++AP
Sbjct: 152 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARG 247
           +L H ++V F G         +V E  +  S+ +   +R+  + P  +  ++Q   +  G
Sbjct: 97  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---IVLG 153
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
             Y+HR  +IHRDLK  NL +  D  +KI DFG+A ++E   E      GT  ++AP
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVR--- 197
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 198 --FIGACRKPMVWC-IVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
             +    +K +V+  +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 9/166 (5%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L +    G   A+KIL++   +   A             L   +HP +    
Sbjct: 19  KGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 75
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIH 258
            + +     C V EYA GG +  F    + R      A     ++   + Y+H    +++
Sbjct: 76  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           RDLK +NL++  D  IKI DFG+ +  ++    M    GT  ++AP
Sbjct: 134 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 179

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 189 TLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARG 247
           +L H ++V F G         +V E  +  S+ +   +R+  + P  +  ++Q   +  G
Sbjct: 71  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---IVLG 127
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
             Y+HR  +IHRDLK  NL +  D  +KI DFG+A ++E   E      GT  ++AP
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EYA GG +   L +      P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NL+I     IK+ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEY 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEY 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 41  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 95
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 155
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 156 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 29/163 (17%)
Query: 139 AFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
              QGAFG++   R   +    AIK +   E                   LA+L H  +V
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-------KLSTILSEVXLLASLNHQYVV 65
Query: 197 RFIGA-------------CRKPMVWCIVTEYAKGGSVRQFLTKR---QNRSVPLKLAVKQ 240
           R+  A              +K     I  EY +  ++   +      Q R    +L  +Q
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL-FRQ 124
Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
            L+    ++Y+H  G+IHR+LK  N+ I   +++KI DFG+A+
Sbjct: 125 ILE---ALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+ R
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 24  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 78
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 139 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 73  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 129
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 187
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 188 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 228

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 37  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 91
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 151
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 152 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 38  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 92
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 152
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 153 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 9/166 (5%)
Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFI 199
           +G FGK  L +    G   A+KIL++   +   A             L   +HP +    
Sbjct: 20  KGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIH 258
            + +     C V EYA GG +  F    + R      A     ++   + Y+H    +++
Sbjct: 77  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           RDLK +NL++  D  IKI DFG+ +  ++    M    GT  ++AP
Sbjct: 135 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 180

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 30  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 84
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 144
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 145 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 30  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 84
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 144
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 145 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 20  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 74
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 135 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 12/176 (6%)
Query: 136 MGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHP 193
           MG+    G F   +  R    G+E A K +++      +              L  ++HP
Sbjct: 16  MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 75
Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV-PLKLAVKQALDVARGMAYVH 252
           NI+             ++ E   GG +  FL ++++ +       +KQ LD   G+ Y+H
Sbjct: 76  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLH 132
Query: 253 RLGLIHRDLKSDNLLIFS----DKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
              + H DLK +N+++      +  IK+ DFG+A +IE   E      GT  ++AP
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAP 187

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 41  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 95
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 155
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 156 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEY 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 24  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 78
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 139 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 109
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 20  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 74
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 135 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 20  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 74
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 135 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 74/184 (40%), Gaps = 17/184 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 25  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 79
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR 299
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR     + MT    T  
Sbjct: 140 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRW 194
Query: 300 WMAP 303
           + AP
Sbjct: 195 YRAP 198

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 109
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAP 208

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLK---QIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/60 (38%), Positives = 34/60 (56%), Gaps = 3/60 (5%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRW 300
           + RG+ Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+   +    G   E    RW
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 101
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 159
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 160 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 200

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 74/184 (40%), Gaps = 17/184 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 25  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 79
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR 299
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR     + MT    T  
Sbjct: 140 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRW 194
Query: 300 WMAP 303
           + AP
Sbjct: 195 YRAP 198

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 74/184 (40%), Gaps = 17/184 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR 299
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR     + MT    T  
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGXVATRW 187
Query: 300 WMAP 303
           + AP
Sbjct: 188 YRAP 191

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 74/184 (40%), Gaps = 17/184 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 25  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 79
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR 299
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR     + MT    T  
Sbjct: 140 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATRW 194
Query: 300 WMAP 303
           + AP
Sbjct: 195 YRAP 198

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 29  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 83
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 143
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 144 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           + RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 93
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NL+I     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 17/161 (10%)
Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXX 183
           ++TID    ++     +G FG +Y  R   N   +A+K+L + + + E            
Sbjct: 10  KFTID--DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 184 XXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVK 239
               + L+HPNI+R            ++ E+A  G + + L K     + RS        
Sbjct: 68  Q---SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF----- 119
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
              ++A  + Y H   +IHRD+K +NLL+     +KIADFG
Sbjct: 120 -MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----------KVLQGKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 38  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 94
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 152
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 153 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL---CGTPEYLAP 193

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 23  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 77
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 138 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 17  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 71
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 72  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 131
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 132 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 25  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 79
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 140 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 109
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 53  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 109
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +    S P   A   A  +     Y+H L LI+RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 16  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 70
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 71  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 130
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 131 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 23  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 77
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 138 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 15  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 69
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 129
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 130 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           A L  P IV   GA R+     I  E  +GGS+ Q +  +Q   +P   A+        G
Sbjct: 119 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEG 176
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKS-IKIADFGVARIEVQTEGM 291
           + Y+H   ++H D+K+DN+L+ SD S   + DFG A + +Q +G+
Sbjct: 177 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGL 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 14  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 68
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 129 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 15  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 69
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 129
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 130 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V EYA GG +   L +      P   A   A  +     Y+H L LI+RDLK +NL+I 
Sbjct: 119 MVMEYAPGGEMFSHLRRIGRFXEPH--ARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID 176
Query: 270 SDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               IK+ DFG A R++ +T  +    GT  ++AP
Sbjct: 177 QQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V +Y  GG +   L+K ++R +P ++A     ++   +  VH+L  +HRD+K DN+L+ 
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209
Query: 270 SDKSIKIADFG--VARIEVQTEGMTPETGTYRWMAP 303
            +  I++ADFG  +  +E  T   +   GT  +++P
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 65  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           A L  P IV   GA R+     I  E  +GGS+ Q +  +Q   +P   A+        G
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEG 162
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKS-IKIADFGVARIEVQTEGM 291
           + Y+H   ++H D+K+DN+L+ SD S   + DFG A + +Q +G+
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGL 206

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 43  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 14  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 68
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +   +     ++  + 
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIY 128
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 129 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 43  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 92
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 203

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 13/147 (8%)
Query: 143 GAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           GA+G +       +GE+VAIK L RP     ++             L  ++H N++  + 
Sbjct: 35  GAYGSVCSAIDKRSGEKVAIKKLSRPF----QSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ----ALDVARGMAYVHRLGL 256
                     +  +     V  F+     + + LK + ++       + +G+ Y+H  G+
Sbjct: 91  VFTPA---SSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV 147
Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +HRDLK  NL +  D  +KI DFG+AR
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 110 GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 159
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 219
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTE 289
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E
Sbjct: 220 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 39  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 88
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 149 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 199

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 50  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 99
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 160 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 210

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 93
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    + P   A   A  + 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 35  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 84
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 145 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 195

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 20/40 (50%), Positives = 27/40 (67%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           + RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 2/97 (2%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           L  LKH NIVR            +V E+      + F     N  +  ++       + +
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF--DSCNGDLDPEIVKSFLFQLLK 112
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           G+ + H   ++HRDLK  NLLI  +  +K+ADFG+AR
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 25/87 (28%), Positives = 45/87 (51%), Gaps = 1/87 (1%)
Query: 218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV-HRLGLIHRDLKSDNLLIFSDKSIKI 276
           G+  + L KR    +P ++  K  + + + + Y+  + G+IHRD+K  N+L+     IK+
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKL 166
Query: 277 ADFGVARIEVQTEGMTPETGTYRWMAP 303
            DFG++   V  +      G   +MAP
Sbjct: 167 CDFGISGRLVDDKAKDRSAGCAAYMAP 193

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 69  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 118
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 178
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTE 289
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E
Sbjct: 179 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
            A L  P IV   GA R+     I  E  +GGS+ Q +  ++   +P   A+        
Sbjct: 139 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQALE 196
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS-IKIADFGVARIEVQTEGM 291
           G+ Y+H   ++H D+K+DN+L+ SD S   + DFG A + +Q +G+
Sbjct: 197 GLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGL 241

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 114
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +      P   A   A  + 
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIV 172
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 59  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 108
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTE 289
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E
Sbjct: 169 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 32  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 81
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 142 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 192

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 67  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 116
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 176
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTE 289
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E
Sbjct: 177 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           A L  P IV   GA R+     I  E  +GGS+ Q +  +Q   +P   A+        G
Sbjct: 121 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEG 178
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKS-IKIADFGVARIEVQTEGM 291
           + Y+H   ++H D+K+DN+L+ SD S   + DFG A + +Q +G+
Sbjct: 179 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGL 222

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 44  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 93
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 154 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 204

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 36  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 85
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTE 289
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E
Sbjct: 146 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 65  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 114
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTE 289
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 6/114 (5%)
Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           A L  P IV   GA R+     I  E  +GGS+ Q +  ++   +P   A+        G
Sbjct: 121 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQALEG 178
Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKS-IKIADFGVARIEVQTEGMTPE--TGTY 298
           + Y+H   ++H D+K+DN+L+ SD S   + DFG A + +Q +G+  +  TG Y
Sbjct: 179 LEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKDLLTGDY 231

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 64/121 (52%), Gaps = 6/121 (4%)
Query: 187 LATLKHPNIVRFIGAC-RKPMVW-CI-VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           + T+  P  V F GA  R+  VW C+ + + +     +Q + K Q  ++P  +  K A+ 
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ--TIPEDILGKIAVS 117
Query: 244 VARGMAYVH-RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
           + + + ++H +L +IHRD+K  N+LI +   +K+ DFG++   V       + G   +MA
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMA 177
Query: 303 P 303
           P
Sbjct: 178 P 178

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAP 191

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 48/95 (50%)
Query: 209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI 268
           C+V     GG ++  +        P   AV  A ++  G+  +HR  +++RDLK +N+L+
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 269 FSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
                I+I+D G+A    + + +    GT  +MAP
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 93
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +      P   A   A  + 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 32  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 89
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +      P   A   A  + 
Sbjct: 90  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIV 146
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 202

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 94
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +      P   A   A  + 
Sbjct: 95  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 3/50 (6%)
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           ++  V Q L   +G+ Y+H  G+IHRDLK  NL +  D  +KI DFG+AR
Sbjct: 130 IQFLVYQML---KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 10/172 (5%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR 93
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +    S P   A   A  + 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGM--TPE 294
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +  TPE
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 203

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 128 TIDLRKLNMGDAFAQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXX 185
           T  L + +       G+FG+  L +   +G   A+KIL++ +    K             
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI-- 94
Query: 186 XLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
            L  +  P +V+   + +      +V EY  GG +   L +      P   A   A  + 
Sbjct: 95  -LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH--ARFYAAQIV 151
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
               Y+H L LI+RDLK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 27/95 (28%), Positives = 48/95 (50%)
Query: 209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI 268
           C+V     GG ++  +        P   AV  A ++  G+  +HR  +++RDLK +N+L+
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 269 FSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
                I+I+D G+A    + + +    GT  +MAP
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----------KVLQGKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 143 GAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRF-- 198
           G+FG +Y+     +GE VAIK          K              +  L H NIVR   
Sbjct: 31  GSFGVVYQAKLCDSGELVAIK----------KVLQGKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 199 ----IGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                G  +  +   +V +Y      R      R  +++P+         + R +AY+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 254 LGLIHRDLKSDNLLIFSDKSI-KIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+ HRD+K  NLL+  D ++ K+ DFG A+  V+ E       +  + AP
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 6   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 117
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 6   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 117
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 19/38 (50%), Positives = 27/38 (71%)
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +G+ Y+H  G++HRDLK  NL +  D  +KI DFG+AR
Sbjct: 155 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI D+G+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 34/176 (19%)
Query: 143 GAFGKLYRGTYNGE--EVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G++ +  R  +     E A+K++++ + DP +              L   +HPNI+    
Sbjct: 38  GSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL---------LRYGQHPNIITLKD 88
Query: 201 ACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
                    +VTE  +GG +      ++F ++R+   V           + + + Y+H  
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV--------LHTIGKTVEYLHSQ 140
Query: 255 GLIHRDLKSDNLLIFSD----KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 303
           G++HRDLK  N+L   +    + ++I DFG A+ +++ E    MTP   T  ++AP
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAK-QLRAENGLLMTP-CYTANFVAP 194

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 140 FAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVR 197
             +G +G++Y+   T   E VAIK + R E++ E               L  L+H NI+ 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSL---LKELQHRNIIE 97
Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
                       ++ EYA+   +++++ K  N  V +++       +  G+ + H    +
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCL 154
Query: 258 HRDLKSDNLLI-FSDKS----IKIADFGVAR 283
           HRDLK  NLL+  SD S    +KI DFG+AR
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 8/61 (13%)
Query: 223 FLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           FLT++  +++   L +        G  ++H  G+IHRDLK  N L+  D S+KI DFG+A
Sbjct: 127 FLTEQHVKTILYNLLL--------GEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLA 178
Query: 283 R 283
           R
Sbjct: 179 R 179

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 45  GSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 101
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +      P   A   A  +     Y+H L LI+RD
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH--ARFYAAQIVLTFEYLHSLDLIYRD 159
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 160 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 200

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 20/38 (52%), Positives = 27/38 (71%)
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           RG+ Y+H   +IHRDLK  NLL+  +  +KI DFG+AR
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 109
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +      P   A   A  +     Y+H L LI+RD
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH--ARFYAAQIVLTFEYLHSLDLIYRD 167
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 168 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 208

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +      P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G+FG+  L +    G   A+KIL++ +    K              L  +  P +V+   
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI---LQAVNFPFLVKLEF 108
Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
           + +      +V EY  GG +   L +      P   A   A  +     Y+H L LI+RD
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH--ARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 261 LKSDNLLIFSDKSIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
           LK +NLLI     I++ DFG A R++ +T  +    GT  ++AP
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAP 207

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 34/176 (19%)
Query: 143 GAFGKLYRGTYNGE--EVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIG 200
           G++ +  R  +     E A+K++++ + DP +              L   +HPNI+    
Sbjct: 38  GSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL---------LRYGQHPNIITLKD 88
Query: 201 ACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
                    +VTE  +GG +      ++F ++R+   V           + + + Y+H  
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV--------LHTIGKTVEYLHSQ 140
Query: 255 GLIHRDLKSDNLLIFSD----KSIKIADFGVARIEVQTEG---MTPETGTYRWMAP 303
           G++HRDLK  N+L   +    + ++I DFG A+ +++ E    MTP   T  ++AP
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAK-QLRAENGLLMTP-CYTANFVAP 194

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 14/167 (8%)
Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXXXX 179
           EN D++       + G+    G F   K  R    G + A K +++      +       
Sbjct: 7   ENVDDY------YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 180 XXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
                  L  ++HPN++             ++ E   GG +  FL +++  S+  + A +
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE--SLTEEEATE 118
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFS----DKSIKIADFGVA 282
               +  G+ Y+H L + H DLK +N+++         IKI DFG+A
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 24/69 (34%), Positives = 37/69 (53%), Gaps = 3/69 (4%)
Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           +  +  VARGM ++     IHRDL + N+L+  +  +KI DFG+AR   +      +  T
Sbjct: 202 ISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 298 ---YRWMAP 303
               +WMAP
Sbjct: 262 RLPLKWMAP 270

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 115 PHIVRIVDVYENLYAGRKCLL--IVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGE 172
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           I+ E  +GG +   + +R +++   + A +   D+   + ++H   + HRD+K +NLL  
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 162
Query: 270 S---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           S   D  +K+ DFG A+   Q    TP    Y ++AP
Sbjct: 163 SKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAP 198

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 20/38 (52%), Positives = 27/38 (71%)
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           RG+ Y+H   +IHRDLK  NLL+  +  +KI DFG+AR
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI DF +AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           I+ E  +GG +   + +R +++   + A +   D+   + ++H   + HRD+K +NLL  
Sbjct: 84  IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYT 143
Query: 270 S---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           S   D  +K+ DFG A+   Q    TP    Y ++AP
Sbjct: 144 SKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAP 179

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 83/222 (37%), Gaps = 54/222 (24%)
Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEV--AIKILERP---ENDPEKAXXXXXXXXXXXXX 186
           +K ++  A  QG++G +     N      AIKI+ +    + +P+               
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL---- 81
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL---------------TKRQNRS 231
           +  L HPNI R           C+V E   GG +   L                K Q   
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 232 VP-----------------LKLAVKQAL------DVARGMAYVHRLGLIHRDLKSDNLLI 268
            P                 L    ++ L       +   + Y+H  G+ HRD+K +N L 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 269 FSDKS--IKIADFGVARIEVQTE-----GMTPETGTYRWMAP 303
            ++KS  IK+ DFG+++   +       GMT + GT  ++AP
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 79/188 (42%), Gaps = 27/188 (14%)
Query: 134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
             +     +GA+G +   T+   GE VAIK +E P + P  A             L   K
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKI----LKHFK 67
Query: 192 HPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+  I   ++P  +       + +      + + ++ +      ++  + Q L   R
Sbjct: 68  HENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL---R 123
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-----------EVQTEGMTPET 295
            +  +H   +IHRDLK  NLLI S+  +K+ DFG+ARI             Q  GMT   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 296 GTYRWMAP 303
            T  + AP
Sbjct: 184 ATRWYRAP 191

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 2/97 (2%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           L  LKH NIVR            +V E+      + F     N  +  ++       + +
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF--DSCNGDLDPEIVKSFLFQLLK 112
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           G+ + H   ++HRDLK  NLLI  +  +K+A+FG+AR
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 45/97 (46%), Gaps = 3/97 (3%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL-- 267
           ++ EYA GG +           V     ++    +  G+ Y+H+  ++H DLK  N+L  
Sbjct: 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165
Query: 268 -IFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            I+    IKI DFG++R       +    GT  ++AP
Sbjct: 166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 85  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 202

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 121 PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 238

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 80/189 (42%), Gaps = 29/189 (15%)
Query: 134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
             +     +GA+G +   T+   GE VAIK +E P + P  A             L   K
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKI----LKHFK 67
Query: 192 HPNIVRFIGACRKPMVW------CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           H NI+  I   ++P  +       I+ E  +    R   T+  +    ++  + Q L   
Sbjct: 68  HENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH-IQYFIYQTL--- 122
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-----------EVQTEGMTPE 294
           R +  +H   +IHRDLK  NLLI S+  +K+ DFG+ARI             Q  GMT  
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 295 TGTYRWMAP 303
             T  + AP
Sbjct: 183 VATRWYRAP 191

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 77  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 194

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGM 248
           L+HP +V    + +      +V +   GG +R  L +  + +   +KL +    ++   +
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI---CELVMAL 128
Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            Y+    +IHRD+K DN+L+     + I DF +A +  +   +T   GT  +MAP
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 115 PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 69  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 186

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 69  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAP 186

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 75  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 192

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 70  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 187

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 71  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 71  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 76  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+       +T    T  ++AP
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 193

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 8/61 (13%)
Query: 223 FLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           FLT+   +++   L +        G  ++H  G+IHRDLK  N L+  D S+K+ DFG+A
Sbjct: 125 FLTEEHIKTILYNLLL--------GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 283 R 283
           R
Sbjct: 177 R 177

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 78/186 (41%), Gaps = 28/186 (15%)
Query: 134 LNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
             +G     G FG+L  G   Y  E VAIK+       P+               L +  
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-----LHLEYRFYKQLGSGD 65
Query: 192 HPNIVRFIGACRK--PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
               V + G C K   MV  ++      G   + L    +R+  LK  +  A+ +   M 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL------GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 250 YVHRLGLIHRDLKSDNLLI-----FSDKSIKIADFGVAR--IEVQTEGMTPE------TG 296
           YVH   LI+RD+K +N LI      + + I I DFG+A+  I+ +T+   P       TG
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTG 179
Query: 297 TYRWMA 302
           T R+M+
Sbjct: 180 TARYMS 185

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI  FG+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 138 DAFAQGAFGKL-YRGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIV 196
           D    GA G + YRG ++  +VA+K +  PE                     + +HPN++
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRI-LPE-------CFSFADREVQLLRESDEHPNVI 81
Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           R+    +      I  E     ++++++ ++    + L+  +        G+A++H L +
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE-PITLLQQTTSGLAHLHSLNI 139
Query: 257 IHRDLKSDNLLIFSDKS---IK--IADFGVA-RIEVQTEGMTPET---GTYRWMAP 303
           +HRDLK  N+LI    +   IK  I+DFG+  ++ V     +  +   GT  W+AP
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 16/158 (10%)
Query: 134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
             +     +GA+G +   T+   GE VAIK +E P + P  A             L   K
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKI----LKHFK 67
Query: 192 HPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           H NI+  I   ++P  +       + +      + + ++ +      ++  + Q L   R
Sbjct: 68  HENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL---R 123
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +  +H   +IHRDLK  NLLI S+  +K+ DFG+ARI
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI D G+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 187 LATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
           L  L+H N+++ +      +     +V EY   G +++ L     +  P+  A      +
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
             G+ Y+H  G++H+D+K  NLL+ +  ++KI+  GVA 
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 22/71 (30%), Positives = 43/71 (60%), Gaps = 1/71 (1%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V +Y  GG +   L+K +++ +P  +A     ++   +  +H+L  +HRD+K DN+L+ 
Sbjct: 167 LVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 225
Query: 270 SDKSIKIADFG 280
            +  I++ADFG
Sbjct: 226 VNGHIRLADFG 236

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 22/71 (30%), Positives = 43/71 (60%), Gaps = 1/71 (1%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V +Y  GG +   L+K +++ +P  +A     ++   +  +H+L  +HRD+K DN+L+ 
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 209
Query: 270 SDKSIKIADFG 280
            +  I++ADFG
Sbjct: 210 VNGHIRLADFG 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 56/114 (49%), Gaps = 3/114 (2%)
Query: 193 PNIVRFIGAC-RKPMVW-CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
           P IV+F GA  R+   W C+           +++    +  +P ++  K  L   + + +
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 251 VHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +   L +IHRD+K  N+L+    +IK+ DFG++   V +   T + G   +MAP
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI D G+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 9/156 (5%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           +TID     +G    +G FG +Y  R   +   VA+K+L + + + E             
Sbjct: 20  FTID--DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 77
Query: 185 XXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
              A L HPNI+R            ++ EYA  G + + L K           + + L  
Sbjct: 78  ---AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL-- 132
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           A  + Y H   +IHRD+K +NLL+     +KIADFG
Sbjct: 133 ADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 21/42 (50%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFGVARI 284
           + RG+ Y+H   ++HRDLK  NL I + D  +KI DFG+ARI
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 13/105 (12%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V E  +GGS+   + KR++ +      V Q  DVA  + ++H  G+ HRDLK +N+L  
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQ--DVASALDFLHNKGIAHRDLKPENILCE 145
Query: 270 SD---KSIKIADFGVAR--------IEVQTEGMTPETGTYRWMAP 303
                  +KI DFG+            + T  +    G+  +MAP
Sbjct: 146 HPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAXXXXXXXXXXX 184
           W +  R  N+      GA+G +     T  G  VA+K L RP     ++           
Sbjct: 18  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF----QSIIHAKRTYREL 72
Query: 185 XXLATLKHPNIVRFIGACRKPMVW-----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             L  +KH N++  +                +  +  G  +   +  ++     ++  + 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q L   RG+ Y+H   +IHRDLK  NL +  D  +KI D G+AR
Sbjct: 133 QIL---RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 13/87 (14%)
Query: 229 NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI-----FSDKSIKIADFGVAR 283
           +R+  LK  +  A+ +   M YVH   LI+RD+K +N LI       +  I I DFG+A+
Sbjct: 91  DRTFTLKTVLMIAIQLLSRMEYVHSKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAK 150
Query: 284 --IEVQTEGMTPE------TGTYRWMA 302
             I+ +T+   P       TGT R+M+
Sbjct: 151 EYIDPETKKHIPYREHKSLTGTARYMS 177

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 13/171 (7%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXX 177
           G+E F +  ++    ++G+    G F   K  R    G E A K +++ ++   +     
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR 59
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    L  + H N++             ++ E   GG +  FL ++++ S     +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 238 -VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADFGVA 282
            +KQ LD   G+ Y+H   + H DLK +N+++  DK+     IK+ DFG+A
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLA 166

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 13/171 (7%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXX 177
           G+E F +  ++    ++G+    G F   K  R    G E A K +++ ++   +     
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR 59
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    L  + H N++             ++ E   GG +  FL ++++ S     +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 238 -VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADFGVA 282
            +KQ LD   G+ Y+H   + H DLK +N+++  DK+     IK+ DFG+A
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLA 166

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 6/119 (5%)
Query: 189 TLKHPNIVRFIGAC-RKPMVWCI--VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           T+  P  V F GA  R+  VW    + + +     +Q + K Q  ++P  +  K A+ + 
Sbjct: 89  TVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQ--TIPEDILGKIAVSIV 146
Query: 246 RGMAYVH-RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           + + ++H +L +IHRD+K  N+LI +   +K  DFG++   V       + G   + AP
Sbjct: 147 KALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAP 205

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 13/171 (7%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXX 177
           G+E F +  ++    ++G+    G F   K  R    G E A K +++ ++   +     
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR 59
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    L  + H N++             ++ E   GG +  FL ++++ S     +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 238 -VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADFGVA 282
            +KQ LD   G+ Y+H   + H DLK +N+++  DK+     IK+ DFG+A
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLA 166

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 13/171 (7%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXX 177
           G+E F +  ++    ++G+    G F   K  R    G E A K +++ ++   +     
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR 59
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    L  + H N++             ++ E   GG +  FL ++++ S     +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 238 -VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADFGVA 282
            +KQ LD   G+ Y+H   + H DLK +N+++  DK+     IK+ DFG+A
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLA 166

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 49/101 (48%), Gaps = 8/101 (7%)
Query: 210 IVTEYAKGGSVRQF------LTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIHRDLK 262
           I+ EY +  S+ +F      L K     +P+++       V    +Y+H    + HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 263 SDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             N+L+  +  +K++DFG +   V  + +    GTY +M P
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVD-KKIKGSRGTYEFMPP 219

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 76/171 (44%), Gaps = 13/171 (7%)
Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFG--KLYRGTYNGEEVAIKILERPENDPEKAXXXX 177
           G+E F +  ++    ++G+    G F   K  R    G E A K +++ ++   +     
Sbjct: 1   GMEPFKQQKVE-DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR 59
Query: 178 XXXXXXXXXLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
                    L  + H N++             ++ E   GG +  FL ++++ S     +
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 238 -VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADFGVA 282
            +KQ LD   G+ Y+H   + H DLK +N+++  DK+     IK+ DFG+A
Sbjct: 120 FIKQILD---GVNYLHTKKIAHFDLKPENIMLL-DKNIPIPHIKLIDFGLA 166

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 209 CIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
           C+V     GG +R  +      N       A+     +  G+ ++H+  +I+RDLK +N+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 267 LIFSDKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAP 303
           L+  D +++I+D G+A +E++  G T      GT  +MAP
Sbjct: 321 LLDDDGNVRISDLGLA-VELKA-GQTKTKGYAGTPGFMAP 358

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 209 CIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
           C+V     GG +R  +      N       A+     +  G+ ++H+  +I+RDLK +N+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 267 LIFSDKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAP 303
           L+  D +++I+D G+A +E++  G T      GT  +MAP
Sbjct: 321 LLDDDGNVRISDLGLA-VELKA-GQTKTKGYAGTPGFMAP 358

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 28/186 (15%)
Query: 134 LNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
             +G     G FG+L  G   Y  E VAIK+       P+               L +  
Sbjct: 32  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-----LHLEYRFYKQLGSGD 86
Query: 192 HPNIVRFIGACRK--PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
               V + G C K   MV  ++      G   + L    +R+  LK  +  A+ +   M 
Sbjct: 87  GIPQVYYFGPCGKYNAMVLELL------GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME 140
Query: 250 YVHRLGLIHRDLKSDNLLI-----FSDKSIKIADFGVAR--IEVQTEGMTPE------TG 296
           YVH   LI+RD+K +N LI      + + I I DF +A+  I+ +T+   P       TG
Sbjct: 141 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 200
Query: 297 TYRWMA 302
           T R+M+
Sbjct: 201 TARYMS 206

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 209 CIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
           C+V     GG +R  +      N       A+     +  G+ ++H+  +I+RDLK +N+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 267 LIFSDKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAP 303
           L+  D +++I+D G+A +E++  G T      GT  +MAP
Sbjct: 321 LLDDDGNVRISDLGLA-VELKA-GQTKTKGYAGTPGFMAP 358

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 13/87 (14%)
Query: 229 NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI-----FSDKSIKIADFGVAR 283
           +R+  LK  +  A+ +   M YVH   LI+RD+K +N L+         +I I DFG+A+
Sbjct: 94  DRTFTLKTVLMIAIQLITRMEYVHTKSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAK 153
Query: 284 --IEVQTEGMTPE------TGTYRWMA 302
             I+ +T+   P       TGT R+M+
Sbjct: 154 EYIDPETKKHIPYREHKSLTGTARYMS 180

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 209 CIVTEYAKGGSVRQFL--TKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL 266
           C+V     GG +R  +      N       A+     +  G+ ++H+  +I+RDLK +N+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 267 LIFSDKSIKIADFGVARIEVQTEGMTPE---TGTYRWMAP 303
           L+  D +++I+D G+A +E++  G T      GT  +MAP
Sbjct: 321 LLDDDGNVRISDLGLA-VELKA-GQTKTKGYAGTPGFMAP 358

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 3/118 (2%)
Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTE-YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           L+ ++H NI++ +        + +V E +  G  +  F+ +      PL   + + L  A
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G  Y+    +IHRD+K +N++I  D +IK+ DFG A    + +      GT  + AP
Sbjct: 143 VG--YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 17/38 (44%), Positives = 30/38 (78%)
Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +G+ Y+H+  ++HRDLK +NLL+  +  +K+ADFG+A+
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 28/186 (15%)
Query: 134 LNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAXXXXXXXXXXXXXLATLK 191
             +G     G FG+L  G   Y  E VAIK+       P+               L +  
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-----LHLEYRFYKQLGSGD 65
Query: 192 HPNIVRFIGACRK--PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
               V + G C K   MV  ++      G   + L    +R+  LK  +  A+ +   M 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL------GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 250 YVHRLGLIHRDLKSDNLLI-----FSDKSIKIADFGVAR--IEVQTEGMTPE------TG 296
           YVH   LI+RD+K +N LI      + + I I DF +A+  I+ +T+   P       TG
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 297 TYRWMA 302
           T R+M+
Sbjct: 180 TARYMS 185

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 5/74 (6%)
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
           L+  +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR ++  +    
Sbjct: 190 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYV 248
Query: 294 ETGTYR----WMAP 303
             G  R    WMAP
Sbjct: 249 RKGDARLPLKWMAP 262

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 11/100 (11%)
Query: 193 PNIVRFIG------ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
           P+IVR +       A RK ++  IV E   GG +   +  R +++   + A +    +  
Sbjct: 71  PHIVRIVDVYENLYAGRKCLL--IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVAR 283
            + Y+H + + HRD+K +NLL  S +    +K+ DFG A+
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 5/74 (6%)
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
           L+  +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR ++  +    
Sbjct: 199 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYV 257
Query: 294 ETGTYR----WMAP 303
             G  R    WMAP
Sbjct: 258 RKGDARLPLKWMAP 271

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 5/74 (6%)
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
           L+  +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR ++  +    
Sbjct: 197 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYV 255
Query: 294 ETGTYR----WMAP 303
             G  R    WMAP
Sbjct: 256 RKGDARLPLKWMAP 269

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 5/74 (6%)
Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
           L+  +  +  VA+GM ++     IHRDL + N+L+     +KI DFG+AR ++  +    
Sbjct: 192 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYV 250
Query: 294 ETGTYR----WMAP 303
             G  R    WMAP
Sbjct: 251 RKGDARLPLKWMAP 264

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 13/75 (17%)
Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG----MTP---- 293
           + +A  + ++H  GL+HRDLK  N+    D  +K+ DFG+     Q E     +TP    
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 294 -----ETGTYRWMAP 303
                + GT  +M+P
Sbjct: 231 ATHXGQVGTKLYMSP 245

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 14/124 (11%)
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV-----KQALDV 244
           LKHP+IV  +       +  +V E+  G  +   + KR +       AV     +Q L+ 
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTP--ETGTYR 299
            R   Y H   +IHRD+K   +L+ S ++   +K+  FGVA I++   G+      GT  
Sbjct: 145 LR---YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRVGTPH 200
Query: 300 WMAP 303
           +MAP
Sbjct: 201 FMAP 204

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 17/169 (10%)
Query: 131 LRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIK-ILERPENDPEKAXXXXXXXXXXXXXL 187
           LRK  +     +GA+G +++      GE VA+K I +  +N  +               L
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD-----AQRTFREIMIL 62
Query: 188 ATLK-HPNIVRFIGACRKPM---VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
             L  H NIV  +   R      V+ +V +Y +   +   +       V  +  V Q + 
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVY-LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIK 120
Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMT 292
           V +   Y+H  GL+HRD+K  N+L+ ++  +K+ADFG++R  V    +T
Sbjct: 121 VIK---YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 14/124 (11%)
Query: 190 LKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV-----KQALDV 244
           LKHP+IV  +       +  +V E+  G  +   + KR +       AV     +Q L+ 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIEVQTEGMTP--ETGTYR 299
            R   Y H   +IHRD+K   +L+ S ++   +K+  FGVA I++   G+      GT  
Sbjct: 143 LR---YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRVGTPH 198
Query: 300 WMAP 303
           +MAP
Sbjct: 199 FMAP 202

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 54/114 (47%), Gaps = 4/114 (3%)
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
           +HP  VR   A  +  +  + TE   G S++Q   +    S+P         D    +A+
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH-CEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP-ETGTYRWMAP 303
           +H  GL+H D+K  N+ +      K+ DFG+  +E+ T G    + G  R+MAP
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL-VELGTAGAGEVQEGDPRYMAP 225

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ--ALDVARGM 248
           +H ++VR+  A  +     I  EY  GGS+   +++        K A  +   L V RG+
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 249 AYVHRLGLIHRDLKSDNLLI 268
            Y+H + L+H D+K  N+ I
Sbjct: 125 RYIHSMSLVHMDIKPSNIFI 144

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 24/182 (13%)
Query: 136 MGDAFAQGAFGKLYRGTY--NGEEVAIKILE-----RPENDPEKAXXXXXXXXXXXXXLA 188
           + D   QGA   ++RG +   G+  AIK+       RP +                  L 
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD----------VQMREFEVLK 62
Query: 189 TLKHPNIVRFIGACRKPMVW--CIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVA 245
            L H NIV+      +       ++ E+   GS+   L +  N   +P    +    DV 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 246 RGMAYVHRLGLIHRDLKSDNLL--IFSD-KSI-KIADFGVARIEVQTEGMTPETGTYRWM 301
            GM ++   G++HR++K  N++  I  D +S+ K+ DFG AR     E      GT  ++
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYL 182
Query: 302 AP 303
            P
Sbjct: 183 HP 184

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ--ALDVARGM 248
           +H ++VR+  A  +     I  EY  GGS+   +++        K A  +   L V RG+
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 249 AYVHRLGLIHRDLKSDNLLI 268
            Y+H + L+H D+K  N+ I
Sbjct: 129 RYIHSMSLVHMDIKPSNIFI 148

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 24/182 (13%)
Query: 136 MGDAFAQGAFGKLYRGTY--NGEEVAIKILE-----RPENDPEKAXXXXXXXXXXXXXLA 188
           + D   QGA   ++RG +   G+  AIK+       RP +                  L 
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD----------VQMREFEVLK 62
Query: 189 TLKHPNIVRFIGACRKPMVW--CIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVA 245
            L H NIV+      +       ++ E+   GS+   L +  N   +P    +    DV 
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 246 RGMAYVHRLGLIHRDLKSDNLL--IFSD-KSI-KIADFGVARIEVQTEGMTPETGTYRWM 301
            GM ++   G++HR++K  N++  I  D +S+ K+ DFG AR     E      GT  ++
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 302 AP 303
            P
Sbjct: 183 HP 184

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ--ALDVARGM 248
           +H ++VR+  A  +     I  EY  GGS+   +++        K A  +   L V RG+
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 249 AYVHRLGLIHRDLKSDNLLI 268
            Y+H + L+H D+K  N+ I
Sbjct: 127 RYIHSMSLVHMDIKPSNIFI 146

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ--ALDVARGM 248
           +H ++VR+  A  +     I  EY  GGS+   +++        K A  +   L V RG+
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 249 AYVHRLGLIHRDLKSDNLLI 268
            Y+H + L+H D+K  N+ I
Sbjct: 127 RYIHSMSLVHMDIKPSNIFI 146

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 13/105 (12%)
Query: 210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF 269
           +V E  +GGS+   + KR++ +      V Q  DVA  + ++H  G+ HRDLK +N+L  
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQ--DVASALDFLHNKGIAHRDLKPENILCE 145
Query: 270 SD---KSIKIADFGVAR--------IEVQTEGMTPETGTYRWMAP 303
                  +KI DF +            + T  +    G+  +MAP
Sbjct: 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 18/113 (15%)
Query: 187 LATLKHPNIVR----FIG-ACRKPMVWCIVTEYAKGG--SVRQFLTKRQNRSVPLKLA-- 237
           L  LKHPN++     F+  A RK  VW ++ +YA+     + +F    +    P++L   
Sbjct: 72  LRELKHPNVISLQKVFLSHADRK--VW-LLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 238 -VKQAL-DVARGMAYVHRLGLIHRDLKSDNLLIFSDKS----IKIADFGVARI 284
            VK  L  +  G+ Y+H   ++HRDLK  N+L+  +      +KIAD G AR+
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 30/152 (19%)
Query: 144 AFGKLYRGTYNGEEVAIK-ILERPENDPEKAXXXXXXXXXXXXXLATLKHPNIVRFIGAC 202
           ++  L  G ++G   A+K IL   + D E+A                  HPNI+R +  C
Sbjct: 43  SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR-------LFNHPNILRLVAYC 95
Query: 203 -----RKPMVWCIVTEYAKGGSVRQ---------FLTKRQNRSVPLKLAVKQALDVARGM 248
                 K   W ++  + +G    +         FLT+ Q         +   L + RG+
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ--------ILWLLLGICRGL 147
Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
             +H  G  HRDLK  N+L+  +    + D G
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG 179

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	303
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-86
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-83
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-81
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-81
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-80
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-80
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-79
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-75
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-75
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-71
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-68
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-67
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-67
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-67
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-66
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-49
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-49
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-47
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-46
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-45
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-44
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-44
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-44
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-43
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-43
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-43
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-42
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-42
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-42
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-42
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-41
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-41
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-41
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-41
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-40
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-40
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-40
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-40
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-39
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-39
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-39
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-38
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-37
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-35
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-33
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-31
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-29
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-29
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-27
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-27
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-27
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-27
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-26
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-25
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-05
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-21
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-17
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-14
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-13
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-09

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  260 bits (667), Expect = 1e-86
 Identities = 68/194 (35%), Positives = 106/194 (54%), Gaps = 8/194 (4%)

Query: 114 SNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKA 173
            N   +G  + D+  I    LN+ +    G+FG ++R  ++G +VA+KIL   +   E  
Sbjct: 19  ENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAE-- 76

Query: 174 QVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SV 232
                +F +EV ++  L+HPNIV F+GA  +P    IVTEY   GS+ + L K   R  +
Sbjct: 77  --RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL 134

Query: 233 PLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG 290
             +  +  A DVA+GM Y+H     ++HR+LKS NLL+    ++K+ DFG++R++  T  
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194

Query: 291 -MTPETGTYRWMAP 303
                 GT  WMAP
Sbjct: 195 SSKSAAGTPEWMAP 208

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  252 bits (646), Expect = 4e-83
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 13/207 (6%)

Query: 103 SDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKI 162
            + +L  A       ++      EW I   +L +G+   +G FG++Y G ++GE VAI++
Sbjct: 4   MNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE-VAIRL 62

Query: 163 LERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQ 222
           ++   ++ +      + F++EVM     +H N+V F+GAC  P    I+T   KG ++  
Sbjct: 63  IDIERDNED----QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 223 FLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
            + +     + +    + A ++ +GM Y+H  G++H+DLKS N+    +  + I DFG+ 
Sbjct: 119 VV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLF 176

Query: 283 RIE------VQTEGMTPETGTYRWMAP 303
            I        + + +  + G    +AP
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAP 203

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  247 bits (633), Expect = 1e-81
 Identities = 61/194 (31%), Positives = 100/194 (51%), Gaps = 10/194 (5%)

Query: 113 DSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEK 172
             +      +  D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P+ 
Sbjct: 5   HHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQ- 62

Query: 173 AQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV 232
                Q F+ EV +L   +H NI+ F+G    P +  IVT++ +G S+   L        
Sbjct: 63  ---QLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHL-HASETKF 117

Query: 233 PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG-- 290
            +K  +  A   ARGM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A  + +  G  
Sbjct: 118 EMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177

Query: 291 -MTPETGTYRWMAP 303
                +G+  WMAP
Sbjct: 178 QFEQLSGSILWMAP 191

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  245 bits (627), Expect = 6e-81
 Identities = 73/188 (38%), Positives = 105/188 (55%), Gaps = 17/188 (9%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM 186
             ID  +L + +    G FGK+YR  + G+EVA+K   R + D + +Q +E   +QE  +
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAA-RHDPDEDISQTIEN-VRQEAKL 59

Query: 187 LATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
            A LKHPNI+   G C K    C+V E+A+GG + + L     + +P  + V  A+ +AR
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIAR 116

Query: 247 GMAYVHRLG---LIHRDLKSDNLLI--------FSDKSIKIADFGVARIEVQTEGMTPET 295
           GM Y+H      +IHRDLKS N+LI         S+K +KI DFG+AR   +T  M+   
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AA 175

Query: 296 GTYRWMAP 303
           G Y WMAP
Sbjct: 176 GAYAWMAP 183

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  244 bits (625), Expect = 1e-80
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 12/183 (6%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEV 184
               ID ++LN      +   G+L++G + G ++ +K+L+  +          + F +E 
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR----KSRDFNEEC 58

Query: 185 MMLATLKHPNIVRFIGACRKPMVW--CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL 242
             L    HPN++  +GAC+ P      ++T +   GS+   L +  N  V    AVK AL
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 243 DVARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           D+ARGMA++H L   +    L S +++I  D + +I+   V         M        W
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAW 174

Query: 301 MAP 303
           +AP
Sbjct: 175 VAP 177

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  242 bits (619), Expect = 1e-79
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 20/204 (9%)

Query: 110 ALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPE 167
           A+  S  P          T+   ++       +G FG +++G    +   VAIK L   +
Sbjct: 2   AMGGSEFPKS-----RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56

Query: 168 NDPEKAQVME-QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTK 226
           ++ E   + + Q+FQ+EV +++ L HPNIV+  G    P    +V E+   G +   L  
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL-L 113

Query: 227 RQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFS-----DKSIKIADF 279
            +   +   + ++  LD+A G+ Y+      ++HRDL+S N+ + S         K+ADF
Sbjct: 114 DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 280 GVARIEVQTEGMTPETGTYRWMAP 303
           G+++  V +  ++   G ++WMAP
Sbjct: 174 GLSQQSVHS--VSGLLGNFQWMAP 195

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  232 bits (594), Expect = 1e-75
 Identities = 61/183 (33%), Positives = 93/183 (50%), Gaps = 17/183 (9%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM 185
              ID +++ + +   +GAFG + +  +  ++VAIK +E             + F  E+ 
Sbjct: 2   LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELR 53

Query: 186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDV 244
            L+ + HPNIV+  GAC  P+  C+V EYA+GGS+   L   +         A+   L  
Sbjct: 54  QLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111

Query: 245 ARGMAYVHRL---GLIHRDLKSDNLLIFSD-KSIKIADFGVARIEVQTEGMTPETGTYRW 300
           ++G+AY+H +    LIHRDLK  NLL+ +    +KI DFG A        MT   G+  W
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAW 169

Query: 301 MAP 303
           MAP
Sbjct: 170 MAP 172

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  232 bits (593), Expect = 3e-75
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 24/196 (12%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQ 182
                    L  G+   +G FG+  + T+   GE + +K L R + +       ++ F +
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE------TQRTFLK 56

Query: 183 EVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL 242
           EV ++  L+HPN+++FIG   K      +TEY KGG++R  + K  +   P    V  A 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAK 115

Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE------------- 289
           D+A GMAY+H + +IHRDL S N L+  +K++ +ADFG+AR+ V  +             
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175

Query: 290 --GMTPETGTYRWMAP 303
                   G   WMAP
Sbjct: 176 RKKRYTVVGNPYWMAP 191

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  222 bits (567), Expect = 3e-71
 Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 28/209 (13%)

Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPE 171
             S+    GL          +++ M     +G +G+++ G + GE+VA+K+    E    
Sbjct: 18  SQSSGSGSGL-PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-- 74

Query: 172 KAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV----WCIVTEYAKGGSVRQFLTKR 227
                    + E+     ++H NI+ FI A  K         ++T+Y + GS+  +L   
Sbjct: 75  -----SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--- 126

Query: 228 QNRSVPLKLAVKQALDVARGMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADF 279
           ++ ++  K  +K A     G+ ++H        +  + HRDLKS N+L+  + +  IAD 
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186

Query: 280 GVARIEVQTEG-----MTPETGTYRWMAP 303
           G+A   +              GT R+M P
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  214 bits (547), Expect = 2e-68
 Identities = 52/191 (27%), Positives = 93/191 (48%), Gaps = 31/191 (16%)

Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQE--VMMLAT 189
           R + + +   +G +G+++RG++ GE VA+KI    +         E+ + +E  +     
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---------EKSWFRETELYNTVM 58

Query: 190 LKHPNIVRFIGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           L+H NI+ FI +            ++T Y + GS+  +L   Q  ++     ++  L +A
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIA 115

Query: 246 RGMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-----GMT 292
            G+A++H        +  + HRDLKS N+L+  +    IAD G+A +  Q+      G  
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 293 PETGTYRWMAP 303
           P  GT R+MAP
Sbjct: 176 PRVGTKRYMAP 186

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  213 bits (543), Expect = 1e-67
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 37/207 (17%)

Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQ 181
               E ++DL  L + +   +G +G +Y+G+ +   VA+K+               Q F 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---------RQNFI 53

Query: 182 QE--VMMLATLKHPNIVRFIGACRKP-----MVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
            E  +  +  ++H NI RFI    +      M + +V EY   GS+ ++L      +   
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDW 110

Query: 235 KLAVKQALDVARGMAYVH---------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE 285
             + + A  V RG+AY+H         +  + HRDL S N+L+ +D +  I+DFG++   
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

Query: 286 VQTE---------GMTPETGTYRWMAP 303
                            E GT R+MAP
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAP 197

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  212 bits (541), Expect = 3e-67
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 34/237 (14%)

Query: 84  DNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQG 143
           ++ S+       G     L  D      M ++    GL    + TI  R + + ++  +G
Sbjct: 1   EDPSLDRPFISEGTTLKDLIYD------MTTSGSGSGLPLLVQRTI-ARTIVLQESIGKG 53

Query: 144 AFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR 203
            FG+++RG + GEEVA+KI    E             + E+     L+H NI+ FI A  
Sbjct: 54  RFGEVWRGKWRGEEVAVKIFSSREER-------SWFREAEIYQTVMLRHENILGFIAADN 106

Query: 204 K----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH------- 252
           K         +V++Y + GS+  +L      +V ++  +K AL  A G+A++H       
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 253 -RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-----GMTPETGTYRWMAP 303
            +  + HRDLKS N+L+  + +  IAD G+A                  GT R+MAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  211 bits (538), Expect = 6e-67
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 114 SNSPTEGLE-NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEK 172
            +  + G++   +        L + +  A+G FG +++     E VA+KI    +     
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ--- 61

Query: 173 AQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP----MVWCIVTEYAKGGSVRQFLTKRQ 228
                 Q + EV  L  +KH NI++FIGA ++     +   ++T + + GS+  FL   +
Sbjct: 62  ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---K 114

Query: 229 NRSVPLKLAVKQALDVARGMAYVH----------RLGLIHRDLKSDNLLIFSDKSIKIAD 278
              V        A  +ARG+AY+H          +  + HRD+KS N+L+ ++ +  IAD
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174

Query: 279 FGVARI---EVQTEGMTPETGTYRWMAP 303
           FG+A              + GT R+MAP
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAP 202

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  163 bits (416), Expect = 3e-49
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 18/197 (9%)

Query: 111 LMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDP 170
           +  S +  +       W +++++L +     +G FG +  G Y G +VA+K +       
Sbjct: 1   MGGSVAAQDEFYR-SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI------- 52

Query: 171 EKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQ 228
            K     Q F  E  ++  L+H N+V+ +G     K  ++ IVTEY   GS+  +L  R 
Sbjct: 53  -KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY-IVTEYMAKGSLVDYLRSRG 110

Query: 229 NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEV 286
              +     +K +LDV   M Y+     +HRDL + N+L+  D   K++DFG+ +     
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170

Query: 287 QTEGMTPETGTYRWMAP 303
           Q  G  P     +W AP
Sbjct: 171 QDTGKLP----VKWTAP 183

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  167 bits (425), Expect = 9e-49
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 22/213 (10%)

Query: 100 HALSDDALARALMD-----SNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN 154
           +    D L   L+           +       W +++++L +     +G FG +  G Y 
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR 215

Query: 155 GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC--RKPMVWCIVT 212
           G +VA+K +        K     Q F  E  ++  L+H N+V+ +G     K  ++ IVT
Sbjct: 216 GNKVAVKCI--------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY-IVT 266

Query: 213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK 272
           EY   GS+  +L  R    +     +K +LDV   M Y+     +HRDL + N+L+  D 
Sbjct: 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 326

Query: 273 SIKIADFGVAR--IEVQTEGMTPETGTYRWMAP 303
             K++DFG+ +     Q  G  P     +W AP
Sbjct: 327 VAKVSDFGLTKEASSTQDTGKLP----VKWTAP 355

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  158 bits (401), Expect = 8e-47
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 19/192 (9%)

Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAQVME 177
           G  N+D+W ++   + M      G +G++Y G +      VA+K L        K   ME
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTME 52

Query: 178 QQ-FQQEVMMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
            + F +E  ++  +KHPN+V+ +G C    P    I+TE+   G++  +L +   + V  
Sbjct: 53  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFMTYGNLLDYLRECNRQEVSA 110

Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE 294
            + +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+ +  +  T  
Sbjct: 111 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAH 169

Query: 295 TGT---YRWMAP 303
            G     +W AP
Sbjct: 170 AGAKFPIKWTAP 181

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  156 bits (397), Expect = 2e-46
 Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 17/185 (9%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQ-FQQ 182
           DEW +    L + +    G FG+++ G YNG  +VA+K L        K   M    F  
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLA 57

Query: 183 EVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
           E  ++  L+H  +VR      ++P+   I+TEY + GS+  FL       + +   +  A
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---Y 298
             +A GMA++     IHRDL++ N+L+    S KIADFG+AR+ ++    T   G     
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPI 174

Query: 299 RWMAP 303
           +W AP
Sbjct: 175 KWTAP 179

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  156 bits (396), Expect = 9e-46
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 35/224 (15%)

Query: 100 HALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG---- 155
           H   D      L    +     E+ D    + R L       +G FG +    Y+     
Sbjct: 9   HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68

Query: 156 --EEVAIKILERPENDPEKAQVMEQQ--FQQEVMMLATLKHPNIVRFIGAC----RKPMV 207
             E VA+K L        +    E    F++E+ +L +L+H NIV++ G C    R+ + 
Sbjct: 69  TGEVVAVKKL--------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL- 119

Query: 208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL 267
             ++ EY   GS+R +L K + R   +KL ++    + +GM Y+     IHRDL + N+L
Sbjct: 120 -KLIMEYLPYGSLRDYLQKHKERIDHIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNIL 177

Query: 268 IFSDKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 303
           + ++  +KI DFG+ ++        +V+  G +P      W AP
Sbjct: 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP----IFWYAP 217

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  159 bits (405), Expect = 1e-45
 Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 19/200 (9%)

Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPEND 169
            +  +      N+D+W ++   + M      G +G++Y G +      VA+K L      
Sbjct: 200 RNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL------ 253

Query: 170 PEKAQVMEQQ-FQQEVMMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTK 226
             K   ME + F +E  ++  +KHPN+V+ +G C    P    I+TE+   G++  +L +
Sbjct: 254 --KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFMTYGNLLDYLRE 309

Query: 227 RQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV 286
              + V   + +  A  ++  M Y+ +   IHR+L + N L+  +  +K+ADFG++R+ +
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-M 368

Query: 287 QTEGMTPETGT---YRWMAP 303
             +  T   G     +W AP
Sbjct: 369 TGDTYTAHAGAKFPIKWTAP 388

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  155 bits (393), Expect = 2e-45
 Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 32/197 (16%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG------EEVAIKILERPENDPEKAQVMEQ 178
           D      R L       +G FGK+    Y+       E VA+K L + +  P+       
Sbjct: 24  DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQ----HRS 78

Query: 179 QFQQEVMMLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
            ++QE+ +L TL H +I+++ G C       +   +V EY   GS+R +L      S+ L
Sbjct: 79  GWKQEIDILRTLYHEHIIKYKGCCEDAGAASL--QLVMEYVPLGSLRDYL---PRHSIGL 133

Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--------EV 286
              +  A  +  GMAY+H    IHRDL + N+L+ +D+ +KI DFG+A+          V
Sbjct: 134 AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193

Query: 287 QTEGMTPETGTYRWMAP 303
           + +G +P      W AP
Sbjct: 194 REDGDSP----VFWYAP 206

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  153 bits (390), Expect = 2e-45
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 19/200 (9%)

Query: 111 LMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPEND 169
           L   N+P+     +  W ID + L        G FG +  G + G+ +VAIK++      
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI------ 56

Query: 170 PEKAQVMEQQ-FQQEVMMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTK 226
             K   M +  F +E  ++  L H  +V+  G C  ++P+   I+TEY   G +  +L +
Sbjct: 57  --KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI--FIITEYMANGCLLNYLRE 112

Query: 227 RQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV 286
            ++R    +L ++   DV   M Y+     +HRDL + N L+     +K++DFG++R  V
Sbjct: 113 MRHRFQTQQL-LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-V 170

Query: 287 QTEGMTPETGT---YRWMAP 303
             +  T   G+    RW  P
Sbjct: 171 LDDEYTSSVGSKFPVRWSPP 190

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  152 bits (387), Expect = 9e-45
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 35/199 (17%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG------EEVAIKILERPENDPEKAQVMEQ 178
           D    + R L       +G FG +    Y+       E VA+K L        +    E 
Sbjct: 3   DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--------QHSTEEH 54

Query: 179 Q--FQQEVMMLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSV 232
              F++E+ +L +L+H NIV++ G C    R+ +   ++ EY   GS+R +L K + R  
Sbjct: 55  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL--KLIMEYLPYGSLRDYLQKHKERID 112

Query: 233 PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-------- 284
            +KL ++    + +GM Y+     IHRDL + N+L+ ++  +KI DFG+ ++        
Sbjct: 113 HIKL-LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171

Query: 285 EVQTEGMTPETGTYRWMAP 303
           +V+  G +P      W AP
Sbjct: 172 KVKEPGESP----IFWYAP 186

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  152 bits (387), Expect = 2e-44
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 31/197 (15%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG------EEVAIKILERPENDPEKAQVMEQ 178
           D    + R L       +G FG +    Y+         VA+K L+   + P++    ++
Sbjct: 16  DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQ----QR 69

Query: 179 QFQQEVMMLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
            FQ+E+ +L  L    IV++ G      R+ +   +V EY   G +R FL + + R +  
Sbjct: 70  DFQREIQILKALHSDFIVKYRGVSYGPGRQSL--RLVMEYLPSGCLRDFLQRHRAR-LDA 126

Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--------EV 286
              +  +  + +GM Y+     +HRDL + N+L+ S+  +KIADFG+A++         V
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186

Query: 287 QTEGMTPETGTYRWMAP 303
           +  G +P      W AP
Sbjct: 187 REPGQSP----IFWYAP 199

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  151 bits (383), Expect = 2e-44
 Identities = 56/185 (30%), Positives = 94/185 (50%), Gaps = 19/185 (10%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQ-FQQE 183
           +W ID  +L        G FG ++ G +  + +VAIK +        +   M ++ F +E
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEE 53

Query: 184 VMMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
             ++  L HP +V+  G C  + P+  C+VTE+ + G +  +L  ++       L +   
Sbjct: 54  AEVMMKLSHPKLVQLYGVCLEQAPI--CLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMC 110

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---Y 298
           LDV  GMAY+    +IHRDL + N L+  ++ IK++DFG+ R  V  +  T  TGT    
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPV 169

Query: 299 RWMAP 303
           +W +P
Sbjct: 170 KWASP 174

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  153 bits (390), Expect = 2e-44
 Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 23/190 (12%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE--VAIKILERPENDPEKAQVMEQQ--- 179
           D+W ++   L +G+   +G FG+++ G    +   VA+K          +  +       
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--------RETLPPDLKAK 158

Query: 180 FQQEVMMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
           F QE  +L    HPNIVR IG C  ++P+   IV E  +GG    FL + +   + +K  
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPI--YIVMELVQGGDFLTFL-RTEGARLRVKTL 215

Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           ++   D A GM Y+     IHRDL + N L+     +KI+DFG++R E          G 
Sbjct: 216 LQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGL 274

Query: 298 ----YRWMAP 303
                +W AP
Sbjct: 275 RQVPVKWTAP 284

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  152 bits (385), Expect = 2e-44
 Identities = 55/193 (28%), Positives = 93/193 (48%), Gaps = 22/193 (11%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQ 178
           D    + R L       +G FGK+    Y       GE+VA+K L +PE+          
Sbjct: 14  DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGN----HIA 68

Query: 179 QFQQEVMMLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
             ++E+ +L  L H NIV++ G C       +   ++ E+   GS++++L K +N+    
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGI--KLIMEFLPSGSLKEYLPKNKNKINLK 126

Query: 235 KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTP 293
           +  +K A+ + +GM Y+     +HRDL + N+L+ S+  +KI DFG+ + IE   E  T 
Sbjct: 127 QQ-LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 185

Query: 294 ETGT---YRWMAP 303
           +        W AP
Sbjct: 186 KDDRDSPVFWYAP 198

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  155 bits (393), Expect = 3e-44
 Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 107 LARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILER 165
           L      S   T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L  
Sbjct: 160 LTTVCPTSKPQTQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-- 216

Query: 166 PENDPEKAQVMEQQ-FQQEVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQF 223
                 K   M  + F QE  ++  L+H  +V+       +P+   IVTEY   GS+  F
Sbjct: 217 ------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDF 268

Query: 224 LTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           L     + + L   V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR
Sbjct: 269 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 328

Query: 284 IEVQTEGMTPETGT---YRWMAP 303
             ++    T   G     +W AP
Sbjct: 329 -LIEDNEYTARQGAKFPIKWTAP 350

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  150 bits (381), Expect = 7e-44
 Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 16/188 (8%)

Query: 125 DEWTIDLRKLNMGDAF-AQGAFGKLYRGTYNGE----EVAIKILERPENDPEKAQVMEQQ 179
            E  +D + L + D     G FG + +G Y  +     VA+KIL+   NDP     ++ +
Sbjct: 9   KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDE 64

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
              E  ++  L +P IVR IG C       +V E A+ G + ++L  +QNR V  K  ++
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 121

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGT- 297
               V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++ +         +T   
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181

Query: 298 --YRWMAP 303
              +W AP
Sbjct: 182 WPVKWYAP 189

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  150 bits (381), Expect = 8e-44
 Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 38/207 (18%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKILERPENDPEKAQVME 177
               I  R + +     +GAFGK++               VA+K L       +      
Sbjct: 8   HVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL------KDPTLAAR 61

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR---------- 227
           + FQ+E  +L  L+H +IV+F G C       +V EY K G + +FL             
Sbjct: 62  KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121

Query: 228 QNRSVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           Q R    +L + Q    A  +A GM Y+     +HRDL + N L+ ++  +KI DFG++R
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

Query: 284 I-------EVQTEGMTPETGTYRWMAP 303
                    V    M P     RWM P
Sbjct: 182 DVYSTDYYRVGGHTMLP----IRWMPP 204

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  154 bits (390), Expect = 1e-43
 Identities = 55/185 (29%), Positives = 91/185 (49%), Gaps = 17/185 (9%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQ-FQQ 182
           D W I    L +      G FG+++  TYN   +VA+K +        K   M  + F  
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--------KPGSMSVEAFLA 232

Query: 183 EVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
           E  ++ TL+H  +V+      ++P+   I+TE+   GS+  FL   +    PL   +  +
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---Y 298
             +A GMA++ +   IHRDL++ N+L+ +    KIADFG+AR+ ++    T   G     
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPI 349

Query: 299 RWMAP 303
           +W AP
Sbjct: 350 KWTAP 354

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  149 bits (379), Expect = 3e-43
 Identities = 44/213 (20%), Positives = 89/213 (41%), Gaps = 29/213 (13%)

Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERP 166
           +      E     ++  ID   L +G    +G FG +  G    E+     VA+K + + 
Sbjct: 14  LVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KL 72

Query: 167 ENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC-----IVTEYAKGGSVR 221
           +N  ++     ++F  E   +    HPN++R +G C +          ++  + K G + 
Sbjct: 73  DNSSQREI---EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLH 129

Query: 222 QFLTKRQNRSVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
            +L   +  + P  + ++      +D+A GM Y+     +HRDL + N ++  D ++ +A
Sbjct: 130 TYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189

Query: 278 DFGVARI-------EVQTEGMTPETGTYRWMAP 303
           DFG+++                P     +W+A 
Sbjct: 190 DFGLSKKIYSGDYYRQGRIAKMP----VKWIAI 218

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  149 bits (378), Expect = 4e-43
 Identities = 45/216 (20%), Positives = 91/216 (42%), Gaps = 31/216 (14%)

Query: 111 LMDSNSPTEGLEN-FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILE 164
           ++DS   ++ L+   ++  I  ++  +G    +G FG +       E+     VA+K+L 
Sbjct: 1   MLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML- 59

Query: 165 RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC------RKPMVWCIVTEYAKGG 218
              +    + + E  F +E   +    HP++ + +G         +  +  ++  + K G
Sbjct: 60  -KADIIASSDIEE--FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116

Query: 219 SVRQFLTKRQNRSVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI 274
            +  FL   +    P  L ++      +D+A GM Y+     IHRDL + N ++  D ++
Sbjct: 117 DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176

Query: 275 KIADFGVARI-------EVQTEGMTPETGTYRWMAP 303
            +ADFG++R                P     +W+A 
Sbjct: 177 CVADFGLSRKIYSGDYYRQGCASKLP----VKWLAL 208

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  148 bits (376), Expect = 5e-43
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 14/188 (7%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAQVMEQQ 179
               I  + L + +    G+FG + RG ++        VA+K L+       +A      
Sbjct: 11  LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM---DD 67

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
           F +EV  + +L H N++R  G    P +  +VTE A  GS+   L K Q     L    +
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSR 125

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGT- 297
            A+ VA GM Y+     IHRDL + NLL+ +   +KI DFG+ R +    +    +    
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185

Query: 298 --YRWMAP 303
             + W AP
Sbjct: 186 VPFAWCAP 193

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  147 bits (374), Expect = 5e-43
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 19/184 (10%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILERPENDPEKAQVMEQQ-FQQEV 184
             +   ++ +      G FG +  G + G+ +VA+K++        K   M +  F QE 
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI--------KEGSMSEDEFFQEA 54

Query: 185 MMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL 242
             +  L HP +V+F G C    P+   IVTEY   G +  +L        P +L ++   
Sbjct: 55  QTMMKLSHPKLVKFYGVCSKEYPI--YIVTEYISNGCLLNYLRSHGKGLEPSQL-LEMCY 111

Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---YR 299
           DV  GMA++     IHRDL + N L+  D  +K++DFG+ R  V  +      GT    +
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVK 170

Query: 300 WMAP 303
           W AP
Sbjct: 171 WSAP 174

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  146 bits (372), Expect = 1e-42
 Identities = 49/188 (26%), Positives = 92/188 (48%), Gaps = 18/188 (9%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAQVMEQQ 179
            ++ I    + +     +G FG++Y G Y   +     VA+K  ++      K     ++
Sbjct: 5   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-----EK 59

Query: 180 FQQEVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV 238
           F  E +++  L HP+IV+ IG    +P    I+ E    G +  +L + +N    L L V
Sbjct: 60  FMSEAVIMKNLDHPHIVKLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKVLTL-V 116

Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT- 297
             +L + + MAY+  +  +HRD+   N+L+ S + +K+ DFG++R  ++ E     + T 
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTR 175

Query: 298 --YRWMAP 303
              +WM+P
Sbjct: 176 LPIKWMSP 183

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  148 bits (375), Expect = 1e-42
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 31/201 (15%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKILERPENDPEKAQVME 177
           DEW +   K+ M     QG+FG +Y G   G         VAIK +    +  E+     
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER----- 72

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR----QNRSVP 233
            +F  E  ++      ++VR +G   +     ++ E    G ++ +L        N  V 
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132

Query: 234 LKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI----- 284
              ++ +    A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R      
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192

Query: 285 --EVQTEGMTPETGTYRWMAP 303
                 +G+ P     RWM+P
Sbjct: 193 YYRKGGKGLLP----VRWMSP 209

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  152 bits (385), Expect = 2e-42
 Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 107 LARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-EVAIKILER 165
           L      S   T+GL   D W I    L +     QG FG+++ GT+NG   VAIK L  
Sbjct: 243 LTTVCPTSKPQTQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-- 299

Query: 166 PENDPEKAQVMEQQ-FQQEVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQF 223
                 K   M  + F QE  ++  L+H  +V+       +P+   IVTEY   GS+  F
Sbjct: 300 ------KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDF 351

Query: 224 LTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           L     + + L   V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR
Sbjct: 352 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 411

Query: 284 IEVQTEGMTPETGT---YRWMAP 303
             ++    T   G     +W AP
Sbjct: 412 -LIEDNEYTARQGAKFPIKWTAP 433

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  146 bits (370), Expect = 3e-42
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 37/205 (18%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKILERPENDPEKAQVMEQQ 179
             I L  +   +   +  FGK+Y+G   G         VAIK L+     P +     ++
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-----EE 58

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR----------QN 229
           F+ E M+ A L+HPN+V  +G   K     ++  Y   G + +FL  R           +
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 230 RSVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI- 284
           R+V   L           +A GM Y+    ++H+DL + N+L++   ++KI+D G+ R  
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 178

Query: 285 ------EVQTEGMTPETGTYRWMAP 303
                 ++    + P     RWMAP
Sbjct: 179 YAADYYKLLGNSLLP----IRWMAP 199

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  147 bits (372), Expect = 3e-42
 Identities = 61/208 (29%), Positives = 88/208 (42%), Gaps = 41/208 (19%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKILERPENDPEKAQVME 177
               I  R + +     +GAFGK++    +          VA+K L       E ++   
Sbjct: 34  CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL------KEASESAR 87

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR------- 230
           Q FQ+E  +L  L+H +IVRF G C +     +V EY + G + +FL  R +        
Sbjct: 88  QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL--RSHGPDAKLLA 145

Query: 231 ----SVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
                 P  L + Q    A  VA GM Y+  L  +HRDL + N L+     +KI DFG++
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

Query: 283 R-------IEVQTEGMTPETGTYRWMAP 303
           R         V    M P     RWM P
Sbjct: 206 RDIYSTDYYRVGGRTMLP----IRWMPP 229

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  145 bits (369), Expect = 4e-42
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 16/188 (8%)

Query: 125 DEWTIDLRKLNMGDA-FAQGAFGKLYRGTYNGE----EVAIKILERPENDPEKAQVMEQQ 179
            +  +    L + D     G FG + +G Y       +VAIK+L +   +        ++
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKA----DTEE 56

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             +E  ++  L +P IVR IG C+   +  +V E A GG + +FL  ++       +  +
Sbjct: 57  MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNV-AE 114

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGT- 297
               V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++ +       T  +   
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174

Query: 298 --YRWMAP 303
              +W AP
Sbjct: 175 WPLKWYAP 182

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (370), Expect = 8e-42
 Identities = 44/188 (23%), Positives = 87/188 (46%), Gaps = 24/188 (12%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQQ--- 179
           +   +         GAFG +Y+G +  E       VAIK L        +     +    
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKE 63

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAV 238
              E  ++A++ +P++ R +G C    V  ++T+    G +  ++  R+++ ++  +  +
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLL 120

Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT- 297
              + +A+GM Y+    L+HRDL + N+L+ + + +KI DFG+A++    E      G  
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180

Query: 298 --YRWMAP 303
              +WMA 
Sbjct: 181 VPIKWMAL 188

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  145 bits (368), Expect = 1e-41
 Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 21/191 (10%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-----EVAIKILERPENDPEKAQVMEQQ 179
               I+  ++++      G  G++  G           VAIK L        KA   E+Q
Sbjct: 42  FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--------KAGYTERQ 93

Query: 180 ---FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
              F  E  ++    HPNI+R  G   +  +  IVTEY + GS+  FL     +   ++L
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153

Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPET 295
            V     V  GM Y+  LG +HRDL + N+L+ S+   K++DFG++R +E   +     T
Sbjct: 154 -VGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212

Query: 296 GT---YRWMAP 303
           G     RW AP
Sbjct: 213 GGKIPIRWTAP 223

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  145 bits (368), Expect = 2e-41
 Identities = 56/192 (29%), Positives = 86/192 (44%), Gaps = 22/192 (11%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQ 178
               I    +        G FG++Y+G            VAIK L        KA   E+
Sbjct: 37  FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------KAGYTEK 88

Query: 179 Q---FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK 235
           Q   F  E  ++    H NI+R  G   K     I+TEY + G++ +FL ++      L+
Sbjct: 89  QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148

Query: 236 LAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPE 294
           L V     +A GM Y+  +  +HRDL + N+L+ S+   K++DFG++R +E   E     
Sbjct: 149 L-VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207

Query: 295 TGT---YRWMAP 303
           +G     RW AP
Sbjct: 208 SGGKIPIRWTAP 219

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  145 bits (368), Expect = 2e-41
 Identities = 57/202 (28%), Positives = 85/202 (42%), Gaps = 33/202 (16%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKILERPENDPEKAQVME 177
           D   +  + + +      GAFG++Y G  +G         VA+K L      PE     +
Sbjct: 23  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL------PEVCSEQD 76

Query: 178 QQ-FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLK 235
           +  F  E ++++   H NIVR IG   + +   I+ E   GG ++ FL   R   S P  
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136

Query: 236 LAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIF---SDKSIKIADFGVAR----- 283
           LA+      A D+A G  Y+     IHRD+ + N L+      +  KI DFG+AR     
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

Query: 284 --IEVQTEGMTPETGTYRWMAP 303
                    M P     +WM P
Sbjct: 197 SYYRKGGCAMLP----VKWMPP 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (364), Expect = 2e-41
 Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 18/188 (9%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAQVMEQQ 179
            ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +     ++
Sbjct: 8   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-----EK 62

Query: 180 FQQEVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV 238
           F QE + +    HP+IV+ IG     P+   I+ E    G +R FL  R+       L +
Sbjct: 63  FLQEALTMRQFDHPHIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDLASL-I 119

Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT- 297
             A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R  ++       +   
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGK 178

Query: 298 --YRWMAP 303
              +WMAP
Sbjct: 179 LPIKWMAP 186

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  143 bits (363), Expect = 3e-41
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 113 DSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDP 170
             +   E        + D R L       +G+F  +Y+G  T    EVA   L+  +   
Sbjct: 7   QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 66

Query: 171 EKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC-----RKPMVWCIVTEYAKGGSVRQFLT 225
                  Q+F++E  ML  L+HPNIVRF  +       K  +  +VTE    G+++ +L 
Sbjct: 67  S----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV-LVTELMTSGTLKTYLK 121

Query: 226 KRQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLI-FSDKSIKIADFGVA 282
           +   + + +K+       + +G+ ++H     +IHRDLK DN+ I     S+KI D G+A
Sbjct: 122 R--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179

Query: 283 RIEVQTEGMTPETGTYRWMAP 303
            ++  +       GT  +MAP
Sbjct: 180 TLKRASFAKA-VIGTPEFMAP 199

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  145 bits (367), Expect = 6e-41
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 22/199 (11%)

Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGE-----EVAIKILERPENDPE 171
           PT+ +  F    +D   +++      G FG++  G           VAIK L        
Sbjct: 31  PTQTVHEF-AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-------- 81

Query: 172 KAQVMEQQ---FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ 228
           K    E+Q   F  E  ++    HPNI+R  G   K     IVTEY + GS+  FL K  
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141

Query: 229 NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQ 287
            +   ++L V     +A GM Y+  +G +HRDL + N+LI S+   K++DFG+ R +E  
Sbjct: 142 AQFTVIQL-VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

Query: 288 TEGMTPETGT---YRWMAP 303
            E      G     RW +P
Sbjct: 201 PEAAYTTRGGKIPIRWTSP 219

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  144 bits (365), Expect = 7e-41
 Identities = 57/202 (28%), Positives = 85/202 (42%), Gaps = 33/202 (16%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKILERPENDPEKAQVME 177
           D   +  + + +      GAFG++Y G  +G         VA+K L      PE     +
Sbjct: 64  DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL------PEVCSEQD 117

Query: 178 QQ-FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFL-TKRQNRSVPLK 235
           +  F  E ++++   H NIVR IG   + +   I+ E   GG ++ FL   R   S P  
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177

Query: 236 LAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIF---SDKSIKIADFGVAR----- 283
           LA+      A D+A G  Y+     IHRD+ + N L+      +  KI DFG+AR     
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

Query: 284 --IEVQTEGMTPETGTYRWMAP 303
                    M P     +WM P
Sbjct: 238 GYYRKGGCAMLP----VKWMPP 255

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  142 bits (361), Expect = 1e-40
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 18/187 (9%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQQF 180
                 +L        G FG +++G +  E       V IK++E             Q  
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-----QAV 62

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVK 239
              ++ + +L H +IVR +G C    +  +VT+Y   GS+   +  RQ+R ++  +L + 
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV--RQHRGALGPQLLLN 119

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT-- 297
             + +A+GM Y+   G++HR+L + N+L+ S   +++ADFGVA +    +     +    
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179

Query: 298 -YRWMAP 303
             +WMA 
Sbjct: 180 PIKWMAL 186

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  143 bits (362), Expect = 2e-40
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 45/215 (20%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVME 177
                    +       +GAFG++++    G         VA+K+L+   +   +     
Sbjct: 40  LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ----- 94

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR---------- 227
             FQ+E  ++A   +PNIV+ +G C      C++ EY   G + +FL             
Sbjct: 95  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154

Query: 228 --------QNRSVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK 275
                    +   P  L+  +    A  VA GMAY+     +HRDL + N L+  +  +K
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 214

Query: 276 IADFGVARI-------EVQTEGMTPETGTYRWMAP 303
           IADFG++R        +       P     RWM P
Sbjct: 215 IADFGLSRNIYSADYYKADGNDAIP----IRWMPP 245

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  142 bits (360), Expect = 2e-40
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 46/209 (22%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE----VAIKILERPENDPEKAQVMEQQ- 179
               +D   +   D   +G FG++ +     +      AIK +        K    +   
Sbjct: 18  IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--------KEYASKDDH 69

Query: 180 --FQQEVMMLATL-KHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
             F  E+ +L  L  HPNI+  +GAC  R  +   +  EYA  G++  FL  R++R +  
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYL--YLAIEYAPHGNLLDFL--RKSRVLET 125

Query: 235 ------------KLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD 278
                        L+ +Q    A DVARGM Y+ +   IHRDL + N+L+  +   KIAD
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 185

Query: 279 FGVARIE----VQTEGMTPETGTYRWMAP 303
           FG++R +     +T G  P     RWMA 
Sbjct: 186 FGLSRGQEVYVKKTMGRLP----VRWMAI 210

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  147 bits (373), Expect = 2e-40
 Identities = 58/253 (22%), Positives = 107/253 (42%), Gaps = 24/253 (9%)

Query: 63  VGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLE 122
           V        I   +   R       +A++  +  R       +    A +     T  + 
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP 380

Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILERPENDPEKAQVME 177
           +  ++ I   ++ +G    +G FG +++G Y   E     VAIK  +   +D  +     
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR----- 435

Query: 178 QQFQQEVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
           ++F QE + +    HP+IV+ IG     P+   I+ E    G +R FL  R+       L
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKFSLDLASL 493

Query: 237 AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI------EVQTEG 290
            +  A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R          ++G
Sbjct: 494 -ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552

Query: 291 MTPETGTYRWMAP 303
             P     +WMAP
Sbjct: 553 KLP----IKWMAP 561

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  141 bits (358), Expect = 3e-40
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 47/222 (21%)

Query: 116 SPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPEN 168
            PT+ L    +W     +L+ G     GAFGK+   T  G         VA+K+L     
Sbjct: 8   DPTQ-LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML----- 61

Query: 169 DPEKAQVMEQQ-FQQEVMMLATL-KHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFL 224
               A + E++    E+ +L+ L  H NIV  +GAC    P    ++TEY   G +  FL
Sbjct: 62  -KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT--LVITEYCCYGDLLNFL 118

Query: 225 TKR------------QNRSVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLI 268
            ++                  L L ++     +  VA+GMA++     IHRDL + N+L+
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178

Query: 269 FSDKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 303
              +  KI DFG+AR         V+     P     +WMAP
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLP----VKWMAP 216

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  140 bits (355), Expect = 6e-40
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 33/210 (15%)

Query: 113 DSNSPTEGLENFDEWTI--DLRKLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILER 165
           D +S    L    +  I  +    +      +G FG +Y G Y  +       AIK L  
Sbjct: 2   DLDSAL--LAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-- 57

Query: 166 PENDPEKAQVME-QQFQQEVMMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQ 222
                   ++ + + F +E +++  L HPN++  IG     + +   ++  Y   G + Q
Sbjct: 58  ----SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQ 112

Query: 223 FLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           F+ +   R+  +K  +   L VARGM Y+     +HRDL + N ++    ++K+ADFG+A
Sbjct: 113 FI-RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171

Query: 283 R---------IEVQTEGMTPETGTYRWMAP 303
           R         ++       P     +W A 
Sbjct: 172 RDILDREYYSVQQHRHARLP----VKWTAL 197

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  142 bits (360), Expect = 6e-40
 Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 57/275 (20%)

Query: 73  LNHQGLRRRANDNY---------SVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLEN 123
           + +       + +           + +  +         + + L    M +      L  
Sbjct: 1   MGYYHHHHHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPE 60

Query: 124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG---------EEVAIKILERPENDPEKAQ 174
              W +   +L +G    +GAFG++      G          +VA+K+L+    + +   
Sbjct: 61  DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-- 118

Query: 175 VMEQQFQQEVMMLATL-KHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
                   E+ M+  + KH NI+  +GAC    P+   ++ EYA  G++R++L  +  R 
Sbjct: 119 ---SDLISEMEMMKMIGKHKNIINLLGACTQDGPL--YVIVEYASKGNLREYL--QARRP 171

Query: 232 VPLKLAVKQ----------------ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK 275
             L+ +                   A  VARGM Y+     IHRDL + N+L+  D  +K
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231

Query: 276 IADFGVARI-------EVQTEGMTPETGTYRWMAP 303
           IADFG+AR        +  T G  P     +WMAP
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLP----VKWMAP 262

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  139 bits (353), Expect = 7e-40
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 32/182 (17%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKI--LERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            G FG++++     +G+   IK                  ++ ++EV  LA L H NIV 
Sbjct: 21  SGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVH 68

Query: 198 FIGA----------------CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
           + G                   K     I  E+   G++ Q++ KR+   +   LA++  
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWM 301
             + +G+ Y+H   LI+RDLK  N+ +   K +KI DFG+          T   GT R+M
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 302 AP 303
           +P
Sbjct: 189 SP 190

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  139 bits (353), Expect = 2e-39
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 43/213 (20%)

Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQV 175
           +  +W     +L +G    +GAFG++      G         VA+K+L+      E    
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 74

Query: 176 MEQQFQQEVMMLATL-KHPNIVRFIGAC---RKPMVWCIVTEYAKGGSVRQFLTKR---- 227
             +    E+ +L  +  H N+V  +GAC     P+   ++ E+ K G++  +L  +    
Sbjct: 75  --RALMSELKILIHIGHHLNVVNLLGACTKPGGPL--MVIVEFCKFGNLSTYLRSKRNEF 130

Query: 228 ------QNRSVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA 277
                         L ++     +  VA+GM ++     IHRDL + N+L+     +KI 
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190

Query: 278 DFGVARI-------EVQTEGMTPETGTYRWMAP 303
           DFG+AR          + +   P     +WMAP
Sbjct: 191 DFGLARDIYKDPDYVRKGDARLP----LKWMAP 219

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  140 bits (354), Expect = 2e-39
 Identities = 44/185 (23%), Positives = 88/185 (47%), Gaps = 18/185 (9%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQQFQQ 182
           +   +         GAFG +Y+G +  E       VAIK L    +         ++   
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-----KEILD 66

Query: 183 EVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR-SVPLKLAVKQA 241
           E  ++A++ +P++ R +G C    V  ++T+    G +  ++  R+++ ++  +  +   
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV--REHKDNIGSQYLLNWC 123

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT---Y 298
           + +A+GM Y+    L+HRDL + N+L+ + + +KI DFG+A++    E      G     
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 299 RWMAP 303
           +WMA 
Sbjct: 184 KWMAL 188

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (351), Expect = 2e-39
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 30/210 (14%)

Query: 112 MDSNSPTEGLENFDEWTIDLR--KLNMGDAFAQGAFGKLYRGTYNGEE-----VAIKILE 164
           + + +P E ++      I      ++  +   +G FG +Y GT    +      A+K L 
Sbjct: 4   LSALNP-ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 62

Query: 165 RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP-MVWCIVTEYAKGGSVRQF 223
           R  +  E       QF  E +++    HPN++  +G C +      +V  Y K G +R F
Sbjct: 63  RITDIGEV-----SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 117

Query: 224 LTKRQNRSVP-LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           +  R     P +K  +   L VA+GM Y+     +HRDL + N ++    ++K+ADFG+A
Sbjct: 118 I--RNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175

Query: 283 R---------IEVQTEGMTPETGTYRWMAP 303
           R         +  +T    P     +WMA 
Sbjct: 176 RDMYDKEYYSVHNKTGAKLP----VKWMAL 201

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  138 bits (350), Expect = 5e-39
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 56/234 (23%)

Query: 111 LMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKIL 163
           L  S    + LE+  +W    + L +G    +G FGK+ + T    +       VA+K+L
Sbjct: 3   LSLSVDAFKILED-PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML 61

Query: 164 ERPENDPEKAQVMEQQ-FQQEVMMLATLKHPNIVRFIGAC--RKPMVWCIVTEYAKGGSV 220
                  E A   E +    E  +L  + HP++++  GAC    P+   ++ EYAK GS+
Sbjct: 62  ------KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL--LLIVEYAKYGSL 113

Query: 221 RQFLTKRQNRSVPLKLAVKQ------------------------ALDVARGMAYVHRLGL 256
           R FL  R++R V                                A  +++GM Y+  + L
Sbjct: 114 RGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 303
           +HRDL + N+L+   + +KI+DFG++R          +++G  P     +WMA 
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP----VKWMAI 221

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  138 bits (351), Expect = 5e-39
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 47/220 (21%)

Query: 116 SPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPEN 168
            PT+ L   ++W      L  G     GAFGK+   T  G        +VA+K+L     
Sbjct: 31  DPTQ-LPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----- 84

Query: 169 DPEKAQVMEQQ-FQQEVMMLATL-KHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFL 224
               A   E++    E+ +++ L +H NIV  +GAC    P+   ++TEY   G +  FL
Sbjct: 85  -KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV--LVITEYCCYGDLLNFL 141

Query: 225 TKRQNRSV----------PLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFS 270
             R+   V              + +     +  VA+GMA++     IHRD+ + N+L+ +
Sbjct: 142 --RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199

Query: 271 DKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 303
               KI DFG+AR         V+     P     +WMAP
Sbjct: 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLP----VKWMAP 235

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  138 bits (349), Expect = 9e-39
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 40/214 (18%)

Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPE 171
           L    +W     KL +G    +GAFG++      G +         VA+K+L+    + +
Sbjct: 24  LPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD 83

Query: 172 KAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR--- 227
                      E+ M+  + KH NI+  +GAC +     ++ EYA  G++R++L  R   
Sbjct: 84  L-----SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138

Query: 228 -------QNRSVPLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI 276
                   NR    ++  K        +ARGM Y+     IHRDL + N+L+  +  +KI
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198

Query: 277 ADFGVARI-------EVQTEGMTPETGTYRWMAP 303
           ADFG+AR        +  T G  P     +WMAP
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLP----VKWMAP 228

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  136 bits (344), Expect = 2e-38
 Identities = 41/195 (21%), Positives = 80/195 (41%), Gaps = 29/195 (14%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGE---------EVAIKILERPENDPEKAQVME 177
             I    L   ++  QG F K+++G              EV +K+L       +  +   
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL------DKAHRNYS 56

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
           + F +   M++ L H ++V   G C       +V E+ K GS+  +L K +N    L   
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK- 115

Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS--------IKIADFGVAR-IEVQT 288
           ++ A  +A  M ++    LIH ++ + N+L+  ++         IK++D G++  +  + 
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

Query: 289 EGMTPETGTYRWMAP 303
                      W+ P
Sbjct: 176 ILQER----IPWVPP 186

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  138 bits (349), Expect = 2e-38
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 49/262 (18%)

Query: 78  LRRRANDNYSVAHSVNRRGRVSHALS--DDALARALMDSNSPTEGLENFDEWTIDLRKLN 135
           LRR+   +   + S+N    +    +         ++   S  E L    +W     KL 
Sbjct: 26  LRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYE-LPEDPKWEFPRDKLT 84

Query: 136 MGDAFAQGAFGKLYRGTYNGEE---------VAIKILERPENDPEKAQVMEQQ-FQQEVM 185
           +G    +G FG++      G +         VA+K+L       + A   +      E+ 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML------KDDATEKDLSDLVSEME 138

Query: 186 MLATL-KHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKR----------QNRSV 232
           M+  + KH NI+  +GAC    P+   ++ EYA  G++R++L  R           NR  
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPL--YVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 233 PLKLAVKQ----ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---- 284
             ++  K        +ARGM Y+     IHRDL + N+L+  +  +KIADFG+AR     
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 285 ---EVQTEGMTPETGTYRWMAP 303
              +  T G  P     +WMAP
Sbjct: 257 DYYKKTTNGRLP----VKWMAP 274

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (346), Expect = 5e-38
 Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 34/233 (14%)

Query: 91  SVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLR--KLNMGDAFAQGAFGKL 148
              + G  +            + + +P E ++      I      ++  +   +G FG +
Sbjct: 47  LYKKAGSENLYFQGANTVHIDLSALNP-ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCV 105

Query: 149 YRGTYNGEE-----VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC- 202
           Y GT    +      A+K L R  +  E       QF  E +++    HPN++  +G C 
Sbjct: 106 YHGTLLDNDGKKIHCAVKSLNRITDIGEV-----SQFLTEGIIMKDFSHPNVLSLLGICL 160

Query: 203 --RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARGMAYVHRLGLIHR 259
                    +V  Y K G +R F+  R     P +K  +   L VA+GM ++     +HR
Sbjct: 161 RSEGSP--LVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216

Query: 260 DLKSDNLLIFSDKSIKIADFGVAR---------IEVQTEGMTPETGTYRWMAP 303
           DL + N ++    ++K+ADFG+AR         +  +T    P     +WMA 
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP----VKWMAL 265

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (343), Expect = 5e-38
 Identities = 41/209 (19%), Positives = 77/209 (36%), Gaps = 25/209 (11%)

Query: 114 SNSPTEGLENFD-EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDP 170
            +S  E L        ID +         +G F  +    G ++G   A+K +   E   
Sbjct: 10  HSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ- 68

Query: 171 EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW----CIVTEYAKGGSVRQFLTK 226
                  ++ Q+E  M     HPNI+R +  C +         ++  + K G++   + +
Sbjct: 69  -----DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123

Query: 227 RQNRSVPL--KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +++   L     +   L + RG+  +H  G  HRDLK  N+L+  +    + D G    
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183

Query: 285 E----------VQTEGMTPETGTYRWMAP 303
                      +  +    +  T  + AP
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAP 212

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (349), Expect = 4e-37
 Identities = 46/188 (24%), Positives = 85/188 (45%), Gaps = 16/188 (8%)

Query: 125 DEWTIDLRKLNMGDA-FAQGAFGKLYRGTYNGE----EVAIKILERPENDPEKAQVMEQQ 179
            +  +    L + D     G FG + +G Y       +VAIK+L +   +        ++
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKA----DTEE 382

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             +E  ++  L +P IVR IG C+   +  +V E A GG + +FL  ++       +  +
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNV-AE 440

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGT- 297
               V+ GM Y+     +HR+L + N+L+ +    KI+DFG+++ +       T  +   
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500

Query: 298 --YRWMAP 303
              +W AP
Sbjct: 501 WPLKWYAP 508

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  134 bits (339), Expect = 4e-37
 Identities = 43/166 (25%), Positives = 87/166 (52%), Gaps = 9/166 (5%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FGK  L + T +G +  IK +        K +   ++ ++EV +LA +KHPNIV++ 
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKER---EESRREVAVLANMKHPNIVQYR 89

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            +  +     IV +Y +GG + + +  ++         +   + +   + +VH   ++HR
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           D+KS N+ +  D ++++ DFG+AR+   T  +      GT  +++P
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACIGTPYYLSP 194

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  133 bits (338), Expect = 5e-37
 Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 51/222 (22%)

Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEE-------VAIKILERPENDPEKA 173
            E   +W      L  G     GAFGK+   T  G         VA+K+L       EKA
Sbjct: 34  YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML------KEKA 87

Query: 174 QVMEQQ-FQQEVMMLATL-KHPNIVRFIGAC--RKPMVWCIVTEYAKGGSVRQFLTKRQN 229
              E++    E+ M+  L  H NIV  +GAC    P+   ++ EY   G +  +L  ++ 
Sbjct: 88  DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI--YLIFEYCCYGDLLNYLRSKRE 145

Query: 230 RSVPLKLAVKQ---------------------ALDVARGMAYVHRLGLIHRDLKSDNLLI 268
           +    ++  +                      A  VA+GM ++     +HRDL + N+L+
Sbjct: 146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV 205

Query: 269 FSDKSIKIADFGVARI-------EVQTEGMTPETGTYRWMAP 303
              K +KI DFG+AR         V+     P     +WMAP
Sbjct: 206 THGKVVKICDFGLARDIMSDSNYVVRGNARLP----VKWMAP 243

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (329), Expect = 3e-36
 Identities = 41/190 (21%), Positives = 74/190 (38%), Gaps = 33/190 (17%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FG     +   +    AIK +  P  +  +     ++  +EV  LA L+HP IVR+ 
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-----EKVMREVKALAKLEHPGIVRYF 69

Query: 200 GAC------------RKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVAR 246
            A                +   I  +  +  +++ ++  R         + +   L +A 
Sbjct: 70  NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-------------EVQTEGMTP 293
            + ++H  GL+HRDLK  N+    D  +K+ DFG+                       T 
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189

Query: 294 ETGTYRWMAP 303
           + GT  +M+P
Sbjct: 190 QVGTKLYMSP 199

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  130 bits (330), Expect = 4e-36
 Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 23/218 (10%)

Query: 89  AHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKL 148
              V+ RG  S  L       +  +S       ++F      L +L  G     G++G++
Sbjct: 28  PRRVSFRGEASETLQSPGYDPSRPESFFQ----QSFQR----LSRL--G----HGSYGEV 73

Query: 149 YRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP 205
           ++     +G   A+K    P   P+       +   EV     + +HP  VR   A  + 
Sbjct: 74  FKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129

Query: 206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDN 265
            +  + TE   G S++Q   +    S+P         D    +A++H  GL+H D+K  N
Sbjct: 130 GILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN 187

Query: 266 LLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           + +      K+ DFG+            + G  R+MAP
Sbjct: 188 IFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  130 bits (329), Expect = 5e-36
 Identities = 50/177 (28%), Positives = 81/177 (45%), Gaps = 21/177 (11%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA   +         E+VAIK +     + EK Q    +  +E+  ++   HPNIV + 
Sbjct: 25  SGATAVVQAAYCAPKKEKVAIKRI-----NLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79

Query: 200 GA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL------DVARGMAYVH 252
            +   K  +W +V +   GGSV   +     +       + ++       +V  G+ Y+H
Sbjct: 80  TSFVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
           + G IHRD+K+ N+L+  D S++IADFGV+        +T         GT  WMAP
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (329), Expect = 5e-36
 Identities = 43/196 (21%), Positives = 87/196 (44%), Gaps = 15/196 (7%)

Query: 113 DSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDP 170
            +  P  G      + I  +K+  G    +G F ++YR     +G  VA+K ++  +   
Sbjct: 20  KALRPDMGYNTLANFRI-EKKI--G----RGQFSEVYRAACLLDGVPVALKKVQIFDLMD 72

Query: 171 EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR 230
            KA+       +E+ +L  L HPN++++  +  +     IV E A  G + + +   + +
Sbjct: 73  AKAR---ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 129

Query: 231 SVPLK--LAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-EVQ 287
              +      K  + +   + ++H   ++HRD+K  N+ I +   +K+ D G+ R    +
Sbjct: 130 KRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189

Query: 288 TEGMTPETGTYRWMAP 303
           T       GT  +M+P
Sbjct: 190 TTAAHSLVGTPYYMSP 205

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  129 bits (327), Expect = 7e-36
 Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 46/196 (23%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QGAFG++ +     +    AIK +          +        EVM+LA+L H  +VR+ 
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIR-------HTEEKLSTILSEVMLLASLNHQYVVRYY 68

Query: 200 GA-------------CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
            A              +K     I  EY + G++   +         L     +   + R
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFR 123

Query: 247 ----GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------- 295
                ++Y+H  G+IHRDLK  N+ I   +++KI DFG+A+   ++  +           
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 296 --------GTYRWMAP 303
                   GT  ++A 
Sbjct: 184 SDNLTSAIGTAMYVAT 199

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  129 bits (326), Expect = 1e-35
 Identities = 41/171 (23%), Positives = 66/171 (38%), Gaps = 14/171 (8%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QGA   ++RG     G+  AIK+                   +E  +L  L H NIV+  
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 200 GA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYVHRLGL 256
                       ++ E+   GS+   L +  N   +P    +    DV  GM ++   G+
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133

Query: 257 IHRDLKSDNLLIFS----DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +HR++K  N++           K+ DFG AR     E      GT  ++ P
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  128 bits (324), Expect = 2e-35
 Identities = 53/173 (30%), Positives = 84/173 (48%), Gaps = 23/173 (13%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G +Y G    N   +AIK +       E+     Q   +E+ +   LKH NIV+++
Sbjct: 32  KGTYGIVYAGRDLSNQVRIAIKEIP------ERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA-------VKQALDVARGMAYVH 252
           G+  +     I  E   GGS+   L   +++  PLK          KQ L    G+ Y+H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQIL---EGLKYLH 139

Query: 253 RLGLIHRDLKSDNLLIFSDK-SIKIADFGVA-RIEVQTEGMTPETGTYRWMAP 303
              ++HRD+K DN+LI +    +KI+DFG + R+          TGT ++MAP
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  128 bits (323), Expect = 4e-35
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 20/200 (10%)

Query: 112 MDSNSPTEGLENFDEWTIDLRKL-NMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPEN 168
           M  +    GL        D  +L    +   +G+FG++++G  N   + VAIKI+     
Sbjct: 1   MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----- 55

Query: 169 DPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA-CRKPMVWCIVTEYAKGGSVRQFLTKR 227
           D E+A+   +  QQE+ +L+    P + ++ G+  +   +W I+ EY  GGS    L   
Sbjct: 56  DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPG 114

Query: 228 QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ 287
                 +   +++ L   +G+ Y+H    IHRD+K+ N+L+     +K+ADFGVA    Q
Sbjct: 115 PLDETQIATILREIL---KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQ 168

Query: 288 -TEGMTPET---GTYRWMAP 303
            T+         GT  WMAP
Sbjct: 169 LTDTQIKRNTFVGTPFWMAP 188

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  129 bits (326), Expect = 6e-35
 Identities = 41/171 (23%), Positives = 66/171 (38%), Gaps = 14/171 (8%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QGA   ++RG     G+  AIK+                   +E  +L  L H NIV+  
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 200 GA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRS-VPLKLAVKQALDVARGMAYVHRLGL 256
                       ++ E+   GS+   L +  N   +P    +    DV  GM ++   G+
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133

Query: 257 IHRDLKSDNLLIFS----DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +HR++K  N++           K+ DFG AR     E      GT  ++ P
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (321), Expect = 7e-35
 Identities = 42/205 (20%), Positives = 82/205 (40%), Gaps = 16/205 (7%)

Query: 107 LARALMDSNSPTEGLEN--FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKIL 163
           +      S+    G EN  F   ++  R  ++      G   K+++      +  AIK +
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60

Query: 164 ERPENDPEKAQVMEQQFQQEVMMLATLKHPN--IVRFIGACRKPMVWCIVTEYAKGGSVR 221
              E D +        ++ E+  L  L+  +  I+R            +V E      + 
Sbjct: 61  NLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLN 115

Query: 222 QFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
            +L K+  +S+          ++   +  +H+ G++H DLK  N L   D  +K+ DFG+
Sbjct: 116 SWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL-IVDGMLKLIDFGI 172

Query: 282 AR-IEVQTEGMTPET--GTYRWMAP 303
           A  ++  T  +  ++  GT  +M P
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPP 197

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  127 bits (321), Expect = 1e-34
 Identities = 36/168 (21%), Positives = 70/168 (41%), Gaps = 14/168 (8%)

Query: 142 QGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN--IVRF 198
            G   K+++      +  AIK +   E D +        ++ E+  L  L+  +  I+R 
Sbjct: 19  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 74

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
                      +V E      +  +L K++  S+          ++   +  +H+ G++H
Sbjct: 75  YDYEITDQYIYMVMECG-NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVH 131

Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 303
            DLK  N L   D  +K+ DFG+A  ++  T  +  ++  GT  +M P
Sbjct: 132 SDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (320), Expect = 1e-34
 Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 26/233 (11%)

Query: 81  RANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAF 140
           +A+   S+A + +        L  +      +      + ++   E+  ++  +      
Sbjct: 9   QAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY--EYREEVHWMTHQPRV 66

Query: 141 AQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +G+FG+++R      G + A+K +            +E    +E++  A L  P IV  
Sbjct: 67  GRGSFGEVHRMKDKQTGFQCAVKKVR-----------LEVFRVEELVACAGLSSPRIVPL 115

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL-KLAVKQALDVARGMAYVHRLGLI 257
            GA R+     I  E  +GGS+ Q + +            + QAL    G+ Y+H   ++
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL---EGLEYLHTRRIL 172

Query: 258 HRDLKSDNLLIFSD-KSIKIADFGVA-RIEVQTEGMTPET-----GTYRWMAP 303
           H D+K+DN+L+ SD     + DFG A  ++    G +  T     GT   MAP
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (323), Expect = 1e-34
 Identities = 35/168 (20%), Positives = 69/168 (41%), Gaps = 14/168 (8%)

Query: 142 QGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN--IVRF 198
            G   K+++      +  AIK +   E D +        ++ E+  L  L+  +  I+R 
Sbjct: 66  SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD----SYRNEIAYLNKLQQHSDKIIRL 121

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
                      +V E      +  +L K++  S+          ++   +  +H+ G++H
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVH 178

Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 303
            DLK  N L   D  +K+ DFG+A  ++  T  +  ++  G   +M P
Sbjct: 179 SDLKPANFL-IVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  125 bits (315), Expect = 6e-34
 Identities = 51/233 (21%), Positives = 103/233 (44%), Gaps = 28/233 (12%)

Query: 75  HQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKL 134
           H      +  +    +   + G V+H     AL R ++D   P   L+++ +        
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAAL-RMVVDQGDPRLLLDSYVK-------- 52

Query: 135 NMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH 192
                  +G+ G +        G +VA+K+++       +     +    EV+++   +H
Sbjct: 53  -----IGEGSTGIVCLAREKHSGRQVAVKMMD-LRKQQRR-----ELLFNEVVIMRDYQH 101

Query: 193 PNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
            N+V    +      +W ++ E+ +GG++   +++ +     +    +  L   + +AY+
Sbjct: 102 FNVVEMYKSYLVGEELW-VLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QALAYL 157

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGV-ARIEVQTEGMTPETGTYRWMAP 303
           H  G+IHRD+KSD++L+  D  +K++DFG  A+I           GT  WMAP
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  124 bits (313), Expect = 8e-34
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 18/169 (10%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GAFGK+Y+      G   A K++E  +++ E      + +  E+ +LAT  HP IV+ +
Sbjct: 29  DGAFGKVYKAKNKETGALAAAKVIE-TKSEEEL-----EDYIVEIEILATCDHPYIVKLL 82

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV--KQALDVARGMAYVHRLGLI 257
           GA        I+ E+  GG+V   + +        ++ V  +Q L     + ++H   +I
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSKRII 139

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 303
           HRDLK+ N+L+  +  I++ADFGV+   ++T  +       GT  WMAP
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAP 186

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  123 bits (311), Expect = 1e-33
 Identities = 45/186 (24%), Positives = 70/186 (37%), Gaps = 31/186 (16%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRF 198
            G FG +++     +G   AIK  ++P          EQ   +EV   A L +H ++VR+
Sbjct: 21  SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRY 76

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK--LAVKQALDVARGMAYVHRLGL 256
             A  +     I  EY  GGS+   +++        K        L V RG+ Y+H + L
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 136

Query: 257 IHRDLKSDNLLIFSDKSI-------------------KIADFGVARIEVQTEGMTPETGT 297
           +H D+K  N+ I                         KI D G      +      E G 
Sbjct: 137 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISSPQVEEGD 193

Query: 298 YRWMAP 303
            R++A 
Sbjct: 194 SRFLAN 199

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  122 bits (308), Expect = 5e-33
 Identities = 63/187 (33%), Positives = 92/187 (49%), Gaps = 14/187 (7%)

Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQ 182
           NFDE  I +    MG    +G FG +Y+G  N   VA+K L     D    + ++QQF Q
Sbjct: 26  NFDERPISVGGNKMG----EGGFGVVYKGYVNNTTVAVKKLA-AMVDITTEE-LKQQFDQ 79

Query: 183 EVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL--KLAVKQ 240
           E+ ++A  +H N+V  +G        C+V  Y   GS+   L+       PL   +  K 
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCKI 138

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----G 296
           A   A G+ ++H    IHRD+KS N+L+    + KI+DFG+AR   +    T  T    G
Sbjct: 139 AQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA-SEKFAQTVMTSRIVG 197

Query: 297 TYRWMAP 303
           T  +MAP
Sbjct: 198 TTAYMAP 204

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  122 bits (307), Expect = 6e-33
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 20/169 (11%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QGA G +Y       G+EVAI+ +   +  P+K     +    E++++   K+PNIV ++
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQMN-LQQQPKK-----ELIINEILVMRENKNPNIVNYL 83

Query: 200 GAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
            +      +W +V EY  GGS+   +T+       +    ++ L   + + ++H   +IH
Sbjct: 84  DSYLVGDELW-VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIH 139

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAP 303
           RD+KSDN+L+  D S+K+ DFG      Q T   +  +   GT  WMAP
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTMVGTPYWMAP 185

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (305), Expect = 1e-32
 Identities = 51/172 (29%), Positives = 89/172 (51%), Gaps = 24/172 (13%)

Query: 141 AQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            +G++G +Y+  +   G+ VAIK +   E+D ++         +E+ ++     P++V++
Sbjct: 38  GEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQE-------IIKEISIMQQCDSPHVVKY 89

Query: 199 IGA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV--KQALDVARGMAYVHRLG 255
            G+  +   +W IV EY   GSV   +  R       ++A   +  L   +G+ Y+H + 
Sbjct: 90  YGSYFKNTDLW-IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL---KGLEYLHFMR 145

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-TEGMTPET---GTYRWMAP 303
            IHRD+K+ N+L+ ++   K+ADFGVA    Q T+ M       GT  WMAP
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTVIGTPFWMAP 194

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  122 bits (308), Expect = 2e-32
 Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 26/177 (14%)

Query: 143 GAFGKLYRGTY--NGEEVAIKI--LERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
                +    Y   GE V ++   LE   N+      M    Q E+ +     HPNIV +
Sbjct: 38  EDLMTVNLARYKPTGEYVTVRRINLEACSNE------MVTFLQGELHVSKLFNHPNIVPY 91

Query: 199 IGA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAV--KQALDVARGMAYVHRL 254
                    +W +VT +   GS +  +       +  L +A   +  L   + + Y+H +
Sbjct: 92  RATFIADNELW-VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHM 147

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVA--------RIEVQTEGMTPETGTYRWMAP 303
           G +HR +K+ ++LI  D  + ++             R  V  +          W++P
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  125 bits (314), Expect = 3e-32
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 30/203 (14%)

Query: 116 SPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKA 173
           SP+   +    W +   +L        G FG + R      GE+VAIK   +     E +
Sbjct: 5   SPSLPTQTCGPWEMK-ERLG------TGGFGYVLRWIHQDTGEQVAIKQCRQ-----ELS 52

Query: 174 QVMEQQFQQEVMMLATLKHPNIVRFI------GACRKPMVWCIVTEYAKGGSVRQFLTKR 227
               +++  E+ ++  L HPN+V                +  +  EY +GG +R++L + 
Sbjct: 53  PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF 112

Query: 228 QNRSVPLKLAVKQAL----DVARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFG 280
           +N      L          D++  + Y+H   +IHRDLK +N+++         KI D G
Sbjct: 113 ENCC---GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169

Query: 281 VARIEVQTEGMTPETGTYRWMAP 303
            A+   Q E  T   GT +++AP
Sbjct: 170 YAKELDQGELCTEFVGTLQYLAP 192

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  119 bits (300), Expect = 9e-32
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 35/212 (16%)

Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFA------QGAFGKLYRGTY--NGEEVAIKIL 163
           M S+SP   L+  D   +     +    F        G +G++Y+G +   G+  AIK++
Sbjct: 2   MASDSPARSLDEIDLSALR----DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM 57

Query: 164 ERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMV-------WCIVTEYA 215
           +    D E      ++ +QE+ ML     H NI  + GA  K          W +V E+ 
Sbjct: 58  D-VTGDEE------EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW-LVMEFC 109

Query: 216 KGGSVRQFLTKRQNRSVP-LKLAV--KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK 272
             GSV   +   +  ++    +A   ++ L   RG++++H+  +IHRD+K  N+L+  + 
Sbjct: 110 GAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGLSHLHQHKVIHRDIKGQNVLLTENA 166

Query: 273 SIKIADFGVARIEVQTEG-MTPETGTYRWMAP 303
            +K+ DFGV+    +T G      GT  WMAP
Sbjct: 167 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  119 bits (300), Expect = 2e-31
 Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 16/167 (9%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G+FG +Y        E VAIK +       +++    Q   +EV  L  L+HPN +++ 
Sbjct: 64  HGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 200 GAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV--KQALDVARGMAYVHRLGL 256
           G   R+   W +V EY   GS    L   +     +++A     AL   +G+AY+H   +
Sbjct: 121 GCYLREHTAW-LVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNM 175

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           IHRD+K+ N+L+     +K+ DFG A I           GT  WMAP
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAP 219

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  117 bits (296), Expect = 2e-31
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 20/176 (11%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPE-NDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            G++G+    R   +G+ +  K L+     + EK     Q    EV +L  LKHPNIVR+
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-----QMLVSEVNLLRELKHPNIVRY 70

Query: 199 IGA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL--KLAVKQALDVARGMAYVHRL 254
                 R      IV EY +GG +   +TK       L  +  ++    +   +   HR 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 255 GL-----IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
                  +HRDLK  N+ +   +++K+ DFG+ARI         +T  GT  +M+P
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFVGTPYYMSP 185

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (294), Expect = 3e-31
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 22/186 (11%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQV----MEQQ 179
           +W ++     +G    +G FG +Y  R   +   +A+K+L        KAQ+    +E Q
Sbjct: 5   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF-------KAQLEKAGVEHQ 55

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
            ++EV + + L+HPNI+R  G         ++ EYA  G+V + L K        +    
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTAT 113

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GT 297
              ++A  ++Y H   +IHRD+K +NLL+ S   +KIADFG +   V           GT
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGT 170

Query: 298 YRWMAP 303
             ++ P
Sbjct: 171 LDYLPP 176

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  115 bits (290), Expect = 3e-30
 Identities = 60/172 (34%), Positives = 86/172 (50%), Gaps = 17/172 (9%)

Query: 142 QGAFGKLYRGT-YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           +G FGK+Y+G   +G  VA+K L       E+ Q  E QFQ EV M++   H N++R  G
Sbjct: 40  RGGFGKVYKGRLADGTLVAVKRL-----KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA--VKQALDVARGMAYVH---RLG 255
            C  P    +V  Y   GSV   L +R     PL      + AL  ARG+AY+H      
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 303
           +IHRD+K+ N+L+  +    + DFG+A++       T  T    GT   +AP
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKL--MDYKDTHVTTAVRGTIGHIAP 204

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  115 bits (290), Expect = 3e-30
 Identities = 46/170 (27%), Positives = 72/170 (42%), Gaps = 19/170 (11%)

Query: 128 TIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM 185
            +   +L +    A+G F  +Y  +   +G E A+K L   E +        +   QEV 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE------KNRAIIQEVC 77

Query: 186 MLATLK-HPNIVRFIGACRKP--------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKL 236
            +  L  HPNIV+F  A              + ++TE  KG  V           +    
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 237 AVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADFGVARI 284
            +K      R + ++HR    +IHRDLK +NLL+ +  +IK+ DFG A  
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  115 bits (289), Expect = 6e-30
 Identities = 43/216 (19%), Positives = 83/216 (38%), Gaps = 42/216 (19%)

Query: 114 SNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILER-------- 165
           +    E  +  +++ I +R LN      QG F K+     + +  A+K  E+        
Sbjct: 20  NKYVKEKDKYINDYRI-IRTLN------QGKFNKIILCEKDNKFYALKKYEKSLLEKKRD 72

Query: 166 ---PENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW------CIVTEYAK 216
                ND    +     F+ E+ ++  +K+   +   G      +        I+ EY +
Sbjct: 73  FTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG------IITNYDEVYIIYEYME 126

Query: 217 GGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIHRDLKSDNLLIF 269
             S+         L K     +P+++       V    +Y+H    + HRD+K  N+L+ 
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186

Query: 270 SDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
            +  +K++DFG +           +   GTY +M P
Sbjct: 187 KNGRVKLSDFGES---EYMVDKKIKGSRGTYEFMPP 219

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  115 bits (289), Expect = 1e-29
 Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 22/175 (12%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERP--ENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            GA G++         ++VAI+I+ +        +        + E+ +L  L HP I++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204

Query: 198 FIGACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
                       IV E  +GG         + L +   +         Q L     + Y+
Sbjct: 205 IKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 255

Query: 252 HRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT  ++AP
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  112 bits (282), Expect = 2e-29
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 22/186 (11%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQV----MEQQ 179
           ++TID    ++G    +G FG +Y  R   N   +A+K+L        K+Q+    +E Q
Sbjct: 10  KFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-------KSQLEKEGVEHQ 60

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
            ++E+ + + L+HPNI+R            ++ E+A  G + + L K        + +  
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSAT 118

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GT 297
              ++A  + Y H   +IHRD+K +NLL+     +KIADFG +   V    +   T  GT
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRTMCGT 175

Query: 298 YRWMAP 303
             ++ P
Sbjct: 176 LDYLPP 181

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  115 bits (289), Expect = 2e-29
 Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 30/206 (14%)

Query: 115 NSPTEGLENFDEWTIDLR----KLNMGDAFAQGAFGK-LYRGTYNGEEVAIKILERPEND 169
           +SP+   ++ DE T  +          D    GA G  +YRG ++  +VA+K +      
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---- 58

Query: 170 PEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ 228
                       +EV +L    +HPN++R+    +      I  E     ++++++ ++ 
Sbjct: 59  -----ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112

Query: 229 NRSVPLKLA--VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADFGV 281
              + L+    ++Q      G+A++H L ++HRDLK  N+LI    +       I+DFG+
Sbjct: 113 FAHLGLEPITLLQQTTS---GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169

Query: 282 ARIEVQTEG----MTPETGTYRWMAP 303
            +            +   GT  W+AP
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAP 195

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  112 bits (282), Expect = 4e-29
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 22/175 (12%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERP--ENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            GA G++         ++VAIKI+ +        +        + E+ +L  L HP I++
Sbjct: 20  SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79

Query: 198 FIGACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
                     + IV E  +GG         + L +   +         Q L     + Y+
Sbjct: 80  IKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLY-----FYQMLL---AVQYL 130

Query: 252 HRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           H  G+IHRDLK +N+L+ S   D  IKI DFG ++I  +T  M    GT  ++AP
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  111 bits (280), Expect = 4e-29
 Identities = 42/174 (24%), Positives = 84/174 (48%), Gaps = 20/174 (11%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILER---PENDPEKAQVMEQQFQQEVMMLATLK-HPNI 195
           +G    + R  +    +E A+KI++         E+ Q + +   +EV +L  +  HPNI
Sbjct: 27  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86

Query: 196 VRFIGACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
           ++          + +V +  K G      + +  L++++ R +     ++  L+V   + 
Sbjct: 87  IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-----MRALLEV---IC 138

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +H+L ++HRDLK +N+L+  D +IK+ DFG +      E +    GT  ++AP
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  111 bits (280), Expect = 5e-29
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 15/158 (9%)

Query: 131 LRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQV----MEQQFQQEV 184
            R+   G    +G F K +  +     E  A KI+        K+ +      ++   E+
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP-------KSLLLKPHQREKMSMEI 66

Query: 185 MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
            +  +L H ++V F G         +V E  +  S+ +   +R  +++    A      +
Sbjct: 67  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQI 124

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
             G  Y+HR  +IHRDLK  NL +  D  +KI DFG+A
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (278), Expect = 9e-29
 Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 17/158 (10%)

Query: 136 MGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP 193
           MGD   +G++GK+            A+KIL++      +    E   ++E+ +L  L+H 
Sbjct: 9   MGDLLGEGSYGKVKEVLDSETLCRRAVKILKK--KKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 194 NIVRF---IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR---- 246
           N+++    +    K  +  +V EY   G          +     +  V QA         
Sbjct: 67  NVIQLVDVLYNEEKQKM-YMVMEYCVCGMQEML-----DSVPEKRFPVCQAHGYFCQLID 120

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           G+ Y+H  G++H+D+K  NLL+ +  ++KI+  GVA  
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  111 bits (280), Expect = 9e-29
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 15/158 (9%)

Query: 131 LRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQV----MEQQFQQEV 184
            R+   G    +G F K +  +     E  A KI+        K+ +      ++   E+
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP-------KSLLLKPHQREKMSMEI 92

Query: 185 MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
            +  +L H ++V F G         +V E  +  S+ +   +R  +++    A      +
Sbjct: 93  SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQI 150

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
             G  Y+HR  +IHRDLK  NL +  D  +KI DFG+A
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  111 bits (280), Expect = 9e-29
 Identities = 53/170 (31%), Positives = 83/170 (48%), Gaps = 20/170 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G F K+        G EVAIKI+++ + +P       Q+  +EV ++  L HPNIV+  
Sbjct: 25  KGNFAKVKLARHILTGREVAIKIIDKTQLNPT----SLQKLFREVRIMKILNHPNIVKLF 80

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR----GMAYVHRLG 255
                     ++ EYA GG V  +L          ++  K+A    R     + Y H+  
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           ++HRDLK++NLL+ +D +IKIADFG +     T G   +   G   + AP
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAP 182

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  110 bits (278), Expect = 2e-28
 Identities = 47/172 (27%), Positives = 90/172 (52%), Gaps = 20/172 (11%)

Query: 142 QGAFGKLYRGT-YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
            G FGK+Y+G   +G +VA+K        PE +Q   ++F+ E+  L+  +HP++V  IG
Sbjct: 49  HGVFGKVYKGVLRDGAKVALKRR-----TPESSQ-GIEEFETEIETLSFCRHPHLVSLIG 102

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL--KLAVKQALDVARGMAYVHRLGLIH 258
            C +     ++ +Y + G++++ L      ++ +  +  ++  +  ARG+ Y+H   +IH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIE-------VQTEGMTPETGTYRWMAP 303
           RD+KS N+L+  +   KI DFG+++         + T       GT  ++ P
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK----GTLGYIDP 210

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  110 bits (276), Expect = 2e-28
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 23/173 (13%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FG++ +       +E A+K++ +     +          +EV +L  L HPNI++  
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87

Query: 200 GACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                   + IV E   GG        R+  ++     +     +KQ       + Y+H+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139

Query: 254 LGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK +N+L+ S   D  IKI DFG++    Q   M    GT  ++AP
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  111 bits (279), Expect = 2e-28
 Identities = 39/173 (22%), Positives = 85/173 (49%), Gaps = 19/173 (10%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERP--ENDPEKAQVMEQQFQQEVMMLATLK-HPNIV 196
           +G    + R  +   G E A+KI+E       PE+ + + +  ++E  +L  +  HP+I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163

Query: 197 RFIGACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
             I +        +V +  + G      + +  L++++ RS+     ++  L+    +++
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLLEA---VSF 215

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +H   ++HRDLK +N+L+  +  I+++DFG +      E +    GT  ++AP
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAP 268

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (275), Expect = 2e-28
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 18/172 (10%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GAFG ++      +G E  IK + +     +++QV  +Q + E+ +L +L HPNI++  
Sbjct: 32  SGAFGDVHLVEERSSGLERVIKTINK-----DRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVARGMAYVHRL 254
                     IV E  +GG + + +   Q R   L        +KQ ++    +AY H  
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQ 143

Query: 255 GLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            ++H+DLK +N+L         IKI DFG+A +    E  T   GT  +MAP
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  108 bits (272), Expect = 6e-28
 Identities = 40/169 (23%), Positives = 85/169 (50%), Gaps = 14/169 (8%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRF 198
           +GA+G + +  +   G+ +A+K + R   + ++    +++   ++ + + T+  P  V F
Sbjct: 17  RGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQE----QKRLLMDLDISMRTVDCPFTVTF 71

Query: 199 IGACRKP-MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV--KQALDVARGMAYVH-RL 254
            GA  +   VW I  E     S+ +F  +  ++   +   +  K A+ + + + ++H +L
Sbjct: 72  YGALFREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            +IHRD+K  N+LI +   +K+ DFG++   V       + G   +MAP
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  109 bits (274), Expect = 8e-28
 Identities = 43/166 (25%), Positives = 83/166 (50%), Gaps = 13/166 (7%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G  G +++ ++   G  +A K++        + Q++     +E+ +L     P IV F 
Sbjct: 43  AGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-----RELQVLHECNSPYIVGFY 97

Query: 200 GA-CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLI 257
           GA      +  I  E+  GGS+ Q L  ++   +P ++  K ++ V +G+ Y+  +  ++
Sbjct: 98  GAFYSDGEIS-ICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           HRD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 199

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  110 bits (277), Expect = 9e-28
 Identities = 43/209 (20%), Positives = 82/209 (39%), Gaps = 36/209 (17%)

Query: 121 LENFDEWTIDLRKL-NMGDAFAQGAFGKL-YRGTYNGEEVAIKILERPENDPEKAQVMEQ 178
           + N   +   L+ L         G+ G + ++G++ G  VA+K +               
Sbjct: 3   IANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---------FCD 53

Query: 179 QFQQEV-MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
               E+ ++  +  HPN++R+  +        I  E     +++  +  +      LKL 
Sbjct: 54  IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQ 112

Query: 238 VKQA-----LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-------------IKIADF 279
            +         +A G+A++H L +IHRDLK  N+L+ +                I I+DF
Sbjct: 113 KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172

Query: 280 GVARIEVQTEG-----MTPETGTYRWMAP 303
           G+ +     +      +   +GT  W AP
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAP 201

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  107 bits (269), Expect = 1e-27
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 17/149 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GA+G++         E VA+KI++      ++A    +  ++E+ +   L H N+V+F 
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR----GMAYVHRLG 255
           G  R+  +  +  EY  GG +   +           +    A         G+ Y+H +G
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           + HRD+K +NLL+    ++KI+DFG+A +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATV 154

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  107 bits (269), Expect = 1e-27
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 26/153 (16%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQV----MEQQFQQEVMMLATLKHPNI 195
           +G+F  +YR    + G EVAIK+++       K  +    M Q+ Q EV +   LKHP+I
Sbjct: 21  KGSFAGVYRAESIHTGLEVAIKMID-------KKAMYKAGMVQRVQNEVKIHCQLKHPSI 73

Query: 196 VRFIGACRKPMVW------CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
           +           +       +V E    G + ++L K + +      A      +  GM 
Sbjct: 74  LELYN------YFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGML 126

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA 282
           Y+H  G++HRDL   NLL+  + +IKIADFG+A
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  107 bits (270), Expect = 2e-27
 Identities = 42/186 (22%), Positives = 86/186 (46%), Gaps = 13/186 (6%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQ 182
             W      L       +GA+G + +  +   G+ +A+K + R   D ++    ++Q   
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKE----QKQLLM 69

Query: 183 EV-MMLATLKHPNIVRFIGACRKP-MVWCIVTEYAKGGSVR--QFLTKRQNRSVPLKLAV 238
           ++ +++ +   P IV+F GA  +    W I  E       +  +++    +  +P ++  
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128

Query: 239 KQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           K  L   + + ++   L +IHRD+K  N+L+    +IK+ DFG++   V +   T + G 
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGC 188

Query: 298 YRWMAP 303
             +MAP
Sbjct: 189 RPYMAP 194

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (267), Expect = 2e-27
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 27/174 (15%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQV-MEQQFQQEVMMLATLKHPNIVRF 198
           +G++G++            A K +        K  V    +F+QE+ ++ +L HPNI+R 
Sbjct: 19  RGSWGEVKIAVQKGTRIRRAAKKIP-------KYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 199 IGACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
                      +V E   GG        ++   +     +     +K  L     +AY H
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLSA---VAYCH 123

Query: 253 RLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +L + HRDLK +N L  +   D  +K+ DFG+A      + M  + GT  +++P
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  106 bits (267), Expect = 3e-27
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 23/173 (13%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GAF  + R      G E A KI+   +          Q+ ++E  +   L+HPNIVR  
Sbjct: 16  KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 71

Query: 200 GACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            + ++     +V +   GG        R+F ++           ++Q L+    +AY H 
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 123

Query: 254 LGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G++HR+LK +NLL+ S     ++K+ADFG+A     +E      GT  +++P
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (267), Expect = 4e-27
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 26/173 (15%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GAF +++       G+  A+K +++           +   + E+ +L  +KH NIV   
Sbjct: 19  SGAFSEVFLVKQRLTGKLFALKCIKK------SPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 200 GACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                   + +V +   GG        R   T++    V     ++Q L     + Y+H 
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---VKYLHE 124

Query: 254 LGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G++HRDLK +NLL  +   +  I I DFG++++E Q   M+   GT  ++AP
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAP 176

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  107 bits (268), Expect = 4e-27
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 17/149 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GA+G++         E VA+KI++      ++A    +  ++E+ +   L H N+V+F 
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDM-----KRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR----GMAYVHRLG 255
           G  R+  +  +  EY  GG +   +           +    A         G+ Y+H +G
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           + HRD+K +NLL+    ++KI+DFG+A +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATV 154

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (275), Expect = 4e-27
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 23/172 (13%)

Query: 141 AQGAFGKLYRGT---YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           A G  G +Y       NG  V +K L     D E     +     E   LA + HP+IV+
Sbjct: 89  AHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAE----AQAMAMAERQFLAEVVHPSIVQ 143

Query: 198 ------FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
                        P+ + IV EY  G S+++   ++    +P+  A+   L++   ++Y+
Sbjct: 144 IFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           H +GL++ DLK +N+++ +++ +K+ D G         G     GT  + AP
Sbjct: 199 HSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRINSF-GYL--YGTPGFQAP 246

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  105 bits (265), Expect = 5e-27
 Identities = 41/149 (27%), Positives = 75/149 (50%), Gaps = 15/149 (10%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G FGK+  G     G +VA+KIL R +        +  + ++E+  L   +HP+I++  
Sbjct: 21  VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD---VVGKIKREIQNLKLFRHPHIIKLY 77

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR----GMAYVHRLG 255
                P  + +V EY  GG +  ++ K        ++   +A  + +     + Y HR  
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRHM 131

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           ++HRDLK +N+L+ +  + KIADFG++ +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNM 160

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  107 bits (269), Expect = 5e-27
 Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 33/176 (18%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G FG     R     E VA+K +E       +   +++  Q+E++   +L+HPNIVRF 
Sbjct: 30  SGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVRFK 82

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR--------GMAYV 251
                P    I+ EYA GG + + +          + +     D AR        G++Y 
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAG------RFSE----DEARFFFQQLLSGVSYC 132

Query: 252 HRLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           H + + HRDLK +N L+    +  +KI DFG ++         P++  GT  ++AP
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAYIAP 186

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 9e-27
 Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 20/174 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G F  + +      G+E A K +++      +  V  ++ ++EV +L  ++HPNI+   
Sbjct: 15  SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74

Query: 200 GACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                     ++ E   GG      + ++ LT+ +         +KQ LD   G+ Y+H 
Sbjct: 75  DIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYLHS 126

Query: 254 LGLIHRDLKSDNLLIFS----DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             + H DLK +N+++      +  IK+ DFG+A             GT  ++AP
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  105 bits (264), Expect = 9e-27
 Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 28/187 (14%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILER--------------------PENDPEKAQVMEQQ 179
           +G++G   L     +    A+K+L +                          + +   +Q
Sbjct: 23  KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA 237
             QE+ +L  L HPN+V+ +     P      +V E    G V   +     + +    A
Sbjct: 83  VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQA 139

Query: 238 VKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET-G 296
                D+ +G+ Y+H   +IHRD+K  NLL+  D  IKIADFGV+     ++ +   T G
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199

Query: 297 TYRWMAP 303
           T  +MAP
Sbjct: 200 TPAFMAP 206

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  105 bits (264), Expect = 1e-26
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 13/161 (8%)

Query: 141 AQGAFGKLYRG--TYNGEEVAIKILERPE--NDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
             G    +Y    T    +VAIK +         E      ++F++EV   + L H NIV
Sbjct: 20  GGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEE----TLKRFEREVHNSSQLSHQNIV 74

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
             I    +   + +V EY +G ++ +++    +  + +  A+     +  G+ + H + +
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           +HRD+K  N+LI S+K++KI DFG+A+  +    +T +T  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLT-QTNH 171

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  107 bits (270), Expect = 1e-26
 Identities = 45/173 (26%), Positives = 86/173 (49%), Gaps = 22/173 (12%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FG++        G+E A+K++ +      K +  ++   +EV +L  L HPNI++  
Sbjct: 36  KGSFGEVILCKDKITGQECAVKVISK---RQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 200 GACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                   + +V E   GG +      R+  ++     +     ++Q L     + Y+H+
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-----IRQVLSG---ITYMHK 144

Query: 254 LGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK +NLL+ S   D +I+I DFG++     ++ M  + GT  ++AP
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (264), Expect = 2e-26
 Identities = 41/238 (17%), Positives = 82/238 (34%), Gaps = 44/238 (18%)

Query: 104 DDALARALMDS-NSPTEGLENFDEWTIDLRKLNMGDAFA-------------QGAFGKLY 149
           DD L   L+   + P     N  EW   L  +     F              +GAF ++Y
Sbjct: 23  DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82

Query: 150 RGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC 202
             T        N ++  +K+ +    +P +  +  Q     +  L        ++F  A 
Sbjct: 83  EATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQ----LMERLKPSMQHMFMKFYSAH 136

Query: 203 RKPMVWCIVTEYAKGGSVRQFLTKRQN---RSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
                  +V E    G++   +   +N   + +P  L +  A+ +   +  VH   +IH 
Sbjct: 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHG 196

Query: 260 DLKSDNLLIFS-----------DKSIKIADFGVAR-IEVQTEGMTPET--GTYRWMAP 303
           D+K DN ++ +              + + D G +  +++  +G        T  +   
Sbjct: 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  105 bits (263), Expect = 2e-26
 Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 15/165 (9%)

Query: 141 AQGAFGKLYRG--TYNGEEVAIKILERPE--NDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
             G   +++      +  +VA+K+L R +   DP        +F++E    A L HP IV
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPS----FYLRFRREAQNAAALNHPAIV 75

Query: 197 RF--IGACRKPMVWC--IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
                G    P      IV EY  G ++R  +       +  K A++   D  + + + H
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH 133

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT 297
           + G+IHRD+K  N++I +  ++K+ DFG+AR    +     +T  
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  107 bits (269), Expect = 2e-26
 Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 28/181 (15%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILER-------PENDPEKAQVMEQQFQQEVMMLATLKH 192
            GA+G++          E AIK++++         +D +  +   ++   E+ +L +L H
Sbjct: 46  SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105

Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVAR 246
           PNI++          + +VTE+ +GG +      R    +    ++     +KQ L    
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-----MKQILSG-- 158

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS----IKIADFGVARIEVQTEGMTPETGTYRWMA 302
            + Y+H+  ++HRD+K +N+L   +K+    IKI DFG++    +   +    GT  ++A
Sbjct: 159 -ICYLHKHNIVHRDIKPENIL-LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216

Query: 303 P 303
           P
Sbjct: 217 P 217

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  104 bits (261), Expect = 3e-26
 Identities = 39/167 (23%), Positives = 78/167 (46%), Gaps = 13/167 (7%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRF 198
            G  G++++  +   G  +A+K + R   + E+     ++   ++ ++L +   P IV+ 
Sbjct: 35  SGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEE----NKRILMDLDVVLKSHDCPYIVQC 89

Query: 199 IGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGL 256
            G       V+ I  E     + +  L KR    +P ++  K  + + + + Y+  + G+
Sbjct: 90  FGTFITNTDVF-IAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           IHRD+K  N+L+     IK+ DFG++   V  +      G   +MAP
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  106 bits (267), Expect = 3e-26
 Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 23/173 (13%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA+G++          E AIKI+ +             +  +EV +L  L HPNI++  
Sbjct: 47  SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLY 102

Query: 200 GACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                   + +V E  KGG +      R    +     +     +KQ L     + Y+H+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLSG---VTYLHK 154

Query: 254 LGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK +NLL+ S   D  IKI DFG++ +    + M    GT  ++AP
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (263), Expect = 3e-26
 Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 20/174 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G F  + +      G E A K +++ ++   +  V  ++ ++EV +L  + HPNI+   
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81

Query: 200 GACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                     ++ E   GG +      ++ L++ +  S      +KQ LD   G+ Y+H 
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133

Query: 254 LGLIHRDLKSDNLLIFS----DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             + H DLK +N+++         IK+ DFG+A             GT  ++AP
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (260), Expect = 5e-26
 Identities = 39/174 (22%), Positives = 75/174 (43%), Gaps = 20/174 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G F  + +      G E A K +++ ++   +  V  ++ ++EV +L  + H N++   
Sbjct: 22  SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81

Query: 200 GACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                     ++ E   GG      + ++ L++ +  S      +KQ LD   G+ Y+H 
Sbjct: 82  DVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYLHT 133

Query: 254 LGLIHRDLKSDNLLIFS----DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             + H DLK +N+++         IK+ DFG+A             GT  ++AP
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  106 bits (266), Expect = 5e-26
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 25/174 (14%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FG++ +       +E A+K++ +     +          +EV +L  L HPNI++  
Sbjct: 32  KGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLF 87

Query: 200 GACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                   + IV E   GG +      R+  ++     +     +KQ       + Y+H+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHK 139

Query: 254 LGLIHRDLKSDNLLIFSDKS----IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK +N+L    K     IKI DFG++    Q   M    GT  ++AP
Sbjct: 140 HNIVHRDLKPENIL-LESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  103 bits (259), Expect = 8e-26
 Identities = 35/146 (23%), Positives = 67/146 (45%), Gaps = 7/146 (4%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKIL--ERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            GAFG ++        +EV +K +  E+   D         +   E+ +L+ ++H NI++
Sbjct: 34  SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93

Query: 198 FIGACRKPMVWCIVTE-YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
            +        + +V E +  G  +  F+ +     +   LA      +   + Y+    +
Sbjct: 94  VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDI 151

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVA 282
           IHRD+K +N++I  D +IK+ DFG A
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSA 177

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (260), Expect = 9e-26
 Identities = 47/173 (27%), Positives = 82/173 (47%), Gaps = 23/173 (13%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GAF  + R  +   G E A KI+   +          Q+ ++E  +   L+HPNIVR  
Sbjct: 39  KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLH 94

Query: 200 GACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            + ++     +V +   GG        R+F ++           ++Q L+    +AY H 
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQILES---IAYCHS 146

Query: 254 LGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G++HR+LK +NLL+ S     ++K+ADFG+A     +E      GT  +++P
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  102 bits (257), Expect = 1e-25
 Identities = 41/154 (26%), Positives = 77/154 (50%), Gaps = 16/154 (10%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FGK+   T     ++VA+K + R          M  + ++E+  L  L+HP+I++  
Sbjct: 19  EGSFGKVKLATHYKTQQKVALKFISRQLLKKSD---MHMRVEREISYLKLLRHPHIIKLY 75

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR----GMAYVHRLG 255
                P    +V EYA GG +  ++ +++      ++   +     +     + Y HR  
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
           ++HRDLK +NLL+  + ++KIADFG++ I     
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 2e-25
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 20/174 (11%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G F  + +      G + A K +++      +  V  +  ++EV +L  ++HPN++   
Sbjct: 21  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80

Query: 200 GACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                     ++ E   GG      + ++ LT+ +         +KQ L+   G+ Y+H 
Sbjct: 81  EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVYYLHS 132

Query: 254 LGLIHRDLKSDNLLIFS----DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           L + H DLK +N+++         IKI DFG+A             GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (257), Expect = 2e-25
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 27/173 (15%)

Query: 142 QGAFGKLYRGTYN--GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GA   +YR       +  A+K+L++  +        ++  + E+ +L  L HPNI++  
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLK 114

Query: 200 GACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                P    +V E   GG +      + + ++R          VKQ L+    +AY+H 
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-----VKQILEA---VAYLHE 166

Query: 254 LGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G++HRDLK +NLL  +   D  +KIADFG+++I      M    GT  + AP
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  102 bits (256), Expect = 2e-25
 Identities = 31/243 (12%), Positives = 59/243 (24%), Gaps = 41/243 (16%)

Query: 93  NRRGRVSHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGT 152
                   A   +A+   +   N+ T       +     RKL + +    G    ++   
Sbjct: 26  REEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ---GERKLKLVEPLRVGDRSVVFLVR 82

Query: 153 --YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW-- 208
                E+ A+K+      +        ++  +     A L   +        R  +    
Sbjct: 83  DVERLEDFALKVFTMGAENSRS---ELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139

Query: 209 ------------------------CIVTEYAKG--GSVRQFLTKRQNRSVPLKLAVKQAL 242
                                    ++   A      +   L           +     L
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 243 --DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
              + R  A +   GL+H     DNL I  D  + + D              P +     
Sbjct: 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVT 256

Query: 301 MAP 303
            AP
Sbjct: 257 YAP 259

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  103 bits (258), Expect = 5e-25
 Identities = 43/149 (28%), Positives = 76/149 (51%), Gaps = 15/149 (10%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G FGK+  G     G +VA+KIL R +        +  + ++E+  L   +HP+I++  
Sbjct: 26  VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD---VVGKIRREIQNLKLFRHPHIIKLY 82

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVAR----GMAYVHRLG 255
                P    +V EY  GG +  ++ K        +L  K++  + +    G+ Y HR  
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRHM 136

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARI 284
           ++HRDLK +N+L+ +  + KIADFG++ +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNM 165

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (252), Expect = 7e-25
 Identities = 35/145 (24%), Positives = 67/145 (46%), Gaps = 8/145 (5%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH--PNIVR 197
            G FG +Y G    +   VAIK +E+             +   EV++L  +      ++R
Sbjct: 53  SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112

Query: 198 FIGACRKPMVWCIVTEYAKG-GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
            +    +P  + ++ E  +    +  F+T+R    +  +LA      V   + + H  G+
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGV 170

Query: 257 IHRDLKSDNLLIFSDK-SIKIADFG 280
           +HRD+K +N+LI  ++  +K+ DFG
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFG 195

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  101 bits (252), Expect = 8e-25
 Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 48/209 (22%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QG++G +            AIKI+ + +      + +E+  + EV ++  L HPNI R  
Sbjct: 36  QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHPNIARLY 94

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV--------------------- 238
                    C+V E   GG +   L    + S                            
Sbjct: 95  EVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154

Query: 239 -------------KQALDVAR----GMAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADF 279
                        K   ++ R     + Y+H  G+ HRD+K +N L  ++KS  IK+ DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214

Query: 280 GVARI-----EVQTEGMTPETGTYRWMAP 303
           G+++        +  GMT + GT  ++AP
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (251), Expect = 1e-24
 Identities = 31/173 (17%), Positives = 67/173 (38%), Gaps = 26/173 (15%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FG ++R     + +    K ++            +   ++E+ +L   +H NI+   
Sbjct: 15  RGEFGIVHRCVETSSKKTYMAKFVK-------VKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 200 GACRKPMVWCIVTEYAKGG-------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            +        ++ E+  G        +    L +R+  S      V Q  +    + ++H
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---ALQFLH 119

Query: 253 RLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
              + H D++ +N++  + +S  IKI +FG AR     +          + AP
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  100 bits (250), Expect = 1e-24
 Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 21/173 (12%)

Query: 141 AQGAFGKLYRG--TYNGEEVAIKILERPE--NDPEKAQVMEQQFQQEVMMLATLKHPNIV 196
            +G  G +Y    T     VA+K++      +DP        + Q+E      L+ P++V
Sbjct: 43  GRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPV----FRTRMQREARTAGRLQEPHVV 97

Query: 197 RF--IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
                G      ++ +      G  +   L  R+   +    AV     +   +   H  
Sbjct: 98  PIHDFGE-IDGQLY-VDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHAA 153

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 303
           G  HRD+K +N+L+ +D    + DFG+A      E +T +     GT  +MAP
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLT-QLGNTVGTLYYMAP 204

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (252), Expect = 1e-24
 Identities = 53/266 (19%), Positives = 101/266 (37%), Gaps = 36/266 (13%)

Query: 57  SVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALMDSNS 116
           S        N     + N      R+  N +     N        +     +   +D  +
Sbjct: 9   SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68

Query: 117 PTEGLENFDEWTIDLRKLNMGDAFA--------QGAFGKLYRGT--YNGEEVAIKILERP 166
           P      FD   +  ++  +   +          G FG++++      G ++A KI+   
Sbjct: 69  PPA---PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII--- 122

Query: 167 ENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGG-------S 219
                +    +++ + E+ ++  L H N+++   A        +V EY  GG        
Sbjct: 123 ---KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179

Query: 220 VRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS--DKSIKIA 277
               LT+           +KQ  +   G+ ++H++ ++H DLK +N+L  +   K IKI 
Sbjct: 180 ESYNLTELDTILF-----MKQICE---GIRHMHQMYILHLDLKPENILCVNRDAKQIKII 231

Query: 278 DFGVARIEVQTEGMTPETGTYRWMAP 303
           DFG+AR     E +    GT  ++AP
Sbjct: 232 DFGLARRYKPREKLKVNFGTPEFLAP 257

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (254), Expect = 2e-24
 Identities = 43/175 (24%), Positives = 82/175 (46%), Gaps = 26/175 (14%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GAF  + R      G+E A  I+   +          Q+ ++E  +   LKHPNIVR  
Sbjct: 21  KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLH 76

Query: 200 GACRKPMVWCIVTEYAKGG------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +  +     ++ +   GG        R++ ++           ++Q L+    + + H+
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---VLHCHQ 128

Query: 254 LGLIHRDLKSDNLLIFSDKS----IKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           +G++HR+LK +NLL  + K     +K+ADFG+A  +E + +      GT  +++P
Sbjct: 129 MGVVHRNLKPENLL-LASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  100 bits (251), Expect = 5e-24
 Identities = 35/173 (20%), Positives = 71/173 (41%), Gaps = 25/173 (14%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GAFG ++R T    G   A K +          +  ++  ++E+  ++ L+HP +V   
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFV------MTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 200 GACRKPMVWCIVTEYAKGG-------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
            A        ++ E+  GG            +++ +         ++Q      G+ ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVCK---GLCHMH 272

Query: 253 RLGLIHRDLKSDNLLIFS--DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
               +H DLK +N++  +     +K+ DFG+       + +   TGT  + AP
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.4 bits (248), Expect = 6e-24
 Identities = 36/174 (20%), Positives = 72/174 (41%), Gaps = 27/174 (15%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILE-RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
            GAFG ++R      G     K +      D           + E+ ++  L HP ++  
Sbjct: 61  SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT-------VKNEISIMNQLHHPKLINL 113

Query: 199 IGACRKPMVWCIVTEYAKGG-------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
             A        ++ E+  GG       +    +++ +  +      ++QA +   G+ ++
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACE---GLKHM 165

Query: 252 HRLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           H   ++H D+K +N++  + K+  +KI DFG+A      E +   T T  + AP
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.9 bits (247), Expect = 6e-24
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 15/173 (8%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G F  + R      G++ A+KI++          +  +  ++E  +   LKHP+IV  +
Sbjct: 34  KGPFSVVRRCINRETGQQFAVKIVDV-AKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVARGMAYVHRL 254
                  +  +V E+  G  +   + KR +             ++Q L+    + Y H  
Sbjct: 93  ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDN 149

Query: 255 GLIHRDLKSDNLLIFS---DKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
            +IHRD+K   +L+ S      +K+  FGVA  +           GT  +MAP
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.0 bits (242), Expect = 1e-23
 Identities = 32/147 (21%), Positives = 62/147 (42%), Gaps = 10/147 (6%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL----KHPNI 195
           +G FG ++ G    +  +VAIK++ R                 EV +L  +     HP +
Sbjct: 41  KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100

Query: 196 VRFIGACRKPMVWCIVTEYA-KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +R +        + +V E       +  ++T++    +    +      V   + + H  
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR 158

Query: 255 GLIHRDLKSDNLLIFSDK-SIKIADFG 280
           G++HRD+K +N+LI   +   K+ DFG
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFG 185

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 97.0 bits (241), Expect = 4e-23
 Identities = 33/235 (14%), Positives = 71/235 (30%), Gaps = 36/235 (15%)

Query: 99  SHALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGT--YNGE 156
             + +D  ++ +L ++  P        E     R L  G    Q         T    GE
Sbjct: 43  MQSAADSLVSTSLWNTGQPFRVESELGERP---RTLVRGTVLGQEDPYAYLEATDQETGE 99

Query: 157 EVAIKILERPENDPEKAQ----------------------VMEQQFQQEVMMLATLKHPN 194
              + +    E  P  A                        +  +F     ++   +   
Sbjct: 100 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 159

Query: 195 IVRFIGACRKPMVWCIVTEY----AKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGM 248
           ++R     R   V      Y    +   +  + L      ++S+     ++  L V R +
Sbjct: 160 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 219

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           A +H  GL+H  L+  ++++     + +  F      V+       + +  +  P
Sbjct: 220 ASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---VRDGARVVSSVSRGFEPP 271

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.4 bits (238), Expect = 5e-23
 Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 34/182 (18%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRF 198
           +GA  ++         +E A+KI+E+      +   +  +  +EV ML   + H N++  
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEK------QPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 199 IGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           I    +   + +V E  +GGS+      R+   + +   V     V+    VA  + ++H
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQD---VASALDFLH 128

Query: 253 RLGLIHRDLKSDNLLIFS---DKSIKIADFGVARI--------EVQTEGMTPETGTYRWM 301
             G+ HRDLK +N+L         +KI DF +            + T  +    G+  +M
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 302 AP 303
           AP
Sbjct: 189 AP 190

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 95.3 bits (238), Expect = 6e-23
 Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 19/170 (11%)

Query: 142 QGAFGKLYRG--TYNGEEVAIK-ILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +G++G +++      G+ VAIK  LE  ++   K   +     +E+ ML  LKHPN+V  
Sbjct: 13  EGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRMLKQLKHPNLVNL 67

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYVHRLGL 256
           +   R+     +V EY    +V   L + Q       +K    Q L   + + + H+   
Sbjct: 68  LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHKHNC 123

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAP 303
           IHRD+K +N+LI     IK+ DFG AR +   ++    E  T  YR  +P
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SP 171

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.0 bits (237), Expect = 9e-23
 Identities = 40/176 (22%), Positives = 74/176 (42%), Gaps = 26/176 (14%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRF 198
           +G F  + +      G+E A K L++     +       +   E+ +L   K  P ++  
Sbjct: 39  RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINL 94

Query: 199 IGACRKPMVWCIVTEYAKGG--------SVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
                      ++ EYA GG         + + +++     +     +KQ L+   G+ Y
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYY 146

Query: 251 VHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +H+  ++H DLK  N+L+ S      IKI DFG++R       +    GT  ++AP
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 19/170 (11%)

Query: 142 QGAFGKLYRG--TYNGEEVAIK-ILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +G++G + +      G  VAIK  LE  ++   K   M     +E+ +L  L+H N+V  
Sbjct: 35  EGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-----REIKLLKQLRHENLVNL 89

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYVHRLGL 256
           +  C+K   W +V E+    ++   L    N      ++  + Q +    G+ + H   +
Sbjct: 90  LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHSHNI 145

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGT--YRWMAP 303
           IHRD+K +N+L+     +K+ DFG AR +    E    E  T  YR  AP
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--AP 193

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 93.9 bits (234), Expect = 3e-22
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 24/173 (13%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRF 198
            G  GK+        G++ A+K+L                 +QEV         P+IV  
Sbjct: 39  LGVNGKVLECFHRRTGQKCALKLLYDSPK-----------ARQEVDHHWQASGGPHIVCI 87

Query: 199 IGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +              I+ E  +GG +   + +R +++   + A +   D+   + ++H  
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147

Query: 255 GLIHRDLKSDNLLIFSDKS----IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + HRD+K +NLL ++ K     +K+ DFG A+   Q    TP   T  ++AP
Sbjct: 148 NIAHRDVKPENLL-YTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAP 198

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.8 bits (233), Expect = 3e-22
 Identities = 28/175 (16%), Positives = 64/175 (36%), Gaps = 14/175 (8%)

Query: 143 GAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC 202
            A+ +     +  E   I + +   + P  +         ++  +      N V  +   
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-LKLAVKQALDVARGMAYVHRLGLIHRDL 261
              +   I  +  +  +++ ++ +R +       + +   + +A  + ++H  GL+HRDL
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190

Query: 262 KSDNLLIFSDKSIKIADFGVARI-------------EVQTEGMTPETGTYRWMAP 303
           K  N+    D  +K+ DFG+                       T + GT  +M+P
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.6 bits (100), Expect = 9e-05
 Identities = 21/77 (27%), Positives = 33/77 (42%), Gaps = 7/77 (9%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FG     +   +    AIK +  P  +  + +VM     +EV  LA L+HP IVR+ 
Sbjct: 16  RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-----REVKALAKLEHPGIVRYF 70

Query: 200 GACRKPMVWCIVTEYAK 216
            A  +        E  +
Sbjct: 71  NAWLETPPEKWQEEMDE 87

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.1 bits (232), Expect = 4e-22
 Identities = 41/177 (23%), Positives = 82/177 (46%), Gaps = 34/177 (19%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILE-RPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVR 197
           +G+F    +     + +  A+KI+  R E + +          +E+  L   + HPNIV+
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ----------KEITALKLCEGHPNIVK 70

Query: 198 FIGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
                   +   +V E   GG +      ++  ++ +   +     +++ +     ++++
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHM 122

Query: 252 HRLGLIHRDLKSDNLLIFSDKS----IKIADFGVARI-EVQTEGMTPETGTYRWMAP 303
           H +G++HRDLK +NLL F+D++    IKI DFG AR+     + +     T  + AP
Sbjct: 123 HDVGVVHRDLKPENLL-FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 93.6 bits (233), Expect = 6e-22
 Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 23/173 (13%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRF 198
            G  GK+ +       E+ A+K+L+              + ++EV +     + P+IVR 
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 120

Query: 199 IGACRKPMVWC----IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +              IV E   GG +   +  R +++   + A +    +   + Y+H +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180

Query: 255 GLIHRDLKSDNLLIFSDKS----IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + HRD+K +NLL ++ K     +K+ DFG A+       +T    T  ++AP
Sbjct: 181 NIAHRDVKPENLL-YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.7 bits (231), Expect = 8e-22
 Identities = 44/177 (24%), Positives = 82/177 (46%), Gaps = 34/177 (19%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRF 198
            G++    R        E A+KI+++ + DP           +E+ ++L   +HPNI+  
Sbjct: 32  VGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----------TEEIEILLRYGQHPNIITL 81

Query: 199 IGACRKPMVWCIVTEYAKGGSV------RQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
                      +VTE  KGG +      ++F ++R+  +V     +     + + + Y+H
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFT---ITKTVEYLH 133

Query: 253 RLGLIHRDLKSDNLLIFSDKS-----IKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
             G++HRDLK  N+L + D+S     I+I DFG A+ +  +   +     T  ++AP
Sbjct: 134 AQGVVHRDLKPSNIL-YVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 28/202 (13%), Positives = 60/202 (29%), Gaps = 33/202 (16%)

Query: 132 RKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQ--------------- 174
           R L  G    Q         T    GE   + +    E  P  A                
Sbjct: 78  RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137

Query: 175 -------VMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW--CIVTEYAKG--GSVRQF 223
                   +  +F     ++   +   ++R     R   V     +    +    +  + 
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197

Query: 224 LT--KRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV 281
           L      ++S+     ++  L V R +A +H  GL+H  L+  ++++     + +  F  
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 282 ARIEVQTEGMTPETGTYRWMAP 303
              +     ++P    +    P
Sbjct: 258 LVRD-GASAVSPIGRGF--APP 276

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 6e-21
 Identities = 20/145 (13%), Positives = 48/145 (33%), Gaps = 9/145 (6%)

Query: 141 AQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
                 + ++   T    +VA+  ++     P+      Q+     + L+ +  P + R 
Sbjct: 40  GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL---QETLSRTLRLSRIDKPGVARV 96

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
           +          +V E+ +GGS+++              A++    +A      HR G+  
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR 283
                  + +  D  + +A      
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMP 177

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 89.3 bits (222), Expect = 7e-21
 Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 24/164 (14%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVM-MLATLKHPNIVRF 198
            G  GK+ +       E+ A+K+L+                ++EV       + P+IVR 
Sbjct: 28  LGINGKVLQIFNKRTQEKFALKMLQDCPK-----------ARREVELHWRASQCPHIVRI 76

Query: 199 IGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +              IV E   GG +   +  R +++   + A +    +   + Y+H +
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136

Query: 255 GLIHRDLKSDNLLIFSDKS----IKIADFGVARIEVQTEGMTPE 294
            + HRD+K +NLL ++ K     +K+ DFG A+ E   E     
Sbjct: 137 NIAHRDVKPENLL-YTSKRPNAILKLTDFGFAK-ETTGEKYDKS 178

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.2 bits (224), Expect = 1e-20
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 36/180 (20%)

Query: 142 QGAFGKLYRG--TYNGEEVAIK-ILERPENDPEKAQVMEQQFQQ-EVMMLATLKHPNIVR 197
            G+FG +Y+     +GE VAIK +L+            +++F+  E+ ++  L H NIVR
Sbjct: 64  NGSFGVVYQAKLCDSGELVAIKKVLQ------------DKRFKNRELQIMRKLDHCNIVR 111

Query: 198 ----FIGACRKPMVWCI--VTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVAR 246
               F  +  K     +  V +Y    +V +           L     KL + Q     R
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF---R 167

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVARIEVQTEGMTPETGT--YRWMAP 303
            +AY+H  G+ HRD+K  NLL+  D   +K+ DFG A+  V+ E       +  YR  AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--AP 225

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 37/185 (20%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QG FG++++      G++VA+K +   EN+ E   +   +   E+ +L  LKH N+V  I
Sbjct: 27  QGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALR---EIKILQLLKHENVVNLI 82

Query: 200 GACRKPMVWC--------IVTEYA----KG--GSVRQFLTKRQNRSVPLKLAVKQALDVA 245
             CR              +V ++      G   +V    T  + + V     ++  L   
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQMLL--- 134

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-----IEVQTEGMTPETGT--Y 298
            G+ Y+HR  ++HRD+K+ N+LI  D  +K+ADFG+AR        Q    T    T  Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 299 RWMAP 303
           R   P
Sbjct: 195 R--PP 197

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.8 bits (218), Expect = 8e-20
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 37/180 (20%)

Query: 142 QGAFGKLYRGTYN-GEEVAIK-IL--ERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            G+FG +++      +EVAIK +L  +R +N             +E+ ++  +KHPN+V 
Sbjct: 50  NGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-------------RELQIMRIVKHPNVVD 96

Query: 198 ----FIGACRKPMVWCI--VTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVAR 246
               F     K     +  V EY    +V +           +     KL + Q L   R
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLL---R 152

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVARIEVQTEGMTPE--TGTYRWMAP 303
            +AY+H +G+ HRD+K  NLL+      +K+ DFG A+I +  E       +  YR  AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 24/170 (14%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA G +           VAIK L RP  +   A+    +  +E++++  + H NI+  +
Sbjct: 72  SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK----RAYRELVLMKCVNHKNIISLL 127

Query: 200 GACRKPMVWC------IVTEYAK---GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
                           +V E         ++  L   +   +     + Q L    G+ +
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-----LYQML---CGIKH 179

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           +H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T R+
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RY 228

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 20/172 (11%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM----MLATLKHPNI 195
           +G+F    L R      E AIKILE       K  ++++     V     +++ L HP  
Sbjct: 40  EGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           V+     +          YAK G + +++  R+  S           ++   + Y+H  G
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGKG 150

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 303
           +IHRDLK +N+L+  D  I+I DFG A+  +  E          GT ++++P
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSP 201

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 84.7 bits (210), Expect = 8e-19
 Identities = 39/175 (22%), Positives = 68/175 (38%), Gaps = 24/175 (13%)

Query: 142 QGAFGKLYRGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQ-----EVMMLATLKHPNI 195
            G++G +  G  + G  VAIK +    +D     ++   F       E+ +L    HPNI
Sbjct: 32  SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91

Query: 196 VRFIGACRKPMVWC-----IVTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVA 245
           +                  +VTE      + Q +  ++   + +     +  +   L   
Sbjct: 92  LGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR---IVISPQHIQYFMYHIL--- 144

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
            G+  +H  G++HRDL   N+L+  +  I I DF +AR +      T      RW
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH-RW 198

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 83.7 bits (208), Expect = 9e-19
 Identities = 55/172 (31%), Positives = 88/172 (51%), Gaps = 22/172 (12%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G +Y+      GE VA+K + R + + E          +E+ +L  L HPNIV+ +
Sbjct: 13  EGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPS---TAIREISLLKELNHPNIVKLL 68

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL---KLAVKQALDVARGMAYVHRLGL 256
                     +V E+     +++F+       +PL   K  + Q L   +G+A+ H   +
Sbjct: 69  DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL---QGLAFCHSHRV 124

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 303
           +HRDLK  NLLI ++ +IK+ADFG+AR   + V+T   T E  T  YR  AP
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYR--AP 172

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 31/178 (17%)

Query: 142 QGAFGKLYRG--TYNGEEVAIK-I-LERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
            G +  +Y+G     G  VA+K + L+  E  P  A        +E+ ++  LKH NIVR
Sbjct: 15  NGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-------REISLMKELKHENIVR 67

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP-------LKLAVKQALDVARGMAY 250
                       +V E+     +++++  R   + P       +K    Q L   +G+A+
Sbjct: 68  LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QGLAF 123

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 303
            H   ++HRDLK  NLLI     +K+ DFG+AR   I V T   + E  T  YR  AP
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYR--AP 177

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.6 bits (205), Expect = 2e-18
 Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 28/174 (16%)

Query: 142 QGAFGKLYRGTYN-GEEVAIKILERPENDPE----KAQVMEQQFQQEVMMLATLKHPNIV 196
           +G +G +Y+   N GE  A+K + R E + E              +E+ +L  LKH NIV
Sbjct: 12  EGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTI-------REISILKELKHSNIV 63

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYVHRL 254
           +            +V E+     +++ L   +        K  + Q L    G+AY H  
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR 119

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 303
            ++HRDLK  NLLI  +  +KIADFG+AR   I V+    T E  T  YR  AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYR--AP 169

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 26/170 (15%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA+G +       +GE+VAIK L RP      A+    +  +E+++L  ++H N++  +
Sbjct: 34  SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK----RAYRELLLLKHMQHENVIGLL 89

Query: 200 GACRKPMVWC------IVTEYAK---GGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
                           +V  + +      +    ++ + + +     V Q L   +G+ Y
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL-----VYQML---KGLKY 141

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           +H  G++HRDLK  NL +  D  +KI DFG+AR       MT    T RW
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVT-RW 188

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 47/214 (21%), Positives = 92/214 (42%), Gaps = 15/214 (7%)

Query: 101 ALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMG-DAF------AQGAFGK--LYRG 151
            +  +  A  L       + L+  +   + L+++ +  D F       +GAF +  + + 
Sbjct: 23  GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKM 82

Query: 152 TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV 211
              G+  A+KI+    +  ++ +V    F++E  +L       I +   A +      +V
Sbjct: 83  KQTGQVYAMKIM-NKWDMLKRGEV--SCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139

Query: 212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD 271
            EY  GG +   L  +    +P ++A     ++   +  VHRLG +HRD+K DN+L+   
Sbjct: 140 MEYYVGGDL-LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC 198

Query: 272 KSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
             I++ADFG          +      GT  +++P
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 82.2 bits (204), Expect = 2e-18
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 21/171 (12%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G +++       E VA+K + R ++D E          +E+ +L  LKH NIVR  
Sbjct: 12  EGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPS---SALREICLLKELKHKNIVRLH 67

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYVHRLGLI 257
                     +V E+     ++++         P  +K  + Q L   +G+ + H   ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSRNVL 123

Query: 258 HRDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 303
           HRDLK  NLLI  +  +K+A+FG+AR   I V+    + E  T  YR   P
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYR--PP 170

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 49/218 (22%), Positives = 99/218 (45%), Gaps = 23/218 (10%)

Query: 101 ALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMG-DAFA------QGAFGK--LYRG 151
            L D+     L    +  E LE    +T  ++++ +  + F       +GAFG+  + + 
Sbjct: 36  CLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKL 95

Query: 152 TYNGEEVAIKILERPENDPEKAQVMEQQ----FQQEVMMLATLKHPNIVRFIGACRKPMV 207
               +  A+KIL        K +++++     F++E  +L       I     A +    
Sbjct: 96  KNADKVFAMKILN-------KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148

Query: 208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL 267
             +V +Y  GG +   L+K ++R +P ++A     ++   +  VH+L  +HRD+K DN+L
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207

Query: 268 IFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           +  +  I++ADFG     ++   +      GT  +++P
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 83.2 bits (206), Expect = 3e-18
 Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 27/187 (14%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQE 183
            +T+  R  N+      GA G +           VAIK L RP  +   A+    +  +E
Sbjct: 20  TFTVLKRYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK----RAYRE 74

Query: 184 VMMLATLKHPNIVRFIGACRKPM-------VWCIVTEYAK---GGSVRQFLTKRQNRSVP 233
           ++++  + H NI+  +              V+ IV E         ++  L   +   + 
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY-IVMELMDANLCQVIQMELDHERMSYL- 132

Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
               + Q L    G+ ++H  G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP
Sbjct: 133 ----LYQML---CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185

Query: 294 ETGTYRW 300
              T R+
Sbjct: 186 YVVT-RY 191

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 59/173 (34%), Positives = 79/173 (45%), Gaps = 26/173 (15%)

Query: 142 QGAFGKLYRGTY--NGEEVAIK--ILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           +G +  +Y+G        VA+K   LE  E  P  A        +EV +L  LKH NIV 
Sbjct: 12  EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-------REVSLLKDLKHANIVT 64

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYVHRLG 255
                       +V EY     ++Q+L    N      +KL + Q L   RG+AY HR  
Sbjct: 65  LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHRQK 120

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 303
           ++HRDLK  NLLI     +K+ADFG+AR   I  +T     E  T  YR   P
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLWYR--PP 169

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.8 bits (203), Expect = 4e-18
 Identities = 55/170 (32%), Positives = 88/170 (51%), Gaps = 20/170 (11%)

Query: 142 QGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           +G +G +Y+     G  VA+K + R + + E          +E+ +L  L HPNIV  I 
Sbjct: 31  EGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPS---TAIREISLLKELHHPNIVSLID 86

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP--LKLAVKQALDVARGMAYVHRLGLIH 258
                    +V E+ +   +++ L + +       +K+ + Q L   RG+A+ H+  ++H
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQHRILH 142

Query: 259 RDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 303
           RDLK  NLLI SD ++K+ADFG+AR   I V++   T E  T  YR  AP
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYR--AP 188

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.9 bits (203), Expect = 4e-18
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 24/178 (13%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---HPNIV 196
            GA+G +Y+    ++G  VA+K + R  N       +     +EV +L  L+   HPN+V
Sbjct: 19  VGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77

Query: 197 RFI------GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL---KLAVKQALDVARG 247
           R +         R+  V  +V E+     +R +L K     +P    K  ++Q L   RG
Sbjct: 78  RLMDVCATSRTDREIKVT-LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL---RG 132

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGT--YRWMAP 303
           + ++H   ++HRDLK +N+L+ S  ++K+ADFG+ARI      +TP   T  YR  AP
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR--AP 188

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.3 bits (203), Expect = 5e-18
 Identities = 41/186 (22%), Positives = 74/186 (39%), Gaps = 20/186 (10%)

Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQV 175
           +  +W     +L +G    +GAFG++      G         VA+K+L+      E    
Sbjct: 13  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 69

Query: 176 MEQQFQQEV-MMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP 233
             +    E+ +++    H N+V  +GAC +      ++ E+ K G++  +L  ++N  VP
Sbjct: 70  --RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTP 293
            K    +     +G  Y   +G I  DLK     I S +S   + F   +     E    
Sbjct: 128 YKT---KGARFRQGKDY---VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181

Query: 294 ETGTYR 299
               Y+
Sbjct: 182 PEDLYK 187

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 81.9 bits (203), Expect = 7e-18
 Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 26/175 (14%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G F  +Y+       + VAIK + +  +  E    + +   +E+ +L  L HPNI+  +
Sbjct: 20  EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTK-RQNRSVPLKLA-VK----QALDVARGMAYVHR 253
            A        +V ++     +   L    ++ S+ L  + +K      L   +G+ Y+H+
Sbjct: 79  DAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLHQ 130

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVAR---IEVQTEGMTPETGT--YRWMAP 303
             ++HRDLK +NLL+  +  +K+ADFG+A+      +    T +  T  YR  AP
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYR--AP 181

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 81.6 bits (202), Expect = 9e-18
 Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 42/186 (22%)

Query: 142 QGAFGKLYRG--TYNGEEVAIK-ILERPENDPEKAQVMEQQFQ----QEVMMLATLKHPN 194
           QG FG +  G     G  VAIK +++ P            +F+    Q +  LA L HPN
Sbjct: 33  QGTFGTVQLGKEKSTGMSVAIKKVIQDP------------RFRNRELQIMQDLAVLHHPN 80

Query: 195 IVR----FIGACRKPMV---WCIVTEYAKGGSVRQFLTKRQNRSVPLKLA-VK----QAL 242
           IV+    F     +        +V EY    ++ +       R V      +K    Q +
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 243 DVARGMAYVHR--LGLIHRDLKSDNLLI-FSDKSIKIADFGVARIEVQTEGMTPETGT-- 297
              R +  +H   + + HRD+K  N+L+  +D ++K+ DFG A+    +E       +  
Sbjct: 140 ---RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196

Query: 298 YRWMAP 303
           YR  AP
Sbjct: 197 YR--AP 200

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.8 bits (200), Expect = 1e-17
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 23/170 (13%)

Query: 143 GAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQ----EVMMLATLKHPNIV 196
           G+FG+  L +   +G   A+KIL+       K +V++ +  +    E  +L  +  P +V
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILD-------KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGL 256
           +   + +      +V EY  GG +   L  R+        A   A  +     Y+H L L
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 257 IHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 303
           I+RDLK +NLLI     I++ DFG A R++ +T  +  TPE      +AP
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE---A--LAP 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.4 bits (199), Expect = 1e-17
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 41/183 (22%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPE----KAQVMEQQFQQEVMMLATLKHPNI 195
           +G +G++Y+   T   E VAIK + R E++ E     A        +EV +L  L+H NI
Sbjct: 44  EGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAI-------REVSLLKELQHRNI 95

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVARGMAY 250
           +             ++ EY         L K  +++  +     K  + Q +    G+ +
Sbjct: 96  IELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLI---NGVNF 147

Query: 251 VHRLGLIHRDLKSDNLLIFSDKS-----IKIADFGVAR---IEVQTEGMTPETGT--YRW 300
            H    +HRDLK  NLL+    +     +KI DFG+AR   I ++    T E  T  YR 
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYR- 204

Query: 301 MAP 303
             P
Sbjct: 205 -PP 206

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 40/162 (24%), Positives = 68/162 (41%), Gaps = 30/162 (18%)

Query: 142 QGAFGKLYRG----TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR 197
           +G +G +Y+       + ++ A+K +E        A        +E+ +L  LKHPN++ 
Sbjct: 31  RGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSAC-------REIALLRELKHPNVIS 82

Query: 198 FIGACRKPMVWCI--VTEYA----KGGSVRQFLTKRQNRSVPLKLA-VK----QALDVAR 246
                       +  + +YA             +K   + V L    VK    Q L    
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL---D 139

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKS----IKIADFGVARI 284
           G+ Y+H   ++HRDLK  N+L+  +      +KIAD G AR+
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 36/168 (21%), Positives = 76/168 (45%), Gaps = 27/168 (16%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRF 198
           +G + +++      N E+V +KIL +P        V +++ ++E+ +L  L+  PNI+  
Sbjct: 46  RGKYSEVFEAINITNNEKVVVKIL-KP--------VKKKKIKREIKILENLRGGPNIITL 96

Query: 199 IGACRKP--MVWCIVTEYAKGGSVRQF---LTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
               + P      +V E+      +Q    LT    R       + + L   + + Y H 
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY-----MYEIL---KALDYCHS 148

Query: 254 LGLIHRDLKSDNLLI-FSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           +G++HRD+K  N++I    + +++ D+G+A      +       + R+
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RY 195

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 17/170 (10%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM----MLATLKHPNI 195
           +G FG+    +    G+  A K LE       K ++ +++ +   +    +L  +    +
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLE-------KKRIKKRKGEAMALNEKQILEKVNSRFV 246

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           V    A       C+V     GG ++  +        P   AV  A ++  G+  +HR  
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           +++RDLK +N+L+     I+I+D G+A   V  EG T +   GT  +MAP
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAV-HV-PEGQTIKGRVGTVGYMAP 354

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 39/207 (18%), Positives = 75/207 (36%), Gaps = 58/207 (28%)

Query: 142 QGAFGKLYRG--TYNGEEVAIK-ILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR- 197
            G+FG +       +G+  A+K +L     DP           +E+ ++  L H NI++ 
Sbjct: 17  TGSFGIVCEVFDIESGKRFALKKVL----QDPRYKN-------RELDIMKVLDHVNIIKL 65

Query: 198 ---FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA----------------- 237
              F     +        +       +       ++SV +  +                 
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125

Query: 238 --------VKQALDVA----------RGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIAD 278
                     +++ +           R + ++H LG+ HRD+K  NLL+ S   ++K+ D
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 279 FGVARIEVQTEGMTPETGT--YRWMAP 303
           FG A+  + +E       +  YR  AP
Sbjct: 186 FGSAKKLIPSEPSVAYICSRFYR--AP 210

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 101 ALSDDALARALMDSNSPTEGLENFDEWTIDLRKLNMG-DAFA------QGAFGK--LYRG 151
           AL  D    AL  + +    L  + +    +R L M  + +       +GAFG+  L R 
Sbjct: 31  ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90

Query: 152 TYNGEEVAIKILERPENDPEKAQVMEQQ----FQQEVMMLATLKHPNIVRFIGACRKPMV 207
               +  A+K+L        K +++++     F +E  ++A    P +V+   A +    
Sbjct: 91  KSTRKVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143

Query: 208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL 267
             +V EY  GG     +    N  VP K A     +V   +  +H +G IHRD+K DN+L
Sbjct: 144 LYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200

Query: 268 IFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           +     +K+ADFG      +   +  +T  GT  +++P
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 79.7 bits (197), Expect = 4e-17
 Identities = 51/202 (25%), Positives = 82/202 (40%), Gaps = 25/202 (12%)

Query: 112 MDSNSPTEG----LENFD-EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILE 164
           M S  P        E     W +     ++      GA+G +        G +VAIK L 
Sbjct: 1   MSSPPPARSGFYRQEVTKTAWEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLY 59

Query: 165 RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC------IVTEYAKGG 218
           RP      A+    +  +E+ +L  ++H N++  +                +V  +  G 
Sbjct: 60  RPFQSELFAK----RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GT 114

Query: 219 SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD 278
            + + +   +     ++  V Q L   +G+ Y+H  G+IHRDLK  NL +  D  +KI D
Sbjct: 115 DLGKLMKHEKLGEDRIQFLVYQML---KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 171

Query: 279 FGVARIEVQTEGMTPETGTYRW 300
           FG+AR       MT    T RW
Sbjct: 172 FGLAR--QADSEMTGYVVT-RW 190

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 79.7 bits (197), Expect = 4e-17
 Identities = 39/168 (23%), Positives = 76/168 (45%), Gaps = 15/168 (8%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQ----FQQEVMMLATLKHPNI 195
           +G+FGK  + +     +  A+K +        K + +E+       +E+ ++  L+HP +
Sbjct: 25  KGSFGKVCIVQKNDTKKMYAMKYMN-------KQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           V    + +      +V +   GG +R  L  +QN     +       ++   + Y+    
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQNQR 135

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +IHRD+K DN+L+     + I DF +A +  +   +T   GT  +MAP
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 35/159 (22%), Positives = 72/159 (45%), Gaps = 22/159 (13%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH------P 193
           +G+FG++ +       + VA+K++    N+        +Q  +E+ +L  L+        
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR---NEKR----FHRQAAEEIRILEHLRKQDKDNTM 159

Query: 194 NIVRFIGA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           N++  +     R  +  C+  E     ++ + + K + +   L L  K A  + + +  +
Sbjct: 160 NVIHMLENFTFRNHI--CMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 252 HRLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQT 288
           H+  +IH DLK +N+L+       IK+ DFG +  E Q 
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 79.1 bits (196), Expect = 5e-17
 Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 25/172 (14%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQ-----EVMMLATLKHPN 194
            G+FG+  L R  +NG   A+K+L+       K  V+  + Q      E +ML+ + HP 
Sbjct: 16  TGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLK-QVEHTNDERLMLSIVTHPF 67

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           I+R  G  +      ++ +Y +GG +   L  R+++  P  +A   A +V   + Y+H  
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEYLHSK 125

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVA-RIEVQTEGM--TPETGTYRWMAP 303
            +I+RDLK +N+L+  +  IKI DFG A  +   T  +  TP+   Y  +AP
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD---Y--IAP 172

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.8 bits (195), Expect = 6e-17
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 28/175 (16%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-----LATLKHPN 194
           +G FGK  L R    G   A+KIL        K  ++ +  +    +     L   +HP 
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILR-------KEVIIAKD-EVAHTVTESRVLQNTRHPF 66

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +     A +     C V EYA GG +  F    + R    + A     ++   + Y+H  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
            +++RD+K +NL++  D  IKI DFG+ +     EG++         GT  ++AP
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAP 174

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.9 bits (195), Expect = 7e-17
 Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 29/172 (16%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA+G +     T  G  VA+K L RP      A+    +  +E+ +L  +KH N++  +
Sbjct: 39  SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK----RTYRELRLLKHMKHENVIGLL 94

Query: 200 GACRKPMVWC------IVTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVARGM 248
                           +VT    G  +   +     +   L     +  + Q L   RG+
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM-GADLNNIV-----KCQKLTDDHVQFLIYQIL---RGL 145

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
            Y+H   +IHRDLK  NL +  D  +KI DFG+AR     + MT    T RW
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVAT-RW 194

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 18/172 (10%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM----MLATLKHPNI 195
           +G FG+    +    G+  A K L        K ++ +++  Q  M    +LA +    I
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLN-------KKRLKKRKGYQGAMVEKKILAKVHSRFI 247

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHR 253
           V    A       C+V     GG +R  +      N       A+     +  G+ ++H+
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
             +I+RDLK +N+L+  D +++I+D G+A  E++      +   GT  +MAP
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAP 358

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 30/174 (17%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G++G +           VAIK + R   D    + +     +E+ +L  L H ++V+ +
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI----LREIAILNRLNHDHVVKVL 118

Query: 200 GACRKPMVWC-----IVTEYA--------KGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
                  V       +V E A        +      +LT+   +++     +   L    
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTP---VYLTELHIKTL-----LYNLL---V 167

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           G+ YVH  G++HRDLK  N L+  D S+K+ DFG+AR     E    +      
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.3 bits (188), Expect = 9e-16
 Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 24/174 (13%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G++G +Y        + VAIK + R   D    +    +  +E+ +L  LK   I+R  
Sbjct: 36  RGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK----RILREITILNRLKSDYIIRLY 91

Query: 200 GACRKPMVWC-----IVTEYA-----KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMA 249
                  +       IV E A     K      FLT+   +++     +   L    G  
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTI-----LYNLL---LGEN 143

Query: 250 YVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++H  G+IHRDLK  N L+  D S+K+ DFG+AR     +             P
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 27/175 (15%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-----LATLKHPN 194
           +G+FGK  L       E  A+KIL+       K  V++    +  M+         K P 
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 403

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + +     +       V EY  GG +      +Q        AV  A ++A G+ ++   
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
           G+I+RDLK DN+++ S+  IKIADFG+ +     E +          GT  ++AP
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAP 511

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 44/212 (20%)

Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGT---YNGEEVAIKILERPEN 168
           M+ +      + ++     + ++       +GA+GK+++       G  VA+K + R + 
Sbjct: 1   MEKDGLCRADQQYEC----VAEIG------EGAYGKVFKARDLKNGGRFVALKRV-RVQT 49

Query: 169 D----PEKAQVMEQQFQQEVMMLATLK---HPNIVRFIGACRKPMVWC-----IVTEYAK 216
                P           +EV +L  L+   HPN+VR    C            +V E+  
Sbjct: 50  GEEGMPLSTI-------REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 102

Query: 217 GGSVRQFLTKRQNRSVPL---KLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS 273
              +  +L K     VP    K  + Q L   RG+ ++H   ++HRDLK  N+L+ S   
Sbjct: 103 Q-DLTTYLDKVPEPGVPTETIKDMMFQLL---RGLDFLHSHRVVHRDLKPQNILVTSSGQ 158

Query: 274 IKIADFGVARIEVQTEGMTPETGT--YRWMAP 303
           IK+ADFG+ARI      +T    T  YR  AP
Sbjct: 159 IKLADFGLARIYSFQMALTSVVVTLWYR--AP 188

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 29/176 (16%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM------LATLKHP 193
           +G+FGK  L R    G+  A+K+L+       K  +++     E  M           HP
Sbjct: 33  KGSFGKVMLARVKETGDLYAVKVLK-------KDVILQDD-DVECTMTEKRILSLARNHP 84

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            + +     + P     V E+  GG +      +++R      A   A ++   + ++H 
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHD 142

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
            G+I+RDLK DN+L+  +   K+ADFG+ +     EG+          GT  ++AP
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAP 193

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM----LATLKHPNI 195
           +G FGK  L +    G   A+KIL+       K  ++ +      +     L   +HP +
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRHPFL 210

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RL 254
                + +     C V EYA GG +  F    + R      A     ++   + Y+H   
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
            +++RDLK +NL++  D  IKI DFG+ +     EG+          GT  ++AP
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAP 318

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 27/175 (15%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-----LATLKHPN 194
           +G+FGK  L       +  AIK L+       K  V+     +  M+         +HP 
Sbjct: 27  KGSFGKVFLAEFKKTNQFFAIKALK-------KDVVLMDDDVECTMVEKRVLSLAWEHPF 79

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +       +       V EY  GG +      +      L  A   A ++  G+ ++H  
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
           G+++RDLK DN+L+  D  IKIADFG+ +     E M  +       GT  ++AP
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAP 187

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 27/175 (15%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM-----MLATLKHPN 194
           +G++ K  L R        A+K+++       K  V + +    V            HP 
Sbjct: 19  RGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQASNHPF 71

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +V      +       V EY  GG +      ++ R +P + A   + +++  + Y+H  
Sbjct: 72  LVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHER 129

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
           G+I+RDLK DN+L+ S+  IK+ D+G+ +     EG+ P        GT  ++AP
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 179

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.5 bits (181), Expect = 5e-15
 Identities = 49/176 (27%), Positives = 77/176 (43%), Gaps = 33/176 (18%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GA+G +       N   VAIK +   E+     Q   Q+  +E+ +L   +H NI+   
Sbjct: 37  EGAYGMVCSAYDNLNKVRVAIKKISPFEH-----QTYCQRTLREIKILLRFRHENIIGIN 91

Query: 200 GACRKPM------VWCIVTEYAKGGSVRQFLTKRQNRSVPL-----KLAVKQALDVARGM 248
              R P       V+ IV +      + + L     ++  L        + Q L   RG+
Sbjct: 92  DIIRAPTIEQMKDVY-IVQDLM-ETDLYKLL-----KTQHLSNDHICYFLYQIL---RGL 141

Query: 249 AYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI----EVQTEGMTPETGTYRW 300
            Y+H   ++HRDLK  NLL+ +   +KI DFG+AR+       T  +T    T RW
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT-RW 196

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.4 bits (181), Expect = 6e-15
 Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 27/175 (15%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-----LATLKHPN 194
           +G+FGK  L R        A+K+L+       K  +++++ ++ +M      L  +KHP 
Sbjct: 48  KGSFGKVLLARHKAEEVFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVKHPF 100

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +V    + +       V +Y  GG +  F   ++ R      A   A ++A  + Y+H L
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSL 158

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
            +++RDLK +N+L+ S   I + DFG+ +     E +   +      GT  ++AP
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCGTPEYLAP 208

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 23/173 (13%)

Query: 142 QGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLA---------TL 190
           +G FG++Y  R    G+  A+K L+       K ++  +Q   E + L          T 
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQ--GETLALNERIMLSLVSTG 249

Query: 191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
             P IV    A   P     + +   GG +   L   Q+           A ++  G+ +
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEH 307

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +H   +++RDLK  N+L+     ++I+D G+A  +   +      GT+ +MAP
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAP 359

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 27/175 (15%)

Query: 142 QGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-----LATLKHPN 194
           +G+FGK  L       E  A+KIL+       K  V++    +  M+         K P 
Sbjct: 30  KGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGKPPF 82

Query: 195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           + +     +       V EY  GG +      +Q        AV  A ++A G+ ++   
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140

Query: 255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
           G+I+RDLK DN+++ S+  IKIADFG+ +     E +          GT  ++AP
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGVTTKTFCGTPDYIAP 190

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 51/236 (21%), Positives = 102/236 (43%), Gaps = 39/236 (16%)

Query: 83  NDNYSVAHSVNRRGRVSHALSDDALARALMDSNSPTE--GLENFDEWTIDLRKLNMGDAF 140
           + +     ++  +G +   + ++  A    +S   +   GL++FD     L ++ +G   
Sbjct: 11  DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFD-----LLRV-IG--- 61

Query: 141 AQGAFGK--LYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVM-----MLATLKHP 193
            +G++ K  L R        A+++++       K  V + +    V            HP
Sbjct: 62  -RGSYAKVLLVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
            +V      +       V EY  GG +      ++ R +P + A   + +++  + Y+H 
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHE 171

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET------GTYRWMAP 303
            G+I+RDLK DN+L+ S+  IK+ D+G+ +     EG+ P        GT  ++AP
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCGTPNYIAP 222

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.0 bits (175), Expect = 3e-14
 Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 22/174 (12%)

Query: 142 QGAFGKLY-----RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-----LATLK 191
           +G +GK++      G   G+  A+K+L+       KA ++               L  +K
Sbjct: 27  KGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILEEVK 79

Query: 192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
           HP IV  I A +      ++ EY  GG +  F+   +        A     +++  + ++
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALGHL 137

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           H+ G+I+RDLK +N+++     +K+ DFG+ +  +    +T  T  GT  +MAP
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAP 190

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.1 bits (173), Expect = 3e-14
 Identities = 37/231 (16%), Positives = 70/231 (30%), Gaps = 59/231 (25%)

Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKI--LERPEND 169
                PTE L+          K+       +G FG++++   +   VAIKI  +E P+  
Sbjct: 13  FSHCLPTEKLQR-------CEKI------GEGVFGEVFQTIADHTPVAIKIIAIEGPDLV 59

Query: 170 PEKAQVMEQQFQQEVMMLATL---------KHPNIVRFIGAC----RKPMVWC------- 209
               Q   ++   E+++   L         +    +            P +         
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 210 -------------------IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
                              IV E+  GG   + +  + +     K  + Q   +   +A 
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQ---LTASLAV 176

Query: 251 VH-RLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYR 299
               L   HRDL   N+L+      K+      +   + + G+      Y 
Sbjct: 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 70.5 bits (173), Expect = 3e-14
 Identities = 48/174 (27%), Positives = 71/174 (40%), Gaps = 24/174 (13%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRF 198
            G+FG +Y GT    GEEVAIK+        E  +    Q   E  +   ++    I   
Sbjct: 19  SGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
                +     +V E   G S+   L    +R   LK  +  A  +   + Y+H    IH
Sbjct: 71  RWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128

Query: 259 RDLKSDNLLIFSDK---SIKIADFGVAR--IEVQTEGMTPE------TGTYRWM 301
           RD+K DN L+   K    + I DFG+A+   + +T    P       TGT R+ 
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 44/165 (26%), Positives = 67/165 (40%), Gaps = 24/165 (14%)

Query: 138 DAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP-- 193
               +G+FG++ +       E VAIKI++   N          Q Q EV +L  +     
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKA----FLNQAQIEVRLLELMNKHDT 112

Query: 194 ----NIVRFIGA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
                IV        R  +  C+V E     ++   L     R V L L  K A  +   
Sbjct: 113 EMKYYIVHLKRHFMFRNHL--CLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 248 MAYVH--RLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQT 288
           + ++    L +IH DLK +N+L+ + K   IKI DFG +    Q 
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 70.3 bits (173), Expect = 5e-14
 Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 22/173 (12%)

Query: 142 QGAFGKLY-----RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM----LATLKH 192
           QG+FGK++      G+   +  A+K+L+       KA +  +  +    M    L  + H
Sbjct: 34  QGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRD-RVRTKMERDILVEVNH 85

Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           P IV+   A +      ++ ++ +GG +  F    +      +       ++A  + ++H
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH 143

Query: 253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
            LG+I+RDLK +N+L+  +  IK+ DFG+++  +  E     +  GT  +MAP
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YSFCGTVEYMAP 195

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.5 bits (173), Expect = 5e-14
 Identities = 37/167 (22%), Positives = 69/167 (41%), Gaps = 36/167 (21%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-------- 191
            G F  ++      N   VA+KI+          +V  +  + E+ +L  +         
Sbjct: 29  WGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 192 ---HPNIVR------FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL 242
                +I++        G     +   +V E   G ++   + K ++R +PL    + + 
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHV--VMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 243 DVARGMAYVHR-LGLIHRDLKSDNLLI------FSDKSIKIADFGVA 282
            +  G+ Y+HR  G+IH D+K +N+L+       +   IKIAD G A
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.0 bits (172), Expect = 9e-14
 Identities = 52/185 (28%), Positives = 74/185 (40%), Gaps = 44/185 (23%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GA+G +   T+   GE VAIK +  P + P  A     +  +E+ +L   KH NI+   
Sbjct: 21  EGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFAL----RTLREIKILKHFKHENIITIF 75

Query: 200 GACRKPMVWC-----IVTEYA--------KGGSVRQFLTKRQNRSVPLKLAVKQALDVAR 246
              R           I+ E                Q L+    +       + Q L   R
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVIST----QMLSDDHIQYF-----IYQTL---R 123

Query: 247 GMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-----------EVQTEGMTPET 295
            +  +H   +IHRDLK  NLLI S+  +K+ DFG+ARI             Q  GM    
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 296 GTYRW 300
            T RW
Sbjct: 184 AT-RW 187

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 38/169 (22%), Positives = 60/169 (35%), Gaps = 40/169 (23%)

Query: 142 QGAFGKLYRGT---YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP----- 193
           +GAFGK+         G  VA+KI++   N         +  + E+ +L  L        
Sbjct: 24  EGAFGKVVECIDHKAGGRHVAVKIVK---NVDR----YCEAARSEIQVLEHLNTTDPNST 76

Query: 194 -NIVRFIGA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
              V+ +        +  CIV E   G S   F+ +       L    K A  + + + +
Sbjct: 77  FRCVQMLEWFEHHGHI--CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133

Query: 251 VHRLGLIHRDLKSDNLLIFSDK-------------------SIKIADFG 280
           +H   L H DLK +N+L                         IK+ DFG
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 41/175 (23%), Positives = 79/175 (45%), Gaps = 22/175 (12%)

Query: 142 QGAFGKLY-----RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-----LATLK 191
            GA+GK++      G   G+  A+K+L+       KA ++++    E        L  ++
Sbjct: 64  TGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLEHIR 116

Query: 192 H-PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
             P +V    A +      ++ +Y  GG +  F    Q              ++   + +
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLALEH 174

Query: 251 VHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET--GTYRWMAP 303
           +H+LG+I+RD+K +N+L+ S+  + + DFG+++  V  E        GT  +MAP
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 51/182 (28%), Positives = 74/182 (40%), Gaps = 26/182 (14%)

Query: 136 MGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH- 192
           +G     G FG+L  G   Y  E VAIK+        E  +    Q   E      L   
Sbjct: 13  VGKKIGCGNFGELRLGKNLYTNEYVAIKL--------EPMKSRAPQLHLEYRFYKQLGSG 64

Query: 193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
             I +            +V E   G S+   L    +R+  LK  +  A+ +   M YVH
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 253 RLGLIHRDLKSDNLLI-----FSDKSIKIADFGVAR--IEVQTEGMTPE------TGTYR 299
              LI+RD+K +N LI      + + I I DF +A+  I+ +T+   P       TGT R
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182

Query: 300 WM 301
           +M
Sbjct: 183 YM 184

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 38/171 (22%), Positives = 63/171 (36%), Gaps = 40/171 (23%)

Query: 142 QGAFGKLYR---GTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP----- 193
           +G FGK+           +VA+KI+    N  +      +  + E+ +L  +K       
Sbjct: 29  EGTFGKVVECLDHARGKSQVALKIIR---NVGK----YREAARLEINVLKKIKEKDKENK 81

Query: 194 -NIVRFIGA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAY 250
              V           M  CI  E   G +  +FL +   +  PL      A  +   + +
Sbjct: 82  FLCVLMSDWFNFHGHM--CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138

Query: 251 VHRLGLIHRDLKSDNLLIFSDK-------------------SIKIADFGVA 282
           +H   L H DLK +N+L  + +                   SI++ADFG A
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 67.3 bits (165), Expect = 5e-13
 Identities = 45/184 (24%), Positives = 69/184 (37%), Gaps = 40/184 (21%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQ----EVMMLATLKHPNI 195
            G  G ++        + VAIK          K  + + Q  +    E+ ++  L H NI
Sbjct: 21  CGGNGLVFSAVDNDCDKRVAIK----------KIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 196 VRFIGACRKPMVWC--------------IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
           V+                          IV EY     +   L +        +L + Q 
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQL 129

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADFGVARI----EVQTEGMTPETG 296
           L   RG+ Y+H   ++HRDLK  NL I + D  +KI DFG+ARI          ++    
Sbjct: 130 L---RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186

Query: 297 TYRW 300
           T +W
Sbjct: 187 T-KW 189

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.4 bits (165), Expect = 7e-13
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 31/168 (18%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRF 198
           +GA+G +++      GE VA+K +     +   AQ    +  +E+M+L  L  H NIV  
Sbjct: 19  KGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ----RTFREIMILTELSGHENIVNL 74

Query: 199 IGACRKPM---VWCIVTEYA--------KGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           +   R      V+ +V +Y         +       L     + V     V Q +   + 
Sbjct: 75  LNVLRADNDRDVY-LVFDYMETDLHAVIRA----NILEPVHKQYV-----VYQLI---KV 121

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET 295
           + Y+H  GL+HRD+K  N+L+ ++  +K+ADFG++R  V    +T   
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 67.0 bits (164), Expect = 9e-13
 Identities = 32/173 (18%), Positives = 67/173 (38%), Gaps = 44/173 (25%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-----PN 194
            G FG++       N +  A+K++    N  +      +  + E  +L  +++      N
Sbjct: 45  DGTFGRVLLCQHIDNKKYYAVKVVR---NIKK----YTRSAKIEADILKKIQNDDINNNN 97

Query: 195 IVRFIGA--CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           IV++ G       M  C++ E   G S+ + +T+       ++      +++ + + Y+ 
Sbjct: 98  IVKYHGKFMYYDHM--CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154

Query: 253 RLGLIHRDLKSDNLLIFSDK-------------------------SIKIADFG 280
           ++ L H DLK +N+L+                              IK+ DFG
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 26/176 (14%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRF 198
           +G+FG ++ GT   N ++VAIK         E  +    Q + E      L     I   
Sbjct: 20  EGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
               ++ +   +V +   G S+   L     R   +K     A  +   +  +H   L++
Sbjct: 72  YYFGQEGLHNVLVIDLL-GPSLEDLL-DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129

Query: 259 RDLKSDNLLIFSDKS-----IKIADFGVAR--IEVQTEGMTPE------TGTYRWM 301
           RD+K DN LI    S     I + DFG+ +   +  T+   P       +GT R+M
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 19/188 (10%), Positives = 60/188 (31%), Gaps = 32/188 (17%)

Query: 142 QGAFGKLYRGT----------YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK 191
           +   G LY                ++ ++K+ +  ++     +    Q   + + +   K
Sbjct: 52  RDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-D-AKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 192 HPNIVRFIGACRKPMVWCIVTEYAK--------GGSVRQFLTKRQNRSVPLKLAVKQALD 243
                  +       +   V +           G S++  L       +  +  ++ A  
Sbjct: 110 KLYSTPLLAIPT--CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVAR--------IEVQTEGMTP 293
           +   + ++H    +H ++ ++N+ +  +    + +A +G A         +       +P
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227

Query: 294 ETGTYRWM 301
             G   ++
Sbjct: 228 HEGDLEFI 235

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 24/174 (13%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRF 198
            G+FG++Y GT     EEVAIK+        E  +    Q   E  +   L+    I   
Sbjct: 17  SGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
                +     +V +   G S+   L    +R + LK  +  A  +   + +VH    +H
Sbjct: 69  RWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126

Query: 259 RDLKSDNLLIFSDKS---IKIADFGVAR--IEVQTEGMTPE------TGTYRWM 301
           RD+K DN L+   +    + I DFG+A+   +  T    P       TGT R+ 
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 35/188 (18%), Positives = 61/188 (32%), Gaps = 32/188 (17%)

Query: 142 QGAFGKLYRGT-YNGEEVAIKILERPENDPEKAQ--VMEQQFQQEVMMLATLKHPNIVRF 198
           QG FG +Y     + E V        + +P        E +F Q       ++     R 
Sbjct: 45  QGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104

Query: 199 IGACRKPMVWCIVTEYAKGGSVR-----------QFLTKRQNRSVPLK----LAVKQALD 243
           +     P  W        G S R           Q + +   +    K    L++ + LD
Sbjct: 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSL-RILD 163

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVAR--IEVQTEGMTPE----- 294
           +   + Y+H    +H D+K+ NLL+       + + D+G+A                   
Sbjct: 164 I---LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC 220

Query: 295 -TGTYRWM 301
             GT  + 
Sbjct: 221 HDGTIEFT 228

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 32/184 (17%), Positives = 62/184 (33%), Gaps = 27/184 (14%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVM---MLATLKHPNIV 196
            G FG +Y        E+ A  +  + E         E +F Q V     +        +
Sbjct: 47  SGGFGLIYLAFPTNKPEKDARHV-VKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL 105

Query: 197 RFIGACRKPMVWCIVTEYAKGGS---VRQFLTK------RQNRSVPLKLAVKQALDVARG 247
            ++G          +TE+        V + L         QN +      ++  + +   
Sbjct: 106 DYLGIPL--FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVAR--------IEVQTEGMTPETGT 297
           + Y+H    +H D+K+ NLL+       + +AD+G++          + Q        GT
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223

Query: 298 YRWM 301
             + 
Sbjct: 224 IEFT 227

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.9 bits (132), Expect = 8e-09
 Identities = 37/191 (19%), Positives = 76/191 (39%), Gaps = 34/191 (17%)

Query: 131 LRKLNMGDAFAQGAFGKLY--RGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLA 188
           +RKL        G F  ++        + VA+K+++  E+  E A         E+ +L 
Sbjct: 42  IRKLG------WGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL-------DEIRLLK 88

Query: 189 TLK-----HPN---IVRFI------GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
           +++      PN   +V+ +      G     +  C+V E   G  + +++ K   + +PL
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHI--CMVFEVL-GHHLLKWIIKSNYQGLPL 145

Query: 235 KLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLI-FSDKSIKIADFGVARIEVQTEGMT 292
               K    V +G+ Y+H    +IH D+K +N+L+  +++ I+         +       
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205

Query: 293 PETGTYRWMAP 303
             +      A 
Sbjct: 206 SGSAVSTAPAT 216

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	303
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.98
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.98
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.98
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.98
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.98
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.98
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.98
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.98
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.98
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.98
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.98
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.98
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.98
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.98
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.98
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.98
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.98
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.98
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.98
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.98
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.98
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.98
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.98
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.98
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.98
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.37
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.91
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.84
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.75
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.75
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.64
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.52
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.45
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.09
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.06
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	98.03
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.9
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.87
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.81
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.69
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.63
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.58
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.41
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.38
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.06
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.98
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.72
3maz_A	125	Signal-transducing adaptor protein 1; modular doma	96.65
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.84
1aot_F	106	FYN protein-tyrosine kinase; SH2 domain, signal tr	95.76
1lkk_A	105	Human P56 tyrosine kinase; complex (tyrosine kinas	95.33
4d8k_A	175	Tyrosine-protein kinase LCK; protein kinases, SH2	95.19
1blj_A	114	P55 BLK protein tyrosine kinase; signal transducti	94.98
3s9k_A	118	Tyrosine-protein kinase ITK/TSK; proline isomeriza	94.35
1rja_A	100	Tyrosine-protein kinase 6; human protein tyrosine	93.84
2ecd_A	119	Tyrosine-protein kinase ABL2; SH2 domain, phosphot	93.79
2dly_A	121	FYN-related kinase; BRK family kinase, structural	93.77
2el8_A	118	Signal-transducing adaptor protein 2; SH2 domain,	93.71
2dm0_A	125	Tyrosine-protein kinase TXK; TEC family kinase, st	93.31
3k2m_A	112	Proto-oncogene tyrosine-protein kinase ABL1; engin	93.09
2cr4_A	126	3BP-2, SH3 domain-binding protein 2; structural ge	92.93
2ekx_A	110	Cytoplasmic tyrosine-protein kinase BMX; SH2 domai	92.75
4fbn_A	246	1-phosphatidylinositol 4,5-bisphosphate phosphodi	92.56
1jyr_A	96	Growth factor receptor-bound protein 2; receptor b	91.92
2kno_A	131	Tensin-like C1 domain-containing phosphatase; SH2	91.68
2ge9_A	125	Tyrosine-protein kinase BTK; SH2 domain, structure	91.62
3us4_A	98	Megakaryocyte-associated tyrosine-protein kinase;	91.43
3eaz_A	106	Tyrosine-protein kinase CSK; SH2, disulfide, oxidi	90.9
1d4t_A	104	T cell signal transduction molecule SAP; SH2 domai	90.54
3ov1_A	117	Growth factor receptor-bound protein 2; GRB2 SH2 d	90.27
2oq1_A	254	Tyrosine-protein kinase ZAP-70; tandem SH2 domains	90.19
1a81_A	254	SYK kinase; complex (transferase-peptide), SYK, ki	90.14
1r1p_A	100	GRB2-related adaptor protein 2; SH2, GADS, phospho	90.12
2gsb_A	119	RAS GTPase-activating protein 1; GAP, RAS P21 prot	90.06
2hdv_A	111	SH2-B PH domain containing signaling mediator 1 ga	89.94
1ka6_A	128	SH2 domain protein 1A; SH2 domain, protein-peptide	89.74
1i3z_A	103	EWS/FLI1 activated transcript 2; SH2 domain phosph	89.67
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	89.5
2ysx_A	119	Signaling inositol polyphosphate phosphatase SHIP	89.08
2eo3_A	111	CRK-like protein; phosphorylation, repeat, SH2 dom	88.55
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	88.37
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.82
1a81_A	254	SYK kinase; complex (transferase-peptide), SYK, ki	86.72
2cs0_A	119	Hematopoietic SH2 domain containing; ALX, FLJ14886	86.05
2oq1_A	254	Tyrosine-protein kinase ZAP-70; tandem SH2 domains	86.01
3pqz_A	117	Growth factor receptor-bound protein 7; SH2, binds	85.51
2cia_A	102	Cytoplasmic protein NCK2; SH2-domain, SH3 domain,	85.5
2lqn_A	303	CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT	84.7
2hmh_A	152	Suppressor of cytokine signaling 3; SOCS3, GP130,	84.02
2eo6_A	141	B-cell linker protein; SH2, cytoplasmic adapter pr	83.65
2dx0_A	138	Phospholipase C, gamma 2; phosphoric diester hydro	83.14
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	82.75
2dlz_A	118	Protein VAV-2; RHO family guanine nucleotide excha	82.6
2iug_A	120	Phosphatidylinositol 3-kinase regulatory alpha sub	82.05
2kk6_A	116	Proto-oncogene tyrosine-protein kinase FER; method	81.95
1mil_A	104	SHC adaptor protein; SH2 domain, phosphorylation,	81.82
2vif_A	141	Suppressor of cytokine signalling 6; growth regula	81.44
1ju5_A	109	CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid	81.12
1h9o_A	112	Phosphatidylinositol 3-kinase; transferase/recepto	80.25

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=318.27  Aligned_cols=174  Identities=33%  Similarity=0.623  Sum_probs=148.1

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ....|+|+.+++.+.++||+|+||+||+|++.+ .||||+++......+.    .+.|.+|+.+|++++|||||+++++|
T Consensus        27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~f~~E~~il~~l~HpNIV~l~g~~  101 (307)
T 3omv_A           27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQ----FQAFRNEVAVLRKTRHVNILLFMGYM  101 (307)
T ss_dssp             --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            346799999999999999999999999999865 5999999865554432    36899999999999999999999998


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .++ .+|||||||++|+|.++|.... ..+++..++.++.||+.||+|||+++||||||||+||||++++.+||+|||+|
T Consensus       102 ~~~-~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  179 (307)
T 3omv_A          102 TKD-NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA  179 (307)
T ss_dssp             CSS-SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred             ECC-eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence            654 5799999999999999998653 46999999999999999999999999999999999999999999999999999


Q ss_pred             eeeecC---CCccCCCCCCcccCC
Q 046106          283 RIEVQT---EGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~---~~~~~~~gt~~y~AP  303 (303)
                      +.....   ......+||+.||||
T Consensus       180 ~~~~~~~~~~~~~~~~GT~~ymAP  203 (307)
T 3omv_A          180 TVKSRWSGSQQVEQPTGSVLWMAP  203 (307)
T ss_dssp             BC------------CCCCTTSCCH
T ss_pred             eecccCCcceeecccccCCCccCH
Confidence            865432   223456899999998

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-42  Score=320.23  Aligned_cols=169  Identities=24%  Similarity=0.413  Sum_probs=145.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++++.||+|+||+||+|++  +|+.||||++++.......    .+.+.+|+.+|++++|||||++++++.++..+
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   98 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLANMKHPNIVQYRESFEENGSL   98 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH----HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            46889999999999999999998  6899999999876654432    36789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |||||||++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999999998776667899999999999999999999999999999999999999999999999999876543


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ..+..+||+.||||
T Consensus       179 ~~~~~~~~GT~~YmAP  194 (350)
T 4b9d_A          179 VELARACIGTPYYLSP  194 (350)
T ss_dssp             HHHHHHHHSCCTTCCH
T ss_pred             cccccccCCCccccCH
Confidence            2 23446899999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.3e-42  Score=311.92  Aligned_cols=174  Identities=28%  Similarity=0.526  Sum_probs=149.3

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR  197 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  197 (303)
                      ..++++..++++.++||+|+||+||+|++       +++.||||+++.......     .+.|.+|+.+|++++|||||+
T Consensus        19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~-----~~~f~~E~~il~~l~HpNIV~   93 (308)
T 4gt4_A           19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-----REEFRHEAMLRARLQHPNVVC   93 (308)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-C-----HHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHH-----HHHHHHHHHHHHhCCCCCCCC
Confidence            34567888899999999999999999987       357899999975433221     257999999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 046106          198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKS  263 (303)
Q Consensus       198 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp  263 (303)
                      ++|+|.++..+|||||||++|+|.++|....              ...+++..++.++.||+.||+|||+++||||||||
T Consensus        94 l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~  173 (308)
T 4gt4_A           94 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLAT  173 (308)
T ss_dssp             EEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             cceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999999999997532              23589999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeccCCceeeecCC---CccCCCCCCcccCC
Q 046106          264 DNLLIFSDKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       264 ~NILv~~~~~vKl~DFGla~~~~~~~---~~~~~~gt~~y~AP  303 (303)
                      +||||++++.+||+|||+|+......   .....+||+.||||
T Consensus       174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  216 (308)
T 4gt4_A          174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP  216 (308)
T ss_dssp             GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCH
T ss_pred             cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCH
Confidence            99999999999999999998654332   23345799999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.3e-42  Score=311.33  Aligned_cols=169  Identities=25%  Similarity=0.396  Sum_probs=148.3

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ..++|++++.||+|+||+||+|++  +++.||||++.+....   .....+.+.+|+.+|+.++|||||++++++.++..
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  106 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII---KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK  106 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            346799999999999999999998  7889999999753211   11123578999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +||||||+++|+|.+++...  +.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus       107 ~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999999999875  4699999999999999999999999999999999999999999999999999997643


Q ss_pred             CC---CccCCCCCCcccCC
Q 046106          288 TE---GMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~---~~~~~~gt~~y~AP  303 (303)
                      ..   ...+.+||+.||||
T Consensus       185 ~~~~~~~~~~~GTp~YmAP  203 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSP  203 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCH
T ss_pred             CCCcccccCcccCcccCCH
Confidence            32   24456999999998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.9e-42  Score=310.29  Aligned_cols=171  Identities=29%  Similarity=0.480  Sum_probs=146.5

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      +.|++++|.+.+.||+|+||+||+|++       +++.||||+++...  .    ...+.|.+|+.+|++++|||||+++
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~----~~~~~f~~E~~il~~l~HpnIV~l~   81 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--D----NARKDFHREAELLTNLQHEHIVKFY   81 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--H----HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--h----HHHHHHHHHHHHHHhCCCCCCccEE
Confidence            467888999999999999999999986       35789999997532  1    2236899999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQ-----------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI  268 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv  268 (303)
                      ++|.+++.+|||||||++|+|.++|+...           ...+++..++.++.||+.||+|||+++||||||||+||||
T Consensus        82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl  161 (299)
T 4asz_A           82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV  161 (299)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence            99999999999999999999999997632           3468999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeccCCceeeecCCCc---cCCCCCCcccCC
Q 046106          269 FSDKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       269 ~~~~~vKl~DFGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      ++++.+||+|||+|+........   ...+||+.||||
T Consensus       162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  199 (299)
T 4asz_A          162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP  199 (299)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH
T ss_pred             CCCCcEEECCcccceecCCCCceeecCceecChhhcCH
Confidence            99999999999999865433322   223689999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-41  Score=312.30  Aligned_cols=164  Identities=25%  Similarity=0.405  Sum_probs=146.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ...|+++++||+|+||+||+|++  +|+.||||+++......      .+.+.+|+.+|+.++|||||++++++.++..+
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  146 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------RELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  146 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS------GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH------HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35688889999999999999998  68999999997643322      14678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |||||||++|+|.+++..   ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus       147 ~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             EEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999999999976   35899999999999999999999999999999999999999999999999999876543


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       ...++.+||+.||||
T Consensus       224 ~~~~~~~~GTp~YmAP  239 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAP  239 (346)
T ss_dssp             SCCBCCCCSCGGGCCH
T ss_pred             CCcccccccCcCcCCH
Confidence             345667999999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-41  Score=302.40  Aligned_cols=166  Identities=27%  Similarity=0.489  Sum_probs=132.4

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      .+|++.+.||+|+||+||+|++  +++.||||++++.......   ....+.+|+.+|+.++|||||++++++.++..+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD---MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH---HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            5788999999999999999997  6899999999875443222   2357899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      |||||+ +|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        90 ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999999 68999999865  469999999999999999999999999999999999999999999999999998776655


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ...+.+||+.||||
T Consensus       167 ~~~~~~GT~~Y~AP  180 (275)
T 3hyh_A          167 FLKTSCGSPNYAAP  180 (275)
T ss_dssp             --------CTTSCH
T ss_pred             ccCCeeECcccCCh
Confidence            56677999999998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=309.56  Aligned_cols=173  Identities=32%  Similarity=0.491  Sum_probs=143.3

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR  197 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  197 (303)
                      ..+.++.+++.+.++||+|+||+||+|++.       ++.||||+++...      ....+.|.+|+.+|++++|||||+
T Consensus        34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~------~~~~~~f~~E~~il~~l~HpnIV~  107 (329)
T 4aoj_A           34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS------ESARQDFQREAELLTMLQHQHIVR  107 (329)
T ss_dssp             CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC------HHHHHHHHHHHHHHHhCCCCCCCc
Confidence            346677889999999999999999999873       5789999997532      122368999999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeecCCCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 046106          198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ-------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSD  264 (303)
Q Consensus       198 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~  264 (303)
                      ++++|.++..+|||||||++|+|.++++...             ..++++..++.++.||+.||+|||+++||||||||+
T Consensus       108 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~  187 (329)
T 4aoj_A          108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATR  187 (329)
T ss_dssp             EEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             EEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHh
Confidence            9999999999999999999999999997542             235899999999999999999999999999999999


Q ss_pred             cEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          265 NLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       265 NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||||++++.+||+|||+|+.......   .+..+||+.||||
T Consensus       188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP  229 (329)
T 4aoj_A          188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP  229 (329)
T ss_dssp             GEEEETTTEEEECCCC----------------CCCCGGGCCH
T ss_pred             hEEECCCCcEEEcccccceeccCCCcceecCcccccccccCh
Confidence            99999999999999999986543322   2345799999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9e-41  Score=314.17  Aligned_cols=164  Identities=25%  Similarity=0.405  Sum_probs=147.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .+.|+++++||+|+||.||+|++  +|+.||||++........      +.+.+|+.+|+.++|||||++++++.++..+
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~  223 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL  223 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG------GGHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH------HHHHHHHHHHHhCCCCCCCceEEEEEECCEE
Confidence            46788999999999999999998  689999999986543321      4678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |||||||++|+|.+++...   .+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus       224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            9999999999999999753   5899999999999999999999999999999999999999999999999999876543


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       ......+||+.||||
T Consensus       301 ~~~~~~~~GTp~YmAP  316 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAP  316 (423)
T ss_dssp             CCCBCCCEECTTTCCH
T ss_pred             CccccccccCcCcCCH
Confidence             345567999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-40  Score=299.14  Aligned_cols=163  Identities=31%  Similarity=0.509  Sum_probs=141.7

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc----CCe
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK----PMV  207 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~~~  207 (303)
                      +++.++||+|+||+||+|++  +++.||+|++........    ..+.|.+|+.+|++++|||||+++++|.+    +..
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS----ERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            36677899999999999998  678999999976554432    23689999999999999999999999865    356


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcC-CCcEEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFS-DKSIKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~~-~~~vKl~DFGla~~  284 (303)
                      +|||||||++|+|.+++...  ..+++..+..++.||+.||+|||++|  ||||||||+||||+. ++.+||+|||+|+.
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            89999999999999999875  46899999999999999999999998  999999999999974 79999999999986


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ... ....+.+||+.||||
T Consensus       182 ~~~-~~~~~~~GTp~YmAP  199 (290)
T 3fpq_A          182 KRA-SFAKAVIGTPEFMAP  199 (290)
T ss_dssp             CCT-TSBEESCSSCCCCCG
T ss_pred             CCC-CccCCcccCccccCH
Confidence            433 334567999999999

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-40  Score=305.43  Aligned_cols=162  Identities=27%  Similarity=0.340  Sum_probs=140.9

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      .....|.+.++||+|+||+||+|++  +|+.||||+++....           ..+|+.+|+.++|||||++++++.++.
T Consensus        55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------~~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------RVEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3445678888999999999999998  688999999986432           236999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccCCceee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVARIE  285 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl~DFGla~~~  285 (303)
                      .+|||||||++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+..
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            999999999999999999875  4699999999999999999999999999999999999999987 6999999999876


Q ss_pred             ecCCC------ccCCCCCCcccCC
Q 046106          286 VQTEG------MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~------~~~~~gt~~y~AP  303 (303)
                      .....      ....+||+.||||
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAP  225 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAP  225 (336)
T ss_dssp             ------------CCCCCCGGGCCH
T ss_pred             cCCCcccceecCCccccCccccCH
Confidence            54321      1235799999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-41  Score=307.58  Aligned_cols=170  Identities=24%  Similarity=0.382  Sum_probs=141.8

Q ss_pred             eeecCCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      .++.++|++++.||+|+||+||+|+.     +++.||||++++.......    ...+.+|+.+|++++|||||++++++
T Consensus        20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~   95 (304)
T 3ubd_A           20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD----RVRTKMERDILVEVNHPFIVKLHYAF   95 (304)
T ss_dssp             CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE----CC------CCCCCCCCTTEECEEEEE
T ss_pred             cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH----HHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            34567899999999999999999986     3578999999765432211    13577899999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .++..+|||||||++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus        96 ~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           96 QTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             EETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             EECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence            9999999999999999999999875  46999999999999999999999999999999999999999999999999999


Q ss_pred             eeeecC-CCccCCCCCCcccCC
Q 046106          283 RIEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      +..... ....+.+||+.||||
T Consensus       174 ~~~~~~~~~~~~~~GT~~YmAP  195 (304)
T 3ubd_A          174 KESIDHEKKAYSFCGTVEYMAP  195 (304)
T ss_dssp             EC-----CCCCSCCCCGGGCCH
T ss_pred             eeccCCCccccccccCcccCCH
Confidence            865433 334567999999998

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.4e-41  Score=309.07  Aligned_cols=175  Identities=28%  Similarity=0.546  Sum_probs=149.6

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEECC-------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC-CCe
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNI  195 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pni  195 (303)
                      .+.|+|++++|++++.||+|+||+||+|++.+       +.||||.++......     ..+.|.+|+.+|.+++| |||
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-----~~~~~~~E~~il~~l~hhpnI  130 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLNV  130 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-----HHHHHHHHHHHHHHcCCCCcE
Confidence            35799999999999999999999999998732       579999997644322     23679999999999976 899


Q ss_pred             eeeeEEEEcC-CeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 046106          196 VRFIGACRKP-MVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRD  260 (303)
Q Consensus       196 v~l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrD  260 (303)
                      |+++++|.++ ..+|||||||++|+|.++|+...              ...+++..++.++.||+.||+|||+++|||||
T Consensus       131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD  210 (353)
T 4ase_A          131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  210 (353)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence            9999999764 56899999999999999998542              23488999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          261 LKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       261 lkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |||+|||+++++.+||+|||+|+.......   ....+||+.||||
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  256 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  256 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence            999999999999999999999987544332   2334789999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.9e-40  Score=297.93  Aligned_cols=167  Identities=26%  Similarity=0.471  Sum_probs=132.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC---
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM---  206 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~---  206 (303)
                      .+|++.+.||+|+||+||+|++  +++.||||+++.....     ...+.+.+|+.+|++++|||||++++++.+.+   
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-----LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence            3578889999999999999998  6889999999765421     22357899999999999999999999986543   


Q ss_pred             ---------eEEEEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          207 ---------VWCIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       207 ---------~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                               .+|||||||++|+|.+++..... ...++..++.++.||+.||+|||++|||||||||+||||+.++.+||
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence                     37999999999999999986432 12456778899999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCCC-------------ccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEG-------------MTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~-------------~~~~~gt~~y~AP  303 (303)
                      +|||+|+.......             .+..+||+.||||
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP  199 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP  199 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCH
Confidence            99999987543321             2335799999999

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.2e-40  Score=297.22  Aligned_cols=162  Identities=34%  Similarity=0.549  Sum_probs=135.0

Q ss_pred             CCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----e
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM----V  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~----~  207 (303)
                      +++.+.++||+|+||+||+|+++|+.||||+++...     ..  ...+..|+..+.+++|||||+++++|..+.    .
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-----~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG-----HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            457788999999999999999999999999996421     11  122335666667899999999999997653    5


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCcEEEcCCCcEEEecc
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL--------GLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +|||||||++|+|.++|+..   .+++..+++++.|++.||+|||++        +||||||||+||||+.++.+||+||
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            79999999999999999864   589999999999999999999987        9999999999999999999999999


Q ss_pred             CCceeeecCCC-----ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~-----~~~~~gt~~y~AP  303 (303)
                      |+|+.......     ....+||+.||||
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAP  181 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCH
T ss_pred             CCCccccCCCCceeeecccccccccccCH
Confidence            99987654332     1235799999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-39  Score=309.42  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=197.3

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCCC---ccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGR---VSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~~---~~~-~~~~~~~~  108 (303)
                      +|++...+|      +..+|.|++|++..+...    ...++||+|++..++.|++.....+.+.   +.+ ....+.++
T Consensus        93 ~G~FLvR~s------~~~~g~y~lsv~~~~~~~----~~~v~H~~I~~~~~g~~~i~~~~~F~sl~eLv~~y~~~~~~l~  162 (454)
T 1qcf_A           93 LGSFMIRDS------ETTKGSYSLSVRDYDPRQ----GDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLC  162 (454)
T ss_dssp             TTCEEEEEC------SSSTTSEEEEEEEEETTT----EEEEEEEEEEECTTSCEESSSSSCBSSHHHHHHHHTSSCTTSS
T ss_pred             CceEEEEEC------cCCCCeEEEEEEecccCC----CCceEEEEEEEcCCCcEEEeCccccCCHHHHHHHHHhccCCcc
Confidence            588888766      356789999998754332    2479999999988888888754333321   222 23333444


Q ss_pred             HHhcCCCCCCc--CCCCCCcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHH
Q 046106          109 RALMDSNSPTE--GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVM  185 (303)
Q Consensus       109 ~~l~~~~~~~~--~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~  185 (303)
                      ..+..++....  .....+.|++..++|++.+.||+|+||.||+|++ ++..||||+++.....       .+.|.+|+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~E~~  235 (454)
T 1qcf_A          163 QKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEAN  235 (454)
T ss_dssp             SCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-------HHHHHHHHH
T ss_pred             ccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc-------HHHHHHHHH
Confidence            44444433221  1223578999999999999999999999999999 5789999999865432       257899999


Q ss_pred             HHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q 046106          186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDN  265 (303)
Q Consensus       186 il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~N  265 (303)
                      +|+.++||||+++++++. ...+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|
T Consensus       236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  314 (454)
T 1qcf_A          236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN  314 (454)
T ss_dssp             HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGG
T ss_pred             HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence            999999999999999987 4567999999999999999986544468999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeccCCceeeecCC--CccCCCCCCcccCC
Q 046106          266 LLIFSDKSIKIADFGVARIEVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       266 ILv~~~~~vKl~DFGla~~~~~~~--~~~~~~gt~~y~AP  303 (303)
                      |||+.++.+||+|||+|+......  ......+|+.|+||
T Consensus       315 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aP  354 (454)
T 1qcf_A          315 ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP  354 (454)
T ss_dssp             EEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCH
T ss_pred             EEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCH
Confidence            999999999999999998654322  12233567899998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.8e-39  Score=308.06  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=193.1

Q ss_pred             CcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHHH
Q 046106           34 GTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALAR  109 (303)
Q Consensus        34 ~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~~  109 (303)
                      |++...+|      +..+|.|++|++..+...    ...++||+|++..++.|++.....+.+   ++.+ ....++++.
T Consensus        89 G~FLvR~s------~~~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~~~~~~~F~Sl~~Li~~y~~~~~~l~~  158 (452)
T 1fmk_A           89 GTFLVRES------ETTKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCH  158 (452)
T ss_dssp             TEEEEEEC------SSSTTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESSTTSEESSHHHHHHHHTTCCTTSSS
T ss_pred             ceEEEEeC------CCCCCceEEEEEeeccCC----CCcEEEEEEEEcCCCCEEEecCcccCCHHHHHHHhhhccccchh
Confidence            88888766      346788999998754222    237999999998888888875433332   2222 334444544


Q ss_pred             HhcCCCCCC---cCCCCCCcceeecCCccccceecccCceEEEEEEEC-CeEEEEEEeeCCCCChHHHHHHHHHHHHHHH
Q 046106          110 ALMDSNSPT---EGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQEVM  185 (303)
Q Consensus       110 ~l~~~~~~~---~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~  185 (303)
                      .+..++...   ......+.|+++.++|.+.+.||+|+||.||+|++. +..||||+++......       +.|.+|+.
T Consensus       159 ~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~  231 (452)
T 1fmk_A          159 RLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQ  231 (452)
T ss_dssp             CCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHH
T ss_pred             hccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH-------HHHHHHHH
Confidence            444444321   112235789999999999999999999999999994 4689999998655432       46889999


Q ss_pred             HHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q 046106          186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDN  265 (303)
Q Consensus       186 il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~N  265 (303)
                      +|++++||||+++++++.. ..+||||||+++|+|.+++....+..+++..++.++.||+.||+|||++||+||||||+|
T Consensus       232 ~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N  310 (452)
T 1fmk_A          232 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN  310 (452)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhh
Confidence            9999999999999999976 567999999999999999986544568999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeccCCceeeecCCC--ccCCCCCCcccCC
Q 046106          266 LLIFSDKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       266 ILv~~~~~vKl~DFGla~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      ||++.++.+||+|||+++.......  .....+|+.|+||
T Consensus       311 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aP  350 (452)
T 1fmk_A          311 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP  350 (452)
T ss_dssp             EEECGGGCEEECCCCTTC--------------CCGGGSCH
T ss_pred             EEECCCCCEEECCCccceecCCCceecccCCcccccccCH
Confidence            9999999999999999986543321  1223567899998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.3e-39  Score=308.55  Aligned_cols=249  Identities=22%  Similarity=0.446  Sum_probs=197.1

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      +|+++..+|      ++.+|.|++|++..         ..++||+|++..++.+++.....+.+   ++.+ ....++++
T Consensus       126 ~G~fLvR~s------~~~~~~~~lsv~~~---------~~v~h~~I~~~~~g~~~~~~~~~F~sl~eLv~~~~~~~~g~~  190 (495)
T 1opk_A          126 NGSFLVRES------ESSPGQRSISLRYE---------GRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLI  190 (495)
T ss_dssp             TTEEEEEEC------SSSTTCEEEEEEET---------TEEEEEECEECTTSCEESSTTSCBSSHHHHHHHHTTCCTTSS
T ss_pred             CceEEEEeC------CCCCCceEEEEeeC---------CeEEEEEEEecCCCceEeccCccchhHHHHhhhhcccccccc
Confidence            688888766      34678899999862         27999999998888887754333322   2222 33334444


Q ss_pred             HHhcCCCCCCc------CCCCCCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHH
Q 046106          109 RALMDSNSPTE------GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQF  180 (303)
Q Consensus       109 ~~l~~~~~~~~------~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~  180 (303)
                      ..+..++....      ....++.|++...+|.+.+.||+|+||.||+|++  ++..||||+++......       +.|
T Consensus       191 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~  263 (495)
T 1opk_A          191 TTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-------EEF  263 (495)
T ss_dssp             SCCCEECCCCSCCCCSSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCH-------HHH
T ss_pred             hhccccccccccccccccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccch-------HHH
Confidence            33333222111      1134678999999999999999999999999998  47899999997654432       578


Q ss_pred             HHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 046106          181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD  260 (303)
Q Consensus       181 ~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrD  260 (303)
                      .+|+.+|++++||||++++++|.....+||||||+++++|.+++.......+++..++.++.||+.||+|||++||+|||
T Consensus       264 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrD  343 (495)
T 1opk_A          264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN  343 (495)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            89999999999999999999999998999999999999999999876556789999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCceeeecCCC--ccCCCCCCcccCC
Q 046106          261 LKSDNLLIFSDKSIKIADFGVARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       261 lkp~NILv~~~~~vKl~DFGla~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      |||+||||+.++.+||+|||+|+.......  .....+|+.|+||
T Consensus       344 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aP  388 (495)
T 1opk_A          344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP  388 (495)
T ss_dssp             CSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCH
T ss_pred             CChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCH
Confidence            999999999999999999999987543221  1223467899998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=309.32  Aligned_cols=252  Identities=28%  Similarity=0.444  Sum_probs=195.8

Q ss_pred             CcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHHH
Q 046106           34 GTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALAR  109 (303)
Q Consensus        34 ~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~~  109 (303)
                      |+|...+|      +...|.|+|||+......    ...++||+|++..++.|++.....+.+   ++.+ ....+.++.
T Consensus       172 G~FLvR~S------~~~~g~y~lsv~~~~~~~----~~~v~h~~I~~~~~g~~~i~~~~~F~SL~eLv~~y~~~~~~~~~  241 (535)
T 2h8h_A          172 GTFLVRES------ETTKGAYCLSVSDFDNAK----GLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCH  241 (535)
T ss_dssp             TEEEEEEC------SSSTTCEEEEEEEEETTT----EEEEEEEEEBC-CCSCEEEETTEEESSHHHHHHHHHHCCTTSSS
T ss_pred             CeEEEEec------CCCCCcEEEEEEeeccCC----CCceEEEEEEEcCCCcEEeeccccccChHHhheeeccccCcccc
Confidence            88888766      345788999998754222    237999999998888898875433332   2222 333444444


Q ss_pred             HhcCCCCC---CcCCCCCCcceeecCCccccceecccCceEEEEEEEC-CeEEEEEEeeCCCCChHHHHHHHHHHHHHHH
Q 046106          110 ALMDSNSP---TEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQEVM  185 (303)
Q Consensus       110 ~l~~~~~~---~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~  185 (303)
                      .+..++..   .......+.|++..++|++.+.||+|+||.||+|++. +..||||+++......       +.|.+|+.
T Consensus       242 ~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~  314 (535)
T 2h8h_A          242 RLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQ  314 (535)
T ss_dssp             CCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHH
T ss_pred             ccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH-------HHHHHHHH
Confidence            44443322   1112235789999999999999999999999999994 4689999998755432       47889999


Q ss_pred             HHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q 046106          186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDN  265 (303)
Q Consensus       186 il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~N  265 (303)
                      +|+.++||||+++++++.. ..+||||||+++++|.+++....+..+++..++.++.||+.||+|||++|||||||||+|
T Consensus       315 ~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N  393 (535)
T 2h8h_A          315 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN  393 (535)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence            9999999999999999976 567999999999999999986544568999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeccCCceeeecCC--CccCCCCCCcccCC
Q 046106          266 LLIFSDKSIKIADFGVARIEVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       266 ILv~~~~~vKl~DFGla~~~~~~~--~~~~~~gt~~y~AP  303 (303)
                      |||+.++.+||+|||+++......  ......+|+.|+||
T Consensus       394 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aP  433 (535)
T 2h8h_A          394 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP  433 (535)
T ss_dssp             EEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCH
T ss_pred             EEEcCCCcEEEcccccceecCCCceecccCCcCcccccCH
Confidence            999999999999999998654321  12233567899998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-38  Score=292.72  Aligned_cols=165  Identities=26%  Similarity=0.392  Sum_probs=142.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP----  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~----  205 (303)
                      ++|++++.||+|+||+||+|++  +|+.||||+++........    .+.+.+|+.+|+.++|||||++++++...    
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN----AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHH----HHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            5799999999999999999998  6899999999765544332    35788999999999999999999998643    


Q ss_pred             --CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          206 --MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       206 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                        ..+|||||||. |+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence              56899999995 6899999764  569999999999999999999999999999999999999999999999999998


Q ss_pred             eeecC-----CCccCCCCCCcccCC
Q 046106          284 IEVQT-----EGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~-----~~~~~~~gt~~y~AP  303 (303)
                      .....     ....+.+||+.||||
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~AP  231 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAP  231 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCH
T ss_pred             ecccCccccccccccceeChHhcCH
Confidence            65322     234557999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.4e-38  Score=308.72  Aligned_cols=172  Identities=20%  Similarity=0.309  Sum_probs=146.1

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +..++|++++.||+|+||+||+|+.  +|+.||||++++.................++.+++.++|||||++++++.++.
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            3456899999999999999999998  78899999997532211111111223344577788889999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|||||||+||+|.++|...  ..+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999999999875  469999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      .. ...+.+||+.||||
T Consensus       344 ~~-~~~t~~GTp~YmAP  359 (689)
T 3v5w_A          344 KK-KPHASVGTHGYMAP  359 (689)
T ss_dssp             SC-CCCSCCSCGGGCCH
T ss_pred             CC-CCCCccCCcCccCH
Confidence            43 34567999999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.5e-38  Score=297.32  Aligned_cols=246  Identities=25%  Similarity=0.438  Sum_probs=187.5

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCCC---ccc-cCChHHH
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGR---VSH-ALSDDAL  107 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~~---~~~-~~~~~~~  107 (303)
                      .+|++...+|      ++.+|.|+||+..     .    ..++||+|. ..++.|++.....+.+.   +.+ ....+.+
T Consensus       100 ~~G~FlvR~S------~~~~g~~~Lsv~~-----~----~~v~H~~I~-~~~~~~~i~~~~~F~sl~eLv~~y~~~~~~~  163 (450)
T 1k9a_A          100 ETGLFLVRES------TNYPGDYTLCVSC-----E----GKVEHYRIM-YHASKLSIDEEVYFENLMQLVEHYTTDADGL  163 (450)
T ss_dssp             CTTEEEEEEC------SSSTTSEEEEEEC-----S----SSEEEEEEE-EETTEEESSSSSCBSSHHHHHHHHHHCCTTS
T ss_pred             CCceEEEEec------CCCCCceEEEEEe-----C----CeeeEEEEE-ecCCceEeccccccccHHHHHhhhcccccch
Confidence            4688877765      3567889999975     1    268999994 45667777644333321   111 1222222


Q ss_pred             HHHhcCCCCCCcCC-----CCCCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHH
Q 046106          108 ARALMDSNSPTEGL-----ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQ  182 (303)
Q Consensus       108 ~~~l~~~~~~~~~~-----~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~  182 (303)
                      +..+..++......     ...+.|+++.++|++.+.||+|+||.||+|.++++.||||+++....        .+.|.+
T Consensus       164 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~--------~~~~~~  235 (450)
T 1k9a_A          164 CTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLA  235 (450)
T ss_dssp             SSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT--------SHHHHH
T ss_pred             hhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH--------HHHHHH
Confidence            22222222211111     01367999999999999999999999999999999999999976432        157889


Q ss_pred             HHHHHHcCCCCCeeeeeEEEEcCC-eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 046106          183 EVMMLATLKHPNIVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDL  261 (303)
Q Consensus       183 E~~il~~l~hpniv~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDl  261 (303)
                      |+.+|++++||||+++++++.... .+||||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||
T Consensus       236 E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDl  315 (450)
T 1k9a_A          236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL  315 (450)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             HHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence            999999999999999999987765 7899999999999999999765555799999999999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          262 KSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       262 kp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ||+||||+.++.+||+|||+|+.....  .....+|+.|+||
T Consensus       316 kp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aP  355 (450)
T 1k9a_A          316 AARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAP  355 (450)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCH
T ss_pred             CHhhEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCH
Confidence            999999999999999999999854322  2233678999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-36  Score=279.87  Aligned_cols=159  Identities=25%  Similarity=0.393  Sum_probs=136.9

Q ss_pred             CCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~  205 (303)
                      ++|++.++||+|+||+||+|+.     +++.||||.+.+...        ..++.+|+.+|+.+ .||||+++++++.+.
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--------PIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--------HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--------HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            5688999999999999999986     357899999865432        13677899999988 599999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCcee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVARI  284 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~~  284 (303)
                      +.+||||||+++++|.+++.     .+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999999999984     38999999999999999999999999999999999999887 8999999999985


Q ss_pred             eecCC-----------------------------CccCCCCCCcccCC
Q 046106          285 EVQTE-----------------------------GMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~-----------------------------~~~~~~gt~~y~AP  303 (303)
                      .....                             ..++.+||+.||||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP  215 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP  215 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCH
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCH
Confidence            43221                             13445899999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.7e-36  Score=296.75  Aligned_cols=166  Identities=23%  Similarity=0.441  Sum_probs=148.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++++.||+|+||.||+|+.  +|+.||||++......      ..+.+.+|+.+|+.++|||||++++++.++..+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~------~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh------hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            35789999999999999999998  7889999999764321      135788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC--CcEEEeccCCceeee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD--KSIKIADFGVARIEV  286 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~--~~vKl~DFGla~~~~  286 (303)
                      |||||||++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+...
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            99999999999999997543 468999999999999999999999999999999999999865  899999999999877


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.||||
T Consensus       309 ~~~~~~~~~GT~~y~AP  325 (573)
T 3uto_A          309 PKQSVKVTTGTAEFAAP  325 (573)
T ss_dssp             TTSEEEEECSSGGGCCH
T ss_pred             CCCceeeeEECccccCH
Confidence            66666677999999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-36  Score=283.47  Aligned_cols=245  Identities=27%  Similarity=0.426  Sum_probs=175.2

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---CccccC-ChHHH
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSHAL-SDDAL  107 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~~~-~~~~~  107 (303)
                      .+|++...+|-      +.+ .|++|+...         ..++||+|++..+ .|.+.. ..+++   ++.|-. ..+.+
T Consensus        31 ~~G~flvR~s~------~~~-~~~lsv~~~---------~~~~h~~i~~~~~-~~~~~~-~~F~sl~~LI~~y~~~~~~l   92 (377)
T 3cbl_A           31 HSGDFLVRESQ------GKQ-EYVLSVLWD---------GLPRHFIIQSLDN-LYRLEG-EGFPSIPLLIDHLLSTQQPL   92 (377)
T ss_dssp             STTEEEEEECC--------C-CEEEEC--------------CCEEEC----C-CCCC-----CCSHHHHHHHHHHHTCCC
T ss_pred             cCCCEEEEEeC------CCC-cEEEEEEEC---------CCccchhhccccc-eEEecc-eeccchHHHHHHHhhccCCc
Confidence            57999998772      233 799999852         2689999988643 443332 22222   111100 00000


Q ss_pred             HHHhcCCCCCCcCCCCCCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHH
Q 046106          108 ARALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVM  185 (303)
Q Consensus       108 ~~~l~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~  185 (303)
                      ...   +..........+.|.++.++|.+.+.||+|+||.||+|++  +++.||||+++.... .    ...+.+.+|+.
T Consensus        93 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~E~~  164 (377)
T 3cbl_A           93 TKK---SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-P----DLKAKFLQEAR  164 (377)
T ss_dssp             --------CCCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-H----HHHTTTTHHHH
T ss_pred             ccc---cCcccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-H----HHHHHHHHHHH
Confidence            000   0011111123468999999999999999999999999998  578999999875422 1    12357889999


Q ss_pred             HHHcCCCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCc
Q 046106          186 MLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDN  265 (303)
Q Consensus       186 il~~l~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~N  265 (303)
                      +|+.++||||+++++++..+..+|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus       165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  243 (377)
T 3cbl_A          165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN  243 (377)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHH
Confidence            9999999999999999999888999999999999999998643 458999999999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeccCCceeeecCCCc---cCCCCCCcccCC
Q 046106          266 LLIFSDKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       266 ILv~~~~~vKl~DFGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      |||+.++.+||+|||+|+........   ....+++.|+||
T Consensus       244 il~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aP  284 (377)
T 3cbl_A          244 CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP  284 (377)
T ss_dssp             EEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCH
T ss_pred             EEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCH
Confidence            99999999999999999864322111   112346789998

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=292.94  Aligned_cols=171  Identities=27%  Similarity=0.557  Sum_probs=138.5

Q ss_pred             cceeecCCccccc-eecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          126 EWTIDLRKLNMGD-AFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       126 ~~~i~~~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      .|.+...++.+.+ .||+|+||.||+|.+    ++..||||+++.......     .+.+.+|+.+|+.++||||+++++
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~E~~il~~l~hpniv~l~~  403 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMMREAQIMHQLDNPYIVRLIG  403 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTT-----HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHH-----HHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3455556666655 799999999999987    345799999986543221     257889999999999999999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      +|..+ .++|||||+++|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus       404 ~~~~~-~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          404 VCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             EEESS-SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             EeccC-CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            99874 579999999999999999754 3568999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCCc----cCCCCCCcccCC
Q 046106          281 VARIEVQTEGM----TPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~----~~~~gt~~y~AP  303 (303)
                      +|+........    ....+|+.|+||
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~AP  508 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAP  508 (613)
T ss_dssp             TTTTCC--------------CCTTSCH
T ss_pred             CcccccCCCceeeeccCCCCccceeCH
Confidence            99865432211    122456899998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-35  Score=294.11  Aligned_cols=170  Identities=31%  Similarity=0.580  Sum_probs=136.9

Q ss_pred             ceeecCCcccc-ceecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          127 WTIDLRKLNMG-DAFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       127 ~~i~~~~~~~~-~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      |.++...+.+. +.||+|+||.||+|.+    .++.||||+++....+..    ..+.+.+|+.+|+.++||||++++++
T Consensus       363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~  438 (635)
T 4fl3_A          363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIGI  438 (635)
T ss_dssp             SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG----GHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            44444445443 3799999999999976    357899999976543322    13578999999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +..+ .+++||||+++++|.+++...  ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus       439 ~~~~-~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGl  515 (635)
T 4fl3_A          439 CEAE-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL  515 (635)
T ss_dssp             EESS-SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred             EecC-CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence            9765 478999999999999999764  4689999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCC----ccCCCCCCcccCC
Q 046106          282 ARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      |+.......    .....+|+.|+||
T Consensus       516 a~~~~~~~~~~~~~~~~~~t~~y~AP  541 (635)
T 4fl3_A          516 SKALRADENYYKAQTHGKWPVKWYAP  541 (635)
T ss_dssp             HHHTTC-------------CGGGSCH
T ss_pred             ccccccCccccccccCCCCceeeeCh
Confidence            986543321    2233567899998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-34  Score=264.10  Aligned_cols=169  Identities=30%  Similarity=0.484  Sum_probs=151.6

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      ....+|.+.+.||+|+||.||+|++  +++.||||++.........    .+.+.+|+.+|+.++||||+++++++..+.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            3456789999999999999999998  7889999999876544322    357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            999999999999999999875  458999999999999999999999999999999999999999999999999998766


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.|+||
T Consensus       166 ~~~~~~~~~gt~~y~aP  182 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAP  182 (328)
T ss_dssp             SSCGGGTTSSSGGGCCH
T ss_pred             CCCccccccCCcceeCc
Confidence            55556677899999998

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-33  Score=253.77  Aligned_cols=172  Identities=35%  Similarity=0.588  Sum_probs=148.7

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..+.+..++|.+.+.||+|+||.||++++  +++.||+|++....  .    ...+.+.+|+.++++++||||+++++++
T Consensus         3 p~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~--~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~   76 (310)
T 3s95_A            3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD--E----ETQRTFLKEVKVMRCLEHPNVLKFIGVL   76 (310)
T ss_dssp             CCEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC--H----HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC--H----HHHHHHHHHHHHHHhCCCcCcccEEEEE
Confidence            45667788999999999999999999998  57899999885422  1    2236889999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .++...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           77 YKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             ecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccc
Confidence            99999999999999999999998743 46899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCc---------------cCCCCCCcccCC
Q 046106          283 RIEVQTEGM---------------TPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~---------------~~~~gt~~y~AP  303 (303)
                      +........               ...+||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP  191 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCH
T ss_pred             eecccccccccccccccccccccccccCCCcceeCH
Confidence            865432221               145799999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.4e-34  Score=265.39  Aligned_cols=173  Identities=21%  Similarity=0.343  Sum_probs=152.9

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .+.+..++|.+.+.||+|+||.||++++  +++.||+|++.+....   .....+.+.+|+.+|+.++||||+++++++.
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~---~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   85 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV---ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ   85 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc---cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4567788999999999999999999998  6789999999642110   1111357889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      +...+|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           86 DEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceee
Confidence            999999999999999999999864  468999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........+||+.|+||
T Consensus       164 ~~~~~~~~~~~~gt~~Y~aP  183 (384)
T 4fr4_A          164 MLPRETQITTMAGTKPYMAP  183 (384)
T ss_dssp             ECCTTCCBCCCCSCGGGCCG
T ss_pred             eccCCCceeccCCCccccCC
Confidence            77666666778999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.4e-34  Score=266.00  Aligned_cols=172  Identities=22%  Similarity=0.387  Sum_probs=147.2

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACR  203 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  203 (303)
                      ..+..++|++++.||+|+||+||++++  +++.||||++++.......   ..+.+.+|..++.++ +||||+++++++.
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~---~~~~~~~E~~il~~~~~hp~Iv~l~~~~~  123 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFLVGLHSCFQ  123 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH---HHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence            445677899999999999999999998  6789999999865432211   124577899999876 8999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ++..+|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            999999999999999999999875  458999999999999999999999999999999999999999999999999998


Q ss_pred             ee-ecCCCccCCCCCCcccCC
Q 046106          284 IE-VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~-~~~~~~~~~~gt~~y~AP  303 (303)
                      .. .........+||+.|+||
T Consensus       202 ~~~~~~~~~~~~~gt~~Y~aP  222 (396)
T 4dc2_A          202 EGLRPGDTTSTFCGTPNYIAP  222 (396)
T ss_dssp             CCCCTTCCBCCCCBCGGGCCH
T ss_pred             ecccCCCccccccCCcccCCc
Confidence            63 333445567899999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-33  Score=259.75  Aligned_cols=170  Identities=26%  Similarity=0.395  Sum_probs=146.8

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +..++|++.+.||+|+||+||+++.  +++.||||++++....   .......+.+|+.+|+.++||||+++++++....
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~   78 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence            3457889999999999999999998  6889999999752110   1111356889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999999999865  458999999999999999999999999999999999999999999999999998633


Q ss_pred             -cCCCccCCCCCCcccCC
Q 046106          287 -QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 -~~~~~~~~~gt~~y~AP  303 (303)
                       ........+||+.|+||
T Consensus       157 ~~~~~~~~~~gt~~y~aP  174 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAP  174 (337)
T ss_dssp             CTTCCBCCCEECGGGCCG
T ss_pred             cCCCcccccccChhhCCh
Confidence             23334556899999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.5e-33  Score=255.49  Aligned_cols=177  Identities=37%  Similarity=0.643  Sum_probs=143.7

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..+.|++...+|++.+.||+|+||.||+|+++++.||||++.........    .+.+.+|+.++++++||||+++++++
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER----VNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHH----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34678899999999999999999999999999999999999876554432    35788999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCcEEEecc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      .....+++||||+++++|.+++..... ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999999985421 23899999999999999999999999  999999999999999999999999


Q ss_pred             CCceeeecCC-CccCCCCCCcccCC
Q 046106          280 GVARIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      |+++...... ......||+.|+||
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aP  208 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAP  208 (309)
T ss_dssp             C-----------------CCTTSCH
T ss_pred             CCCccccccccccccCCCCccccCh
Confidence            9998644332 23345799999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-33  Score=262.11  Aligned_cols=170  Identities=24%  Similarity=0.426  Sum_probs=148.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      +.|.+.+.||+|+||.||+|+.  +++.||+|++++............+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            5688899999999999999998  68899999998765432111111257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEeccCCceee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK----SIKIADFGVARIE  285 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~----~vKl~DFGla~~~  285 (303)
                      +||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|+..
T Consensus        92 lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            999999999999999764  4689999999999999999999999999999999999998877    7999999999877


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      .........+||+.|+||
T Consensus       170 ~~~~~~~~~~gt~~y~aP  187 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAP  187 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCH
T ss_pred             CCCCccccCCCCccEECc
Confidence            665556667899999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-33  Score=260.32  Aligned_cols=171  Identities=23%  Similarity=0.369  Sum_probs=140.9

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  204 (303)
                      .+..++|++.+.||+|+||+||+|++  +++.||||++++...   ......+.+.+|..++..+ +||||+++++++.+
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~---~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~   95 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI---LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT   95 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH---HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh---cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence            35567899999999999999999998  678999999975311   1111235678899999988 69999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +..+|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            99999999999999999999875  4589999999999999999999999999999999999999999999999999985


Q ss_pred             eec-CCCccCCCCCCcccCC
Q 046106          285 EVQ-TEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~-~~~~~~~~gt~~y~AP  303 (303)
                      ... .......+||+.|+||
T Consensus       174 ~~~~~~~~~~~~gt~~y~aP  193 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAP  193 (353)
T ss_dssp             SCC---------CCGGGCCH
T ss_pred             cccCCccccccCCCcCeECh
Confidence            332 2334456899999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.2e-33  Score=257.40  Aligned_cols=170  Identities=22%  Similarity=0.398  Sum_probs=148.0

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP  205 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~  205 (303)
                      +...+|++.+.||+|+||.||++++  +++.||||++++......   ...+.+.+|..+++.+ +||||+++++++.+.
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch---HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            3456888999999999999999998  578999999986543322   2235688999999987 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+|+||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            9999999999999999999865  45899999999999999999999999999999999999999999999999999863


Q ss_pred             e-cCCCccCCCCCCcccCC
Q 046106          286 V-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~-~~~~~~~~~gt~~y~AP  303 (303)
                      . ........+||+.|+||
T Consensus       161 ~~~~~~~~~~~gt~~y~aP  179 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAP  179 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCH
T ss_pred             cCCCCcccccCCCccccCc
Confidence            3 23344566899999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-33  Score=249.59  Aligned_cols=174  Identities=26%  Similarity=0.513  Sum_probs=148.3

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      .....|+++.++|++.+.||+|+||.||++.+ ++..||||+++......       +.+.+|+.+++.++||||+++++
T Consensus        14 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~   86 (283)
T 3gen_A           14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYG   86 (283)
T ss_dssp             --CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH-------HHHHHHHHHHhcCCCCCEeeEEE
Confidence            34578999999999999999999999999998 56689999998655432       46889999999999999999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      ++.....+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           87 VCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             EECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             EEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence            9999999999999999999999998643 458999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCC--CccCCCCCCcccCC
Q 046106          281 VARIEVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~--~~~~~~gt~~y~AP  303 (303)
                      +++......  ......+|+.|+||
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aP  190 (283)
T 3gen_A          166 LSRYVLDDEYTSSVGSKFPVRWSPP  190 (283)
T ss_dssp             GGGGBCCHHHHSTTSTTSCGGGCCH
T ss_pred             ccccccccccccccCCccCcccCCH
Confidence            997653322  12234567889998

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-33  Score=268.14  Aligned_cols=175  Identities=23%  Similarity=0.329  Sum_probs=149.2

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..+.+..++|++.+.||+|+||+||+|++  +++.||+|++++....   .......+.+|+.++..++||||++++++|
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---KRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH---HTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh---hHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34566778999999999999999999998  5789999999642110   000113478899999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .++..+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            99999999999999999999998643 46899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC--ccCCCCCCcccCC
Q 046106          283 RIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      +.......  ....+||+.|+||
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~AP  245 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISP  245 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCH
T ss_pred             hhcccCCCcccccccCCcCeeCh
Confidence            86544332  2346899999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.8e-33  Score=246.73  Aligned_cols=171  Identities=29%  Similarity=0.567  Sum_probs=149.7

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ..|.++.++|++.+.||+|+||.||+|++ +++.||+|+++......       +.+.+|+.++++++||||+++++++.
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~   75 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCL   75 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH-------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH-------HHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            46899999999999999999999999998 77899999998655432       46889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ++...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           76 EQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             cCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence            9999999999999999999997643 468999999999999999999999999999999999999999999999999997


Q ss_pred             eeecCC--CccCCCCCCcccCC
Q 046106          284 IEVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~--~~~~~~gt~~y~AP  303 (303)
                      ......  ......+|+.|+||
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aP  176 (269)
T 4hcu_A          155 FVLDDQYTSSTGTKFPVKWASP  176 (269)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCH
T ss_pred             cccccccccccCcccccccCCH
Confidence            653322  22334577889998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.4e-33  Score=258.04  Aligned_cols=175  Identities=31%  Similarity=0.546  Sum_probs=149.2

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE---------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCC
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY---------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHP  193 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp  193 (303)
                      ...|.+..++|.+.+.||+|+||.||+|++         ++..||||+++....     ....+.+.+|+.+|+.+ +||
T Consensus        73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~~hp  147 (370)
T 2psq_A           73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-----EKDLSDLVSEMEMMKMIGKHK  147 (370)
T ss_dssp             CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-----HHHHHHHHHHHHHHHHSCCCT
T ss_pred             cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-----HHHHHHHHHHHHHHHHhcCCC
Confidence            356888899999999999999999999986         234799999976432     12235789999999999 899


Q ss_pred             CeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 046106          194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHR  259 (303)
Q Consensus       194 niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHr  259 (303)
                      ||+++++++.....+|+||||+++|+|.+++....              ...+++..++.++.||+.||+|||++||+||
T Consensus       148 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  227 (370)
T 2psq_A          148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR  227 (370)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             CEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            99999999999999999999999999999998653              1357899999999999999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       260 Dlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||||+||||+.++.+||+|||+|+.......   .....+|+.|+||
T Consensus       228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  274 (370)
T 2psq_A          228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  274 (370)
T ss_dssp             CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH
T ss_pred             ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECH
Confidence            9999999999999999999999986543322   2334578899998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.2e-34  Score=267.64  Aligned_cols=173  Identities=24%  Similarity=0.365  Sum_probs=148.3

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..+.+..++|.+.+.||+|+||+||+|++  +++.||+|++++.....   ......+.+|+.+++.++||||+++++++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~  138 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK---RSDSAFFWEERDIMAFANSPWVVQLFYAF  138 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---TCCCSTHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh---hHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            35567778999999999999999999998  57899999996421000   00013477899999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .++..+|+||||+++|+|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus       139 ~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          139 QDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            9999999999999999999999763   5899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC--ccCCCCCCcccCC
Q 046106          283 RIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      +.......  ....+||+.|+||
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~AP  238 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISP  238 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCH
T ss_pred             EeeccCCcccccCCcCCccccCH
Confidence            87554332  3356899999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-33  Score=264.14  Aligned_cols=175  Identities=24%  Similarity=0.328  Sum_probs=150.3

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      .++.+..++|++.+.||+|+||+||+++.  +++.||||++++....   .....+.+.+|..++..++||||+++++++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~---~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML---KRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh---hHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            34567788999999999999999999998  6889999999642110   111124578899999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .+...+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999999998653 46899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC--ccCCCCCCcccCC
Q 046106          283 RIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      +.......  ....+||+.|+||
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~AP  232 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSP  232 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCH
T ss_pred             eeccCCCccccceeccccCcCCH
Confidence            87654332  2345899999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-33  Score=254.56  Aligned_cols=170  Identities=24%  Similarity=0.427  Sum_probs=147.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|+.  +++.||+|+++.............+.+.+|+.+|+.++||||+++++++..+..++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4678889999999999999998  58899999998754432111111257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEeccCCceee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK----SIKIADFGVARIE  285 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~----~vKl~DFGla~~~  285 (303)
                      +||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|+..
T Consensus        91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999999999999754  4689999999999999999999999999999999999999887    8999999999877


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      .........+||+.|+||
T Consensus       169 ~~~~~~~~~~gt~~y~aP  186 (326)
T 2y0a_A          169 DFGNEFKNIFGTPEFVAP  186 (326)
T ss_dssp             CTTSCCCCCCSCTTTCCH
T ss_pred             CCCCccccccCCcCcCCc
Confidence            655555667899999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.6e-33  Score=248.36  Aligned_cols=169  Identities=26%  Similarity=0.440  Sum_probs=143.0

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      -.++|++.+.||+|+||.||++++  +++.||+|++........   ...+.+.+|+.+++.++||||+++++++..+..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH---HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            356889999999999999999997  678999999976544332   224678999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +|+||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999999999875  4689999999999999999999999999999999999999999999999999976543


Q ss_pred             CCC--ccCCCCCCcccCC
Q 046106          288 TEG--MTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~--~~~~~gt~~y~AP  303 (303)
                      ...  ....+||+.|+||
T Consensus       164 ~~~~~~~~~~gt~~y~aP  181 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSP  181 (294)
T ss_dssp             -----------CCSSCCH
T ss_pred             ccccccCccccCccccCH
Confidence            321  2334799999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.9e-33  Score=248.45  Aligned_cols=164  Identities=28%  Similarity=0.461  Sum_probs=145.2

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.......      .+.+.+|+.+++.++||||+++++++..+..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH------HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            46788899999999999999986  78899999997544332      24688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++++|.+++...   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            9999999999999999864   4899999999999999999999999999999999999999999999999999865543


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . .....+||+.|+||
T Consensus       170 ~~~~~~~~gt~~y~aP  185 (297)
T 3fxz_A          170 QSKRSTMVGTPYWMAP  185 (297)
T ss_dssp             TCCBCCCCSCGGGCCH
T ss_pred             ccccCCccCCcCccCh
Confidence            3 23455899999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-32  Score=255.11  Aligned_cols=167  Identities=27%  Similarity=0.423  Sum_probs=147.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++.........    .+.+.+|+.+++.++||||+++++++.++...
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            35688889999999999999998  6889999999876554322    35788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---~~vKl~DFGla~~~  285 (303)
                      |+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|+..
T Consensus       104 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999999999764  458999999999999999999999999999999999999865   45999999999876


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      .........+||+.|+||
T Consensus       182 ~~~~~~~~~~gt~~y~aP  199 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSP  199 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCH
T ss_pred             cCCcccccCCCCccccCH
Confidence            655555667899999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.7e-33  Score=255.82  Aligned_cols=167  Identities=29%  Similarity=0.419  Sum_probs=138.2

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      ....++|.+.+.||+|+||.||+++.  +++.||||++.......       ..+.+|+.+++.++||||+++++++..+
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-------ENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-------HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-------HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            44567899999999999999999998  68899999998654332       3577999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc--EEEeccCCce
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVAR  283 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~--vKl~DFGla~  283 (303)
                      ..+|+||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             CEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            9999999999999999999765  35899999999999999999999999999999999999987765  9999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........+||+.|+||
T Consensus       167 ~~~~~~~~~~~~gt~~y~aP  186 (361)
T 3uc3_A          167 SSVLHSQPKSTVGTPAYIAP  186 (361)
T ss_dssp             --------------CTTSCH
T ss_pred             cccccCCCCCCcCCCCcCCh
Confidence            65444445556899999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-32  Score=250.17  Aligned_cols=167  Identities=25%  Similarity=0.468  Sum_probs=138.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC---
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM---  206 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~---  206 (303)
                      ++|++.+.||+|+||.||+|++  +++.||||+++.......     .+.+.+|+.+|+.++||||+++++++.+..   
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----REKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTH-----HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            4678889999999999999998  688999999986543222     257889999999999999999999986543   


Q ss_pred             ------------------------------------------------------eEEEEEeecCCCCHHHHHHhcCC-CC
Q 046106          207 ------------------------------------------------------VWCIVTEYAKGGSVRQFLTKRQN-RS  231 (303)
Q Consensus       207 ------------------------------------------------------~~~iv~E~~~~gsL~~~l~~~~~-~~  231 (303)
                                                                            .+++||||+++++|.+++..... ..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  37999999999999999986432 23


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-------------CccCCCCCC
Q 046106          232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-------------GMTPETGTY  298 (303)
Q Consensus       232 ~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-------------~~~~~~gt~  298 (303)
                      .++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......             .....+||+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            4566789999999999999999999999999999999999999999999998755432             223457999


Q ss_pred             cccCC
Q 046106          299 RWMAP  303 (303)
Q Consensus       299 ~y~AP  303 (303)
                      .|+||
T Consensus       241 ~y~aP  245 (332)
T 3qd2_B          241 LYMSP  245 (332)
T ss_dssp             GGSCH
T ss_pred             CccCh
Confidence            99998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-33  Score=252.22  Aligned_cols=167  Identities=28%  Similarity=0.441  Sum_probs=145.4

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ..++|++.+.||+|+||.||+++.  +++.||+|++++....   .....+.+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~   80 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV---RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ   80 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence            456788999999999999999998  6889999999752110   00113567889999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999999999865  4589999999999999999999999999999999999999999999999999986432


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                        .....+||+.|+||
T Consensus       159 --~~~~~~gt~~y~aP  172 (318)
T 1fot_A          159 --VTYTLCGTPDYIAP  172 (318)
T ss_dssp             --CBCCCCSCTTTCCH
T ss_pred             --ccccccCCccccCH
Confidence              23456899999998

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.9e-33  Score=255.27  Aligned_cols=172  Identities=24%  Similarity=0.384  Sum_probs=144.6

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACR  203 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  203 (303)
                      ..+..++|.+.+.||+|+||.||+|++  +++.||||++++....   .....+.+..|..++..+ +||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh---hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            345677899999999999999999998  6889999999753110   001124677888888876 8999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ++..+|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999999999875  358999999999999999999999999999999999999999999999999998


Q ss_pred             eeec-CCCccCCCCCCcccCC
Q 046106          284 IEVQ-TEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~-~~~~~~~~gt~~y~AP  303 (303)
                      .... .......+||+.|+||
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aP  187 (345)
T 1xjd_A          167 ENMLGDAKTNTFCGTPDYIAP  187 (345)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCH
T ss_pred             hcccCCCcccCCCCCcccCCh
Confidence            6432 2334566899999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.4e-33  Score=255.65  Aligned_cols=167  Identities=26%  Similarity=0.495  Sum_probs=146.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ..+|.+.+.||+|+||.||+|++  +++.||||++.+....   .......+.+|+.+++.++||||+++++++..+..+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK---KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc---chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            46788999999999999999998  7889999998642110   011124788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++||||+ +|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999999 78999999865  45899999999999999999999999999999999999999999999999999876665


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      ......+||+.|+||
T Consensus       162 ~~~~~~~gt~~y~aP  176 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAP  176 (336)
T ss_dssp             BTTCCCTTSTTTSCG
T ss_pred             cccccccCCcCcCCH
Confidence            556677899999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-33  Score=252.52  Aligned_cols=165  Identities=17%  Similarity=0.277  Sum_probs=145.8

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|++  +++.+|+|+++....       ....+.+|+.+|+.++||||+++++++.+...+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-------DQVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-------cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence            35788899999999999999998  678999999975321       124688999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--CCcEEEeccCCceeee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS--DKSIKIADFGVARIEV  286 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~--~~~vKl~DFGla~~~~  286 (303)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+++...
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999999999997543 46899999999999999999999999999999999999987  7899999999998776


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      .........||+.|+||
T Consensus       156 ~~~~~~~~~gt~~y~aP  172 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAP  172 (321)
T ss_dssp             TTCEEEEEESCGGGSCH
T ss_pred             CCCccccccCChhhcCc
Confidence            55555556799999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.2e-33  Score=252.05  Aligned_cols=174  Identities=23%  Similarity=0.357  Sum_probs=138.7

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      ...+..++|++.+.||+|+||.||+++.     +++.||+|++++......  ......+.+|+.+|+.++||||+++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~   88 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPFIVDLIY   88 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------HHHHHHHCCCTTBCCEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh--hhHHHHHHHHHHHHHhCCCCCccceeE
Confidence            3456678899999999999999999986     578999999976542211  112246788999999999999999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      ++.....+|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           89 AFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             EEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            999999999999999999999999865  458999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecC-CCccCCCCCCcccCC
Q 046106          281 VARIEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      +|+..... ......+||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aP  190 (327)
T 3a62_A          167 LCKESIHDGTVTHTFCGTIEYMAP  190 (327)
T ss_dssp             CC----------CTTSSCCTTSCH
T ss_pred             cccccccCCccccccCCCcCccCH
Confidence            99754322 233456899999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=256.10  Aligned_cols=177  Identities=32%  Similarity=0.543  Sum_probs=151.9

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-C
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-K  191 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~  191 (303)
                      .....|++..++|.+.+.||+|+||.||+|++.         +..||||+++.....     ...+.+.+|+.+++.+ +
T Consensus        59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~  133 (382)
T 3tt0_A           59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-----KDLSDLISEMEMMKMIGK  133 (382)
T ss_dssp             CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHHCC
T ss_pred             ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-----HHHHHHHHHHHHHHHhcC
Confidence            445679999999999999999999999999862         257999999765322     2236788999999999 8


Q ss_pred             CCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 046106          192 HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLI  257 (303)
Q Consensus       192 hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~gii  257 (303)
                      ||||+++++++..+..+|+||||+++++|.+++....              ...+++..++.++.||+.||+|||++||+
T Consensus       134 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  213 (382)
T 3tt0_A          134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI  213 (382)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             CchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            9999999999999999999999999999999998754              23589999999999999999999999999


Q ss_pred             eCCCCCCcEEEcCCCcEEEeccCCceeeecCC---CccCCCCCCcccCC
Q 046106          258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       258 HrDlkp~NILv~~~~~vKl~DFGla~~~~~~~---~~~~~~gt~~y~AP  303 (303)
                      ||||||+||||+.++.+||+|||+|+......   ......+|+.|+||
T Consensus       214 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  262 (382)
T 3tt0_A          214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  262 (382)
T ss_dssp             CSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH
T ss_pred             cCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCH
Confidence            99999999999999999999999998654332   22334678899998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-32  Score=242.64  Aligned_cols=170  Identities=27%  Similarity=0.511  Sum_probs=148.7

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      .|++..++|++.+.||+|+||.||+|.+ ++..||+|+++......       +.+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-------DEFFQEAQTMMKLSHPKLVKFYGVCSK   74 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH-------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            5778889999999999999999999998 55689999997654432       468899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             CCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence            999999999999999999998653 4589999999999999999999999999999999999999999999999999986


Q ss_pred             eecCCC--ccCCCCCCcccCC
Q 046106          285 EVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~--~~~~~gt~~y~AP  303 (303)
                      ......  .....+|+.|+||
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aP  174 (268)
T 3sxs_A          154 VLDDQYVSSVGTKFPVKWSAP  174 (268)
T ss_dssp             CCTTCEEECCSCCCCGGGCCH
T ss_pred             cchhhhhcccCCCcCcccCCH
Confidence            544332  1233567789998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.4e-33  Score=253.42  Aligned_cols=170  Identities=32%  Similarity=0.458  Sum_probs=147.3

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ...|.+...+|++.+.||+|+||.||+|++.++.||||+++...       .....+.+|+.++++++||||+++++++.
T Consensus        16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-------KQSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-------hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            35788899999999999999999999999999999999996421       11234566999999999999999999998


Q ss_pred             cCC----eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeCCCCCCcEEEc
Q 046106          204 KPM----VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL----------GLIHRDLKSDNLLIF  269 (303)
Q Consensus       204 ~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------giiHrDlkp~NILv~  269 (303)
                      ...    .+|+||||+++++|.+++...   .+++..++.++.|++.||+|||+.          ||+||||||+|||++
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~  165 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK  165 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence            743    479999999999999999763   489999999999999999999999          999999999999999


Q ss_pred             CCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          270 SDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       270 ~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      .++.+||+|||+|+.......   ....+||+.|+||
T Consensus       166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aP  202 (322)
T 3soc_A          166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP  202 (322)
T ss_dssp             TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCH
T ss_pred             CCCeEEEccCCcccccccccCccccccCccCccccCH
Confidence            999999999999987654332   2335799999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.4e-33  Score=255.61  Aligned_cols=172  Identities=18%  Similarity=0.260  Sum_probs=148.0

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEE-----E--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC---C
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGT-----Y--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---H  192 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~-----~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---h  192 (303)
                      ....+++..++|.+.+.||+|+||.||+|.     .  +++.||||+++...         ...+.+|+.+++.++   |
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~l~~~~~  126 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---------PWEFYIGTQLMERLKPSMQ  126 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---------HHHHHHHHHHHHHSCGGGG
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---------hhHHHHHHHHHHHhhhhhh
Confidence            346778888999999999999999999993     2  67899999997532         135778888888887   8


Q ss_pred             CCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc
Q 046106          193 PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKR---QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF  269 (303)
Q Consensus       193 pniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~  269 (303)
                      +||+++++++..+...|+||||+++|+|.+++...   ....+++..++.++.||+.||+|||++|||||||||+||||+
T Consensus       127 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~  206 (365)
T 3e7e_A          127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG  206 (365)
T ss_dssp             GGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred             hhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence            99999999999999999999999999999999753   235699999999999999999999999999999999999999


Q ss_pred             C-----------CCcEEEeccCCceeee---cCCCccCCCCCCcccCC
Q 046106          270 S-----------DKSIKIADFGVARIEV---QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       270 ~-----------~~~vKl~DFGla~~~~---~~~~~~~~~gt~~y~AP  303 (303)
                      .           ++.+||+|||+|+...   ........+||+.|+||
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  254 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV  254 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh
Confidence            8           8999999999997543   22234556899999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.3e-33  Score=248.41  Aligned_cols=175  Identities=26%  Similarity=0.572  Sum_probs=154.0

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      +.++.|++...+|++.+.||+|+||.||+|.+  +++.||+|+++.....       .+.+.+|+.+++.++||||++++
T Consensus         3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~   75 (288)
T 3kfa_A            3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------VEEFLKEAAVMKEIKHPNLVQLL   75 (288)
T ss_dssp             TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------HHHHHHHHHHHHhCCCCCEeeEE
Confidence            45789999999999999999999999999998  4789999999754321       25788999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +++..+..+|+||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Df  155 (288)
T 3kfa_A           76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF  155 (288)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccC
Confidence            99999999999999999999999998766667999999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCC--ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      |+++.......  .....+|+.|+||
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~y~aP  181 (288)
T 3kfa_A          156 GLSRLMTGDTYTAHAGAKFPIKWTAP  181 (288)
T ss_dssp             CGGGTSCSSSSEEETTEEECGGGCCH
T ss_pred             ccceeccCCccccccCCccccCcCCh
Confidence            99986543322  1223467889998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8e-33  Score=269.86  Aligned_cols=172  Identities=23%  Similarity=0.343  Sum_probs=151.3

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +..++|.+.+.||+|+||.||+|+.  +++.||||++.+....   .......+.+|+.+|+.++||||+++++++.+..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~---~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  257 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD  257 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh---hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence            5677899999999999999999998  6889999999652111   1111356789999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999999999987655569999999999999999999999999999999999999999999999999998776


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.|+||
T Consensus       338 ~~~~~~~~~GT~~Y~AP  354 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAP  354 (576)
T ss_dssp             TTCCEECCCSCGGGCCH
T ss_pred             cCccccccCCCccccCH
Confidence            55555667999999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-32  Score=249.73  Aligned_cols=170  Identities=25%  Similarity=0.357  Sum_probs=146.5

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +...+|.+.+.||+|+||.||+|++  +++.||||+++.......     .+.+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----VDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----HHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence            3456788999999999999999998  488999999975332111     246779999999999999999999998755


Q ss_pred             --eEEEEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEecc
Q 046106          207 --VWCIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI----FSDKSIKIADF  279 (303)
Q Consensus       207 --~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv----~~~~~vKl~DF  279 (303)
                        .+|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||||    +.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence              78999999999999999986432 348999999999999999999999999999999999999    77888999999


Q ss_pred             CCceeeecCCCccCCCCCCcccCC
Q 046106          280 GVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+|+............||+.|+||
T Consensus       161 g~a~~~~~~~~~~~~~gt~~y~aP  184 (319)
T 4euu_A          161 GAARELEDDEQFVSLYGTEEYLHP  184 (319)
T ss_dssp             TTCEECCTTCCBCCCCSCGGGCCH
T ss_pred             CCceecCCCCceeecccCCCccCH
Confidence            999887666656667899999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=250.68  Aligned_cols=172  Identities=29%  Similarity=0.490  Sum_probs=144.9

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      .+++...+|.+.+.||+|+||.||+|.+     .+..||||+++.....     ...+.+.+|+.+++.++||||+++++
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~  117 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-----RQRRDFLSEASIMGQFDHPNIIRLEG  117 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-----HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3567788999999999999999999998     2346999999754322     12367899999999999999999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      ++.....+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          118 VVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             EECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             EEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCC
Confidence            9999989999999999999999997643 468999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCC----ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      +++.......    .....+|+.|+||
T Consensus       197 ~a~~~~~~~~~~~~~~~~~~t~~y~aP  223 (325)
T 3kul_A          197 LSRVLEDDPDAAYTTTGGKIPIRWTAP  223 (325)
T ss_dssp             SCEECC----CCEECC---CCGGGSCH
T ss_pred             cccccccCccceeeccCCCCcccccCH
Confidence            9987543321    1223467889998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8e-33  Score=257.42  Aligned_cols=171  Identities=25%  Similarity=0.383  Sum_probs=139.7

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHH-HHcCCCCCeeeeeEEEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMM-LATLKHPNIVRFIGACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~  204 (303)
                      .+..++|++.+.||+|+||+||++++  +++.||||++++.......   ....+.+|..+ ++.++||||+++++++.+
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~---~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---EEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH---HHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            34567899999999999999999998  5779999999865432211   12455667766 577899999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ...+|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            99999999999999999999865  4589999999999999999999999999999999999999999999999999986


Q ss_pred             ee-cCCCccCCCCCCcccCC
Q 046106          285 EV-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~-~~~~~~~~~gt~~y~AP  303 (303)
                      .. ........+||+.|+||
T Consensus       189 ~~~~~~~~~~~~gt~~y~aP  208 (373)
T 2r5t_A          189 NIEHNSTTSTFCGTPEYLAP  208 (373)
T ss_dssp             GBCCCCCCCSBSCCCCCCCH
T ss_pred             cccCCCccccccCCccccCH
Confidence            33 23345567899999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.8e-33  Score=254.99  Aligned_cols=171  Identities=27%  Similarity=0.350  Sum_probs=144.8

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  204 (303)
                      .+...+|++.+.||+|+||+||+|+.  +++.||||++++....   .....+.+.+|..++..+ +||+|+++++++.+
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~---~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   92 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI---QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT   92 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence            34567889999999999999999998  4678999999753110   011135678899999988 79999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ...+|+||||+++|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            99999999999999999999865  3589999999999999999999999999999999999999999999999999986


Q ss_pred             ee-cCCCccCCCCCCcccCC
Q 046106          285 EV-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~-~~~~~~~~~gt~~y~AP  303 (303)
                      .. ........+||+.|+||
T Consensus       171 ~~~~~~~~~~~~gt~~y~aP  190 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAP  190 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCH
T ss_pred             cccCCcccccccCCccccCh
Confidence            43 23334556899999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.9e-32  Score=243.27  Aligned_cols=166  Identities=23%  Similarity=0.418  Sum_probs=143.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||.||+|++  +++.||||+++........    .+.+.+|+.++++++||||+++++++..+..++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCc----chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEE
Confidence            5788899999999999999998  6789999999876543322    256789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-  288 (303)
                      +||||+++ ++.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        78 lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           78 LVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             EEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99999965 7777776543 56999999999999999999999999999999999999999999999999999865432 


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      .......||+.|+||
T Consensus       156 ~~~~~~~~t~~y~aP  170 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPP  170 (292)
T ss_dssp             SCCCSCCSCGGGCCH
T ss_pred             ccccCCccccCCcCh
Confidence            234456789999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.1e-32  Score=253.90  Aligned_cols=175  Identities=17%  Similarity=0.274  Sum_probs=151.5

Q ss_pred             CcceeecCCccccceeccc--CceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          125 DEWTIDLRKLNMGDAFAQG--AFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G--~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      ..+.....+|++.+.||+|  +||.||+|++  +++.||||+++.......    ..+.+.+|+.+++.++||||+++++
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~   93 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE----MVTFLQGELHVSKLFNHPNIVPYRA   93 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH----HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH----HHHHHHHHHHHHHhCCCCCCCcEeE
Confidence            3455667789999999999  9999999998  588999999987544332    3367889999999999999999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      ++..+..+|+||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B           94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccc
Confidence            99999999999999999999999987655679999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCC--------CccCCCCCCcccCC
Q 046106          281 VARIEVQTE--------GMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~--------~~~~~~gt~~y~AP  303 (303)
                      ++.......        .....+||+.|+||
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred             cceeeccccccccccccccccccccccccCH
Confidence            986543221        12234789999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-32  Score=253.79  Aligned_cols=168  Identities=26%  Similarity=0.339  Sum_probs=146.0

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      ...++|++.+.||+|+||.||++++  +++.||||++++....   .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV---KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc---cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3456888899999999999999998  6889999999652110   0111357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence            999999999999999999875  458999999999999999999999999999999999999999999999999998654


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      .  .....+||+.|+||
T Consensus       193 ~--~~~~~~gt~~y~aP  207 (350)
T 1rdq_E          193 G--RTWTLCGTPEALAP  207 (350)
T ss_dssp             S--CBCCCEECGGGCCH
T ss_pred             C--CcccccCCccccCH
Confidence            3  23456899999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-32  Score=251.06  Aligned_cols=174  Identities=29%  Similarity=0.512  Sum_probs=148.5

Q ss_pred             CcceeecCCccccceecccCceEEEEEEECC-------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG-------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR  197 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  197 (303)
                      ..|.+..++|.+.+.||+|+||.||+|++.+       +.||||+++.....     ...+.+.+|+.+++.++||||++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~  114 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIVK  114 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEEE
Confidence            4577888999999999999999999999843       78999999754321     22367899999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeecCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 046106          198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----------------------NRSVPLKLAVKQALDVARGMAYVHRLG  255 (303)
Q Consensus       198 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~g  255 (303)
                      +++++.....+|+||||+++++|.+++....                      ...+++..++.++.||+.||+|||++|
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  194 (343)
T 1luf_A          115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK  194 (343)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999998642                      146899999999999999999999999


Q ss_pred             ceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC---CccCCCCCCcccCC
Q 046106          256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       256 iiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~---~~~~~~gt~~y~AP  303 (303)
                      |+||||||+|||++.++.+||+|||+++......   ......+|+.|+||
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  245 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  245 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecCh
Confidence            9999999999999999999999999997643322   12334678999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-32  Score=250.82  Aligned_cols=165  Identities=26%  Similarity=0.471  Sum_probs=142.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||.||+|++  +++.||||++.......     ..+.+.+|+.+++.++||||+++++++..+...|
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            5788889999999999999998  68899999997643321     1256889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999999998654  458999999999999999999999999999999999999999999999999998654322


Q ss_pred             ---CccCCCCCCcccCC
Q 046106          290 ---GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ---~~~~~~gt~~y~AP  303 (303)
                         .....+||+.|+||
T Consensus       160 ~~~~~~~~~gt~~y~aP  176 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAP  176 (323)
T ss_dssp             EECCBCSCCSCGGGSCH
T ss_pred             cccccCCCccCcCccCc
Confidence               23456899999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.9e-32  Score=240.25  Aligned_cols=170  Identities=29%  Similarity=0.468  Sum_probs=150.6

Q ss_pred             cceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .+.++.++|.+.+.||+|+||.||+|+++++.||||+++........    .+.+.+|+.++++++||||+++++++..+
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRK----SRDFNEECPRLRIFSHPNVLPVLGACQSP   79 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHH----HHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHH----HHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence            46778889999999999999999999999999999999876554432    25789999999999999999999999887


Q ss_pred             --CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          206 --MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       206 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                        ..+++||||+++++|.+++.......+++..++.++.|++.||+|||++|  ++||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~  159 (271)
T 3kmu_A           80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV  159 (271)
T ss_dssp             TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred             CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence              77899999999999999998765556899999999999999999999999  99999999999999999999999998


Q ss_pred             ceeeecCCCccCCCCCCcccCC
Q 046106          282 ARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +...    ......||+.|+||
T Consensus       160 ~~~~----~~~~~~~t~~y~aP  177 (271)
T 3kmu_A          160 KFSF----QSPGRMYAPAWVAP  177 (271)
T ss_dssp             CCTT----SCTTCBSCGGGSCH
T ss_pred             eeee----cccCccCCccccCh
Confidence            7542    22345789999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-32  Score=261.23  Aligned_cols=153  Identities=25%  Similarity=0.400  Sum_probs=124.3

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .|.+ .++|.+.+.||+|+||.||+|++  +++.||||++.........    .+.+.+|+.+|+.++||||+++++++.
T Consensus        48 ~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~  122 (458)
T 3rp9_A           48 DWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID----CKRILREIAILNRLNHDHVVKVLDIVI  122 (458)
T ss_dssp             SCCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cCcc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHH----HHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            4444 36899999999999999999987  6789999999765443322    357889999999999999999999994


Q ss_pred             cC-----CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          204 KP-----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       204 ~~-----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                      ..     ..+|+||||+ +++|.+++...  ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             CSCTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecc
Confidence            43     5689999998 57999999754  4689999999999999999999999999999999999999999999999


Q ss_pred             cCCceeee
Q 046106          279 FGVARIEV  286 (303)
Q Consensus       279 FGla~~~~  286 (303)
                      ||+|+...
T Consensus       200 FGla~~~~  207 (458)
T 3rp9_A          200 FGLARTVD  207 (458)
T ss_dssp             CTTCBCTT
T ss_pred             cccchhcc
Confidence            99998653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.5e-32  Score=263.23  Aligned_cols=171  Identities=28%  Similarity=0.513  Sum_probs=150.1

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .+...+|.+++.||+|+||.||+|++  +|+.||||++++...   ........+.+|+.+|+.++||||+++++++..+
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI---RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH---HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            34567889999999999999999998  688999999965211   1111235788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            9999999999999999999754  46899999999999999999999999999999999999999999999999999877


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      .........+||+.|+||
T Consensus       167 ~~~~~~~~~~gt~~y~aP  184 (476)
T 2y94_A          167 SDGEFLRTSCGSPNYAAP  184 (476)
T ss_dssp             CTTCCBCCCCSCSTTCCH
T ss_pred             cccccccccCCCcCeECh
Confidence            665556667899999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.6e-32  Score=257.78  Aligned_cols=167  Identities=24%  Similarity=0.378  Sum_probs=144.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|..  +++.+|+|++.........    .+.+.+|+.+|+.++||||+++++++.++...
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----HQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH----HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            35678889999999999999987  7899999999876543322    35788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc---CCCcEEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF---SDKSIKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~---~~~~vKl~DFGla~~~  285 (303)
                      |+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++   .++.+||+|||+|+..
T Consensus        86 ~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999999999875  4589999999999999999999999999999999999998   4578999999999865


Q ss_pred             ecCC-CccCCCCCCcccCC
Q 046106          286 VQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~-~~~~~~gt~~y~AP  303 (303)
                      .... .....+||+.|+||
T Consensus       164 ~~~~~~~~~~~gt~~Y~AP  182 (444)
T 3soa_A          164 EGEQQAWFGFAGTPGYLSP  182 (444)
T ss_dssp             CTTCCBCCCSCSCGGGCCH
T ss_pred             cCCCceeecccCCcccCCH
Confidence            5433 23456899999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.6e-32  Score=246.36  Aligned_cols=168  Identities=29%  Similarity=0.428  Sum_probs=141.4

Q ss_pred             ecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      -.++|++.+.||+|+||.||+|++ +++.||+|+++......    ...+.+.+|+.+++.++||||+++++++..+..+
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE----GIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC----------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc----hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            346788899999999999999998 78899999997543222    1235788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        95 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           95 TLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99999997 58988887653 45899999999999999999999999999999999999999999999999999865422


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       .......||+.|+||
T Consensus       173 ~~~~~~~~~t~~y~aP  188 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAP  188 (311)
T ss_dssp             CC---CCCCCCTTCCH
T ss_pred             cccccCCcccCCcCCH
Confidence             234455789999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.8e-32  Score=245.82  Aligned_cols=176  Identities=28%  Similarity=0.565  Sum_probs=150.6

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI  195 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni  195 (303)
                      ....|++..++|.+.+.||+|+||.||+|++       +++.||||+++.... .    ...+.+.+|+.+++.++||||
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~E~~~l~~l~hp~i   88 (314)
T 2ivs_A           14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-P----SELRDLLSEFNVLKQVNHPHV   88 (314)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-H----HHHHHHHHHHHHHTTCCCTTB
T ss_pred             CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-H----HHHHHHHHHHHHHhhCCCCce
Confidence            3467899999999999999999999999986       237899999975432 1    223678899999999999999


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN----------------------RSVPLKLAVKQALDVARGMAYVHR  253 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~  253 (303)
                      +++++++......++||||+++++|.+++.....                      ..+++..++.++.||+.||+|||+
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  168 (314)
T 2ivs_A           89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE  168 (314)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999986532                      237899999999999999999999


Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +||+||||||+|||++.++.+||+|||+++.......   .....+|+.|+||
T Consensus       169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  221 (314)
T 2ivs_A          169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI  221 (314)
T ss_dssp             TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH
T ss_pred             CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccCh
Confidence            9999999999999999999999999999986543322   2234578889998

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.98  E-value=2.9e-32  Score=245.60  Aligned_cols=177  Identities=30%  Similarity=0.495  Sum_probs=151.5

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCC
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHP  193 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp  193 (303)
                      +....|++..++|.+.+.||+|+||.||+|++       +++.||||+++......     ..+.+.+|+.+++++ +||
T Consensus        13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~   87 (313)
T 1t46_A           13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNHM   87 (313)
T ss_dssp             CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCT
T ss_pred             CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-----HHHHHHHHHHHHhhcccCC
Confidence            34467999999999999999999999999985       35789999997643321     236788999999999 899


Q ss_pred             CeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 046106          194 NIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN----------------RSVPLKLAVKQALDVARGMAYVHRLGLI  257 (303)
Q Consensus       194 niv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~gii  257 (303)
                      ||+++++++..+...++||||+++++|.+++.....                ..+++..++.++.||+.||+|||++||+
T Consensus        88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  167 (313)
T 1t46_A           88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI  167 (313)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             CeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            999999999999999999999999999999986542                2489999999999999999999999999


Q ss_pred             eCCCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          258 HRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       258 HrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||||||+|||++.++.+||+|||+++.......   .....||+.|+||
T Consensus       168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  216 (313)
T 1t46_A          168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (313)
T ss_dssp             CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeCh
Confidence            999999999999999999999999986544332   1233467889998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.98  E-value=8.4e-32  Score=243.77  Aligned_cols=169  Identities=23%  Similarity=0.288  Sum_probs=139.8

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHH-HcCCCCCeeeeeEEEEcC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML-ATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~~~~~~~  205 (303)
                      +-.++|++.++||+|+||.||+|++  +++.||||++..........    ..+..|+..+ +..+||||++++++|...
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR----ARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH----HHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            3346788999999999999999998  68899999987655443221    2344455554 445899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             CEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            9999999999 679999988754 56999999999999999999999999999999999999999999999999999876


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........||+.|+||
T Consensus       208 ~~~~~~~~~~gt~~y~aP  225 (311)
T 3p1a_A          208 GTAGAGEVQEGDPRYMAP  225 (311)
T ss_dssp             C------CCCCCGGGCCG
T ss_pred             ccCCCCcccCCCccccCH
Confidence            655555566899999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.98  E-value=9e-33  Score=254.01  Aligned_cols=176  Identities=28%  Similarity=0.546  Sum_probs=148.0

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCC
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPN  194 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn  194 (303)
                      ....|++..++|.+.+.||+|+||.||+|++       +++.||||+++......     ..+.+.+|+.++..+ +|||
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hpn   87 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLN   87 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-----HHHHHHHHHHHHHhhcCCcc
Confidence            4468999999999999999999999999985       34789999997643221     235789999999999 7899


Q ss_pred             eeeeeEEEEcCC-eEEEEEeecCCCCHHHHHHhcCC--------------------------------------------
Q 046106          195 IVRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQN--------------------------------------------  229 (303)
Q Consensus       195 iv~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~--------------------------------------------  229 (303)
                      |+++++++..+. .+++||||+++|+|.+++.....                                            
T Consensus        88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            999999998754 48999999999999999986532                                            


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          230 --------------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       230 --------------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                                          ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                                128899999999999999999999999999999999999999999999999998653322


Q ss_pred             C---ccCCCCCCcccCC
Q 046106          290 G---MTPETGTYRWMAP  303 (303)
Q Consensus       290 ~---~~~~~gt~~y~AP  303 (303)
                      .   .....||+.|+||
T Consensus       248 ~~~~~~~~~~t~~y~aP  264 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAP  264 (359)
T ss_dssp             TCEEC--CEECGGGCCH
T ss_pred             cchhccccCCCceeECh
Confidence            2   2234678899998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.98  E-value=3.2e-32  Score=241.88  Aligned_cols=171  Identities=31%  Similarity=0.561  Sum_probs=148.1

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ++|++..++|++.+.||+|+||.||+|.+ +++.||||+++......       +.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH-------HHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            68999999999999999999999999998 55689999997654332       46889999999999999999999987


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .+ ..++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        79 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           79 QE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (279)
T ss_dssp             SS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CC-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence            54 46899999999999999976543468999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCC--ccCCCCCCcccCC
Q 046106          284 IEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      .......  .....+|+.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aP  179 (279)
T 1qpc_A          158 LIEDNEYTAREGAKFPIKWTAP  179 (279)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCH
T ss_pred             cccCcccccccCCCCccCccCh
Confidence            7543321  2233567889998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.98  E-value=6.8e-33  Score=263.30  Aligned_cols=173  Identities=25%  Similarity=0.386  Sum_probs=138.7

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .+.+..++|.+.+.||+|+||.||+|+.  +++.||||+++.....   .......+.+|+.+++.++||||+++++++.
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~  218 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENRVLQNSRHPFLTALKYSFQ  218 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------CCCCCSCTTSCCEEEEEE
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh---hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence            4556678899999999999999999998  6889999999753111   1112356788999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ....+|+||||+++++|.+++...  ..+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|
T Consensus       219 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          219 THDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             ETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             eCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence            999999999999999999999865  468999999999999999999998 99999999999999999999999999999


Q ss_pred             eeee-cCCCccCCCCCCcccCC
Q 046106          283 RIEV-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~-~~~~~~~~~gt~~y~AP  303 (303)
                      +... ........+||+.|+||
T Consensus       297 ~~~~~~~~~~~~~~gt~~y~aP  318 (446)
T 4ejn_A          297 KEGIKDGATMKTFCGTPEYLAP  318 (446)
T ss_dssp             CTTCC-----CCSSSCGGGCCH
T ss_pred             eeccCCCcccccccCCccccCH
Confidence            8633 22334556899999998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.98  E-value=1.1e-31  Score=240.90  Aligned_cols=175  Identities=29%  Similarity=0.511  Sum_probs=146.3

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCee
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV  196 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv  196 (303)
                      ..+...+....|++.+.||+|+||.||+|++      +++.||||+++......     ..+.+.+|+.+++.++||||+
T Consensus        12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~   86 (302)
T 4e5w_A           12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-----HIADLKKEIEILRNLYHENIV   86 (302)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C-----CHHHHHHHHHHHHTCCCTTBC
T ss_pred             ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch-----hHHHHHHHHHHHHhCCCCCee
Confidence            3455566778899999999999999999984      67899999997543221     125788999999999999999


Q ss_pred             eeeEEEEcC--CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcE
Q 046106          197 RFIGACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI  274 (303)
Q Consensus       197 ~l~~~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~v  274 (303)
                      ++++++...  ..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~  165 (302)
T 4e5w_A           87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV  165 (302)
T ss_dssp             CEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCE
Confidence            999999876  66899999999999999997654 458999999999999999999999999999999999999999999


Q ss_pred             EEeccCCceeeecCCC----ccCCCCCCcccCC
Q 046106          275 KIADFGVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       275 Kl~DFGla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      ||+|||+++.......    .....||+.|+||
T Consensus       166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  198 (302)
T 4e5w_A          166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP  198 (302)
T ss_dssp             EECCCTTCEECCTTCCEEECCCCTTCCGGGCCH
T ss_pred             EECcccccccccCCCcceeccCCCCCCccccCC
Confidence            9999999987654332    2334688889998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.98  E-value=2.6e-32  Score=245.03  Aligned_cols=173  Identities=28%  Similarity=0.415  Sum_probs=140.4

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHH--------------------HHHHHHHHHHHHH
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEK--------------------AQVMEQQFQQEVM  185 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~--------------------~~~~~~~~~~E~~  185 (303)
                      .+..++|.+.+.||+|+||.||+|+.  +++.||||++.........                    .....+.+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            34567889999999999999999987  6889999999765432110                    0112356889999


Q ss_pred             HHHcCCCCCeeeeeEEEEc--CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 046106          186 MLATLKHPNIVRFIGACRK--PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKS  263 (303)
Q Consensus       186 il~~l~hpniv~l~~~~~~--~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp  263 (303)
                      +|+.++||||+++++++..  ...+|+||||+++++|.+++..   ..+++..+..++.||+.||+|||++||+||||||
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            9999999999999999986  5678999999999999876532   4689999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeccCCceeeecCC-CccCCCCCCcccCC
Q 046106          264 DNLLIFSDKSIKIADFGVARIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       264 ~NILv~~~~~vKl~DFGla~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      +|||++.++.+||+|||+++...... ......||+.|+||
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP  206 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAP  206 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCG
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccCh
Confidence            99999999999999999998654332 23455799999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=2.2e-32  Score=250.21  Aligned_cols=174  Identities=29%  Similarity=0.510  Sum_probs=146.9

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIV  196 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv  196 (303)
                      ..|+++.++|.+.+.||+|+||.||+|++       +++.||||+++.....     ...+.+.+|+.+++++ +||||+
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~iv  112 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-----SEREALMSELKMMTQLGSHENIV  112 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH-----HHHHHHHHHHHHHHhhcCCCCee
Confidence            57999999999999999999999999986       3458999999754321     1235788999999999 899999


Q ss_pred             eeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 046106          197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN---------------------RSVPLKLAVKQALDVARGMAYVHRLG  255 (303)
Q Consensus       197 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~g  255 (303)
                      ++++++.....+++||||+++++|.+++.....                     ..+++..++.++.||+.||+|||++|
T Consensus       113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  192 (344)
T 1rjb_A          113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  192 (344)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999986532                     23789999999999999999999999


Q ss_pred             ceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc---cCCCCCCcccCC
Q 046106          256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       256 iiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      |+||||||+||||+.++.+||+|||+++........   ....||+.|+||
T Consensus       193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  243 (344)
T 1rjb_A          193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  243 (344)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCH
Confidence            999999999999999999999999999865443321   223567889998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=4e-32  Score=239.31  Aligned_cols=170  Identities=29%  Similarity=0.580  Sum_probs=149.1

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      .|.++.++|++.+.||+|+||.||++.+ +++.||+|+++......       +.+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~   74 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLE   74 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH-------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH-------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            6889999999999999999999999998 77899999998654432       468899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus        75 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  153 (267)
T 3t9t_A           75 QAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF  153 (267)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             CCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence            989999999999999999998653 4689999999999999999999999999999999999999999999999999976


Q ss_pred             eecCC--CccCCCCCCcccCC
Q 046106          285 EVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~--~~~~~~gt~~y~AP  303 (303)
                      .....  ......+|+.|+||
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aP  174 (267)
T 3t9t_A          154 VLDDQYTSSTGTKFPVKWASP  174 (267)
T ss_dssp             BCCHHHHSTTSTTCCGGGCCH
T ss_pred             cccccccccccccccccccCh
Confidence            43221  12334577889998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.98  E-value=3.2e-32  Score=247.35  Aligned_cols=171  Identities=22%  Similarity=0.398  Sum_probs=148.3

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||+++.............+.+.+|+.+++.++||||+++++++.....+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            35678889999999999999998  6889999999876543221111125788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEeccCCcee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK----SIKIADFGVARI  284 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~----~vKl~DFGla~~  284 (303)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++    .+||+|||+++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            9999999999999999764  4689999999999999999999999999999999999999888    799999999987


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........||+.|+||
T Consensus       169 ~~~~~~~~~~~gt~~y~aP  187 (321)
T 2a2a_A          169 IEDGVEFKNIFGTPEFVAP  187 (321)
T ss_dssp             CCTTCCCCCCCSCGGGCCH
T ss_pred             cCccccccccCCCCCccCc
Confidence            6655555566899999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=6.5e-32  Score=245.15  Aligned_cols=167  Identities=26%  Similarity=0.445  Sum_probs=130.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++.......     .+.+.+|+.+++.++||||+++++++..+..+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----PSTAIREISLMKELKHENIVRLYDVIHTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-----CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-----HHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence            35788899999999999999987  688999999976543221     14677899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQ----NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      |+||||++ ++|.+++....    ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99999997 59999997543    13588999999999999999999999999999999999999999999999999986


Q ss_pred             eecC-CCccCCCCCCcccCC
Q 046106          285 EVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~-~~~~~~~gt~~y~AP  303 (303)
                      .... ......+||+.|+||
T Consensus       158 ~~~~~~~~~~~~~t~~y~aP  177 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAP  177 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCH
T ss_pred             cCCCcccCCCCcccccccCc
Confidence            5432 233455789999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.98  E-value=1.7e-31  Score=237.57  Aligned_cols=167  Identities=27%  Similarity=0.421  Sum_probs=147.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++.........    .+.+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHH----HHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            35788899999999999999998  5789999999865544322    35788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~---vKl~DFGla~~~  285 (303)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        81 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999999999876  45899999999999999999999999999999999999987655   999999999876


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........||+.|+||
T Consensus       159 ~~~~~~~~~~~~~~y~aP  176 (284)
T 3kk8_A          159 NDSEAWHGFAGTPGYLSP  176 (284)
T ss_dssp             CSSCBCCCSCSCGGGCCH
T ss_pred             ccCccccCCCCCcCCcCc
Confidence            655555667899999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.98  E-value=7e-32  Score=255.47  Aligned_cols=172  Identities=24%  Similarity=0.342  Sum_probs=143.8

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ...|.+ .++|.+.+.||+|+||.||+|++  +++.||||+++........    .+.+.+|+.+|+.++||||++++++
T Consensus        19 ~~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~   93 (432)
T 3n9x_A           19 IKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID----CKRILREITILNRLKSDYIIRLYDL   93 (432)
T ss_dssp             GGGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHH----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHH----HHHHHHHHHHHHHcCCCCcceEEEE
Confidence            344444 46889999999999999999998  6789999999765443322    3678899999999999999999999


Q ss_pred             EEcC-----CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          202 CRKP-----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       202 ~~~~-----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      +...     ..+|+||||+. ++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL  170 (432)
T 3n9x_A           94 IIPDDLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKV  170 (432)
T ss_dssp             CCCSCTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred             EecCCCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEE
Confidence            9765     56899999995 6999999764  46899999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCC-----------------------CccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTE-----------------------GMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~-----------------------~~~~~~gt~~y~AP  303 (303)
                      +|||+|+......                       ..+..+||+.|+||
T Consensus       171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  220 (432)
T 3n9x_A          171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP  220 (432)
T ss_dssp             CCCTTCEEC-------------------------------CCCCCTTCCH
T ss_pred             ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCH
Confidence            9999998754332                       13556899999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.98  E-value=5.9e-32  Score=262.62  Aligned_cols=172  Identities=23%  Similarity=0.302  Sum_probs=148.1

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +..++|.+.+.||+|+||+||+|++  +++.||||++++....   .....+.+.+|+.+|+.++||||+++++++....
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~---~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK---KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh---hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            4567888899999999999999998  6889999999652211   1111357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .+|+||||+++|+|.+++....  ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence            9999999999999999998643  34689999999999999999999999999999999999999999999999999987


Q ss_pred             eecCCC-ccCCCCCCcccCC
Q 046106          285 EVQTEG-MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~-~~~~~gt~~y~AP  303 (303)
                      ...... ....+||+.|+||
T Consensus       339 ~~~~~~~~~~~~GT~~Y~AP  358 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAP  358 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCH
T ss_pred             ccCCCcccccccCCccccCh
Confidence            654433 3345899999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.98  E-value=5.1e-32  Score=241.19  Aligned_cols=173  Identities=27%  Similarity=0.520  Sum_probs=136.0

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeee
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF  198 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l  198 (303)
                      ..+|++..++|++.+.||+|+||.||+|.+.     +..||+|+++....     ....+.+.+|+.+++.++||||+++
T Consensus         7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~   81 (281)
T 1mp8_A            7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-----DSVREKFLQEALTMRQFDHPHIVKL   81 (281)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-----HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-----HHHHHHHHHHHHHHHhCCCCccceE
Confidence            3568889999999999999999999999872     34699999865432     1233678999999999999999999


Q ss_pred             eEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       199 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                      ++++.. ...|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D  159 (281)
T 1mp8_A           82 IGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD  159 (281)
T ss_dssp             EEEECS-SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEEEcc-CccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECc
Confidence            999854 55789999999999999998653 4689999999999999999999999999999999999999999999999


Q ss_pred             cCCceeeecCCC--ccCCCCCCcccCC
Q 046106          279 FGVARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      ||+|+.......  .....+|+.|+||
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~aP  186 (281)
T 1mp8_A          160 FGLSRYMEDSTYYKASKGKLPIKWMAP  186 (281)
T ss_dssp             -------------------CCGGGCCH
T ss_pred             cccccccCcccccccccCCCcccccCh
Confidence            999987544332  2233567899998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.98  E-value=5.3e-32  Score=249.34  Aligned_cols=164  Identities=27%  Similarity=0.447  Sum_probs=128.8

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      -.++|.+.+.||+|+||.||+|++  +++.||||+++....        .+.+.+|+.+|+.++||||+++++++..+..
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTE  122 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh--------HHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence            346788899999999999999998  567899999976421        2467789999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---~~~vKl~DFGla~~  284 (303)
                      +++||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999999999764  45899999999999999999999999999999999999976   88999999999987


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........+||+.|+||
T Consensus       201 ~~~~~~~~~~~gt~~y~aP  219 (349)
T 2w4o_A          201 VEHQVLMKTVCGTPGYCAP  219 (349)
T ss_dssp             ------------CGGGSCH
T ss_pred             cCcccccccccCCCCccCH
Confidence            6555445566899999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.98  E-value=2.8e-32  Score=244.32  Aligned_cols=170  Identities=29%  Similarity=0.536  Sum_probs=140.6

Q ss_pred             ceeecCCccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      .++..++|++.+.||+|+||.||+|++      +++.||||+++...  .    ...+.+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~   78 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--E----EHLRDFEREIEILKSLQHDNIVKYKG   78 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--H----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--H----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            456778899999999999999999985      57899999997532  1    22357889999999999999999999


Q ss_pred             EEEcC--CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          201 ACRKP--MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       201 ~~~~~--~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                      ++...  ..+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             EECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEcc
Confidence            99653  45799999999999999998753 3589999999999999999999999999999999999999999999999


Q ss_pred             cCCceeeecCCC----ccCCCCCCcccCC
Q 046106          279 FGVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      ||+++.......    .....+|+.|+||
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aP  186 (295)
T 3ugc_A          158 FGLTKVLPQDKEFFKVKEPGESPIFWYAP  186 (295)
T ss_dssp             CCSCC-------------CTTCGGGGCCH
T ss_pred             CcccccccCCcceeeeccCCCCccceeCc
Confidence            999986543321    2234577889998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.98  E-value=3.5e-32  Score=252.90  Aligned_cols=171  Identities=30%  Similarity=0.513  Sum_probs=136.4

Q ss_pred             ceeecCCccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      .+++..+|.+.+.||+|+||.||+|++.     +..||||+++.....     ...+.+.+|+.+|++++||||++++++
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~  114 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-----KQRRDFLGEASIMGQFDHPNIIRLEGV  114 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4667789999999999999999999863     567999999764321     223679999999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +.....+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          115 VTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence            999999999999999999999998643 4689999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCC--cc--CCCCCCcccCC
Q 046106          282 ARIEVQTEG--MT--PETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~--~~--~~~gt~~y~AP  303 (303)
                      ++.......  ..  ...+|+.|+||
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aP  219 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSP  219 (373)
T ss_dssp             --------------------CTTSCH
T ss_pred             ccccccCCccceeccCCCcCCCccCh
Confidence            987543321  11  12356789998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.98  E-value=3.4e-31  Score=237.20  Aligned_cols=171  Identities=25%  Similarity=0.396  Sum_probs=151.1

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCC---ChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEc
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPEN---DPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRK  204 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~---~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~  204 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||+++....   .........+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            46788899999999999999998  678999999986542   23333445678899999999996 9999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ....++||||+++++|.+++...  ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            99999999999999999999875  4589999999999999999999999999999999999999999999999999987


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........||+.|+||
T Consensus       174 ~~~~~~~~~~~~~~~y~aP  192 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAP  192 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCH
T ss_pred             cCCCcccccccCCccccCH
Confidence            6655555666899999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.98  E-value=2.7e-32  Score=246.72  Aligned_cols=169  Identities=24%  Similarity=0.435  Sum_probs=137.8

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC-
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM-  206 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-  206 (303)
                      -.++|.+.+.||+|+||.||++++  +++.||||+++.......   .....+.+|+.+++.++||||+++++++.... 
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH---HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH---HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            356788999999999999999997  788999999987543322   22367889999999999999999999987643 


Q ss_pred             ---eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          207 ---VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       207 ---~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                         ..|+||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             CCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence               349999999999999999865  458999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCC----ccCCCCCCcccCC
Q 046106          284 IEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      .......    ....+||+.|+||
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aP  188 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSP  188 (311)
T ss_dssp             -----------------CCTTCCH
T ss_pred             cccccccccccccccCcCcccCCH
Confidence            6543221    2234689999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.98  E-value=1.5e-31  Score=237.23  Aligned_cols=164  Identities=26%  Similarity=0.421  Sum_probs=146.0

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|.+  ++..||+|.+.......      .+.+.+|+.+++.++||||+++++++......|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY   82 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence            4678889999999999999998  56689999997643322      257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccCCceeee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI---FSDKSIKIADFGVARIEV  286 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv---~~~~~vKl~DFGla~~~~  286 (303)
                      +||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999999999999865  458999999999999999999999999999999999999   788999999999998776


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      .........||+.|+||
T Consensus       161 ~~~~~~~~~~t~~y~aP  177 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSP  177 (277)
T ss_dssp             TTSCBCCCCSCTTTCCH
T ss_pred             CccchhccCCCCCccCh
Confidence            65556667899999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=5.7e-34  Score=260.44  Aligned_cols=168  Identities=21%  Similarity=0.251  Sum_probs=137.3

Q ss_pred             eecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChH--HHHHHHHHHHHHHHHHHcCC---------CCCeee
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPE--KAQVMEQQFQQEVMMLATLK---------HPNIVR  197 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~---------hpniv~  197 (303)
                      +..++|.+.+.||+|+||.||+|+++++.||||+++.......  ......+.+.+|+.+|+.++         ||||++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            4567899999999999999999999999999999986543200  00011246778888888775         888888


Q ss_pred             eeEEEE------------------------------cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q 046106          198 FIGACR------------------------------KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG  247 (303)
Q Consensus       198 l~~~~~------------------------------~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~  247 (303)
                      +.+++.                              ....+||||||+++|++.+.+..   ..+++..+..++.||+.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            877653                              26778999999999977666643   458999999999999999


Q ss_pred             HHHHH-hCCceeCCCCCCcEEEcCCC--------------------cEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          248 MAYVH-RLGLIHRDLKSDNLLIFSDK--------------------SIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       248 l~~LH-~~giiHrDlkp~NILv~~~~--------------------~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+||| ++||+||||||+||||+.++                    .+||+|||+|+.....    ..+||+.|+||
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            99999 99999999999999999987                    8999999999876532    34799999999

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.98  E-value=1e-31  Score=247.59  Aligned_cols=172  Identities=23%  Similarity=0.364  Sum_probs=143.2

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||+|++  +++.||||++........ .....+.+.+|+.+++.++||||+++++++..+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS-PGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS-SSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-ccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35788899999999999999998  688999999864210000 000125788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEeccCCce
Q 046106          209 CIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVAR  283 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~---vKl~DFGla~  283 (303)
                      |+||||+++++|.+++....  +..+++..+..++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            99999999999998886532  345899999999999999999999999999999999999987654   9999999998


Q ss_pred             eeecCCC-ccCCCCCCcccCC
Q 046106          284 IEVQTEG-MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~-~~~~~gt~~y~AP  303 (303)
                      ....... ....+||+.|+||
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aP  202 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAP  202 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCH
T ss_pred             EecCCCeeecCCcCCcCccCH
Confidence            7654332 3456899999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.98  E-value=2.7e-32  Score=252.95  Aligned_cols=174  Identities=28%  Similarity=0.457  Sum_probs=145.9

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR  197 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  197 (303)
                      +.+++..++|.+.+.||+|+||.||+|++       +++.||||+++......     ....+.+|+.+++.++||||++
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~  138 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-----DELDFLMEALIISKFNHQNIVR  138 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHHHCCCTTBCC
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-----hHHHHHHHHHHHHhCCCCCCCe
Confidence            34567788999999999999999999985       35689999996533221     2257889999999999999999


Q ss_pred             eeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC
Q 046106          198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN-----RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK  272 (303)
Q Consensus       198 l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~  272 (303)
                      +++++......|+||||+++++|.+++.....     ..+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus       139 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS
T ss_pred             EEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC
Confidence            99999999889999999999999999986532     3589999999999999999999999999999999999999554


Q ss_pred             ---cEEEeccCCceeeecCC---CccCCCCCCcccCC
Q 046106          273 ---SIKIADFGVARIEVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       273 ---~vKl~DFGla~~~~~~~---~~~~~~gt~~y~AP  303 (303)
                         .+||+|||+|+......   ......||+.|+||
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  255 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP  255 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred             CCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence               59999999997543322   12234678999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.98  E-value=9.5e-32  Score=245.51  Aligned_cols=178  Identities=31%  Similarity=0.542  Sum_probs=151.1

Q ss_pred             CCCCCcceeecCCccccceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-
Q 046106          121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-  190 (303)
Q Consensus       121 ~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-  190 (303)
                      .+....|++..++|.+.+.||+|+||.||+|++.         ++.||||+++.....     ...+.+.+|+.+++.+ 
T Consensus        24 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~   98 (334)
T 2pvf_A           24 LPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-----KDLSDLVSEMEMMKMIG   98 (334)
T ss_dssp             CCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-----HHHHHHHHHHHHHHHHC
T ss_pred             CCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-----HHHHHHHHHHHHHHHhh
Confidence            3455789999999999999999999999999863         457999999754321     2235788999999999 


Q ss_pred             CCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 046106          191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN--------------RSVPLKLAVKQALDVARGMAYVHRLGL  256 (303)
Q Consensus       191 ~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~gi  256 (303)
                      +||||+++++++.....+|+||||+++++|.+++.....              ..+++..++.++.||+.||+|||++||
T Consensus        99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  178 (334)
T 2pvf_A           99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC  178 (334)
T ss_dssp             CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            899999999999999999999999999999999986532              248899999999999999999999999


Q ss_pred             eeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          257 IHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       257 iHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +||||||+||||+.++.+||+|||+++.......   .....+|+.|+||
T Consensus       179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  228 (334)
T 2pvf_A          179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP  228 (334)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH
T ss_pred             eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeCh
Confidence            9999999999999999999999999986544322   2234578899998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.98  E-value=8.5e-32  Score=240.54  Aligned_cols=167  Identities=26%  Similarity=0.425  Sum_probs=139.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+++.  +++.||+|++........     .+.+.+|+.+++.++||||+++++++......|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            5678889999999999999998  578999999976543221     257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccCCcee
Q 046106          210 IVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI---FSDKSIKIADFGVARI  284 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv---~~~~~vKl~DFGla~~  284 (303)
                      +||||+++++|.+++...  ....+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+|+.
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999999998643  23568999999999999999999999999999999999999   4568899999999987


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........||+.|+||
T Consensus       177 ~~~~~~~~~~~~t~~y~aP  195 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAP  195 (285)
T ss_dssp             ----------CTTGGGCCH
T ss_pred             cCCcccCcCcccccCcCCh
Confidence            6655555666899999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.98  E-value=6.8e-32  Score=241.49  Aligned_cols=175  Identities=34%  Similarity=0.649  Sum_probs=138.4

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ...+.+++...+|.+.+.||+|+||.||+|++.+ .||||+++........    .+.+.+|+.+++.++||||++++++
T Consensus        14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHH----HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHH----HHHHHHHHHHHHhCCCCcEEEEEee
Confidence            3467889999999999999999999999998765 5999999776544332    3678899999999999999999997


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +. ...+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        89 ~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           89 ST-APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             EC-SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             cc-CCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence            64 445789999999999999997543 4689999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecC---CCccCCCCCCcccCC
Q 046106          282 ARIEVQT---EGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~---~~~~~~~gt~~y~AP  303 (303)
                      ++.....   .......||+.|+||
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aP  191 (289)
T 3og7_A          167 ATEKSRWSGSHQFEQLSGSILWMAP  191 (289)
T ss_dssp             -----------------CCCTTCCH
T ss_pred             ccccccccccccccccCCCccccCc
Confidence            9754321   223345789999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.98  E-value=7.1e-32  Score=252.19  Aligned_cols=166  Identities=20%  Similarity=0.369  Sum_probs=145.3

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|..  +++.||+|++.....      .....+.+|+.+|+.++||||+++++++.....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP------LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch------hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            35788899999999999999998  678999999976431      1124788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--CCcEEEeccCCceeee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS--DKSIKIADFGVARIEV  286 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~--~~~vKl~DFGla~~~~  286 (303)
                      ++||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+|+...
T Consensus       124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            9999999999999998754 246899999999999999999999999999999999999975  4789999999998766


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.|+||
T Consensus       203 ~~~~~~~~~gt~~y~aP  219 (387)
T 1kob_A          203 PDEIVKVTTATAEFAAP  219 (387)
T ss_dssp             TTSCEEEECSSGGGCCH
T ss_pred             CCcceeeeccCCCccCc
Confidence            55545556899999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=4.5e-32  Score=242.52  Aligned_cols=166  Identities=29%  Similarity=0.408  Sum_probs=139.2

Q ss_pred             CCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      ++|.+.+.||+|+||.||+|++ +++.||+|+++........    .+.+.+|+.+++.++||||+++++++..+..+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC----CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc----chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEE
Confidence            4688899999999999999998 5889999999765432211    2467799999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-C
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-E  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-~  289 (303)
                      ||||+++ +|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus        78 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            9999975 9999987643 46899999999999999999999999999999999999999999999999999764322 2


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......||+.|+||
T Consensus       156 ~~~~~~~t~~y~aP  169 (288)
T 1ob3_A          156 KYTHEIVTLWYRAP  169 (288)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccccccccccccCc
Confidence            23445789999998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=2.5e-31  Score=246.25  Aligned_cols=170  Identities=24%  Similarity=0.425  Sum_probs=150.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCC--ChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCC
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPEN--DPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPM  206 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~--~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~  206 (303)
                      .+|.+.+.||+|+||.||+|++  +|+.||||+++....  .........+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            5688889999999999999998  588999999987542  2333344457889999999999 7999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ..|+||||+++++|.+++...  ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            999999999999999999865  458999999999999999999999999999999999999999999999999998776


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.|+||
T Consensus       252 ~~~~~~~~~gt~~y~aP  268 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAP  268 (365)
T ss_dssp             TTCCBCCCCSCGGGCCH
T ss_pred             CCcccccCCCCCCccCh
Confidence            65556667899999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=7.7e-32  Score=239.68  Aligned_cols=170  Identities=24%  Similarity=0.449  Sum_probs=142.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||++++  +++.||+|+++.............+.+.+|+.+++.++||||+++++++..+...+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            4678889999999999999998  57899999998764432211111357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEeccCCceee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK----SIKIADFGVARIE  285 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~----~vKl~DFGla~~~  285 (303)
                      +||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++    .+||+|||++...
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            999999999999999865  4589999999999999999999999999999999999998877    8999999999876


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........||+.|+||
T Consensus       163 ~~~~~~~~~~~~~~y~aP  180 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAP  180 (283)
T ss_dssp             C--------CCCGGGCCH
T ss_pred             cCCCcccccCCCcCccCc
Confidence            554445556799999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=241.00  Aligned_cols=166  Identities=28%  Similarity=0.471  Sum_probs=139.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||.||+|++  +++.||||++........    ..+.+.+|+.+++.++||||+++++++......+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH   78 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH----HHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence            5788899999999999999998  588999999876554332    2357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999998898887754  458999999999999999999999999999999999999999999999999998755332


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       .....+||+.|+||
T Consensus       157 ~~~~~~~~~~~y~aP  171 (311)
T 4agu_A          157 DYYDDEVATRWYRSP  171 (311)
T ss_dssp             ---------GGGCCH
T ss_pred             cccCCCcCCccccCh
Confidence             23455789999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=1.1e-31  Score=258.13  Aligned_cols=166  Identities=28%  Similarity=0.426  Sum_probs=141.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|++  +++.||||++++.......    ...+.+|+.+|+.++||||+++++++.....+|
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT----THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH----HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            4688899999999999999998  6789999999865432221    257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccCCceeee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIEV  286 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---~~vKl~DFGla~~~~  286 (303)
                      +||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.+   +.+||+|||+|+...
T Consensus       113 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999999999865  458999999999999999999999999999999999999764   559999999998876


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.|+||
T Consensus       191 ~~~~~~~~~gt~~y~aP  207 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAP  207 (494)
T ss_dssp             TTBCBCCCCSCTTTCCH
T ss_pred             CCccccccCCCcCeeCH
Confidence            66556677899999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=3.3e-32  Score=247.25  Aligned_cols=176  Identities=32%  Similarity=0.526  Sum_probs=149.6

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ...++.+..++|.+.+.||+|+||.||+|++ +++.||||+++.......     ...+.+|+.+++.++||||++++++
T Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-----ELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-----CCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-----HHHHHHHHHHHHhccCCCccceEEE
Confidence            3456677788999999999999999999987 688999999976432211     1368899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCcEEEcCCCcEEE
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQN--RSVPLKLAVKQALDVARGMAYVHRL---GLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---giiHrDlkp~NILv~~~~~vKl  276 (303)
                      +..+...++||||+++++|.+++.....  ..+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            9999999999999999999999986532  3489999999999999999999999   9999999999999999999999


Q ss_pred             eccCCceeeecCCC--ccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      +|||+|+.......  .....||+.|+||
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP  204 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAP  204 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCH
T ss_pred             ccCccccccCcccccccccccCCcCccCH
Confidence            99999987543322  3344699999998

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=1.2e-31  Score=244.33  Aligned_cols=165  Identities=28%  Similarity=0.341  Sum_probs=143.6

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKP  205 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~  205 (303)
                      +...+|.+.+.||+|+||.||+|+.  +++.||||++......        +.+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   77 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--------PQLHLEYRFYKQLGSGDGIPQVYYFGPCG   77 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--------CCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence            3456889999999999999999996  7899999999765432        3577899999999 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc-----EEEeccC
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADFG  280 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~-----vKl~DFG  280 (303)
                      ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           78 KYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             CccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            9999999999 89999999865 356999999999999999999999999999999999999999887     9999999


Q ss_pred             CceeeecCCC--------ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~--------~~~~~gt~~y~AP  303 (303)
                      +|+.......        ....+||+.|+||
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  186 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSI  186 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccCh
Confidence            9987543322        2355799999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=2.6e-31  Score=241.87  Aligned_cols=161  Identities=24%  Similarity=0.422  Sum_probs=141.4

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv  211 (303)
                      +...+.||+|+||.||+|+.  +|+.||||++.......      .+.+.+|+.+++.++||||+++++++......++|
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            44556899999999999998  68899999997654332      24688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-C
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-G  290 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~  290 (303)
                      |||+++++|.+++..   ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus       121 ~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             ECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence            999999999999875   358999999999999999999999999999999999999999999999999998654432 2


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....||+.|+||
T Consensus       198 ~~~~~gt~~y~aP  210 (321)
T 2c30_A          198 RKSLVGTPYWMAP  210 (321)
T ss_dssp             BCCCCSCGGGCCH
T ss_pred             cccccCCccccCH
Confidence            3455899999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=8e-32  Score=244.09  Aligned_cols=176  Identities=27%  Similarity=0.463  Sum_probs=149.7

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI  195 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni  195 (303)
                      ..++|++..++|.+.+.||+|+||.||+|++.       ++.||||++......     .....+.+|+.+++.++||||
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i   90 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-----RERIEFLNEASVMKEFNCHHV   90 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-----HHHHHHHHHHHHGGGCCCTTB
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-----HHHHHHHHHHHHHHhcCCCCE
Confidence            45789999999999999999999999999863       568999999754322     123578899999999999999


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL  267 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NIL  267 (303)
                      +++++++......++||||+++++|.+++....        ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl  170 (322)
T 1p4o_A           91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM  170 (322)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred             eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence            999999999889999999999999999997532        135689999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          268 IFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       268 v~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |+.++.+||+|||+++.......   .....+|+.|+||
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  209 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  209 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccCh
Confidence            99999999999999976543321   1233568899998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=5.5e-32  Score=253.26  Aligned_cols=170  Identities=25%  Similarity=0.353  Sum_probs=145.9

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +...+|.+.+.||+|+||.||+|++  +++.||||+++......     ..+.+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-----PVDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-----hHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence            3456788899999999999999998  48899999997532211     1256779999999999999999999998754


Q ss_pred             --eEEEEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEecc
Q 046106          207 --VWCIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI----FSDKSIKIADF  279 (303)
Q Consensus       207 --~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv----~~~~~vKl~DF  279 (303)
                        ..|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence              67999999999999999986432 348999999999999999999999999999999999999    77788999999


Q ss_pred             CCceeeecCCCccCCCCCCcccCC
Q 046106          280 GVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+|+...........+||+.|+||
T Consensus       161 G~a~~~~~~~~~~~~~gt~~y~aP  184 (396)
T 4eut_A          161 GAARELEDDEQFVSLYGTEEYLHP  184 (396)
T ss_dssp             GGCEECCCGGGSSCSSSCCTTCCH
T ss_pred             CCceEccCCCccccccCCccccCH
Confidence            999877665555667899999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=9e-32  Score=250.20  Aligned_cols=161  Identities=24%  Similarity=0.401  Sum_probs=136.8

Q ss_pred             ccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 046106          136 MGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      ..+.||+|+||.||+|+.  +++.||+|+++....      ...+.+.+|+.+|+.++||||+++++++.....+++|||
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E  166 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM------KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME  166 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSH------HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            356799999999999998  688999999986432      123578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE--cCCCcEEEeccCCceeeecCCCc
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI--FSDKSIKIADFGVARIEVQTEGM  291 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv--~~~~~vKl~DFGla~~~~~~~~~  291 (303)
                      |+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+  +.++.+||+|||+|+........
T Consensus       167 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          167 YVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             CCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            999999999987543 458999999999999999999999999999999999999  56689999999999987665555


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      ...+||+.|+||
T Consensus       246 ~~~~gt~~y~aP  257 (373)
T 2x4f_A          246 KVNFGTPEFLAP  257 (373)
T ss_dssp             CCCCSSCTTCCH
T ss_pred             ccccCCCcEeCh
Confidence            666899999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=8.3e-32  Score=244.42  Aligned_cols=172  Identities=26%  Similarity=0.490  Sum_probs=146.8

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      +.....++|++.+.||+|+||.||+|++ +++.||||++.......      .+.+.+|+.+++.++||||+++++++..
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG------IEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH------HHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH------HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3344567899999999999999999998 57899999987654322      2578899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ....++||||+++++|.+++....  ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999999987543  235899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCC---CccCCCCCCcccCC
Q 046106          283 RIEVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~---~~~~~~gt~~y~AP  303 (303)
                      +......   ......||+.|+||
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aP  210 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDP  210 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCH
T ss_pred             cccccccccccccccCCCccccCH
Confidence            8643222   12334589999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=8.2e-32  Score=241.39  Aligned_cols=162  Identities=31%  Similarity=0.576  Sum_probs=137.6

Q ss_pred             ecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHc--CCCCCeeeeeEEEEc---
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT--LKHPNIVRFIGACRK---  204 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~---  204 (303)
                      -.++|.+.+.||+|+||.||+|+++++.||||++....         ...+.+|.+++..  ++||||+++++++..   
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---------EKSWFRETELYNTVMLRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence            35688899999999999999999999999999986421         1345566666666  799999999998754   


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCcEEEcCCCcEE
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH--------RLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~giiHrDlkp~NILv~~~~~vK  275 (303)
                       ...+|+||||+++++|.+++..   ..+++..++.++.|++.||+|||        ++||+||||||+|||++.++.+|
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence             3458999999999999999964   46899999999999999999999        99999999999999999999999


Q ss_pred             EeccCCceeeecCCC-----ccCCCCCCcccCC
Q 046106          276 IADFGVARIEVQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~~~-----~~~~~gt~~y~AP  303 (303)
                      |+|||+|+.......     ....+||+.|+||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  186 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP  186 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCH
T ss_pred             EeeCCCeeecccccccccccccccccccceeCh
Confidence            999999987554332     2334799999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=2.4e-31  Score=244.97  Aligned_cols=171  Identities=20%  Similarity=0.338  Sum_probs=148.8

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-----CCCe
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-----HPNI  195 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpni  195 (303)
                      .+....+-.++|.+.+.||+|+||.||+|++  +++.||||+++...       ...+.+..|+.+++.++     ||||
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-------KYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-------HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-------hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            4456667788999999999999999999998  77899999996421       12256778999999987     9999


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-----
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-----  270 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-----  270 (303)
                      +++++++......|+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.     
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence            99999999999999999999 899999999876567999999999999999999999999999999999999975     


Q ss_pred             --------------------CCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          271 --------------------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       271 --------------------~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                                          ++.+||+|||+|+....  ......||+.|+||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aP  228 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAP  228 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCc
Confidence                                78999999999986432  23456899999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=1.1e-31  Score=243.50  Aligned_cols=178  Identities=23%  Similarity=0.465  Sum_probs=132.7

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEEC--Ce---EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCee
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--GE---EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV  196 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv  196 (303)
                      .....+.+..++|.+.+.||+|+||.||+|++.  +.   .||||+++........    .+.+.+|+.+++.++||||+
T Consensus        13 ~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv   88 (323)
T 3qup_A           13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD----IEEFLREAACMKEFDHPHVA   88 (323)
T ss_dssp             ---CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH----HHHHHHHHHHHTTCCCTTBC
T ss_pred             HHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH----HHHHHHHHHHHHHCCCCcee
Confidence            345678888999999999999999999999872  22   7999999765433222    36788999999999999999


Q ss_pred             eeeEEEEcCCeE------EEEEeecCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcE
Q 046106          197 RFIGACRKPMVW------CIVTEYAKGGSVRQFLTKRQN----RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNL  266 (303)
Q Consensus       197 ~l~~~~~~~~~~------~iv~E~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NI  266 (303)
                      ++++++......      ++||||+++++|.+++.....    ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NI  168 (323)
T 3qup_A           89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNC  168 (323)
T ss_dssp             CCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             hhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceE
Confidence            999999877654      899999999999999975431    2589999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeccCCceeeecCCCc---cCCCCCCcccCC
Q 046106          267 LIFSDKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       267 Lv~~~~~vKl~DFGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      ||+.++.+||+|||+|+........   ....+|+.|+||
T Consensus       169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  208 (323)
T 3qup_A          169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL  208 (323)
T ss_dssp             EECTTSCEEECCCCC-----------------CCGGGCCH
T ss_pred             EEcCCCCEEEeeccccccccccccccccccccCcccccCc
Confidence            9999999999999999865433322   223567889998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=1.3e-31  Score=238.79  Aligned_cols=172  Identities=23%  Similarity=0.347  Sum_probs=135.4

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      |++..++|++.+.||+|+||.||++++  +++.||||+++......    ...+.+.++..+++.++||||+++++++..
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   77 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ----EQKRLLMDLDISMRTVDCPFTVTFYGALFR   77 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH----HHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence            567788999999999999999999998  78999999997643322    222455566667888999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +...++||||++ ++|.+++...  ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence            999999999996 5898887642  345799999999999999999999998 999999999999999999999999999


Q ss_pred             ceeeecCCCccCCCCCCcccCC
Q 046106          282 ARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+............||+.|+||
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aP  178 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAP  178 (290)
T ss_dssp             -------------CCCCCCSCH
T ss_pred             cccccccccccccCCCccccCh
Confidence            9876655545556899999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=2.6e-31  Score=256.16  Aligned_cols=171  Identities=24%  Similarity=0.447  Sum_probs=144.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChH-------HHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPE-------KAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~-------~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      .++|.+.+.||+|+||.||+|+.  +++.||||+++.......       ......+.+.+|+.+|+.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            45788899999999999999998  578999999987543211       001123678899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEec
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK---SIKIAD  278 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~---~vKl~D  278 (303)
                      +..+..+|+||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            99999999999999999999999875  4589999999999999999999999999999999999998876   699999


Q ss_pred             cCCceeeecCCCccCCCCCCcccCC
Q 046106          279 FGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ||+|+...........+||+.|+||
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aP  217 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAP  217 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCH
T ss_pred             CCCCEEcCCCCccccccCCcCCCCH
Confidence            9999887666556677899999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=5.3e-32  Score=248.05  Aligned_cols=171  Identities=22%  Similarity=0.361  Sum_probs=146.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHH--HHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEK--AQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||+++........  .....+.+.+|+.+++.++||||+++++++....
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            35788889999999999999987  7889999999876432110  0001135678999999999999999999999999


Q ss_pred             eEEEEEeecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 VWCIVTEYAKGG-SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 ~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      .+++||||+.+| +|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            999999999766 999999764  45899999999999999999999999999999999999999999999999999877


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      .........+||+.|+||
T Consensus       181 ~~~~~~~~~~gt~~y~aP  198 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAP  198 (335)
T ss_dssp             CTTCCBCEECSCGGGCCH
T ss_pred             CCCCceeccCCCccccCh
Confidence            665555566899999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=1.4e-31  Score=237.74  Aligned_cols=162  Identities=28%  Similarity=0.513  Sum_probs=143.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-----  204 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----  204 (303)
                      .+|.+.+.||+|+||.||+|++  +++.||+|+++...          ..+.+|+.+++.++||||+++++++..     
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            4678889999999999999998  58899999997643          245689999999999999999998854     


Q ss_pred             -----------CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc
Q 046106          205 -----------PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS  273 (303)
Q Consensus       205 -----------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~  273 (303)
                                 ...+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC
Confidence                       345799999999999999998765567999999999999999999999999999999999999999999


Q ss_pred             EEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          274 IKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       274 vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +||+|||+++............||+.|+||
T Consensus       161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aP  190 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSP  190 (284)
T ss_dssp             EEECCCTTCEESSCCSCCCCCCSCCTTSCH
T ss_pred             EEECcchhheeccccccccccCCcccccCh
Confidence            999999999876655555566799999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=9.3e-32  Score=257.04  Aligned_cols=164  Identities=26%  Similarity=0.364  Sum_probs=135.8

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  205 (303)
                      .++|++++.||+|+||.||+|.+  +++.||||++.......    ...+.+.+|+.+|+.++||||+++++++...   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  136 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ----THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL  136 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh----HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence            57899999999999999999987  68899999998653322    2236788999999999999999999999654   


Q ss_pred             ---CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          206 ---MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       206 ---~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                         ..+|+||||+++ +|.+.+..    .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus       137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence               357999999965 67777643    4899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +........+..+||+.|+||
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aP  232 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAP  232 (464)
T ss_dssp             -----CCCC----CCCTTCCH
T ss_pred             eecCCCcccCCCcccccccCH
Confidence            877655556677899999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=2.1e-31  Score=240.30  Aligned_cols=173  Identities=28%  Similarity=0.477  Sum_probs=140.3

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC---CCCCeeeeeEEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL---KHPNIVRFIGACR  203 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~  203 (303)
                      +..++|++.+.||+|+||.||+|++  +++.||||+++......... .....+.+|+.+++.+   +||||+++++++.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGG-GLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSS-CCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccc-ccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            3456889999999999999999996  78899999997543211100 0012455677766665   4999999999997


Q ss_pred             cCC-----eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          204 KPM-----VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       204 ~~~-----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                      ...     .+++||||+. ++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            754     5799999996 6999999877655699999999999999999999999999999999999999999999999


Q ss_pred             cCCceeeecCCCccCCCCCCcccCC
Q 046106          279 FGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ||+|+...........+||+.|+||
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aP  188 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAP  188 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCH
T ss_pred             CccccccCCCcccCCccccccccCc
Confidence            9999876555555667899999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=9.3e-32  Score=244.96  Aligned_cols=175  Identities=30%  Similarity=0.530  Sum_probs=149.1

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEEC--C-----eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCe
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--G-----EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNI  195 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpni  195 (303)
                      .+.|++..++|.+.+.||+|+||.||+|++.  +     ..||+|+++......     ..+.+.+|+.+++.+ +||||
T Consensus        38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~~i  112 (333)
T 2i1m_A           38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-----EKEALMSELKIMSHLGQHENI  112 (333)
T ss_dssp             CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH-----HHHHHHHHHHHHHhhcCCCCe
Confidence            4579999999999999999999999999973  2     379999997644221     235788999999999 89999


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKS  263 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp  263 (303)
                      +++++++..+..+++||||+++++|.+++....            ...+++..++.++.||+.||+|||++||+||||||
T Consensus       113 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  192 (333)
T 2i1m_A          113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA  192 (333)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             eeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence            999999999999999999999999999997542            24579999999999999999999999999999999


Q ss_pred             CcEEEcCCCcEEEeccCCceeeecCCCc---cCCCCCCcccCC
Q 046106          264 DNLLIFSDKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       264 ~NILv~~~~~vKl~DFGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      +|||++.++.+||+|||+++........   ....||+.|+||
T Consensus       193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  235 (333)
T 2i1m_A          193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP  235 (333)
T ss_dssp             GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH
T ss_pred             ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCH
Confidence            9999999999999999999865433321   223467889998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=1.6e-31  Score=250.71  Aligned_cols=161  Identities=24%  Similarity=0.392  Sum_probs=129.3

Q ss_pred             CCcccc-ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHH-HcCCCCCeeeeeEEEEc---
Q 046106          132 RKLNMG-DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML-ATLKHPNIVRFIGACRK---  204 (303)
Q Consensus       132 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~~~~~~---  204 (303)
                      ++|.+. +.||+|+||+||++.+  +++.||||+++..           ..+.+|+.++ +..+||||+++++++..   
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            345554 6899999999999998  6789999999641           2456788877 45689999999999865   


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccC
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFG  280 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---~~~vKl~DFG  280 (303)
                       ...+||||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             567899999999999999998765556999999999999999999999999999999999999998   7899999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|+...........+||+.|+||
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aP  232 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAP  232 (400)
T ss_dssp             TCEECC-----------CTTCCG
T ss_pred             cccccCCCCccccCCCCCCccCH
Confidence            99876555555667899999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=7e-32  Score=239.73  Aligned_cols=170  Identities=29%  Similarity=0.549  Sum_probs=140.8

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ...|.+..++|++.+.||+|+||.||+++++++.||||+++....        .+.+.+|+.+++.++||||+++++++.
T Consensus        13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (278)
T 1byg_A           13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIV   84 (278)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH--------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            357889999999999999999999999999999999999975431        257889999999999999999999976


Q ss_pred             cC-CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          204 KP-MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       204 ~~-~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .. ...++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence            54 46899999999999999998654334789999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +.....  .....+|+.|+||
T Consensus       165 ~~~~~~--~~~~~~~~~y~aP  183 (278)
T 1byg_A          165 KEASST--QDTGKLPVKWTAP  183 (278)
T ss_dssp             -------------CCTTTSCH
T ss_pred             cccccc--ccCCCccccccCH
Confidence            754432  2234678899998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2.2e-31  Score=248.17  Aligned_cols=165  Identities=27%  Similarity=0.427  Sum_probs=131.1

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCC-
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPM-  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~-  206 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.........    .+.+.+|+.++..+. ||||+++++++..+. 
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD----AQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHH----HHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            45788899999999999999988  6889999999765443322    357789999999997 999999999997644 


Q ss_pred             -eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 -VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                       .+|+||||++ ++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence             6899999996 699999876   35899999999999999999999999999999999999999999999999999864


Q ss_pred             ec----------------------CCCccCCCCCCcccCC
Q 046106          286 VQ----------------------TEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~----------------------~~~~~~~~gt~~y~AP  303 (303)
                      ..                      ....+..+||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP  199 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCH
Confidence            32                      1123345799999998

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=1.6e-31  Score=236.18  Aligned_cols=170  Identities=39%  Similarity=0.728  Sum_probs=134.6

Q ss_pred             eeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      +++..+|.+.+.||+|+||.||+|.++++.||||+++......  .....+.+.+|+.+++.++||||+++++++..+..
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDED--ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCccc--HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            4567889999999999999999999999999999987643221  11223578899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCcEEEcC--------CCcEEE
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG---LIHRDLKSDNLLIFS--------DKSIKI  276 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g---iiHrDlkp~NILv~~--------~~~vKl  276 (303)
                      .++||||+++++|.+++..   ..+++..++.++.|++.||+|||++|   |+||||||+|||++.        ++.+||
T Consensus        81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            9999999999999999864   46899999999999999999999999   999999999999986        678999


Q ss_pred             eccCCceeeecCCCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|||+++...... .....||+.|+||
T Consensus       158 ~Dfg~~~~~~~~~-~~~~~~~~~y~aP  183 (271)
T 3dtc_A          158 TDFGLAREWHRTT-KMSAAGAYAWMAP  183 (271)
T ss_dssp             CCCCC--------------CCGGGSCH
T ss_pred             ccCCccccccccc-ccCCCCccceeCH
Confidence            9999998654333 3345799999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=2.5e-31  Score=235.59  Aligned_cols=171  Identities=28%  Similarity=0.511  Sum_probs=139.4

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      .+..++|.+.+.||+|+||.||+|++  +++.||||++.....   ......+.+.+|+.+++.++||||+++++++..+
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP   83 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc---cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            45567899999999999999999998  588999999864211   1111235788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...++||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            9999999999999999999865  35899999999999999999999999999999999999999999999999999876


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~y~aP  179 (276)
T 2h6d_A          162 SDGEFLRTSCGSPNYAAP  179 (276)
T ss_dssp             CC-------------CCT
T ss_pred             CCCcceecccCCccccCH
Confidence            554444556789999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=5.8e-31  Score=242.50  Aligned_cols=164  Identities=29%  Similarity=0.467  Sum_probs=143.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      +.|.+.+.||+|+||.||+|+.  +++.||||++........   ...+.+.+|+.+++.++||||+++++++..+...|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence            4577888999999999999997  788999999987544332   22367889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+. |+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus       131 lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            9999996 68988887543 5689999999999999999999999999999999999999999999999999976432  


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                       ....+||+.|+||
T Consensus       207 -~~~~~gt~~y~aP  219 (348)
T 1u5q_A          207 -ANSFVGTPYWMAP  219 (348)
T ss_dssp             -BCCCCSCGGGCCH
T ss_pred             -CCcccCCcceeCH
Confidence             2345799999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=8.8e-32  Score=258.26  Aligned_cols=167  Identities=28%  Similarity=0.479  Sum_probs=142.9

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||++.+......    ....+.+|+.+|+.++||||+++++++.....+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK----DTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch----HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            35788889999999999999998  688999999864321111    125788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc---CCCcEEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF---SDKSIKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~---~~~~vKl~DFGla~~~  285 (303)
                      |+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+   .++.+||+|||+|+..
T Consensus        97 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999999999875  4589999999999999999999999999999999999995   4567999999999876


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      .........+||+.|+||
T Consensus       175 ~~~~~~~~~~gt~~y~aP  192 (486)
T 3mwu_A          175 QQNTKMKDRIGTAYYIAP  192 (486)
T ss_dssp             CCC----CCTTGGGGCCG
T ss_pred             CCCCccCCCcCCCCCCCH
Confidence            655555667899999998

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=4.1e-31  Score=234.58  Aligned_cols=165  Identities=27%  Similarity=0.409  Sum_probs=141.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~  208 (303)
                      .+|++.+.||+|+||.||+|++  +++.||||+++........    ...+.+|+.++..+ +||||+++++++..+..+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH----HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH----HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            5678889999999999999998  6889999999876443322    25778899999998 899999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---------------
Q 046106          209 CIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---------------  271 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---------------  271 (303)
                      ++||||+++++|.+++....  ...+++..++.++.||+.||+|||++||+||||||+|||++.+               
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999999998642  2468999999999999999999999999999999999999844               


Q ss_pred             ----CcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          272 ----KSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       272 ----~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                          ..+||+|||++......   ....||+.|+||
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aP  199 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLAN  199 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCH
T ss_pred             cCCceEEEEcccccccccCCc---cccCCCccccCh
Confidence                47999999999865432   334699999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=7.5e-31  Score=234.91  Aligned_cols=168  Identities=26%  Similarity=0.343  Sum_probs=146.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||++.+  +++.||+|++........   ...+.+.+|+.+++.++||||+++++++......
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH---HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            45788899999999999999998  578999999976543322   2236788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999999998765  45899999999999999999999999999999999999999999999999999875432


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       .......||+.|+||
T Consensus       169 ~~~~~~~~~~~~y~aP  184 (294)
T 2rku_A          169 GERKKVLCGTPNYIAP  184 (294)
T ss_dssp             TCCBCCCCSCCSSCCH
T ss_pred             ccccccccCCCCcCCc
Confidence             223445789999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=8.3e-32  Score=258.12  Aligned_cols=170  Identities=26%  Similarity=0.456  Sum_probs=148.1

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +-.++|++.+.||+|+||.||+|+.  +++.||||++.+........   .+.+.+|+.+|++++||||+++++++....
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   99 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESLLREVQLLKQLDHPNIMKLYEFFEDKG   99 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC---HHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH---HHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            3446788899999999999999998  68899999997654332111   257889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccCCce
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI---FSDKSIKIADFGVAR  283 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv---~~~~~vKl~DFGla~  283 (303)
                      .+|+||||+.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999999999765  468999999999999999999999999999999999999   567899999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........+||+.|+||
T Consensus       178 ~~~~~~~~~~~~gt~~y~aP  197 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAP  197 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCH
T ss_pred             EcccccccccCCCCccccCc
Confidence            76655555556899999998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.3e-31  Score=243.01  Aligned_cols=169  Identities=22%  Similarity=0.332  Sum_probs=142.6

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC--CCeeeeeEEEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH--PNIVRFIGACR  203 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~  203 (303)
                      .++..++|.+.+.||+|+||.||++.. +++.||||++.........    .+.+.+|+.+|+.++|  |||+++++++.
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   79 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT----LDSYRNEIAYLNKLQQHSDKIIRLYDYEI   79 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHH----HHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence            456677899999999999999999987 6789999999876544322    3578899999999986  99999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .+..+|+|||+ .+++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+ ++.+||+|||+|+
T Consensus        80 ~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           80 TDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             CSSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             eCCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence            99999999995 478999999875  4689999999999999999999999999999999999996 6889999999998


Q ss_pred             eeecCCC---ccCCCCCCcccCC
Q 046106          284 IEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      .......   ....+||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aP  178 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPP  178 (343)
T ss_dssp             CC------------CCCCSSCCH
T ss_pred             ccCcccccccCCCCcCCcCcCCH
Confidence            6543322   2345799999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=1.7e-31  Score=265.93  Aligned_cols=173  Identities=27%  Similarity=0.337  Sum_probs=145.4

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGAC  202 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~  202 (303)
                      ...+...+|++++.||+|+||+||+|++  +++.||||++++....   .....+.+..|..++..+ +||+|+++++++
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~  411 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI---QDDDVECTMVEKRVLALPGKPPFLTQLHSCF  411 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH---HTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence            3455678899999999999999999998  6778999999752110   011124677899999987 699999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .+...+||||||+++|+|.+++...  ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|
T Consensus       412 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          412 QTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             BCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence            9999999999999999999999875  45899999999999999999999999999999999999999999999999999


Q ss_pred             eeee-cCCCccCCCCCCcccCC
Q 046106          283 RIEV-QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~-~~~~~~~~~gt~~y~AP  303 (303)
                      +... ........+||+.|+||
T Consensus       490 ~~~~~~~~~~~~~~GT~~Y~AP  511 (674)
T 3pfq_A          490 KENIWDGVTTKTFCGTPDYIAP  511 (674)
T ss_dssp             EECCCTTCCBCCCCSCSSSCCH
T ss_pred             eccccCCcccccccCCCcccCH
Confidence            8643 23344567899999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=7e-31  Score=240.13  Aligned_cols=168  Identities=26%  Similarity=0.343  Sum_probs=146.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||++++  +++.||+|++........   ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP---HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            45788899999999999999998  577999999976543221   2236788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999999998865  45899999999999999999999999999999999999999999999999999875432


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       .......||+.|+||
T Consensus       195 ~~~~~~~~gt~~y~aP  210 (335)
T 2owb_A          195 GERKKVLCGTPNYIAP  210 (335)
T ss_dssp             TCCBCCCCSCCSSCCH
T ss_pred             cccccccCCCccccCH
Confidence             233445799999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=2.7e-31  Score=236.02  Aligned_cols=169  Identities=29%  Similarity=0.458  Sum_probs=142.0

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      ...++|.+.+.||+|+||.||+|.+  +++.||+|++.....   ........+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL---EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   82 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc---chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence            3457888999999999999999998  567899999864221   11112357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ..++||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999999999876  458999999999999999999999999999999999999999999999999986543


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      .. ......||+.|+||
T Consensus       161 ~~-~~~~~~~~~~y~aP  176 (279)
T 3fdn_A          161 SS-RRTDLCGTLDYLPP  176 (279)
T ss_dssp             --------CCCCTTCCH
T ss_pred             cc-cccccCCCCCccCH
Confidence            32 23445789999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=9.2e-32  Score=253.76  Aligned_cols=170  Identities=26%  Similarity=0.380  Sum_probs=134.1

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCCh--HHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDP--EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~--~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.+.....  .........+.+|+.+|++++||||+++++++..+ 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            46788999999999999999998  67899999997643211  11111223578999999999999999999998654 


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEeccCCce
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK---SIKIADFGVAR  283 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~---~vKl~DFGla~  283 (303)
                      .+|+||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||++.++   .+||+|||+|+
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            478999999999999988754  4689999999999999999999999999999999999997654   59999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........+||+.|+||
T Consensus       291 ~~~~~~~~~~~~gt~~y~aP  310 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAP  310 (419)
T ss_dssp             SCC-----------CTTCCT
T ss_pred             ecCCCccccccCCCCCccCc
Confidence            76655555667899999999

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=4.1e-31  Score=234.60  Aligned_cols=169  Identities=30%  Similarity=0.492  Sum_probs=133.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||++.....   ......+.+.+|+.+++.++||||+++++++......
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM---YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh---hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            35688889999999999999997  788999999964211   0111135788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999998643 46899999999999999999999999999999999999999999999999999865432


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......||+.|+||
T Consensus       166 ~~~~~~~~~~~~y~aP  181 (278)
T 3cok_A          166 HEKHYTLCGTPNYISP  181 (278)
T ss_dssp             ----------------
T ss_pred             CCcceeccCCCCcCCc
Confidence            2 23345789999998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=6.2e-31  Score=244.87  Aligned_cols=166  Identities=25%  Similarity=0.458  Sum_probs=138.9

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      ++....+|.+.+.||+|+||.||+|++  +++.||||++.....          ...+|+.+|+.++||||+++++++..
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----------~~~~E~~il~~l~hpnIv~l~~~~~~   71 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----------YKNRELDIMKVLDHVNIIKLVDYFYT   71 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----------hHHHHHHHHHHcCCCCccchhheeee
Confidence            455677899999999999999999998  788999999876432          22379999999999999999999844


Q ss_pred             --------------------------------------CCeEEEEEeecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHH
Q 046106          205 --------------------------------------PMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDV  244 (303)
Q Consensus       205 --------------------------------------~~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi  244 (303)
                                                            ...+++||||++ ++|.+.+..  ..+..+++..+..++.||
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi  150 (383)
T 3eb0_A           72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQL  150 (383)
T ss_dssp             C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred             cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHH
Confidence                                                  334889999997 588888764  334679999999999999


Q ss_pred             HHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          245 ARGMAYVHRLGLIHRDLKSDNLLIF-SDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       245 ~~~l~~LH~~giiHrDlkp~NILv~-~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +.||+|||++||+||||||+|||++ .++.+||+|||+|+............||+.|+||
T Consensus       151 ~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP  210 (383)
T 3eb0_A          151 FRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP  210 (383)
T ss_dssp             HHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred             HHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence            9999999999999999999999998 6899999999999977666556667899999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.97  E-value=5.9e-31  Score=239.41  Aligned_cols=170  Identities=32%  Similarity=0.529  Sum_probs=141.2

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeE--EEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEE--VAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACR  203 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  203 (303)
                      ++.++|++.+.||+|+||.||+|++  ++..  +|+|.++......     ..+.+.+|+.+++++ +||||+++++++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   96 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGACE   96 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-----HHHHHHHHHHHHHhccCCCchhhhceeee
Confidence            4567888899999999999999987  5664  5999987533221     125788999999999 8999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF  269 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~  269 (303)
                      ....+|+||||+++++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG  176 (327)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence            9999999999999999999998642              24689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          270 SDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       270 ~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .++.+||+|||+++............+|+.|+||
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aP  210 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI  210 (327)
T ss_dssp             GGGCEEECCTTCEESSCEECCC----CCTTTCCH
T ss_pred             CCCeEEEcccCcCccccccccccCCCCCccccCh
Confidence            9999999999999754433333445678899998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9e-31  Score=233.80  Aligned_cols=172  Identities=27%  Similarity=0.543  Sum_probs=145.0

Q ss_pred             CcceeecCCccccc-eecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          125 DEWTIDLRKLNMGD-AFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       125 ~~~~i~~~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      +.|.+..+++.+.+ .||+|+||.||+|.+    +++.||||+++.....     ...+.+.+|+.+++.++||||++++
T Consensus         2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~   76 (287)
T 1u59_A            2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----ADTEEMMREAQIMHQLDNPYIVRLI   76 (287)
T ss_dssp             CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-----hHHHHHHHHHHHHHhCCCCCEeEEE
Confidence            35677788888877 999999999999986    5678999999765321     2236788999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +++.. ...++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           77 GVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             EEEES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred             EEecC-CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcc
Confidence            99954 4579999999999999999754 346899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCC----ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      |+++.......    .....+|+.|+||
T Consensus       155 g~~~~~~~~~~~~~~~~~~~~~~~y~aP  182 (287)
T 1u59_A          155 GLSKALGADDSYYTARSAGKWPLKWYAP  182 (287)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCH
T ss_pred             cceeeeccCcceeeccccccccccccCH
Confidence            99987543322    2233568899998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=3.7e-31  Score=235.77  Aligned_cols=172  Identities=25%  Similarity=0.425  Sum_probs=146.3

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      ...+..++|.+.+.||+|+||.||+|++  +++.||||++......   .....+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A            8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE---KEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc---hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            3445567889999999999999999998  5789999998642111   1111357889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      .....++||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            999999999999999999999875  358999999999999999999999999999999999999999999999999997


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ..... ......||+.|+||
T Consensus       163 ~~~~~-~~~~~~~~~~y~aP  181 (284)
T 2vgo_A          163 HAPSL-RRRTMCGTLDYLPP  181 (284)
T ss_dssp             ECSSS-CBCCCCSCGGGCCH
T ss_pred             cCccc-ccccccCCCCcCCH
Confidence            64432 23455799999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=1.2e-30  Score=234.92  Aligned_cols=167  Identities=31%  Similarity=0.485  Sum_probs=142.3

Q ss_pred             cccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          135 NMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      ..++.||+|+||.||+|.++++.||||++........  ....+.+.+|+.+++.++||||+++++++......++||||
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT--EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT--TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ccCCccccCCCeEEEEEEECCceEEEEEEecccCcch--HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            3457899999999999999999999999976432111  11236788999999999999999999999999899999999


Q ss_pred             cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC---
Q 046106          215 AKGGSVRQFLTKRQ-NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---  290 (303)
Q Consensus       215 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---  290 (303)
                      +++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            99999999997533 34689999999999999999999999999999999999999999999999999986543221   


Q ss_pred             ccCCCCCCcccCC
Q 046106          291 MTPETGTYRWMAP  303 (303)
Q Consensus       291 ~~~~~gt~~y~AP  303 (303)
                      .....||+.|+||
T Consensus       192 ~~~~~g~~~y~aP  204 (307)
T 2nru_A          192 TSRIVGTTAYMAP  204 (307)
T ss_dssp             CSSCCSCGGGCCH
T ss_pred             ccccCCCcCcCCh
Confidence            2334789999998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=8.1e-31  Score=243.18  Aligned_cols=164  Identities=27%  Similarity=0.362  Sum_probs=132.1

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM--  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--  206 (303)
                      .++|.+.+.||+|+||.||+|..  +++.||||++........    ..+.+.+|+.+++.++||||+++++++....  
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----HHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----HHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence            46889999999999999999987  688999999986544332    2357889999999999999999999997654  


Q ss_pred             ----eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          207 ----VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       207 ----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                          .+|+||||++ ++|.+++..    .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus       100 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          100 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence                7899999996 588888863    4899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +...........+||+.|+||
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aP  195 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAP  195 (371)
T ss_dssp             ---------------CTTCCH
T ss_pred             cccccccccCCceecCCccCH
Confidence            876554445566899999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=1.3e-30  Score=236.64  Aligned_cols=168  Identities=33%  Similarity=0.542  Sum_probs=141.8

Q ss_pred             eeecCCccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      .+..+.|++.+.||+|+||.||++.+      +++.||||+++.... .    ...+.+.+|+.+++.++||||++++++
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~----~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-P----QHRSGWKQEIDILRTLYHEHIIKYKGC  101 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-H----HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-h----HHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence            34445568899999999999999875      578899999976432 1    223678899999999999999999999


Q ss_pred             EEc--CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          202 CRK--PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       202 ~~~--~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +..  ...+++||||+++++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df  178 (318)
T 3lxp_A          102 CEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF  178 (318)
T ss_dssp             EEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred             EecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence            987  46789999999999999999764   4899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCC----ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      |+++.......    .....||+.|+||
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aP  206 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAP  206 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCH
T ss_pred             cccccccccccccccccCCCCCceeeCh
Confidence            99987654322    2234678889998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=7.4e-31  Score=239.30  Aligned_cols=169  Identities=24%  Similarity=0.453  Sum_probs=141.3

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      ...++|++.+.||+|+||.||+|++  +++.||||++........    ..+.+.+|+.+++.++||||+++++++....
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchH----HHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            3466888899999999999999998  588999999977654432    2356789999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++...
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            999999999988888776543  458999999999999999999999999999999999999999999999999997654


Q ss_pred             cC-CCccCCCCCCcccCC
Q 046106          287 QT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~-~~~~~~~gt~~y~AP  303 (303)
                      .. .......||+.|+||
T Consensus       176 ~~~~~~~~~~~t~~y~aP  193 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAP  193 (331)
T ss_dssp             --------CCCCCTTCCH
T ss_pred             CCccccCCCcCCccccCc
Confidence            32 233456799999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=7.8e-31  Score=245.20  Aligned_cols=170  Identities=21%  Similarity=0.312  Sum_probs=143.3

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC--CCCeeeeeEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK--HPNIVRFIGAC  202 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~  202 (303)
                      ...+...+|.+.+.||+|+||.||++.. +++.||||++........    ..+.+.+|+.+|+.++  ||||+++++++
T Consensus        50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~  125 (390)
T 2zmd_A           50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ----TLDSYRNEIAYLNKLQQHSDKIIRLYDYE  125 (390)
T ss_dssp             CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHH----HHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence            3455566799999999999999999987 678999999987654432    2367889999999997  59999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ..+..+|+|||+ .+++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|
T Consensus       126 ~~~~~~~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          126 ITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             ECSSEEEEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             ecCCEEEEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            999999999994 578999999875  3688999999999999999999999999999999999995 689999999999


Q ss_pred             eeeecCC---CccCCCCCCcccCC
Q 046106          283 RIEVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~---~~~~~~gt~~y~AP  303 (303)
                      +......   .....+||+.|+||
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aP  225 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPP  225 (390)
T ss_dssp             CCC---------CCSCCCGGGCCH
T ss_pred             ccccCCCccccCCCCCcCCCccCh
Confidence            8654332   12455899999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=3e-31  Score=241.98  Aligned_cols=167  Identities=25%  Similarity=0.419  Sum_probs=134.5

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ..++|.+.+.||+|+||.||+|++  +++.||||+++......    ...+.+.+|+.+++.++||||+++++++..+..
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE----GVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc----ccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            356788899999999999999987  78899999997654322    123567799999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-----CCCcEEEeccCCc
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF-----SDKSIKIADFGVA  282 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~-----~~~~vKl~DFGla  282 (303)
                      +|+||||++ ++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+     .++.+||+|||+|
T Consensus       108 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          108 LHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999999997 5999999875  3589999999999999999999999999999999999994     4556999999999


Q ss_pred             eeeecC-CCccCCCCCCcccCC
Q 046106          283 RIEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      +..... ......+||+.|+||
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPP  206 (329)
T ss_dssp             HHHC-----------CCTTCCH
T ss_pred             cccCCcccccCCCcCCccccCH
Confidence            765422 233455789999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=1.3e-30  Score=235.43  Aligned_cols=164  Identities=27%  Similarity=0.401  Sum_probs=135.8

Q ss_pred             CCcccc-ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCe
Q 046106          132 RKLNMG-DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMV  207 (303)
Q Consensus       132 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~  207 (303)
                      +.|.+. +.||+|+||.||+|++  +++.||||+++......      .+.+.+|+.++.++ +||||+++++++..+..
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~   85 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI------RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR   85 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh------HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            355653 6799999999999987  68899999997654322      24788999999885 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~---vKl~DFGla~~  284 (303)
                      +|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            99999999999999999875  45899999999999999999999999999999999999988765   99999999875


Q ss_pred             eecCC--------CccCCCCCCcccCC
Q 046106          285 EVQTE--------GMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~--------~~~~~~gt~~y~AP  303 (303)
                      .....        .....+||+.|+||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  190 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAP  190 (316)
T ss_dssp             ------------------CCSGGGCCH
T ss_pred             cccCCccccccccccccccCCcCccCh
Confidence            43211        12234699999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=9.8e-31  Score=236.21  Aligned_cols=178  Identities=24%  Similarity=0.478  Sum_probs=140.0

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCee
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV  196 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv  196 (303)
                      .....+.++.++|.+.+.||+|+||.||+|++     +++.||+|+++........    .+.+.+|+.+++.++||||+
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv   99 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE----IEEFLSEAACMKDFSHPNVI   99 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH----HHHHHHHHHHHHTCCCTTBC
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH----HHHHHHHHHHHhcCCCCCee
Confidence            44678889999999999999999999999986     2348999999765544322    35788999999999999999


Q ss_pred             eeeEEEEcCC-----eEEEEEeecCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEE
Q 046106          197 RFIGACRKPM-----VWCIVTEYAKGGSVRQFLTKR----QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLL  267 (303)
Q Consensus       197 ~l~~~~~~~~-----~~~iv~E~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NIL  267 (303)
                      ++++++....     ..++||||+++++|.+++...    ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       100 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIl  179 (313)
T 3brb_A          100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM  179 (313)
T ss_dssp             CCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEE
T ss_pred             eeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence            9999997754     359999999999999999532    2356899999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          268 IFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       268 v~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ++.++.+||+|||+++.......   .....+++.|+||
T Consensus       180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  218 (313)
T 3brb_A          180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  218 (313)
T ss_dssp             ECTTSCEEECSCSCC----------------CCGGGSCH
T ss_pred             EcCCCcEEEeecCcceecccccccCcccccCCCccccCc
Confidence            99999999999999986543321   2233567889998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=1.6e-31  Score=238.27  Aligned_cols=166  Identities=24%  Similarity=0.460  Sum_probs=142.0

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CC-------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeee
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NG-------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF  198 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l  198 (303)
                      ++..++|.+.+.||+|+||.||+|++  ++       ..||+|++......      ..+.+.+|+.+++.++||||+++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~   77 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN------YSESFFEAASMMSKLSHKHLVLN   77 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG------GHHHHHHHHHHHHTSCCTTBCCE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH------HHHHHHHHHHHHHhCCCCCEeEE
Confidence            46678899999999999999999987  33       57999998653211      22578899999999999999999


Q ss_pred             eEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc-----
Q 046106          199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----  273 (303)
Q Consensus       199 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~-----  273 (303)
                      ++++..+...++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.     
T Consensus        78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           78 YGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             EEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred             EEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccc
Confidence            999999988999999999999999998653 34899999999999999999999999999999999999999887     


Q ss_pred             ---EEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          274 ---IKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       274 ---vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                         +||+|||++......   ....||+.|+||
T Consensus       157 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aP  186 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLPK---DILQERIPWVPP  186 (289)
T ss_dssp             CCEEEECCCCSCTTTSCH---HHHHHTTTTSCH
T ss_pred             cceeeeccCcccccccCc---cccCCcCcccCH
Confidence               999999998643221   223578889998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=7.4e-31  Score=239.32  Aligned_cols=156  Identities=26%  Similarity=0.436  Sum_probs=124.5

Q ss_pred             cceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEe
Q 046106          137 GDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      .+.||+|+||.||+|.+  +++.||||++....         ...+.+|+.+++.+. ||||+++++++.++...|+|||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            36799999999999998  57899999996421         246778999999997 9999999999999999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC---cEEEeccCCceeeecCC-
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK---SIKIADFGVARIEVQTE-  289 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~---~vKl~DFGla~~~~~~~-  289 (303)
                      |+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++   .+||+|||+|+...... 
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            99999999999875  4689999999999999999999999999999999999998765   89999999998654332 


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      .....+||+.|+||
T Consensus       165 ~~~~~~~t~~y~aP  178 (325)
T 3kn6_A          165 PLKTPCFTLHYAAP  178 (325)
T ss_dssp             --------------
T ss_pred             cccccCCCcCccCH
Confidence            23456789999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=3.9e-31  Score=240.94  Aligned_cols=167  Identities=32%  Similarity=0.557  Sum_probs=136.0

Q ss_pred             CcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHH--HHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM--LATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~i--l~~l~hpniv~l~~~~  202 (303)
                      ..+.++.++|++.+.||+|+||.||+|+++++.||||+++....         +.+..|.++  +..++||||+++++.+
T Consensus         6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---------~~~~~e~~~~~~~~~~h~~i~~~~~~~   76 (336)
T 3g2f_A            6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---------QNFINEKNIYRVPLMEHDNIARFIVGD   76 (336)
T ss_dssp             ---CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---------HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cCCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---------hhHHHHHHHHHHHhccCcchhhheecc
Confidence            35567788999999999999999999999999999999964221         233444444  4558999999999865


Q ss_pred             Ec-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeCCCCCCcEEE
Q 046106          203 RK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL---------GLIHRDLKSDNLLI  268 (303)
Q Consensus       203 ~~-----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------giiHrDlkp~NILv  268 (303)
                      ..     ...+++||||+++++|.+++...   ..++..++.++.||+.||+|||+.         ||+||||||+||||
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill  153 (336)
T 3g2f_A           77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV  153 (336)
T ss_dssp             EEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred             cccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence            42     33678999999999999999764   358999999999999999999999         99999999999999


Q ss_pred             cCCCcEEEeccCCceeeecCC---------CccCCCCCCcccCC
Q 046106          269 FSDKSIKIADFGVARIEVQTE---------GMTPETGTYRWMAP  303 (303)
Q Consensus       269 ~~~~~vKl~DFGla~~~~~~~---------~~~~~~gt~~y~AP  303 (303)
                      +.++.+||+|||+|+......         .....+||+.|+||
T Consensus       154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (336)
T 3g2f_A          154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP  197 (336)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCH
T ss_pred             cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCc
Confidence            999999999999998654321         12244799999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7.4e-31  Score=243.39  Aligned_cols=167  Identities=26%  Similarity=0.436  Sum_probs=138.0

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .|++ .++|.+.+.||+|+||.||+|.+  +++.||||++.......    ...+.+.+|+.+|+.++||||+++++++.
T Consensus        20 ~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   94 (367)
T 1cm8_A           20 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE----LFAKRAYRELRLLKHMRHENVIGLLDVFT   94 (367)
T ss_dssp             EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH----HHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             eeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH----HHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence            3444 46789999999999999999998  68899999997654332    22367889999999999999999999997


Q ss_pred             cCC------eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          204 KPM------VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       204 ~~~------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                      ...      .+|+||||+ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A           95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             cCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEE
Confidence            653      459999999 7899999976   358999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||+|+....  ..+..+||+.|+||
T Consensus       171 Dfg~a~~~~~--~~~~~~~t~~y~aP  194 (367)
T 1cm8_A          171 DFGLARQADS--EMTGYVVTRWYRAP  194 (367)
T ss_dssp             CCTTCEECCS--SCCSSCSCGGGCCT
T ss_pred             eeeccccccc--ccCcCcCCCCcCCH
Confidence            9999986542  34556899999999

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=8.7e-31  Score=237.68  Aligned_cols=172  Identities=26%  Similarity=0.477  Sum_probs=143.2

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGA  201 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~  201 (303)
                      ..+.....+|++.+.||+|+||.||+|++  +++.||||++.......       ..+.+|+.+++.+ +||||++++++
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-------EEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT-------HHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH-------HHHHHHHHHHHhccCCCCeeeeeeE
Confidence            44555678899999999999999999998  78899999997654332       4678999999998 79999999999


Q ss_pred             EEc------CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 046106          202 CRK------PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       202 ~~~------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vK  275 (303)
                      +..      ...+|+||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEE
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEE
Confidence            976      46789999999999999999876556789999999999999999999999999999999999999999999


Q ss_pred             EeccCCceeeecCC-CccCCCCCCcccCC
Q 046106          276 IADFGVARIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      |+|||++....... ......||+.|+||
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aP  198 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAP  198 (326)
T ss_dssp             ECCCTTTC-------------CCGGGCCH
T ss_pred             EeeCcCceecCcCccccccccCCccccCh
Confidence            99999997654322 23345789999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7.9e-31  Score=239.72  Aligned_cols=172  Identities=27%  Similarity=0.461  Sum_probs=140.6

Q ss_pred             cceeecCCccccceecccCceEEEEEEEC------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYN------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      .+++...+|.+.+.||+|+||.||+|.+.      +..||||+++.....     .....+.+|+.+++.++||||++++
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~  112 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-----KQRVDFLGEAGIMGQFSHHNIIRLE  112 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-----HHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            35778889999999999999999999872      235999999754321     1235788999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +++......++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df  191 (333)
T 1mqb_A          113 GVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF  191 (333)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCC
Confidence            99999999999999999999999998643 46899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCC----ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      |+++.......    .....+|+.|+||
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aP  219 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAP  219 (333)
T ss_dssp             CC-----------------CCCGGGSCH
T ss_pred             CcchhhccccccccccCCCCccccccCc
Confidence            99986543321    1223467889998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=1e-30  Score=233.95  Aligned_cols=172  Identities=32%  Similarity=0.588  Sum_probs=141.2

Q ss_pred             CcceeecCCccccc-eecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          125 DEWTIDLRKLNMGD-AFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       125 ~~~~i~~~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      .++.++.++|.+.+ .||+|+||.||+|.+    .++.||||+++......    ...+.+.+|+.+++.++||||++++
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~   84 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----ALKDELLAEANVMQQLDNPYIVRMI   84 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH----HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            46677888898888 999999999999965    35789999997653322    2236789999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +++. ...+++||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus        85 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           85 GICE-AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             EEEE-SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEC-CCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccC
Confidence            9994 45678999999999999999874  45899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCC----ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      |+++.......    .....+|+.|+||
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aP  189 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAP  189 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCH
T ss_pred             CcceeeccCCCcccccccCCCCceeeCh
Confidence            99986544332    1223567889998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=1.1e-30  Score=237.58  Aligned_cols=168  Identities=28%  Similarity=0.489  Sum_probs=143.7

Q ss_pred             eecCCccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +..++|++.+.||+|+||.||++++      +++.||||++.....      ...+.+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP------DQQRDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH------HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH------HHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence            4567888999999999999999985      567999999976421      1235788999999999999999999998


Q ss_pred             E--cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          203 R--KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       203 ~--~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      .  ....+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||||+.++.+||+|||
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           94 YGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             ECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             ecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence            7  4566899999999999999998643 358999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCC----ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      +++.......    .....||+.|+||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAP  199 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCH
T ss_pred             cceecccCCccceeeccCCccccccCH
Confidence            9987543322    2334678889998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=1.1e-30  Score=240.20  Aligned_cols=161  Identities=25%  Similarity=0.419  Sum_probs=138.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~  207 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++++....          ..+|++++.++ +||||+++++++.++..
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   90 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----------PTEEIEILLRYGQHPNIITLKDVYDDGKY   90 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----------CHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence            35678889999999999999998  6889999999875432          23577888777 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC----CcEEEeccCCce
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD----KSIKIADFGVAR  283 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~----~~vKl~DFGla~  283 (303)
                      +|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+.++    +.+||+|||+|+
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999999999764  468999999999999999999999999999999999998543    359999999998


Q ss_pred             eeecC-CCccCCCCCCcccCC
Q 046106          284 IEVQT-EGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~-~~~~~~~gt~~y~AP  303 (303)
                      ..... ......+||+.|+||
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aP  189 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAP  189 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCH
T ss_pred             cCcCCCCceeccCCCccccCH
Confidence            75443 234456899999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=1.2e-30  Score=237.11  Aligned_cols=160  Identities=18%  Similarity=0.397  Sum_probs=142.1

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEc--
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRK--  204 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~--  204 (303)
                      ..++|++.+.||+|+||.||+|++  +++.||||+++...         .+.+.+|+.+++.++ ||||+++++++..  
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~  104 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPV  104 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence            457889999999999999999987  77899999997432         146889999999997 9999999999987  


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccCCce
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVAR  283 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl~DFGla~  283 (303)
                      ....++||||+++++|.+++..     +++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus       105 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          105 SRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             TCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            5678999999999999988853     78999999999999999999999999999999999999776 89999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ............||+.|+||
T Consensus       180 ~~~~~~~~~~~~~~~~y~aP  199 (330)
T 3nsz_A          180 FYHPGQEYNVRVASRYFKGP  199 (330)
T ss_dssp             ECCTTCCCCSCCSCGGGCCH
T ss_pred             EcCCCCccccccccccccCh
Confidence            77665556667899999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=1.4e-31  Score=239.85  Aligned_cols=174  Identities=26%  Similarity=0.410  Sum_probs=129.2

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..|.+..++|.+.+.||+|+||.||+|++  +++.||||++......     ...+.+.+|+.+++.++||||+++++++
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-----TSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------CCCCCCCTTBCCEEEEE
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-----hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            46888899999999999999999999986  6789999998653321     1235788999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKR------QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      ......++||||+++++|.+++...      ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence            9999999999999999999999742      2345899999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCC------CccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTE------GMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~------~~~~~~gt~~y~AP  303 (303)
                      +|||++.......      ......||+.|+||
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP  195 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCH
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCH
Confidence            9999987543221      12334789999998

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=4.2e-31  Score=240.84  Aligned_cols=168  Identities=25%  Similarity=0.510  Sum_probs=135.9

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +...+|++.+.||+|+||.||+|++  +++    +||+|.++.....     ...+.+.+|+.++++++||||++++++|
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~   86 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----KANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH-----HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            4567889999999999999999997  444    4688877543221     1235788999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ..+. .++|+||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        87 ~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             ESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             ecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence            9876 578999999999999998754 46899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCc---cCCCCCCcccCC
Q 046106          283 RIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      +........   ....+|+.|+||
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aP  188 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCH
T ss_pred             eEccCCcccccccCCCccccccCh
Confidence            865433221   223568899998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=5.2e-31  Score=242.85  Aligned_cols=169  Identities=26%  Similarity=0.399  Sum_probs=145.8

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      .++..++|.+.+.||+|+||.||++++  +++.||+|+++.....     ...+.+.+|+.+++.++||||+++++++..
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-----AIRNQIIRELQVLHECNSPYIVGFYGAFYS  102 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-----HHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence            345567889999999999999999998  5889999999865321     223678999999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      +..+|+||||+++++|.+++...  ..+++..+..++.|++.||+|||+. ||+||||||+||||+.++.+||+|||+++
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             CCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            99999999999999999999875  3589999999999999999999996 99999999999999999999999999997


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ..... ......||+.|+||
T Consensus       181 ~~~~~-~~~~~~gt~~y~aP  199 (360)
T 3eqc_A          181 QLIDS-MANSFVGTRSYMSP  199 (360)
T ss_dssp             HHHHH-C----CCCCTTCCH
T ss_pred             ccccc-cccCCCCCCCeECH
Confidence            54332 23445799999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=2.7e-30  Score=231.16  Aligned_cols=166  Identities=25%  Similarity=0.346  Sum_probs=143.9

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  204 (303)
                      .+..++|.+.+.||+|+||.||+|++  +++.||||++......        +.+.+|+.+++.+ +||+++++++++..
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~   77 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQE   77 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--------HHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence            45567899999999999999999996  7899999999764432        3567899999999 79999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc-----EEEecc
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS-----IKIADF  279 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~-----vKl~DF  279 (303)
                      ....++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.     +||+||
T Consensus        78 ~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           78 GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             CceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            99999999999 999999998653 46899999999999999999999999999999999999987765     999999


Q ss_pred             CCceeeecCCC--------ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~--------~~~~~gt~~y~AP  303 (303)
                      |+|+.......        .....||+.|+||
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  187 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSI  187 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCc
Confidence            99987654322        2345799999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=1.2e-30  Score=232.51  Aligned_cols=171  Identities=30%  Similarity=0.562  Sum_probs=144.3

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHH-HHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQ-VMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      ++..++|++.+.||+|+||.||+|++  +++.||||++........... ...+.+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            45567889999999999999999998  678999999976544322211 112578899999999999999999999977


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEcCCCc-----EEEe
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIFSDKS-----IKIA  277 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~~~~~-----vKl~  277 (303)
                      ..  ++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|  |+||||||+|||++.++.     +||+
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            66  69999999999999987643 46899999999999999999999999  999999999999988776     9999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||+|+....  ......||+.|+||
T Consensus       172 Dfg~~~~~~~--~~~~~~g~~~y~aP  195 (287)
T 4f0f_A          172 DFGLSQQSVH--SVSGLLGNFQWMAP  195 (287)
T ss_dssp             CCTTCBCCSS--CEECCCCCCTTSCG
T ss_pred             CCCccccccc--cccccCCCccccCc
Confidence            9999975332  34456799999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=2.1e-30  Score=231.58  Aligned_cols=167  Identities=31%  Similarity=0.509  Sum_probs=143.0

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc---
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK---  204 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---  204 (303)
                      +...|.+.+.||+|+||.||+|.+  ++..||+|++.........    .+.+.+|+.+++.++||||+++++++..   
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH----HHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            445678888999999999999998  5678999999865544322    3678899999999999999999999865   


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEc-CCCcEEEeccC
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIF-SDKSIKIADFG  280 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~-~~~~vKl~DFG  280 (303)
                       ...+++||||+++++|.+++...  ..+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence             45689999999999999999875  45899999999999999999999999  99999999999997 78999999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ++...... ......||+.|+||
T Consensus       178 ~~~~~~~~-~~~~~~~t~~y~aP  199 (290)
T 1t4h_A          178 LATLKRAS-FAKAVIGTPEFMAP  199 (290)
T ss_dssp             GGGGCCTT-SBEESCSSCCCCCG
T ss_pred             Cccccccc-ccccccCCcCcCCH
Confidence            99754332 33445799999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2.4e-30  Score=232.61  Aligned_cols=165  Identities=30%  Similarity=0.496  Sum_probs=145.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .+.|.+.+.||+|+||.||+|++  +++.||||++........     .+.+.+|+.+++.++||||+++++++.....+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            35688899999999999999987  678999999986543322     25788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++++|.+++..   ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999999999865   45899999999999999999999999999999999999999999999999999875543


Q ss_pred             C-CccCCCCCCcccCC
Q 046106          289 E-GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~-~~~~~~gt~~y~AP  303 (303)
                      . ......||+.|+||
T Consensus       173 ~~~~~~~~~~~~y~aP  188 (303)
T 3a7i_A          173 QIKRNTFVGTPFWMAP  188 (303)
T ss_dssp             BCCBCCCCSCGGGCCH
T ss_pred             ccccCccCCCcCccCH
Confidence            3 23445789999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9.5e-31  Score=238.07  Aligned_cols=162  Identities=29%  Similarity=0.507  Sum_probs=136.3

Q ss_pred             ecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC--CCCCeeeeeEEEEcC--
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL--KHPNIVRFIGACRKP--  205 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~~~~~~~--  205 (303)
                      -.++|++.+.||+|+||.||+|+++++.||||++....    .     ..+.+|.+++..+  +||||+++++++...  
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE----E-----ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG----H-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc----c-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            34678899999999999999999999999999986421    1     2344556666554  899999999999877  


Q ss_pred             --CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCcEEEcCCCcEE
Q 046106          206 --MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL--------GLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       206 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------giiHrDlkp~NILv~~~~~vK  275 (303)
                        ..+|+||||+++++|.+++...   .+++..++.++.|++.||+|||++        ||+||||||+|||++.++.+|
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence              6889999999999999999763   589999999999999999999999        999999999999999999999


Q ss_pred             EeccCCceeeecCCCc-----cCCCCCCcccCC
Q 046106          276 IADFGVARIEVQTEGM-----TPETGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~~~~-----~~~~gt~~y~AP  303 (303)
                      |+|||+|+........     ...+||+.|+||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  215 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP  215 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCH
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeCh
Confidence            9999999765433221     245799999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=1e-30  Score=232.62  Aligned_cols=172  Identities=25%  Similarity=0.495  Sum_probs=142.8

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      ..|.+..++|.+.+.||+|+||.||+|++.     +..||+|+++.....     ...+.+.+|+.+++.++||||++++
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~   79 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-----DNKEKFMSEAVIMKNLDHPHIVKLI   79 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-----HHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-----hHHHHHHHHHHHHHhCCCCCcceEE
Confidence            357788899999999999999999999862     236999999764321     1236788999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +++..+. .|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           80 GIIEEEP-TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             EEECSSS-CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             EEEcCCC-CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence            9987654 589999999999999998653 45899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCC--ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      |+++.......  .....+|+.|+||
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~y~aP  183 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASVTRLPIKWMSP  183 (281)
T ss_dssp             CGGGCC---------CCCCCGGGCCH
T ss_pred             CCCcccccccccccccCCCCcceeCc
Confidence            99986543322  2334578899998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.1e-31  Score=247.81  Aligned_cols=171  Identities=22%  Similarity=0.388  Sum_probs=143.7

Q ss_pred             eecCCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGAC  202 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~  202 (303)
                      +...+|++.+.||+|+||.||+++.     +++.||||+++........  ...+.+.+|+.+|+.+ +||||+++++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh--hHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            4457888999999999999999987     6789999998653210000  0013566799999999 699999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .....+++||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999999999875  35899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCC--CccCCCCCCcccCC
Q 046106          283 RIEVQTE--GMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~--~~~~~~gt~~y~AP  303 (303)
                      +......  .....+||+.|+||
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aP  229 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAP  229 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCH
T ss_pred             eecccCCCCcccCcccCcCccCh
Confidence            8654322  22345799999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.97  E-value=1.1e-30  Score=234.05  Aligned_cols=168  Identities=28%  Similarity=0.486  Sum_probs=141.8

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||+|++  +++.||||+++......    ...+.+.+|+.++++++||||+++++++..+...
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   77 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccch----hhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCce
Confidence            45788889999999999999998  68899999987543221    1125678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+. ++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        78 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  156 (299)
T 2r3i_A           78 YLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  156 (299)
T ss_dssp             EEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             EEEEEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence            99999997 69999998765567899999999999999999999999999999999999999999999999999765332


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       .......||+.|+||
T Consensus       157 ~~~~~~~~~~~~y~aP  172 (299)
T 2r3i_A          157 VRTYTHEVVTLWYRAP  172 (299)
T ss_dssp             SBCTTSCBCCCTTCCH
T ss_pred             ccccCcccccccccCc
Confidence             223445789999998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=1e-30  Score=240.15  Aligned_cols=168  Identities=26%  Similarity=0.420  Sum_probs=141.5

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC--
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP--  205 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--  205 (303)
                      ...+|.+.+.||+|+||.||+|++  +++.||||++.........    ...+.+|+.+++.++||||+++++++...  
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF----PITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS----CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc----hHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            346888999999999999999998  6789999998665433221    14677899999999999999999999763  


Q ss_pred             ------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          206 ------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       206 ------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                            ..+|+||||++ ++|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus        91 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             ------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence                  46899999996 48888887543 46899999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecC-----CCccCCCCCCcccCC
Q 046106          280 GVARIEVQT-----EGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~-----~~~~~~~gt~~y~AP  303 (303)
                      |+|+.....     ......+||+.|+||
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPP  197 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred             hhcccccccccccccccCCcccccCccCc
Confidence            999865421     223445789999998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=1.4e-30  Score=235.47  Aligned_cols=168  Identities=20%  Similarity=0.345  Sum_probs=138.6

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||++++  +++.||||++.......   ....+.+.+|+.+++.++||||+++++++..+..+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            46788889999999999999997  68899999997543221   22346788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999999865  45899999999999999999999999999999999999999999999999999765433


Q ss_pred             C--CccCCCCCCcccCC
Q 046106          289 E--GMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~--~~~~~~gt~~y~AP  303 (303)
                      .  ......||+.|+||
T Consensus       188 ~~~~~~~~~~~~~y~aP  204 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAP  204 (309)
T ss_dssp             ---------CCGGGCCG
T ss_pred             ccccccccCCCcCccCH
Confidence            2  22345789999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=8.7e-31  Score=231.85  Aligned_cols=165  Identities=26%  Similarity=0.471  Sum_probs=143.5

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||.||+|++  +++.||||++.......     ..+.+.+|+.+++.++||||+++++++..+...|
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-----hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence            4678889999999999999998  58899999997543322     1257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+++++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999999988653  458999999999999999999999999999999999999999999999999998654322


Q ss_pred             ---CccCCCCCCcccCC
Q 046106          290 ---GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ---~~~~~~gt~~y~AP  303 (303)
                         ......||+.|+||
T Consensus       160 ~~~~~~~~~~~~~y~aP  176 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAP  176 (276)
T ss_dssp             EECCBCCCCSCGGGCCG
T ss_pred             chhcccCCccccCccCh
Confidence               23445789999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=3e-30  Score=232.73  Aligned_cols=171  Identities=23%  Similarity=0.415  Sum_probs=135.2

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ...+|++.+.||+|+||.||+|..  +++.||||+++.......   .....+.+|+.+++.++||||+++++++.....
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            446788899999999999999997  688999999976443322   223678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          208 WCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      .++||||+++++|.+++...  ....+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++..
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999999999999752  2356899999999999999999999999999999999999999999999999999765


Q ss_pred             ecCC-CccCCCCCCcccCC
Q 046106          286 VQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~-~~~~~~gt~~y~AP  303 (303)
                      .... ......||+.|+||
T Consensus       187 ~~~~~~~~~~~~~~~y~aP  205 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSP  205 (310)
T ss_dssp             ------------CCSSCCH
T ss_pred             cCCCccccccCCCeeEeCh
Confidence            4332 22345789999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.5e-31  Score=241.96  Aligned_cols=165  Identities=28%  Similarity=0.426  Sum_probs=134.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|.+.+.||+|+||.||+|++  +++.||||+++.......     ...+.+|+.+++.++||||+++++++..+..++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-----chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence            5688899999999999999998  678999999975432111     124557999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-  288 (303)
                      +||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        77 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             EEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            9999996 59999988653 46899999999999999999999999999999999999999999999999999865432 


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      .......||+.|+||
T Consensus       155 ~~~~~~~~t~~y~aP  169 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPP  169 (324)
T ss_dssp             --------CGGGCCH
T ss_pred             cccccccCcccccCh
Confidence            223445789999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=3.8e-31  Score=240.17  Aligned_cols=169  Identities=27%  Similarity=0.390  Sum_probs=138.0

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChH--HHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPE--KAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ++|.+.+.||+|+||.||+|++  +++.||||++........  ........+.+|+.+|+.++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            4678889999999999999998  678999999976432211  11112346889999999999999999999998766 


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~---vKl~DFGla~~  284 (303)
                      +|+||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.   +||+|||+++.
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            79999999999999999754  46899999999999999999999999999999999999987654   99999999987


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ...........||+.|+||
T Consensus       167 ~~~~~~~~~~~gt~~y~aP  185 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAP  185 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCH
T ss_pred             cccccccccccCCcCccCc
Confidence            6543333345689999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=4.8e-31  Score=240.46  Aligned_cols=168  Identities=23%  Similarity=0.371  Sum_probs=139.6

Q ss_pred             CCcccc-ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCe
Q 046106          132 RKLNMG-DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMV  207 (303)
Q Consensus       132 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~  207 (303)
                      .+|.+. +.||+|+||.||+|++  +++.||||+++........    ...+.+|+.+++.++ ||||+++++++.....
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC----RAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            344554 7899999999999998  5889999999865433221    247889999999995 6999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---~~~vKl~DFGla~~  284 (303)
                      +++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            999999999999999987655567999999999999999999999999999999999999988   78999999999987


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........+||+.|+||
T Consensus       184 ~~~~~~~~~~~gt~~y~aP  202 (327)
T 3lm5_A          184 IGHACELREIMGTPEYLAP  202 (327)
T ss_dssp             C---------CCCGGGCCH
T ss_pred             cCCccccccccCCcCccCC
Confidence            6655555566899999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=6.3e-31  Score=243.06  Aligned_cols=173  Identities=16%  Similarity=0.260  Sum_probs=138.5

Q ss_pred             eecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHH-----HHHHHHHHHHHHHcCCCCCee
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQV-----MEQQFQQEVMMLATLKHPNIV  196 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~-----~~~~~~~E~~il~~l~hpniv  196 (303)
                      +..++|.+.+.||+|+||.||+|.+.       ++.||||++............     ....+.+|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            34568999999999999999999882       468999998765421111100     012345677788899999999


Q ss_pred             eeeEEEEcC----CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc--C
Q 046106          197 RFIGACRKP----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF--S  270 (303)
Q Consensus       197 ~l~~~~~~~----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~--~  270 (303)
                      ++++++...    ...||||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+  .
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            999998764    4589999999 99999999864 35699999999999999999999999999999999999999  8


Q ss_pred             CCcEEEeccCCceeeecCCCc--------cCCCCCCcccCC
Q 046106          271 DKSIKIADFGVARIEVQTEGM--------TPETGTYRWMAP  303 (303)
Q Consensus       271 ~~~vKl~DFGla~~~~~~~~~--------~~~~gt~~y~AP  303 (303)
                      ++.+||+|||+|+........        ...+||+.|+||
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  230 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI  230 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCH
Confidence            899999999999865433211        234599999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.3e-30  Score=235.54  Aligned_cols=172  Identities=29%  Similarity=0.537  Sum_probs=143.7

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF  198 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l  198 (303)
                      +...+..++|++.+.||+|+||.||++++      +++.||||++.....      ...+.+.+|+.+++.++||||+++
T Consensus        34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~  107 (326)
T 2w1i_A           34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------EHLRDFEREIEILKSLQHDNIVKY  107 (326)
T ss_dssp             ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH------HHHHHHHHHHHHHHhCCCCCeeeE
Confidence            34456677889999999999999999985      578999999976432      123578899999999999999999


Q ss_pred             eEEEEcCC--eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          199 IGACRKPM--VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       199 ~~~~~~~~--~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      ++++....  .+++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus       108 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL  186 (326)
T 2w1i_A          108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI  186 (326)
T ss_dssp             EEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred             EEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEE
Confidence            99987643  6799999999999999998753 45899999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCCC----ccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      +|||+++.......    .....+|..|+||
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  217 (326)
T 2w1i_A          187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAP  217 (326)
T ss_dssp             CCCTTCEECCSSCSEEECSSCCSCCGGGCCH
T ss_pred             ecCcchhhccccccccccccCCCCceeEECc
Confidence            99999987654332    2234577889998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=5.4e-30  Score=228.89  Aligned_cols=174  Identities=26%  Similarity=0.427  Sum_probs=146.1

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ...+.....++.....||+|+||.||+|++  +++.||||++......      ..+.+.+|+.+++.++||||++++++
T Consensus        14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~   87 (295)
T 2clq_A           14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR------YSQPLHEEIALHKHLKHKNIVQYLGS   87 (295)
T ss_dssp             CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH------HHHHHHHHHHHHHhCCCCCEeeEeeE
Confidence            345666667777777899999999999998  6789999999765322      12578899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-CCcEEEecc
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-DKSIKIADF  279 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-~~~vKl~DF  279 (303)
                      +......++||||+++++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+||
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Df  167 (295)
T 2clq_A           88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF  167 (295)
T ss_dssp             EEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCT
T ss_pred             EEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeec
Confidence            9999999999999999999999986532 35678899999999999999999999999999999999988 899999999


Q ss_pred             CCceeeecCC-CccCCCCCCcccCC
Q 046106          280 GVARIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      |+++...... ......||+.|+||
T Consensus       168 g~~~~~~~~~~~~~~~~~~~~y~aP  192 (295)
T 2clq_A          168 GTSKRLAGINPCTETFTGTLQYMAP  192 (295)
T ss_dssp             TTCEESCC-----CCCCCCGGGCCH
T ss_pred             ccccccCCCCCcccccCCCccccCh
Confidence            9998654322 23445789999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=3.5e-31  Score=241.01  Aligned_cols=168  Identities=27%  Similarity=0.526  Sum_probs=136.9

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeE----EEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEE----VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~----vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +..++|++.+.||+|+||.||+|++  +++.    ||+|.+........     .+.+.+|+.+++.++||||+++++++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-----FQAVTDHMLAIGSLDHAHIVRLLGLC   84 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-----BCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-----HHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            4567888999999999999999997  4443    78888754432211     13567899999999999999999998


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .. ...++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        85 ~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           85 PG-SSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             CB-SSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             cC-CccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcc
Confidence            75 45789999999999999998642 46889999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC---ccCCCCCCcccCC
Q 046106          283 RIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +.......   .....||+.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aP  186 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMAL  186 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCH
T ss_pred             cccCcccccccccCCCCcccccCh
Confidence            87543322   2334678899998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.2e-31  Score=242.02  Aligned_cols=170  Identities=24%  Similarity=0.382  Sum_probs=137.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||+++........ ....+.+.+|+.+++.++||||+++++++......
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK-DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhh-hhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            46788899999999999999998  5789999999754322111 11224678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec-
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ-  287 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~-  287 (303)
                      ++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.... 
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            999999975 8988887643 4688899999999999999999999999999999999999999999999999986533 


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                      .......+||+.|+||
T Consensus       166 ~~~~~~~~~t~~y~aP  181 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAP  181 (346)
T ss_dssp             CCCCCCSCCCCTTCCH
T ss_pred             cccCCcccccccccCc
Confidence            2234456899999998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=4.1e-31  Score=238.40  Aligned_cols=175  Identities=28%  Similarity=0.543  Sum_probs=147.1

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCe
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNI  195 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpni  195 (303)
                      ...|++..++|.+.+.||+|+||.||+|++       +++.||||+++.....     ...+.+.+|+.++..+ +||||
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~~hp~i   93 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-----SEHRALMSELKILIHIGHHLNV   93 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-----HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-----HHHHHHHHHHHHHHhcccCCCe
Confidence            457899999999999999999999999985       3478999999764322     1235788999999999 68999


Q ss_pred             eeeeEEEEcCC-eEEEEEeecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 046106          196 VRFIGACRKPM-VWCIVTEYAKGGSVRQFLTKRQN--------------RSVPLKLAVKQALDVARGMAYVHRLGLIHRD  260 (303)
Q Consensus       196 v~l~~~~~~~~-~~~iv~E~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHrD  260 (303)
                      +++++++..+. .+++||||+++++|.+++.....              ..+++..++.++.|++.||+|||++||+|||
T Consensus        94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d  173 (316)
T 2xir_A           94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD  173 (316)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence            99999997754 58999999999999999986532              1278999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          261 LKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       261 lkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |||+|||++.++.+||+|||+++.......   .....||+.|+||
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  219 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence            999999999999999999999986543322   1233578899998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2.2e-31  Score=243.51  Aligned_cols=172  Identities=27%  Similarity=0.438  Sum_probs=138.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++....... ......+.+.+|+.+++.++||||+++++++.+....
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc-cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            46788899999999999999998  67799999986531100 0011236788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 046106          209 CIVTEYAKGGSVRQFLTKRQ--------------------------------------NRSVPLKLAVKQALDVARGMAY  250 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~qi~~~l~~  250 (303)
                      |+||||+++++|.+++....                                      ...+++..++.++.||+.||+|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            99999999999999985210                                      1123567788999999999999


Q ss_pred             HHhCCceeCCCCCCcEEEcCCC--cEEEeccCCceeeecCC-----CccCCCCCCcccCC
Q 046106          251 VHRLGLIHRDLKSDNLLIFSDK--SIKIADFGVARIEVQTE-----GMTPETGTYRWMAP  303 (303)
Q Consensus       251 LH~~giiHrDlkp~NILv~~~~--~vKl~DFGla~~~~~~~-----~~~~~~gt~~y~AP  303 (303)
                      ||++||+||||||+||||+.++  .+||+|||+|+......     ......||+.|+||
T Consensus       184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  243 (345)
T 3hko_A          184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP  243 (345)
T ss_dssp             HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred             HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence            9999999999999999998776  89999999998653322     12445799999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=1.6e-30  Score=237.17  Aligned_cols=161  Identities=35%  Similarity=0.592  Sum_probs=141.3

Q ss_pred             cCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHc--CCCCCeeeeeEEEEcCC--
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLAT--LKHPNIVRFIGACRKPM--  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~~~--  206 (303)
                      .++|.+.+.||+|+||.||+|+++++.||||++....         .+.+.+|++++..  ++||||+++++++....  
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            4678889999999999999999999999999996421         1467788888887  78999999999998875  


Q ss_pred             --eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCcEEEcCCCcEEE
Q 046106          207 --VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH--------RLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       207 --~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                        .+|+||||+++++|.+++...   .+++..++.++.|++.||+|||        +.||+||||||+||||+.++.+||
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence              789999999999999999763   5899999999999999999999        899999999999999999999999


Q ss_pred             eccCCceeeecCCC-----ccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~-----~~~~~gt~~y~AP  303 (303)
                      +|||+++.......     .....||+.|+||
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aP  220 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP  220 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCH
T ss_pred             EECCCceeccccccccccccccCCcCcccCCH
Confidence            99999987654432     2445799999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=2.9e-30  Score=234.69  Aligned_cols=175  Identities=23%  Similarity=0.388  Sum_probs=133.6

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHH-HHHcCCCCCeeeee
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVM-MLATLKHPNIVRFI  199 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~hpniv~l~  199 (303)
                      ....|.+..++|++.+.||+|+||.||+|.+  +++.||||+++.......     ...+..|+. +++.++||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~e~~~~~~~~~h~niv~~~   87 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----QKQLLMDLDVVMRSSDCPYIVQFY   87 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----HHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----HHHHHHHHHHHHHcCCCCcEeeee
Confidence            3467889999999999999999999999998  588999999986543221     134445555 77888999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEE
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTK---RQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vK  275 (303)
                      +++..+...++||||+++ +|.+++..   .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           88 GALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             EEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred             eEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence            999999999999999975 88888763   2245689999999999999999999999 999999999999999999999


Q ss_pred             EeccCCceeeecCCCccCCCCCCcccCC
Q 046106          276 IADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+|||+++............||+.|+||
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aP  194 (327)
T 3aln_A          167 LCDFGISGQLVDSIAKTRDAGCRPYMAP  194 (327)
T ss_dssp             ECCCSSSCC-------------------
T ss_pred             EccCCCceecccccccccCCCCccccCc
Confidence            9999999876554444455799999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=9.7e-31  Score=236.44  Aligned_cols=173  Identities=21%  Similarity=0.275  Sum_probs=144.2

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +.+.++.++|.+.+.||+|+||.||++..  +++.||||++....  .    ...+.+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--Q----QDREEAQREADMHRLFNHPNILRLVAYC   95 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--H----HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--H----HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            56778889999999999999999999997  78899999986532  1    2235788999999999999999999998


Q ss_pred             E----cCCeEEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          203 R----KPMVWCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       203 ~----~~~~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      .    .....|+||||+++++|.+++...  ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl  175 (317)
T 2buj_A           96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL  175 (317)
T ss_dssp             EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred             EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence            6    345789999999999999999863  2356899999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCCC----------ccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEG----------MTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~----------~~~~~gt~~y~AP  303 (303)
                      +|||+++.......          .....||+.|+||
T Consensus       176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  212 (317)
T 2buj_A          176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP  212 (317)
T ss_dssp             CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCG
T ss_pred             EecCcchhcccccccccccccccccccccCCcccCCH
Confidence            99999875432110          1123578999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=5.2e-30  Score=231.33  Aligned_cols=167  Identities=28%  Similarity=0.474  Sum_probs=139.6

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      ....++|.+.+.||+|+||.||+|.+  +++.||||++......        +.+.+|+.+++.++||||+++++++...
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~   96 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--------QEIIKEISIMQQCDSPHVVKYYGSYFKN   96 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH--------HHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            34456788899999999999999998  4889999999764322        4678999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..+|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            9999999999999999999743 356899999999999999999999999999999999999999999999999999865


Q ss_pred             ecCC-CccCCCCCCcccCC
Q 046106          286 VQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~-~~~~~~gt~~y~AP  303 (303)
                      .... ......||+.|+||
T Consensus       176 ~~~~~~~~~~~~~~~y~aP  194 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAP  194 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCH
T ss_pred             hhhccccCccCCCCCccCh
Confidence            4332 23345789999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=1.8e-31  Score=247.94  Aligned_cols=171  Identities=17%  Similarity=0.216  Sum_probs=136.7

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHH---HHHHcCCCCCeeeee-
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEV---MMLATLKHPNIVRFI-  199 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~---~il~~l~hpniv~l~-  199 (303)
                      .|....++|.+.+.||+|+||.||+|++  +++.||||++.........   ..+.+.+|+   .+|+.++||||++++ 
T Consensus        67 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~~l~hpniv~~~~  143 (377)
T 3byv_A           67 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN---AIKQMKEEVLRLRLLRGIKNQKQAKVHL  143 (377)
T ss_dssp             SSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT---HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred             ecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH---HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence            4455567899999999999999999996  6889999999854332211   125788999   555566899999998 


Q ss_pred             ------EEEEcCC-----------------eEEEEEeecCCCCHHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHH
Q 046106          200 ------GACRKPM-----------------VWCIVTEYAKGGSVRQFLTKRQNR-----SVPLKLAVKQALDVARGMAYV  251 (303)
Q Consensus       200 ------~~~~~~~-----------------~~~iv~E~~~~gsL~~~l~~~~~~-----~~~~~~~~~i~~qi~~~l~~L  251 (303)
                            +++..+.                 ..|+||||+ +|+|.+++......     .+++..++.++.||+.||+||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  222 (377)
T 3byv_A          144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL  222 (377)
T ss_dssp             CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence                  7766553                 278999999 68999999864211     123478889999999999999


Q ss_pred             HhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       252 H~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |++||+||||||+||||+.++.+||+|||+|+...  ......+| +.|+||
T Consensus       223 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aP  271 (377)
T 3byv_A          223 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPP  271 (377)
T ss_dssp             HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCH
T ss_pred             HhCCeecCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccCh
Confidence            99999999999999999999999999999998532  23445678 999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=3.6e-30  Score=238.00  Aligned_cols=164  Identities=27%  Similarity=0.389  Sum_probs=140.9

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  205 (303)
                      ..+|.+.+.||+|+||.||+|.+  +++.||||++.....     ....+.+.+|+.+++.++||||+++++++...   
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-----QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-----HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-----cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            35789999999999999999987  678999999975332     12236788999999999999999999999765   


Q ss_pred             --CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          206 --MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       206 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                        ...|+||||+. ++|.+++...   .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence              36899999996 5999999763   58999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCC----ccCCCCCCcccCC
Q 046106          284 IEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      .......    ....+||+.|+||
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aP  200 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAP  200 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCH
T ss_pred             ecCCCCCccccccccccccCCCCC
Confidence            7653322    2345899999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=2.5e-30  Score=232.77  Aligned_cols=164  Identities=26%  Similarity=0.431  Sum_probs=141.1

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|.+.+.||+|+||.||+++.  +++.||+|+++......      .+.+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------DSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------hHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            35678889999999999999998  68899999998643221      24678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI---FSDKSIKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv---~~~~~vKl~DFGla~~~  285 (303)
                      |+||||+++++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999999999999765  358999999999999999999999999999999999999   77899999999999754


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ... .....+||+.|+||
T Consensus       160 ~~~-~~~~~~~~~~y~aP  176 (304)
T 2jam_A          160 QNG-IMSTACGTPGYVAP  176 (304)
T ss_dssp             CCB-TTHHHHSCCCBCCT
T ss_pred             CCC-ccccccCCCCccCh
Confidence            322 23344689999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=1.9e-30  Score=239.12  Aligned_cols=175  Identities=21%  Similarity=0.320  Sum_probs=136.7

Q ss_pred             ceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCCh-----HHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDP-----EKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~-----~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      .....++|.+.+.||+|+||.||+|.. +++.||||++.......     .......+.+.+|+.+++.++||||+++++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   96 (362)
T 3pg1_A           17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD   96 (362)
T ss_dssp             HHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             HHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence            344467888999999999999999987 78899999986543321     112233468899999999999999999999


Q ss_pred             EEEc-----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEE
Q 046106          201 ACRK-----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIK  275 (303)
Q Consensus       201 ~~~~-----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vK  275 (303)
                      ++..     ...+|+||||+. ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence            9843     346899999997 6899888754 34689999999999999999999999999999999999999999999


Q ss_pred             EeccCCceeeecCCCccCCCCCCcccCC
Q 046106          276 IADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       276 l~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+|||+|+............||+.|+||
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aP  202 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAP  202 (362)
T ss_dssp             ECCTTC---------------CGGGCCH
T ss_pred             EEecCcccccccccccceecccceecCc
Confidence            9999999866555555566899999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=1.1e-30  Score=242.31  Aligned_cols=168  Identities=26%  Similarity=0.413  Sum_probs=126.7

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..|++. ++|.+.+.||+|+||.||+|.+  +++.||||++........    ..+.+.+|+.+|+.++||||+++++++
T Consensus        23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~   97 (367)
T 2fst_X           23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----HAKRTYRELRLLKHMKHENVIGLLDVF   97 (367)
T ss_dssp             EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            345554 7899999999999999999987  688999999976544332    235788999999999999999999999


Q ss_pred             EcC------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          203 RKP------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       203 ~~~------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      ...      ..+|+|+|++ +++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus        98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X           98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             CSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEE
Confidence            754      4579999999 7899998875   45899999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCCCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|||+|+....  ..+..+||+.|+||
T Consensus       174 ~DFG~a~~~~~--~~~~~~~t~~y~aP  198 (367)
T 2fst_X          174 LDFGLARHTAD--EMTGYVATRWYRAP  198 (367)
T ss_dssp             CC-----------------CCCTTCCH
T ss_pred             eeccccccccc--cCCCcCcCcCccCh
Confidence            99999986432  23456899999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=1.4e-30  Score=235.29  Aligned_cols=164  Identities=37%  Similarity=0.660  Sum_probs=134.6

Q ss_pred             eeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      .++.++|++.+.||+|+||.||++++.++.||||++....        ..+.+.+|+.++++++||||+++++++.+.  
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   73 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES--------ERKAFIVELRQLSRVNHPNIVKLYGACLNP--   73 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT--------HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh--------HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence            3567788999999999999999999999999999986421        125788999999999999999999988744  


Q ss_pred             EEEEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCCCcEEEcCCCc-EEEeccCCc
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHR---LGLIHRDLKSDNLLIFSDKS-IKIADFGVA  282 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~giiHrDlkp~NILv~~~~~-vKl~DFGla  282 (303)
                      .|+||||+++++|.+++..... ..+++..++.++.|++.||+|||+   +||+||||||+|||++.++. +||+|||++
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           74 VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            6899999999999999986432 247889999999999999999999   89999999999999998886 799999999


Q ss_pred             eeeecCCCccCCCCCCcccCC
Q 046106          283 RIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ......  .....||+.|+||
T Consensus       154 ~~~~~~--~~~~~gt~~y~aP  172 (307)
T 2eva_A          154 CDIQTH--MTNNKGSAAWMAP  172 (307)
T ss_dssp             -------------CCTTSSCH
T ss_pred             cccccc--cccCCCCCceECh
Confidence            754322  2345799999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=2.7e-30  Score=230.99  Aligned_cols=164  Identities=26%  Similarity=0.438  Sum_probs=134.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-----  204 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----  204 (303)
                      ++|++.+.||+|+||.||+|+.  +++.||||+++..       ....+.+.+|+.+++.++||||+++++++..     
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            4678889999999999999997  6889999999642       1223678899999999999999999998864     


Q ss_pred             --------CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          205 --------PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       205 --------~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                              ....|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence                    356899999999999999998643 45788999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecC---------------CCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQT---------------EGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~---------------~~~~~~~gt~~y~AP  303 (303)
                      +|||+++.....               .......||+.|+||
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  199 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT  199 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence            999999754321               122345689999998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.3e-30  Score=235.09  Aligned_cols=168  Identities=25%  Similarity=0.520  Sum_probs=134.8

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeE----EEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEE----VAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~----vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +...+|++.+.||+|+||.||+|++  +++.    ||+|.++.......     .+.+.+|+.+++.++||||+++++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~   86 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----NKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCC-----HHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHH-----HHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence            4567899999999999999999997  4543    57777754432221     25788999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ..+. .++|+||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus        87 ~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             ESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             ecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            8876 688999999999999998754 46899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC---ccCCCCCCcccCC
Q 046106          283 RIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +.......   .....+|+.|+||
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aP  188 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMAL  188 (327)
T ss_dssp             ---------------CCCGGGSCH
T ss_pred             eEccCccccccccCCCccccccCH
Confidence            86543322   2223567889998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=2.2e-30  Score=235.24  Aligned_cols=173  Identities=29%  Similarity=0.429  Sum_probs=135.6

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIG  200 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~  200 (303)
                      ...+++...+|++.+.||+|+||.||+|++  +++.||||++....      ....+.+.+|+.+++++. ||||+++++
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~~h~~iv~~~~   93 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE------EEKNRAIIQEVCFMKKLSGHPNIVQFCS   93 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS------HHHHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc------hHHHHHHHHHHHHHHHhccCCChhhccc
Confidence            356777888999999999999999999998  78899999986532      122357889999999996 999999999


Q ss_pred             EEE--------cCCeEEEEEeecCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEc
Q 046106          201 ACR--------KPMVWCIVTEYAKGGSVRQFLTKR-QNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIF  269 (303)
Q Consensus       201 ~~~--------~~~~~~iv~E~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~  269 (303)
                      ++.        ....+++||||+. |+|.+++... ....+++..++.++.||+.||+|||++|  |+||||||+||||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~  172 (337)
T 3ll6_A           94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS  172 (337)
T ss_dssp             EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred             cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence            994        3445899999995 7999998752 2346999999999999999999999999  99999999999999


Q ss_pred             CCCcEEEeccCCceeeecCCCc-------------cCCCCCCcccCC
Q 046106          270 SDKSIKIADFGVARIEVQTEGM-------------TPETGTYRWMAP  303 (303)
Q Consensus       270 ~~~~vKl~DFGla~~~~~~~~~-------------~~~~gt~~y~AP  303 (303)
                      .++.+||+|||+++........             ....||+.|+||
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (337)
T 3ll6_A          173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP  219 (337)
T ss_dssp             TTSCEEBCCCTTCBCCSSCC---------------------------
T ss_pred             CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCCh
Confidence            9999999999999865432221             134689999998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=2.1e-30  Score=237.28  Aligned_cols=177  Identities=22%  Similarity=0.367  Sum_probs=149.4

Q ss_pred             cceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHH-----------HHHHHHHHHHHHHHHcCCCCC
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKA-----------QVMEQQFQQEVMMLATLKHPN  194 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~-----------~~~~~~~~~E~~il~~l~hpn  194 (303)
                      ...+..++|.+.+.||+|+||.||+|+++++.||||++..........           ....+.+.+|+.+++.++|||
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           25 EKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             SSCEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             hcccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            334556789999999999999999999999999999986432110000           000157889999999999999


Q ss_pred             eeeeeEEEEcCCeEEEEEeecCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEE
Q 046106          195 IVRFIGACRKPMVWCIVTEYAKGGSVRQF------LTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLL  267 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NIL  267 (303)
                      |+++++++.....+++||||+++++|.++      +.......+++..++.++.|++.||+|||+ +||+||||||+|||
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999998      655435679999999999999999999999 99999999999999


Q ss_pred             EcCCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          268 IFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       268 v~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ++.++.+||+|||+++..... ......||+.|+||
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aP  219 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPP  219 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCG
T ss_pred             EcCCCcEEEeccccccccccc-cccCCCCCcCccCc
Confidence            999999999999999875433 34456799999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=3.7e-30  Score=230.65  Aligned_cols=166  Identities=29%  Similarity=0.469  Sum_probs=136.9

Q ss_pred             CCccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE-cC
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR-KP  205 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~  205 (303)
                      .+|++.+.||+|+||.||+|++.     ...+|+|.++.....     ...+.+.+|+.++++++||||+++++++. .+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-----HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-----HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            35778899999999999999862     235899998753322     12357889999999999999999999975 45


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             CceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            5779999999999999999754 356899999999999999999999999999999999999999999999999999865


Q ss_pred             ecCCC-----ccCCCCCCcccCC
Q 046106          286 VQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~-----~~~~~gt~~y~AP  303 (303)
                      .....     .....||+.|+||
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aP  201 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMAL  201 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCH
T ss_pred             cccchhccccccCCCCCccccCh
Confidence            43221     2234567889998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.7e-30  Score=241.61  Aligned_cols=173  Identities=28%  Similarity=0.480  Sum_probs=132.7

Q ss_pred             CcceeecC--CccccceecccCceEEEEEEE---CC--eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 046106          125 DEWTIDLR--KLNMGDAFAQGAFGKLYRGTY---NG--EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR  197 (303)
Q Consensus       125 ~~~~i~~~--~~~~~~~lG~G~fg~Vy~~~~---~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  197 (303)
                      ..+.+...  .|.+.+.||+|+||.||+|++   ++  ..||||.++......     ..+.+.+|+.++++++||||++
T Consensus        80 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~il~~l~hpnIv~  154 (373)
T 3c1x_A           80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-----EVSQFLTEGIIMKDFSHPNVLS  154 (373)
T ss_dssp             TTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSH-----HHHHHHHHHTTSTTCCCTTBCC
T ss_pred             cccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHH-----HHHHHHHHHHHHHhCCCCCcce
Confidence            34444443  456788999999999999986   22  368999987643322     1357899999999999999999


Q ss_pred             eeEEEEc-CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          198 FIGACRK-PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       198 l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      +++++.. +...++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus       155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL  233 (373)
T 3c1x_A          155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKV  233 (373)
T ss_dssp             CCEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             EEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEE
Confidence            9999754 457799999999999999997543 45889999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCCC-----ccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~-----~~~~~gt~~y~AP  303 (303)
                      +|||+|+.......     .....+|+.|+||
T Consensus       234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aP  265 (373)
T 3c1x_A          234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL  265 (373)
T ss_dssp             CCC---------------------CCGGGSCH
T ss_pred             eeccccccccccccccccccCCCCCcccccCh
Confidence            99999986533221     1233577899998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=2.7e-30  Score=234.24  Aligned_cols=168  Identities=29%  Similarity=0.476  Sum_probs=140.6

Q ss_pred             cCCccccceecccCceEEEEEEE---CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC---CCCCeeeeeEEEE-
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL---KHPNIVRFIGACR-  203 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~-  203 (303)
                      .++|.+.+.||+|+||.||+|++   +++.||||+++.........    ..+.+|+.+++.+   +||||+++++++. 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC----chhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            46788999999999999999997   46899999987543221111    2345666666655   8999999999987 


Q ss_pred             ----cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          204 ----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       204 ----~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                          ....+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence                5567899999997 69999998766566999999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCCccCCCCCCcccCC
Q 046106          280 GVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+++............||+.|+||
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aP  188 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAP  188 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCH
T ss_pred             cccccccCCCCccccccccceeCH
Confidence            999876544445566899999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=2.6e-30  Score=232.16  Aligned_cols=170  Identities=24%  Similarity=0.421  Sum_probs=140.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE--cCC
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR--KPM  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~--~~~  206 (303)
                      .++|.+.+.||+|+||.||++.+  +++.||+|+++......  .......+.+|+.+++.++||||+++++++.  ...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc--cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence            35788999999999999999998  67899999996421100  0112367899999999999999999999984  445


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      ..|+||||++++ |.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            789999999765 8888887666779999999999999999999999999999999999999999999999999998654


Q ss_pred             cC---CCccCCCCCCcccCC
Q 046106          287 QT---EGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~---~~~~~~~gt~~y~AP  303 (303)
                      ..   .......||+.|+||
T Consensus       161 ~~~~~~~~~~~~~~~~y~aP  180 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPP  180 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCH
T ss_pred             ccccccccccCCCCCCCcCh
Confidence            22   122345689999998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=2.7e-30  Score=237.20  Aligned_cols=172  Identities=15%  Similarity=0.223  Sum_probs=136.7

Q ss_pred             eecCCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHH-----HHHHHHHHHHHHHcCCCCCeeee
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQV-----MEQQFQQEVMMLATLKHPNIVRF  198 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~-----~~~~~~~E~~il~~l~hpniv~l  198 (303)
                      +..++|.+.+.||+|+||.||+|++     ++..+|||++............     ....+.+|+.+++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            3457899999999999999999998     3468999999865432211111     12357789999999999999999


Q ss_pred             eEEEEc----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC--
Q 046106          199 IGACRK----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK--  272 (303)
Q Consensus       199 ~~~~~~----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~--  272 (303)
                      ++++..    ....|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||||+.++  
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            999987    67899999999 999999998653  689999999999999999999999999999999999999887  


Q ss_pred             cEEEeccCCceeeecCCC--------ccCCCCCCcccCC
Q 046106          273 SIKIADFGVARIEVQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       273 ~vKl~DFGla~~~~~~~~--------~~~~~gt~~y~AP  303 (303)
                      .+||+|||+|+.......        .....||+.|+||
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  229 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL  229 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCH
Confidence            999999999986543221        1345799999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=2.4e-30  Score=235.42  Aligned_cols=173  Identities=28%  Similarity=0.454  Sum_probs=141.2

Q ss_pred             cceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeee
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF  198 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l  198 (303)
                      ..++..++|.+.+.||+|+||.||+|++       +++.||||++......     .....+.+|+.+++.++||||+++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~   98 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-----QDELDFLMEALIISKFNHQNIVRC   98 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-----hhHHHHHHHHHHHhhCCCCCCCeE
Confidence            3467788999999999999999999983       4568999999643321     123578899999999999999999


Q ss_pred             eEEEEcCCeEEEEEeecCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---
Q 046106          199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQN-----RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---  270 (303)
Q Consensus       199 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---  270 (303)
                      ++++......|+||||+++++|.+++.....     ..+++..++.++.||+.||.|||++||+||||||+||||+.   
T Consensus        99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~  178 (327)
T 2yfx_A           99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  178 (327)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence            9999999889999999999999999986532     34889999999999999999999999999999999999984   


Q ss_pred             CCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          271 DKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       271 ~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +..+||+|||+++.......   .....||+.|+||
T Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  214 (327)
T 2yfx_A          179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP  214 (327)
T ss_dssp             TCCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred             cceEEECccccccccccccccccCCCcCCCcceeCH
Confidence            45699999999975432221   2234578899998

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=4.8e-30  Score=242.06  Aligned_cols=162  Identities=27%  Similarity=0.420  Sum_probs=135.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  205 (303)
                      ..+|.+.+.||+|+||.||+|++  +++.||||++.....          .+.+|+.+|+.++||||+++++++...   
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~E~~il~~l~hpniv~l~~~~~~~~~~  122 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK  122 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----------hHHHHHHHHHHcCCCCccceeeEEeccCCC
Confidence            34678889999999999999998  688999999875432          233699999999999999999998532   


Q ss_pred             ---CeEEEEEeecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEecc
Q 046106          206 ---MVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADF  279 (303)
Q Consensus       206 ---~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DF  279 (303)
                         ..+++||||+++ +|.+++..  .....+++..+..++.||+.||+|||++||+||||||+||||+.+ +.+||+||
T Consensus       123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccc
Confidence               246799999975 77776653  234579999999999999999999999999999999999999965 67899999


Q ss_pred             CCceeeecCCCccCCCCCCcccCC
Q 046106          280 GVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+|+...........+||+.|+||
T Consensus       202 G~a~~~~~~~~~~~~~~t~~y~aP  225 (420)
T 1j1b_A          202 GSAKQLVRGEPNVSYICSRYYRAP  225 (420)
T ss_dssp             TTCEECCTTCCCCSCCSCTTSCCH
T ss_pred             hhhhhcccCCCceeeeeCCCcCCH
Confidence            999876655555566899999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.97  E-value=3.7e-31  Score=239.19  Aligned_cols=175  Identities=29%  Similarity=0.606  Sum_probs=145.6

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      .....|.++.++|++.+.||+|+||.||+|.+.+ .+|+|+++........    .+.+.+|+.++++++||||++++++
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~   97 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ----LKAFKREVMAYRQTRHENVVLFMGA   97 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC----CCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH----HHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            3457899999999999999999999999999865 5999999765432211    1356789999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +..+..+++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+
T Consensus        98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B           98 CMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             EECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             EecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence            999999999999999999999997643 4689999999999999999999999999999999999998 68999999999


Q ss_pred             ceeeec------CCCccCCCCCCcccCC
Q 046106          282 ARIEVQ------TEGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~------~~~~~~~~gt~~y~AP  303 (303)
                      ++....      ........||+.|+||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aP  203 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAP  203 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCH
T ss_pred             ccccccccccccccccccCCCcccccCh
Confidence            875421      1122334688999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=1.9e-30  Score=230.21  Aligned_cols=169  Identities=26%  Similarity=0.430  Sum_probs=141.9

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--CC
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--PM  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~  206 (303)
                      .++|++.+.||+|+||.||++++  +++.||+|++.........    .+.+.+|+.++++++||||+++++++..  ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   80 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH----HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH----HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence            45788889999999999999998  6789999999876554322    3678999999999999999999998853  56


Q ss_pred             eEEEEEeecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCcEEEcCCCcEEEecc
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQ--NRSVPLKLAVKQALDVARGMAYVHRLG-----LIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g-----iiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      .+++||||+++++|.+++....  ...+++..++.++.|++.||+|||+.|     |+||||||+|||++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            8899999999999999997542  345899999999999999999999999     999999999999999999999999


Q ss_pred             CCceeeecCCC-ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG-MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~-~~~~~gt~~y~AP  303 (303)
                      |+++....... .....||+.|+||
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aP  185 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSP  185 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCH
T ss_pred             chheeeccccccccccCCCccccCh
Confidence            99976543221 1234689999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=2.9e-30  Score=230.45  Aligned_cols=167  Identities=28%  Similarity=0.482  Sum_probs=143.6

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||+|+.  +++.||||++.........    .+.+.+|+.++++++||||+++++++.....+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD----TSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH----HHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            35788889999999999999998  6889999999764332211    25788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC---CcEEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD---KSIKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~---~~vKl~DFGla~~~  285 (303)
                      ++||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+.+   +.+||+|||+++..
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            9999999999999999765  358999999999999999999999999999999999999764   47999999999865


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........||+.|+||
T Consensus       175 ~~~~~~~~~~~~~~y~aP  192 (287)
T 2wei_A          175 QQNTKMKDRIGTAYYIAP  192 (287)
T ss_dssp             CCCSSCSCHHHHHTTCCH
T ss_pred             cCCCccccccCcccccCh
Confidence            544444445688899998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=8.5e-30  Score=227.91  Aligned_cols=173  Identities=28%  Similarity=0.465  Sum_probs=141.2

Q ss_pred             CcceeecCC--ccccceecccCceEEEEEEE--CC---eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 046106          125 DEWTIDLRK--LNMGDAFAQGAFGKLYRGTY--NG---EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR  197 (303)
Q Consensus       125 ~~~~i~~~~--~~~~~~lG~G~fg~Vy~~~~--~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  197 (303)
                      .++.++..+  |.+.+.||+|+||.||+|++  ++   ..||+|+++.....     ...+.+.+|+.+++.++||||++
T Consensus        12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~   86 (298)
T 3pls_A           12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-----QQVEAFLREGLLMRGLNHPNVLA   86 (298)
T ss_dssp             GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-----HHHHHHHHHHHHHHhCCCCCeee
Confidence            455555553  44568999999999999986  32   27999998753321     12367889999999999999999


Q ss_pred             eeEEEEcCCeE-EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          198 FIGACRKPMVW-CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       198 l~~~~~~~~~~-~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      +++++...... ++||||+.+++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl  165 (298)
T 3pls_A           87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKV  165 (298)
T ss_dssp             CCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEe
Confidence            99999876554 8999999999999999864 356899999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCC-----CccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTE-----GMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~-----~~~~~~gt~~y~AP  303 (303)
                      +|||+|+......     ......+|+.|+||
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aP  197 (298)
T 3pls_A          166 ADFGLARDILDREYYSVQQHRHARLPVKWTAL  197 (298)
T ss_dssp             CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCH
T ss_pred             CcCCCcccccCCcccccccCcCCCCCccccCh
Confidence            9999997543221     22334678899997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=6.6e-30  Score=241.84  Aligned_cols=165  Identities=21%  Similarity=0.322  Sum_probs=141.5

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC------CCCCeeeeeE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL------KHPNIVRFIG  200 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l------~hpniv~l~~  200 (303)
                      ....+|++.+.||+|+||.||+|.+  +++.||||+++...       ...+.+.+|+.+++.+      .|+||+++++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-------chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            3456789999999999999999988  57899999997521       1224667788887776      5779999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc--EEEec
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS--IKIAD  278 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~--vKl~D  278 (303)
                      ++.....+|+||||+. ++|.+++.......+++..+..++.||+.||+|||++||+||||||+||||+.++.  +||+|
T Consensus       167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence            9999999999999995 69999998876667999999999999999999999999999999999999999987  99999


Q ss_pred             cCCceeeecCCCccCCCCCCcccCC
Q 046106          279 FGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ||+|+...  ......+||+.|+||
T Consensus       246 FG~a~~~~--~~~~~~~gt~~y~aP  268 (429)
T 3kvw_A          246 FGSSCYEH--QRVYTYIQSRFYRAP  268 (429)
T ss_dssp             CTTCEETT--CCCCSSCSCGGGCCH
T ss_pred             cccceecC--CcccccCCCCCccCh
Confidence            99997543  234456899999998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=7.9e-30  Score=236.51  Aligned_cols=167  Identities=25%  Similarity=0.455  Sum_probs=139.7

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..|++. ++|.+.+.||+|+||.||+|.+  +++.||||++.......    ...+.+.+|+.+++.++||||+++++++
T Consensus        36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~  110 (371)
T 4exu_A           36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----IFAKRAYRELLLLKHMQHENVIGLLDVF  110 (371)
T ss_dssp             EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch----hHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence            456664 6889999999999999999998  68899999997654433    2236788999999999999999999999


Q ss_pred             EcCCeE------EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          203 RKPMVW------CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       203 ~~~~~~------~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      ......      |+||||+. ++|.+++.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus       111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL  185 (371)
T 4exu_A          111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI  185 (371)
T ss_dssp             CSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred             eccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEE
Confidence            876654      99999996 68887774    34899999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCCCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|||+|+....  .....+||+.|+||
T Consensus       186 ~Dfg~a~~~~~--~~~~~~~t~~y~aP  210 (371)
T 4exu_A          186 LDFGLARHADA--EMTGYVVTRWYRAP  210 (371)
T ss_dssp             CSTTCC----------CTTCCCTTSCH
T ss_pred             EecCccccccc--CcCCcccCccccCH
Confidence            99999986432  23456789999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=3.6e-30  Score=231.00  Aligned_cols=167  Identities=28%  Similarity=0.490  Sum_probs=138.8

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ..++|++.+.||+|+||.||+|++  +++.||+|++.......      .+.+.+|+.+++.++||||+++++++..+..
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE------LEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC------HHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH------HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            456788899999999999999998  47899999987543221      2578899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999999999987643 4689999999999999999999999999999999999999999999999999754321


Q ss_pred             -CCCccCCCCCCcccCC
Q 046106          288 -TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 -~~~~~~~~gt~~y~AP  303 (303)
                       ........||+.|+||
T Consensus       170 ~~~~~~~~~~~~~y~aP  186 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAP  186 (302)
T ss_dssp             HHHC-----CCGGGCCH
T ss_pred             cccccccccCChhhcCC
Confidence             1122345789999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=1e-29  Score=233.13  Aligned_cols=164  Identities=27%  Similarity=0.410  Sum_probs=138.3

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP---  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  205 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||+++.... .    .....+.+|+.+++.++||||+++++++...   
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK-P----LFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS-H----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc-c----hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            36788899999999999999998  588999999965332 1    2235778999999999999999999998654   


Q ss_pred             --CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          206 --MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       206 --~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                        ...|+||||+. ++|.+++..   ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence              56899999996 699999876   358999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCC-----------ccCCCCCCcccCC
Q 046106          284 IEVQTEG-----------MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~-----------~~~~~gt~~y~AP  303 (303)
                      .......           ....+||+.|+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  191 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAP  191 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCH
T ss_pred             ccccccccccCccccccchhhccccccccCC
Confidence            6542211           2234789999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=9.9e-30  Score=252.58  Aligned_cols=173  Identities=27%  Similarity=0.520  Sum_probs=143.9

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeee
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF  198 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l  198 (303)
                      ...|++..++|.+.+.||+|+||.||+|.+.     +..||||.++....     ....+.+.+|+.+|+.++||||+++
T Consensus       382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l  456 (656)
T 2j0j_A          382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-----DSVREKFLQEALTMRQFDHPHIVKL  456 (656)
T ss_dssp             GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-----HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-----HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3567888899999999999999999999872     35799999865332     1233678999999999999999999


Q ss_pred             eEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       199 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                      ++++.. ...|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus       457 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          457 IGVITE-NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             EEEECS-SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEEEec-CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEe
Confidence            999854 45799999999999999998653 4689999999999999999999999999999999999999999999999


Q ss_pred             cCCceeeecCCCc--cCCCCCCcccCC
Q 046106          279 FGVARIEVQTEGM--TPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~~--~~~~gt~~y~AP  303 (303)
                      ||+|+........  ....+|+.|+||
T Consensus       535 FG~a~~~~~~~~~~~~~~~~t~~y~aP  561 (656)
T 2j0j_A          535 FGLSRYMEDSTYYKASKGKLPIKWMAP  561 (656)
T ss_dssp             CCCCCSCCC----------CCGGGCCH
T ss_pred             cCCCeecCCCcceeccCCCCCcceeCH
Confidence            9999865433222  233567899998

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=3.3e-30  Score=238.85  Aligned_cols=171  Identities=14%  Similarity=0.151  Sum_probs=125.8

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC--CCCCeeeee--
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL--KHPNIVRFI--  199 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~--  199 (303)
                      .|.....+|.+.+.||+|+||.||+|++  +++.||||+++........   ..+.+.+|+.+++.+  +||||++++  
T Consensus        56 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~~~~l~~~hp~iv~~~~~  132 (371)
T 3q60_A           56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---ELERLHEATFAAARLLGESPEEARDRRR  132 (371)
T ss_dssp             TTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHH---HHHHHHHHHHHHHHHHC----------C
T ss_pred             cCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccccc---HHHHHHHHHHHHHHhcccChhhhhhcee
Confidence            3444556688999999999999999997  6889999999886553322   235677785444444  699988755  


Q ss_pred             -----EEEEcC-----------------CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHH
Q 046106          200 -----GACRKP-----------------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLA------VKQALDVARGMAYV  251 (303)
Q Consensus       200 -----~~~~~~-----------------~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~qi~~~l~~L  251 (303)
                           +++..+                 ..+||||||++ ++|.+++.... ..+++..+      ..++.||+.||+||
T Consensus       133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~L  210 (371)
T 3q60_A          133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANL  210 (371)
T ss_dssp             BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence                 555433                 33799999998 89999998643 23455555      67889999999999


Q ss_pred             HhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       252 H~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |++||+||||||+||||+.++.+||+|||+|+.....  .....+|+.|+||
T Consensus       211 H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aP  260 (371)
T 3q60_A          211 QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPR  260 (371)
T ss_dssp             HHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCH
T ss_pred             HHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcCh
Confidence            9999999999999999999999999999999864322  2234567999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.6e-30  Score=254.16  Aligned_cols=159  Identities=16%  Similarity=0.151  Sum_probs=125.2

Q ss_pred             ecccCceEEEEEE--ECCeEEEEEEeeCCC----CChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEEcCCeEEEEE
Q 046106          140 FAQGAFGKLYRGT--YNGEEVAIKILERPE----NDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       140 lG~G~fg~Vy~~~--~~~~~vAvK~~~~~~----~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~iv~  212 (303)
                      .+.|.+|.+..++  +.|+.+|+|++.+..    ....+.+...++|.+|+++|+++ .|+||+++++++.++..+||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            5567777666544  378899999998653    23344455567899999999999 6999999999999999999999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-Cc
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GM  291 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~~  291 (303)
                      ||++|++|.+++...  ..++..   .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ..
T Consensus       322 Eyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             ECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             ecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            999999999999865  456654   478999999999999999999999999999999999999999998654332 23


Q ss_pred             cCCCCCCcccCC
Q 046106          292 TPETGTYRWMAP  303 (303)
Q Consensus       292 ~~~~gt~~y~AP  303 (303)
                      .+.+||+.||||
T Consensus       397 ~t~vGTp~YmAP  408 (569)
T 4azs_A          397 TNLVQSFFVFVN  408 (569)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             cCceechhhccH
Confidence            445799999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=1.4e-29  Score=235.14  Aligned_cols=167  Identities=20%  Similarity=0.344  Sum_probs=141.9

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC--------CCCee
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK--------HPNIV  196 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--------hpniv  196 (303)
                      ..+-..+|.+.+.||+|+||.||+|++  +++.||||+++..       ....+.+.+|+.+++.++        ||||+
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-------EHYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-------CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            344467899999999999999999987  6889999999642       122357889999999986        78899


Q ss_pred             eeeEEEE----cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCC
Q 046106          197 RFIGACR----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSD  271 (303)
Q Consensus       197 ~l~~~~~----~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~  271 (303)
                      ++++++.    ....+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+||||+.+
T Consensus       105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~  183 (397)
T 1wak_A          105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN  183 (397)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred             eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence            9999997    556789999999 67888888766556799999999999999999999998 99999999999999877


Q ss_pred             C-------------------------------------------------cEEEeccCCceeeecCCCccCCCCCCcccC
Q 046106          272 K-------------------------------------------------SIKIADFGVARIEVQTEGMTPETGTYRWMA  302 (303)
Q Consensus       272 ~-------------------------------------------------~vKl~DFGla~~~~~~~~~~~~~gt~~y~A  302 (303)
                      +                                                 .+||+|||+|+....  .....+||+.|+|
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~a  261 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCC
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccC
Confidence            5                                                 799999999986543  2445689999999


Q ss_pred             C
Q 046106          303 P  303 (303)
Q Consensus       303 P  303 (303)
                      |
T Consensus       262 P  262 (397)
T 1wak_A          262 L  262 (397)
T ss_dssp             H
T ss_pred             C
Confidence            8

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=4.9e-30  Score=240.47  Aligned_cols=158  Identities=24%  Similarity=0.437  Sum_probs=121.7

Q ss_pred             cceecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--CCeEEE
Q 046106          137 GDAFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--PMVWCI  210 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~~i  210 (303)
                      +++||+|+||.||+|++    +++.||||++......        ..+.+|+.+|+.++||||+++++++..  ...+|+
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--------MSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--------HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--------HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            56799999999999996    3678999999765433        357789999999999999999999954  678999


Q ss_pred             EEeecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE----cCCCcEEEecc
Q 046106          211 VTEYAKGGSVRQFLTKRQ-------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI----FSDKSIKIADF  279 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv----~~~~~vKl~DF  279 (303)
                      ||||+. ++|.+++....       ...+++..++.++.||+.||+|||++||+||||||+||||    +.++.+||+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            999996 58888886321       1248999999999999999999999999999999999999    67789999999


Q ss_pred             CCceeeecC----CCccCCCCCCcccCC
Q 046106          280 GVARIEVQT----EGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~----~~~~~~~gt~~y~AP  303 (303)
                      |+|+.....    ......+||+.|+||
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~y~aP  204 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFWYRAP  204 (405)
T ss_dssp             TCCC----------------CCCTTCCH
T ss_pred             CCceecCCCCcccccCCCceecCcccCc
Confidence            999865432    223446899999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=2e-30  Score=234.02  Aligned_cols=175  Identities=21%  Similarity=0.299  Sum_probs=136.8

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC----CCCCeeeee
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL----KHPNIVRFI  199 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l----~hpniv~l~  199 (303)
                      ..+.-.++|++.+.||+|+||.||+|++  +++.||||++................+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4455567899999999999999999987  6789999999765443222212224566789999888    899999999


Q ss_pred             EEEEcCCeEEEEEee-cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEe
Q 046106          200 GACRKPMVWCIVTEY-AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF-SDKSIKIA  277 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~-~~~~vKl~  277 (303)
                      +++......++|+|+ +.+++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEE
Confidence            999988889999999 7889999999875  3589999999999999999999999999999999999999 78999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||+++..... ......||+.|+||
T Consensus       183 dfg~~~~~~~~-~~~~~~~~~~y~aP  207 (312)
T 2iwi_A          183 DFGSGALLHDE-PYTDFDGTRVYSPP  207 (312)
T ss_dssp             CCSSCEECCSS-CBCCCCSCTTTSCH
T ss_pred             EcchhhhcccC-cccccCCcccccCc
Confidence            99999876543 34556799999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=6.7e-30  Score=227.82  Aligned_cols=172  Identities=32%  Similarity=0.495  Sum_probs=134.4

Q ss_pred             ceeecCCccccceecccCceEEEEEEE---CCe--EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY---NGE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ..+..++|++.+.||+|+||.||+|++   +++  .||||+++.......   ...+.+.+|+.+++.++||||++++++
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~   89 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGV   89 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            456678899999999999999999986   223  689999876432221   223678899999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +..+. .++|+||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           90 VLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             ECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             EccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence            98766 689999999999999998653 4589999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCC----ccCCCCCCcccCC
Q 046106          282 ARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      ++.......    .....+|+.|+||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAP  193 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCH
T ss_pred             cccccccccchhhhccCCCCceeeCc
Confidence            987543322    2234578889998

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=229.25  Aligned_cols=174  Identities=22%  Similarity=0.408  Sum_probs=131.2

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ...|.+..++|.+.+.||+|+||.||+|++  +++.||||++........    ..+.+.++..+++.++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~~~~~~~h~~i~~~~~~   92 (318)
T 2dyl_A           17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGT   92 (318)
T ss_dssp             SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH----HHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH----HHHHHHHHHHHHHhcCCCceeeEEEE
Confidence            356778888999999999999999999998  688999999987543221    22445566667888999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      +..+..+++||||+ ++.+..+... ....+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A           93 FITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             EECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence            99999999999999 5555555443 345689999999999999999999995 99999999999999999999999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +++............||+.|+||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aP  193 (318)
T 2dyl_A          171 ISGRLVDDKAKDRSAGCAAYMAP  193 (318)
T ss_dssp             TC--------------CCTTCCH
T ss_pred             CchhccCCccccccCCCccccCh
Confidence            99866554444556799999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=2.4e-29  Score=228.30  Aligned_cols=166  Identities=26%  Similarity=0.394  Sum_probs=142.5

Q ss_pred             eeecCCccccceecccCceEEEEEEE---CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCC------Ceeee
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP------NIVRF  198 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp------niv~l  198 (303)
                      ++-.++|++.+.||+|+||.||+|.+   +++.||||+++...       ...+.+.+|+.+++.++|+      +++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-------RYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-------chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            34567899999999999999999987   57899999996421       1235678899999888765      49999


Q ss_pred             eEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--------
Q 046106          199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS--------  270 (303)
Q Consensus       199 ~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~--------  270 (303)
                      ++++.....+|+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.        
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 889999998776567899999999999999999999999999999999999987        


Q ss_pred             -----------CCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          271 -----------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       271 -----------~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                                 ++.+||+|||+|+...  .......||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aP  203 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAP  203 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCH
T ss_pred             CccccccccccCCCceEeeCcccccCc--cccccccCCccccCh
Confidence                       6689999999998643  233456899999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=1.3e-29  Score=237.13  Aligned_cols=163  Identities=25%  Similarity=0.412  Sum_probs=135.3

Q ss_pred             ecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC--
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM--  206 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--  206 (303)
                      ...+|.+.+.||+|+||.||+|++ .+..||+|.+.....          ...+|+.+|+.++||||+++++++....  
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----------~~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            345788899999999999999998 556799998865332          1236999999999999999999995433  


Q ss_pred             ----eEEEEEeecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEecc
Q 046106          207 ----VWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF-SDKSIKIADF  279 (303)
Q Consensus       207 ----~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~-~~~~vKl~DF  279 (303)
                          .+++||||+++ ++.+.+..  .....+++..+..++.||+.||+|||++||+||||||+||||+ .++.+||+||
T Consensus       108 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence                37899999976 55444432  2235689999999999999999999999999999999999999 7899999999


Q ss_pred             CCceeeecCCCccCCCCCCcccCC
Q 046106          280 GVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+|+............||+.|+||
T Consensus       187 G~a~~~~~~~~~~~~~~t~~y~aP  210 (394)
T 4e7w_A          187 GSAKILIAGEPNVSYICSRYYRAP  210 (394)
T ss_dssp             TTCEECCTTCCCCSSCSCGGGCCH
T ss_pred             CCcccccCCCCCcccccCcCccCH
Confidence            999887665556667899999998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=2.2e-30  Score=235.32  Aligned_cols=177  Identities=24%  Similarity=0.354  Sum_probs=144.8

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC--CCCeeeee
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK--HPNIVRFI  199 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~  199 (303)
                      ....+.-.++|.+.+.||+|+||.||+|++  +++.||||+++.............+.+.+|+.+++.++  ||||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            345556677899999999999999999998  78899999997653321000000135667999999996  59999999


Q ss_pred             EEEEcCCeEEEEEeecCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCcEEEe
Q 046106          200 GACRKPMVWCIVTEYAKG-GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF-SDKSIKIA  277 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~-~~~~vKl~  277 (303)
                      +++..+...++|+|++.+ ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||||+ +++.+||+
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            999999999999999975 8999999875  4689999999999999999999999999999999999999 77999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||+++..... ......||+.|+||
T Consensus       193 Dfg~~~~~~~~-~~~~~~gt~~y~aP  217 (320)
T 3a99_A          193 DFGSGALLKDT-VYTDFDGTRVYSPP  217 (320)
T ss_dssp             CCTTCEECCSS-CBCCCCSCGGGSCH
T ss_pred             eCccccccccc-cccCCCCCccCCCh
Confidence            99999876533 34456799999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=1.4e-29  Score=232.83  Aligned_cols=169  Identities=25%  Similarity=0.341  Sum_probs=130.4

Q ss_pred             ceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      .....++|.+.+.||+|+||.||+|++  +++.||||++.......       ..+.+|+..+..++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-------CHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-------HHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            445567899999999999999999998  57899999986643322       245678888888999999999999965


Q ss_pred             CC-------eEEEEEeecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCcEEEcC-CC
Q 046106          205 PM-------VWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVH--RLGLIHRDLKSDNLLIFS-DK  272 (303)
Q Consensus       205 ~~-------~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH--~~giiHrDlkp~NILv~~-~~  272 (303)
                      ..       .+++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||  ++||+||||||+||||+. ++
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence            33       27899999975 66655543  23356889999999999999999999  999999999999999997 89


Q ss_pred             cEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          273 SIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       273 ~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      .+||+|||+|+............||+.|+||
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  200 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEPNVAYICSRYYRAP  200 (360)
T ss_dssp             EEEECCCTTCBCCCTTSCCCSTTSCGGGCCH
T ss_pred             cEEEeeCCCceecCCCCCcccccCCcceeCH
Confidence            9999999999877665555667899999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=1.1e-29  Score=253.41  Aligned_cols=164  Identities=25%  Similarity=0.379  Sum_probs=138.4

Q ss_pred             ceeecCCccccceecccCceEEEEEEE---CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          127 WTIDLRKLNMGDAFAQGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       127 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      -++-..+|.+.+.||+|+||.||++.+   +++.||||++..... .    .....+.+|+.+++.++||||+++++++.
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  149 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-A----EAQAMAMAERQFLAEVVHPSIVQIFNFVE  149 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-H----HHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-H----HHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence            345567899999999999999999997   478999999875432 1    12357889999999999999999999998


Q ss_pred             cCCe-----EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEec
Q 046106          204 KPMV-----WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIAD  278 (303)
Q Consensus       204 ~~~~-----~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~D  278 (303)
                      ....     .||||||+++++|.+++..    .+++..++.++.||+.||+|||++|||||||||+||||+.+ .+||+|
T Consensus       150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             EECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECC
T ss_pred             ecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEe
Confidence            7554     6999999999999987754    58999999999999999999999999999999999999875 899999


Q ss_pred             cCCceeeecCCCccCCCCCCcccCC
Q 046106          279 FGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       279 FGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ||+++.....   ...+||+.|+||
T Consensus       225 FG~a~~~~~~---~~~~gt~~y~aP  246 (681)
T 2pzi_A          225 LGAVSRINSF---GYLYGTPGFQAP  246 (681)
T ss_dssp             CTTCEETTCC---SCCCCCTTTSCT
T ss_pred             cccchhcccC---CccCCCccccCH
Confidence            9999865432   456799999999

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=3.7e-30  Score=236.75  Aligned_cols=161  Identities=14%  Similarity=0.246  Sum_probs=137.7

Q ss_pred             cCCccccceecccCceEEEEEEEC----------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeee---
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTYN----------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVR---  197 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~---  197 (303)
                      .++|.+.+.||+|+||.||+|++.          ++.||||++...           +.+.+|+.+++.++||||++   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~  109 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------GRLFNEQNFFQRAAKPLQVNKWK  109 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------STHHHHHHHHHHHCCHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------chHHHHHHHHHHhcccchhhhhh
Confidence            478999999999999999999873          678999999753           25778999999999999887   


Q ss_pred             ------------eeEEEEc-CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 046106          198 ------------FIGACRK-PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSD  264 (303)
Q Consensus       198 ------------l~~~~~~-~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~  264 (303)
                                  +++++.. ...+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+
T Consensus       110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~  188 (352)
T 2jii_A          110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE  188 (352)
T ss_dssp             HHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred             hhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence                        6777765 67889999999 999999998764467999999999999999999999999999999999


Q ss_pred             cEEEcCCC--cEEEeccCCceeeecCCC--------ccCCCCCCcccCC
Q 046106          265 NLLIFSDK--SIKIADFGVARIEVQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       265 NILv~~~~--~vKl~DFGla~~~~~~~~--------~~~~~gt~~y~AP  303 (303)
                      |||++.++  .+||+|||+|+.......        .....||+.|+||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  237 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM  237 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCH
Confidence            99999998  999999999976543221        2334799999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=5.1e-29  Score=222.62  Aligned_cols=163  Identities=28%  Similarity=0.384  Sum_probs=138.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE-EcCCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC-RKPMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~~~  207 (303)
                      .++|++.+.||+|+||.||+|++  +++.||||++......        +.+.+|+.+++.++|++++..+..+ .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--------hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            46788999999999999999996  7899999998765433        3577899999999988866666655 56778


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI---FSDKSIKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv---~~~~~vKl~DFGla~~  284 (303)
                      .++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+   +.++.+||+|||+|+.
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             eEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            89999999 899999998543 468999999999999999999999999999999999999   4889999999999987


Q ss_pred             eecCCC--------ccCCCCCCcccCC
Q 046106          285 EVQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~--------~~~~~gt~~y~AP  303 (303)
                      ......        .....||+.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCH
T ss_pred             ccccccccccccccccccccccccCCh
Confidence            554322        2345799999998

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=2.4e-29  Score=227.26  Aligned_cols=173  Identities=22%  Similarity=0.336  Sum_probs=143.8

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC--CCCeeeee
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK--HPNIVRFI  199 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~  199 (303)
                      .+....+..++|.+.+.||+|+||.||++.+ +++.||||++.........    .+.+.+|+.+++.++  ||||++++
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~E~~~l~~l~~~~~~iv~~~   94 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT----LDSYRNEIAYLNKLQQHSDKIIRLY   94 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHH----HHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccc----hHHHHHHHHHHHhccccCCceEEEE
Confidence            4567788888999999999999999999988 6789999999876544322    367889999999997  59999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +++..+..+++|||+ .+++|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+||
T Consensus        95 ~~~~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Df  170 (313)
T 3cek_A           95 DYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDF  170 (313)
T ss_dssp             EEEECSSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred             EEeecCCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeec
Confidence            999999999999994 578999999875  4689999999999999999999999999999999999996 589999999


Q ss_pred             CCceeeecCCC---ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |+++.......   .....||+.|+||
T Consensus       171 g~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (313)
T 3cek_A          171 GIANQMQPDTTSVVKDSQVGTVNYMPP  197 (313)
T ss_dssp             SSSCC--------------CCGGGCCH
T ss_pred             cccccccCccccccccCCCCCCCcCCH
Confidence            99986543321   2344789999998

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=3.9e-29  Score=223.16  Aligned_cols=163  Identities=28%  Similarity=0.384  Sum_probs=134.9

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE-EcCCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC-RKPMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~~~  207 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||++......        +.+.+|+.+++.++|++++..+..+ .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence            35788899999999999999996  7889999987654332        3577899999999988777766655 66778


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI---FSDKSIKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv---~~~~~vKl~DFGla~~  284 (303)
                      .++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|+.
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             eEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            89999999 899999998543 468999999999999999999999999999999999999   7889999999999987


Q ss_pred             eecCCC--------ccCCCCCCcccCC
Q 046106          285 EVQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~--------~~~~~gt~~y~AP  303 (303)
                      ......        .....||+.|+||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aP  184 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASI  184 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCH
T ss_pred             ccCcccCccCCCCcccccCCCccccch
Confidence            554322        2245789999998

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=3e-29  Score=226.10  Aligned_cols=163  Identities=26%  Similarity=0.350  Sum_probs=131.2

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE-----
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR-----  203 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-----  203 (303)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++....  .    ...+.+.+|+.+++.++||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--P----QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--H----HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--h----HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            46788999999999999999998  48899999997542  1    12357889999999999999999999874     


Q ss_pred             ---------cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc-CCCc
Q 046106          204 ---------KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF-SDKS  273 (303)
Q Consensus       204 ---------~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~-~~~~  273 (303)
                               .....|+||||++ ++|.+++..   ..+++..++.++.|++.||+|||++||+||||||+|||++ +++.
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence                     3467899999997 699999864   4589999999999999999999999999999999999997 5679


Q ss_pred             EEEeccCCceeeecC----CCccCCCCCCcccCC
Q 046106          274 IKIADFGVARIEVQT----EGMTPETGTYRWMAP  303 (303)
Q Consensus       274 vKl~DFGla~~~~~~----~~~~~~~gt~~y~AP  303 (303)
                      +||+|||+++.....    .......+|+.|+||
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  193 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSP  193 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCc
Confidence            999999999865322    122334678999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=4.1e-29  Score=228.70  Aligned_cols=162  Identities=23%  Similarity=0.378  Sum_probs=120.9

Q ss_pred             cCCcccc-ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc---
Q 046106          131 LRKLNMG-DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK---  204 (303)
Q Consensus       131 ~~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---  204 (303)
                      .++|.+. +.||+|+||.||+|++  +++.||||++...   .       ....+....++.++||||+++++++..   
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P-------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            3456664 4699999999999998  5889999999652   1       111223344667799999999999875   


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccC
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFG  280 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---~~~vKl~DFG  280 (303)
                       ...+++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             455899999999999999999776567999999999999999999999999999999999999976   4569999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +++..... .....+||+.|+||
T Consensus       177 ~~~~~~~~-~~~~~~~t~~y~aP  198 (336)
T 3fhr_A          177 FAKETTQN-ALQTPCYTPYYVAP  198 (336)
T ss_dssp             TCEEC------------------
T ss_pred             cceecccc-ccccCCCCcCccCh
Confidence            99865433 33456789999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=231.49  Aligned_cols=166  Identities=25%  Similarity=0.462  Sum_probs=137.6

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .|++ .++|.+.+.||+|+||.||+|++  +++.||||++.......    ...+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----IFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH----HHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch----HHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            4554 35788899999999999999998  68899999997654332    22367889999999999999999999998


Q ss_pred             cCCe------EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          204 KPMV------WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       204 ~~~~------~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                      ....      +|+||||+. ++|.+++.    ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~  168 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL  168 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred             cccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEe
Confidence            7653      499999996 58877764    348999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||+++....  ......||+.|+||
T Consensus       169 Dfg~~~~~~~--~~~~~~~t~~y~aP  192 (353)
T 3coi_A          169 DFGLARHADA--EMTGYVVTRWYRAP  192 (353)
T ss_dssp             STTCTTC----------CCSBCCSCH
T ss_pred             ecccccCCCC--CccccccCcCcCCH
Confidence            9999976432  23445789999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=1e-28  Score=236.97  Aligned_cols=163  Identities=27%  Similarity=0.369  Sum_probs=139.0

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC-CCeeeeeEEEEcCCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRFIGACRKPMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~~~  207 (303)
                      .++|.+.+.||+|+||.||+|++  +++.||||++......        ..+.+|+.+++.++| ++|+.+..++.....
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------PQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            46889999999999999999997  5889999998765433        256789999999987 566666677778888


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE---cCCCcEEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI---FSDKSIKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv---~~~~~vKl~DFGla~~  284 (303)
                      .+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||   +.++.+||+|||+|+.
T Consensus        78 ~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            99999999 899999998543 469999999999999999999999999999999999999   6889999999999987


Q ss_pred             eecCCC--------ccCCCCCCcccCC
Q 046106          285 EVQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~--------~~~~~gt~~y~AP  303 (303)
                      ......        ....+||+.|+||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aP  182 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASV  182 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             ccCCccccccccccccccCCCccccCH
Confidence            654332        1245799999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=1e-28  Score=225.83  Aligned_cols=165  Identities=25%  Similarity=0.381  Sum_probs=140.8

Q ss_pred             eecCCccccceecccCceEEEEEEE--CC-eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC------eeeee
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NG-EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN------IVRFI  199 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn------iv~l~  199 (303)
                      .-.++|++.+.||+|+||.||+|.+  ++ +.||||+++...       ...+.+.+|+.+++.++|++      ++.++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-------KYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-------cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            3467899999999999999999997  34 789999996421       12356778999999887665      99999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE-----------
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI-----------  268 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv-----------  268 (303)
                      +++.....+|+||||+ ++++.+++.......+++..++.++.||+.||+|||++||+||||||+||||           
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence            9999999999999999 6788888887655679999999999999999999999999999999999999           


Q ss_pred             --------cCCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          269 --------FSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       269 --------~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                              +.++.+||+|||+++...  ......+||+.|+||
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aP  208 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPP  208 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCH
T ss_pred             cccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCC
Confidence                    567899999999998643  233456899999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=239.20  Aligned_cols=169  Identities=24%  Similarity=0.389  Sum_probs=135.0

Q ss_pred             CCcceeecCCccccceecccCceEE-EEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKL-YRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGA  201 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~V-y~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~  201 (303)
                      ...+.+...+|.+.+.||+|+||.| +++..+++.||||++......         .+.+|+.+|+.+ +||||++++++
T Consensus        16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---------~~~~E~~~l~~l~~HpnIv~l~~~   86 (432)
T 3p23_A           16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---------FADREVQLLRESDEHPNVIRYFCT   86 (432)
T ss_dssp             --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---------ECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---------HHHHHHHHHHhccCCCCcCeEEEE
Confidence            4567777788999999999999984 555668999999999653321         345799999998 79999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-----CcEEE
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-----KSIKI  276 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-----~~vKl  276 (303)
                      +.+....||||||+. ++|.+++.... ...++..++.++.||+.||+|||++||+||||||+||||+.+     ..+||
T Consensus        87 ~~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A           87 EKDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             EEETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             EecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence            999999999999995 69999998654 334555677899999999999999999999999999999532     36889


Q ss_pred             eccCCceeeecCC----CccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTE----GMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~----~~~~~~gt~~y~AP  303 (303)
                      +|||+|+......    .....+||+.|+||
T Consensus       165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~AP  195 (432)
T 3p23_A          165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP  195 (432)
T ss_dssp             CCTTEEECC------------CCSCTTSCCG
T ss_pred             ecccceeeccCCCcceeeccccCCCcCccCh
Confidence            9999998654332    23345799999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=3.4e-29  Score=231.07  Aligned_cols=169  Identities=23%  Similarity=0.343  Sum_probs=142.6

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-----------
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-----------  191 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----------  191 (303)
                      ....+...+|.+.+.||+|+||.||+|++  +++.||||+++...       .....+.+|+.+++.++           
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~~~   84 (373)
T 1q8y_A           12 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VYTEAAEDEIKLLQRVNDADNTKEDSMG   84 (373)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred             cCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-------cchhhhhHHHHHHHHhhcccccchhccc
Confidence            34455677899999999999999999997  78899999996421       12256778999988876           


Q ss_pred             CCCeeeeeEEEEcCC----eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCcE
Q 046106          192 HPNIVRFIGACRKPM----VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL-GLIHRDLKSDNL  266 (303)
Q Consensus       192 hpniv~l~~~~~~~~----~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-giiHrDlkp~NI  266 (303)
                      ||||+++++++....    .+++|||++ +++|.+++.......+++..+..++.||+.||+|||++ ||+||||||+||
T Consensus        85 ~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NI  163 (373)
T 1q8y_A           85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV  163 (373)
T ss_dssp             HTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred             cchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHe
Confidence            899999999997643    789999999 88999999886666799999999999999999999998 999999999999


Q ss_pred             EEcC------CCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          267 LIFS------DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       267 Lv~~------~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ||+.      .+.+||+|||+|+....  ......||+.|+||
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aP  204 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSP  204 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCH
T ss_pred             EEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCc
Confidence            9953      34899999999986543  23455899999998

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=5.1e-28  Score=216.87  Aligned_cols=147  Identities=14%  Similarity=0.149  Sum_probs=129.3

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      +-..+|.+.+.||+|+||.||+|++  +++.||||+++.......   ...+.+.+|+.++..++||||+++++++..+.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  104 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD---DVLQETLSRTLRLSRIDKPGVARVLDVVHTRA  104 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH---HHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence            4456799999999999999999998  489999999987654332   22367889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ..|+||||+++++|.+++...    .....+..++.||+.||+|||++||+||||||+||||+.++.+||++++..
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             cEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence            999999999999999999542    355678899999999999999999999999999999999999999987764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=3.5e-28  Score=226.15  Aligned_cols=165  Identities=26%  Similarity=0.360  Sum_probs=139.5

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CC-----CeeeeeE
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HP-----NIVRFIG  200 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp-----niv~l~~  200 (303)
                      .-.++|.+.+.||+|+||.||+|++  +++.||||+++...       .....+.+|+.+++.++ |+     +|+++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-------HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            3467899999999999999999998  67899999997421       12356778888888875 44     4999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCcEEEc--CCCcEEE
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH--RLGLIHRDLKSDNLLIF--SDKSIKI  276 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~giiHrDlkp~NILv~--~~~~vKl  276 (303)
                      ++.....+|+||||+. ++|.+++.......+++..+..++.|++.||.|||  +.||+||||||+||||+  .++.+||
T Consensus       124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            9999999999999995 59999998766567999999999999999999999  57999999999999995  4688999


Q ss_pred             eccCCceeeecCCCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|||+|+....  .....+||+.|+||
T Consensus       203 ~DFG~a~~~~~--~~~~~~~t~~y~aP  227 (382)
T 2vx3_A          203 VDFGSSCQLGQ--RIYQYIQSRFYRSP  227 (382)
T ss_dssp             CCCTTCEETTC--CCCSSCSCGGGCCH
T ss_pred             EeccCceeccc--ccccccCCccccCh
Confidence            99999986532  34456899999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=1.1e-27  Score=215.25  Aligned_cols=144  Identities=24%  Similarity=0.404  Sum_probs=126.4

Q ss_pred             CCcccc-ceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHH-HcCCCCCeeeeeEEEEc---
Q 046106          132 RKLNMG-DAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML-ATLKHPNIVRFIGACRK---  204 (303)
Q Consensus       132 ~~~~~~-~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~~~~~~---  204 (303)
                      .+|.+. +.||+|+||.||++.+  +++.||||+++..           ..+.+|+.++ +.++||||+++++++..   
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            345554 6799999999999998  6789999999641           3566788887 66789999999999876   


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccC
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFG  280 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---~~~vKl~DFG  280 (303)
                       ...+++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.   ++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             667899999999999999999876567999999999999999999999999999999999999998   7899999999


Q ss_pred             Cceeee
Q 046106          281 VARIEV  286 (303)
Q Consensus       281 la~~~~  286 (303)
                      +|+...
T Consensus       166 ~a~~~~  171 (299)
T 3m2w_A          166 FAKETT  171 (299)
T ss_dssp             TCEECT
T ss_pred             cccccc
Confidence            997643

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=7.3e-29  Score=244.92  Aligned_cols=167  Identities=28%  Similarity=0.426  Sum_probs=141.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-----  204 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----  204 (303)
                      .+|.+.+.||+|+||.||+|.+  +++.||||+++.... .    ...+.+.+|+.+++.++||||+++++++..     
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~-~----~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-P----KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC-H----HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC-H----HHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            5788899999999999999987  688999999876432 2    123578899999999999999999998755     


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCc---EEEecc
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKRQN-RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS---IKIADF  279 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~---vKl~DF  279 (303)
                       ....|+||||+++++|.+++..... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.   +||+||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence             6677999999999999999986432 35889999999999999999999999999999999999997764   999999


Q ss_pred             CCceeeecCCCccCCCCCCcccCC
Q 046106          280 GVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+++............||+.|+||
T Consensus       169 G~a~~~~~~~~~~~~~gt~~Y~AP  192 (676)
T 3qa8_A          169 GYAKELDQGELCTEFVGTLQYLAP  192 (676)
T ss_dssp             CCCCBTTSCCCCCCCCSCCTTCSS
T ss_pred             ccccccccccccccccCCcccCCh
Confidence            999876655555666899999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=2.1e-28  Score=231.81  Aligned_cols=167  Identities=23%  Similarity=0.372  Sum_probs=125.5

Q ss_pred             ceeecCCc-cccceecccCceEEEEE-EECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEEE
Q 046106          127 WTIDLRKL-NMGDAFAQGAFGKLYRG-TYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGACR  203 (303)
Q Consensus       127 ~~i~~~~~-~~~~~lG~G~fg~Vy~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  203 (303)
                      ++....++ ...+.||+|+||+||.+ ..+|+.||||++....         .+.+.+|+.+|+.+ +||||+++++++.
T Consensus         9 ~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---------~~~~~~E~~~l~~l~~HpnIv~~~~~~~   79 (434)
T 2rio_A            9 FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---------CDIALMEIKLLTESDDHPNVIRYYCSET   79 (434)
T ss_dssp             CSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             hhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---------HHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence            33333333 44578999999999754 4489999999986521         13567899999875 8999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-------
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSV-----PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-------  271 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~-----~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-------  271 (303)
                      .+..+||||||+. ++|.+++........     ++..++.++.||+.||+|||++||+||||||+||||+.+       
T Consensus        80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred             cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence            9999999999995 699999986432111     223457899999999999999999999999999999754       


Q ss_pred             ------CcEEEeccCCceeeecCCC-----ccCCCCCCcccCC
Q 046106          272 ------KSIKIADFGVARIEVQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       272 ------~~vKl~DFGla~~~~~~~~-----~~~~~gt~~y~AP  303 (303)
                            +.+||+|||+|+.......     ....+||+.|+||
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aP  201 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP  201 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC--------------CCTTSCH
T ss_pred             ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCH
Confidence                  4899999999987654321     2235799999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6.5e-29  Score=241.50  Aligned_cols=155  Identities=19%  Similarity=0.185  Sum_probs=122.5

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCCh--HHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDP--EKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      .+.||+|+||.||+|++.++.+|+|.........  .......+++.+|+.+|++++||||+++..++......||||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~  420 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY  420 (540)
T ss_dssp             -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred             CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence            5689999999999998899999999876543322  12223356789999999999999999666666566667999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC----
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG----  290 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~----  290 (303)
                      +++++|.+++..          +..++.|++.||+|||++||+||||||+|||++.  .+||+|||+|+.......    
T Consensus       421 ~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          421 INGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             CCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             CCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            999999999875          4688999999999999999999999999999998  999999999997654322    


Q ss_pred             ----ccCCCCCCcccCC
Q 046106          291 ----MTPETGTYRWMAP  303 (303)
Q Consensus       291 ----~~~~~gt~~y~AP  303 (303)
                          ....+||+.||||
T Consensus       489 ~~~~~~~~~GT~~y~AP  505 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFD  505 (540)
T ss_dssp             HHHHHHHHHHHCGGGHH
T ss_pred             hhhhhhhhcCCCCcCCH
Confidence                1245799999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.94  E-value=1.9e-27  Score=223.79  Aligned_cols=171  Identities=18%  Similarity=0.207  Sum_probs=128.3

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC-CCe-------
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNI-------  195 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pni-------  195 (303)
                      ++......|...+.||+|+||.||+|++  +++.||||+++.......   ...+.+.+|+.+++.++| ++.       
T Consensus        72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~~~~~~~~  148 (413)
T 3dzo_A           72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---NAIKQMKEEVLRLRLLRGIKNQKQAKVHL  148 (413)
T ss_dssp             SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred             cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH---HHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence            3444556688889999999999999998  589999999874433221   123578899999999987 211       


Q ss_pred             --eeeeEEE------------Ec-----CCeEEEEEeecCCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHH
Q 046106          196 --VRFIGAC------------RK-----PMVWCIVTEYAKGGSVRQFLTK-----RQNRSVPLKLAVKQALDVARGMAYV  251 (303)
Q Consensus       196 --v~l~~~~------------~~-----~~~~~iv~E~~~~gsL~~~l~~-----~~~~~~~~~~~~~i~~qi~~~l~~L  251 (303)
                        +.....+            ..     ...++++|+++ +++|.+++..     .....+++..++.++.||+.||+||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  227 (413)
T 3dzo_A          149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL  227 (413)
T ss_dssp             CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence              1111111            11     22357778876 6799999852     2234577888999999999999999


Q ss_pred             HhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       252 H~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |++|||||||||+||||+.++.+||+|||+|+.....  ....+| +.|+||
T Consensus       228 H~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aP  276 (413)
T 3dzo_A          228 HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPP  276 (413)
T ss_dssp             HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCH
T ss_pred             HhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCc
Confidence            9999999999999999999999999999999864432  455678 999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2.1e-25  Score=199.72  Aligned_cols=137  Identities=14%  Similarity=0.115  Sum_probs=107.7

Q ss_pred             cccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChH------------HHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          135 NMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPE------------KAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~------------~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      .+++.||+|+||.||+|++ +++.||||+++.......            ........+.+|+.+|+.++|   ++++++
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~  169 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV  169 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred             EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence            4558999999999999999 688999999975432110            000234678999999999994   555555


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +.. ...|+||||+++++|.+ +..        .....++.|++.||+|||++||+||||||+||||+ ++.+||+|||+
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             Eec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            544 34589999999999987 421        22457999999999999999999999999999999 99999999999


Q ss_pred             ceee
Q 046106          282 ARIE  285 (303)
Q Consensus       282 a~~~  285 (303)
                      |+..
T Consensus       239 a~~~  242 (282)
T 1zar_A          239 SVEV  242 (282)
T ss_dssp             CEET
T ss_pred             CeEC
Confidence            9854

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=3.2e-23  Score=183.03  Aligned_cols=141  Identities=16%  Similarity=0.182  Sum_probs=107.1

Q ss_pred             ccccceecccCceEEEEEEE--CCeE--EEEEEeeCCCCChHH------------------HHHHHHHHHHHHHHHHcCC
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEE--VAIKILERPENDPEK------------------AQVMEQQFQQEVMMLATLK  191 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~~~~~------------------~~~~~~~~~~E~~il~~l~  191 (303)
                      +.+.+.||+|+||.||+|.+  +|+.  ||||+++........                  .......+.+|+.+|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678899999999999998  8888  999998654321110                  1122357889999999998


Q ss_pred             CCCe--eeeeEEEEcCCeEEEEEeecCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCC
Q 046106          192 HPNI--VRFIGACRKPMVWCIVTEYAKG-G----SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIHRDLKS  263 (303)
Q Consensus       192 hpni--v~l~~~~~~~~~~~iv~E~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~giiHrDlkp  263 (303)
                      |+++  +.+++.    ...+|||||+.+ |    +|.++...     .++..+..++.|++.+|.||| ++||+||||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            8754  444442    234899999942 3    67665432     234457789999999999999 99999999999


Q ss_pred             CcEEEcCCCcEEEeccCCceee
Q 046106          264 DNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       264 ~NILv~~~~~vKl~DFGla~~~  285 (303)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999988  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=9.8e-20  Score=168.93  Aligned_cols=141  Identities=17%  Similarity=0.134  Sum_probs=100.8

Q ss_pred             ccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCC---------------hHHH-HHHHHHHHHHHHHHHcCCCCCee
Q 046106          134 LNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPEND---------------PEKA-QVMEQQFQQEVMMLATLKHPNIV  196 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~---------------~~~~-~~~~~~~~~E~~il~~l~hpniv  196 (303)
                      |.++..||+|+||.||+|.. +|+.||||+++.....               .... ...+-...+|...|.++.++++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            56788999999999999997 7899999998643211               0000 11112334677788877655543


Q ss_pred             eeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----
Q 046106          197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK----  272 (303)
Q Consensus       197 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~----  272 (303)
                      ...-+....  .+|||||+++++|.++..      .  +....++.||+.+|.+||++|||||||||.||||++++    
T Consensus       177 vp~p~~~~~--~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          177 VPEPIAQSR--HTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CCCEEEEET--TEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCeeeeccC--ceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            222222222  279999999888754321      1  23456789999999999999999999999999998877    


Q ss_pred             ------cEEEeccCCcee
Q 046106          273 ------SIKIADFGVARI  284 (303)
Q Consensus       273 ------~vKl~DFGla~~  284 (303)
                            .+.|+||+.+..
T Consensus       247 ~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTSEEEEEEECCCTTCEE
T ss_pred             ccccccceEEEEeCCccc
Confidence                  389999998854

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=6e-14  Score=122.97  Aligned_cols=139  Identities=15%  Similarity=0.092  Sum_probs=108.3

Q ss_pred             ccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEE
Q 046106          134 LNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVT  212 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~iv~  212 (303)
                      +.+...++.|+.+.||+....++.+++|+........      ...+.+|+.+++.+. +..++++++++......|+||
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            4455567778889999998878899999986421111      025778999998885 677889999998888889999


Q ss_pred             eecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 046106          213 EYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR---------------------------------------  253 (303)
Q Consensus       213 E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---------------------------------------  253 (303)
                      ||++|.+|.+.+.       +......++.+++.+|..||+                                       
T Consensus        90 e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           90 SEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             ECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            9999998876531       112234678899999999998                                       


Q ss_pred             --------------------CCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          254 --------------------LGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       254 --------------------~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                                          ..++|+|++|.|||+++++.+.|+||+.|...
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                                45899999999999987666789999988653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.37  E-value=1.4e-12  Score=113.30  Aligned_cols=126  Identities=13%  Similarity=0.095  Sum_probs=93.8

Q ss_pred             cccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC--eeeeeEEEEcCCeEEEEEeecCC
Q 046106          141 AQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN--IVRFIGACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       141 G~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~~~~~~~~~iv~E~~~~  217 (303)
                      +.|..+.||+... +|+.+++|+......         ..+.+|+.+++.+.+.+  +++++++...+...++||||++|
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~---------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGAL---------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   99 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCTT---------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcccc---------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence            3566689999976 467899999765311         24667888888886434  56788888887778999999999


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 046106          218 GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG------------------------------------------  255 (303)
Q Consensus       218 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g------------------------------------------  255 (303)
                      .+|.  ..     ....   ..++.+++..|..||+..                                          
T Consensus       100 ~~l~--~~-----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A          100 QDLL--SS-----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             EETT--TS-----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             cccC--cC-----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            8773  11     1121   245667777777777643                                          


Q ss_pred             ----------------ceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          256 ----------------LIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       256 ----------------iiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                                      ++|+|++|.|||++.++.++|+||+.|...
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                            999999999999987777789999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.37  E-value=1.6e-12  Score=119.31  Aligned_cols=138  Identities=13%  Similarity=0.253  Sum_probs=104.7

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEee--CCCCChHHHHHHHHHHHHHHHHHHcCC--CCCeeeeeEEEEcC---CeEEE
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILE--RPENDPEKAQVMEQQFQQEVMMLATLK--HPNIVRFIGACRKP---MVWCI  210 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~---~~~~i  210 (303)
                      +.|+.|.++.||+....+..+++|+..  ......     ....+.+|+.+++.+.  +..+++++.++.+.   ...|+
T Consensus        44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~-----~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLP-----SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EECCC-CCSCEEEEECSSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCC-----cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            468899999999998877888999875  322111     1146778999999887  45688899988776   34689


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-------------------------------------  253 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-------------------------------------  253 (303)
                      ||||++|..+.+..    ...++......++.+++..|..||+                                     
T Consensus       119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            99999987764311    1236778888999999999999997                                     


Q ss_pred             ---------------------CCceeCCCCCCcEEEcCCC--cEEEeccCCcee
Q 046106          254 ---------------------LGLIHRDLKSDNLLIFSDK--SIKIADFGVARI  284 (303)
Q Consensus       254 ---------------------~giiHrDlkp~NILv~~~~--~vKl~DFGla~~  284 (303)
                                           ..++|+|+++.|||++.++  .+.|+||+.|..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 3599999999999999775  369999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.91  E-value=3.8e-09  Score=94.52  Aligned_cols=133  Identities=22%  Similarity=0.228  Sum_probs=96.7

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCC--eeeeeEEEEcCC---eEEEE
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPN--IVRFIGACRKPM---VWCIV  211 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpn--iv~l~~~~~~~~---~~~iv  211 (303)
                      +.++.|.+..||+..   ..+++|+....        .....+.+|+.+|+.+. +..  +++++.......   ..|+|
T Consensus        26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN---RDFIFKFPKHS--------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CEEEECSSEEEEEST---TSEEEEEESSH--------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             EecCCCCcceEEEEC---CEEEEEecCCc--------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            358899999999764   56889986431        11257889999998873 332  445555443332   34789


Q ss_pred             EeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 046106          212 TEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR--------------------------------------  253 (303)
Q Consensus       212 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------  253 (303)
                      ||+++|.++.+....    .++......++.|++..|..||+                                      
T Consensus        95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            999999888654332    36677777888888888888885                                      


Q ss_pred             --------------------CCceeCCCCCCcEEEcC--CCcEEEeccCCceee
Q 046106          254 --------------------LGLIHRDLKSDNLLIFS--DKSIKIADFGVARIE  285 (303)
Q Consensus       254 --------------------~giiHrDlkp~NILv~~--~~~vKl~DFGla~~~  285 (303)
                                          ..++|+|++|.||++++  ...+.|+||+.+...
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                                23799999999999998  567899999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.84  E-value=6.2e-08  Score=86.88  Aligned_cols=133  Identities=19%  Similarity=0.182  Sum_probs=90.5

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCC---CeeeeeEEEE-cCCeEEEEEe
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHP---NIVRFIGACR-KPMVWCIVTE  213 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp---niv~l~~~~~-~~~~~~iv~E  213 (303)
                      +.++.|....||+.   +..+++|+.+.    .    .....+.+|+.+|+.+.+.   .+.+++.++. .....++|||
T Consensus        25 ~~l~~G~~n~v~~v---g~~~VlR~~~~----~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           25 ESLGEGFRNYAILV---NGDWVFRFPKS----Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEECSSEEEEEE---TTTEEEEEESS----H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eecCCCcceeEEEE---CCEEEEEecCC----c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            34788888899987   67788898532    1    1125788999999998742   3567777764 3445689999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL---------------------------------------  254 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------------------------------------  254 (303)
                      +++|.++.+....    .++......++.+++..|..||+.                                       
T Consensus        94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            9999877653211    133444444444444444444431                                       


Q ss_pred             ---------------------CceeCCCCCCcEEEcC---CCc-EEEeccCCceee
Q 046106          255 ---------------------GLIHRDLKSDNLLIFS---DKS-IKIADFGVARIE  285 (303)
Q Consensus       255 ---------------------giiHrDlkp~NILv~~---~~~-vKl~DFGla~~~  285 (303)
                                           .++|+|++|.|||++.   ++. +.|+||+.+...
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                 3699999999999987   355 589999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.75  E-value=1.7e-07  Score=81.85  Aligned_cols=131  Identities=22%  Similarity=0.174  Sum_probs=92.0

Q ss_pred             ecccCce-EEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEeec
Q 046106          140 FAQGAFG-KLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       140 lG~G~fg-~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      +..|..+ .||+...  .+..+.+|+-...     .    ...+.+|+.+|+.+. +--+.++++++.++...|+|||++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----V----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH-----H----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----C----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            4445554 6898765  4568899987542     1    146778999988775 334678889998888889999999


Q ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 046106          216 KGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR------------------------------------------  253 (303)
Q Consensus       216 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~------------------------------------------  253 (303)
                      +|.++.+......      .....++.+++..|.-||.                                          
T Consensus       103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            9988776544311      1122344455555555552                                          


Q ss_pred             ---------C-------CceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          254 ---------L-------GLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       254 ---------~-------giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                               .       .++|+|+.+.|||++.++.+-|+||+.|...
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                     1       2799999999999998877889999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.52  E-value=1.1e-07  Score=86.54  Aligned_cols=77  Identities=9%  Similarity=0.053  Sum_probs=52.1

Q ss_pred             cee-cccCceEEEEEEEC--------CeEEEEEEeeCCC---CChHHHHHHHHHHHHHHHHHHcCC-C--CCeeeeeEEE
Q 046106          138 DAF-AQGAFGKLYRGTYN--------GEEVAIKILERPE---NDPEKAQVMEQQFQQEVMMLATLK-H--PNIVRFIGAC  202 (303)
Q Consensus       138 ~~l-G~G~fg~Vy~~~~~--------~~~vAvK~~~~~~---~~~~~~~~~~~~~~~E~~il~~l~-h--pniv~l~~~~  202 (303)
                      +.| +.|....+|+....        ++.+++|+.....   ....      ..+.+|+.+|+.+. +  ..+.+++.++
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~------~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT------YRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC------CCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch------hHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            457 88999999988764        6789999865432   0000      24557777777764 2  3567788887


Q ss_pred             EcC---CeEEEEEeecCCCCH
Q 046106          203 RKP---MVWCIVTEYAKGGSV  220 (303)
Q Consensus       203 ~~~---~~~~iv~E~~~~gsL  220 (303)
                      ...   ...++|||+++|..+
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCC
T ss_pred             cCCCccCCceEEEEecCCCCh
Confidence            654   245799999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.48  E-value=1.5e-06  Score=78.20  Aligned_cols=31  Identities=23%  Similarity=0.347  Sum_probs=28.3

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ..++|+|+++.|||++.++.+.|+||+.|..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998888999999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.45  E-value=3.6e-07  Score=84.62  Aligned_cols=79  Identities=13%  Similarity=0.013  Sum_probs=47.1

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCC-ChHHHHHHHHHHHHHHHHHHcCCC--C-CeeeeeEEEEcCCeEEEE
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPEN-DPEKAQVMEQQFQQEVMMLATLKH--P-NIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~-~~~~~~~~~~~~~~E~~il~~l~h--p-niv~l~~~~~~~~~~~iv  211 (303)
                      +.||.|.++.||+++.  .++.++||...+... ..........++..|+.+|+.+..  | .+++++.+.  ....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence            4689999999999964  567899998754221 000000001345678888877632  3 345666543  3334799


Q ss_pred             EeecCCC
Q 046106          212 TEYAKGG  218 (303)
Q Consensus       212 ~E~~~~g  218 (303)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.09  E-value=1.5e-05  Score=71.62  Aligned_cols=74  Identities=19%  Similarity=0.164  Sum_probs=58.7

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK---HPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      +.|+.|.+..+|+....+..+++|+....     .    ...+..|+..|+.+.   ...++++++++......++||||
T Consensus        42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDEVQTVFVKINERS-----Y----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEECCSSSSEEEEEESSSCEEEEEEEEGG-----G----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             EEeCCccceeeeEEEECCCeEEEEeCCcc-----c----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            46889999999998877788999987642     1    246778888888774   36688889988877888999999


Q ss_pred             cCCCCH
Q 046106          215 AKGGSV  220 (303)
Q Consensus       215 ~~~gsL  220 (303)
                      +++..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            988653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.06  E-value=1.5e-05  Score=74.41  Aligned_cols=32  Identities=22%  Similarity=0.349  Sum_probs=28.2

Q ss_pred             hCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          253 RLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       253 ~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ...++|+|++|.|||++.++ ++|+||+.|...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            46799999999999998877 999999998753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=98.03  E-value=3.1e-07  Score=87.17  Aligned_cols=136  Identities=10%  Similarity=0.066  Sum_probs=58.6

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCCCccccCChHHHHHHhc
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRGRVSHALSDDALARALM  112 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l~  112 (303)
                      +|++...+|      ++.+|.|++|++.     +    ..++||+|++  ++.|++.... +.+..  .+-.++++..+.
T Consensus        71 ~G~FLvR~S------~~~~g~~~Lsv~~-----~----~~v~H~~I~~--~g~~~~~~~~-F~sl~--~Lv~dGl~~~~~  130 (463)
T 3cxl_A           71 EGSYLIRES------QRQPGTYTLALRF-----G----SQTRNFRLYY--DGKHFVGEKR-FESIH--DLVTDGLITLYI  130 (463)
T ss_dssp             TTEEEEEEC------SSSTTCEEEEEEC-----S----SSEEEEECEE--SSSEESSSCC-BSCHH--HHHHHHHHHHHH
T ss_pred             CCeEEEecc------CCCCCCEEEEEEE-----C----CEEEEEEEec--CCeEEECCCc-cCCHH--HHHHHHHHhhhc
Confidence            799999887      3467889999986     2    2789999987  5778765322 22111  111245555544


Q ss_pred             CCCCCCcCCCCCCcceeecCCccccceecccCceEEEEEEECC--eEEEE------EEeeCCCCChHHHHHHHHHHHHHH
Q 046106          113 DSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTYNG--EEVAI------KILERPENDPEKAQVMEQQFQQEV  184 (303)
Q Consensus       113 ~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~vAv------K~~~~~~~~~~~~~~~~~~~~~E~  184 (303)
                      .+...        .+......-.+.+.||   ||.||+|.+.+  .+||+      |..+......    .....+.+|+
T Consensus       131 ~~~~~--------~~~l~~~i~~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~----e~~~~~~rea  195 (463)
T 3cxl_A          131 ETKAA--------EYIAKMTINPIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE----KRLTSLVRRA  195 (463)
T ss_dssp             HHHTH--------HHHHHTTSSCSTTTSS---BCCC---------CCBGGGC----------------------------
T ss_pred             cCCCc--------chhhccccccccccCC---chhhhcccccccCCchhhhhccCccccccccccc----cccccccccc
Confidence            33211        0000000114556676   99999999854  47888      6654433222    1224688899


Q ss_pred             HHHHcCCCCCeeeeeEEEE
Q 046106          185 MMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       185 ~il~~l~hpniv~l~~~~~  203 (303)
                      .+++.++|||+++.+++..
T Consensus       196 ~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          196 TLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             -----------CBCCCEEE
T ss_pred             cccccccccccCCCcceEE
Confidence            9999999999999988653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.90  E-value=5.5e-05  Score=66.65  Aligned_cols=74  Identities=16%  Similarity=0.157  Sum_probs=51.3

Q ss_pred             ccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-C--CCeeeeeEEEEcCCeEEEE
Q 046106          136 MGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-H--PNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h--pniv~l~~~~~~~~~~~iv  211 (303)
                      -.+.+|.|..+.||+.+. +|+.+.+|+.........      ..|..|+..|+.+. .  --+++++++.  ..  ++|
T Consensus        19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~------~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~--~lv   88 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALD------GLFRAEALGLDWLGRSFGSPVPQVAGWD--DR--TLA   88 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCT------THHHHHHHHHHHHTCSTTCCSCCEEEEE--TT--EEE
T ss_pred             EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchh------hHHHHHHHHHHHHHhhCCCCcceEEecc--Cc--eEE
Confidence            345789999999999998 789999998654332211      35678988888774 2  2345555543  22  689


Q ss_pred             EeecCCCC
Q 046106          212 TEYAKGGS  219 (303)
Q Consensus       212 ~E~~~~gs  219 (303)
                      |||++++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99997654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.87  E-value=3.7e-05  Score=68.27  Aligned_cols=134  Identities=14%  Similarity=0.152  Sum_probs=71.9

Q ss_pred             cceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEeec
Q 046106          137 GDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI-VRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~iv~E~~  215 (303)
                      .+.|+.|....+|+.    ..+++|+........       ....+|+.+++.+...++ .++++.+.+.  -++++||+
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~-------~~r~~E~~~l~~l~~~g~~P~~~~~~~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY-------INRANEAVAAREAAKAGVSPEVLHVDPAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC----C-------CCHHHHHHHHHHHHHTTSSCCEEEECTTT--CCEEEECC
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccce-------eCHHHHHHHHHHHHHcCCCCceEEEECCC--CEEEEeec
Confidence            456888999999998    678889876532110       112356666665542122 4555543322  36899999


Q ss_pred             -CCCCHHH---------------HHHhcC--CCCC----C-HHHHHHHHH--------------HHHHHHHHH----Hh-
Q 046106          216 -KGGSVRQ---------------FLTKRQ--NRSV----P-LKLAVKQAL--------------DVARGMAYV----HR-  253 (303)
Q Consensus       216 -~~gsL~~---------------~l~~~~--~~~~----~-~~~~~~i~~--------------qi~~~l~~L----H~-  253 (303)
                       ++.++..               .|....  ...+    . ...+..+..              .+...+..|    .. 
T Consensus        90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~  169 (301)
T 3dxq_A           90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH  169 (301)
T ss_dssp             TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence             6544321               111100  0101    1 111111111              111112211    11 


Q ss_pred             ---CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 ---LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ---~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                         ..++|+|+.+.||+ ..++.+.|+||..|..
T Consensus       170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence               23899999999999 5667789999998865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.81  E-value=0.00013  Score=65.03  Aligned_cols=139  Identities=14%  Similarity=0.156  Sum_probs=77.0

Q ss_pred             ceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC--eeeeeEE------EEcCCeEE
Q 046106          138 DAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN--IVRFIGA------CRKPMVWC  209 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~------~~~~~~~~  209 (303)
                      +.|+.|....+|+....+..+++|+...... .       ..+..|+.++..+....  +++++..      .......+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~-~-------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKDPLILTLYEKRVE-K-------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEECC---EEEEEEEESSCCEEEEEECC----C-------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eccCCCcccceEEEEeCCccEEEEEeCCCCC-H-------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            4577888889999987656788999865211 1       23445666665553111  2333321      12234568


Q ss_pred             EEEeecCCCCHH-----------HH---HHhc-CCCC------CC---HHHHHH------------HHHHHHHHHHHHHh
Q 046106          210 IVTEYAKGGSVR-----------QF---LTKR-QNRS------VP---LKLAVK------------QALDVARGMAYVHR  253 (303)
Q Consensus       210 iv~E~~~~gsL~-----------~~---l~~~-~~~~------~~---~~~~~~------------i~~qi~~~l~~LH~  253 (303)
                      ++++|++|..+.           ..   ++.. ....      ..   |.....            +...+...++.+..
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999875421           11   1111 0000      01   111100            00123445566653


Q ss_pred             -------CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 -------LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 -------~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                             .+++|+|+.+.|||++.++.+.|+||+.|..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                   3699999999999998876678999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.69  E-value=0.00041  Score=62.25  Aligned_cols=32  Identities=28%  Similarity=0.608  Sum_probs=27.9

Q ss_pred             CCceeCCCCCCcEEEcCC----CcEEEeccCCceee
Q 046106          254 LGLIHRDLKSDNLLIFSD----KSIKIADFGVARIE  285 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~----~~vKl~DFGla~~~  285 (303)
                      ..++|+|+.+.|||++.+    +.+.|+||+.|...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999875    68999999998753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.63  E-value=0.00048  Score=61.47  Aligned_cols=136  Identities=15%  Similarity=0.132  Sum_probs=75.4

Q ss_pred             eecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC--CCeeeeeEE-----EEcCCeEEE
Q 046106          139 AFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH--PNIVRFIGA-----CRKPMVWCI  210 (303)
Q Consensus       139 ~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~-----~~~~~~~~i  210 (303)
                      .++ |....||+... +|+.+++|+.+......       ..+..|..++..+..  -.+++++..     .......++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~-------~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~  104 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  104 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH-------HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence            355 77789998876 56689999987543322       244556666665531  123444432     122345678


Q ss_pred             EEeecCCCCHH-----------HHH---Hhc-CC------CCCCHHHH----HHH---------------HHHHHHHHHH
Q 046106          211 VTEYAKGGSVR-----------QFL---TKR-QN------RSVPLKLA----VKQ---------------ALDVARGMAY  250 (303)
Q Consensus       211 v~E~~~~gsL~-----------~~l---~~~-~~------~~~~~~~~----~~i---------------~~qi~~~l~~  250 (303)
                      ++|+++|..+.           ..|   +.. ..      ....+...    ..+               ...+...++.
T Consensus       105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  184 (328)
T 1zyl_A          105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA  184 (328)
T ss_dssp             EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred             EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence            99999874321           111   110 00      01111111    000               0111112333


Q ss_pred             HH-------hCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          251 VH-------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       251 LH-------~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +.       ...++|+|+++.|||++ + .+.|+||+.|..
T Consensus       185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            32       23589999999999998 4 899999998865

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.58  E-value=0.00015  Score=66.80  Aligned_cols=136  Identities=15%  Similarity=0.234  Sum_probs=79.4

Q ss_pred             ceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCe
Q 046106          138 DAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMV  207 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~  207 (303)
                      +.|..|....+|+....         ++.+++|+.-.....       ...+.+|..+++.+. +.-..++++.+..   
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~-------~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG-------VDSLVLESVMFAILAERSLGPQLYGVFPE---  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC-------HHHHHHHHHHHHHHHHTTSSCCEEEEETT---
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch-------HHHHHHHHHHHHHHHhcCCCCeEEEEcCC---
Confidence            45767888889998863         368899986331111       134558888887774 3333666766643   


Q ss_pred             EEEEEeecCCCCHH--------------HHHHhcC------CCCCC--HHHHHHHHHHHHH-------------------
Q 046106          208 WCIVTEYAKGGSVR--------------QFLTKRQ------NRSVP--LKLAVKQALDVAR-------------------  246 (303)
Q Consensus       208 ~~iv~E~~~~gsL~--------------~~l~~~~------~~~~~--~~~~~~i~~qi~~-------------------  246 (303)
                       .+|+||++|..|.              +.|....      +....  +.++.++..++..                   
T Consensus       126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence             3899999875432              1111111      11111  3445555444321                   


Q ss_pred             HHHHHH----hC----CceeCCCCCCcEEEcCC----CcEEEeccCCcee
Q 046106          247 GMAYVH----RL----GLIHRDLKSDNLLIFSD----KSIKIADFGVARI  284 (303)
Q Consensus       247 ~l~~LH----~~----giiHrDlkp~NILv~~~----~~vKl~DFGla~~  284 (303)
                      .++.|.    ..    .++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            233333    22    49999999999999876    7899999999864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.41  E-value=0.0023  Score=60.44  Aligned_cols=71  Identities=13%  Similarity=0.099  Sum_probs=45.7

Q ss_pred             ceecccCceEEEEEEECC--eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe-eeeeEEEEcCCeEEEEEee
Q 046106          138 DAFAQGAFGKLYRGTYNG--EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI-VRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~~iv~E~  214 (303)
                      +.|+.|-...+|+....+  ..+++|+.........       ...+|..+++.+...++ +++++.+.  +  .+|+||
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-------dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~  182 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-------NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF  182 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-------CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-------CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence            468888889999999865  8899998754321110       11468888888764434 56777763  2  359999


Q ss_pred             cCCCC
Q 046106          215 AKGGS  219 (303)
Q Consensus       215 ~~~gs  219 (303)
                      ++|.+
T Consensus       183 I~G~~  187 (458)
T 2qg7_A          183 MDGYA  187 (458)
T ss_dssp             CCSEE
T ss_pred             eCCcc
Confidence            98743

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.40  E-value=0.00064  Score=63.62  Aligned_cols=68  Identities=15%  Similarity=0.243  Sum_probs=45.4

Q ss_pred             ceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC-eeeeeEEEEcCCe
Q 046106          138 DAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN-IVRFIGACRKPMV  207 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~  207 (303)
                      +.|+.|....||+....         ++.+++|+..... ..       ..+.+|..+++.+...+ .+++++.+..   
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~-------~~li~E~~~l~~L~~~g~~P~l~~~~~~---  147 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE-------SHLVAESVIFTLLSERHLGPKLYGIFSG---  147 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH-------HHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cH-------HHHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence            46788888999999874         4689999884321 10       13446888887775323 3667766542   


Q ss_pred             EEEEEeecCC
Q 046106          208 WCIVTEYAKG  217 (303)
Q Consensus       208 ~~iv~E~~~~  217 (303)
                       .+|+||++|
T Consensus       148 -g~v~e~l~G  156 (429)
T 1nw1_A          148 -GRLEEYIPS  156 (429)
T ss_dssp             -EEEECCCCE
T ss_pred             -CEEEEEeCC
Confidence             388999976

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.38  E-value=0.00018  Score=65.69  Aligned_cols=71  Identities=11%  Similarity=0.159  Sum_probs=41.3

Q ss_pred             ceecccCceEEEEEEECC----------eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCC-eeeeeEEEEcCC
Q 046106          138 DAFAQGAFGKLYRGTYNG----------EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPN-IVRFIGACRKPM  206 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~----------~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~  206 (303)
                      +.|+.|....+|+....+          ..+++|+........       .....|..+++.+...+ ++++++..  +.
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~~~~~E~~~l~~L~~~g~~P~~~~~~--~~  109 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-------YNTISEFEVYKTMSKYKIAPQLLNTF--NG  109 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-------SCHHHHHHHHHHHHHTTSSCCEEEEE--TT
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-------ecHHHHHHHHHHHHhcCCCCceEEec--CC
Confidence            457778888999998754          688899875421100       01246777777664222 44666554  22


Q ss_pred             eEEEEEeecCCCC
Q 046106          207 VWCIVTEYAKGGS  219 (303)
Q Consensus       207 ~~~iv~E~~~~gs  219 (303)
                        ++|+||++|..
T Consensus       110 --~~v~e~i~G~~  120 (369)
T 3c5i_A          110 --GRIEEWLYGDP  120 (369)
T ss_dssp             --EEEEECCCSEE
T ss_pred             --cEEEEEecCCc
Confidence              68999998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.06  E-value=0.0077  Score=54.26  Aligned_cols=32  Identities=28%  Similarity=0.441  Sum_probs=28.5

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                      ..++|+|+.+.||++++++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46999999999999998888999999988753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.72  E-value=0.0027  Score=59.30  Aligned_cols=71  Identities=13%  Similarity=0.142  Sum_probs=44.9

Q ss_pred             ceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCe
Q 046106          138 DAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMV  207 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~  207 (303)
                      +.|..|....+|+....         ++.+++|+........       -...+|..+++.+. +.-.+++++.+  +. 
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-------idR~~E~~~l~~L~~~gi~P~l~~~~--~~-  145 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-------YDSKVELDVFRYLSNINIAPNIIADF--PE-  145 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-------CCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-------cCHHHHHHHHHHHHhcCCCCCEEEEc--CC-
Confidence            45667888899999875         5789999865432111       12236777776664 32345566543  22 


Q ss_pred             EEEEEeecCCCC
Q 046106          208 WCIVTEYAKGGS  219 (303)
Q Consensus       208 ~~iv~E~~~~gs  219 (303)
                       ++|+||++|..
T Consensus       146 -~~I~efI~G~~  156 (424)
T 3mes_A          146 -GRIEEFIDGEP  156 (424)
T ss_dssp             -EEEEECCCSEE
T ss_pred             -CEEEEEeCCcc
Confidence             68999998854

>3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens}

Probab=96.65  E-value=0.00012  Score=56.23  Aligned_cols=70  Identities=10%  Similarity=0.128  Sum_probs=47.7

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee--eccCCC---Cccc-cCChHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH--SVNRRG---RVSH-ALSDDA  106 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~--~~~~~~---~~~~-~~~~~~  106 (303)
                      .|++...+|.      +.+ +|++||++...      ...|+||+|++. +++|+|..  ...+++   +|.| ....++
T Consensus        37 ~GaFLVR~Se------~~~-~ySLSVR~~~~------~~~VKHYkI~~~-~G~y~I~~~~~~~F~SL~eLV~yY~~~adG  102 (125)
T 3maz_A           37 LGNMILRPGS------DSR-NYSITIRQEID------IPRIKHYKVMSV-GQNYTIELEKPVTLPNLFSVIDYFVKETRG  102 (125)
T ss_dssp             GCSEEEEECT------TSS-SEEEEEEECSS------SCEEEEEEEEEE-TTEEEECSSSCEEESSHHHHHHHHHHHTTT
T ss_pred             CCcEEEEeCC------CCC-CEEEEEEecCC------CCCEeeeEEEEe-CCEEEEecCCCcCcCCHHHHHHHHHhCCCc
Confidence            5888887772      223 79999998422      248999999998 78999983  333444   4555 667777


Q ss_pred             HHHHhcCCCC
Q 046106          107 LARALMDSNS  116 (303)
Q Consensus       107 ~~~~l~~~~~  116 (303)
                      ++..|..||.
T Consensus       103 l~~~L~~~c~  112 (125)
T 3maz_A          103 NLRPFIASTD  112 (125)
T ss_dssp             CCCBCCC---
T ss_pred             Cccccccccc
Confidence            7887777773

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.84  E-value=0.021  Score=52.64  Aligned_cols=29  Identities=21%  Similarity=0.443  Sum_probs=25.4

Q ss_pred             ceeCCCCCCcEEE------cCCCcEEEeccCCcee
Q 046106          256 LIHRDLKSDNLLI------FSDKSIKIADFGVARI  284 (303)
Q Consensus       256 iiHrDlkp~NILv------~~~~~vKl~DFGla~~  284 (303)
                      ++|+|+.+.|||+      +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4467899999999865

>1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F*

Probab=95.76  E-value=0.0014  Score=48.87  Aligned_cols=49  Identities=18%  Similarity=0.248  Sum_probs=36.8

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +|++...+|-      +.+|.|+||++......    ...++||+|++..++.|++...
T Consensus        28 ~G~FLVR~S~------~~~g~~~LSv~~~~~~~----~~~v~H~~I~~~~~g~~~l~~~   76 (106)
T 1aot_F           28 RGTFLIRESE------TTKGAYSLSIRDWDDMK----GDHVKHYKIRKLDNGGYYITTR   76 (106)
T ss_dssp             TTEECCBCBS------SSSSBBCCEEECCBTTT----BCCEEECCBEEETTTEEEEETT
T ss_pred             CcEEEEEeCC------CCCCCEEEEEEecccCC----CCcEEEEEEEEeCCCCEEECCC
Confidence            6999998772      45789999998643211    2379999999988888988743

>1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A*

Probab=95.33  E-value=0.0016  Score=48.38  Aligned_cols=48  Identities=19%  Similarity=0.324  Sum_probs=36.1

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      +|++...+|-      +.+|.|+||++......    ...++||+|.+..++.|++..
T Consensus        27 ~G~FLVR~S~------~~~g~~~LSv~~~~~~~----~~~v~H~~I~~~~~g~~~l~~   74 (105)
T 1lkk_A           27 HGSFLIRESE------STAGSFSLSVRDFDQNQ----GEVVKHYKIRNLDNGGFYISP   74 (105)
T ss_dssp             TTCEEEEECS------SSTTCEEEEEEEEETTT----EEEEEEEEEEECTTSCEESST
T ss_pred             CceEEEEECC------CCCCcEEEEEEEcccCC----CCcEEEEEEEECCCCCEEECC
Confidence            6999998772      45789999998643211    247999999998888888764

>4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A*

Probab=95.19  E-value=0.0023  Score=52.20  Aligned_cols=73  Identities=21%  Similarity=0.332  Sum_probs=46.8

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      +|++...+|      .+.+|.|+||++......    ...++||+|++..++.|++.....+.+   ++.+ ....+.++
T Consensus        97 ~G~FLVR~S------~~~~g~y~LSv~~~~~~~----~~~v~H~~I~~~~~g~~~~~~~~~F~sl~~LV~~y~~~~~gl~  166 (175)
T 4d8k_A           97 HGSFLIRES------ESTAGSFSLSVRDFDQNQ----GEVVKHYKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLC  166 (175)
T ss_dssp             TTCEEEEEC------SSSTTCEEEEEEEECTTS----CEEEEEEEEEECSSSCEESSTTSEESSHHHHHHHHHHCCTTSS
T ss_pred             CCEEEEEEC------CCCCCeEEEEEEeCcccC----CCceEEEEEEECCCCCEEECCCCccCCHHHHHHHHhhCCCCCc
Confidence            789988877      356788999998643222    247999999998888888765333333   3333 33444444


Q ss_pred             HHhcCCC
Q 046106          109 RALMDSN  115 (303)
Q Consensus       109 ~~l~~~~  115 (303)
                      ..|..||
T Consensus       167 ~~L~~Pc  173 (175)
T 4d8k_A          167 TRLSRPC  173 (175)
T ss_dssp             SCCCSBC
T ss_pred             ccCCCcC
Confidence            4444444

>1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A

Probab=94.98  E-value=0.0041  Score=46.91  Aligned_cols=47  Identities=19%  Similarity=0.384  Sum_probs=36.1

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      +|++...+|      ++.+|.|+||++..+..     ...++||+|.+..++.|++..
T Consensus        35 ~G~FLVR~S------~~~~g~y~LSv~~~~~~-----~~~v~H~~I~~~~~g~~~l~~   81 (114)
T 1blj_A           35 AGSFLIRES------ESNKGAFSLSVKDITTQ-----GEVVKHYKIRSLDNGGYYISP   81 (114)
T ss_dssp             TTCEEBCBC------TTCSSCEEEEECBCCTT-----TCBCCCEEEEEETTTEEEEET
T ss_pred             CceEEEEeC------CCCCCCEEEEEEEecCC-----CCcEEEEEEEEcCCCCEEECC
Confidence            699999877      24578999999864321     237999999998888898874

>3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B

Probab=94.35  E-value=0.016  Score=43.73  Aligned_cols=76  Identities=20%  Similarity=0.186  Sum_probs=46.9

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccc--cccCCCCeeeeeeccCCC---Cccc-cCChHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGL--RRRANDNYSVAHSVNRRG---RVSH-ALSDDA  106 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i--~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~  106 (303)
                      +|++...+|       +.+|.|+||++....+.   ....++||+|  .+..++.|++.....+.+   ++.+ ....+.
T Consensus        31 ~G~FLVR~S-------~~~g~y~LSv~~~~~~~---~~~~v~H~~I~~~~~~~g~~~~~~~~~F~sl~~LV~~y~~~~~~  100 (118)
T 3s9k_A           31 EGAFMVRDS-------RTPGTYTVSVFTKAIIS---ENPCIKHYHIKETNDSPKRYYVAEKYVFDSIPLLIQYHQYNGGG  100 (118)
T ss_dssp             TTCEEEEEC-------SSTTCEEEEEEECCSCS---SSCEEEEEEEEECSCSSCCEEEECSCCCSCHHHHHHHHHHCCTT
T ss_pred             CCeEEEEee-------CCCCCEEEEEEeccccc---CCCceEEEEEeEEECCCCCEEECCCcccCCHHHHHHHheeCCCC
Confidence            799999877       24678999999753221   1247999999  456778888875444443   2333 333344


Q ss_pred             HHHHhcCCCCCC
Q 046106          107 LARALMDSNSPT  118 (303)
Q Consensus       107 ~~~~l~~~~~~~  118 (303)
                      +...|..|+.+.
T Consensus       101 l~~~L~~Pv~~~  112 (118)
T 3s9k_A          101 LVTRLRYPVCGS  112 (118)
T ss_dssp             SSSCCCCCCCCS
T ss_pred             CccCCCCcCCCC
Confidence            444455555443

>1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1

Probab=93.84  E-value=0.0089  Score=43.91  Aligned_cols=44  Identities=18%  Similarity=0.237  Sum_probs=34.9

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +|++...+|-      +.+|.|+||++.     +    ..++||+|.+..++.|++...
T Consensus        25 ~G~FLVR~S~------~~~g~~~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~~   68 (100)
T 1rja_A           25 TGAFLIRVSE------KPSADYVLSVRD-----T----QAVRHYKIWRRAGGRLHLNEA   68 (100)
T ss_dssp             SCCEEEEECS------SSSSCEEEEECT-----T----SSCEEEEEEECSSSCEEEETT
T ss_pred             CCEEEEEeCC------CCCCCEEEEEEE-----C----CEEEEEEEEEcCCCcEEECCC
Confidence            7999998772      456889999985     2    278999999988888988743

>2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=93.79  E-value=0.014  Score=44.45  Aligned_cols=44  Identities=16%  Similarity=0.257  Sum_probs=34.7

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +|+|...+|      ++.+|.|+||++..         ..++||+|++..++.|++...
T Consensus        37 ~G~FLVR~S------~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~~~   80 (119)
T 2ecd_A           37 NGSFLVRES------ESSPGQLSISLRYE---------GRVYHYRINTTADGKVYVTAE   80 (119)
T ss_dssp             TTBEEEEEE------SSSTTEEEEEEECS---------SCEEEECCCCCSSSCCCCCSS
T ss_pred             CCeEEEEeC------CCCCCCEEEEEEEC---------CeEEEEEEEEcCCCCEEEcCC
Confidence            799998877      24578999999862         278999999988888887643

>2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus}

Probab=93.77  E-value=0.015  Score=44.32  Aligned_cols=69  Identities=17%  Similarity=0.198  Sum_probs=44.5

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      +|+|...+|-      +.+|.|+||++.     +    ..++||+|.+..++.|++.....+.+   ++.+ ....+.+.
T Consensus        39 ~G~FLVR~S~------~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~~~~F~sl~eLV~~y~~~~~~l~  103 (121)
T 2dly_A           39 TGAFLIRESE------SQKGDFSLSVLD-----E----GVVKHYRIRRLDEGGFFLTRRKVFSTLNEFVNYYTTTSDGLC  103 (121)
T ss_dssp             TTCEEEEECS------SSSSCEEEEEES-----S----SCEEEEEEEECSSSCEEEETTEEESSHHHHHHHHTTCCSSSS
T ss_pred             CCEEEEEcCC------CCCCceEEEEEE-----C----CeEEEEEEEEcCCCCEEECCCCccCCHHHHHHHHhhCCCCCc
Confidence            4999988772      457889999986     2    27999999998888899874333332   3333 33333344


Q ss_pred             HHhcCCCC
Q 046106          109 RALMDSNS  116 (303)
Q Consensus       109 ~~l~~~~~  116 (303)
                      ..|..|+.
T Consensus       104 ~~L~~P~~  111 (121)
T 2dly_A          104 VKLEKPCL  111 (121)
T ss_dssp             SCCCSBCC
T ss_pred             eeCCeecC
Confidence            44444443

>2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens}

Probab=93.71  E-value=0.048  Score=41.31  Aligned_cols=47  Identities=19%  Similarity=0.362  Sum_probs=35.3

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +|+|...+|      ++.+|.|+||++....+     ...|+||+|.+ .++.|++...
T Consensus        43 ~G~FLVR~S------~~~~g~y~LSv~~~~~~-----~~~v~H~~I~~-~~g~~~i~~~   89 (118)
T 2el8_A           43 CGNLLLRPS------GDGADGVSVTTRQMHNG-----THVVRHYKVKR-EGPKYVIDVE   89 (118)
T ss_dssp             TCSBEEEEC------CSSSSSEEEEECCCBTT-----BCCCEEECBCC-BTTBCCBSSS
T ss_pred             CcEEEEeeC------CCCCCceEEEEEEecCC-----CCcEEEEEEEE-cCCEEEEeCC
Confidence            699999877      24578899999864311     23799999998 6788887643

>2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=93.31  E-value=0.019  Score=44.05  Aligned_cols=50  Identities=24%  Similarity=0.270  Sum_probs=36.7

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      -+|+|...+| +      .+|.|+||++....+.   ....|+||+|.+..++.|++...
T Consensus        37 ~~G~FLVR~S-~------~~g~y~LSv~~~~~~~---~~~~v~H~~I~~~~~g~~~l~~~   86 (125)
T 2dm0_A           37 KEGAFIVRDS-R------HLGSYTISVFMGARRS---TEAAIKHYQIKKNDSGQWYVAER   86 (125)
T ss_dssp             STTCBCEEEE-T------TEEEEEEEEECCCSSS---SSCCEEEEEEEECTTCCEESSSS
T ss_pred             CCCEEEEEec-C------CCCCEEEEEEeccccC---CCCcEEEEEEEEcCCCCEEECCC
Confidence            4699999887 2      3678999999643221   12479999999988888888643

>3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A

Probab=93.09  E-value=0.0095  Score=44.71  Aligned_cols=70  Identities=16%  Similarity=0.195  Sum_probs=45.1

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      +|++...+|      .+.+|.|+||++.     +    ..++||+|.+..++.|++.....+.+   ++.+ ....+++.
T Consensus        26 ~G~FLVR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~~~~~~~F~sl~~LV~~y~~~~~~l~   90 (112)
T 3k2m_A           26 NGSFLVRES------ESSPGQRSISLRY-----E----GRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLI   90 (112)
T ss_dssp             TTEEEEEEC------SSSTTCEEEEEEE-----T----TEEEEEEEEECTTSCEESSTTCCBSSHHHHHHHHHHCCTTSS
T ss_pred             CceEEEEeC------CCCCCCEEEEEEe-----C----CcEEEEEEEECCCCcEEECCCCeECCHHHHHHHHhhCCCCCc
Confidence            688888776      3457899999987     2    27999999998888887754333333   2333 33344444


Q ss_pred             HHhcCCCCC
Q 046106          109 RALMDSNSP  117 (303)
Q Consensus       109 ~~l~~~~~~  117 (303)
                      ..|..|+.+
T Consensus        91 ~~L~~P~~~   99 (112)
T 3k2m_A           91 TTLHYPAPK   99 (112)
T ss_dssp             SCCCEECCC
T ss_pred             cCCCCCCCC
Confidence            445544443

>2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=92.93  E-value=0.074  Score=40.82  Aligned_cols=52  Identities=8%  Similarity=0.158  Sum_probs=38.4

Q ss_pred             hHHHHHhc------CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           25 QGFYHKLG------EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        25 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +.+||.|-      .|+++..+|      + .+|.|+||++...       ...|+||+|++..+ .|++...
T Consensus        30 ~~Wyh~Ll~~g~~~dG~FLVR~S------~-~~g~y~LSv~~~~-------~~~vkH~rI~~~~~-~~~i~~~   87 (126)
T 2cr4_A           30 ERLFKATSPRGEPQDGLYCIRNS------S-TKSGKVLVVWDET-------SNKVRNYRIFEKDS-KFYLEGE   87 (126)
T ss_dssp             HHHHHHHSTTSCCCTTCEEEEEC------S-STTCEEEEEEETT-------TTEECCEECEEETT-EEESSSS
T ss_pred             CCCHHHHhhCCCCCCCeEEEEec------C-CCCCEEEEEEeCC-------CCCEEEEEEEECCC-eEEEcCC
Confidence            36888772      299999887      2 5789999999731       13799999998765 7777543

>2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens}

Probab=92.75  E-value=0.089  Score=39.13  Aligned_cols=49  Identities=20%  Similarity=0.253  Sum_probs=36.2

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      -+|++...+|       ..+|.|+||++..+.+..   ...++||+|++..++.|++..
T Consensus        32 ~~G~FLVR~S-------~~~g~y~LSv~~~~~~~~---~~~v~H~~I~~~~~g~~~l~~   80 (110)
T 2ekx_A           32 KEGAFMVRNS-------SQVGMYTVSLFSKAVNDK---KGTVKHYHVHTNAENKLYLAE   80 (110)
T ss_dssp             CTTEEEEEEC-------SSTTCEEEEECCCCSSCS---SCCCEEEECEECTTCCEESST
T ss_pred             CCceEEEEec-------CCCCCEEEEEEeccccCC---CCcEEEEEEEECCCCCEEECC
Confidence            4699999887       237889999986442211   237999999998888888764

>4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A*

Probab=92.56  E-value=0.024  Score=48.86  Aligned_cols=45  Identities=13%  Similarity=0.240  Sum_probs=34.4

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCC---Ceeeeeec
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRAND---NYSVAHSV   92 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~---~~~i~~~~   92 (303)
                      +|+|...+|      .+.+|.|+||+...         ..++||+|.+..++   .|++....
T Consensus        36 dG~FLVR~S------~s~~G~y~LSv~~~---------~~v~H~~I~~~~~~g~~~~~~~~~~   83 (246)
T 4fbn_A           36 DGSFLVRES------ETFVGDYTLSFWRN---------GKVQHCRIHSRQDAGTPKFFLTDNL   83 (246)
T ss_dssp             TTCEEEEEC------SSSTTCEEEEEEET---------TEEEEEEEEEECGGGCCEEEEETTE
T ss_pred             CCEEEEEcC------CCCCCCEEEEEEEC---------CEEEEEEEEEECCCCceeEEecCCc
Confidence            699999887      46789999999862         27999999887655   36666443

>1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A*

Probab=91.92  E-value=0.14  Score=37.10  Aligned_cols=49  Identities=18%  Similarity=0.208  Sum_probs=37.1

Q ss_pred             HHHHhc-CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           27 FYHKLG-EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        27 ~~~~~~-~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      .++.-+ +|++...+|-      +.+|.|+||++..         ..++||+|.+..++.|++..
T Consensus        18 lL~~~~~~G~FLVR~S~------~~~g~~~LSv~~~---------~~v~H~~I~~~~~g~~~l~~   67 (96)
T 1jyr_A           18 MLSKQRHDGAFLIRESE------SAPGDFSLSVKFG---------NDVQHFKVLRDGAGKYFLWV   67 (96)
T ss_dssp             HHHTCCSTTBEEEEECS------SSTTCEEEEEEET---------TEEEEEECEECTTSCEESSS
T ss_pred             HHhcCCCCcEEEEEecC------CCCCCEEEEEEeC---------CeEEEEEEEEcCCCCEEECC
Confidence            344444 7999998772      4578899999972         27999999998788888763

>2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A

Probab=91.68  E-value=0.056  Score=41.76  Aligned_cols=50  Identities=12%  Similarity=0.187  Sum_probs=34.5

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCC-CCCcC-----ccccccccccccCCCCeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVG-SNESH-----TRILNHQGLRRRANDNYSV   88 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~-~~~~~-----~~~v~h~~i~~~~~~~~~i   88 (303)
                      .+|+|...+|      ++.+|.|+||++..... +.+..     ...|+||+|++..++ |++
T Consensus        40 ~~G~FLVR~S------~s~~g~y~LSv~~~~~~~~~~~~~g~~~~~~v~H~~I~~~~~g-~~l   95 (131)
T 2kno_A           40 DPGAFLIRDS------HSFQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIETGPKG-VKI   95 (131)
T ss_dssp             CTTBEEEEEC------SSSTTEEEEEEECSCCSSSSSSCCSCHHHHHEEEEEEECCSSC-CCE
T ss_pred             CCCeEEEecC------CCCCCCEEEEEEeCCCCcccccccccccCCceEEEEEEECCCC-CEE
Confidence            5799999877      34678999999974311 11111     137999999987665 877

>2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens}

Probab=91.62  E-value=0.11  Score=39.58  Aligned_cols=50  Identities=26%  Similarity=0.319  Sum_probs=36.9

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      -+|+|...+| +      .+|.|+||++..+.+.   ....|+||+|++..++.|++...
T Consensus        32 ~~G~FLVR~S-s------~~g~y~LSv~~~~~~~---~~~~v~H~~I~~~~~g~~~l~~~   81 (125)
T 2ge9_A           32 KEGGFIVRDS-S------KAGKYTVSVFAKSTGD---PQGVIRHYVVCSTPQSQYYLAEK   81 (125)
T ss_dssp             CTTEEEEEEC-S------SSCCEEEEEEESSSSS---TTCEEEEEECEEETTTEEESSTT
T ss_pred             CCceEEEEec-C------CCCCEEEEEEeccccC---CCCeEEEEEEEEcCCCCEEECCC
Confidence            4699999887 2      3788999999754322   12479999999988888887643

>3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A

Probab=91.43  E-value=0.018  Score=41.94  Aligned_cols=43  Identities=14%  Similarity=0.219  Sum_probs=32.7

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      .+|++...+|      ++.+|.|+||++.     +    ..++||+|.+ .++.|++..
T Consensus        25 ~~G~FLVR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~-~~~~~~~~~   67 (98)
T 3us4_A           25 EDGLFLVRES------ARHPGDYVLCVSF-----G----RDVIHYRVLH-RDGHLTIDE   67 (98)
T ss_dssp             CTTCEEEEEC------SSSTTCEEEEEEE-----T----TEEEEEEEEE-ETTEEESSS
T ss_pred             CCcEEEEEeC------CCCCCcEEEEEEE-----C----CceEEEEEEE-eCCEEEECC
Confidence            3688888776      3567899999987     2    2799999987 456777754

>3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A

Probab=90.90  E-value=0.02  Score=42.48  Aligned_cols=44  Identities=16%  Similarity=0.238  Sum_probs=32.9

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      .+|++...+|      ++.+|.|+||++.     +    ..++||+|.+. ++.|++...
T Consensus        28 ~~G~FLVR~S------~~~~g~~~LSv~~-----~----~~v~H~~I~~~-~g~~~l~~~   71 (106)
T 3eaz_A           28 ETGLFLVRES------TNYPGDYTLCVSS-----D----GKVEHYRIMYH-ASKLSIDEE   71 (106)
T ss_dssp             CTTEEEEEEC------TTSTTCEEEEEEE-----T----TEEEEEECEEE-TTEEESSSS
T ss_pred             CCCEEEEEEC------CCCCCcEEEEEEe-----C----CceEEEEEEec-CCEEEECCC
Confidence            3688888776      3567899999986     2    27999999864 677877643

>1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A*

Probab=90.54  E-value=0.18  Score=36.89  Aligned_cols=44  Identities=14%  Similarity=0.159  Sum_probs=34.9

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      -+|++...+|      ++.+|.|+||++.     +    ..++||+|.+..++.|.+..
T Consensus        25 ~~G~FLVR~S------~~~~g~~~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~   68 (104)
T 1d4t_A           25 LDGSYLLRDS------ESVPGVYCLCVLY-----H----GYIYTYRVSQTETGSWSAET   68 (104)
T ss_dssp             CTTEEEEEEC------SSSTTCEEEEEEE-----T----TEEEEEEEEECTTSCEEECB
T ss_pred             CCCEEEEeeC------CCCCCCEEEEEEE-----C----CeEEEEEEEECCCCeEEEec
Confidence            4699999877      2457889999986     2    27999999987788888763

>3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ...

Probab=90.27  E-value=0.19  Score=37.81  Aligned_cols=43  Identities=19%  Similarity=0.253  Sum_probs=34.6

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      +|++...+|      ++.+|.|+||++.     +    ..++||+|.+..++.|++..
T Consensus        28 ~G~FLVR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~   70 (117)
T 3ov1_A           28 DGAFLIRES------ESAPGDFSLSVKF-----G----NDVQHFKVLRDGAGKYFLWV   70 (117)
T ss_dssp             TTBEEEEEC------SSSTTCEEEEEEE-----T----TEEEEEECEECTTSCEESSS
T ss_pred             CCcEEEEeC------CCCCCCEEEEEec-----C----CceEEEEEEECCCCeEEECC
Confidence            599998877      3567889999986     2    27999999988888888764

>2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A

Probab=90.19  E-value=0.07  Score=46.04  Aligned_cols=71  Identities=17%  Similarity=0.222  Sum_probs=48.3

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHH
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDAL  107 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~  107 (303)
                      .+|++...+|      ++.+|.|+||++.     +    ..++||+|++..++.|++.....+.+   ++.+ ....+.+
T Consensus        28 ~~G~FLVR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~~~~F~sl~~LV~~y~~~~~~l   92 (254)
T 2oq1_A           28 ADGLFLLRQC------LRSLGGYVLSLVH-----D----VRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGL   92 (254)
T ss_dssp             CTTCEEEEEC------SSSTTCEEEEEEE-----T----TEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHHHHCCTTS
T ss_pred             CCcEEEEEeC------CCCCCCEEEEEEE-----C----CeEEEEEEEEeCCCCEEeCCCCccCCHHHHHHHHHhCCCCc
Confidence            3799999877      2457889999986     2    27999999998888898864433333   3333 3344555


Q ss_pred             HHHhcCCCCC
Q 046106          108 ARALMDSNSP  117 (303)
Q Consensus       108 ~~~l~~~~~~  117 (303)
                      +..|..|+..
T Consensus        93 ~~~L~~p~~~  102 (254)
T 2oq1_A           93 PCNLRKPCNR  102 (254)
T ss_dssp             SSCCCSBCCC
T ss_pred             ccccccccCC
Confidence            5556666544

>1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A*

Probab=90.14  E-value=0.071  Score=46.00  Aligned_cols=70  Identities=23%  Similarity=0.258  Sum_probs=47.2

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      +|++...+|      ++.+|.|+||++.     +    ..++||+|.+..++.|++.....+.+   ++.+ ....++++
T Consensus        28 ~G~FLVR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~~~~F~sl~eLv~~y~~~~~~l~   92 (254)
T 1a81_A           28 DGLYLLRQS------RNYLGGFALSVAH-----G----RKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLV   92 (254)
T ss_dssp             TTEEEEEEC------SSSTTCEEEEEEE-----T----TEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHHTTCCTTSS
T ss_pred             CcEEEEEec------CCCCCCEEEEEEE-----C----CeeEEEEEEEcCCCCEEeCCCCCcCCHHHHHHHHHhCCCCce
Confidence            799999887      3457899999986     2    27999999998888898864433333   3333 34444555


Q ss_pred             HHhcCCCCC
Q 046106          109 RALMDSNSP  117 (303)
Q Consensus       109 ~~l~~~~~~  117 (303)
                      ..|..|+..
T Consensus        93 ~~L~~p~~~  101 (254)
T 1a81_A           93 CLLKKPFNR  101 (254)
T ss_dssp             SCCCEECCC
T ss_pred             ECCccccCC
Confidence            555555443

>1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A*

Probab=90.12  E-value=0.21  Score=36.35  Aligned_cols=43  Identities=21%  Similarity=0.234  Sum_probs=34.1

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      .+|++...+|      ++.+|.|+||++..         ..++||+|.+..++.|++.
T Consensus        29 ~~G~FLVR~S------~~~~g~~~LSv~~~---------~~v~H~~I~~~~~g~~~l~   71 (100)
T 1r1p_A           29 DIGFFIIRAS------QSSPGDFSISVRHE---------DDVQHFKVMRDTKGNYFLW   71 (100)
T ss_dssp             CTTBEEEEEC------SSSTTCEEEEEECS---------SSEEEEECEECTTCCEESS
T ss_pred             CCCEEEEEec------CCCCCCEEEEEEEC---------CEEEEEEEEEcCCCCEEEe
Confidence            4799998877      24578899999862         2799999999878888875

>2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=90.06  E-value=0.24  Score=37.42  Aligned_cols=43  Identities=9%  Similarity=0.119  Sum_probs=34.0

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      +|+|...+|      ++.+|.|+||++..         ..++||+|++..++.|.+..
T Consensus        38 ~G~FLVR~S------~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~~   80 (119)
T 2gsb_A           38 VCSFLVRPS------DNTPGDYSLYFRTN---------ENIQRFKICPTPNNQFMMGG   80 (119)
T ss_dssp             SSEEEEEEC------SSSTTCEEEEEECS---------SCBCCCCEEEETTTEEEESS
T ss_pred             CCeEEEEeC------CCCCCceEEEEEEC---------CEEEEEEEEEcCCCCEEECC
Confidence            588988877      24578999999862         27999999998888888764

>2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C*

Probab=89.94  E-value=0.22  Score=37.06  Aligned_cols=43  Identities=16%  Similarity=0.187  Sum_probs=34.2

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      -+|++...+|      ++.+|.|+||++.     +    ..++||+|.+..++.|.+.
T Consensus        32 ~~G~FLVR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~l~   74 (111)
T 2hdv_A           32 SHGVFLVRQS------ETRRGECVLTFNF-----Q----GKAKHLRLSLNAAGQCRVQ   74 (111)
T ss_dssp             GTTEEEEEEC------SSCTTEEEEEEEE-----T----TEEEEEEEEECTTCCEEET
T ss_pred             CCCeEEEEec------CCCCCCEEEEEEe-----C----CeEEEEEEEEcCCCCEEeC
Confidence            4689988877      3467889999986     2    2799999998878888775

>1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A

Probab=89.74  E-value=0.27  Score=37.61  Aligned_cols=44  Identities=14%  Similarity=0.128  Sum_probs=35.0

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      -+|+|...+|-      +.+|.|+||++.     +    ..++||+|.+..++.|.+..
T Consensus        25 ~~G~FLVR~S~------~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~   68 (128)
T 1ka6_A           25 LDGSYLLRDSE------SVPGVYCLCVLY-----H----GYIYTYRVSQTETGSWSAET   68 (128)
T ss_dssp             CTTCEEEEECS------SSTTCEEEEEES-----S----SCEEEEEEEECTTSCEEEEC
T ss_pred             CCCEEEEeecC------CCCCCEEEEEEe-----C----CEEEEEEEEECCCCeEEEee
Confidence            36999998772      457889999986     2    27999999988788888873

>1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1

Probab=89.67  E-value=0.24  Score=36.15  Aligned_cols=42  Identities=17%  Similarity=0.325  Sum_probs=33.7

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      +|++...+|      ++.+|.|+||++.     +    ..++||+|.+..++.|++.
T Consensus        25 ~G~FLVR~S------~~~~g~~~LSv~~-----~----~~v~H~~I~~~~~g~~~l~   66 (103)
T 1i3z_A           25 DGNFLIRDS------ESVPGALCLCVSF-----K----KLVYSYRIFREKHGYYRIE   66 (103)
T ss_dssp             TTEEEEEEC------SSSTTCEEEEEEC-----S----SSEEEEEEEECTTSCEEEC
T ss_pred             CceEEEEeC------CCCCCCEEEEEEE-----C----CEEEEEEEEECCCCeEEEe
Confidence            688888877      2456789999986     2    2799999998888888886

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=89.50  E-value=0.088  Score=51.53  Aligned_cols=76  Identities=22%  Similarity=0.268  Sum_probs=54.2

Q ss_pred             HHHHhc--CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-
Q 046106           27 FYHKLG--EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-  100 (303)
Q Consensus        27 ~~~~~~--~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-  100 (303)
                      .++.-|  +|+|...+|      ++.+|.|+||++.     +    ..++||+|++..++.|++.....+.+   ++.| 
T Consensus        28 ~L~~~~~~~G~FLvR~S------~~~~g~y~lsv~~-----~----~~v~h~~i~~~~~g~~~~~~~~~f~sl~~Lv~~y   92 (635)
T 4fl3_A           28 YLVQGGMSDGLYLLRQS------RNYLGGFALSVAH-----G----RKAHHYTIERELNGTYAIAGGRTHASPADLCHYH   92 (635)
T ss_dssp             HHHHTTCCTTEEEEEEC------TTSSSCEEEEEEE-----T----TEEEEEEEEECTTSCEESTTCCCBSSHHHHHHHH
T ss_pred             HHhcCCCCCceEEEeec------ccCCCCEEEEEEe-----C----CEEEeEEEEEcCCCCEEeCCCCccCCHHHHHHHH
Confidence            344434  799999888      3668889999997     2    27999999998889998865444443   3444 


Q ss_pred             cCChHHHHHHhcCCCCC
Q 046106          101 ALSDDALARALMDSNSP  117 (303)
Q Consensus       101 ~~~~~~~~~~l~~~~~~  117 (303)
                      ....++++..|..|+..
T Consensus        93 ~~~~~~l~~~L~~p~~~  109 (635)
T 4fl3_A           93 SQESDGLVCLLKKPFNR  109 (635)
T ss_dssp             TTCCTTSSSCCCEECCC
T ss_pred             hhCCCCCeeccCCcCCC
Confidence            55666677777776654

>2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens}

Probab=89.08  E-value=0.27  Score=37.05  Aligned_cols=43  Identities=14%  Similarity=0.136  Sum_probs=34.7

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      +|+|...+|-      +.+|.|+||++..         ..|+||+|.+..++.|++..
T Consensus        32 ~G~FLVR~S~------~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~l~~   74 (119)
T 2ysx_A           32 DGSFLVRASE------SISRAYALCVLYR---------NCVYTYRILPNEDDKFTVQA   74 (119)
T ss_dssp             TTEEEEEECS------SCTTSEEEEEECS---------SCEEEEEEEECTTSCEEECC
T ss_pred             CCEEEEEeCC------CCCCCEEEEEEEC---------CEEEEEEEEEcCCCCEEEec
Confidence            6999998772      4578999999862         27999999988888898874

>2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=88.55  E-value=0.27  Score=36.50  Aligned_cols=43  Identities=21%  Similarity=0.280  Sum_probs=33.5

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      -+|++...+|-      +.+|.|+||++.     +    ..++||+|.+..++.|.+.
T Consensus        39 ~~G~FLVR~S~------~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~l~   81 (111)
T 2eo3_A           39 RHGMFLVRDSS------TCPGDYVLSVSE-----N----SRVSHYIINSLPNRRFKIG   81 (111)
T ss_dssp             CTTCEEEEECS------SSSSCEEEEEEE-----T----TEEEEEEEEEETTTEEEET
T ss_pred             CCceEEEEeec------CCCCCEEEEEEe-----C----CeEEEEEEEEcCCCCEEEC
Confidence            36888888772      456889999986     2    2799999998777888875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=88.37  E-value=0.1  Score=50.84  Aligned_cols=70  Identities=17%  Similarity=0.222  Sum_probs=51.2

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      +|+|...+|      ++.+|.|+||++.     +    ..++||+|++..++.|++.....+.+   ++.| ....++++
T Consensus        31 ~G~fLvR~s------~~~~g~~~ls~~~-----~----~~~~h~~i~~~~~g~~~~~~~~~f~sl~~Lv~~y~~~~~~l~   95 (613)
T 2ozo_A           31 DGLFLLRQC------LRSLGGYVLSLVH-----D----VRFHHFPIERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGLP   95 (613)
T ss_dssp             TTEEEEEEC------TTBTTCEEEEEEE-----T----TEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHHTSCCTTSS
T ss_pred             CCeEEEEec------CCCCCCEEEEEEE-----C----CeEEEEEEEECCCCcEEECCCCCcCCHHHHHHHHhhCCCCCC
Confidence            599999887      3578899999986     2    27999999998889998865444443   4444 55566677


Q ss_pred             HHhcCCCCC
Q 046106          109 RALMDSNSP  117 (303)
Q Consensus       109 ~~l~~~~~~  117 (303)
                      ..|..|+..
T Consensus        96 ~~L~~p~~~  104 (613)
T 2ozo_A           96 CNLRKPCNR  104 (613)
T ss_dssp             SCCCSBCCC
T ss_pred             ccCCccCCC
Confidence            777777754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.82  E-value=2.2  Score=35.70  Aligned_cols=85  Identities=12%  Similarity=0.010  Sum_probs=58.2

Q ss_pred             CCCCeeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC
Q 046106          191 KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS  270 (303)
Q Consensus       191 ~hpniv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~  270 (303)
                      .||.+  -..+-.+++.+.|.++.-+++.-+..++     .++....++++.+|+.... -|...-+|--|.|+||+++.
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~  119 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNR  119 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeC
Confidence            57887  3344466777666666554443333343     3678888888888766444 12245677789999999999


Q ss_pred             CCcEEEeccCCce
Q 046106          271 DKSIKIADFGVAR  283 (303)
Q Consensus       271 ~~~vKl~DFGla~  283 (303)
                      ++.++|.-.|+-.
T Consensus       120 ~~~p~i~hRGi~~  132 (219)
T 4ano_A          120 ALEPFFLHVGVKE  132 (219)
T ss_dssp             TCCEEESCCEETT
T ss_pred             CCcEEEEEcCCcc
Confidence            9999999888744

>1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A*

Probab=86.72  E-value=0.14  Score=44.13  Aligned_cols=43  Identities=14%  Similarity=0.233  Sum_probs=33.7

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +|++...+|       +.+|.|+||+..     +    ..++||+|.+..++.|++...
T Consensus       181 ~G~FLVR~S-------~~~g~~~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~~  223 (254)
T 1a81_A          181 NGKFLIRAR-------DNNGSYALCLLH-----E----GKVLHYRIDKDKTGKLSIPEG  223 (254)
T ss_dssp             TTCEEEEEC-------SSSSCEEEEEEE-----T----TEEEEEEEEECTTSCEECTTS
T ss_pred             CceEEEEec-------CCCCCEEEEEEE-----C----CEEEEEEEEEcCCCCEEecCC
Confidence            688888776       256889999986     2    279999999988888887633

>2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1

Probab=86.05  E-value=0.5  Score=35.53  Aligned_cols=41  Identities=12%  Similarity=0.091  Sum_probs=32.3

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      +|+|...+|-      +.+| |+||++..         ..++||+|++..++.|++.
T Consensus        37 ~G~FLVR~S~------~~~~-y~LSv~~~---------~~v~H~~I~~~~~g~~~l~   77 (119)
T 2cs0_A           37 LGSFLIRVSH------SHVG-YTLSYKAQ---------SSCCHFMVKLLDDGTFMIP   77 (119)
T ss_dssp             TTCEEEEECS------SSSS-EEEEECCS---------SSCEEEEEEECTTSCEECT
T ss_pred             CCEEEEEecC------CCCC-EEEEEEEC---------CEEEEEEEEEcCCCcEEEe
Confidence            7999998773      3456 99999862         2789999999888888875

>2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A

Probab=86.01  E-value=0.11  Score=44.83  Aligned_cols=43  Identities=14%  Similarity=0.254  Sum_probs=33.9

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +|+|...+|       +.+|.|+||++.     +    ..++||+|.+..++.|++...
T Consensus       182 ~G~FLVR~S-------~~~g~~~LSv~~-----~----~~v~H~~I~~~~~g~~~~~~~  224 (254)
T 2oq1_A          182 DGKFLLRPR-------KEQGTYALSLIY-----G----KTVYHYLISQDKAGKYCIPEG  224 (254)
T ss_dssp             TTEEEEEEC-------SSTTEEEEEEEE-----T----TEEEEEEEEECTTSCEESTTS
T ss_pred             CceEEEEec-------CCCCCEEEEEEE-----C----CeEEEEEEEEcCCCCEEECCC
Confidence            688888776       356899999986     2    279999999988888887643

>3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A

Probab=85.51  E-value=0.85  Score=33.97  Aligned_cols=48  Identities=10%  Similarity=0.110  Sum_probs=33.6

Q ss_pred             HHHHhc--CCcccccccccceecccCCCeEEEEEeecCCCCCCcCcccccccccccc-CCCCeeee
Q 046106           27 FYHKLG--EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRR-ANDNYSVA   89 (303)
Q Consensus        27 ~~~~~~--~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~-~~~~~~i~   89 (303)
                      .++.-|  +|++...+|-      +.+|.|+||++.     +    ..++||+|++. .++.|++.
T Consensus        29 lL~~~g~~~G~FLVR~S~------~~~g~y~LSv~~-----~----~~v~H~~I~~~~~~g~~~~~   79 (117)
T 3pqz_A           29 LIGQQGLVDGLFLVRESQ------RNPQGFVLSLCH-----L----QKVKHYLILPSEEEGRLYFS   79 (117)
T ss_dssp             HHHHTTCCTTEEEEEECC------C-CCCEEEEEEE-----T----TEEEEEEEEEECCTTCCEEE
T ss_pred             HHhcCCCCCCEEEEEecC------CCCCcEEEEEEe-----C----CeeEEEEEEEecCCCCEEEE
Confidence            344434  7999998772      456889999987     2    27999999986 46655443

>2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A*

Probab=85.50  E-value=0.39  Score=35.00  Aligned_cols=43  Identities=19%  Similarity=0.253  Sum_probs=32.9

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      -+|++...+|      ++.+|.|+||++..         ..++||+|. ..++.|.+..
T Consensus        26 ~~G~FLVR~S------~~~~g~~~LSv~~~---------~~v~H~~I~-~~~g~~~l~~   68 (102)
T 2cia_A           26 VEGDFLIRDS------ESSPSDFSVSLKAS---------GKNKHFKVQ-LVDNVYCIGQ   68 (102)
T ss_dssp             CTTEEEEEEC------SSSTTCEEEEECCS---------SSCEEEEEE-EETTEEEETT
T ss_pred             CCcEEEEEEC------CCCCCCEEEEEEeC---------CeeEEEEEE-ecCCEEEECC
Confidence            4799999877      24578899999862         278999999 5677788764

>2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A*

Probab=84.70  E-value=0.2  Score=44.36  Aligned_cols=71  Identities=15%  Similarity=0.142  Sum_probs=46.8

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeecc--CCCCccccCChHHHHH
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVN--RRGRVSHALSDDALAR  109 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~  109 (303)
                      -+|+|...+|      ++..|.|+||++.     +    ..++||+|++..++.|.+....|  ...++.|-......+.
T Consensus        32 ~~G~FLvR~S------~~~~g~~~LSv~~-----~----~~v~H~~I~~~~~g~~~~~~~~F~sl~~Lv~~y~~~~~~~~   96 (303)
T 2lqn_A           32 RHGMFLVRDS------STCPGDYVLSVSE-----N----SRVSHYIINSLPNRRFKIGDQEFDHLPALLEFYKIHYLDTT   96 (303)
Confidence            3688888777      2457789999985     2    27999999998777788775433  2356665332323455


Q ss_pred             HhcCCCCC
Q 046106          110 ALMDSNSP  117 (303)
Q Consensus       110 ~l~~~~~~  117 (303)
                      .|..|+..
T Consensus        97 ~L~~P~~r  104 (303)
T 2lqn_A           97 TLIEPAPR  104 (303)
Confidence            56555543

>2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus}

Probab=84.02  E-value=0.62  Score=36.75  Aligned_cols=44  Identities=18%  Similarity=0.202  Sum_probs=34.4

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      .+|++...+|      ++.+|.|+||++..         ..++||+|.+ .++.|++...
T Consensus        54 ~~G~FLVR~S------~~~~g~y~LSv~~~---------~~v~H~rI~~-~~g~f~l~~~   97 (152)
T 2hmh_A           54 PAGTFLIRDS------SDQRHFFTLSVKTQ---------SGTKNLRIQX-EGGSFSLQSD   97 (152)
T ss_dssp             CTTEEEEEEC------CSTTCSEEEEEEET---------TEEEEEEEEC-GGGCBEECBC
T ss_pred             CCCcEEEEeC------CCCCCcEEEEEEcC---------CceEEEEEEe-cCCEEEEecc
Confidence            4799999887      24578899999872         2799999998 6778888653

>2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus}

Probab=83.65  E-value=0.74  Score=35.73  Aligned_cols=44  Identities=9%  Similarity=0.101  Sum_probs=33.0

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCC-eeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDN-YSVA   89 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~-~~i~   89 (303)
                      +|+|...+|-.    .+.+|.|+||++..         ..++||+|++..++. |.+.
T Consensus        45 ~G~FLVR~S~~----~~~~g~y~LSv~~~---------~~v~H~~I~~~~~g~~~~l~   89 (141)
T 2eo6_A           45 DGSFLIRKSSG----HDSKQPYTLVAFFN---------KRVYNIPVRFIEATKQYALG   89 (141)
T ss_dssp             TTCBCEEECST----TCSSCSEEEEEEET---------TEEEEEEECEETTTTEECSS
T ss_pred             CceEEEEECCC----CCCCCCEEEEEEEC---------CEEEEEEEEEeCCCCEEEEc
Confidence            69999988731    12578899999972         279999999877777 5554

>2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus}

Probab=83.14  E-value=0.47  Score=36.70  Aligned_cols=44  Identities=16%  Similarity=0.183  Sum_probs=33.3

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCC---Ceeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRAND---NYSVAH   90 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~---~~~i~~   90 (303)
                      .+|+|...+|-      +.+|.|+||++.     +    ..|+||+|++..++   .|++..
T Consensus        49 ~~G~FLVR~S~------~~~g~y~LSv~~-----~----~~v~H~~I~~~~~gg~~~~~l~~   95 (138)
T 2dx0_A           49 KDGTFLVRESE------TFPNDYTLSFWR-----S----GRVQHCRIRSTMENGVMKYYLTD   95 (138)
T ss_dssp             CTTCEEEEECS------SSTTCEEEEEEE-----T----TEEEEEEEEEEEETTEEEEESST
T ss_pred             CCCEEEEEeCC------CCCCCeEEEEEE-----C----CeEEEEEEEEecCCCceEEEeCC
Confidence            46999998872      457889999986     2    27999999988655   477653

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=82.75  E-value=24  Score=34.12  Aligned_cols=83  Identities=16%  Similarity=0.181  Sum_probs=49.7

Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHH----------HHhcCCCC-----CCHHHHHHHHHHHHH--HHHHHHhCCcee
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQF----------LTKRQNRS-----VPLKLAVKQALDVAR--GMAYVHRLGLIH  258 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~----------l~~~~~~~-----~~~~~~~~i~~qi~~--~l~~LH~~giiH  258 (303)
                      +..|.+........ +.|++++.++.+.          +.......     ..+..+..++..+|.  .+-|+=.-|   
T Consensus       402 i~~Y~Vipls~~~G-lIE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILGig---  477 (614)
T 3ls8_A          402 LTPYKVLATSTKHG-FMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVG---  477 (614)
T ss_dssp             CCCCCEEESSSSEE-EEECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHTCC---
T ss_pred             eeccEEEEecCCCc-eEEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeeecc---
Confidence            55666666555434 4577776544444          43321111     123445556555543  234444333   


Q ss_pred             CCCCCCcEEEcCCCcEEEeccCCce
Q 046106          259 RDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       259 rDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                       |=.++||||+.+|.+.=+|||.+-
T Consensus       478 -DRH~~NILld~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          478 -DRHLDNLLLTKTGKLFHIDFGYIL  501 (614)
T ss_dssp             -CCCTTSEEECTTSCEEECCCSSCT
T ss_pred             -CCCCcceeEcCCCCEeeeehHHhh
Confidence             678999999999999999999873

>2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=82.60  E-value=0.66  Score=34.81  Aligned_cols=43  Identities=14%  Similarity=0.197  Sum_probs=33.1

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      -+|++...+|-      +.+|.|+||++.     +    ..++||+|.+. ++.|++..
T Consensus        36 ~~G~FLVR~S~------~~~g~y~LSv~~-----~----~~v~H~~I~~~-~g~~~l~~   78 (118)
T 2dlz_A           36 ASGTYLIRERP------AEAERFAISIKF-----N----DEVKHIKVVEK-DNWIHITE   78 (118)
T ss_dssp             CTTBEEEECCS------CSSCCEEEEEEC-----S----SSEEEEEEEEE-TTEEESTT
T ss_pred             CCCEEEEEeCC------CCCCCEEEEEEE-----C----CcEEEEEEEEc-CCEEEEeC
Confidence            47999988772      357899999996     2    27999999984 67787763

>2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A

Probab=82.05  E-value=0.59  Score=35.15  Aligned_cols=42  Identities=14%  Similarity=0.237  Sum_probs=32.2

Q ss_pred             CCcccccccccceecccC-CCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNG-GGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~-~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      +|+|...+|-      +. +|.|+||++..         ..++||+|++. ++.|++..
T Consensus        32 ~G~FLVR~S~------~~~~g~y~LSv~~~---------~~v~H~~I~~~-~g~~~l~~   74 (120)
T 2iug_A           32 DGTFLVRDAS------TKMHGDYTLTLRKG---------GNNKLIKIFHR-DGKYGFSD   74 (120)
T ss_dssp             TTEEEEEECS------SGGGCSEEEEEEET---------TEEEEEEEEEE-TTEEESSS
T ss_pred             CcEEEEECCC------CCCCCcEEEEEEEC---------CEEEEEEEEEc-CCEEEECC
Confidence            7999888772      23 78899999862         26899999886 67787754

>2kk6_A Proto-oncogene tyrosine-protein kinase FER; methods development, SH2, NESG, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein; NMR {Homo sapiens}

Probab=81.95  E-value=0.74  Score=34.49  Aligned_cols=42  Identities=17%  Similarity=0.203  Sum_probs=31.5

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      -+|++...+|      ++.+|.|+||++..         ..++||+|+. .++.|.+.
T Consensus        35 ~~G~FLVR~S------~~~~g~y~LSv~~~---------~~v~H~~I~~-~~g~y~~~   76 (116)
T 2kk6_A           35 KQGDFLVRES------HGKPGEYVLSVYSD---------GQRRHFIIQY-VDNMYRFE   76 (116)
T ss_dssp             STTCEEEEEC------TTCTTCEEEEEEET---------TEEEEEEEEE-ETTEEESS
T ss_pred             cCCcEEEEEC------CCCCCcEEEEEEEC---------CeEEEEEEEe-cCCEEEEC
Confidence            3799998877      24567899999862         2799999996 55667664

>1mil_A SHC adaptor protein; SH2 domain, phosphorylation, collagen, growth regulation, transforming protein, alternative initiation; 2.70A {Homo sapiens} SCOP: d.93.1.1 PDB: 1tce_A*

Probab=81.82  E-value=1  Score=32.81  Aligned_cols=42  Identities=12%  Similarity=-0.005  Sum_probs=30.4

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      .+|++...+|-      +.+|.|+||++.     +    ..++||+|+ ..++.|.+.
T Consensus        25 ~~G~FLVR~S~------~~~g~~~LSv~~-----~----~~v~H~~I~-~~~g~~~~~   66 (104)
T 1mil_A           25 LNGDFLVREST------TTPGQYVLTGLQ-----S----GQPKHLLLV-DPEGVVRTK   66 (104)
T ss_dssp             STTEEEEEECC------SSCSSEEEEEEE-----T----TEEEEEEEB-CTTSSEECS
T ss_pred             cCCcEEEEeCC------CCCCCEEEEEEE-----C----CEEEEEEEE-eCCCEEEEC
Confidence            46899888772      457899999986     2    278999996 445666553

>2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens}

Probab=81.44  E-value=0.89  Score=35.22  Aligned_cols=41  Identities=17%  Similarity=0.208  Sum_probs=32.8

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      +|+|...+|-      +.+|.|+||++..         ..++||+|.+. ++.|++.
T Consensus        45 ~G~FLVR~S~------~~~~~~~LSv~~~---------~~v~H~~I~~~-~g~~~l~   85 (141)
T 2vif_A           45 DGSFLVRDSS------DDRYLLSLSFRSH---------GKTLHTRIEHS-NGRFSFY   85 (141)
T ss_dssp             TTCEEEEECS------STTCSEEEEEEET---------TEEEEEEEEEE-TTEEEET
T ss_pred             CceEEEEecC------CCCCCEEEEEEEC---------CEEEEEEEEEE-CCEEEEe
Confidence            7999988773      3578899999862         27899999986 7788886

>1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1

Probab=81.12  E-value=1.2  Score=32.77  Aligned_cols=36  Identities=19%  Similarity=0.240  Sum_probs=28.1

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCC
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRAN   83 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~   83 (303)
                      +|++...+|-      +.+|.|+||++..         ..++||+|.+...
T Consensus        21 ~G~FLVR~S~------~~~g~y~LSv~~~---------~~v~H~~I~~~~~   56 (109)
T 1ju5_A           21 HGVFLVRDSS------TSPGDYVLSVSEN---------SRVSHYIINSSGP   56 (109)
T ss_dssp             TTEEEEEECS------SSTTEEEEEEECS---------SCEEEEEEECCSS
T ss_pred             CCEEEEEecC------CCCCCEEEEEEEC---------CeEEEEEEEECCC
Confidence            6999888772      4578999999862         2789999988764

>1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A

Probab=80.25  E-value=0.68  Score=34.33  Aligned_cols=38  Identities=24%  Similarity=0.239  Sum_probs=28.9

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCC
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDN   85 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~   85 (303)
                      -+|++...+|       +.+|.|+||++.     +    ..++||+|.+..++.
T Consensus        30 ~~G~FLVR~S-------~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~   67 (112)
T 1h9o_A           30 RDGTFLVRES-------SKQGCYACSVVV-----D----GEVKHCVINKTATGY   67 (112)
T ss_dssp             CTTEEEEEEC-------SSTTCEEEEEEE-----T----TEEEEEEEEEETTEE
T ss_pred             CCceEEEeec-------CCCCCEEEEEEE-----C----CEEEEEEEEEcCCce
Confidence            4688988877       246789999986     2    279999999876543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	303
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-43
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-43
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-40
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-40
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-39
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-39
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-38
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-38
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-38
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-35
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-34
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-31
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-28
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 6e-51
 Identities = 59/182 (32%), Positives = 100/182 (54%), Gaps = 10/182 (5%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEV 184
           D+W I   ++ +G     G+FG +Y+G ++G+ VA+K+L      P+      Q F+ EV
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQ----QLQAFKNEV 55

Query: 185 MMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDV 244
            +L   +H NI+ F+G    P +  IVT++ +G S+   L   + +   +   +  A   
Sbjct: 56  GVLRKTRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQT 113

Query: 245 ARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWM 301
           A+GM Y+H   +IHRDLKS+N+ +  D ++KI DFG+A ++ +  G       +G+  WM
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 302 AP 303
           AP
Sbjct: 174 AP 175

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 5e-47
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 11/178 (6%)

Query: 127 WTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMM 186
           W +++++L +     +G FG +  G Y G +VA+K ++             Q F  E  +
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--------TAQAFLAEASV 53

Query: 187 LATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVA 245
           +  L+H N+V+ +G    +     IVTEY   GS+  +L  R    +     +K +LDV 
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 246 RGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             M Y+     +HRDL + N+L+  D   K++DFG+ +    +          +W AP
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAP 169

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-46
 Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 11/182 (6%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQE 183
           DEW +    L + +    G FG+++ G YN   +VA+K L+       +  +    F  E
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-------QGSMSPDAFLAE 58

Query: 184 VMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
             ++  L+H  +VR      +  ++ I+TEY + GS+  FL       + +   +  A  
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--EVQTEGMTPETGTYRWM 301
           +A GMA++     IHRDL++ N+L+    S KIADFG+AR+  + +           +W 
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 302 AP 303
           AP
Sbjct: 178 AP 179

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (385), Expect = 5e-45
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 16/196 (8%)

Query: 112 MDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPEND 169
           MD +SP     N+D+W ++   + M      G +G++Y G +      VA+K L+     
Sbjct: 2   MDPSSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----- 51

Query: 170 PEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN 229
             +  +  ++F +E  ++  +KHPN+V+ +G C +   + I+TE+   G++  +L +   
Sbjct: 52  --EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR 109

Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--EVQ 287
           + V   + +  A  ++  M Y+ +   IHRDL + N L+  +  +K+ADFG++R+     
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169

Query: 288 TEGMTPETGTYRWMAP 303
                      +W AP
Sbjct: 170 YTAHAGAKFPIKWTAP 185

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 7e-44
 Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 11/165 (6%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G  G +++ ++  +G  +A K++       E    +  Q  +E+ +L     P IV F 
Sbjct: 16  AGNGGVVFKVSHKPSGLVMARKLI-----HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 70

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH-RLGLIH 258
           GA        I  E+  GGS+ Q L K     +P ++  K ++ V +G+ Y+  +  ++H
Sbjct: 71  GAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMH 128

Query: 259 RDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           RD+K  N+L+ S   IK+ DFGV+   + +   +   GT  +M+P
Sbjct: 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRSYMSP 172

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (373), Expect = 4e-43
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 16/184 (8%)

Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQ 179
           ++ ++   DLR++        G+FG +Y      N E VAIK +        +     Q 
Sbjct: 11  DDPEKLFSDLREI------GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQD 61

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
             +EV  L  L+HPN +++ G   +     +V EY  G +    L +   + +       
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAA 119

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYR 299
                 +G+AY+H   +IHRD+K+ N+L+     +K+ DFG A I           GT  
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPY 176

Query: 300 WMAP 303
           WMAP
Sbjct: 177 WMAP 180

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 7e-43
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 10/165 (6%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GAFGK+Y+          A K+++       K++   + +  E+ +LA+  HPNIV+ +
Sbjct: 22  DGAFGKVYKAQNKETSVLAAAKVIDT------KSEEELEDYMVEIDILASCDHPNIVKLL 75

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A        I+ E+  GG+V   + + + R +               + Y+H   +IHR
Sbjct: 76  DAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHR 134

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQT-EGMTPETGTYRWMAP 303
           DLK+ N+L   D  IK+ADFGV+    +T +      GT  WMAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 7e-43
 Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 12/190 (6%)

Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQV 175
            T+GL   D W I    L +     QG FG+++ GT+     VAIK L+          +
Sbjct: 3   QTQGL-AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTM 54

Query: 176 MEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLK 235
             + F QE  ++  L+H  +V+      +  ++ IVTEY   GS+  FL     + + L 
Sbjct: 55  SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLP 113

Query: 236 LAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--EVQTEGMTP 293
             V  A  +A GMAYV R+  +HRDL++ N+L+  +   K+ADFG+AR+  + +      
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173

Query: 294 ETGTYRWMAP 303
                +W AP
Sbjct: 174 AKFPIKWTAP 183

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-42
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 12/167 (7%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GA+G++         E VA+KI+     D ++A    +  ++E+ +   L H N+V+F 
Sbjct: 15  EGAYGEVQLAVNRVTEEAVAVKIV-----DMKRAVDCPENIKKEICINKMLNHENVVKFY 69

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
           G  R+  +  +  EY  GG +   +    +  +P   A +    +  G+ Y+H +G+ HR
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127

Query: 260 DLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 303
           D+K +NLL+    ++KI+DFG+A +     +   +    GT  ++AP
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-42
 Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 10/180 (5%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQE 183
           +W ++     +G    +G FG +Y      +   +A+K+L + + +      +E Q ++E
Sbjct: 2   QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG---VEHQLRRE 56

Query: 184 VMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           V + + L+HPNI+R  G         ++ EYA  G+V + L  ++      +       +
Sbjct: 57  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 114

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           +A  ++Y H   +IHRD+K +NLL+ S   +KIADFG +     +   T   GT  ++ P
Sbjct: 115 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPP 173

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-40
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 11/178 (6%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           ID + L        G FG +  G +    +VAIK+++       +  + E +F +E  ++
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-------EGSMSEDEFIEEAKVM 53

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L H  +V+  G C K     I+TEY   G +  +L + ++R    +  ++   DV   
Sbjct: 54  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEA 112

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--EVQTEGMTPETGTYRWMAP 303
           M Y+     +HRDL + N L+     +K++DFG++R   + +           RW  P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  141 bits (357), Expect = 3e-40
 Identities = 38/184 (20%), Positives = 76/184 (41%), Gaps = 18/184 (9%)

Query: 124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQ 181
           +D + I L +L        GAFG ++R      G     K +  P        + +   +
Sbjct: 28  YDYYDI-LEEL------GSGAFGVVHRCVEKATGRVFVAKFINTPY------PLDKYTVK 74

Query: 182 QEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
            E+ ++  L HP ++    A        ++ E+  GG +   +   ++  +     +   
Sbjct: 75  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYM 133

Query: 242 LDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYR 299
                G+ ++H   ++H D+K +N++  + K+  +KI DFG+A      E +   T T  
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 193

Query: 300 WMAP 303
           + AP
Sbjct: 194 FAAP 197

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-40
 Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 16/184 (8%)

Query: 129 IDLRKLNMGD-AFAQGAFGKLYRGTYN----GEEVAIKILERPENDPEKAQVMEQQFQQE 183
           +D + L + D     G FG + +G Y      + VA+KIL+   NDP     ++ +   E
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAE 58

Query: 184 VMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
             ++  L +P IVR IG C     W +V E A+ G + ++L +  NR V  K  ++    
Sbjct: 59  ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQ 115

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI----EVQTEGMTPETGTYR 299
           V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++     E   +  T      +
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 300 WMAP 303
           W AP
Sbjct: 176 WYAP 179

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-40
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 33/214 (15%)

Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPEND 169
           PT+ L    +W     +L+ G     GAFGK+   T            VA+K+L      
Sbjct: 9   PTQ-LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-----K 62

Query: 170 PEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ 228
           P       +    E+ +L+ L  H NIV  +GAC       ++TEY   G +  FL +++
Sbjct: 63  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122

Query: 229 NR----------------SVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK 272
           +                 ++ L+  +  +  VA+GMA++     IHRDL + N+L+   +
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182

Query: 273 SIKIADFGVARIEVQTEGMTPET---GTYRWMAP 303
             KI DFG+AR          +       +WMAP
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 7e-40
 Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 11/178 (6%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML 187
           ID  +L        G FG ++ G + N ++VAIK +        +  + E+ F +E  ++
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-------EGAMSEEDFIEEAEVM 54

Query: 188 ATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
             L HP +V+  G C +    C+V E+ + G +  +  + Q      +  +   LDV  G
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEG 113

Query: 248 MAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--EVQTEGMTPETGTYRWMAP 303
           MAY+    +IHRDL + N L+  ++ IK++DFG+ R   + Q    T      +W +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  139 bits (351), Expect = 2e-39
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 11/166 (6%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GAFG ++R T    G   A K +  P          ++  ++E+  ++ L+HP +V   
Sbjct: 36  TGAFGVVHRVTERATGNNFAAKFVMTPHES------DKETVRKEIQTMSVLRHPTLVNLH 89

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A        ++ E+  GG + + +    N+ +    AV+    V +G+ ++H    +H 
Sbjct: 90  DAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHL 148

Query: 260 DLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK +N++  + +S  +K+ DFG+       + +   TGT  + AP
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-39
 Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 12/165 (7%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QGA G +Y       G+EVAI+ +   +  P+K     +    E++++   K+PNIV ++
Sbjct: 30  QGASGTVYTAMDVATGQEVAIRQM-NLQQQPKK-----ELIINEILVMRENKNPNIVNYL 83

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            +        +V EY  GGS+   +T+                +  + + ++H   +IHR
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 260 DLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           D+KSDN+L+  D S+K+ DFG    I  +    +   GT  WMAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-39
 Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 16/187 (8%)

Query: 126 EWTIDLRKLNMGDA-FAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQF 180
           +  +    L + D     G FG + +G Y       +VAIK+L          +   ++ 
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-----KQGTEKADTEEM 56

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
            +E  ++  L +P IVR IG C+      +V E A GG + +FL   +   +P+    + 
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAEL 114

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI----EVQTEGMTPETG 296
              V+ GM Y+     +HRDL + N+L+ +    KI+DFG+++     +      +    
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 297 TYRWMAP 303
             +W AP
Sbjct: 175 PLKWYAP 181

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-39
 Identities = 50/210 (23%), Positives = 81/210 (38%), Gaps = 37/210 (17%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRG-------TYNGEEVAIKILERPENDPEKAQVMEQ 178
           +W      L  G     GAFGK+          T    +VA+K+L       +      +
Sbjct: 31  KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-----KEKADSSERE 85

Query: 179 QFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNR------- 230
               E+ M+  L  H NIV  +GAC       ++ EY   G +  +L  ++ +       
Sbjct: 86  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145

Query: 231 --------------SVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI 276
                          +  +  +  A  VA+GM ++     +HRDL + N+L+   K +KI
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205

Query: 277 ADFGVARIEVQTEGMTPET---GTYRWMAP 303
            DFG+AR  +               +WMAP
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAP 235

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-39
 Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 27/189 (14%)

Query: 132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK 191
           R + + ++  +G FG+++RG + GEEVA+KI           +      + E+     L+
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS-------SREERSWFREAEIYQTVMLR 55

Query: 192 HPNIVRFIGACRKP----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARG 247
           H NI+ FI A  K         +V++Y + GS+  +L      +V ++  +K AL  A G
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASG 112

Query: 248 MAYVH--------RLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-----EVQTEGMTPE 294
           +A++H        +  + HRDLKS N+L+  + +  IAD G+A       +         
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172

Query: 295 TGTYRWMAP 303
            GT R+MAP
Sbjct: 173 VGTKRYMAP 181

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  135 bits (341), Expect = 1e-38
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 8/168 (4%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPEND---PEKAQVMEQQFQQEVMMLATLK-HPNI 195
           +G    + R  +    +E A+KI++         E+ Q + +   +EV +L  +  HPNI
Sbjct: 13  RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72

Query: 196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
           ++          + +V +  K G +  +L   +  ++  K   K    +   +  +H+L 
Sbjct: 73  IQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALHKLN 130

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           ++HRDLK +N+L+  D +IK+ DFG +      E +    GT  ++AP
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-38
 Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 16/185 (8%)

Query: 128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVM 185
           + D R L       +G+F  +Y+G       EVA   L+  +    +     Q+F++E  
Sbjct: 5   SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAE 60

Query: 186 MLATLKHPNIVRFIGAC----RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQA 241
           ML  L+HPNIVRF  +     +      +VTE    G+++ +L  ++ + + +K+     
Sbjct: 61  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 118

Query: 242 LDVARGMAYVHRLG--LIHRDLKSDNLLIFS-DKSIKIADFGVARIEVQTEGMTPETGTY 298
             + +G+ ++H     +IHRDLK DN+ I     S+KI D G+A +  +        GT 
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTP 177

Query: 299 RWMAP 303
            +MAP
Sbjct: 178 EFMAP 182

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (337), Expect = 3e-38
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 16/174 (9%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G++G+  +     +G+ +  K L+       +    +Q    EV +L  LKHPNIVR+ 
Sbjct: 14  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYY 69

Query: 200 GAC--RKPMVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLG 255
                R      IV EY +GG +   +TK  ++ + +  +  ++    +   +   HR  
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 256 -----LIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
                ++HRDLK  N+ +   +++K+ DFG+AR +   T       GT  +M+P
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (338), Expect = 4e-38
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 18/198 (9%)

Query: 117 PTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPE 171
           P E +  F +  ID+  + +      G FG++  G           VAIK L        
Sbjct: 12  PNEAVREFAK-EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-----KSG 65

Query: 172 KAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRS 231
             +   + F  E  ++    HPN++   G   K     I+TE+ + GS+  FL +   + 
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124

Query: 232 VPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI------E 285
             +   V     +A GM Y+  +  +HRDL + N+L+ S+   K++DFG++R       +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184

Query: 286 VQTEGMTPETGTYRWMAP 303
                        RW AP
Sbjct: 185 PTYTSALGGKIPIRWTAP 202

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 5e-38
 Identities = 49/184 (26%), Positives = 90/184 (48%), Gaps = 14/184 (7%)

Query: 126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQF 180
           ++ I   ++ +G    +G FG +++G Y         VAIK  +   +D  +     ++F
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-----EKF 55

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
            QE + +    HP+IV+ IG   +  VW I+ E    G +R FL  R+  S+ L   +  
Sbjct: 56  LQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRK-YSLDLASLILY 113

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI--EVQTEGMTPETGTY 298
           A  ++  +AY+     +HRD+ + N+L+ S+  +K+ DFG++R   +      +      
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 299 RWMA 302
           +WMA
Sbjct: 174 KWMA 177

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 1e-36
 Identities = 55/184 (29%), Positives = 82/184 (44%), Gaps = 14/184 (7%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQE 183
           I  + L + +    G+FG + RG ++        VA+K L+    D          F +E
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP---DVLSQPEAMDDFIRE 61

Query: 184 VMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
           V  + +L H N++R  G    P +  +VTE A  GS+   L K Q     L    + A+ 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQ 119

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG----MTPETGTYR 299
           VA GM Y+     IHRDL + NLL+ +   +KI DFG+ R   Q +            + 
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 300 WMAP 303
           W AP
Sbjct: 180 WCAP 183

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-36
 Identities = 33/186 (17%), Positives = 74/186 (39%), Gaps = 19/186 (10%)

Query: 122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQVMEQQ 179
           E ++++ I    L       +G FG ++R   T + +    K ++    D       +  
Sbjct: 2   ELYEKYMI-AEDL------GRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVL 47

Query: 180 FQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVK 239
            ++E+ +L   +H NI+    +        ++ E+  G  + + +       +  +  V 
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVS 106

Query: 240 QALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKS--IKIADFGVARIEVQTEGMTPETGT 297
               V   + ++H   + H D++ +N++  + +S  IKI +FG AR     +        
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166

Query: 298 YRWMAP 303
             + AP
Sbjct: 167 PEYYAP 172

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 4e-36
 Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 24/194 (12%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE----EVAIKILERPENDPEKAQVMEQQFQQEV 184
           +D   +   D   +G FG++ +     +    + AIK +         ++   + F  E+
Sbjct: 7   LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGEL 61

Query: 185 MMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------N 229
            +L  L  HPNI+  +GAC       +  EYA  G++  FL K +               
Sbjct: 62  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121

Query: 230 RSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE 289
            ++  +  +  A DVARGM Y+ +   IHRDL + N+L+  +   KIADFG++R +    
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181

Query: 290 GMTPETGTYRWMAP 303
             T      RWMA 
Sbjct: 182 KKTMGRLPVRWMAI 195

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (325), Expect = 5e-36
 Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 12/167 (7%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GAF ++         + VAIK +       +  +  E   + E+ +L  +KHPNIV   
Sbjct: 19  TGAFSEVILAEDKRTQKLVAIKCI-----AKKALEGKEGSMENEIAVLHKIKHPNIVALD 73

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
                     ++ +   GG +   +   +      + A +    V   + Y+H LG++HR
Sbjct: 74  DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 260 DLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK +NLL +S   D  I I+DFG++++E     ++   GT  ++AP
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-35
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 23/197 (11%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVME 177
           DEW +   K+ M     QG+FG +Y G             VAIK +     +   +    
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRER 67

Query: 178 QQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV----- 232
            +F  E  ++      ++VR +G   +     ++ E    G ++ +L   +         
Sbjct: 68  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127

Query: 233 ---PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI---EV 286
               L   ++ A ++A GMAY++    +HRDL + N ++  D ++KI DFG+ R      
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187

Query: 287 QTEGMTPETGTYRWMAP 303
                       RWM+P
Sbjct: 188 YYRKGGKGLLPVRWMSP 204

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-35
 Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 10/167 (5%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+F  +          E AIKILE+     E          +E  +++ L HP  V+  
Sbjct: 18  EGSFSTVVLARELATSREYAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFVKLY 74

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
              +          YAK G + +++ K    S           ++   + Y+H  G+IHR
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHR 132

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET---GTYRWMAP 303
           DLK +N+L+  D  I+I DFG A++              GT ++++P
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (320), Expect = 2e-35
 Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 37/212 (17%)

Query: 124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVM 176
                     +       +GAFG++++              VA+K+L       E +  M
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADM 59

Query: 177 EQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSV---- 232
           +  FQ+E  ++A   +PNIV+ +G C      C++ EY   G + +FL      +V    
Sbjct: 60  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 233 ------------------PLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSI 274
                                  +  A  VA GMAY+     +HRDL + N L+  +  +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179

Query: 275 KIADFGVARIEVQTEGMTPET---GTYRWMAP 303
           KIADFG++R     +    +       RWM P
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  127 bits (319), Expect = 9e-35
 Identities = 35/163 (21%), Positives = 73/163 (44%), Gaps = 5/163 (3%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FG++Y       G+  A+K L++     ++ + +    +  + +++T   P IV   
Sbjct: 14  RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A   P     + +   GG +   L   Q+           A ++  G+ ++H   +++R
Sbjct: 74  YAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 131

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMA 302
           DLK  N+L+     ++I+D G+A  +   +      GT+ +MA
Sbjct: 132 DLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMA 173

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-34
 Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 7/165 (4%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G+FGK++   +    +  AIK L++  +       +E    ++ ++    +HP +    
Sbjct: 12  KGSFGKVFLAEFKKTNQFFAIKALKK--DVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
              +       V EY  GG +   +  +      L  A   A ++  G+ ++H  G+++R
Sbjct: 70  CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 127

Query: 260 DLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           DLK DN+L+  D  IKIADFG+ +   +         GT  ++AP
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-34
 Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 8/168 (4%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G F  + +      G + A K +++      +  V  +  ++EV +L  ++HPN++   
Sbjct: 20  SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
                     ++ E   GG +  FL ++   S+  + A +    +  G+ Y+H L + H 
Sbjct: 80  EVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHF 137

Query: 260 DLKSDNLLIFSD----KSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK +N+++         IKI DFG+A             GT  ++AP
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 6e-34
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 29/206 (14%)

Query: 123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQV 175
           +  +W     +L +G    +GAFG++                VA+K+L+      E    
Sbjct: 4   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--- 60

Query: 176 MEQQFQQEVMMLATLKHPNIVRFIGACRKP-MVWCIVTEYAKGGSVRQFLTKRQNRSVPL 234
                 +  +++    H N+V  +GAC KP     ++ E+ K G++  +L  ++N  VP 
Sbjct: 61  -RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119

Query: 235 KL--------------AVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
           K+               +  +  VA+GM ++     IHRDL + N+L+     +KI DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179

Query: 281 VARIEVQTEGMTPET---GTYRWMAP 303
           +AR   +      +       +WMAP
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAP 205

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 7e-34
 Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 16/185 (8%)

Query: 129 IDLRKLNMGDAFAQGAFGKLYRGTYNGE------EVAIKILERPENDPEKAQVMEQQFQQ 182
           I    +        G FG++Y+G            VAIK L          +     F  
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDFLG 58

Query: 183 EVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQAL 242
           E  ++    H NI+R  G   K     I+TEY + G++ +F  + ++    +   V    
Sbjct: 59  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLR 117

Query: 243 DVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI----EVQTEGMTPETGTY 298
            +A GM Y+  +  +HRDL + N+L+ S+   K++DFG++R+       T   +      
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 299 RWMAP 303
           RW AP
Sbjct: 178 RWTAP 182

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 8e-34
 Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 21/172 (12%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEV-MMLATLKHPNIVRF 198
            G  GK+ +       E+ A+K+L+              + ++EV +     + P+IVR 
Sbjct: 22  LGINGKVLQIFNKRTQEKFALKMLQD-----------CPKARREVELHWRASQCPHIVRI 70

Query: 199 IGACRKPMVW----CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRL 254
           +              IV E   GG +   +  R +++   + A +    +   + Y+H +
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 255 GLIHRDLKSDNLLIFS---DKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            + HRD+K +NLL  S   +  +K+ DFG A+       +T    T  ++AP
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 9e-34
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 20/205 (9%)

Query: 112 MDSNSPTEGLENFDEWTI--DLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILE 164
           + + +P E ++      I      ++  +   +G FG +Y GT           A+K L 
Sbjct: 6   LSALNP-ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64

Query: 165 RPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC-RKPMVWCIVTEYAKGGSVRQF 223
           R  +  E       QF  E +++    HPN++  +G C R      +V  Y K G +R F
Sbjct: 65  RITDIGE-----VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 224 LTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
             + +  +  +K  +   L VA+GM ++     +HRDL + N ++    ++K+ADFG+AR
Sbjct: 120 -IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 284 IEVQTEGMTPET-----GTYRWMAP 303
                E  +           +WMA 
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMAL 203

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-33
 Identities = 40/165 (24%), Positives = 77/165 (46%), Gaps = 6/165 (3%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G F  +Y+       + VAIK + +  +  E    + +   +E+ +L  L HPNI+  +
Sbjct: 8   EGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 66

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A        +V ++ +     + + K  +  +         L   +G+ Y+H+  ++HR
Sbjct: 67  DAFGHKSNISLVFDFMET--DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124

Query: 260 DLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGTYRWMAP 303
           DLK +NLL+  +  +K+ADFG+A+         T +  T  + AP
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (304), Expect = 6e-33
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 19/183 (10%)

Query: 127 WTID----LRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQF 180
           +++     LR L        G+FG+++     +NG   A+K+L++      K     +  
Sbjct: 1   YSLQDFQILRTL------GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK---QVEHT 51

Query: 181 QQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQ 240
             E +ML+ + HP I+R  G  +      ++ +Y +GG +      R+++  P  +A   
Sbjct: 52  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFY 109

Query: 241 ALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRW 300
           A +V   + Y+H   +I+RDLK +N+L+  +  IKI DFG A+     +      GT  +
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDY 167

Query: 301 MAP 303
           +AP
Sbjct: 168 IAP 170

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-32
 Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 18/172 (10%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +GA+G +       N   VAIK +      P + Q   Q+  +E+ +L   +H NI+   
Sbjct: 18  EGAYGMVCSAYDNVNKVRVAIKKI-----SPFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 200 GACRKP----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
              R P    M    +  +  G  + + L   + + +           + RG+ Y+H   
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHSAN 129

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARI----EVQTEGMTPETGTYRWMAP 303
           ++HRDLK  NLL+ +   +KI DFG+AR+       T  +T    T  + AP
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-32
 Identities = 36/167 (21%), Positives = 70/167 (41%), Gaps = 7/167 (4%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK--HPNIVR 197
            G FG +Y G    +   VAIK +E+             +   EV++L  +      ++R
Sbjct: 14  SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73

Query: 198 FIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLI 257
            +    +P  + ++ E  +           +   +  +LA      V   + + H  G++
Sbjct: 74  LLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVL 132

Query: 258 HRDLKSDNLLIFSDK-SIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           HRD+K +N+LI  ++  +K+ DFG   + ++    T   GT  +  P
Sbjct: 133 HRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPP 178

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-32
 Identities = 40/167 (23%), Positives = 84/167 (50%), Gaps = 8/167 (4%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GAFG +Y+G +   GE+V I +  +   +    +   ++   E  ++A++ +P++ R +
Sbjct: 19  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPHVCRLL 77

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
           G C    V  I  +    G +  ++ + ++  +  +  +   + +A+GM Y+    L+HR
Sbjct: 78  GICLTSTVQLIT-QLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHR 135

Query: 260 DLKSDNLLIFSDKSIKIADFGVARI---EVQTEGMTPETGTYRWMAP 303
           DL + N+L+ + + +KI DFG+A++   E +           +WMA 
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-32
 Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 32/206 (15%)

Query: 125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY---------NGEEVAIKILERPENDPEKAQV 175
             W +   +L +G    +GAFG++                 +VA+K+L       +  + 
Sbjct: 6   PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-----KSDATEK 60

Query: 176 MEQQFQQEVMMLATL-KHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ------ 228
                  E+ M+  + KH NI+  +GAC +     ++ EYA  G++R++L  R+      
Sbjct: 61  DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120

Query: 229 --------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG 280
                      +  K  V  A  VARGM Y+     IHRDL + N+L+  D  +KIADFG
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 180

Query: 281 VARIEVQTEGMT---PETGTYRWMAP 303
           +AR     +            +WMAP
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAP 206

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  118 bits (295), Expect = 5e-32
 Identities = 43/163 (26%), Positives = 66/163 (40%), Gaps = 7/163 (4%)

Query: 142 QGAFGKLYRGTYN-GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG 200
           +G +G +Y+   N GE  A+K +   + D      +     +E+ +L  LKH NIV+   
Sbjct: 12  EGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKLYD 67

Query: 201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRD 260
                    +V E+      +          +    A    L +  G+AY H   ++HRD
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125

Query: 261 LKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           LK  NLLI  +  +KIADFG+AR                W   
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  117 bits (293), Expect = 1e-31
 Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 15/172 (8%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G   +++         +VA+K+L     D  +      +F++E    A L HP IV   
Sbjct: 17  FGGMSEVHLARDLRLHRDVAVKVLRA---DLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 200 GACR----KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG 255
                      +  IV EY  G ++R  +       +  K A++   D  + + + H+ G
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSHQNG 131

Query: 256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPET----GTYRWMAP 303
           +IHRD+K  N++I +  ++K+ DFG+AR    +     +T    GT ++++P
Sbjct: 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-31
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 18/186 (9%)

Query: 121 LENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQ 178
           +ENF +    + K+       +G +G +Y+      GE VA+K +            +  
Sbjct: 1   MENFQK----VEKI------GEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----VPS 46

Query: 179 QFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAV 238
              +E+ +L  L HPNIV+ +          +V E+     +++F+       +PL L  
Sbjct: 47  TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK 105

Query: 239 KQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR-IEVQTEGMTPETGT 297
                + +G+A+ H   ++HRDLK  NLLI ++ +IK+ADFG+AR   V     T E  T
Sbjct: 106 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 298 YRWMAP 303
             + AP
Sbjct: 166 LWYRAP 171

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-30
 Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 8/164 (4%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G +G +++       E VA+K +   ++D      +     +E+ +L  LKH NIVR  
Sbjct: 12  EGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLH 67

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
                     +V E+       +      N  +  ++       + +G+ + H   ++HR
Sbjct: 68  DVLHSDKKLTLVFEFCD--QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
           DLK  NLLI  +  +K+A+FG+AR                W  P
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 3e-30
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 10/170 (5%)

Query: 142 QGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRF 198
           +GA+GK+++       G  VA+K + R +   E   +   +    +  L T +HPN+VR 
Sbjct: 17  EGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 75

Query: 199 IGACRKPMV-----WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
              C            +V E+     +  +L K     VP +        + RG+ ++H 
Sbjct: 76  FDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             ++HRDLK  N+L+ S   IK+ADFG+ARI      +T    T  + AP
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 5e-30
 Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 8/165 (4%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           +G FGK+        G   A+KIL +   +   A+        E  +L   +HP +    
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHR 259
            A +     C V EYA GG +   L   + R    + A     ++   + Y+H   +++R
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129

Query: 260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPE-TGTYRWMAP 303
           D+K +NL++  D  IKI DFG+ +  +          GT  ++AP
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  110 bits (275), Expect = 9e-29
 Identities = 39/201 (19%), Positives = 88/201 (43%), Gaps = 27/201 (13%)

Query: 109 RALMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGT--YNGEEVAIKILERP 166
           R   D  S      N D++ + +RKL       +G + +++      N E+V +KIL+  
Sbjct: 19  REYWDYESHVVEWGNQDDYQL-VRKL------GRGKYSEVFEAINITNNEKVVVKILKP- 70

Query: 167 ENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPM--VWCIVTEYAKGGSVRQF 223
                   V +++ ++E+ +L  L+  PNI+      + P+     +V E+      +Q 
Sbjct: 71  --------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122

Query: 224 LTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVA 282
                 +++          ++ + + Y H +G++HRD+K  N++I  + + +++ D+G+A
Sbjct: 123 Y-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177

Query: 283 RIEVQTEGMTPETGTYRWMAP 303
                 +       +  +  P
Sbjct: 178 EFYHPGQEYNVRVASRYFKGP 198

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-28
 Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 21/177 (11%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
           QG FG++++  +   G++VA+K +   EN+ E          +E+ +L  LKH N+V  I
Sbjct: 20  QGTFGEVFKARHRKTGQKVALKKV-LMENEKEG---FPITALREIKILQLLKHENVVNLI 75

Query: 200 GACRKPMV--------WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYV 251
             CR              +V ++ +              ++     V     +  G+ Y+
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 133

Query: 252 HRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI-----EVQTEGMTPETGTYRWMAP 303
           HR  ++HRD+K+ N+LI  D  +K+ADFG+AR        Q    T    T  +  P
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-28
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 20/172 (11%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G+FG +Y+     +GE VAIK + + +          +   +E+ ++  L H NIVR  
Sbjct: 30  NGSFGVVYQAKLCDSGELVAIKKVLQDK----------RFKNRELQIMRKLDHCNIVRLR 79

Query: 200 GAC------RKPMVWCIVTEYAKGGSVRQFLT-KRQNRSVPLKLAVKQALDVARGMAYVH 252
                    +  +   +V +Y      R      R  +++P+         + R +AY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 253 RLGLIHRDLKSDNLLIFSDKS-IKIADFGVARIEVQTEGMTPETGTYRWMAP 303
             G+ HRD+K  NLL+  D + +K+ DFG A+  V+ E       +  + AP
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  108 bits (269), Expect = 5e-28
 Identities = 44/176 (25%), Positives = 67/176 (38%), Gaps = 24/176 (13%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            G+FG +Y GT    GEEVAIK+           +    Q   E  +   ++    +  I
Sbjct: 17  SGSFGDIYLGTDIAAGEEVAIKLE--------CVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 200 GAC-RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
             C  +     +V E        + L    +R   LK  +  A  +   + Y+H    IH
Sbjct: 69  RWCGAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 259 RDLKSDNLLIFSDKS---IKIADFGVARIEVQTEG--------MTPETGTYRWMAP 303
           RD+K DN L+   K    + I DFG+A+                   TGT R+ + 
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  108 bits (270), Expect = 8e-28
 Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 16/195 (8%)

Query: 111 LMDSNSPTEGLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPEN 168
           L    +P++     D++   ++ L        G+FG++    +  +G   A+KIL++ + 
Sbjct: 27  LKKWETPSQNTAQLDQFDR-IKTL------GTGSFGRVMLVKHKESGNHYAMKILDKQKV 79

Query: 169 DPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ 228
              K     +    E  +L  +  P +V+   + +      +V EY  GG +   L +  
Sbjct: 80  VKLK---QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136

Query: 229 NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT 288
                   A   A  +     Y+H L LI+RDLK +NLLI     I++ DFG A+     
Sbjct: 137 R--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVK 192

Query: 289 EGMTPETGTYRWMAP 303
                  GT   +AP
Sbjct: 193 GRTWTLCGTPEALAP 207

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-27
 Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 17/170 (10%)

Query: 142 QGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA G +           VAIK L RP  +        ++  +E++++  + H NI+  +
Sbjct: 27  SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----HAKRAYRELVLMKCVNHKNIISLL 82

Query: 200 GACRKPMVW------CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                           +V E       +          +  +        +  G+ ++H 
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHS 137

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+IHRDLK  N+++ SD ++KI DFG+AR    +  MTP   T  + AP
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 3e-26
 Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 18/170 (10%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI 199
            GA+G +        G +VAIK L RP           ++  +E+ +L  ++H N++  +
Sbjct: 28  SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLL 83

Query: 200 GACRKP------MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR 253
                         + +V  +  G  + + +   ++  +           + +G+ Y+H 
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQFLVYQMLKGLRYIHA 139

Query: 254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            G+IHRDLK  NL +  D  +KI DFG+AR       MT    T  + AP
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAP 187

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 6e-26
 Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 22/191 (11%)

Query: 120 GLENFDEWTIDLRKLNMGDAFAQGAFGKLYRGT-----YNGEEVAIKILERPENDPEKAQ 174
           G+ENF+     L+ L        GA+GK++          G+  A+K+L +     +KA+
Sbjct: 22  GIENFEL----LKVL------GTGAYGKVFLVRKISGHDTGKLYAMKVL-KKATIVQKAK 70

Query: 175 VMEQQFQQEVMMLATLKH-PNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVP 233
             E   + E  +L  ++  P +V    A +      ++ +Y  GG +   L   Q     
Sbjct: 71  TTEH-TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFT 127

Query: 234 LKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR--IEVQTEGM 291
                    ++   + ++H+LG+I+RD+K +N+L+ S+  + + DFG+++  +  +TE  
Sbjct: 128 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187

Query: 292 TPETGTYRWMA 302
               GT  +MA
Sbjct: 188 YDFCGTIEYMA 198

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  100 bits (250), Expect = 2e-25
 Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 26/178 (14%)

Query: 142 QGAFGKLYRGT--YNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRF 198
           +G+FG ++ GT   N ++VAIK   R  + P        Q + E      L     I   
Sbjct: 15  EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--------QLRDEYRTYKLLAGCTGIPNV 66

Query: 199 IGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIH 258
               ++ +   +V +    G   + L     R   +K     A  +   +  +H   L++
Sbjct: 67  YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 259 RDLKSDNLLI-----FSDKSIKIADFGVARI--------EVQTEGMTPETGTYRWMAP 303
           RD+K DN LI      +   I + DFG+ +          +        +GT R+M+ 
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 3e-24
 Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 27/193 (13%)

Query: 123 NFDEWTID-----LRKLNMGDAFAQGAFGKLYRG--TYNGEEVAIKILERPENDPEKAQV 175
           N   W +      L  +        GA+G +     T  G  VA+K L RP      A+ 
Sbjct: 10  NKTIWEVPERYQNLSPV------GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK- 62

Query: 176 MEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC-----IVTEYAKGGSVRQFLTKRQNR 230
              +  +E+ +L  +KH N++  +                +  +  G  +   +  ++  
Sbjct: 63  ---RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119

Query: 231 SVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG 290
              ++  + Q   + RG+ Y+H   +IHRDLK  NL +  D  +KI DFG+AR       
Sbjct: 120 DDHVQFLIYQ---ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174

Query: 291 MTPETGTYRWMAP 303
           MT    T  + AP
Sbjct: 175 MTGYVATRWYRAP 187

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 3e-19
 Identities = 22/160 (13%), Positives = 50/160 (31%), Gaps = 27/160 (16%)

Query: 137 GDAFAQGAFGKLYRGT-YNGEEVAIKILE------------RPENDPEKAQVMEQQFQQE 183
           G    +G    ++        E  +K  +            R   D   + +  +  + E
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 184 VMMLATLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALD 243
              L  L+   + +            ++ E      + +   +  +              
Sbjct: 65  FRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYRVRVENPDEV---------LDM 111

Query: 244 VARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR 283
           +   +A  +  G++H DL   N+L+ S++ I I DF  + 
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 78.9 bits (193), Expect = 3e-17
 Identities = 36/178 (20%), Positives = 75/178 (42%), Gaps = 18/178 (10%)

Query: 142 QGAFGKLYRG--TYNGEEVAIKILERPENDPEKA----QVMEQQFQQEVMMLATLKHPNI 195
            G F  ++      N   VA+KI+   +   E A    +++++    +     ++   +I
Sbjct: 23  WGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82

Query: 196 VRFIGACRKPM---VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVH 252
           ++ +          V  ++     G ++   + K ++R +PL    + +  +  G+ Y+H
Sbjct: 83  LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH 142

Query: 253 -RLGLIHRDLKSDNLLIFSDK------SIKIADFGVARIEVQTEGMTPETGTYRWMAP 303
            R G+IH D+K +N+L+           IKIAD G A    +    +    T  + +P
Sbjct: 143 RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTREYRSP 198

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	303
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.98
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.72
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.25
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.97
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.02
d2oq1a1	130	Tyrosine-protein kinase zap-70 {Human (Homo sapien	96.94
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.88
d1qcfa2	103	Hemopoetic cell kinase Hck {Human (Homo sapiens) [	95.35
d1blja_	114	P55 Blk protein tyrosine kinase {Mouse (Mus muscul	94.83
d1lkka_	105	p56-lck tyrosine kinase {Human (Homo sapiens) [Tax	94.71
d1rjaa_	100	Tyrosine-protein kinase 6 (Breast tumor kinase, Br	94.53
d1o48a_	106	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	94.31
d1a81a1	129	Syk tyrosine kinase {Human (Homo sapiens) [TaxId:	94.2
d2oq1a2	124	Tyrosine-protein kinase zap-70 {Human (Homo sapien	92.98
d1a81a2	125	Syk tyrosine kinase {Human (Homo sapiens) [TaxId:	92.38
d1g83a2	104	Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId:	91.28
d1jwoa_	97	Csk homologous kinase Chk {Human (Homo sapiens) [T	90.86
d1k9aa2	101	Carboxyl-terminal src kinase (csk) {Human (Homo sa	89.54
d1i3za_	103	Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus	88.16
d1jyra_	96	Growth factor receptor-bound protein 2 (GRB2) {Hum	85.04
d1opka2	101	Abl tyrosine kinase {Mouse (Mus musculus) [TaxId:	83.66
d1r1qa_	97	GRB2-related adaptor protein 2 (MONA, GRID) {Mouse	83.35
d2al6a2	110	Focal adhesion kinase 1 {Chicken (Gallus gallus) [	82.59
d1luia_	108	Itk/tsk protein tyrosine kinase {Mouse (Mus muscul	81.76

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-42  Score=309.30  Aligned_cols=175  Identities=26%  Similarity=0.573  Sum_probs=156.4

Q ss_pred             CCCCcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeee
Q 046106          122 ENFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFI  199 (303)
Q Consensus       122 ~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  199 (303)
                      ++++.|+++.++|++.+.||+|+||+||+|++  +++.||||+++......       ++|.+|+.+|++++|||||+++
T Consensus         7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~il~~l~HpnIv~~~   79 (287)
T d1opja_           7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-------EEFLKEAAVMKEIKHPNLVQLL   79 (287)
T ss_dssp             TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH-------HHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH-------HHHHHHHHHHHhCCCCCEecCC
Confidence            46789999999999999999999999999998  58899999997654432       4688999999999999999999


Q ss_pred             EEEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          200 GACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       200 ~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      ++|.+++.++|||||+++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||++++.+||+||
T Consensus        80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             ccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccc
Confidence            99999999999999999999999998776678999999999999999999999999999999999999999999999999


Q ss_pred             CCceeeecCCCc--cCCCCCCcccCC
Q 046106          280 GVARIEVQTEGM--TPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~~--~~~~gt~~y~AP  303 (303)
                      |+|+........  ....||+.|+||
T Consensus       160 G~a~~~~~~~~~~~~~~~g~~~y~aP  185 (287)
T d1opja_         160 GLSRLMTGDTYTAHAGAKFPIKWTAP  185 (287)
T ss_dssp             CCTTTCCSSSSEEETTEEECGGGCCH
T ss_pred             cceeecCCCCceeeccccccccccCh
Confidence            999876543322  223478999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=301.09  Aligned_cols=172  Identities=34%  Similarity=0.659  Sum_probs=147.2

Q ss_pred             CcceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      |+|+++.++|.+.+.||+|+||+||+|++++ .||||+++....+...    .+.|.+|+.+|++++|||||++++++..
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~~~~~~   75 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILLFMGYSTA   75 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH----HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH----HHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence            5899999999999999999999999998765 5999999876554432    3688999999999999999999998865


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      + .++|||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.
T Consensus        76 ~-~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          76 P-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             S-SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             c-EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence            4 5799999999999999997643 4689999999999999999999999999999999999999999999999999987


Q ss_pred             eecCC---CccCCCCCCcccCC
Q 046106          285 EVQTE---GMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~---~~~~~~gt~~y~AP  303 (303)
                      .....   .....+||+.||||
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~AP  175 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAP  175 (276)
T ss_dssp             ------------CCCCGGGCCH
T ss_pred             ccccCCcccccccccCcccCCH
Confidence            54322   23455799999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-41  Score=297.82  Aligned_cols=172  Identities=31%  Similarity=0.550  Sum_probs=151.4

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      .++|+|+.++|++.+.||+|+||.||+|++ +++.||||+++......       +.|.+|+.+|++++|||||++++++
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~   77 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-------DAFLAEANLMKQLQHQRLVRLYAVV   77 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH-------HHHHHHHHHHHhCCCCCEeEEEeee
Confidence            478999999999999999999999999999 56789999997654432       4789999999999999999999988


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .++ .+||||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+||||++++.+||+|||+|
T Consensus        78 ~~~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          78 TQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             CSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccC-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccce
Confidence            654 5689999999999999887655556899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC--ccCCCCCCcccCC
Q 046106          283 RIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      +.......  .....||+.|+||
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~AP  179 (272)
T d1qpca_         157 RLIEDNEYTAREGAKFPIKWTAP  179 (272)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCH
T ss_pred             EEccCCccccccccCCcccccCh
Confidence            97654332  2345789999998

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-41  Score=296.09  Aligned_cols=165  Identities=26%  Similarity=0.471  Sum_probs=143.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||+||+|++  +++.||||+++......     ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence            4678889999999999999998  68899999997653221     1257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      |||||+++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||+++++.+||+|||+|+......
T Consensus        80 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999999998654  469999999999999999999999999999999999999999999999999998764332


Q ss_pred             ---CccCCCCCCcccCC
Q 046106          290 ---GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ---~~~~~~gt~~y~AP  303 (303)
                         ..+..+||+.||||
T Consensus       158 ~~~~~~~~~GT~~Y~AP  174 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAP  174 (271)
T ss_dssp             EECCBCCCCSCGGGSCT
T ss_pred             ccccccceeeCcCccCH
Confidence               23456899999999

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-40  Score=291.12  Aligned_cols=170  Identities=29%  Similarity=0.494  Sum_probs=147.9

Q ss_pred             cceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACR  203 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  203 (303)
                      .|.+  ++|++++.||+|+||+||+|++  +++.||+|++.+....   .....+.+.+|+.+|+.++|||||++++++.
T Consensus         2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   76 (263)
T d2j4za1           2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE---KAGVEHQLRREVEIQSHLRHPNILRLYGYFH   76 (263)
T ss_dssp             CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc---ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence            4554  5789999999999999999998  6789999998642211   1112357889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      ++..+||||||+++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+
T Consensus        77 ~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          77 DATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             ECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence            999999999999999999999875  458999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ..... .....+||+.||||
T Consensus       155 ~~~~~-~~~~~~Gt~~Y~AP  173 (263)
T d2j4za1         155 HAPSS-RRTTLCGTLDYLPP  173 (263)
T ss_dssp             CCCCC-CCEETTEEGGGCCH
T ss_pred             ecCCC-cccccCCCCcccCH
Confidence            65433 34456899999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-40  Score=289.06  Aligned_cols=167  Identities=29%  Similarity=0.543  Sum_probs=139.0

Q ss_pred             eecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      |+.++|++.+.||+|+||.||+|++ +++.||||+++......       +.|.+|+.++++++|||||+++++|..+..
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   74 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH-------HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH-------HHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence            5678899999999999999999999 67889999997654432       478999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||||++++.+||+|||+|+....
T Consensus        75 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          75 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             eEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence            999999999999999987653 4689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc--cCCCCCCcccCC
Q 046106          288 TEGM--TPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~--~~~~gt~~y~AP  303 (303)
                      ....  ....||+.|+||
T Consensus       154 ~~~~~~~~~~gt~~y~aP  171 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASP  171 (263)
T ss_dssp             -----------CTTSCCH
T ss_pred             CCceeecceecCcccCCh
Confidence            3322  234789999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=290.93  Aligned_cols=163  Identities=28%  Similarity=0.468  Sum_probs=145.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||+||+|++  +|+.||||+++......      .+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------KELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH------HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            4788899999999999999997  68999999997644322      257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      |||||+++|+|.+++...   .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus        94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            999999999999988753   58999999999999999999999999999999999999999999999999998765433


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       .....+||+.|+||
T Consensus       171 ~~~~~~~gt~~Y~aP  185 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAP  185 (293)
T ss_dssp             CCBCCCCSCGGGCCH
T ss_pred             ccccccccCCCccCh
Confidence             34556899999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-40  Score=297.51  Aligned_cols=168  Identities=26%  Similarity=0.400  Sum_probs=147.1

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP  205 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  205 (303)
                      ++..++|++.+.||+|+||+||+|++  +++.||+|+++.......     .+.+.+|+.+|+.++|||||+++++|.++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   76 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----RNQIIRELQVLHECNSPYIVGFYGAFYSD   76 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTH-----HHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            35567899999999999999999998  689999999986543221     25788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      ..+||||||+++|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+||||+.++.+||+|||+|+.
T Consensus        77 ~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          77 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             SEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             CEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            9999999999999999999865  458999999999999999999997 5999999999999999999999999999986


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      .... ..++.+||+.|+||
T Consensus       155 ~~~~-~~~~~~GT~~Y~AP  172 (322)
T d1s9ja_         155 LIDS-MANSFVGTRSYMSP  172 (322)
T ss_dssp             HHHH-TC---CCSSCCCCH
T ss_pred             cCCC-ccccccCCccccCc
Confidence            5443 34456899999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=290.23  Aligned_cols=173  Identities=34%  Similarity=0.560  Sum_probs=146.9

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      ..++|+|+.++|++.+.||+|+||+||+|++ +++.||||+++......       +.|.+|+.+|++++|||||+++++
T Consensus         8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~-------~~~~~E~~~l~~l~h~nIv~~~g~   80 (285)
T d1fmka3           8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-------EAFLQEAQVMKKLRHEKLVQLYAV   80 (285)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH-------HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH-------HHHHHHHHHHHhcccCCEeEEEEE
Confidence            3578999999999999999999999999999 55789999997654432       478999999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      |.++ ..++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||++++.+||+|||+
T Consensus        81 ~~~~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          81 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             ECSS-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             EecC-CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence            8654 568999999999999999876556799999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCC--ccCCCCCCcccCC
Q 046106          282 ARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      |+.......  .....||+.|+||
T Consensus       160 a~~~~~~~~~~~~~~~gt~~y~aP  183 (285)
T d1fmka3         160 ARLIEDNEYTARQGAKFPIKWTAP  183 (285)
T ss_dssp             TC--------------CCGGGSCH
T ss_pred             hhhccCCCceeeccccccccccCh
Confidence            987543332  2335789999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-39  Score=290.11  Aligned_cols=165  Identities=29%  Similarity=0.469  Sum_probs=145.4

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      +.|++++.||+|+||+||+|++  +++.||||+++......      .+.+.+|+.+|++++|||||++++++.++..+|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE------LEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG------GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            3578899999999999999998  67899999997653322      246889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      |||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus        86 lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            9999999999999987643 469999999999999999999999999999999999999999999999999998654332


Q ss_pred             -CccCCCCCCcccCC
Q 046106          290 -GMTPETGTYRWMAP  303 (303)
Q Consensus       290 -~~~~~~gt~~y~AP  303 (303)
                       .....+||+.|+||
T Consensus       165 ~~~~~~~Gt~~y~AP  179 (288)
T d2jfla1         165 QRRDSFIGTPYWMAP  179 (288)
T ss_dssp             HHHTCCCSCCTTCCH
T ss_pred             ccccccccccccCCH
Confidence             23456899999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-39  Score=288.46  Aligned_cols=164  Identities=28%  Similarity=0.456  Sum_probs=144.6

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      +.|+.++.||+|+||+||+|++  +++.||||+++........   ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH---HHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEE
Confidence            3578889999999999999997  6889999999876544322   2367899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      ||||||++|+|..++...  ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+....  
T Consensus        92 iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            999999998887666554  4699999999999999999999999999999999999999999999999999986432  


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                       ....+||+.||||
T Consensus       168 -~~~~~GT~~Y~AP  180 (309)
T d1u5ra_         168 -ANSFVGTPYWMAP  180 (309)
T ss_dssp             -BCCCCSCGGGCCH
T ss_pred             -CCccccCccccCH
Confidence             3456899999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-39  Score=287.40  Aligned_cols=170  Identities=24%  Similarity=0.427  Sum_probs=150.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++++.||+|+||+||+|++  +|+.||||++++............+.+.+|+.+|++++|||||++++++.++..+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4688999999999999999998  68899999998765433222222367899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC----cEEEeccCCceee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK----SIKIADFGVARIE  285 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~----~vKl~DFGla~~~  285 (303)
                      |||||+++|+|.+++...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++    .+||+|||+|+..
T Consensus        90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            999999999999999875  4699999999999999999999999999999999999998876    5999999999987


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........||+.|+||
T Consensus       168 ~~~~~~~~~~~t~~y~AP  185 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAP  185 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCH
T ss_pred             CCCccccccCCCCcccCH
Confidence            666666677899999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-39  Score=288.83  Aligned_cols=169  Identities=25%  Similarity=0.396  Sum_probs=144.4

Q ss_pred             ecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ..++|++++.||+|+||+||+|++  +++.||||++++....   .....+.+.+|+.+|++++||||+++++++.++..
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~   82 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII---KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK   82 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc---CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence            346788999999999999999998  6889999999752211   11123578899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +||||||+++|+|.+++...  +.+++..+..++.|++.||+|||++|||||||||+||||++++.+||+|||+|+....
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999999998876  4699999999999999999999999999999999999999999999999999987643


Q ss_pred             CC---CccCCCCCCcccCC
Q 046106          288 TE---GMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~---~~~~~~gt~~y~AP  303 (303)
                      ..   .....+||+.|+||
T Consensus       161 ~~~~~~~~~~~GT~~Y~AP  179 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSP  179 (288)
T ss_dssp             ---------CCCCGGGCCH
T ss_pred             CCcccccccccCCccccCc
Confidence            32   23446899999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-39  Score=290.20  Aligned_cols=165  Identities=27%  Similarity=0.465  Sum_probs=129.0

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      +.|++.+.||+|+||+||+|++  +++.||||++.+......     ...+.+|+.+|+.++|||||++++++.++..+|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-----EGSMENEIAVLHKIKHPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4588899999999999999998  588999999986543322     246789999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc---CCCcEEEeccCCceeee
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF---SDKSIKIADFGVARIEV  286 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~---~~~~vKl~DFGla~~~~  286 (303)
                      |||||+++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||+.   +++.+||+|||+|+...
T Consensus        84 lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999999999764  4699999999999999999999999999999999999995   47899999999999776


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.||||
T Consensus       162 ~~~~~~~~~GT~~y~AP  178 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAP  178 (307)
T ss_dssp             -----------CTTSCH
T ss_pred             CCCeeeeeeeCccccCc
Confidence            66656667899999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=279.13  Aligned_cols=167  Identities=26%  Similarity=0.493  Sum_probs=148.2

Q ss_pred             eecCCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCe
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMV  207 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  207 (303)
                      ++.++|++.++||+|+||+||+|++ +++.||||++++.....       +.|.+|+.++++++||||++++++|.++..
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~   73 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   73 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH-------HHHHHHHHHHHTCCCTTBCCEEEEECCSSS
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH-------HHHHHHHHHHHhcCCCceeeEEEEEeeCCc
Confidence            3567899999999999999999999 56799999998765543       478899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeec
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~  287 (303)
                      +++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||||++++.+||+|||+|+....
T Consensus        74 ~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          74 IFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             eEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            999999999999999987654 4689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc--cCCCCCCcccCC
Q 046106          288 TEGM--TPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~--~~~~gt~~y~AP  303 (303)
                      ....  ....||+.|+||
T Consensus       153 ~~~~~~~~~~~t~~y~aP  170 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPP  170 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCH
T ss_pred             CCceeecccCCCCCcCCc
Confidence            4332  235689999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-39  Score=285.23  Aligned_cols=169  Identities=26%  Similarity=0.423  Sum_probs=135.6

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc--CC
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK--PM  206 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~  206 (303)
                      .++|++.+.||+|+||+||+|++  +|+.||||+++....+...    .+.+.+|+.+|++++|||||++++++.+  ..
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   78 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT   78 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH----HHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH----HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence            35788899999999999999998  6889999999876654432    3578899999999999999999999965  45


Q ss_pred             eEEEEEeecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCcEEEcCCCcEEEecc
Q 046106          207 VWCIVTEYAKGGSVRQFLTKR--QNRSVPLKLAVKQALDVARGMAYVHRLG-----LIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~g-----iiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      .+||||||+++|+|.+++...  ....+++..++.++.||+.||+|||++|     ||||||||+||||+.++.+||+||
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            689999999999999998743  2357999999999999999999999876     999999999999999999999999


Q ss_pred             CCceeeecCC-CccCCCCCCcccCC
Q 046106          280 GVARIEVQTE-GMTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~-~~~~~~gt~~y~AP  303 (303)
                      |+|+...... .....+||+.||||
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~AP  183 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSP  183 (269)
T ss_dssp             HHHHHC-----------CCCSCCCH
T ss_pred             cceeecccCCCccccCCCCcccCCH
Confidence            9998765433 23456899999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.7e-38  Score=279.98  Aligned_cols=171  Identities=25%  Similarity=0.395  Sum_probs=153.2

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCC---hHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEc
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPEND---PEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRK  204 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~---~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~  204 (303)
                      .++|++.+.||+|+||+||+|+.  +++.||||++++....   ....+...+.+.+|+.+|++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            35788999999999999999998  7899999999876543   2333445678999999999997 9999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +..+||||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            99999999999999999999875  4689999999999999999999999999999999999999999999999999998


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      .......+..+||+.|+||
T Consensus       160 ~~~~~~~~~~~gt~~y~~P  178 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAP  178 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCH
T ss_pred             ccCCCceeeeeccCCCCCH
Confidence            7666556667899999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-39  Score=291.72  Aligned_cols=174  Identities=29%  Similarity=0.515  Sum_probs=147.2

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC--C-----eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCee
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN--G-----EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIV  196 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv  196 (303)
                      ..|+++.++|++++.||+|+||+||+|++.  +     ..||+|.+.......     ....+.+|+.+|.++ +|||||
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~~HpnIv  104 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-----EREALMSELKMMTQLGSHENIV  104 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH-----HHHHHHHHHHHHHHhcCCCcEe
Confidence            469999999999999999999999999872  2     369999986543222     225788999999988 899999


Q ss_pred             eeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 046106          197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN---------------------RSVPLKLAVKQALDVARGMAYVHRLG  255 (303)
Q Consensus       197 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~g  255 (303)
                      ++++++.++..+|+||||+++|+|.+++.....                     ..+++..++.++.||+.||+|||+++
T Consensus       105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~  184 (325)
T d1rjba_         105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  184 (325)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999986432                     24789999999999999999999999


Q ss_pred             ceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCCc---cCCCCCCcccCC
Q 046106          256 LIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEGM---TPETGTYRWMAP  303 (303)
Q Consensus       256 iiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~~---~~~~gt~~y~AP  303 (303)
                      ||||||||+|||++.++.+||+|||+|+........   ....||+.||||
T Consensus       185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  235 (325)
T d1rjba_         185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP  235 (325)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH
T ss_pred             eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCCh
Confidence            999999999999999999999999999876544332   234679999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-39  Score=287.96  Aligned_cols=170  Identities=28%  Similarity=0.501  Sum_probs=135.5

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCe---EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGE---EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~---~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +++.++|++.+.||+|+||+||+|++  +++   .||||.+.......     ..+.|.+|+.+|++++|||||+++++|
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~   96 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-----QRRDFLSEASIMGQFDHPNVIHLEGVV   96 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH-----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH-----HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            56678899999999999999999987  232   58899886543321     235799999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      ..+..+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+||||+.++++||+|||+|
T Consensus        97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_          97 TKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             eeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence            99999999999999999999988643 46899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCcc------CCCCCCcccCC
Q 046106          283 RIEVQTEGMT------PETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~~~------~~~gt~~y~AP  303 (303)
                      +.........      ...||+.||||
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aP  202 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAP  202 (299)
T ss_dssp             --------------------CGGGSCH
T ss_pred             eEccCCCCcceeeecccccCCccccCH
Confidence            8765432211      23578999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-38  Score=290.94  Aligned_cols=170  Identities=26%  Similarity=0.393  Sum_probs=148.7

Q ss_pred             eecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC
Q 046106          129 IDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM  206 (303)
Q Consensus       129 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  206 (303)
                      |..++|++++.||+|+||+||+|+.  +++.||||++++....   .....+.+.+|+.+|+.++||||+++++++.++.
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~---~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc---CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            4567899999999999999999997  7889999999753211   1112357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeee
Q 046106          207 VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEV  286 (303)
Q Consensus       207 ~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~  286 (303)
                      .+|+||||+++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             ccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            999999999999999999876  458999999999999999999999999999999999999999999999999998654


Q ss_pred             c-CCCccCCCCCCcccCC
Q 046106          287 Q-TEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~-~~~~~~~~gt~~y~AP  303 (303)
                      . .......+||+.|+||
T Consensus       157 ~~~~~~~~~~GT~~Y~aP  174 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAP  174 (337)
T ss_dssp             CTTCCBCCCEECGGGCCG
T ss_pred             cCCcccccceeCHHHhhh
Confidence            3 3334567899999999

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=283.04  Aligned_cols=171  Identities=27%  Similarity=0.550  Sum_probs=144.4

Q ss_pred             cceeecCCccccc-eecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          126 EWTIDLRKLNMGD-AFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       126 ~~~i~~~~~~~~~-~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      .|.+..+++.+.+ +||+|+||.||+|.+    ++..||||+++.....     ...+.|.+|+.+|++++|||||++++
T Consensus         2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~g   76 (285)
T d1u59a_           2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----ADTEEMMREAQIMHQLDNPYIVRLIG   76 (285)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-----HHHHHHHHHHHHHHhCCCCCEeeEee
Confidence            3556777888877 499999999999986    3457999999764322     12367899999999999999999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      ++..+ .+||||||+++|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||
T Consensus        77 ~~~~~-~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          77 VCQAE-ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             EEESS-SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             eeccC-eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccch
Confidence            99765 4689999999999999986543 468999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCC----ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      +|+.......    ....+||+.|+||
T Consensus       155 la~~~~~~~~~~~~~~~~~gt~~y~aP  181 (285)
T d1u59a_         155 LSKALGADDSYYTARSAGKWPLKWYAP  181 (285)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCH
T ss_pred             hhhcccccccccccccccccCccccCh
Confidence            9987644322    2344689999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-38  Score=280.82  Aligned_cols=163  Identities=31%  Similarity=0.518  Sum_probs=140.7

Q ss_pred             ccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc----CCe
Q 046106          134 LNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK----PMV  207 (303)
Q Consensus       134 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~~~  207 (303)
                      +++.++||+|+||+||+|++  +++.||+|.+.........    .+.+.+|+++|++++|||||++++++..    +..
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            46667899999999999998  5779999999875544322    3578999999999999999999999864    356


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCcEEEc-CCCcEEEeccCCcee
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLG--LIHRDLKSDNLLIF-SDKSIKIADFGVARI  284 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--iiHrDlkp~NILv~-~~~~vKl~DFGla~~  284 (303)
                      +||||||+++|+|.+++...  ..+++..+..++.||+.||+|||+++  ||||||||+||||+ +++.+||+|||+|+.
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            89999999999999999875  46899999999999999999999998  99999999999996 578999999999986


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      .... .....+||+.||||
T Consensus       165 ~~~~-~~~~~~GT~~Y~aP  182 (270)
T d1t4ha_         165 KRAS-FAKAVIGTPEFMAP  182 (270)
T ss_dssp             CCTT-SBEESCSSCCCCCG
T ss_pred             ccCC-ccCCcccCccccCH
Confidence            4432 34456899999999

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.4e-38  Score=290.06  Aligned_cols=166  Identities=23%  Similarity=0.438  Sum_probs=147.4

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||+|++  +|+.||||++.....      ...+.+.+|+.+|++++|||||++++++.++..+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE------SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH------HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch------hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35788999999999999999998  689999999975432      1235788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC--CCcEEEeccCCceeee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS--DKSIKIADFGVARIEV  286 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~--~~~vKl~DFGla~~~~  286 (303)
                      |||||||++|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.  ++.+||+|||+|+...
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            99999999999999996543 46999999999999999999999999999999999999964  5789999999999876


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.||||
T Consensus       178 ~~~~~~~~~gT~~Y~aP  194 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAP  194 (350)
T ss_dssp             TTSCEEEECSCTTTCCH
T ss_pred             cccccceecCcccccCH
Confidence            66656667899999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.3e-38  Score=289.36  Aligned_cols=165  Identities=21%  Similarity=0.357  Sum_probs=146.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||+||+|++  +|+.||||+++.....      ..+.+.+|+.+|++++|||||++++++.++..+|
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL------DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH------HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4688899999999999999998  6889999999764321      1257889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEc--CCCcEEEeccCCceeeec
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIF--SDKSIKIADFGVARIEVQ  287 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~--~~~~vKl~DFGla~~~~~  287 (303)
                      |||||+++|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+  .++.+||+|||+|+....
T Consensus       103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999999999887654 34689999999999999999999999999999999999998  568999999999998776


Q ss_pred             CCCccCCCCCCcccCC
Q 046106          288 TEGMTPETGTYRWMAP  303 (303)
Q Consensus       288 ~~~~~~~~gt~~y~AP  303 (303)
                      .......+||+.|+||
T Consensus       182 ~~~~~~~~gt~~y~aP  197 (352)
T d1koba_         182 DEIVKVTTATAEFAAP  197 (352)
T ss_dssp             TSCEEEECSSGGGCCH
T ss_pred             CCceeeccCcccccCH
Confidence            6666667899999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-38  Score=279.61  Aligned_cols=170  Identities=28%  Similarity=0.478  Sum_probs=139.5

Q ss_pred             eeecCCccccceecccCceEEEEEEEC--C----eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTYN--G----EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~----~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      +|+.+.|++.+.||+|+||.||+|.+.  +    ..||||+++......     ....|.+|+.+|++++|||||+++++
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~E~~il~~l~H~nIv~~~g~   77 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-----QRVDFLGEAGIMGQFSHHNIIRLEGV   77 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-----HHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence            466778888999999999999999872  2    379999996543321     23578999999999999999999999


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      +.+...+++||||+.++++.+++.... ..+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+
T Consensus        78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          78 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             EecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence            999999999999999999999887653 5689999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCC----ccCCCCCCcccCC
Q 046106          282 ARIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      |+.......    .....||+.||||
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~AP  182 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAP  182 (283)
T ss_dssp             -----------------CCCGGGSCH
T ss_pred             hhcccCCCccceEeccCCCCccccCH
Confidence            987544322    2234689999998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6e-38  Score=283.64  Aligned_cols=166  Identities=28%  Similarity=0.443  Sum_probs=145.3

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++++.||+|+||+||+|++  +|+.||||++++....   .....+.+.+|+.+|+.++|||||++++++.++..+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   79 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV---RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   79 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc---CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCee
Confidence            35788999999999999999998  6889999999652211   111235788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      |+||||+++|+|..++...  ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.... 
T Consensus        80 ~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-  156 (316)
T d1fota_          80 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  156 (316)
T ss_dssp             EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-
Confidence            9999999999999988865  4578999999999999999999999999999999999999999999999999987543 


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                       .....+||+.||||
T Consensus       157 -~~~~~~Gt~~Y~AP  170 (316)
T d1fota_         157 -VTYTLCGTPDYIAP  170 (316)
T ss_dssp             -CBCCCCSCTTTCCH
T ss_pred             -ccccccCcccccCH
Confidence             24456899999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-38  Score=278.44  Aligned_cols=171  Identities=28%  Similarity=0.538  Sum_probs=136.7

Q ss_pred             cceeecCCccccceecccCceEEEEEEEC-----CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeE
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYN-----GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIG  200 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  200 (303)
                      +|+|+.++|++++.||+|+||.||+|++.     +..||||.++.....     ...+.+.+|+.+|++++|||||++++
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~   75 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-----SVREKFLQEALTMRQFDHPHIVKLIG   75 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            59999999999999999999999999872     246889988654322     22367999999999999999999999


Q ss_pred             EEEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          201 ACRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       201 ~~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                      ++.+ ..+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||+++++.+||+|||
T Consensus        76 ~~~~-~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          76 VITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             EECS-SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEec-CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence            9964 56799999999999999887643 568999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCC--ccCCCCCCcccCC
Q 046106          281 VARIEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      +|+.......  .+...||+.|+||
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~ap  178 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAP  178 (273)
T ss_dssp             -----------------CCGGGCCH
T ss_pred             hheeccCCcceeccceecCcccchh
Confidence            9987543322  2344689999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-38  Score=278.44  Aligned_cols=159  Identities=32%  Similarity=0.603  Sum_probs=132.7

Q ss_pred             ceecccCceEEEEEEE----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEe
Q 046106          138 DAFAQGAFGKLYRGTY----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTE  213 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E  213 (303)
                      ++||+|+||+||+|.+    .++.||||+++....+..    ..+.|.+|+.+|++++|||||+++++|..+. ++||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----LKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----HHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-EEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH----HHHHHHHHHHHHHhCCCCCCceEEEEeccCC-EEEEEE
Confidence            4699999999999987    236899999976443322    2367999999999999999999999997654 689999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC---
Q 046106          214 YAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---  290 (303)
Q Consensus       214 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---  290 (303)
                      |+++|+|.+++...  ..+++..++.++.||+.||+|||+++||||||||+||||+.++.+||+|||+|+.......   
T Consensus        88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999999999865  4689999999999999999999999999999999999999999999999999987543322   


Q ss_pred             -ccCCCCCCcccCC
Q 046106          291 -MTPETGTYRWMAP  303 (303)
Q Consensus       291 -~~~~~gt~~y~AP  303 (303)
                       .....||+.|+||
T Consensus       166 ~~~~~~gt~~y~AP  179 (277)
T d1xbba_         166 AQTHGKWPVKWYAP  179 (277)
T ss_dssp             C----CCCGGGCCH
T ss_pred             cccccCCCceecCc
Confidence             2234689999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.8e-38  Score=288.51  Aligned_cols=170  Identities=21%  Similarity=0.307  Sum_probs=143.8

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      .++|++.+.||+|+||.||+|++  +|+.||||++.+................+|+.+++.++|||||++++++.++..+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            46788999999999999999998  6889999999653221111111122334557788888999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ||||||+++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999999999875  45899999999999999999999999999999999999999999999999999866543


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                       .....+||+.|+||
T Consensus       161 -~~~~~~GT~~y~AP  174 (364)
T d1omwa3         161 -KPHASVGTHGYMAP  174 (364)
T ss_dssp             -CCCSCCSCGGGCCH
T ss_pred             -cccccccccccchh
Confidence             34556899999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-38  Score=277.32  Aligned_cols=168  Identities=29%  Similarity=0.560  Sum_probs=141.7

Q ss_pred             cceeecCCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-
Q 046106          126 EWTIDLRKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-  204 (303)
Q Consensus       126 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-  204 (303)
                      .|+++.++|++.+.||+|+||.||+|+++|+.||||+++....        .+.|.+|+.+|++++||||++++++|.+ 
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--------AQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH--------HHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            4999999999999999999999999999999999999975332        1578899999999999999999999965 


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +..+|+||||+++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccccee
Confidence            45679999999999999999865444689999999999999999999999999999999999999999999999999986


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ....  .....+|+.|+||
T Consensus       153 ~~~~--~~~~~~~~~y~aP  169 (262)
T d1byga_         153 ASST--QDTGKLPVKWTAP  169 (262)
T ss_dssp             -----------CCTTTSCH
T ss_pred             cCCC--CccccccccCCCh
Confidence            5432  3344689999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-37  Score=280.82  Aligned_cols=165  Identities=18%  Similarity=0.290  Sum_probs=145.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeE
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  208 (303)
                      +++|.+++.||+|+||+||+|++  +++.||||+++....+       ...+.+|+.+|+.++|||||++++++.++..+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-------~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------QVLVKKEISILNIARHRNILHLHESFESMEEL   76 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-------HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            45788999999999999999998  6889999999764321       24678999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC--CcEEEeccCCceeee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD--KSIKIADFGVARIEV  286 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~--~~vKl~DFGla~~~~  286 (303)
                      |||||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+  ..+||+|||+|+...
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999999999997643 468999999999999999999999999999999999999854  589999999998766


Q ss_pred             cCCCccCCCCCCcccCC
Q 046106          287 QTEGMTPETGTYRWMAP  303 (303)
Q Consensus       287 ~~~~~~~~~gt~~y~AP  303 (303)
                      ........+||+.|+||
T Consensus       156 ~~~~~~~~~~t~~y~ap  172 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAP  172 (321)
T ss_dssp             TTCEEEEEESCGGGSCH
T ss_pred             cCCcccccccccccccc
Confidence            55545556899999997

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=278.37  Aligned_cols=176  Identities=27%  Similarity=0.541  Sum_probs=138.7

Q ss_pred             CCCcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCC
Q 046106          123 NFDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPN  194 (303)
Q Consensus       123 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn  194 (303)
                      ..+.|+++.++|++.+.||+|+||+||+|++       +++.||||+++......     ..+.+.+|..++.++ +|||
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~e~~~l~~~~~h~~   78 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-----EHRALMSELKILIHIGHHLN   78 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-----HHHHHHHHHHHHHHHCCCTT
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-----HHHHHHHHHHHHHhhcCCCe
Confidence            3468999999999999999999999999987       23689999987543322     235677787777766 6899


Q ss_pred             eeeeeEEEEcC-CeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 046106          195 IVRFIGACRKP-MVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHR  259 (303)
Q Consensus       195 iv~l~~~~~~~-~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHr  259 (303)
                      |+.+++++..+ ..+++||||+++|+|.+++....              ...+++..++.++.||+.||+|||+++||||
T Consensus        79 iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHr  158 (299)
T d1ywna1          79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR  158 (299)
T ss_dssp             BCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            99999998764 46899999999999999997542              2347899999999999999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       260 Dlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||||+||||+.++.+||+|||+|+.......   .+..+||+.|+||
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  205 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence            9999999999999999999999986543332   2345799999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-37  Score=277.01  Aligned_cols=175  Identities=28%  Similarity=0.482  Sum_probs=149.3

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCee
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV  196 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv  196 (303)
                      +..|++++++|++.+.||+|+||+||+|++.       ++.||||+++.....     ...++|.+|+.+|++++||||+
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~E~~il~~l~h~niv   79 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-----DMQADFQREAALMAEFDNPNIV   79 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-----HHHHHHHHHHHHHHTCCCTTBC
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-----HHHHHHHHHHHHHHhcCCCCcc
Confidence            3468889999999999999999999999973       368999998754322     2236899999999999999999


Q ss_pred             eeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 046106          197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ----------------------NRSVPLKLAVKQALDVARGMAYVHRL  254 (303)
Q Consensus       197 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~  254 (303)
                      +++++|......+++|||+++|+|.+++....                      ...+++..++.++.|++.||+|||++
T Consensus        80 ~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~  159 (301)
T d1lufa_          80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER  159 (301)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence            99999999999999999999999999997532                      12478899999999999999999999


Q ss_pred             CceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          255 GLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       255 giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +||||||||+||||+.++.+||+|||+|+.......   .+..+||+.|+||
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aP  211 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP  211 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCH
Confidence            999999999999999999999999999986543322   2345788999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-37  Score=281.61  Aligned_cols=165  Identities=25%  Similarity=0.341  Sum_probs=145.2

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++++.||+|+||+||+|++  +|+.||||++.+...   ......+.+.+|+.+|+.++|||||++++++.....++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV---VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc---cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            5788899999999999999998  688999999864211   11112357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+..... 
T Consensus       118 ~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            999999999999999876  46899999999999999999999999999999999999999999999999999876432 


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                       ....+||+.||||
T Consensus       195 -~~~~~Gt~~Y~AP  207 (350)
T d1rdqe_         195 -TWTLCGTPEALAP  207 (350)
T ss_dssp             -BCCCEECGGGCCH
T ss_pred             -cccccCccccCCH
Confidence             3456899999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-37  Score=277.29  Aligned_cols=175  Identities=27%  Similarity=0.472  Sum_probs=150.5

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEEC-------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCee
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTYN-------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV  196 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv  196 (303)
                      .++|+|+.++|.+++.||+|+||.||+|++.       ++.||||+++......     ....|.+|+.++++++||||+
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv   86 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-----ERIEFLNEASVMKEFNCHHVV   86 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-----HHHHHHHHHHHGGGCCCTTBC
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-----HHHHHHHHHHHHHHcCCCCEe
Confidence            3689999999999999999999999999873       3689999997543221     235789999999999999999


Q ss_pred             eeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 046106          197 RFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI  268 (303)
Q Consensus       197 ~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv  268 (303)
                      +++++|..+...++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+++|+||||||+||||
T Consensus        87 ~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV  166 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred             eeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence            99999999899999999999999999987432        1346889999999999999999999999999999999999


Q ss_pred             cCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          269 FSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       269 ~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      +.++++||+|||+|+.......   .....||+.|+||
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aP  204 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP  204 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCH
Confidence            9999999999999986544332   2334689999998

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-36  Score=273.16  Aligned_cols=167  Identities=28%  Similarity=0.483  Sum_probs=142.4

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|++.+.||+|+||+||+|++  +++.||||+++......    ...+.+.+|+.+|++++|||||++++++.++..+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~   77 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY   77 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh----HHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence            5788899999999999999998  68899999997543221    12357889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC-
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT-  288 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~-  288 (303)
                      +||||+. +.+.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... 
T Consensus        78 iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          78 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             EEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9999995 56777776665667999999999999999999999999999999999999999999999999999875433 


Q ss_pred             CCccCCCCCCcccCC
Q 046106          289 EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 ~~~~~~~gt~~y~AP  303 (303)
                      ......+||+.|+||
T Consensus       157 ~~~~~~~gt~~y~ap  171 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAP  171 (298)
T ss_dssp             BCTTCCBCCCTTCCH
T ss_pred             ccceeecccceeeeh
Confidence            334455899999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=276.83  Aligned_cols=161  Identities=24%  Similarity=0.385  Sum_probs=140.0

Q ss_pred             CCccccc-eecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHH-cCCCCCeeeeeEEEEc---
Q 046106          132 RKLNMGD-AFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLA-TLKHPNIVRFIGACRK---  204 (303)
Q Consensus       132 ~~~~~~~-~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~hpniv~l~~~~~~---  204 (303)
                      ++|.+.. .||+|+||+||+|++  +++.||||+++..           ..+.+|+.++. ..+|||||++++++.+   
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            4676654 599999999999998  6889999999641           35668998865 4589999999999865   


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccC
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFG  280 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---~~~vKl~DFG  280 (303)
                       ...+|||||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+||+|||
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence             456899999999999999998765567999999999999999999999999999999999999986   4679999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|+...........+||+.|+||
T Consensus       160 ~a~~~~~~~~~~~~~gt~~y~aP  182 (335)
T d2ozaa1         160 FAKETTSHNSLTTPCYTPYYVAP  182 (335)
T ss_dssp             TCEECCCCCCCCCCSCCCSSCCC
T ss_pred             eeeeccCCCccccccCCcccCCc
Confidence            99987666666777999999999

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.3e-36  Score=266.99  Aligned_cols=167  Identities=25%  Similarity=0.439  Sum_probs=137.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC---
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM---  206 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~---  206 (303)
                      ++|++.+.||+|+||.||+|++  +++.||||++++......   ...+.+.+|+.+|+.++||||+++++++....   
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~   83 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP---SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   83 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH---HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence            5688899999999999999997  689999999987544322   22367999999999999999999999997643   


Q ss_pred             -eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 -VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                       .+||||||+++++|.+++...  ..+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||+++..
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             ceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence             479999999999999998765  46899999999999999999999999999999999999999999999999998764


Q ss_pred             ecCC----CccCCCCCCcccCC
Q 046106          286 VQTE----GMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~----~~~~~~gt~~y~AP  303 (303)
                      ....    .....+||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aP  183 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSP  183 (277)
T ss_dssp             C----------------TTCCH
T ss_pred             ccccccccccccccCcccccCH
Confidence            3322    23445799999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-36  Score=272.33  Aligned_cols=175  Identities=30%  Similarity=0.504  Sum_probs=151.1

Q ss_pred             CCcceeecCCccccceecccCceEEEEEEE-------CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCe
Q 046106          124 FDEWTIDLRKLNMGDAFAQGAFGKLYRGTY-------NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNI  195 (303)
Q Consensus       124 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpni  195 (303)
                      -..|+++.++|++++.||+|+||.||+|++       +++.||||+++......     ....|.+|+.+++.+ +||||
T Consensus        15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~E~~~~~~l~~HpnI   89 (311)
T d1t46a_          15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-----EREALMSELKVLSYLGNHMNI   89 (311)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-----HHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH-----HHHHHHHHHHHHHhccCCCCE
Confidence            358999999999999999999999999986       23589999997654322     235788999999998 69999


Q ss_pred             eeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 046106          196 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQN----------------RSVPLKLAVKQALDVARGMAYVHRLGLIHR  259 (303)
Q Consensus       196 v~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~giiHr  259 (303)
                      |+++++|.++..+++||||+++|+|.++++....                ..+++..+..++.||+.||+|||++++|||
T Consensus        90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr  169 (311)
T d1t46a_          90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR  169 (311)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            9999999999999999999999999999986431                258899999999999999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          260 DLKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       260 Dlkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ||||+|||++.++.+||+|||+++.......   ....+||+.|+||
T Consensus       170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aP  216 (311)
T d1t46a_         170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP  216 (311)
T ss_dssp             CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH
T ss_pred             ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCH
Confidence            9999999999999999999999987544332   2335789999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-36  Score=272.04  Aligned_cols=167  Identities=25%  Similarity=0.385  Sum_probs=141.8

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHH-HcCCCCCeeeeeEEEEcCCeE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMML-ATLKHPNIVRFIGACRKPMVW  208 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~~~~~~~~~~  208 (303)
                      ++|++++.||+|+||+||+|++  +++.||||++++....   .....+.+..|..++ +.++|||||++++++.++..+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~---~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~   78 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   78 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH---HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc---ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence            5688899999999999999998  7899999999752110   001123455666665 478999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecC
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQT  288 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~  288 (303)
                      ||||||+++|+|.+++...  ..+++..+..++.||+.||+|||++|||||||||+|||+++++.+||+|||+|+.....
T Consensus        79 yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          79 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             eEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999999999999875  45899999999999999999999999999999999999999999999999999865433


Q ss_pred             -CCccCCCCCCcccCC
Q 046106          289 -EGMTPETGTYRWMAP  303 (303)
Q Consensus       289 -~~~~~~~gt~~y~AP  303 (303)
                       ...+..+||+.|+||
T Consensus       157 ~~~~~~~~gt~~y~aP  172 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAP  172 (320)
T ss_dssp             TCCBCCCCSCGGGCCH
T ss_pred             cccccccCCCCCcCCH
Confidence             334456899999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=271.13  Aligned_cols=171  Identities=32%  Similarity=0.528  Sum_probs=143.6

Q ss_pred             eeecCCccccceecccCceEEEEEEE--CCe--EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCCeeeeeEEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTY--NGE--EVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPNIVRFIGAC  202 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~--~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~  202 (303)
                      .|+.++|++.+.||+|+||.||+|++  ++.  .||||.++......     ..+.|.+|+.+|.++ +|||||+++++|
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----DHRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH-----HHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            35678899999999999999999998  454  57888876543222     125789999999998 799999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEE
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKR--------------QNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLI  268 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv  268 (303)
                      .++..++|||||+++|+|.++++..              ....+++..++.++.||+.||.|||+++||||||||+|||+
T Consensus        81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~  160 (309)
T d1fvra_          81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV  160 (309)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE
Confidence            9999999999999999999999753              23568999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          269 FSDKSIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       269 ~~~~~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +.++.+||+|||+|+............||+.|+||
T Consensus       161 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aP  195 (309)
T d1fvra_         161 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI  195 (309)
T ss_dssp             CGGGCEEECCTTCEESSCEECCC----CCTTTCCH
T ss_pred             cCCCceEEccccccccccccccccceecCCcccch
Confidence            99999999999999876555445556799999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-36  Score=271.53  Aligned_cols=166  Identities=25%  Similarity=0.515  Sum_probs=136.2

Q ss_pred             cCCccccceecccCceEEEEEEE--CCe----EEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGE----EVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK  204 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  204 (303)
                      ..+|++++.||+|+||+||+|++  +|+    +||+|.++......     ..+.|.+|+.+|++++|||||+++++|.+
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   82 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----ANKEILDEAYVMASVDNPHVCRLLGICLT   82 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-----THHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45788999999999999999987  343    68899886533221     13578999999999999999999999987


Q ss_pred             CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          205 PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       205 ~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      +. .++++|++.+++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus        83 ~~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          83 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             CC-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence            65 478889999999999988653 5689999999999999999999999999999999999999999999999999987


Q ss_pred             eecCCC---ccCCCCCCcccCC
Q 046106          285 EVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~---~~~~~gt~~y~AP  303 (303)
                      ......   .....||+.|+||
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~AP  182 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMAL  182 (317)
T ss_dssp             TTTTCC--------CCTTTSCH
T ss_pred             cccccccccccccccCccccCh
Confidence            543332   2233689999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-36  Score=269.72  Aligned_cols=174  Identities=33%  Similarity=0.568  Sum_probs=144.8

Q ss_pred             CcceeecCCccccceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC-CCCC
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL-KHPN  194 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpn  194 (303)
                      ..|+|+.++|++++.||+|+||.||+|+..         +..||||++++......     ...+.+|+..+.++ +|||
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----~~~~~~e~~~l~~~~~Hpn   80 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----LSDLISEMEMMKMIGKHKN   80 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-----HHHHHHHHHHHHHHCCCTT
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-----HHHHHHHHHHHHHhcCCCe
Confidence            569999999999999999999999999862         23799999976443221     25788888888887 7999


Q ss_pred             eeeeeEEEEcCCeEEEEEeecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 046106          195 IVRFIGACRKPMVWCIVTEYAKGGSVRQFLTKRQ--------------NRSVPLKLAVKQALDVARGMAYVHRLGLIHRD  260 (303)
Q Consensus       195 iv~l~~~~~~~~~~~iv~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrD  260 (303)
                      ||+++++|.++..+++||||+++|+|.+++....              ...+++..++.++.||+.||+|||+++|||||
T Consensus        81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD  160 (299)
T d1fgka_          81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD  160 (299)
T ss_dssp             BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeee
Confidence            9999999999999999999999999999997653              24589999999999999999999999999999


Q ss_pred             CCCCcEEEcCCCcEEEeccCCceeeecCCC---ccCCCCCCcccCC
Q 046106          261 LKSDNLLIFSDKSIKIADFGVARIEVQTEG---MTPETGTYRWMAP  303 (303)
Q Consensus       261 lkp~NILv~~~~~vKl~DFGla~~~~~~~~---~~~~~gt~~y~AP  303 (303)
                      |||+|||++.++.+||+|||+++.......   .....||+.|+||
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  206 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP  206 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH
T ss_pred             ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhh
Confidence            999999999999999999999987654332   3345789999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=272.22  Aligned_cols=164  Identities=24%  Similarity=0.361  Sum_probs=133.4

Q ss_pred             cceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEEEEee
Q 046106          137 GDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCIVTEY  214 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~iv~E~  214 (303)
                      ++.||+|+||+||+|++  +|+.||||+++........ ....+.+.+|+.+|+.++|||||++++++..+..+||||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK-DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC-------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhh-HHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46799999999999997  6889999999765433211 12235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-CccC
Q 046106          215 AKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-GMTP  293 (303)
Q Consensus       215 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-~~~~  293 (303)
                      +.++++..+...  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus        82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred             hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence            987665544432  3568899999999999999999999999999999999999999999999999998654332 3345


Q ss_pred             CCCCCcccCC
Q 046106          294 ETGTYRWMAP  303 (303)
Q Consensus       294 ~~gt~~y~AP  303 (303)
                      .+||+.|+||
T Consensus       160 ~~gt~~y~aP  169 (299)
T d1ua2a_         160 QVVTRWYRAP  169 (299)
T ss_dssp             SCCCCTTCCH
T ss_pred             eecChhhccH
Confidence            6899999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=269.34  Aligned_cols=169  Identities=24%  Similarity=0.392  Sum_probs=141.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC--CCCeeeeeEEEEcCCe
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK--HPNIVRFIGACRKPMV  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~~~  207 (303)
                      ++|++.+.||+|+||.||+|++  +++.||||++++.............++.+|+.+|++++  |||||++++++.++..
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4788999999999999999998  68899999997643221110000124668999999986  8999999999999999


Q ss_pred             EEEEEeecCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCC-CcEEEeccCCceee
Q 046106          208 WCIVTEYAKG-GSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSD-KSIKIADFGVARIE  285 (303)
Q Consensus       208 ~~iv~E~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~-~~vKl~DFGla~~~  285 (303)
                      +|+||||+.+ +++.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            9999999975 5888888765  468999999999999999999999999999999999999855 79999999999865


Q ss_pred             ecCCCccCCCCCCcccCC
Q 046106          286 VQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~~~~~~gt~~y~AP  303 (303)
                      .. ...+..+||+.|+||
T Consensus       162 ~~-~~~~~~~GT~~y~aP  178 (273)
T d1xwsa_         162 KD-TVYTDFDGTRVYSPP  178 (273)
T ss_dssp             CS-SCBCCCCSCGGGSCH
T ss_pred             cc-ccccccccCCCcCCH
Confidence            43 345567899999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-36  Score=265.59  Aligned_cols=171  Identities=32%  Similarity=0.497  Sum_probs=134.0

Q ss_pred             eeecCCccccceecccCceEEEEEEEC---C--eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          128 TIDLRKLNMGDAFAQGAFGKLYRGTYN---G--EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       128 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      .|+.++|++.+.||+|+||.||+|++.   +  ..||||++++......   ...+.|.+|+.+|++++||||++++++|
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~~~g~~   80 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP---EAMDDFIREVNAMHSLDHRNLIRLYGVV   80 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH---HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            356788999999999999999999872   2  3799999876543322   2236799999999999999999999999


Q ss_pred             EcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCc
Q 046106          203 RKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVA  282 (303)
Q Consensus       203 ~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla  282 (303)
                      .++ .+++||||++++++.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|
T Consensus        81 ~~~-~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          81 LTP-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             CSS-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eec-chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence            765 5689999999999999888654 45899999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC----ccCCCCCCcccCC
Q 046106          283 RIEVQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~~----~~~~~gt~~y~AP  303 (303)
                      +.......    .....||+.|+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aP  183 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAP  183 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCH
T ss_pred             hhcccCCCcceecCccccCcccCCH
Confidence            87644322    2233578899998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-36  Score=268.96  Aligned_cols=162  Identities=34%  Similarity=0.550  Sum_probs=134.6

Q ss_pred             CCccccceecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC----e
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM----V  207 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~----~  207 (303)
                      +++.+.+.||+|+||.||+|+++|+.||||+++...     ..  ......|+..+.+++||||++++++|.++.    .
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-----~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-----HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-----hh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            467788899999999999999999999999986421     11  112234555566789999999999997643    6


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeCCCCCCcEEEcCCCcEEEecc
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR--------LGLIHRDLKSDNLLIFSDKSIKIADF  279 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------~giiHrDlkp~NILv~~~~~vKl~DF  279 (303)
                      +|+||||+++|+|.++++..   .+++..++.++.|++.||+|||+        +|||||||||+||||+.++.+||+||
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            89999999999999999863   58999999999999999999996        59999999999999999999999999


Q ss_pred             CCceeeecCCC-----ccCCCCCCcccCC
Q 046106          280 GVARIEVQTEG-----MTPETGTYRWMAP  303 (303)
Q Consensus       280 Gla~~~~~~~~-----~~~~~gt~~y~AP  303 (303)
                      |+|+.......     .....||+.|+||
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aP  181 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCH
T ss_pred             CccccccCCCcceeccccceecccCcCCh
Confidence            99987654332     2345799999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-35  Score=262.20  Aligned_cols=166  Identities=28%  Similarity=0.378  Sum_probs=137.9

Q ss_pred             CCccccceecccCceEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWCI  210 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~i  210 (303)
                      ++|++.++||+|+||.||+|++ +++.||||+++.......    ..+.+.+|+.+|++++||||+++++++..+...++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC----CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH----HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence            5788999999999999999998 678999999976543221    12578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC-
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE-  289 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~-  289 (303)
                      ++|++.++.+..+....  ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|....... 
T Consensus        78 ~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            99999765555444432  569999999999999999999999999999999999999999999999999997654332 


Q ss_pred             CccCCCCCCcccCC
Q 046106          290 GMTPETGTYRWMAP  303 (303)
Q Consensus       290 ~~~~~~gt~~y~AP  303 (303)
                      ......|++.|+||
T Consensus       156 ~~~~~~~~~~y~~p  169 (286)
T d1ob3a_         156 KYTHEIVTLWYRAP  169 (286)
T ss_dssp             ------CCCTTCCH
T ss_pred             ccceecccchhhhH
Confidence            23344688999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.7e-35  Score=263.97  Aligned_cols=159  Identities=19%  Similarity=0.416  Sum_probs=139.5

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcC--
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKP--  205 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~--  205 (303)
                      .++|+++++||+|+||+||+|++  +++.||||+++...         .+++.+|+.+|+.++ ||||+++++++..+  
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~  104 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---------KKKIKREIKILENLRGGPNIITLADIVKDPVS  104 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence            45799999999999999999998  68999999997532         146789999999996 99999999999753  


Q ss_pred             CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccCCcee
Q 046106          206 MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGVARI  284 (303)
Q Consensus       206 ~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl~DFGla~~  284 (303)
                      ..+++||||+.+++|.++.     +.+++..+..++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.
T Consensus       105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence            5689999999999987653     3589999999999999999999999999999999999998755 699999999998


Q ss_pred             eecCCCccCCCCCCcccCC
Q 046106          285 EVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       285 ~~~~~~~~~~~gt~~y~AP  303 (303)
                      ..........+||+.|+||
T Consensus       180 ~~~~~~~~~~~~t~~y~aP  198 (328)
T d3bqca1         180 YHPGQEYNVRVASRYFKGP  198 (328)
T ss_dssp             CCTTCCCCSCCSCGGGCCH
T ss_pred             ccCCCcccccccCccccCc
Confidence            7766666777899999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=263.69  Aligned_cols=168  Identities=26%  Similarity=0.424  Sum_probs=139.1

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      ..|++ .++|++.++||+|+||+||+|++  +|+.||||++++......    ..+.+.+|+.+|+.++|||||+++++|
T Consensus        12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~Ei~il~~l~hpniv~l~~~~   86 (346)
T d1cm8a_          12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----FAKRAYRELRLLKHMRHENVIGLLDVF   86 (346)
T ss_dssp             SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----HHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----HHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence            34666 56899999999999999999998  589999999986554432    236788999999999999999999999


Q ss_pred             EcCC------eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEE
Q 046106          203 RKPM------VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKI  276 (303)
Q Consensus       203 ~~~~------~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl  276 (303)
                      ....      .+|+||||+ +.+|..+...   ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred             ccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccc
Confidence            7654      469999999 6678777654   35999999999999999999999999999999999999999999999


Q ss_pred             eccCCceeeecCCCccCCCCCCcccCC
Q 046106          277 ADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       277 ~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +|||+|+....  ..+..+||+.|+||
T Consensus       163 ~Dfg~a~~~~~--~~~~~~~t~~y~aP  187 (346)
T d1cm8a_         163 LDFGLARQADS--EMTGYVVTRWYRAP  187 (346)
T ss_dssp             CCCTTCEECCS--SCCSSCSCGGGCCT
T ss_pred             ccccceeccCC--ccccccccccccCH
Confidence            99999986543  34567899999999

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-34  Score=259.35  Aligned_cols=161  Identities=30%  Similarity=0.498  Sum_probs=135.3

Q ss_pred             cceecccCceEEEEEEEC---C--eEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-CCeEEE
Q 046106          137 GDAFAQGAFGKLYRGTYN---G--EEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-PMVWCI  210 (303)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~~i  210 (303)
                      .++||+|+||+||+|++.   +  ..||||.+++... .    ...++|.+|+.+|++++||||+++++++.. +...++
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-I----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-H----HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-H----HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            567999999999999972   2  2689999975332 2    123679999999999999999999999875 567899


Q ss_pred             EEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCCC
Q 046106          211 VTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTEG  290 (303)
Q Consensus       211 v~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~~  290 (303)
                      ||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus       107 v~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999999988653 4678889999999999999999999999999999999999999999999999986543322


Q ss_pred             -----ccCCCCCCcccCC
Q 046106          291 -----MTPETGTYRWMAP  303 (303)
Q Consensus       291 -----~~~~~gt~~y~AP  303 (303)
                           .....||+.|+||
T Consensus       186 ~~~~~~~~~~gt~~y~aP  203 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMAL  203 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCH
T ss_pred             ccceecccccccccccCh
Confidence                 2224689999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-34  Score=263.47  Aligned_cols=164  Identities=26%  Similarity=0.381  Sum_probs=135.0

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCC---
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPM---  206 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~---  206 (303)
                      .+|+++++||+|+||+||+|+.  +++.||||++++....     ...+.+.+|+.+|+.++||||+++++++..+.   
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~   82 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ   82 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-----HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence            3589999999999999999997  6889999999764321     22357889999999999999999999997643   


Q ss_pred             -eEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          207 -VWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       207 -~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                       ..+++++++.+++|.+++...   .+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+..
T Consensus        83 ~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          83 MKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             CCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence             223445566689999999763   5899999999999999999999999999999999999999999999999999865


Q ss_pred             ecCCC----ccCCCCCCcccCC
Q 046106          286 VQTEG----MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~----~~~~~gt~~y~AP  303 (303)
                      .....    ....+||+.|+||
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aP  181 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAP  181 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCG
T ss_pred             cCCCccceeeccccccceechH
Confidence            43322    3445799999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-34  Score=262.09  Aligned_cols=160  Identities=28%  Similarity=0.431  Sum_probs=135.1

Q ss_pred             CccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcC-----
Q 046106          133 KLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKP-----  205 (303)
Q Consensus       133 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----  205 (303)
                      +|+.+++||+|+||+||+|++  +++.||||+++....          .+.+|+.+|++++||||+++++++...     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            567778899999999999998  688999999976532          233799999999999999999998542     


Q ss_pred             -CeEEEEEeecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCC-cEEEeccCC
Q 046106          206 -MVWCIVTEYAKGGSVRQFLTK--RQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDK-SIKIADFGV  281 (303)
Q Consensus       206 -~~~~iv~E~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~-~vKl~DFGl  281 (303)
                       ..+||||||++++ +.+.+..  .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus        91 ~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          91 EVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             CCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             ceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccc
Confidence             3579999999764 4444432  2345799999999999999999999999999999999999999775 899999999


Q ss_pred             ceeeecCCCccCCCCCCcccCC
Q 046106          282 ARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       282 a~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |+...........+||+.|+||
T Consensus       170 a~~~~~~~~~~~~~gt~~y~aP  191 (350)
T d1q5ka_         170 AKQLVRGEPNVSYICSRYYRAP  191 (350)
T ss_dssp             CEECCTTSCCCSCCSCTTSCCH
T ss_pred             hhhccCCcccccccccccccCh
Confidence            9987766666677899999998

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-34  Score=258.55  Aligned_cols=167  Identities=29%  Similarity=0.469  Sum_probs=136.7

Q ss_pred             CCccccceecccCceEEEEEEE---CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcC---CCCCeeeeeEEEEc-
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY---NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATL---KHPNIVRFIGACRK-  204 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~-  204 (303)
                      ++|++++.||+|+||+||+|++   +++.||||+++.........    ..+.+|+.+|+.+   +||||++++++|.. 
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~   82 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP----LSTIREVAVLRHLETFEHPNVVRLFDVCTVS   82 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB----CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH----HHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence            5789999999999999999997   35689999997643322111    2345677666554   89999999999853 


Q ss_pred             ----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          205 ----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       205 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                          ...++++|||+.++.+. +........+++..+..++.|++.||+|||++|||||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~~~~~~~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          83 RTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             ECSSEEEEEEEEECCSCBHHH-HHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccccCceEEEEEEeccCCchh-hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence                34689999999775554 4444445678999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCCCccCCCCCCcccCC
Q 046106          281 VARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      +++...........+||+.|+||
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~AP  184 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAP  184 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCH
T ss_pred             hhhhhcccccCCCcccChhhcCc
Confidence            99876666666677999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-33  Score=250.29  Aligned_cols=166  Identities=24%  Similarity=0.395  Sum_probs=142.9

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEcCCeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRKPMVWC  209 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  209 (303)
                      ++|+++++||+|+||+||+|++  +++.||||+++.......    ....+.+|+.+|+.++||||+++++++..+...+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   77 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT----HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH----HHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence            5789999999999999999998  678999999987654332    2367889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCceeeecCC
Q 046106          210 IVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVARIEVQTE  289 (303)
Q Consensus       210 iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~~~~~~~  289 (303)
                      +|+|++.+++|..++...  +.+++..+..++.|++.||+|||++|||||||||+|||++.++.+||+|||.|+......
T Consensus        78 iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          78 LVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             EEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988887777654  568999999999999999999999999999999999999999999999999998765443


Q ss_pred             Cc-cCCCCCCcccCC
Q 046106          290 GM-TPETGTYRWMAP  303 (303)
Q Consensus       290 ~~-~~~~gt~~y~AP  303 (303)
                      .. ....+++.|+||
T Consensus       156 ~~~~~~~~~~~~~~p  170 (292)
T d1unla_         156 RCYSAEVVTLWYRPP  170 (292)
T ss_dssp             SCCCSCCSCGGGCCH
T ss_pred             ccceeeccccchhhh
Confidence            32 233456777665

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4e-33  Score=249.13  Aligned_cols=163  Identities=25%  Similarity=0.349  Sum_probs=139.7

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC-CCeeeeeEEEEcCCe
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRFIGACRKPMV  207 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~~~  207 (303)
                      .++|++++.||+|+||+||+|++  +++.||||+++.....        ..+.+|+++++.++| +|++.+++++.....
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   75 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   75 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence            46789999999999999999998  6899999998764432        246688999999975 899999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC-----CCcEEEeccCCc
Q 046106          208 WCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS-----DKSIKIADFGVA  282 (303)
Q Consensus       208 ~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~-----~~~vKl~DFGla  282 (303)
                      .++||||+ +++|.+++... +..+++..+..++.|++.||+|||++|||||||||+||||+.     ++.+||+|||+|
T Consensus        76 ~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             cEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence            99999999 78999998764 356899999999999999999999999999999999999974     578999999999


Q ss_pred             eeeecCC--------CccCCCCCCcccCC
Q 046106          283 RIEVQTE--------GMTPETGTYRWMAP  303 (303)
Q Consensus       283 ~~~~~~~--------~~~~~~gt~~y~AP  303 (303)
                      +......        .....+||+.||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aP  182 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSI  182 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             EEcccCccccceeecccCceEEchhhcCH
Confidence            8754321        12345799999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=254.51  Aligned_cols=167  Identities=26%  Similarity=0.400  Sum_probs=134.3

Q ss_pred             cCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc----
Q 046106          131 LRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK----  204 (303)
Q Consensus       131 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----  204 (303)
                      .++|++.++||+|+||+||+|++  +|+.||||++........    ....+.+|+.+|+.++||||+++++++..    
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~   84 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG----FPITALREIKILQLLKHENVVNLIEICRTKASP   84 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS----SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH----HHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence            46889999999999999999998  688999999876543321    12467899999999999999999999855    


Q ss_pred             ----CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccC
Q 046106          205 ----PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFG  280 (303)
Q Consensus       205 ----~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFG  280 (303)
                          +..+|+||||+.++.+..+..  ....+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||
T Consensus        85 ~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          85 YNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             ------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence                345799999997665543332  23568999999999999999999999999999999999999999999999999


Q ss_pred             CceeeecCC-----CccCCCCCCcccCC
Q 046106          281 VARIEVQTE-----GMTPETGTYRWMAP  303 (303)
Q Consensus       281 la~~~~~~~-----~~~~~~gt~~y~AP  303 (303)
                      +|+......     .....+||+.|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aP  190 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPP  190 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCH
T ss_pred             eeeecccccccccccccceecCHHHhhH
Confidence            997644221     22335799999998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=256.61  Aligned_cols=169  Identities=25%  Similarity=0.389  Sum_probs=139.7

Q ss_pred             CcceeecCCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEE
Q 046106          125 DEWTIDLRKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGAC  202 (303)
Q Consensus       125 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  202 (303)
                      +.|++. ++|+++++||+|+||+||+|++  +|+.||||++++...+...    .+.+.+|+.+|+.++|||||++++++
T Consensus        12 ~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----~~~~~~Ei~il~~l~h~~iv~~~~~~   86 (348)
T d2gfsa1          12 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH----AKRTYRELRLLKHMKHENVIGLLDVF   86 (348)
T ss_dssp             SEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHH----HHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            457774 6799999999999999999997  6899999999876554433    25788999999999999999999999


Q ss_pred             EcC-----CeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEe
Q 046106          203 RKP-----MVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIA  277 (303)
Q Consensus       203 ~~~-----~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~  277 (303)
                      ...     ...++++|++.+++|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++
T Consensus        87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          87 TPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             CSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             eeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccc
Confidence            643     233566677789999999864   359999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCCCccCCCCCCcccCC
Q 046106          278 DFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       278 DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                      |||+|.....  ......||+.|+||
T Consensus       164 dfg~a~~~~~--~~~~~~g~~~y~ap  187 (348)
T d2gfsa1         164 DFGLARHTDD--EMTGYVATRWYRAP  187 (348)
T ss_dssp             CC----CCTG--GGSSSCHHHHTSCH
T ss_pred             ccchhcccCc--ccccccccccccCc
Confidence            9999975432  23456788999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-33  Score=254.45  Aligned_cols=163  Identities=26%  Similarity=0.354  Sum_probs=129.4

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEEEEc-----
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIVRFIGACRK-----  204 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----  204 (303)
                      ++|+++++||+|+||+||+|++  +|+.||||+++....+...    .+++.+|+.+|++++||||+++++++..     
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~   92 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE   92 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHH----HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHH----HHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence            6799999999999999999998  5899999999876654332    3578899999999999999999999964     


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          205 -PMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       205 -~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                       ...+|+||||+.+ ++.+.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++
T Consensus        93 ~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          93 EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence             3678999999965 5555553    358999999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCCccCCCCCCcccCC
Q 046106          284 IEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~~~~~~gt~~y~AP  303 (303)
                      ........+..+||+.|+||
T Consensus       168 ~~~~~~~~~~~~~t~~y~aP  187 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAP  187 (355)
T ss_dssp             -------------CCTTCCH
T ss_pred             ccccccccccccccccccCh
Confidence            76665556667899999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-32  Score=245.98  Aligned_cols=162  Identities=27%  Similarity=0.358  Sum_probs=133.7

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCee-eeeEEEEcCCeE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNIV-RFIGACRKPMVW  208 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpniv-~l~~~~~~~~~~  208 (303)
                      ++|++.+.||+|+||.||+|++  +++.||||++......        ..+.+|+++++.++|++++ .+.++.......
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--------HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            4688999999999999999998  6889999998865433        2567899999999877655 455566778888


Q ss_pred             EEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcC---CCcEEEeccCCceee
Q 046106          209 CIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFS---DKSIKIADFGVARIE  285 (303)
Q Consensus       209 ~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~---~~~vKl~DFGla~~~  285 (303)
                      ++||||+ ++++.+.+... ...+++..+..++.|++.||+|||++|||||||||+|||++.   +..+||+|||+|+..
T Consensus        79 ~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          79 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9999999 56777776654 356999999999999999999999999999999999999864   457999999999876


Q ss_pred             ecCCC--------ccCCCCCCcccCC
Q 046106          286 VQTEG--------MTPETGTYRWMAP  303 (303)
Q Consensus       286 ~~~~~--------~~~~~gt~~y~AP  303 (303)
                      .....        ....+||+.||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aP  182 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASI  182 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCH
T ss_pred             cccccccceeccccCCcCCCccccCH
Confidence            54321        2345799999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.3e-33  Score=255.67  Aligned_cols=170  Identities=22%  Similarity=0.391  Sum_probs=143.3

Q ss_pred             ecCCccccceecccCceEEEEEEE-----CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCC-CCeeeeeEEEE
Q 046106          130 DLRKLNMGDAFAQGAFGKLYRGTY-----NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKH-PNIVRFIGACR  203 (303)
Q Consensus       130 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~  203 (303)
                      ..++|++++.||+|+||+||+|..     +|+.||||++++.......  ...+.+.+|+.+|++++| |||+++++++.
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE--SSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch--HHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            457799999999999999999986     4689999998653211100  011467789999999977 89999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCCce
Q 046106          204 KPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGVAR  283 (303)
Q Consensus       204 ~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGla~  283 (303)
                      +...++++|||+.+++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             cCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999999998763  57899999999999999999999999999999999999999999999999998


Q ss_pred             eeecCCC--ccCCCCCCcccCC
Q 046106          284 IEVQTEG--MTPETGTYRWMAP  303 (303)
Q Consensus       284 ~~~~~~~--~~~~~gt~~y~AP  303 (303)
                      .......  .....||+.|+||
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~p  199 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAP  199 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCH
T ss_pred             hhcccccccccccccccccchh
Confidence            6543222  3345789999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.94  E-value=2.9e-27  Score=216.04  Aligned_cols=163  Identities=24%  Similarity=0.394  Sum_probs=129.3

Q ss_pred             CCccccceecccCceEEEEEEE--CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-----------CCCeeee
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTY--NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-----------HPNIVRF  198 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----------hpniv~l  198 (303)
                      .+|+++++||+|+||+||+|++  +|+.||||++++..       ...+.+.+|+.+++.+.           ||||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            4699999999999999999998  68999999997532       11246678888887765           5789999


Q ss_pred             eEEEEc--CCeEEEEEeecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCcEEEcCCC--
Q 046106          199 IGACRK--PMVWCIVTEYAKGG-SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR-LGLIHRDLKSDNLLIFSDK--  272 (303)
Q Consensus       199 ~~~~~~--~~~~~iv~E~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~giiHrDlkp~NILv~~~~--  272 (303)
                      ++++..  ....+++++++... ....+........+++..+..++.||+.||+|||+ .||+||||||+||||+.++  
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            998864  34556666665443 44444555555678999999999999999999998 8999999999999998765  


Q ss_pred             ----cEEEeccCCceeeecCCCccCCCCCCcccCC
Q 046106          273 ----SIKIADFGVARIEVQTEGMTPETGTYRWMAP  303 (303)
Q Consensus       273 ----~vKl~DFGla~~~~~~~~~~~~~gt~~y~AP  303 (303)
                          .+||+|||.|.....  .....+||+.|+||
T Consensus       166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aP  198 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSP  198 (362)
T ss_dssp             TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCH
T ss_pred             cccceeeEeeccccccccc--ccccccccccccCh
Confidence                399999999975432  33556899999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=3.6e-26  Score=190.95  Aligned_cols=138  Identities=14%  Similarity=0.122  Sum_probs=106.9

Q ss_pred             cccceecccCceEEEEEEE-CCeEEEEEEeeCCCCC------------hHHHHHHHHHHHHHHHHHHcCCCCCeeeeeEE
Q 046106          135 NMGDAFAQGAFGKLYRGTY-NGEEVAIKILERPEND------------PEKAQVMEQQFQQEVMMLATLKHPNIVRFIGA  201 (303)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~~~~~~~~------------~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  201 (303)
                      .++++||+|+||.||+|++ +|+.||||+++.....            ............+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3578999999999999997 7899999998643211            01112223456678999999999999998876


Q ss_pred             EEcCCeEEEEEeecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCcEEEcCCCcEEEeccCC
Q 046106          202 CRKPMVWCIVTEYAKGGSVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHRLGLIHRDLKSDNLLIFSDKSIKIADFGV  281 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~giiHrDlkp~NILv~~~~~vKl~DFGl  281 (303)
                      ..    .+++|||+++..+.         .++......++.|++.+|+|||++||+||||||+|||+++++ ++|+|||+
T Consensus        83 ~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~  148 (191)
T d1zara2          83 EG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ  148 (191)
T ss_dssp             ET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred             cC----CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence            42    27999999875442         234455678899999999999999999999999999998654 89999999


Q ss_pred             ceeee
Q 046106          282 ARIEV  286 (303)
Q Consensus       282 a~~~~  286 (303)
                      |+...
T Consensus       149 a~~~~  153 (191)
T d1zara2         149 SVEVG  153 (191)
T ss_dssp             CEETT
T ss_pred             cccCC
Confidence            97643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.72  E-value=2.9e-08  Score=84.25  Aligned_cols=133  Identities=16%  Similarity=0.109  Sum_probs=86.9

Q ss_pred             ecccCceEEEEEEECCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEEEEcCCeEEEEEeecCCC
Q 046106          140 FAQGAFGKLYRGTYNGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGACRKPMVWCIVTEYAKGG  218 (303)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~iv~E~~~~g  218 (303)
                      .+.++.+.||+...+++.+.+|+.........      ..+.+|..++..+. +--+.+++.++..+...++||++++|.
T Consensus        22 ~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~------~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~   95 (263)
T d1j7la_          22 TEGMSPAKVYKLVGENENLYLKMTDSRYKGTT------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV   95 (263)
T ss_dssp             SCCCSSSEEEEEECSSCEEEEEEECGGGTTST------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred             CCCCCCCcEEEEEeCCCeEEEEEcCCCcccch------hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccc
Confidence            33344578999887888888998764322111      23557777776664 434677788888888889999999987


Q ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 046106          219 SVRQFLTKRQNRSVPLKLAVKQALDVARGMAYVHR---------------------------------------------  253 (303)
Q Consensus       219 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---------------------------------------------  253 (303)
                      ++.+.....    ...   ..++.+++..+..||+                                             
T Consensus        96 ~~~~~~~~~----~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T d1j7la_          96 LCSEEYEDE----QSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             EHHHHTTTC----SCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred             ccccccccc----ccH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence            765433211    111   1122333333333331                                             


Q ss_pred             --------------CCceeCCCCCCcEEEcCCCcEEEeccCCceee
Q 046106          254 --------------LGLIHRDLKSDNLLIFSDKSIKIADFGVARIE  285 (303)
Q Consensus       254 --------------~giiHrDlkp~NILv~~~~~vKl~DFGla~~~  285 (303)
                                    ..++|+|+.|.|||+++++.+-|+||+.|...
T Consensus       169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             HHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                          12799999999999988777789999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.25  E-value=1.5e-06  Score=73.00  Aligned_cols=136  Identities=13%  Similarity=0.063  Sum_probs=81.5

Q ss_pred             ecccCc-eEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC--CCCeeeeeEEEEcCCeEEEEEeec
Q 046106          140 FAQGAF-GKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK--HPNIVRFIGACRKPMVWCIVTEYA  215 (303)
Q Consensus       140 lG~G~f-g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~~~~~iv~E~~  215 (303)
                      +..|.. +.||+... .+..+.+|........         .+..|+..++.+.  .-.+.+++.++.++...++||+++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i   88 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   88 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence            444443 57999887 4556888987654322         3456777776653  333677888888888889999999


Q ss_pred             CCCCHHH--------------HHHhcC-----CCC--CCHHHHHHHHH--------------------HHHHHHHHHHhC
Q 046106          216 KGGSVRQ--------------FLTKRQ-----NRS--VPLKLAVKQAL--------------------DVARGMAYVHRL  254 (303)
Q Consensus       216 ~~gsL~~--------------~l~~~~-----~~~--~~~~~~~~i~~--------------------qi~~~l~~LH~~  254 (303)
                      +|.++.+              .+....     ...  -.......-..                    .....+..+...
T Consensus        89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  168 (255)
T d1nd4a_          89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  168 (255)
T ss_dssp             SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence            8754321              111110     000  01111100000                    011223333322


Q ss_pred             -------CceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          255 -------GLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       255 -------giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                             .++|+|+.|.|||++++..+-|+||+.+..
T Consensus       169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                   389999999999999877788999999865

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.97  E-value=1.7e-05  Score=71.35  Aligned_cols=80  Identities=11%  Similarity=-0.017  Sum_probs=45.3

Q ss_pred             ceecccCceEEEEEEE--CCeEEEEEEeeCCCCC-hHHHHHHHHHHHHHHHHHHcCC---CCCeeeeeEEEEcCCeEEEE
Q 046106          138 DAFAQGAFGKLYRGTY--NGEEVAIKILERPEND-PEKAQVMEQQFQQEVMMLATLK---HPNIVRFIGACRKPMVWCIV  211 (303)
Q Consensus       138 ~~lG~G~fg~Vy~~~~--~~~~vAvK~~~~~~~~-~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~~iv  211 (303)
                      +.||.|....||+.+.  .++.++||.-.+.... .+.......+...|+..|+.+.   ...+++++.+...  ..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEEE
Confidence            3589999999999975  4668999975431100 0000000023345777666552   2346667665433  33689


Q ss_pred             EeecCCCC
Q 046106          212 TEYAKGGS  219 (303)
Q Consensus       212 ~E~~~~gs  219 (303)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.55  E-value=0.00012  Score=63.78  Aligned_cols=65  Identities=11%  Similarity=0.125  Sum_probs=41.2

Q ss_pred             eEEEEEEE-CCeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCCCCCe--eeeeE-----EEEcCCeEEEEEeecCC
Q 046106          146 GKLYRGTY-NGEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLKHPNI--VRFIG-----ACRKPMVWCIVTEYAKG  217 (303)
Q Consensus       146 g~Vy~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hpni--v~l~~-----~~~~~~~~~iv~E~~~~  217 (303)
                      -.||+.+. +|+.+++|+.++.....       .++..|...|..|....+  +..+.     ........+.++++++|
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~-------~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTA-------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCH-------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCH-------HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            58999987 78899999988765543       345567777666542222  11111     22334566888999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.02  E-value=0.0011  Score=58.96  Aligned_cols=74  Identities=14%  Similarity=0.223  Sum_probs=47.3

Q ss_pred             CCccccceecccCceEEEEEEEC---------CeEEEEEEeeCCCCChHHHHHHHHHHHHHHHHHHcCC-CCCeeeeeEE
Q 046106          132 RKLNMGDAFAQGAFGKLYRGTYN---------GEEVAIKILERPENDPEKAQVMEQQFQQEVMMLATLK-HPNIVRFIGA  201 (303)
Q Consensus       132 ~~~~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~  201 (303)
                      +++.+ +.|+.|-.-.+|+....         .+.|.+++.-.. ...       ....+|..+++.+. +.-.++++++
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~-------idr~~E~~i~~~ls~~gl~Pkll~~  113 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE-------SHLVAESVIFTLLSERHLGPKLYGI  113 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH-------HHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chh-------hHHHHHHHHHHHHHhCCCCCeEEEE
Confidence            33443 46777888899998863         245777776422 111       23447888888774 4444677887


Q ss_pred             EEcCCeEEEEEeecCCC
Q 046106          202 CRKPMVWCIVTEYAKGG  218 (303)
Q Consensus       202 ~~~~~~~~iv~E~~~~g  218 (303)
                      +..    .+|+||+++.
T Consensus       114 ~~~----g~I~efi~g~  126 (395)
T d1nw1a_         114 FSG----GRLEEYIPSR  126 (395)
T ss_dssp             ETT----EEEECCCCEE
T ss_pred             cCC----ceEEEEeccc
Confidence            743    5889999764

>d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine-protein kinase zap-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.94  E-value=6.4e-06  Score=62.50  Aligned_cols=97  Identities=18%  Similarity=0.254  Sum_probs=61.8

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      +|++...+|      ++..|.|+||++.     +.    .++||+|++..++.|++.....+.+   ++.+ ....+++.
T Consensus        29 ~G~FLVR~S------~~~~g~yvLSv~~-----~~----~v~H~~I~~~~~g~~~l~~~~~F~sl~~Lv~~Y~~~~~gL~   93 (130)
T d2oq1a1          29 DGLFLLRQC------LRSLGGYVLSLVH-----DV----RFHHFPIERQLNGTYAIAGGKAHCGPAELCEFYSRDPDGLP   93 (130)
T ss_dssp             TTCEEEEEC------SSSTTCEEEEEEE-----TT----EEEEEEEEECTTSCEEETTSCCBSSHHHHHHHHHHCCTTSS
T ss_pred             CceEEEEec------CCCCccEEEEEee-----CC----ceEEEEEEEcCCCceeccCCCCcCCHHHHHHHHhhCCCCCC
Confidence            599998877      4678889999986     22    7899999998888898865443443   3333 44555555


Q ss_pred             HHhcCCCCCCcCCCCC-CcceeecCCccccceecccCceEEEE
Q 046106          109 RALMDSNSPTEGLENF-DEWTIDLRKLNMGDAFAQGAFGKLYR  150 (303)
Q Consensus       109 ~~l~~~~~~~~~~~~~-~~~~i~~~~~~~~~~lG~G~fg~Vy~  150 (303)
                      ..|..|+......... ..|+      .+.+.+|+|.||.||+
T Consensus        94 ~~L~~P~~r~~~~~~~~~~~~------~~~~~~~~~~~~~~w~  130 (130)
T d2oq1a1          94 CNLRKPCNRPSGLEPQPGVFD------CLRDAMVRDYVRQTWK  130 (130)
T ss_dssp             SCCCSBCCCCTTCCCBCCHHH------HHHHHHHHHHHHHHHC
T ss_pred             ccCCccCCCCCCCCCCcchHH------HHHHHHHHhhccCccC
Confidence            5666665433221111 1111      1335688999988874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.88  E-value=0.001  Score=56.98  Aligned_cols=31  Identities=35%  Similarity=0.495  Sum_probs=27.9

Q ss_pred             CCceeCCCCCCcEEEcCCCcEEEeccCCcee
Q 046106          254 LGLIHRDLKSDNLLIFSDKSIKIADFGVARI  284 (303)
Q Consensus       254 ~giiHrDlkp~NILv~~~~~vKl~DFGla~~  284 (303)
                      .|+||+|+.++||+++.+...-|+||+.|..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            4799999999999999888889999999854

>d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Hemopoetic cell kinase Hck
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.35  E-value=0.0011  Score=47.31  Aligned_cols=73  Identities=22%  Similarity=0.247  Sum_probs=46.5

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      .|+|...+|      .+.+|.|+||+.......    ...|+||.|++..++.|++.....+.+   ++.+ ....+++.
T Consensus        24 ~G~FLVR~S------~~~~g~~~Lsv~~~~~~~----~~~v~H~~i~~~~~g~~~~~~~~~F~sl~~LV~~y~~~~~gL~   93 (103)
T d1qcfa2          24 LGSFMIRDS------ETTKGSYSLSVRDYDPRQ----GDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLC   93 (103)
T ss_dssp             TTCEEEEEC------SSSTTSEEEEEEEEETTT----EEEEEEEEEEECTTSCEESSSSSCBSSHHHHHHHHTSSCTTSS
T ss_pred             CCcEEEEcc------CCCCCCeEEEEEecCCCc----CceEEEEEEEEcCCCceeecCCcccCCHHHHHHHHhhCCCCCC
Confidence            589988877      367889999998543222    238999999999999888754433333   3333 33334444


Q ss_pred             HHhcCCC
Q 046106          109 RALMDSN  115 (303)
Q Consensus       109 ~~l~~~~  115 (303)
                      ..|..||
T Consensus        94 ~~L~~PC  100 (103)
T d1qcfa2          94 QKLSVPC  100 (103)
T ss_dssp             SCCCSBC
T ss_pred             ccCCccC
Confidence            4444444

>d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: P55 Blk protein tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=94.83  E-value=0.0021  Score=46.78  Aligned_cols=73  Identities=19%  Similarity=0.322  Sum_probs=47.2

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      .|+|...+|      .+.+|.|++|++...     .....|+||.|++..++.|++.....+.+   ++.+ ....+++.
T Consensus        35 ~G~FLVR~S------~~~~g~~~Lsv~~~~-----~~~~~v~H~~i~~~~~g~~~l~~~~~F~sl~eLV~~y~~~~~gL~  103 (114)
T d1blja_          35 AGSFLIRES------ESNKGAFSLSVKDIT-----TQGEVVKHYKIRSLDNGGYYISPRITFPTLQALVQHYSKKGDGLC  103 (114)
T ss_dssp             TTCEEBCBC------TTCSSCEEEEECBCC-----TTTCBCCCEEEEEETTTEEEEETTEEESSHHHHHHHHHHCCSSSS
T ss_pred             CceEEEecc------CCCCCCeEEEEEeec-----cCCCEEEEEEEEEcCCCCEEecCCceECCHHHHHHHHhhCCCCCC
Confidence            499998876      356788999998532     12237999999999888998875443443   3333 33344444


Q ss_pred             HHhcCCCC
Q 046106          109 RALMDSNS  116 (303)
Q Consensus       109 ~~l~~~~~  116 (303)
                      .+|..||.
T Consensus       104 ~~L~~PC~  111 (114)
T d1blja_         104 QKLTLPCV  111 (114)
T ss_dssp             SCCCCCSC
T ss_pred             ccCCccCc
Confidence            45555443

>d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: p56-lck tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.71  E-value=0.0014  Score=47.09  Aligned_cols=53  Identities=17%  Similarity=0.325  Sum_probs=38.9

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCC
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRR   95 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~   95 (303)
                      +|+|...+|      ++.+|.|+||+.......+    ..|+||.|++..++.|++.....++
T Consensus        27 ~GtFLVR~S------~~~~g~~~lsv~~~~~~~~----~~v~h~~i~~~~~~~~~~~~~~~F~   79 (105)
T d1lkka_          27 HGSFLIRES------ESTAGSFSLSVRDFDQNQG----EVVKHYKIRNLDNGGFYISPRITFP   79 (105)
T ss_dssp             TTCEEEEEC------SSSTTCEEEEEEEEETTTE----EEEEEEEEEECTTSCEESSTTSCBS
T ss_pred             CCcEEEEcc------CCCCCCEEEEEEEcccCCC----ccEEEEEEEEcCCCCEEecCCcccC
Confidence            589988776      3577889999986433332    3689999999999999886543333

>d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.53  E-value=0.0025  Score=45.28  Aligned_cols=47  Identities=19%  Similarity=0.258  Sum_probs=36.0

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccC
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNR   94 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~   94 (303)
                      .|++...+|      .+.+|.|+||++.     +    ..++|++|.+..++.|++.....+
T Consensus        25 ~G~FLvR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~l~~~~~F   71 (100)
T d1rjaa_          25 TGAFLIRVS------EKPSADYVLSVRD-----T----QAVRHYKIWRRAGGRLHLNEAVSF   71 (100)
T ss_dssp             SCCEEEEEC------SSSSSCEEEEECT-----T----SSCEEEEEEECSSSCEEEETTEEE
T ss_pred             CCeEEeecC------CCCCCCEEEEEEc-----C----CCceEEEEEECCCCCEEecCCCcc
Confidence            488888776      3567889999975     2    268999999988888988644333

>d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.31  E-value=0.0022  Score=45.98  Aligned_cols=53  Identities=15%  Similarity=0.241  Sum_probs=38.6

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCC
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRR   95 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~   95 (303)
                      .|++...+|      .+.+|.|+||++.......    ..|+||.+.+..++.|++.....++
T Consensus        28 ~G~FLVR~S------~~~~g~y~LSv~~~~~~~~----~~i~h~~i~~~~~g~~~~~~~~~F~   80 (106)
T d1o48a_          28 RGTFLVRES------ETTKGAYCLSVSDFDNAKG----LNVKHYKIRKLDSGGFYITSRTQFN   80 (106)
T ss_dssp             TTCEEEEEC------SSSTTCEEEEEEEEETTTE----EEEEEEEEEECTTSCEESSTTSEES
T ss_pred             CCcEEEEcc------cCCCCCEEEEEEecccCcc----cceEEEEEEEecCCCEEEcCCeeEC
Confidence            589998877      3578889999986432222    3689999999999998876443333

>d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Syk tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.20  E-value=0.004  Score=46.36  Aligned_cols=69  Identities=23%  Similarity=0.266  Sum_probs=47.4

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeeeccCCC---Cccc-cCChHHHH
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHSVNRRG---RVSH-ALSDDALA  108 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~~~~~~---~~~~-~~~~~~~~  108 (303)
                      .|+|...+|      ++..|.|+||++.     +    ..|+||+|.+..++.|++.....+.+   ++.+ ....+++.
T Consensus        28 dG~FLVR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~~~~g~~~i~~~~~F~sl~eLV~~Y~~~~~gl~   92 (129)
T d1a81a1          28 DGLYLLRQS------RNYLGGFALSVAH-----G----RKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLV   92 (129)
T ss_dssp             TTEEEEEEC------SSSTTCEEEEEEE-----T----TEEEEEEEEECTTSCEEETTSCCBSSHHHHHHHHTTCCTTSS
T ss_pred             CccEEEEcc------CCCCcceEEEeee-----c----ccceEEEEEEcCCCCeeecCCcccCCHHHHHHHHhhCCCCCc
Confidence            488988876      3567889999985     2    27899999998888898865443443   3443 44455555


Q ss_pred             HHhcCCCC
Q 046106          109 RALMDSNS  116 (303)
Q Consensus       109 ~~l~~~~~  116 (303)
                      ..|..|+.
T Consensus        93 ~~L~~P~~  100 (129)
T d1a81a1          93 CLLKKPFN  100 (129)
T ss_dssp             SCCCEECC
T ss_pred             ccCCCCCC
Confidence            55555543

>d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine-protein kinase zap-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.98  E-value=0.006  Score=45.04  Aligned_cols=43  Identities=14%  Similarity=0.254  Sum_probs=32.9

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +|++-..+|       ...|.|+||+..     +    ..++||+|++...+.|++...
T Consensus        52 dGtFLVR~S-------~~~g~yvLSv~~-----~----~~v~H~~I~~~~~g~~~l~~~   94 (124)
T d2oq1a2          52 DGKFLLRPR-------KEQGTYALSLIY-----G----KTVYHYLISQDKAGKYCIPEG   94 (124)
T ss_dssp             TTEEEEEEC-------SSTTEEEEEEEE-----T----TEEEEEEEEECTTSCEESTTS
T ss_pred             CceEEeEec-------CCCCCEEEEeec-----C----CceEEEEEEECCCCCEEeCCC
Confidence            488887766       236889999985     2    279999999988888887543

>d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Syk tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.38  E-value=0.012  Score=43.40  Aligned_cols=43  Identities=14%  Similarity=0.234  Sum_probs=32.8

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      +|+|...+|       ...|+|+||+..     +.    .++||.|.+..++.|.+...
T Consensus        52 ~G~FLVR~S-------~~~~~yvLSv~~-----~~----~v~H~~I~~~~~g~~~~~~~   94 (125)
T d1a81a2          52 NGKFLIRAR-------DNNGSYALCLLH-----EG----KVLHYRIDKDKTGKLSIPEG   94 (125)
T ss_dssp             TTCEEEEEC-------SSSSCEEEEEEE-----TT----EEEEEEEEECTTSCEECTTS
T ss_pred             CceEEEEec-------CCCCCEEEEeec-----cc----cceeEeeeEcCCCcEeccCC
Confidence            588888766       235789999986     22    68999999988888877543

>d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine kinase Fyn
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.28  E-value=0.058  Score=37.91  Aligned_cols=49  Identities=18%  Similarity=0.286  Sum_probs=37.6

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      .|++...+|      .+.+|.|+||++......+    ..|+|+.|.+..++.|.+...
T Consensus        29 ~G~FLVR~S------~~~~g~~~Lsv~~~~~~~~----~~v~h~~i~~~~~g~~~~~~~   77 (104)
T d1g83a2          29 RGTFLIRES------ETTKGAYSLSIRDWDDMKG----DHVKHYKIRKLDNGGYYITTR   77 (104)
T ss_dssp             TTCEEEEEC------SSSTTCEEEEEEEECSSSC----EEEEEEEEEECTTSCEEETTT
T ss_pred             CCcEEEecc------CCCCCCeEEEEEEeecCcC----CeEEEEEEEEcCCCCEEecCC
Confidence            589988877      3678899999987554333    379999999988888877543

>d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Csk homologous kinase Chk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.86  E-value=0.011  Score=41.44  Aligned_cols=45  Identities=16%  Similarity=0.240  Sum_probs=32.6

Q ss_pred             hcCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           31 LGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      -.+|++...+|      ++.+|.|+||+..     +    ..++||+|++. ++.|++...
T Consensus        23 ~~~G~FLVR~S------~~~~g~~vLSv~~-----~----~~v~H~~I~~~-~~~~~~~~~   67 (97)
T d1jwoa_          23 PEDGLFLVRES------ARHPGDYVLCVSF-----G----RDVIHYRVLHR-DGHLTIDEA   67 (97)
T ss_dssp             CCTTCEEEEEC------SSSTTCEEEEEEE-----T----TEEEEEEEEES-SSEESSTTS
T ss_pred             CCCCeEEEEec------CCCCccEEEEEEe-----c----CceEEEEEEEc-CCcEEecCC
Confidence            34688988776      3577899999986     2    26899999764 456766543

>d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.54  E-value=0.014  Score=41.17  Aligned_cols=44  Identities=16%  Similarity=0.208  Sum_probs=32.1

Q ss_pred             cCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeeee
Q 046106           32 GEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAHS   91 (303)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~~   91 (303)
                      .+|++...+|      ++.+|.|+||++.     +    ..++||+|... +++|++...
T Consensus        24 ~~G~FLVR~S------~~~~g~y~LSv~~-----~----~~v~H~~I~~~-~~~~~~~~~   67 (101)
T d1k9aa2          24 ETGLFLVRES------TNYPGDYTLCVSC-----E----GKVEHYRIMYH-ASKLSIDEE   67 (101)
T ss_dssp             CTTEEEEEEC------SSSTTSEEEEEEC-----S----SSEEEEEEEEE-TTEEESSSS
T ss_pred             CCCCEEEecc------CCCCCCEEEEEEe-----C----CccEEEEEEEc-CCCceecCC
Confidence            4688888766      4567889999985     2    26899999875 456766543

>d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Ews/fli1 activated transcript 2, Eat2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=88.16  E-value=0.17  Score=35.31  Aligned_cols=42  Identities=17%  Similarity=0.302  Sum_probs=33.2

Q ss_pred             CcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           34 GTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        34 ~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      |++...+|      ++.+|.|+||++.     +    ..|+||+|.+..++.|.+..
T Consensus        26 G~FLVR~S------~~~~g~~~LSv~~-----~----~~v~H~~I~~~~~g~~~~~~   67 (103)
T d1i3za_          26 GNFLIRDS------ESVPGALCLCVSF-----K----KLVYSYRIFREKHGYYRIET   67 (103)
T ss_dssp             TEEEEEEC------SSSTTCEEEEEEC-----S----SSEEEEEEEECTTSCEEECB
T ss_pred             CeEEEEec------CCCCCCEEEEEEe-----C----CeEEEEEeEEcCCCcEEEec
Confidence            88888776      3567889999985     2    27899999988888887753

>d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Growth factor receptor-bound protein 2 (GRB2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.04  E-value=0.31  Score=33.51  Aligned_cols=43  Identities=19%  Similarity=0.258  Sum_probs=32.7

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      .|++...+|      .+.+|.|+||++.     +.    .++||+|.+..++.|.+..
T Consensus        25 ~G~FLvR~S------~~~~g~~~LSv~~-----~~----~v~H~~I~~~~~g~~~~~~   67 (96)
T d1jyra_          25 DGAFLIRES------ESAPGDFSLSVKF-----GN----DVQHFKVLRDGAGKYFLWV   67 (96)
T ss_dssp             TTBEEEEEC------SSSTTCEEEEEEE-----TT----EEEEEECEECTTSCEESSS
T ss_pred             CCeEEEEec------CCCCCCEEEEEEe-----CC----ceEEEEEEECCCCeEEeCC
Confidence            488888776      3567889999986     22    7899999988777776543

>d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Abl tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=83.66  E-value=0.37  Score=33.28  Aligned_cols=47  Identities=13%  Similarity=0.152  Sum_probs=34.9

Q ss_pred             HHhcCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeeee
Q 046106           29 HKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVAH   90 (303)
Q Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~~   90 (303)
                      +.-.+|++-..+|      .+.+|.|+||++..         ..++||+|.+..++.|.+..
T Consensus        22 ~~~~~G~FLVR~S------~~~~~~~~LSv~~~---------~~v~H~~I~~~~~g~~~~~~   68 (101)
T d1opka2          22 SSGINGSFLVRES------ESSPGQRSISLRYE---------GRVYHYRINTASDGKLYVSS   68 (101)
T ss_dssp             GGCCTTEEEEEEC------SSSTTCEEEEEEET---------TEEEEEECEECTTSCEESST
T ss_pred             cCCCCCeEEEEec------CCCCCCEEEEEEcC---------cceEEEEeEECCCCCEEeCC
Confidence            3335788877766      35678899999862         27899999998888877653

>d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: GRB2-related adaptor protein 2 (MONA, GRID)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=83.35  E-value=0.56  Score=32.14  Aligned_cols=47  Identities=19%  Similarity=0.209  Sum_probs=34.7

Q ss_pred             HHHhcCCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCCeeee
Q 046106           28 YHKLGEGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDNYSVA   89 (303)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~~~i~   89 (303)
                      ++--..|++...+|      .+.+|.|+||++.     ..    .++||.|.+..++.|.+.
T Consensus        22 L~~~~~G~FLVR~S------~~~~g~~~LSv~~-----~~----~v~H~~I~~~~~g~~~~~   68 (97)
T d1r1qa_          22 LMGKDIGFFIIRAS------QSSPGDFSISVRH-----ED----DVQHFKVMRDTKGNYFLW   68 (97)
T ss_dssp             HHTSCTTCEEEEEC------SSSTTCEEEEEEC-----SS----SEEEEECEECTTCCEESS
T ss_pred             HhcCCCCCEEEeec------CCCCCCEEEEEEe-----cC----CeEEEEEEEcCCCeEEeC
Confidence            33335788888776      3567889999985     22    689999999888777654

>d2al6a2 b.55.1.5 (A:254-363) Focal adhesion kinase 1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: All beta proteins
fold: PH domain-like barrel
superfamily: PH domain-like
family: Third domain of FERM
domain: Focal adhesion kinase 1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=82.59  E-value=0.13  Score=36.54  Aligned_cols=35  Identities=20%  Similarity=0.275  Sum_probs=27.3

Q ss_pred             CCCCCCceeeecc--CCcccccccchHHHHHhcCCcc
Q 046106            2 EGGSKFPGIIGLN--NHVNNYDDLSQGFYHKLGEGTN   36 (303)
Q Consensus         2 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~   36 (303)
                      +.|+..|..+-.+  +.+.+++||.+||||.++....
T Consensus        67 i~ga~epL~it~~s~~~Ae~lAdLIdGYCrL~~~~~~  103 (110)
T d2al6a2          67 IAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQ  103 (110)
T ss_dssp             ETTCSSCEEEEESSHHHHHHHHHHHHHHHHHHHTCSS
T ss_pred             EcCCCCCeEEEcCCHHHHHHHHHHhhheEEEeeCCCc
Confidence            3577778777665  5588999999999999996543

>d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Itk/tsk protein tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=81.76  E-value=0.57  Score=32.75  Aligned_cols=43  Identities=23%  Similarity=0.304  Sum_probs=30.4

Q ss_pred             CCcccccccccceecccCCCeEEEEEeecCCCCCCcCccccccccccccCCCC
Q 046106           33 EGTNMSIDSFSSLQTSNGGGSVAMSVDNSSVGSNESHTRILNHQGLRRRANDN   85 (303)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~~g~~~~s~~~~~~~~~~~~~~~v~h~~i~~~~~~~   85 (303)
                      +|++...+|       ..+|.|+||++.......   ...++||+|....++.
T Consensus        28 ~G~FLVR~S-------~~~g~y~LSv~~~~~~~~---~~~i~h~~I~~~~~~~   70 (108)
T d1luia_          28 EGAFMVRDS-------RTPGTYTVSVFTKAIISE---NPCIKHYHIKETNDSP   70 (108)
T ss_dssp             TTEEEEEEC-------CTTTCEEEEEECSCCTTT---CSCEEEEECEECCCSS
T ss_pred             CCeEEEEec-------CCCCCEEEEEEecCCccc---CCceeEEEEEEecCCC
Confidence            499998876       246789999986443222   2479999998876553